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MRI: FROM GROSS ANATOMY TO THE CONSTITUENTS OF
CARTILAGE
D. Burstein
Harvard Institute of Medicine, Boston, MA, United States
Magnetic resonance imaging (MRI) has the potential to non-
invasively obtain morphologic and biochemical metrics of cartilage
disease. Since cartilage can be visualized directly by MRI, the
cartilage can be segmented from surrounding tissues and repre-
sented in three dimensions, from which local and global indices of
cartilage thickness and volume can be obtained. Although only
available over the past several years, important observations are
already emerging regarding the rate of cartilage loss in different
compartments in osteoarthritis; this localized information may aid in
the understanding of the mechanisms of disease progression as
well as provide a sensitive indicator of cartilage loss over time.
There is relatively little known regarding the temporal changes in
cartilage constituents during the evolution of arthritic disease
in vivo. Two major constituents of cartilage are collagen and
glycosaminoglycans (GAG). It is generally thought that collagen is
damaged and GAG is lost before there is frank loss of cartilage
tissue. MRI has the potential to visualize these events non-
invasively. The MRI parameter T2 has been demonstrated to be
sensitive to slight changes in collagen concentration (tissue
hydration). Collagen molecular structure also may impact T2, as
well as overall collagen architecture (alignment of the collagen
ﬁbrils relative to the main magnetic ﬁeld). In addition, other cartilage
macromolecules have some (lesser) impact on T2. Therefore while
T2 may not be speciﬁc, it may provide a sensitive indication of
pathologic changes in cartilage. Ongoing studies in several groups
are investigating T2 changes with age, gender, and level of
osteoarthritis. With further development of complementary MRI
metrics, differentiation of T2 changes due to collagen concentra-
tion, molecular, or architectural structure might be possible.
The GAG component can be assessed with an MRI technique
referred to as dGEMRIC (delayed Gadolinium Enhanced MRI of
Cartilage). The approach is based on the premise that if the MRI
contrast agent Gd(DTPA)2 (Magnevist; Berlex, NJ) is given time to
penetrate into cartilage, it will distribute in higher concentration in
areas of cartilage in which the negatively charged GAG content is
relatively low, and will be lower in concentration in regions rich in
the negatively charged GAG. Since the Gd(DTPA)2 inversely
affects the MRI parameter T1, T1 measured after full penetration of
contrast (T1Gd) is used as a dGEMRIC index.
An advantage of interrogating the biochemical aspects of cartilage
in intact tissue is that one might be able to observe cartilage repair
as well as cartilage degeneration. dGEMRIC has been used to
explore the repair process of cartilage in culture studies after trypsin
and interleukin-1 cartilage degradation. Increases in the dGEMRIC
index have also been observed in several case studies clinically
with patients recovering from surgery and taking nutritional
supplements, and in cartilage implants. Additional studies have
demonstrated an improvement in the dGEMRIC index with an
exercise intervention study. Data are also emerging as to the
characteristics of dGEMRIC distribution in patients with osteoar-
thritis, and how the biochemical indices correspond to the
morphologic and radiographic indices. The potential for dGEMRIC
to be used as a predictor of the success of surgical interventions
has also recently been demonstrated.
MRI has advantages as a metric for understanding and monitoring
osteoarthritis in that it has the potential to provide information
regarding the structural and molecular state of cartilage. With longer-
termmonitoring we stand to gain enormous insights into the temporalSand spatial evolution of cartilage degeneration and into the factors
that modulate this degeneration, as well as regression of disease.
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KNEE CARTILAGE VOLUME WITH FLUCTUATING
EQUILIBRIUM MRI
G. E. Goldy, B. A. Hargreavesz, S. S. Vasanawalay, J. Webby,
A. Shimakawax, J. H. Brittainx, J. M. Paulyz, C. F. Beaulieuy
y Department of Radiology, Stanford University, Stanford, CA, USA
z Department of Electrical Engineering, Stanford University, Stan-
ford, CA, USA
x Applied Sciences Laboratory West, General Electric Medical
Systems, Menlo Park, CA, USA
Aim: We compared Fluctuating Equilibrium MR (FEMR), a rapid,
three-dimensional steady-state sequence with high SNR and lipid
suppression, to spoiled gradient-recalled echo imaging (SPGR) for
measurement of cartilage volume.
Methods and materials: We compared FEMR with spoiled gradient-
recalled echo (3D-SPGR) in 10 healthy volunteers and a phantom
of known cartilage volume. Imaging was approved by the local
institutional review board and was done on a GE 1.5 T whole body
scanner with CV/I gradients (GE Medical Systems, Milwaukee, WI)
and a standard extremity coil. Linear magnetic ﬁeld shimming
preceded all scans. Parameters for FEMR were 512! 256, 16 cm
FOV, 2.0 mm slice thickness, TR/TE 6.6/1.2 ms, ﬂip angle of 25(,
and an imaging time of 2:43. 3D-SPGR was performed with 512!
256, 16 cm FOV, 2 mm slice thickness, TR/TE of 50/5 ms, ﬂip angle
of 40(, fat suppression, and an imaging time of 8:56. Signal-to-
noise (SNR) efﬁciency was compared. One trained observer
segmented the cartilage in all cases and the volume of cartilage
on each surface (patella, femur, and tibia) was compared.
Results: SNR efﬁciency for cartilage using FEMR was 1.5
compared with 0.9 for 3D-SPGR. For synovial ﬂuid, SNR efﬁciency
for FEMR was 4.5, compared with only 0.5 for 3D-SPGR. Cartilage
volume in the phantom showed less than 2% difference. Volume
measurements in the normal volunteers were similar with FMER
and 3D-SPGR, with less than 5% difference on average on each
surface. Measurement of tibial cartilage volume showed the most
variation. Some effects of magnetic ﬁeld inhomogeneity were
visible on the high-resolution FEMR images, but these improved
after localized automatic shimming was applied.
Conclusions: FEMR is a promising method for high-resolution
imaging of articular cartilage in the knee. FEMR requires good
magnetic ﬁeld homogeneity to avoid banding artifacts, and image
quality improves with application of localized shimming techniques.
FEMR can image an entire knee at high resolution in less than 3
min, making it more practical for incorporation into osteoarthritis
research imaging protocols than 3D-SPGR.
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CARTILAGE VOLUME QUANTIFICATION WITH 3 T MRI:
COMPARISON OF 3D-DESS WITH 3D-FLASH IMAGING
SEQUENCES
C. G. Peterfyy, E. Schneiderz, D. Whitey, A. Guermaziy, J. Zhaoy,
M. Kothariy, Y. Miauxy, J. Yux, H. K. Genantyjj, R. Jacksonx,
M. Nevittjj
y Synarc, Inc., San Francisco, CA, USA
z SciTrials, LLC, Westwood, MA, USA
x Ohio State University, Columbus, OH, USA
jj University of California San Francisco, San Francisco, CA, USA1
S2Aim: Articular cartilage volume measurements using MRI have
become an important measure in clinical trials and epidemiological
studies of osteoarthritis (OA) of the knee. Various methods for
quantifying cartilage have been validated by numerous investiga-
tors over the years. These measurements are typically made using
images acquired at 1.5 Tesla (T) with fat-suppressed, single-echo,
T1-weighted spoiled gradient echo imaging sequences (FLASH or
SPGR). Optimal sequences for cartilage volume measurements
using images acquired at 3.0 T remain to be determined. Because
of the shorter T2* and longer T1 values at 3.0 T, T2*-weighted
DESS (dual echo in the steady state) acquisitions at 3.0 T offer the
potential advantages of a broader range of tissue contrast and
better delineation of cartilage–ﬂuid interfaces, and may reveal
structural features within the cartilage itself. Additionally, the higher
contrast per unit time provided by DESS may allow favorable
tradeoffs between increased signal-to-noise ratio and spatial
resolution. The purpose of this study was to compare the
performance of 3D-DESS to that of 3D FLASH at 3 T for cartilage
volume measurements.
Methods: As part of a pilot study for the NIH Osteoarthritis Initiative,
a large longitudinal epidemiological study of knee OA, 9 knees of 9
adult volunteers (4 men, 5 women; median age 56 years, range 40–
71 years) were each imaged two separate times within 2 days using
both double oblique coronal 3D-FLASH with water excitation (TR/
TE/Flip 20/7.57/12; NEX 1; BW 130 Hz/pixel; matrix 512 ! 512;
FOV 160 mm ! 160 mm; 80 1.5 mm slices; acquisition time 8.6
min) and oblique sagittal 3D-DESS with water excitation (TR/TE/
Flip 16.3/4.7/25; NEX 1; BW 185 Hz/pixel; matrix 384! 307; FOV
140 mm! 140 mm; 160 0.7 mm slices; acquisition time 10.6 min)
sequences with a 3 T MRI scanner (Seimens Trio) and a circularly
polarized transmit/receive extremity coil (USA Instruments). For
comparison with the primary coronal 3D-FLASH images (0.313 mm
! 0.313 mm ! 1.5 mm voxels), the primary sagittal 3D-DESS
images were reformatted to the double oblique coronal plane
(0.365 mm! 0.7 mm! 1.5 mm voxels). The medial tibial cartilage
was manually segmented in all 18 test–retest pairs of coronal
image sets using a bounded-region-growing tool (‘‘EndPoint’’,
Imorphics, Inc) by a single reader experienced in cartilage
segmentation.
Results: 3D-FLASH images generated a mean medial tibial
cartilage volume of 2042 mm3 (range 1397–3295 mm3). The
corresponding volume determined using 3D-DESS was 2124 mm3
(range 1451–3295 mm3). The mean pairwise difference was 82
mm3 [95% CI: 0–164 mm3]. The root-mean-squared coefﬁcient of
variation for test–retest volume was 3.2% for 3D-FLASH and 2.2%
for 3D-DESS.
Conclusions: Medial tibial cartilage volumes derived from segmen-
tation of reformatted 3D-DESS images acquired at 3 T were similar
in magnitude and test–retest precision to those derived from
corresponding coronal 3D-FLASH images.
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CARTILAGE VOLUME MUST BE NORMALIZED TO BONE
SURFACE AREA IN ORDER TO PROVIDE SATISFACTORY
CONSTRUCT VALIDITY: THE FRAMINGHAM STUDY
D. J. Huntery, J. Niuy, Y. Q. Zhangy, C. McLennany, M. LaValleyy,
X. Tuy, M. Hudelmaierz, F. Ecksteinz, D. T. Felsony
y Clinical Epidemiology and Research Training Unit, Boston
University School of Medicine, Boston, MA, USA
z Musculoskeletal Research Group, Ludwig-Maximilians-Universi-
ta¨t Mu¨nchen, Munich, Germany
While cartilage can now be quantitatively measured using MRI,
many studies have been conﬁned to measuring cartilage volume
alone. However, different measurements including volume normal-
ized to bone surface areas and thickness can be derived, but it is
unclear which of these parameters is most valid. Direct measures of
cartilage thickness or cartilage volume normalized to bone surface
interface area may overcome this potential concern of metaphyseal
enlargement with age. In the current descriptive study we
addressed the following questions: How well do different measuresof cartilage morphology discriminate between subjects with and
without evidence of radiographic osteoarthritis, and change with
age?
Materials and methods: Participants from the Framingham OA
Study Cohort, a population based study of elderly subjects recruited
from the community, had MRIs of the knee performed (2002–2004).
The bone and cartilage morphology of the patella, medial femur,
lateral femur, medial tibia and the lateral tibia were quantiﬁed, using
coronal and axial 3D FLASH-water excitation sequences acquired
on a 1.5 T MRI (resolution 1.5 mm! 0.3 mm! 0.3 mm) and digital
image analysis, involving three-dimensional reconstruction. We
conducted gender speciﬁc analyses to explore the mean and
variability of total cartilage volume, total cartilage volume normal-
ized to total bone interface area (TvolBi Z denuded C
cartilaginous interface), total mean cartilage thickness
(ToThMea Z total mean thickness, including denuded cartilage
areas), and ToBiCrP% (total bone interface area, covered with
cartilage, percent) in deciles from 50–59, 60–69, and 70–79. We
tested different cartilage parameters for construct validity which we
deﬁned as (1) lower cartilage measures in those with OA (deﬁned
as knee showing K/L grade R 2 on PA ﬁxed ﬂexion knee
radiograph) and (2) decrease in measures with age (this analysis
was conﬁned to those with K/L grade !2).
Results: The mean age of the 275 study participants was 66.3 G
9.2 years, 62% were women. Twenty-six percent of participants
had a K&L grade P2 (38 women and 28 men had knee OA). With
increasing age there was a decline in TVolBi, ToThMea and
ToBiCrP%. For the various cartilage plates total cartilage volume
either remained constant or increased with age. Cartilage volume
did not discriminate between participants with and without knee OA,
in fact for some cartilage plates the total volume increased. In
contrast TVolBi, ToThMea, and ToBiCrP% discriminated between
participants with and without tibiofemoral OA and patellofemoral
OA.
Conclusion: The results provide a normative range of cartilage
parameters in the knee joints of elders. We have demonstrated that
measures of cartilage thickness or cartilage volume normalized to
bone surface interface area have better construct validity than
cartilage volume through its ability to distinguish participants with
and without knee OA and that they consistently decline with age.
We would discourage use of total cartilage volume as a stand-alone
variable unless this is normalized to bone surface interface area.
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HIGH RESOLUTION DIFFUSION TENSOR IMAGING OF ARTIC-
ULAR CARTILAGE: FEASIBILITY AND INITIAL RESULTS
C. Glasery, L. Filidoroy, O. Dietrichy, T. Oertherz, M. Reisery
y Clinical Radiology, Ludwig Maximilians University, Munich,
Germany
z Bruker BioSpin GmbH, Rheinstetten, Germany
Purpose: To assess the applicability of diffusion tensor MR Imaging
(DTI) on articular cartilage. To analyse cartilage’s zonal anisotropy.
Material and methods: Cylindrical human patellar cartilage-on-bone
samples were imaged at 9.4 T using a diffusion-w SE sequence
(b Z 1000 s/mm2, 12 gradient directions, resolution: 39 ! 78 !
1500 mm3). Voxel-based maps of mean diffusivity, fractional
anisotropy and eigenvectors were calculated.
Results: Mean diffusivity decreased from the surface (1.28! 103
G 0.14 mm2/s) to the tide mark (0.74 ! 103 G 0.19 mm2/s).
Fractional anisotropy was low (0.05G 0.02–0.28G 0.09) and had
local maxima in the lower third of cartilage. The eigenvector
corresponding to the largest eigenvalue showed a distinct zonal
pattern being oriented tangentially in the upper 10–30% and radially
in the lower 40–60% of cartilage.
Conclusion: High ﬁeld strength DTI appears applicable on structural
analysis of articular cartilage. The ﬁndings correspond to current
Scanning-Electron-Microscopy data on zonal architecture of
cartilage. The eigenvector maps seem to reﬂect the alignment of
the collagenous ﬁbres as important structure giving component
essential to the long term integrity of the cartilage matrix. In view of
S3current efforts to evaluate structure modifying therapeutic ap-
proaches, DTI may offer a tool for detection and follow-up of early
cartilage damage in osteoarthritis.
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WHAT MAKES A RHEUMATOLOGIST RUN? ACHES AND
PAINS OF A NEWBORN MEDICAL SCIENTIFIC SOCIETY
C. Jo’’l Menkes
St. Jacques, Paris, France
According to United Nations, the people over age 60 who now
make up 10% of the world population will account for 38% in the
coming years. Osteoarthritis (OA) is a chronic and disabling
condition with an age related prevalence and ensuring the quality
of life of such a wide number of elderly people is a main challenge
for the future.
In contrast with this major worldwide health problem, osteoarthritis
is still a poorly understood disease by patients, media and health
authorities. It justiﬁed the creation of a new clinical and scientiﬁc
society dedicated to this peculiar disease.
At the beginning, in the 1990s, the new society, OARS, was well
accepted by most leaders of the research in the ﬁeld of OA but its
acceptance by the international and regional organizations of
rheumatology was more difﬁcult to obtain.
Friendship and good relation is a major determinant of progress in
most human activities and particularly in science. This applied to
our new Society who ﬁnally was accepted as a member of ILAR,
meaning an ofﬁcial and international recognition.
To day, with the in-put and efforts of devoted physicians and
scientists, the help of the pharmaceutical industry, OARS has
developed as a leading international society (OARSI) represented
by an outstanding journal, Osteoarthritis and Cartilage.
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HOW TO SURVIVE 50 YEARS OF RHEUMATOLOGY?
M. Lequesne
Paris, France
To make a long story short, let us divide my studies into two
categories: tools for measuring osteoarthritis (OA) and studies
devoted to the OA of the hip and other hip disorders.
I—Tools for assessing and measuring OA: (1) The algofunctional
index for the hip OA was established and validated in 1980. It is
largely used in and out of Europe (it has been translated into
Spanish, German, Italian, etc.) as an assessment tool for pain,
discomfort and disability in randomized controlled trials (RCT). It
also serves for deciding upon the timing of total hip arthroplasty
when it reaches 12G 2 points despite a relevant medical treatment
(threshold validated in 2002). (2) The algofunctional index for knee
OA was published in 1987, 1 year before the WOMAC and is also
widely used in RCT. (3) Measurement of the joint space in hip and
knee OA on plain radiographs was proposed at the ILAR meeting in
Rio (1989) and developed in the book ‘‘OA Disorders’’ (AAOSS
1995) and at the OARSI meeting in Vienna (1999). This manual
method applied to hip and knee OA using caliper and/or lens (1/10
mm graduated) yielded a reproducibility at 0.5 mm (standard error)
and appeared as more reliable than the current automated digitized
technique in two studies in France and USA (ECHODIAH study,
2001; Mazzuca-Brandt, 2003–2004). (4) Measurement of the hip
and knee developmental dysmorphias. Measurement of the hip and
knee developmental dysmorphias arthrometer, a combination of
protractors and millimetric rulers on a transparent material to be
applied on plain and reduced (up to 50%) X-ray of the hip, knee and
foot. It is used in France, Italy, Spain, Portugal etc. II—Studies on
OA of the hip and other hip disorders: In 1954, I wrote my Ph.D.
thesis on OA of the hip (a prospective study with 200 patients) and I
showed that osteophytosis is the earliest and the most frequent
radiological sign; it appears before the clear joint space narrowing(JSN) in 1/3 of the patients. Unlike in many countries, in France
rheumatologists are responsible for the management of OA of
a given joint—and other monoarthropathies—years and years
before orthopedic surgeons. This provides many possibilities for
clinical research. I jumped upon the opportunities to conduct
research on the hip joint. I am still working on this joint. My main
contribution in the 1960s was the false profile view of the hip, a new
radiological view that I again studied in 1998 with J.-D. Laredo. This
view shows the JSN in 70% of the incipient OA hips which involve
no or doubtful JSN on the coronal view. On the latter, to assert JSN
necessitates a ﬁne knowledge of the normal hip JS width on X-ray.
With this aim in mind, we conducted a study of 223 controls
(accepted in ARD, 2004); it appears that the normal JS is thicker in
its superolateral and apical part than in its superomedial site. In
1970, we brought to light the rapidly destructive OA of the hip
(RDOAH) characterized by a JSN of at least 2 mm per year (1 to 2
mm in the ‘‘half rapid ‘‘form), and this without chondrocalcinosis
(another condition involving often rapid chondrolysis). We partici-
pated in the ECHODIAH study with more than 500 hip OA patients
(Arthritis & Rh, 2001) among whom we found 9% of RDOAH.
Moreover, this study showed all the intermediate annual pro-
gression rates of JSN between this severe form and the common
slow hip OA, indicating that RDOAH is a part of the spectrum of OA
of the hip. We described a similar rapid form involving the knee and
the shoulder and I chose as a topic ‘‘destructive osteoarthropa-
thies’’ in general for the EULAR symposium—in which I served as
president—in Paris in 1998.
In addition to OA, I was interested in other diseases of the hip joint.
In 1968, I published the ﬁrst description of the primary transient
osteoporosis of the hip, showing with 10 patients that this syndrome
is a hip algodystrophy. Later, in a study of 100 patients with this
condition, we found that hip algodystrophy occurs without any
precipitating factor in two thirds of the patients. It is self-limited and
resolves within 3 to 6 months. We gave also—in 1977—the ﬁrst
description of a new form: the partial transient osteoporosis, which
blurs the bone structure of only either one condyle of the knee or
one quadrant of the femoral head, a radiological aspect easily
mistaken for malignancy.
We found in our series of synovial chondromatosis of the hip two
features hitherto not described: a capsular constriction (one third of
our 30 patients) and a curious clear thickening of the joint space
(one quarter of our patients). My present research involves
trochanteric tendinitis and bursitis. We found a new clinical sign
very suggestive of these conditions, which sometimes involve
a tear of the tendon. The validation of this sign is in process. I am
greatly grateful to all my coworkers who helped me to publish more
than 450 papers and 6 books and to my colleagues and friends,
European and American, especially the OARSI ofﬁcers, whose
encouragements and regards helped me to survive 50 years on
rheumatological clinical research.
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THE OSTEOARTHRITIS INITATIVE: A REPORT FROM THE
NATIONAL INSTITUTES OF HEALTH
G. E. Lester
National Institute of Arthritis and Musculoskeletal and Skin Diseases,
National Institutes of Health, Bethesda, MD, United States
Scientiﬁc and clinical experts in the ﬁeld of osteoarthritis perceive
that the lack of discreet indicators of disease progression that are
acceptable as clinical endpoints is a major obstacle to the ability to
diagnose, monitor, and treat this degenerative joint disease. The
objective of the Osteoarthritis Initiative (OAI) is to pool public and
private scientiﬁc expertise and funding to collect, analyze, and
make widely available the largest research resource to date of OA
patient data, imaging data, and biospecimens. The goal is to create
a public resource to validate prospective biomarkers, obtain early-
stage input from the FDA (US Food and Drug Administration) as to
acceptability of biomarkers as clinical endpoints, and ensure that
validated biomarkers are as widely available as possible to further
product development and the public health.
S4The OAI is coordinated by the National Institute on Aging (NIA) and
the National Institute on Arthritis and Musculoskeletal and Skin
Diseases (NIAMS). It originated from discussions exploring ways
that the public and private research organizations could work
together to improve the efﬁciency of drug development and clinical
trials. Among the suggestions was the creation of clinical research
resources such as well-deﬁned natural history population cohorts,
and biospecimen and bioimaging repositories to facilitate the
discovery and evaluation of biomarkers.
The result is the initiation of a longitudinal study of approximately
5000 subjects over 5 years through the award of NIH peer-reviewed
contracts. The OAI will rely on the following centers and their
principal investigators: University of Maryland School of Medicine,
Baltimore; Marc Hochberg, M.D., M.P.H.; The Ohio State Univer-
sity, Columbus; Rebecca Jackson, M.D.; University of Pittsburgh;
C. Kent Kwoh, M.D.; Memorial Hospital of Rhode Island, Pawtuck-
et; Charles Eaton, M.D.; University of California, San Francisco
(data coordinating center); Michael Nevitt, Ph.D. A Steering
Committee advises on the scientiﬁc aspects of the study. The
FDA participates as a liaison to the Steering Committee. Funding
for the OAI is contributed by Pﬁzer, Merck, and Novartis from the
private sector and NIAMS and NIA, the National Center for
Complementary and Alternative Medicine (NCCAM), the National
Center on Minority Health and Health Disparities (NCMHD), the
National Institute of Dental and Craniofacial Research (NIDCR),
the NIH Ofﬁce of Research on Women’s Health (ORWH) from NIH.
The study protocol has been developed and enrollment was begun
in spring 2004.
The NIH partners have determined that widespread availability of
validated biomarkers and other research tools arising from use of
the OAI resource is necessary to maximize the public health
beneﬁt. Thus, renewable resources arising from the OAI, such as
clinical data and imaging data, will be made available to the public.
For OAI resources that are limited, such as the biospecimens,
priority will be given to validation of biomarkers that, in addition to
demonstrating scientiﬁc merit, will be widely available for use in
accordance with the NIH principles and guidelines.
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DESIGN AND RATIONALE OF THE OSTEOARHTRITIS
INITIATIVE
M. C. Nevitty, D. T. Felsonz, G. E. Lesterx
y University of California, San Francisco, San Francisco, CA,
United States
z Boston University, Boston, MA, United States
x National Institute of Arthritis and Musculoskeletal and Skin
Diseases, United States
The need for validated biomarkers of osteoarthritis (OA) is well-
recognized, and this is reﬂected in a number of projects organized
speciﬁcally to develop and test promising candidate biomarkers for
OA. One such project is the Osteoarthritis Initiative (OAI), a large
multi-center cohort study focusing on imaging, biochemical and
genetic markers for knee OA. The OAI is funded by NIAMS and
a consortium of pharmaceutical company partners. The design of
the OAI responds to a variety of epidemiological and methodolog-
ical issues and challenges in the evaluation of OA biomarkers.
There are many potential uses for biomarkers and a diverse
spectrum of potential candidates to meet these needs. Candidate
biomarkers range from biochemical/molecular markers that reﬂect
turnover and degeneration of matrix components of joint tissue,
molecular markers reﬂecting factors that inﬂuence these processes
(e.g., cytokines), imaging markers that reﬂect the outcome of
pathologic processes on joint tissue morphology (e.g., MRI
cartilage volume), imaging markers that reﬂect changes in tissue
composition (e.g., MRI T2 relaxation), and susceptibility markers
that reﬂect the risk of onset and progression of disease (e.g.,
genetic markers). Clinical validation studies are a key component of
the biomarker development enterprise. The most valuable clinical
validation studies are longitudinal cohort investigations of well-
deﬁned groups of patients with OA, with measurements of jointsymptoms and disability, joint imaging, body ﬂuid specimens for
molecular marker measurement and risk factors, all assessed at
multiple time points. Several such studies focusing on persons with
established OA are already yielding useful insights into biomarkers
for assessing and predicting progression of the disease, and these
ﬁndings should help speed the development of new treatments for
OA. The OAI also includes a major component focusing on disease
progression in persons who already have knee OA. In addition,
developing biomarkers useful in prevention and in treatment of very
early disease will require epidemiological validation studies in
subjects who do not have OA, but are at risk of developing it. This
requires a different study design and larger numbers of subjects
than studies of OA progression. Since the most important outcome
from a prevention standpoint is the onset of clinically signiﬁcant
disease, the OAI needs to be large enough and long enough to
detect sufﬁcient numbers of new cases of clinical disease in
addition to large numbers of new cases of structural change in the
joint. The OAI cohort is enriched with subjects who have an
increased risk of developing a variety of OA outcomes to ensure
sufﬁcient power for the clinical validation of a complete range of
biomarkers, including those that predict the onset of OA pathology
and symptoms, those that identify the presence of early disease,
and those that predict in whom, and at what rate, early changes
develop into full blown clinical disease. The development of valid
biomarkers that identify persons at increased risk of OA onset, or
that provide more sensitive measures of early disease than current
X-ray methods, will greatly facilitate studies of the early pathogen-
esis of OA in human populations and speed the development of
preventive measures and treatments for early OA.
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THE USE OF GENE ARRAYS IN OA RESEARCH
T. A. Aigner
Department of Pathology, Osteoarticular and Arthritis Research,
University of Erlangen-Nu¨rnberg, Erlangen, Germany
Large scale gene expression analysis and functional genomics is
a challenging new way to address a complex disease like
osteoarthritis on a molecular level. Abundant data are easily
generated. The major challenge of modern large scale (functional)
genomics, in the ﬁeld of osteoarthritis research as elsewhere, is,
however, how to channel abundantly revealed ‘‘data’’ into useful
‘‘information’’ on genes and molecular pathways and how to ﬁnally
achieve ‘‘knowledge’’ in terms of pathogenetic concepts, i.e., real
understanding of biological systems and diseases, out of the mass
of data.
Fundaments of such efforts can be pre-existing knowledge on
relevant biological systems (‘‘genes of known relevance’’), ranking
genes along biostatistical signiﬁcance (‘‘P-value-approach’’), the
comparison of gene expression patterns to in vivo (‘‘evo-devo-
approach’’) or in vitro models, bioinformatical tools (‘‘clustering and
neighbourhood-analyses’’) as well as an envisioned combination of
both, pre-existing knowledge and computational processing of
obtained data (i.e., bioinformatical ‘‘pathway modelling’’ etc.).
Clearly, tomorrow data obtained by cDNA expression analysis will
be one basis of a new world of biological understanding. These new
insights will be network-based and no longer primarily molecule-
centred.
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PATHOGENSIS AND IMPLICATIONS OF CHONDROCYTE
HYPERTROPHY IN OSTEOARTHRITIS
R. Terkeltaub
VAMC/UCSD, La Jolla, CA, United States
In physiologic endochondral growth plate mineralization, chondro-
cytes undergo a multi-step differentiation process in which there is
ordered progression from a resting to proliferative state followed by
S5maturation to a terminally differentiated hypertrophic state. Hyper-
trophic chondrocytes are specialized to remodel and mineralize
their matrix, as illustrated by up-regulated MMP-13 and aggreca-
nase-2. In addition, hypertrophic chondrocytes demonstrate altered
matrix biosynthesis that includes stereotypic up-regulated type X
collagen expression, down-regulated type II collagen and aggre-
can, and markedly increased release of mineralization-competent
secretory vesicles. Hypertrophic chondrocytes also demonstrate
increased alkaline phosphatase (AP) activity and other alterations
in the metabolism of Pi and PPi that mediate both calciﬁcation and
growth plate organization. Signiﬁcantly, Pi excess promotes
chondrocyte hypertrophy.
In contrast to chondrocytes in growth plate cartilage, chondrocytes
in normal articular cartilage remain largely in a resting state and do
not undergo terminal differentiation or mineralize their matrix. But in
OA, foci of articular chondrocyte hypertrophy develop, typically
near sites of cartilage surface lesions and calciﬁcation. One of the
shared features of hypertrophic chondrocytes in growth plate and
articular cartilages is up-regulated expression of at least two
transglutaminase (TG) isoenzymes (Factor XIIIA (FXIIIA), a distinct
tissue homodimeric form of the circulating heterotetrameric co-
agulation factor Factor XIII, and TG2 (also termed tissue TG and
Gh), which is unique among the human TG isoenzymes in being
a dual function TG and GTPase/ATPase). TGs catalyze a calcium-
dependent transamidation reaction that produces covalent cross-
linking of available substrate glutamine residues to a primary amino
group. TGs thereby can modify the matrix through effects including
protein cross-linking and stabilization, and OA cartilage contains
a variety of potential TG substrates including several collagen
subtypes and ﬁbronectin. Furthermore, TG transamidation catalytic
activity has been shown to increase in both an OA-severity-
dependent and age-dependant manner in joint cartilages. We
recently observed that certain mediators implicated in OA, including
the chemokines IL-8 and GROalpha stimulates chondrocyte
hypertrophy and matrix calciﬁcation, which were shown to be
dependent on TG2. Hence, TG2 is not simply a marker of
chondrocyte hypertrophy but also a direct mediator of the de-
velopment of chondrocyte hypertrophic differentiation. The discus-
sion will highlight recent developments in understanding how TG2,
low-grade inﬂammation supported by IL-8, and speciﬁc down-
stream signals promote chondrocyte hypertrophy, and how excess
PPi released by hypertrophic chondrocytes modulates chondrocyte
differentiation and function. The relevance of these events to
pathogenesis of OA will be addressed.
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REGULATION OF HUMAN AND MOUSE NFATp GENE
PROMOTERS BY RUNX2
K. Thirunavukkarasu, Y. Pei, S. Chandrasekhar
Bone & Inflammation, Eli Lilly and Company, Indianapolis, IN, USA
Objective: Nuclear Factor of Activated T cells-p (NFATp) is
a transcription factor that functions as a repressor of cartilagegrowth and differentiation in adult mice. The pathways involved in
NFATp gene regulation are not fully understood. The objective of
the present study was to understand the transcriptional regulation
of the mouse and human NFATp genes based on promoter cloning
and their characterization using promoter-reporter assays in
ﬁbroblastic, mesenchymal and chondrocytic cell lines.
Methods: 2.5 kb promoters from the 5#-ﬂanking region of the mouse
(2478 toC61) and human (2271 toC220) NFATp genes were
cloned by genome walking PCR. Random 5#-deletion fragments of
the promoters were generated by PCR with primers designed from
the 2.5 kb sequences. A total of four promoter fragments (2.5 kb,
1.0 kb, 0.8 kb and 0.3 kb) were generated for the mouse NFATp
gene and three fragments (2.5 kb, 2.0 kb and 1.1 kb) for the human
NFATp gene. All promoter fragments were inserted into pbgal-
Basic vector (Clontech) to generate promoter-reporter constructs.
Transient cotransfection of each of the reporter construct along with
a Runx2 expression construct or a control vector was performed in
ﬁbroblastic (COS-1), mesenchymal (C3H10T1/2), and chondrocytic
(SW1353) cell lines. b-gal activity in cell extracts was measured
36–48 h after transfection using a luminescent b-gal assay kit
(Roche).
Results: Sequence analysis of the 2.5 kb mouse and human
NFATp promoters revealed the presence of seven putative binding
sites (OSE2) for the Runx family of transcription factors, of which
one member Runx2 plays a major role in chondrocyte maturation
and osteoblast differentiation. To determine whether Runx2 affects
NFATp gene expression, we cotransfected the full-length human or
mouse NFATp promoter along with a Runx2 expression construct
or a control vector into COS-1, C3H10T1/2, and SW1353 cells.
Runx2 overexpression resulted in a signiﬁcant induction of the
NFATp promoters (26-, 13-, and 31-fold increase in mouse NFATp
promoter activity, and 15-, 6-, and 31-fold increase in human
NFATp promoter activity, respectively, in COS-1, C3H10T1/2, and
SW1353 cells). This data suggests the NFATp gene as a potential
downstream target for Runx2. The relative contribution of the
various OSE2 elements to mediating Runx2 responsiveness was
assessed in cotransfection experiments using the promoter de-
letion constructs. The short promoter fragments still showed
substantial induction by Runx2 implicating the importance of the
proximal promoter region for mediating Runx2 stimulation of the
mouse and human NFATp promoters.
Conclusions: We have cloned the promoters of human and mouse
NFATp genes and identiﬁed Runx2 as a potential stimulator of
NFATp gene transcription. It has been demonstrated previously
that lack of NFATp results in proliferation of existing cartilage cells
in the knock out animals, whereas overexpression of NFATp in
cartilage cell lines extinguishes the cartilage phenotype. Our results
suggest that Runx2 may execute its role in promoting chondrocyte
maturation and hypertrophy, at least in part, via the stimulation of
NFATp expression.
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S100A4 STIMULATES MATRIX METALLOPROTEINASE-13
EXPRESSION BY HUMAN ARTICULAR CHONDROCYTES VIA
THE RECEPTOR FOR ADVANCE GLYCATION END
PRODUCTS (RAGE)
R. R. Yammani, R. F. Loeser
Medicine (Rheumatology) and Biochemistry, Rush University
Medical Center, Chicago, IL, USA
Aim: S100A4 belongs to a family of S100 calcium binding proteins,
some of which have been shown to bind to the Receptor for
Advance Glycation End Products (RAGE). Studies have shown that
extracellular S100A4 modulates the synthesis and activity of MMP-
13 in endothelial cells; however, the cellular mechanisms involved
are not fully understood. The aim of this study was to examine if
S100A4 can stimulate the expression of MMP-13 by articular
chondrocytes and determine the role of RAGE-mediated signaling.
Methods: Human articular chondrocytes isolated from normal
ankle obtained from tissue donors were cultured in high-density
S6monolayers in media with 10% serum for 5–7 days. Conﬂuent
monolayers were then changed to serum free media 16–18 h prior
to treatment with 5–50 ng/ml of S100A4. In some experiments, cells
were pre-treated with soluble-RAGE (sRAGE), a truncated form of
RAGE, comprising only the extracellular ligand binding domain,
which acts as an antagonist to RAGE. Immunoblotting with
phosphospeciﬁc antibodies was used to determine the activation
of cell signaling proteins. Production of MMP-13 was determined in
the conditioned media by immunoblotting with polyclonal antibodies
to MMP-13.
Results: Human articular chondrocytes were found to respond to
S100A4 by increased phosphorylation of proline rich tyrosine
kinase 2 (PYK2), and the MAP kinases, extracellular signal-
regulated kinase (ERK1/ERK2), c-Jun N terminal kinase (JNK),
and p38. Increased phosphorylation of nuclear factor-kappaB was
also noted, followed by increased production of MMP-13 in the
conditioned media. S100A4 stimulation of MMP-13 production was
dose-dependent starting at 5 ng/ml and peaking at 50 ng/ml.
Human articular chondrocyte RAGE expression was conﬁrmed by
immunoblotting cell lystes. Production of MMP-13 in response to 5
ng/ml of S100A4 was inhibited upon pre-treatment with 10 mg/ml
sRAGE.
Conclusion: This is the ﬁrst study to demonstrate that S100A4
stimulates the expression of MMP-13 by activating RAGE and its
signaling cascade in human chondrocytes. Since both S100A4 and
RAGE have been found to be increased in OA cartilage, this
signaling pathway could contribute to cartilage degradation in OA
by promoting MMP-13 production. Studies are underway to further
determine the mechanism of the S100A4-RAGE mediated regula-
tion of MMP-13 activity in chondrocytes.
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INDUCTION OF HEME OXYGENASE-1 INHIBITS INTER-
LEUKIN-1b-DEPENDANT NITRITE OXIDE PRODUCTION IN
ARTICULAR CHONDROCYTES
F. P. Rannouyzx, Y. Liuz, M. Benallaouax, M. Francoisx,
P. Richettex, S. Poiraudeauy, J. Y. Shyyz, T. S. Leez
y Division of Rehabilitation, Hopital Cochin – Universite Paris 5,
Paris, France
z Division of Biomedical Sciences, University of California, River-
side, CA, USA
x INSERM UMR-S 530, Universite Paris 5, Paris, France
Aim of study: Interleukin-1b (IL-1b) is one of the main cytokines
involved in the degradation of articular cartilage. One mechanism
through which this cytokine exerts its effects is by inducing articular
chondrocytes to produce nitrite oxide (NO). These ﬁndings are
supported by results of experimental studies and clinical studies
revealing a signiﬁcant increase in NO production in the synovial
ﬂuid of patients with rheumatoid arthritis and osteoarthritis.
Modulating IL-1b-induced NO in articular chondrocytes appears to
be an interesting challenge for reducing or inhibiting the cartilage
destruction. Heme oxygenase-1 (HO-1) is the key enzyme re-
sponsible for the physiological breakdown of heme into equimolar
amounts of biliverdin, carbon monoxide, and iron. In addition, it has
been shown recently that this enzyme confers cellular protection
mainly through its antioxidant and anti-inﬂammatory function. The
objective of this study was to investigate the expression and activity
of HO-1 in IL-1b-treated articular chondrocytes and the correspond-
ing molecular mechanism.
Methods and results: Western blot analysis revealed that, in the
presence of cobalt protoporphyrin (CoPP), a known HO-1 inducer,
the expression of HO-1 in IL-1b-treated chondrocytes was dose
dependant. CoPP or overexpression of HO-1 by transient trans-
fection, greatly decreased the induced NO production. The relative
luciferase activity of the iNOS promoter was decreased, which
indicates a potential regulation of iNOS transcription. Furthermore,
the level of IL-1b-induced NF-kB activation, assessed by the IkB
degradation, was diminished in the presence of CoPP, which
suggests the involvement of NF-kB. Lastly, we incubated chon-
drocytes with 15d-PGJ2, a PPAR-g ligand known to inhibit NOproduction in IL-1b-treated chondrocytes. Western blot analysis
revealed the presence of HO-1 with 15d-PGJ2 but not with
Rosiglitazone, another PPAR-g ligand. Treatment with IL-1b and
15d-PGJ2 in the presence of a wild-type PPAR-g or a mutated
dominant-negative PPAR-g greatly decreases NO production. In
addition, treatment with zinc protoporphyrine, a known HO-1
inhibitor, abolished the decreased NO production, which suggests
an HO-1-dependant and PPAR-g-independent phenomenon. HO-1
could mediate the anti-inﬂammatory effect of 15d-PGJ2 in a PPAR-
g-independent mechanism.
Conclusions: These data suggest that HO-1 can exert an anti-
inﬂammatory effect in articular chondrocytes through a mechanism
involving the NF-kB signaling pathway. Furthermore, they support
the essential role of HO-1 in mediating the anti-inﬂammatory effect
of 15d-PGJ2 in a PPAR-g-independent mechanism. 15d-PGJ2
could be used in vivo to induce the HO-1 system.
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CONSTITUTIVE EXPRESSION OF THE TWO NOVEL
CYCLOOXYGENASE-1 (PROSTAGLANDIN H2 SYNTHASE)
ISOFORMS COX-3 AND COX-1A BY NORMAL AND OSTEO-
ARTHRITIC (OA) HUMAN ARTICULAR CARTILAGE CHON-
DROCYTES
S. Piera-Velazquez, S. A. Jimenez
Division of Rheumatology, Department of Medicine, Thomas
Jefferson University, Jefferson Medical School, Philadelphia, PA,
USA
Aim of the study: COX-3 and COX-1A isoforms of the Prostaglandin
H2 synthase have been described recently. In contrast with COX-1,
both isoforms express intron 1 from the COX-1 gene. The function
and cartilage expression of COX-1A are not known. The COX-3
isoform is inhibited by acetaminophen and other analgesic-
antipyretic drugs. Although these drugs are extensively used for
the symptomatic treatment of osteoarthritis, their mechanism of
action remains unknown. The purpose of this work was to
determine whether these variants are expressed in normal and
OA articular cartilage chondrocytes and to examine their induction
by cytokines known to be involved in the pathogenesis of the
cartilage destruction characteristic of OA.
Methods: Human articular cartilage chondrocytes were isolated
from knee joints from ﬁve normal individuals (tissue donors from
the National Transplant Network) and from the knee joints
removed at joint replacement surgery from 5 OA patients. Normal
and OA chondrocyte cell lines were established and cultured in
primary monolayer cultures. The cultures were treated with IL-1b
(1 ng/ml) and TNF-a (5 ng/ml) alone or in combination for 24 h.
mRNA and total proteins from isolated and cultured cells were
prepared. RT-PCR was performed with speciﬁc primers containing
the ﬁrst intron of the COX-1 gene. An antibody speciﬁc for peptide
corresponding to the ﬁrst 17 amino acids of human COX-3 was
prepared and western blots with 30 mg of total protein were
performed.
Results: PCR showed the ampliﬁcation of the ﬁrst intron of COX-1
indicating the expression of both COX-1A and COX-3 in every
sample.
Western blots with the speciﬁc antibody demonstrated the
existence of two bands; one migrating with w65 kDa (COX-3)
and the other with w50 kDa (COX-1A). There were no differences
in the expression of the two novel cyclooxygenase-1 isoforms
between normal and OA chondrocytes.
Treatment with IL-1 and/or TNF did not induce COX-3 and COX-1A
protein expression.
Conclusions: We demonstrate for the ﬁrst time that COX-3 and
COX-1A isoforms of cyclooxygenase-1 are expressed by normal
and OA human chondrocytes and that their expression is
constitutive since they are not induced by IL-1b and/or TNF-a.
These studies pave the way to the identiﬁcation of the role that
these isoforms may play in normal or pathologic articular cartilage
chondrocyte function.
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IS THERE A ROLE FOR ANABOLISM IN OSTEOARTHRITIS?
L. Sandell
Washington University School of Medicine, St. Louis, MO, United
States
Osteoarthritis (OA) is characterized by a progressive loss of
cartilage. However, recent studies have demonstrated vigorous
anabolism in OA cartilage that may be a reparative response of the
chondrocytes. Many growth factors, cytokines and chemokines are
present in normal and in OA cartilage that may be able to contribute
to normal turnover of the extracellular matrix, the repair of mildly
injured tissue, or the reconstruction of degenerated cartilage.
Interestingly, BMP’s are present in cartilage and may be partially
under the control of pro-inﬂammatory cytokines. Therefore, the
interplay between anabolic and catabolic forces within cartilage are
likely to be complex, and may even change over time and in
disease. Data on these anabolic factors such as BMP-2, BMP-7,
anabolin, IGF-1, and others will be presented as well as potential
mechanisms for regulating gene expression. Finally, we will explore
the changes in cartilage metabolism that may be important for
cartilage repair in normal and osteoarthritic cartilage.
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THE ROLE OF INTERLEUKIN-1 BETA IN THE REGULATION OF
OSTEOGENIC PROTEIN-1 SIGNALING IN HUMAN ARTICULAR
CARTILAGE
A. M. Elshaiery, A. Hakimiyany, A. Margulisy, D. C. Ruegerz,
S. Chubinskayay
y Biochemistry, Rush University Medical Center, Chicago, IL, USA
z Stryker Biotech, Hopkinton, MA, USA
Interleukin-1b (IL-1b) and Osteogenic Protein-1 (OP-1) are two
factors critical for articular cartilage homeostasis. IL-1b contributes
to the pathogenesis of osteoarthritis, while OP-1 regulates cartilage
regeneration and repair. The objective of this study was to
investigate the mechanisms of cross-talk between IL-1b and OP-
1 signaling in human adult articular chondrocytes cultured as high-
density monolayers with or without serum in the presence of
10 ng/ml IL-1b and 100 ng/ml OP-1. Proteoglycan (PG) synthesis
was measured by sulfate incorporation; gene expression of OP-1,
aggrecan, Smad 1, 4, 5, and 6 was detected by RT-PCR. Total and
phosphorylated Smads and NF-kB were investigated at different
time points by Western blots. We found that the ability of OP-1 to
counteract catabolic effect of IL-1b depends upon the presence of
serum. In serum, OP-1 stimulates (P ! 0.01) and IL-1b down-
regulates (P! 0.05) PG synthesis and aggrecan expression; when
combined, OP-1 restores PG synthesis and aggrecan message
inhibited by IL-1b up to the control levels. However, in the absence
of serum, no recovery is detected under combined OP-1 and IL-1b.
Studying the mechanisms responsible for such failure, we found
that OP-1 gene expression was up-regulated in response to IL-1b
under both culture conditions. However, in the absence of serum,
IL-1b down-regulated Smad 1 (P ! 0.01) and Smad 6 (P ! 0.03)
gene expression, which was not recovered by addition of OP-1.
Smad 4 & 5 expression remained stable under either condition. On
the protein level, OP-1 alone activated receptor-binding Smads 1/5/
8 (R-Smads) in two phases: ﬁrst peak of phosphorylation occurs at
15 min of culture, while activation lasted between 5 and 60 min.
Second phase began at 1 h and reached its maximum by 4 h. IL-1b
itself did not induce R-Smad phosphorylation at the BMP site,
however, when combined with OP-1, IL-1b reduced, delayed
(began at 30 min) and terminated earlier (at 2 h) R-Smads
phosphorylation, while total Smad 1 & 5 remained unchanged
under either treatment. Maximal inhibition by OP-1 of the IL-1b-
induced NF-kB activity was detected only at 30 min, when its
phosphorylation was almost abolished. However, at later time
points (45 min to 4 h) NF-kB phosphorylation was only partially
inhibited in the presence of OP-1. In summary, our results suggestthat in the absence of serum IL-1b down-regulates mRNA
expression of R-Smad1, which in a feedback loop mechanism
down-regulates expression of inhibitory Smad 6. IL-1b also delays
and reduces phosphorylation of R-Smads thus affecting the kinetics
of the OP-1 signaling. Since phosphorylation of R-Smads is a key
step in OP-1 signaling, dysregulation in this process may inﬂuence
the formation of heteromeric complexes between R-Smads and
Smad 4 and subsequent nuclear translocation of Smad 4, thus
resulting in reduced responsiveness of chondrocytes to the OP-1.
Activation of NF-kB by IL-1b and its only partial inhibition by OP-1
may be another possible explanation for the reduced anabolic
activity of OP-1 in the presence of IL-1b under serum-free
conditions.
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EFFECTS OF CHRONIC GROWTH HORMONE/INSULIN-LIKE
GROWTH FACTOR-1 DEFICIENCY ON OSTEOARTHRITIS IN
RAT KNEE JOINTS
K. J. Ekenstedty, W. E. Sonntagz, R. F. Loeserx, B. R. Lindgrenjj,
C. S. Carlsony
y College of Veterinary Medicine, University of Minnesota, St. Paul,
MN, USA
z School of Medicine, Wake Forest University, Winston-Salem, NC,
USA
x Rush Medical College, Rush University Medical Center, Chicago,
IL, USA
jj School of Public Health, University of Minnesota, Minneapolis,
MN, USA
This study examined the effects of chronic deﬁciency of insulin-like
growth factor 1 (IGF-1), the downstream product of growth hormone
(GH), on osteoarthritis (OA) development in joint tissues. Thirty-ﬁve
rats were divided into four treatment groups: one control group
(normal GH levels -Wild) and 3 groups of dwarves possessing
a genetic mutation resulting in GH deﬁciency. The ﬁrst dwarf group
received GH injections (200 mg, twice daily) from 4 weeks to 18
months of age (GHC) and the second received GH from 4 weeks to
14 weeks of age, followed by saline until 18 months (GH),
mimicking adult-onset GH/IGF-1 deﬁciency. The third dwarf group
received saline only from 4 weeks to 18 months (Dw Sal). IGF-1
levels were measured at sacriﬁce (18 months) and were
signiﬁcantly affected by treatment (P Z 0.002, ANOVA), being
higher in the GHC (324 ng/mL) and Wild (327 ng/mL) groups than
the Dw Sal (199 ng/mL) and GH (169 ng/mL) groups (P! 0.05).
Body weights were also signiﬁcantly affected by treatment group
(P ! 0.001, ANOVA), with the Dw Sal rats weighing less than the
other three treatment groups (Dw Sal vs Wild and Dw Sal vs GHC,
P! 0.001; Dw Sal vs GH P! 0.05) and the GH rats weighing
less than both the Wild group (P ! 0.001) and the GHC group
(P! 0.01). At necropsy, the left knee of each rat was processed for
histology. Medial and lateral femoral condyles and tibial plateaus
were scored blindly using a comprehensive OA histologic grading
scheme, and articular cartilage and subchondral bone thicknesses
Table I
Factor Weightings % Variance ANOVA
1 MFC articular cartilage area
and width; Max # TM (–)
19 NS
2 MTP subchondral bone
area and width
19 NS
3 MFC subchondral bone
area and width
17 NS
4 MTP articular cartilage
area and width
17 P Z 0.012
5 MTP articular cartilage
structure and loss of T. Blue;
Max # TM (–)
16 P ! 0.001
MFC Z medial femoral condyle, MTP Z medial tibial plateau,
TM Z tidemark, NS Z not signiﬁcant.
S8and areas were evaluated by histomorphometry. Principal compo-
nents analysis (PCA) was used to summarize the severity scores
and measurements from the medial tibial plateau and medial
femoral condyle. These factors were then analyzed by least
squares analysis adjusted for body weight, and pairwise tests were
done with adjustment for multiple comparisons. PCA resulted in ﬁve
factors that explained 87% of the variation in the data (Table I). The
maximum number of tidemarks received a negative weighting; all
other variables were weighted positively. Factor 4 (articular
cartilage area and width) was signiﬁcantly affected by treatment
(P ! 0.012), being higher in the GH group than in the Dw Sal
group (P ! 0.05). Factor 5 (OA severity) also was signiﬁcantly
affected by treatment (P ! 0.001), with values by treatment group
as follows: Dw Sal O GH > Wild O GHC. The GHC group
had signiﬁcantly lower Factor 5 scores than the other three groups
(P ! 0.05). These results indicate that, in this animal model,
chronic GH/IGF-1 deﬁciency leads to an increased severity of
articular cartilage lesions of OA.
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HYPOXIA-INDUCIBLE FACTOR-1a INFLUENCES METABOLIC
ACTIVITY OF ARTICULAR CHONDROCYTES
P. U. Bruckery, N. J. Izzoy, C. R. Chuy
y Department of Orthopaedic Surgery, University of Pittsburgh
School of Medicine, Pittsburgh, PA, USA
Aim: Changes in oxygen tension of articular cartilage have been
described in osteoarthritis. The aim of this study is to test the
hypotheses that HIF-1 a – a transcription factor important to cell
survival in low oxygen tensions – is differentially expressed in
physiologic and non-physiologic oxygen tensions of bovine articular
chondrocytes (BAC) and that proteoglycan synthesis (PG-S)
decreases at oxygen tensions and conditions that also increase
nuclear translocation of HIF-1 a.
Methods: BAC from knee joints of freshly slaughtered calves were
isolated and cultured in 21% O2, 2% O2, and hypoxia-simulated
conditions using cobalt chloride (CoCl2). HIF-1 a was analyzed by
Western blotting of nuclear extracts and by indirect immunoﬂuo-
rescence using nuclear and Golgi counterstaining for assessment
of nuclear, perinuclear, or cytoplasmic localization, respectively
(Hep3B cells as controls). In addition, osteochondral explants of the
same knee joints were harvested by standard coring devices.
Deeper chondral layers of bovine osteochondral explants were
exposed by removal of 20% or 50% of the cartilage thickness
(intact cores as control). After cultivation in 21% O2, 2% O2, and
CoCl2, PG-S was assessed by
35S-sulfate uptake and normalized
by DNA content. Cell viability of the osteochondral explants
was assessed by ﬂuorescent labeling with propidium iodide and
5-chloromethylﬂuorescein diacetate. A General Linear Models
Procedure was performed for statistical analysis. Results were
considered signiﬁcant at P ! 0.05.
Results: HIF-1 a was strongly detectable in the cytoplasm and the
nuclei by immunoﬂuorescence in 2% O2 and in CoCl2. Only
cytoplasmic and perinuclear staining was seen in 21% O2. Golgi
counterstaining demonstrated a co-localization of the perinuclear
HIF-1 a staining with the Golgi complex in 21% O2. Nuclear
accumulation of HIF-1 a was strongly detected in BAC and in
Hep3B cells by Western blot in 2% O2, but not in 21% O2. After 3
days of culture under the different oxygen tensions, no signiﬁcant
differences in cell viability were noted. However, PG-S was
signiﬁcantly (P Z 0.0001) greater in 21% O2 than in 2% O2 for
all groups. Exposure of the bottom 50% of the cartilage resulted in
a marked increase in PG-S above control in 21% O2. The
upregulation of PG-S was not as great in 2% O2 and in CoCl2.
Exposure of the bottom 50% of the cartilage resulted in a marked
increase in PG-S above control in 21% O2. CoCl2 led to similar
effects on PG-S as 2% O2.
Conclusions: This study demonstrated upregulation of HIF-1 a in
BAC in conditions of low oxygen tension and simulated hypoxia.
We also showed co-localization of HIF-1 a in the Golgi complex at
21% O2, and translocation of HIF-1 a to the nuclei at 2% O2 and inthe presence of CoCl2. Decreased PG-S was found in both
experimental conditions where HIF-1 a was translocated to the
nucleus. These results suggest that HIF-1 a may play a role in
modulating PG-S in BAC. Understanding chondrocyte metabolic
adaptations to low oxygen tensions is important to the development
of strategies to maintain cartilage health in conditions of altered
oxygen tensions such as what may be found in early osteoarthritis.
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GADD45b EXPRESSION IN NORMAL AND OSTEOARTHRITIC
CARTILAGE
K. Ijiriy, H. Pengy, L. F. Zerbiniy, N. Walshy, M. Wedigx, M. Grayx,
S. Komiyajj, T. Aignerz, H. H. Otuy, T. Libermanny, M. B. Goldringy
y New England Baptist Bone & Joint Institute, Beth Israel
Deaconess Medical Center, Boston, MA, USA
z Cartilage Research, Department of Pathology, University of
Erlangen-Nurnberg, Krankenhausstrassen, Germany
x Division of Health Sciences & Technology, Harvard-MIT, Boston,
MA, USA
jj Orthopaedic Surgery, Kagoshima University, School of Medicine
& Dentistry, Kagoshima, Japan
Aim of study: The expression of GADD45b expression in normal
and osteoarthritic (OA) cartilage was investigated to address its
essential function in chondrocyte anabolic activities.
Methods: Normal or OA cartilage was harvested from cadavers or
patients with OA and graded by histological analysis using the
Mankin scale. Total RNA was isolated and was subjected to
microarray analysis with the Gene Chip Human Genome U133A
(Affymetrix) and real-time PCR (MJ Research DNA Engine Opticon
Continuous Fluorescence Detection System). Immunohistochem-
istry was performed with goat anti-human polyclonal GADD45b
antibody (Santa Cruz Biotechnology) and Vector Elite Kit (Vector
Laboratories). Lentivirus-based siRNA delivery was performed in
the chondrocyte cell lines, C-28/I2, to knockdown GADD45b and
pcDNA3-Gadd45b-ﬂag expression vector was used to overexpress
GADD45b. COL2A1 promoter activity was assessed using a re-
porter vector, pGL2-B/4.0:577/C3428, after transfection using
LipofectamineC (Invitrogen).
Results: Identiﬁcation of highly expressed genes in normal cartilage
(90% lower conﬁdence limit with fold-change ofO1.2, compared to
OA) yielded 358 transcript variants. GADD45b gene expression in
normal cartilage was 3.85! higher than in late OA and 1.72! higher
than in early OA by microarray analysis. Real-time PCR conﬁrmed
the differential expression of GADD45b mRNA in normal cartilage.
Immunohistochemistry demonstrated that GADD45b was strongly
expressed in chondrocytes in peripheral OA cartilage. In C-28/I2
cells, COL2A1 promoter activity was decreased by over-expression
of GADD45b but increased by GADD45b silencing (Fig. 1).
Conclusions: Previous studies have shown that the anabolic
activity is up-regulated in OA cartilage even though catabolic
activity leads ﬁnally to the destruction of the matrix (Aigner, 2003;
Herbage, 1990), possibly related to increased BMP-2 (Fukui,
Fig. 1. Luciferase activity (!105) expressed by C-28/12 chondro-
cyctes transfected with PGL2-COL2A 1/4.0. Bars show the
mean G STD.
S92003). Our microarray data showed that mRNAs for collagen type I,
II, III and V were all up-regulated in late OA compared to normal
cartilage. Our results suggest one explanation for the increased
synthetic activity of OA chondrocytes remaining in the degenerated
cartilage matrix. High GADD45b expression, therefore, may be
associated with the low collagen turnover in cartilage in physiolog-
ical conditions. In response to environmental stress, the decreased
expression of GADD45b would then permit increased anabolic
activity by OA chondrocytes.
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USING EPIDEMIOLOGIC STUDIES TO IDENTIFY SURRO-
GATES FOR RADIOGRAPHIC OUTCOME
V. B. Kraus
Duke University Medical Center, Durham, NC, United States
The markers used to measure it deﬁne a disease. The early
diagnosis and detection of the progression of osteoarthritis have
been hampered by the traditional reliance on radiographic markers
or criteria of the disease. The advent of new imaging methodologies
and biochemical markers is providing insights into the disease
pathogenesis and offers the possibility of redeﬁning the disease.
Our experience with biochemical markers has taught us that
epitopes of joint tissue macromolecules can show strong associ-
ations with the presence, severity, extent and progression of
osteoarthritis. We have recognized the vital importance of
validating osteoarthritis markers in diverse populations as we have
noted signiﬁcant impacts of age, gender, ethnicity, BMI and other
co-morbid conditions on joint tissue macromolecule levels. We are
exploring the use of biochemical markers to evaluate the potential
efﬁcacy of disease modifying therapies and to quantify total body
burden of OA. The Osteoarthritis Biomarkers Network is a newly
formed consortium that has developed a mandate to draft
a comprehensive framework in which to codify markers. The
expanding scope of work on imaging and biochemical markers in
the ﬁeld of osteoarthritis in conjunction with a deepening un-
derstanding of their potential will no doubt impact the face of
osteoarthritis therapy in the future.
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TREATMENT WITH RISEDRONATE REDUCED URINARY
CTX-II, A SPECIFIC BIOCHEMICAL MARKER OF TYPE II
COLLAGEN DEGRADATION, IN A 24-MONTH STUDY OF KNEE
OA
C. Bingham, W. Aronstein, S. Adami, S. Cohen, P. Conaghan,
M. Dougados, J. Beary, J. Meyer, P. Garnero
Rheumatology, NYU-Hospital for Joint Diseases, New York, NY,
USA
Arthritis Research, Procter and Gamble Pharmaceuticals, Mason,
OH, USA
Rheumatology, University of Verona, Verona, Italy
Rheumatology, St. Paul Medical Center, Dallas, TX, USA
Rheumatology, Leeds General Infirmary, Leeds, United Kingdom
Rheumatology, Hopital Cochin, Paris, France
Synarc, Edward Herriot Hospital, Lyon, France
Purpose: Quantitative determination of urinary collagen type II
C-telopeptide fragments (CTX-II), has been used in a variety
of epidemiologic osteoarthritis (OA) studies as a speciﬁc marker for
articular cartilage degradation. Increased levels are consistently
associated with a higher risk of radiological progression. In this
study, urinary excretion of CTX-II was measured serially during
therapy with risedronate providing the opportunity to examine the
effects of treatment.
Methods: 1000 patients with full baseline and follow-up urinary
CTX-II results completed a randomized, double-blind, placebo-
controlled 2 year study of risedronate treatment of mild-moderateknee OA in Europe. Study patients qualiﬁed by fulﬁlling ACR criteria
for knee OA and by having a medial compartment knee JSW of 2–4
mm using the ﬂuoro positioned standardized radiographic method
of Buckland-Wright (average of 7( of ﬂexion). Patients were treated
with either placebo (NZ 243), or risedronate: 5 mg daily (258), 15
mg daily (251), or 35 mg weekly (248). Urinary excretion of CTX-II
was measured and corrected for urinary creatinine at Baseline, and
after 6, 12, and 24 months of dosing.
Results: Urinary excretion of CTX-II was reduced in a dose-
dependent manner by treatment with risedronate. At 6 months, the
mean baseline level of CTX-II excretion in the placebo group
(adjusted analysis, intent-to-treat population) rose by 6%. After 6
months, risedronate 5 mg daily reduced the mean CTX-II excretion
by 31% (P! 0.001 based on mean percent change from baseline).
Weekly treatment with 35 mg risedronate reduced CTX-II excretion
by 27% (P! 0.001) at 6 months. Treatment with risedronate 15 mg
daily reduced mean CTX-II excretion by 53% (P ! 0.001) after 6
months. Reductions were maintained throughout the study. These
results were conﬁrmed by similar ﬁndings in a separate study of
835 patients with CTX-II results who completed 24 months of
treatment under a similar protocol in North America.
Conclusions: Although the pre-deﬁned clinical and structural
endpoints were not reached in this study, the dose-dependent
reductions in mean levels of excreted CTX-II in two large
randomized, double-blind, placebo-controlled trials of patients with
mild-moderate knee OA suggest that risedronate directly and
favorably affected biochemical pathways thought to be involved in
the progression of joint destruction in osteoarthritis.
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A NEW ELISA FOR URINARY TYPE II COLLAGEN HELICAL
PEPTIDE (HELIX-II) AS A MOLECULAR MARKER FOR
CARTILAGE DEGRADATION IN ARTHRITIS
N. Charni, F. Juillet, P. Garnero
Molecular Markers Research Department, Synarc, Lyon, France
Aim: Type II collagen is speciﬁc of cartilage and represents about
20% of matrix proteins of this tissue. Type II collagen comprises
a large helical domain and linear N and C-telopeptide at each end.
Urinary excretion of degradation fragments of the C-telopeptide
(CTX-II) has been shown to be increased in patients with
osteoarthritis (OA) and rheumatoid arthritis (RA). The aim of this
study was to develop an ELISA for urinary degradation products of
the helical domain of type II collagen (Helix-II) and evaluate its
clinical utility in OA and RA.
Methods: A synthetic peptide, corresponding to amino acid
residues 622–632 of the helical region of the a1 chain of type II
collagen (Helix-II), was used to develop a speciﬁc competitive
polyclonal antibody-based ELISA. We measured the urinary
excretion of Helix-II and CTX-II (Cartilaps) in 90 patients with knee
OA (73% women; mean age: 63.0 G 8.0 years; mean disease
duration: 6.1 G 6.8 years), 89 patients with early RA (disease
duration less than 3 years, 78.7% women, mean age: 48.7G 11.6
years), 25 patients with active Paget’s disease of bone (mean age:
70G 7 years) and in 85 healthy subjects (82% women, mean age:
52G 15 years). In RA patients, the relationships between baseline
urinary Helix-II and CTX-II and progression of joint destruction as
measured by changes of total Sharp score over 1 year was
investigated.
Results: The anti Helix-II antibody did not recognize intact or
denatured human type II collagen and homologous peptides from
a1 chains of type I and III collagens. The ELISA for urinary Helix-II
demonstrated intra- and inter-assay variability below 15% and
recovery of diluted urine samples from 82 to 123% (mean: 107%).
Compared to healthy controls, urinary Helix-II levels were in-
creased by 54% in patients with knee OA and by 125% in patients
with RA (!0.0001 for both groups), with no signiﬁcant changes in
patients with Paget’s disease of bone providing in vivo evidence
that Helix-II is a speciﬁc marker of cartilage degradation.
In patients with early RA, baseline levels of urinary Helix-II and
CTX-II in the highest tertile signiﬁcantly and independently of each
S10other predicted the risk of joint damage progression (increase of
Sharp score O0.5 unit) with odds-ratio (95% CI) of 6.9 (2.4–20.5)
and 3.0 (1.1–8.5), respectively. Patients with elevated levels of both
Helix-II and CTX-II at baseline had the highest rate of progression
with a mean Sharp score increase (unit per year) of 3.6 compared
to 0.7–0.8 in those with only high Helix-II or high CTX-II and 0.4 for
patients with low levels of both markers (P Z 0.004 for difference
between groups).
Conclusion: Helix-II ELISA is highly speciﬁc for degradation
products arising from the helical domain of type II collagen and
demonstrates adequate technical performances. Urinary Helix-II
predicts progression of joint damage in early RA independently of
CRP, baseline joint damage and urinary CTX-II. This new marker
appears to provide different and additional information on type II
collagen degradation processes compared to CTX-II, suggesting its
usefulness alone or in combination with other tests to predict
disease progression in OA and RA.
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PLASMA MMP-3 (STROMELYSIN) LEVELS REFLECT JOINT
SPACE NARROWING IN PATIENTS WITH KNEE OSTEOAR-
THRITIS
L. S. Lohmandery, K. D. Brandtz, S. A. Mazzucaz, S. Larssony,
K. A. Lanez, A. Struglicsy, B. P. Katzz
y Orthopaedic Surgery, Lund University, Lund, Sweden
z Medicine, Indiana University School of Medicine, Indianapolis, IN,
USA
MMP-3 (stromelysin), which is produced by chondrocytes and
synoviocytes, has been implicated in the degradation of articular
cartilage in OA. Compared to healthy controls, subjects with knee
OA exhibit higher concentrations of MMP-3 in synovial ﬂuid
and blood. The present study examined whether baseline and
serial plasma concentrations of MMP-3 distinguish subjects
with progressive radiographic knee OA from those with stable
disease.
Methods: Subjects were 69 women, 45–64 years old, with unilateral
knee OA who were randomized to the placebo group of a clinical
trial of a disease-modifying OA drug. They were selected from
a larger sample to permit comparisons of plasma MMP-3 levels
between radiographic progressors vs non-progressors over 16
months and 30 months (Table I). Radiographs were obtained with
ﬂuoroscopically standardized positioning of the knee (semiﬂexed
AP view) at baseline, 16 months and 30 months.
Plasma samples were collected every 6 months for assay of MMP-
3 by ELISA. Reproducibility (intraclass correlation) of MMP-3
values in 30 masked pairs of plasma samples was 0.89.
Results: Multiple logistic regression indicated that, after adjustment
for age, subjects in the upper tertile of MMP-3 concentrations at
baseline (11.3–28.6 ng/ml) were O6-fold more likely to exhibit
progression of JSN in the index knee than those in the lower tertile
(1.5–6.6 ng/ml) (odds ratio (OR) Z 6.3, P Z 0.008). The
association was less striking at 30 months (OR Z 3.4, P Z
0.06). Similar results were found in the contralateral knee: OR Z
5.5, P Z 0.012 at 16 months; OR Z 3.3, P Z 0.06 at 30 months.
Table II contains the results of multiple regression analyses to
determine the association between JSN and intercurrent MMP-3
levels (mean and maximum) over discrete intervals (months 0–16,
months 16–30).
Table I
Mean JSN G SD (mm)
Index knee Contralateral knee
16 Months 30 Months 16 Months 30 Months
Progressors 0.76 G 0.52 1.04 G 0.90 0.75 G 0.69 1.16 G 0.89
Non-progressors 0.05 G 0.16 0.00 G 0.15 0.08 G 0.20 0.02 G 0.17Discussion: These data support the use of plasma MMP-3
concentration as a predictor of JSN knee OA. However, the
predictive value of MMP-3 attenuates between 16 and 30 months.
MMP-3 levels appeared to reﬂect concurrent JSN in the index knee
over the entire 30-month period of observation. These ﬁndings
should be conﬁrmed in other, more heterogeneous samples using
similarly well standardized radiographic methods.
Supported by NIH (AR43348, AR43370, AR20582) and the
Swedish Research Council Medicine.
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PROTEOMIC ANALYSIS OF HUMAN ARTICULAR CARTILAGE
USING MASS SPECTROMETRY
B. A. Garciay, T. L. Bornz, M. D. Platty, J. Shabanowitzy,
D. F. Hunty, N. A. Marcusx
y Department of Chemistry, University of Virginia, Charlottesville,
VA, USA
z Department of Biochemistry, George Mason University, Mana-
ssas, VA, USA
xCell Mechanics LLC, Fairfax, VA, USA
Introduction: Typical methods to monitor chondrocyte secreted
protein levels in cartilage involve biochemical techniques that are
time consuming, laborious and can be prone to false positive hits.
Mass spectrometry has emerged as a powerful tool for the biologist
to help assist in the identiﬁcation of proteins, post-translational
modiﬁcations and even to monitor protein expression levels. In
these experiments a proteomic mass spectrometry based approach
was utilized for the identiﬁcation of proteins secreted into the extra-
cellular matrix.
Materials and methods: Human knee cartilage was obtained from
fresh allograft material from normal and osteoarthritic patients
undergoing surgery. Cells were dissociated from cartilage material
by digestion with Liberase enzyme. The resulting material was
centrifuged and supernatant removed. Proteins in the resulting
supernatant were fractionated by 1D-SDS-PAGE and the entire gel
lane was cut into sections for in-gel digestion with trypsin. Extracted
peptides were then loaded onto C18 packed capillary precolumns,
rinsed with 0.1% HOAc and connected to analytical columns
constructed with an integrated electrospray emitter tip. Peptides
loaded onto these columns were then HPLC gradient eluted directly
into either an LCQ Deca XP ion trap or LTQ-FT mass spectrometer.
The LTQ-FT mass spectrometer operates at 2 ppm mass accuracy,
100,000 resolution and possesses a higher dynamic range and
sensitivity than other ion trap mass spectrometers. Data dependent
mode experiments were employed to obtain sequence information
(MS/MS spectra) on the peptides. All mass spectrometry data were
searched using the SEQUEST database searching program and
manually veriﬁed afterwards.
Results: Preliminary analysis of the in-gel digested protein solutions
has identiﬁed approximately 100 proteins in both normal and
osteoarthritic cartilage samples. About one-ﬁfth of these proteins
are known to play a role in the normal function of cartilage and
include structural proteins such as aggrecan, ﬁbronectin, cartilage
Table II
Association between serial MMP-3 concentrations and JSN
Index knee Contralateral knee
Months: 0–16 16–30 0–16 16-30
Mean value for intercurrent
MMP-3 concentrations
0.023* 0.030y 0.032y 0.011
Maximum value for
intercurrent MMP-3
concentrations
0.037y 0.033y 0.046y 0.017
Note: Numbers represent age-adjusted parameter estimates
indicating the change in JSN associated with each unit increase
in MMP-3 concentration.
*P ! 0.05
yP ! 0.01
S11link protein and several isoforms of collagen. These mass
spectrometry experiments have also identiﬁed several proteins
involved in extra-cellular matrix signaling and processing such as
members of the Tenascin family. Most interestingly, growth and
inductive factors were also detected in these studies, some of
which have not been fully detailed to be expressed in cartilage.
Investigations to determine protein expression differences between
normal and osteoarthritic samples using a novel stable isotope
labeling technique have also resulted in the identiﬁcation of proteins
differentially expressed between samples.
Conclusions: Our results demonstrate how mass spectrometry can
be utilized for the identiﬁcation of proteins from a complex mixture
of cartilage supernatant. It is believed that these experiments can
be used not only for the identiﬁcation of proteins, but rather for the
discovery of potential biomarkers of osteoarthritis in a rapid,
sensitive and accurate manner.
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THE PRESENCE OF TYPE XI COLLAGEN LIMITS LATERAL
GROWTH OF TYPE II COLLAGEN FIBRILS IN CARTILAGE
L. Xuy, K. Huz, B. R. Olsenyz, Y. Liz
y Cell Biology, Harvard Medical School, Boston, MA, USA
z Oral and Developmental Biology, Harvard School of Dental
Medicine, Boston, MA, USA
Understanding how lateral growth (diameter) of type II collagen
ﬁbrils is controlled provides not only novel insights into collagen
ﬁbrillogenesis, but also broadens our knowledge of osteoarthritis
(OA) pathogenesis since the presence of thick type II collagen ﬁbrils
in articular cartilages is one of the characteristics at early stages of
human OA. In a previous study of chondrodysplasia (cho) mice, we
showed that the presence of thick type II collagen ﬁbrils in cartilage
was due to the lack of type XI collagen. In vitro studies of
ﬁbrillogenesis found that type XI collagen was sufﬁcient for limiting
lateral growth of type II collagen ﬁbrils. Here we report that the
correct molar proportions of cartilage type II and type XI collagens
are essential for the control of the precise diameter of type II
collagen ﬁbrils in cartilage. Using electron microscopy we examined
type II collagen ﬁbrils at three different locations in cartilages of mice
of three different genotypes at embryonic day 18. The three
locations were costal and growth plate cartilage (both containing
type XI collagen) and the surface of knee joints articular cartilage
where type XI collagen is absent. The three different mice were
homozygous (cho/cho) mice, lacking type XI collagen, heterozy-
gous (cho/C) mice, having 50% of type XI collagen and wild-type
mice. We measured the shortest diameter of 1000 cross sections of
type II collagen ﬁbrils at each location in different mice. The diameter
of the majority (943) of the ﬁbrils was 22 nm in costal cartilages of
normal day-18 embryos, but almost half (452) of the ﬁbrils in costal
cartilages of cho/C and two thirds (653) of the ﬁbrils in cho/cho mice
was 44 nm. In normal embryonic growth plates, the diameter of the
majority (877) of the ﬁbrils was 22 nm, but the diameter of majority
(750) of the ﬁbrils in cho/C growth plates was 44 nm. In cho/cho
growth plates, the diameter of half (476) of the ﬁbrils was 66 nm and
one quarter (220) of them was 88 nm. In knee joint surfaces of three
different genotype embryos, cho/cho, cho/C and wild-type, the
diameter of the ﬁbrils appeared same, 44 nm. The results show that
the diameter of the ﬁbrils was tightly correlated with the molar
proportions of type II and type XI collagens; the lower the amount the
type XI collagen, the lower the number of thin type II collagen ﬁbrils.
Type II collagen ﬁbrils tend to be thickening without the presence of
type XI collagen. In summary, this study indicates that the correct
molar ratio of type II and type XI collagens is required for the
formation of thin type II collagen ﬁbrils in cartilage.
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HUMAN MMP-13 OVER-EXPRESSION IN TRANSGENIC MICE
IS EXACERBATED BY JOINT INSTABILITY
S. S. Glasson, T. J. Blanchet, H. L. Ma, E. A. Morris
Women’s Health and Bone, Wyeth, Cambridge, MA, USAAim: MMP-13 is a collagenase responsible for type II collagen
cleavage in many physiological and pathological processes.
Excessive MMP-13 activity may be critical to the progression of
osteoarthritis (OA). Development of ’spontaneous’, mild OA has
previously been described in a transgenic mouse which over-
expresses human MMP-13 (hMMP-13). This mouse was designed
with tetracycline-off regulated transcription and a cartilage speciﬁc
(type II collagen) promoter to result in constitutively active hMMP-
13 in the cartilage. The purpose of this study was to evaluate the
effect of surgically induced joint instability in this hMMP-13
overexpressing mouse to develop a rapid, repeatable, MMP-13-
dependent murine model for screening of MMP-13 speciﬁc
inhibitors for arthritis therapeutics.
Methods: Overexpression of hMMP-13 was induced in the cartilage
by doxycycline withdrawal at d-5 (in utero) in the unmanipulated
transgenic group, and male mice were sacriﬁced at 8 and 20 weeks
of age. In the surgically manipulated transgenic mice, doxycycline
was withdrawn at 5 weeks of age, and joint instability was induced
by destabilization of the medial meniscus at 10 weeks of age. Mice
were sacriﬁced 4 or 8 weeks after surgery. Strain matched (FVB/N)
WT mice were also surgically manipulated for comparison.
Following sacriﬁce of all animals, the knees were decalciﬁed,
stained with safranin-O and scored by 2–3 blinded observers using
a semi-quantitative system where a higher score reﬂects greater
OA severity. All procedures were approved by the Institutional
Animal Care and Use Committee.
Results: Mild ’spontaneous’ OA was observed in the hMMP-13
overexpressing mice. Following surgical joint instability, the WT
mice developed mild OA. In contrast, surgical instability of the
hMMP-13 overexpressing mice induced severe OA, with scores
4 times higher than the surgically induced WT mice or the
‘spontaneous’ OA in the unmanipulated hMMP-13 overexpressing
mice.
Conclusions: Since the type II collagen promoter drives hMMP-13
overexpression in this trangenic mouse, it is reasonable that
increased MMP-13 transcription would occur in periods of growth or
remodeling. This study showed only minor pathology due to
excessive hMMP-13 expression during development or growth. In
contrast, severe OA was observed in the transgenic mouse with an
unstable joint. It is possible that joint instability initiated pathology
that promoted repair responses, including up-regulation of type II
collagen, in turn leading to increased MMP-13. This process would
promote a vicious cycle of attempted repair and type II collagen
destruction. Future studies will evaluate the ability of MMP-13
speciﬁc inhibitors to inhibit OA progression in this model.
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THE SMALL PROTEOGLYCAN BIGLYCAN BINDS TO THE
CELL SURFACE AND EXERTS AN ANTI-ANABOLIC EFFECT
ON CHONDROCYTE HOMEOSTASIS
D. Gerard, I. Morozova, S. Chubinskaya, G. Cs-Szabo
Biochemistry and Orthopedic Surgery, Rush University Medical
Center, Chicago, IL, USA
Aim: Biglycan plays regulatory roles in matrix assembly of articular
cartilage through binding to different matrix molecules, including
ﬁbrillar collagens and growth factors. We reported that the
S12expression of biglycan is increased in aging and in degenerated
and osteoarthritic cartilage. The aim of the study was to determine
whether biglycan binds to chondrocytes and to delineate its
biological effect on chondrocyte homeostasis.
Methods: Chondrocytes harvested from normal human ankle
cartilage (n Z 9) were cultured in conﬂuent monolayers. Human
prostatic cancer cells (PC-3) rich in EGF receptor, were used as
a model. For binding assays biglycan was labeled with Rhodamine-
red (RR). Cells in chamber slides were subjected to RR-biglycan in
different concentrations for time periods between 30 m and 24 h.
Competition assays were performed by using RR-biglycan and
non-labeled biglycan, EGF receptor blocking antibody, isotype
antibody or decorin. Fluorescent signal was observed under
a ﬂuorescent microscope and/or a confocal microscope. Internal-
ization of the RR-biglycan was determined after trypsinization. EGF
receptor expression was demonstrated by antibody staining and
RT/PCR. For gene expression studies, chondrocytes were cultured
between 2 and 24 h in the presence or absence of biglycan.
Expression levels of aggrecan, collagen type II, OP-1 (BMP-7),
ALK-2 (OP-1 receptor) and cyclin-dependent kinase inhibitor p27
were determined by RT/PCR using GAPDH as a control.
Results: Both chondrocytes and PC-3 cells were shown to express
EGF receptors and were able to bind biglycan in a concentration-
and time-dependent manner. RR-biglycan was found to initiate
binding upon the cell surface of both cell types within 30 min and
was internalized in 3 h. Non-labeled biglycan was able to abolish the
binding of RR-biglycan completely while the EGF receptor blocking
antibody showed partial (about 70%) competition. Biglycan-decorin
competition was also observed in both cell types. Biglycan
signiﬁcantly decreased the expression levels of aggrecan and type
II collagen: 50% of the control level by 4 h with further decrease by
24 h. OP-1 and ALK-2 expression levels also decreased signiﬁ-
cantly. p27 message, however, was strongly upregulated.
Conclusions: We demonstrate for the ﬁrst time that biglycan can
bind to chondrocytes predominantly through the EGF receptor. This
is further supported by the ﬁnding that PC-3 cells rich in EGF
receptors also bind biglycan. Upregulation of p27 may be re-
sponsible for halting cancer cell proliferation and for initiating
chondrocyte quiescence. The downregulation of aggrecan, colla-
gen, OP-1 and OP-1 receptor expression suggests that biglycan
may regulate the effects of growth factors by downregulating their
expression levels (e.g., of OP-1) and/or by imposing an opposite
effect (e.g., to TGF-b) on the expression levels of the major matrix
molecules. The ability of biglycan and decorin to compete implies
that they may complement each other’s biological effects. These
results suggest that the presence of increased amounts of biglycan
in osteoarthritic or older cartilage may contribute to the cells’
inability for proper repair.
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DISPROPORTIONATE MATRIX GENE EXPRESSION IN
OSTEOARTHRITIC CHONDROCYTES
N. Fukuiy, L. J. Sandellz, Y. Ikeday, T. Ohnukiy, K. Tanakay,
S. Yamamotox, H. Ishibashix, M. Sawabex, R. Suzukiy, T. Ochiy
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mihara Hospital, Sagamihara, Kanagawa, Japan
z Department of Orthopaedics, Washington University School of
Medicine, St. Louis, MO, USA
x Departments of Orthopaedics and Pathology, Tokyo Metropolitan
Geriatric Hospital, Itabashi, Tokyo, Japan
Aim: This study was conducted to investigate the expression of
major matrix genes in OA and normal cartilage chondrocytes,
correlating with the location in cartilage and the severity of cartilage
degeneration.
Methods: The study was conducted under the approval of
institutional review boards. OA cartilage was obtained from 11
patients at joint replacement surgery, and the specimens were
harvested from the areas with various disease severity. Control
cartilage was obtained from non-arthritic joints of the age-matched
donors at autopsy. Frozen sections were prepared, and the tissuewas obtained (1) by the severity of the disease and (2) by the
cartilage zones using a laser captured microdissection device. RNA
was extracted, cDNA was synthesized, and the expression of Col
a1(II), Col a1(IX), Col a1(XI), and aggrecan were quantitatively
assessed by real-time PCR. The data were compared by cartilage
layers between OA and control cartilage.
Results: In general, the expression of all four genes was enhanced
in OA cartilage. The increase was most obvious in the deep zone:
the expression of aggrecan was increased more than 4-fold, and
the expression of type II collagen was 10-fold over control cartilage
at the equivalent zone. However, with the progression of the
disease and loss of cartilage matrix, expression was suppressed at
the surface of degenerated cartilage. The trend was most obvious
with aggrecan and type IX collagen, and to a lesser extent with type
II and type XI collagen.
Next, considering that the collagen framework in cartilage is
composed of types II, IX, and XI collagen, the expression levels
were compared among these genes. Although the expression of all
three collagen genes was elevated in OA cartilage, there was
a signiﬁcant discrepancy in the levels of enhancement. The
expression of type II collagen was most strongly augmented, while
the levels of increase for type IX and type XI collagen were only 20–
30% of that for type II. Consequently, the expression ratios between
type II and type IX or type XI collagen were signiﬁcantly reduced in
OA cartilage compared with those in control cartilage.
Conclusions: The result of this study shows that the chondrocyte
anabolism is signiﬁcantly altered in OA cartilage. First, although the
expression of cartilage matrix genes are generally up-regulated in
OA chondrocytes, the expression are actually suppressed at the
surface of degenerated cartilage, suggesting that chondrocytes are
no longer anabolic where the matrix loss occurs. Secondly, the
current result revealed that the expression of type IX and XI
collagen is relatively low in OA cartilage compared with type II
collagen. It is widely thought that proper matrix assembly requires
the correct proportion of matrix molecules as building blocks, which
has been supported by the analyses of gene mutated mice and the
patients with genetic mutations. Consequently, the discoordinated
collagen gene expression observed in these samples of OA tissues
might explain, at least partly, why matrix loss progresses in OA in
spite of the enhanced anabolism.
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STUDY: FREQUENCIES OF LARGE JOINT INVOLVEMENT
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Aim of study: No standardized deﬁnition of osteoarthritis (OA) exists
for the purposes of genetic studies. Past genetic studies have
commonly focused on hand OA ascertained by physical examina-
tion or radiograph, hip or knee OA ascertained by radiograph or
history of joint replacement, and spine OA ascertained by
radiograph or MRI. Participants in the GOGO study were
ascertained by clinical hand OA. We hypothesized that this clinical
phenotype would facilitate identiﬁcation of participants for linkage
analysis with a variety of multijoint radiographic involvement in and
beyond the hand.
Methods: The GOGO study is conducted by a consortium of seven
clinical research sites in the US and UK. A qualifying family con-
sisted of at least two siblings affected with radiographic OA (rOA) of
the hand, deﬁned by Kellgren Lawrence (KL) grade of R2 involv-
ing R3 joints, distributed bilaterally, of the distal interphalangeal
S13(DIP), proximal interphalangeal (PIP), or carpometacarpal (CMC)
joint groups, and self-reported Caucasian ethnicity. Participants
underwent radiography of the hands, hips, and knees with OA
deﬁned as KL grade R 2 or a veriﬁed history of joint replacement
for OA. Patellofemoral joint (PFJ) OA was deﬁned by an osteophyte
grade R2. Lumbar spine X-rays were obtained at the US sites with
OA deﬁned as osteophyte grade R1 and disc narrowing R1 at the
same vertebral level.
Results: The frequencies of large joint rOA in individuals who met
rOA hand criteria (n Z 1962) were highest in the knee—49.2%
(8.6% due to joint replacement), and spine—60.4% (in the US
sample only), and less common in the hip—12.9% (6% due to joint
replacement). A total of 278 participants (14.2%) had radiographic
PFJ OA and all but 38 of these participants also had OA of the
tibiofemoral joint. Thus, PFJ OA occurred in the setting of
tibiofemoral OA in an overwhelming majority (86.3%) and rarely
in isolation. A majority (57%) of sib pairs were concordant for
speciﬁc patterns of multijoint rOA.
Conclusion: Multijoint rOA of the hand as an ascertainment strategy
resulted in high concordance for speciﬁc patterns of multijoint rOA
in sib pairs. The US cohort with hand rOA demonstrated common
involvement of the spine. The GOGO cohort provides large
numbers of individuals with various combinations of multijoint
involvement for linkage studies.
This study was supported by a grant from GlaxoSmithKline.
M31
THE LONG TERM EFFECT OF ALENDRONATE ON
THE DEVELOPMENT OF THE GUINEA PIG ACCELERATED
SPONTANEOUS OSTEOARTHRITIS MODEL
S. X. Wangyz, R. Formosaz, C. Howy, R. Kandely, M. D. Grynpasyz
y Laboratory Medicine and Pathobiology Department, University of
Toronto, Toronto, ON, Canada
z Samuel Lunenfeld Research Institute, Mount Sinai Hospital,
Toronto, ON, Canada
Bone and cartilage changes co-exist in human OA during the
course of the disease. Increased bone turnover could be a key
factor in disease progression. The aim of this study is to investigate
if alendronate (bisphosphonate) treatment could prevent or delay
the progression of OA by decreasing subchondral bone turnover.
Methods: Sixty 3-month old male Hartley-Dunkin guinea pigs
underwent a partial medial meniscectomy in the right knee to
accelerate the onset of OA. The unoperated knee served as
internal control. Thirty animals received alendronate twice a week
after surgery (0.35 mg/kg, subcutaneous injection). Ten treated and
10 untreated animals were sacriﬁced at 1, 3, and 6 months after
surgery, respectively. Another 10 animals served as time 0 controls.
Cartilage samples harvested from distal femur were used for
biochemical assays to determine glycosaminoglycan, DNA, and
collagen content. Bone mineral density (BMD) was measured in the
distal femur, medial and lateral femoral condyle, proximal tibia, and
the medial and lateral tibial plateau. The tibias were then ﬁxed,
decalciﬁed and parafﬁn embedded. Safranin-O stained histological
sections were evaluated using a modiﬁed Mankin grading to
quantify OA disease severity. Femurs were cut coronally, embed-
ded in spurr resin, and scanned using back scatter electron
microscopy (BSE). The images were analyzed for subchondral
trabecular bone structure and connectivity, as well as growth plate
thickness. All data were analyzed using SPSS statistical software
using one way ANOVA and signiﬁcance assigned at P Z 0.05.
Results
Histology: Mankin grading was 6.4 G 1.4 at 1 month and showed
a signiﬁcant progression in severity to 7.5 G 1.3 at 3 months and
10 G 1.4 at 6 months after surgery. The treated group showed
a smaller increase in disease severity, from 6.1G 1.2 at 1 month to
6.9 G 1.3 and 8.6 G 1.4 at 3 and 6 months.
Bone mineral density: The BMD of the untreated group decreased
signiﬁcantly at 1 month after surgery and increased thereafter. The
treated operated group showed a constant increase in BMD at all
time points after surgery.Bone morphometry: Trabecular bone volume and thickness de-
creased in the ﬁrst month and then increased in the untreated
femurs. In contrast in the treated animals the femurs only show an
increase in these parameters. Trabecular bone connectivity in the
femurs of the untreated group decreased in the ﬁrst month and
increased thereafter, whereas in treated group there were no
signiﬁcant changes.
Cartilage biochemistry: The alendronate treated group showed
higher GAG, DNA and collagen content than the untreated group at
all time points examined.
Discussion: In this study alendronate was shown to prevent
subchondral bone resorption early in the disease and this
correlated with a slowing of the progression of OA in this model.
As reﬂected by the Mankin grading, by preventing the bone
resorption occurring early in OA the rate of bone turnover is
reduced and remodeling effects modulated. This is a potential
mechanism for chondroprotection and suggests a role for bi-
sphosphonate treatment early in OA.
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THE RELATIONSHIP BETWEEN PEAK EXTERNAL KNEE
ADDUCTION MOMENTS, PEAK VARUS ALIGNMENT AND
MEDIAL COMPARTMENT PATHOLOGY IN OSTEOARTHRITIS
OF THE KNEE
J. Woodburny, D. E. Turnery, A. Graingerz, E. Hensory, L. Rhodesx,
C. Thomasy, P. Emeryy, P. G. Conaghany
y Academic Unit of Musculoskeletal Disease & Rehabilitation
Medicine, University of Leeds, Leeds, United Kingdom
z Department of Radiology, Leeds General Infirmary, Leeds, United
Kingdom
x Medical Physics, University of Leeds, Leeds, United Kingdom
Aim: The adduction moment determines medial–lateral load
distribution at the knee and correlates with osteoarthritis (OA)
radiographic severity, bone mineral distribution and the mechanical
axis of the leg. Varus knee alignment is also associated with
medial MRI bone marrow edema (BME) and cartilage volume. This
study aimed to establish the relationship between both peak
external knee adduction moments and peak varus alignment with
MRI medial compartment knee pathology in knee OA.
Methods: Subjects with ACR OA knee were enrolled. A six-
camera motion analysis system captured three-dimensional
kinematic data from the lower limb. Ground reaction forces were
measured using a force platform and inverse dynamic analyses
were performed to obtain the peak external knee adduction
moment and maximum varus/valgus knee angle during the
stance phase of gait. MRI features (including cartilage morphol-
ogy, osteophytes, BME, sub-articular cysts, bone attrition, and
menisci) were scored using the semi-quantitative WORMS
system. Non-parametric Spearman correlations were used to
assess the degree of association between gait variables and MRI
features.
Results: To date 25 subjects have been analysed with mean age 66
(range 54–83). As previously reported, varus knee alignment was
signiﬁcantly correlated with peak external knee moment (P Z
0.001). Medial scores for bone attrition (P Z 0.001) and menisci
(P ! 0.001) were signiﬁcantly positively associated with the varus
alignment. There were trends towards medial scores for BME (PZ
0.009) being signiﬁcantly positively associated with the varus
alignment, and for bone attrition (P Z 0.026) and menisci (P Z
0.015) being associated with peak external knee moment, however
following correction for multiple comparison these were not
signiﬁcant. There was a non-signiﬁcant trend towards scores for
osteophytes and BME being associated with peak external knee
moment.
Conclusions: The preliminary analysis of this cohort supports
the concept that there is a relationship between the magnitude of
the dynamic loads (elevated external knee adduction moment), the
degree of abnormal knee joint alignment (increased knee varus
alignment) and increasing severity of knee joint pathology, in-
cluding bone attrition and meniscal abnormalities.
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DEVELOPMENT OF COMPREHENSIVE FUNCTIONAL
GENOMIC SCREENS TO IDENTIFY NOVEL MEDIATORS OF
OSTEOARTHRITIS
C. S. Kumary, S. Daoutiy, B. J. Latarioy, S. Nagulapalliy, S. Uziel-
Fusiz, G. Chirny, D. Bodiany, C. Songy, M. Labowy, M. Lotzx,
J. Quintavallaz
y Functional Genomics, Novartis Institutes for Biomedical Re-
search, Cambridge, MA, USA
z Arthritis and Bone Metabolism, Novartis Pharmaceuticals, East
Hanover, NJ, USA
x Arthritis Research, The Scripps Research Institute, La Jolla, CA,
USA
Aims: Molecular mechanisms underlying the pathogenesis osteo-
arthritis (OA) remain to be elucidated. Gene proﬁling studies on
normal and OA cartilage demonstrate that a large number of genes
are differentially expressed in OA cartilage. In addition, by
sequencing OA cDNA libraries, large numbers of genes expressed
in OA cartilage have been catalogued. The full potential of this
information can be realized only if biologically meaningful high
throughput assays are available. The objectives of the present
study were to develop high throughput assays for the analysis of
major chondrocyte functions that are important in OA pathogenesis
and to develop methods for high level gene expression and
analysis in primary human chondrocytes.
Methods: In the ﬁrst approach, OA cDNA libraries were con-
structed, sequenced and full-length clones were selected. These
cDNAs were transferred into a retroviral vector using Gateway
Technology. Full-length clones were over-expressed in human
articular chondrocytes (HAC) by retroviral-mediated gene transfer.
The induction of OA-associated markers, including aggrecanase-1
(Agg-1), matrix metalloproteinase-13 (MMP-13), inducible nitric
oxide synthase (iNOS), cyclooxygenase-2 (COX-2), collagen IIA
and collagen X was measured by quantitative real time PCR
(QPCR). In the second approach, whole cDNA libraries were
transduced into chondrocytes and screened for chondrocyte cluster
formation in three-dimensional agarose cultures.
Results: Using green ﬂuorescent protein (eGFP) as a marker gene
it was shown that the transduction efﬁciency wasO90%. A total of
38 veriﬁed hits were identiﬁed in the QPCR screen. Hits were
deﬁned as genes that induced mRNA expression of at least one OA
phenotypic marker by three fold or more. The ﬁrst set of 17 hits
coordinately induced iNOS, COX-2, Agg-1 and MMP-13. The most
potent of these genes were receptor interacting kinase-2, tumor
necrosis factor receptor 1A, ﬁbroblast growth factor and its receptor
FGFR, MUS81 endonuclease and Sentrin/SUMO speciﬁc protease
3. The second set of 7 hits induced both Agg-1 and MMP-13. Five
of these regulate the phosphoinositide 3-kinase pathway. Seven
genes potently induced iNOS (20–500 fold). Collagen IIa was also
induced by 7 genes. This screening assay did not identify any
inducers of collagen X.
The second chondrocyte cluster formation screen identiﬁed 14
veriﬁed hits including bFGF, a known inducer of this phenotype. Most
of the genes inducing cluster formation were kinases. Additional hits
had not been previously known to regulate chondrocyte cluster
formation. However, all these genes when over-expressed in
chondrocytes induced expression of bFGF mRNA.
Conclusions: The methods developed in this study enabled us to
screen for genes capable of inducing an OA-like phenotype in
chondrocytes on a genome wide scale and identify novel
mediators. Thus coordinated functional genomic approaches can
be used to delineate key genes and pathways activated in complex
human diseases such as OA.
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CHONDROCYTE CELL CULTURE SYSTEMS-WHICH SHOULD I
USE AND WHY
E. J. Thonar
Department of Biochemistry, Rush Medical College at Rush
University Medical Center, Chicago, IL, United StatesChondrocytes are particularly susceptible to changes in their
environment. For example, articular chondrocytes plated at a low
density as a monolayer rapidly lose their round shape and begin to
express genes for proteins not normally found in the tissue from
which the cells were derived. While most culture systems currently
available have been successful in demonstrating that the cells do
retain most aspects of the chondrocytic phenotype, some systems
have been more successful than others in reaching this goal. The
different culture systems all have something unique to offer.
Monolayers of articular chondrocytes plated at high density proved
useful in the early 1980s in helping unravel intracellular mecha-
nisms regulating the synthesis of aggrecan molecules. The fact that
most of the molecules newly synthesized by these cells rapidly
appearing in the medium made it possible to study the formation of
proteoglycan aggregates in their native state. Monolayers also
were used to show that bovine calf and steer articular chondrocytes
denuded from their matrix were capable of reforming in culture
a limited amount of matrix exhibiting age-speciﬁc characteristics. In
more recent years, a variety of culture systems (roller bottles, pellet,
agarose, alginate, etc.) were developed to study one or other
aspects of the synthesis, turnover or degradation of matrix
macromolecules. Some of these systems proved much more
effective than monolayers in retaining the chondrocytic phenotype
over the longer term (i.e., up to 8 months). They were modiﬁed over
the years to allow scientists to address speciﬁc questions. The
alginate bead system, for example, was modiﬁed to show that
aggrecan in the cell-associated matrix turns over much more
rapidly than aggrecan molecules that had become established in
the more abundant interterritorial areas further removed from the
cell membrane. This system was subsequently incorporated as
a ﬁrst step in the Alginate-Recovered Chondrocytes (ARC) system
for the rapid reformation of a metabolically active cartilage-like
tissue with many potential uses. It is worth noting that the culture
systems that developed to study the metabolism of articular
chondrocytes and of their matrix are proving useful to study the
metabolism of related cells, i.e., nucleus pulposus cells, nasal
chondrocytes, meniscal cells, etc.
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CHONDROCYTE CELL CULTURE SYSTEMS AND MODELS
FOR STUDIES OF GENE EXPRESSION
M. B. Goldring
Division of Rheumatology, Beth Israel Deaconess Medical Center,
and New England Baptist Bone & Joint Institute, Harvard Institutes
of Medicine, Boston, MA, United States
The human adult articular chondrocyte is a unique cell type that has
reached a terminally differentiated state within the cartilage matrix
as an end-point of development. Isolated chondrocytes in primary
culture have provided useful models to study cellular responses to
alterations in the environment such as those occurring in different
forms of arthritis. Immortalized chondrocytes of human origin have
been developed to serve as reproducible models for studying
chondrocyte function. However, expansion of primary or immortal-
ized chondrocytes in monolayer culture results in decreased
expression of phenotypic markers, particularly if high cell density
is not maintained. Suspension culture systems may be used to
reinduce or maintain the expression of chondrocyte-speciﬁc
markers. Retroviral-mediated transduction of SV40-Tag, HPV-16
E6/E7, or telomerase has been used somewhat successfully to
immortalize primary human chondrocytes. However, the source
and developmental state of the isolated chondrocytes, e.g., adult
articular or juvenile costal have inﬂuence on the retained character-
istics such as proliferative capacity and differentiated phenotype.
The detection of even low levels of COL2A1, aggrecan, and Sox9
mRNA assessed by sensitive RT-PCR techniques is an indicator of
the capacity to support the expression of chondrocyte-speciﬁc gene
promoters in transient transfections. Our studies indicate that the
endogenous levels of Sox9, L-Sox5, and Sox6 are sufﬁcient to
support expression of naked COL2A1 promoter fragments (–577/
C125 bp or –131/C125 bp) in either the absence or presence of
S15the Sox9-binding enhancer fragment required for expression
in vivo. However, the expression of 4.0 kb regulatory region
(–577/C3428 bp), which is 10% of the levels expressed by
promoter fragments, can be stimulated by cotransfection of Sox9
together with L-Sox5 or Sox6, or by a combination of all three SOX
proteins. In addition to transfections, we have used human
chondrocyte cell lines most successfully in studies requiring large
numbers of cells to generate, for example, nuclear extracts for DNA
binding analysis of induced and endogenous transcription factors.
Nevertheless, immortalized chondrocytes should not be considered
as substitutes for primary chondrocytes, but are useful as tools for
evaluating and further validating mechanisms relevant to cartilage
biology.
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OSTEOARTHRITIS RESEARCH SOCIETY INTERNATIONAL
HAND OA TASK FORCE: DESIGN AND CONDUCT OF
CLINICAL TRIALS ON OSTEOARTHRITIS (OA) OF THE HAND
R. D. Altman, N. Bellamy
CA, USA
Queensland, Australia
Objective: A subcommittee was established to update clinical trial
design for OA of the hand.
Method: A systematic review of the literature on clinical trials in OA
of the hand was performed addressing clinical and radiological
assessment methods. Expert opinion supplemented the evidence-
based reports to modify the study design from a prior OARSI report.
Results: The American College of Rheumatology classiﬁcation
criteria remain the only research based classiﬁcation criteria. There
are no biochemical or speciﬁc genetic markers that are helpful in
classiﬁcation of disease or deﬁning progression; however, collec-
tion of serum for future analysis is felt to be important. There is
a poor correlation between symptoms, signs, and radiographic
change, particularly in mild and moderate OA that needs to be
considered in certain study designs.
A number of condition-speciﬁc outcome measures have been
developed, and to varying degrees validated. For trials examining
symptoms, a validated pain score (single or multi-item) was felt to
be the most relevant primary outcome measure. The instrument
used at the time of screening should be the same instrument used
during follow-up examinations. Several secondary variables
should be included. A functional index is strongly recommended
(e.g., AUSCAN Index, Cochin Index, Dreiser-FIHOA Index). The
patient global assessment question may become more informative
with further development. Other measurements may include
validated measures of joint stiffness, joint tenderness, aesthetic
damage, etc.
For trials examining joint structure, the plain radiograph remains the
standard technique. Twenty to 30 hand joints should be examined,
depending on the radiographic grading system selected. Group
consensus recommended that each joint should be examined for
individual radiographic features; and progression graded based on
changes in those features. Further comparisons of existing
radiographic scales are needed to determine their relative re-
sponsiveness. The role of MRI remains to be deﬁned.Conclusion: In recent years, there has been reﬁnement in the
methodology of hand OA clinical trials. Future trials should utilize
these reﬁnements, and preferentially incorporate validated classi-
ﬁcation, imaging, grading and clinical evaluation techniques. A
workshop at the OARSI 2004 Congress will further reﬁne these
recommendations.
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DEFINING HAND OSTEOARTHRITIS FOR EPIDEMIOLOGIC
STUDIES AND CLINICAL TRIALS
J. M. Jordan*, M.D., M.P.H.
Thurston Arthritis Research Center, University of North Carolina at
Chapel Hill, Chapel Hill, NC, USA
Osteoarthritis (OA) of the hand can be deﬁned in several related,
but distinct ways. Three common deﬁnitions are radiographic hand
OA, clinical hand OA, and symptomatic hand OA. Which method is
optimal may be determined by the type and purpose of the research
question. For example, radiographic criteria might be most
appropriate for a study of the prevalence of hand OA in the
community, while a clinical trial of a symptom-modifying drug might
require symptomatic hand OA of a pre-determined severity for
inclusion, that is, hand symptoms (usually pain, aching, or stiffness)
in addition to radiographic evidence of hand OA. A clinical trial of
a putative structure-modifying drug would require some type of
imaging that could reliably and validly represent change in structure
of the joints. OMERACT has recommended that clinical trials
assess a core set of measures including pain, physical function,
patient global assessment, and imaging, the last particularly for
studies of 1 year or more in duration.
Radiographic hand OA can be deﬁned for the hand as a whole, for
individual joint groups (distal interphalangeal joints DIP, proximal
interphalangeal joints PIP, metacarpophalangeal joints MCP, and
carpometacarpal joints CMC or the thumb base), numbers or
proportions of affected hand joints, or according to various
combinations of affected joint groups. Radiographic OA of the
MCP, PIP, DIP, and CMC is commonly deﬁned as a score of 2 or
more on the Kellgren-Lawrence (KL) radiographic scale, although
other scales and atlases have also been devised. Because hand
joints are so small and subject to variability in radiographic
positioning, it is not possible to measure joint space width or
its change over time reliably using hand radiographs. Consequent-
ly, measures such as an increase in the number of hand joints of KL
2 or more, or an increase in KL grade in speciﬁc joints over
time, may be used to deﬁne incidence and progression of
radiographic hand OA. Whether magnetic resonance imaging or
other imaging modalities will improve upon this deserves further
study.
Clinical hand OA usually refers to the presence of Heberden’s
and/or Bouchard’s nodes on physical examination, sometimes
including bony enlargement or squaring of the CMC as well. The
American College of Rheumatology (ACR) criteria for clinical hand
OA include the presence of hand pain and a selection of
abnormalities on physical examination. Unfortunately, the corre-
spondence between clinical hand OA, radiographic hand OA, and
hand symptoms is not perfect. Screening for hand OA has been
attempted with postal surveys, photographs, and physical
examination. Whether the selection of individuals to be screened
was from the general population, from clinics, from families with
a history of generalized OA, or from individuals with hand
symptoms may inﬂuence the utility of the various screening
methods.
The Australian–Canadian Scale for Hand OA (AUSCAN) and
Dreiser hand index are valid instruments with adequate sensitivity
to change for the longitudinal assessment of hand OA symptoms
and function in epidemiologic studies or in clinical trials. Visual
analogue scales for pain can also be used for this purpose. Imaging
modalities, such as MRI, for longitudinal change in structure of
hand joints, require validation, such as is currently occurring for the
use of MRI in OA of the knee.
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SYSTEMATIC REVIEW OF THERAPY FOR OSTEOARTHRITIS
OF THE HAND
T. Towheed, M.D.
Division of Rheumatology, Queens University, Kingston, Ontario,
Canada
Background: Osteoarthritis (OA) is the most common form of
arthritis. Although symptomatic OA affecting the hand joints is such
a common site of involvement, which frequently impairs hand
function, there is remarkably little published data regarding the
evaluation of optimal therapies as determined by a randomized
controlled trial (RCT). Due to the unique aspect of OA affecting the
hand, one cannot necessarily extrapolate from the results of RCTs
that evaluate therapies in OA of the knee or hip. OA of the hand
warrants further research, especially with respect to a characteriza-
tion of useful non-pharmacological and pharmacological therapies.
Objectives: The purpose of this presentation is to systematically
review all published RCTs evaluating non-pharmacological and
pharmacological therapies for OA of the hand. A critical analysis of
the methodological aspects will be performed. A quantitative
pooling or meta-analysis will be performed where possible, utilizing
the key outcomes of pain, functional impairment, and global
assessments. Recommendations for future conduct of RCTs in
OA of the hand will be summarized.
Search strategy: A comprehensive electronic search of the
published literature has been performed. This includes Pre-Medline
(January 2004), MEDLINE (1966 to January 2004), EMBASE (up to
January 2004), Cochrane Registry of Controlled Trials (as of
January 2004). Reference lists of identiﬁed RCTs, as well as of
pertinent review articles, were searched for additional RCTs.
Search criteria: Published RCTs evaluating the efﬁcacy and safety
of non-pharmacological therapies and pharmacological therapies
for OA of the hand were considered for inclusion. RCTs evaluating
surgical therapies were excluded.
Presentation of results and conclusions: The current state of the art
of RCTs evaluating therapy of OA of the hand will be summarized.
Based on the results of this systematic review, recommendations
for the future conduct of such trials will be presented.
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DISABILITY DUE TO OA: ASSESSMENT, NATURAL HISTORY,
AND RISK FACTORS
A. M. Jette
Health & Disability Research Institute, Boston University, Boston,
MA, USA
Disability, deﬁned as limitation in performing socially deﬁned roles
and tasks expected of an individual within a socio-cultural and
physical environment, is a signiﬁcant health problem for adults with
OA. Despite the prevalence and signiﬁcant detrimental impact of
disability, little is known about how to minimize or prevent this
important health problem. Disability theory posits that there are
three inter-related domains leading to disability. The ﬁrst phase is
pathology, the presence of diseases such as OA that, presumably,
leads to impairments, deﬁned as abnormalities in anatomic and
structural abnormalities such as muscle weakness and pain.
Impairments, in turn, lead to functional limitations, deﬁned as
restrictions in the performance of basic physical tasks and actions.
Functional limitations are hypothesized as the ﬁnal pathway to
disability. Recent research suggests that this hypothesized pro-
gression from pathology to disability is overly simplistic and a more
complex model involving the interaction of clinical and non-clinical
factors are important to understand the etiology of disability among
those with chronic OA.
In this presentation, I will review the research literature on the
epidemiology of disability secondary to chronic OA focusing on the
major risk factors for disability. Particular attention will be placed on
examining the degree to which clinical and non-clinical factorsinteract to either exacerbate or minimize the disablement process.
Using Verbrugge and Jette’s Disablement Process Framework as
a conceptual framework, I will summarize current understanding of
clinical risk factors for disability in the main disablement pathway
(i.e., impairments and functional limitations), and the extent to
which their impact on disability is modiﬁed by personal beliefs and
demographic background factors (e.g., reduced self-efﬁcacy,
motivation, age, SES) as well as external factors (e.g., physical
and/or social environment or barriers to health care services).
I will also discuss the clinical intervention implications of current
understanding of risk factors for disability and priorities for future
research in this area of investigation.
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MUSCULOSKELETAL FINDINGS IN MORBIDLY OBESE
SUBJECTS BEFORE AND AFTER WEIGHT LOSS DUE TO
GASTRIC BYPASS SURGERY
M. M. Hooper, T. A. Stellato, P. T. Hallowell, R. W. Moskowitz
Department of Medicine, University Hospitals of Cleveland,
Cleveland, OH, USA
Purpose: To determine the prevalence of musculoskeletal (MSK)
complaints and their response to weight loss in morbidly obese
subjects before and after gastric bypass surgery and weight loss.
Methods: Consecutive subjects were recruited from the Bariatric
Surgery Program. Twenty percent declined to participate. Fifty-four
enrolled; 48 were available for follow-up at 6–12 months (mean
201 G 50 days). MSK signs and symptoms were recorded.
(Description of pain and location; joint, tendon, bursal exams and
trigger points.) Comorbid diseases were noted. Subjects completed
the London Fibromyalgia Epidemiology Study Screening Question-
naire (LFESSQ), the WOMAC composite index and subscale
questionnaires and were examined by a rheumatologist or trained
rheumatology nurse.
Results: There were 52 women, 2 men; 70% Caucasian, 28%
African American, 2% Hispanic. Mean age 44 G 9 years. Mean
weight (women) before surgery was 292 G 42 lbs (BMI 51 G 8)
and 202 G 50 lbs (BMI 36 G 7) after. Baseline comorbid
conditions: hypertension (52%), sleep apnea (46%), GERD
(31%), type II diabetes (30%), asthma (30%), bladder incontinence
(22%). See Table I. Shoulder ﬁndings were due to impingement
syndrome or rotator cuff injury; hand ﬁndings to arthritis or
tendonitis. Carpal tunnel (occurred in 31%) was recorded sepa-
rately. Hip complaints related to trochanteric bursitis in all but three
subjects. There was a decrease of 52% in the number of sites of
MSK complaints and a 92% reduction in FMS (by LFESSQ and
ACR criteria). The WOMAC scores indicate a signiﬁcant magnitude
of improvement (Table II).
Table I
MSK symptoms before and after weight loss (% affected)
Shoulder Hand L Spine Hip Knee Anserine FMS
Before 40 35 38 23 75 17 25
After 27 21 15 15 44 2 2
Table II
WOMAC index composite and subscales before and after weight
loss
WOMAC Composite Pain Function Stiffness
Before 150 G 75.4 189 G 120 742 G 390 107 G 54
After 49 G 51 92 G 100 188 G 200 38 G 41
Change 88 G 60* 106 G 90* 552 G 323* 68 G 50*
*P ! 0.001. Mean G sd.
S17Conclusion: There was a high frequency of MSK complaints before
surgery, including non-weight bearing sites, which decreased
signiﬁcantly following weight loss. The dramatic resolution of FMS
may be due to a decrease in comorbid syndromes (sleep apnea,
GERD) and an increase in physical activity. These beneﬁts may
improve further, as weight loss may continue for up to 24 months.
This highly motivated group of individuals may not reﬂect the
general obese population, but the beneﬁts seen with weight loss
indicate that prevention and treatment of obesity can improve MSK
health and function.
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ELECTROMYOGRAPHIC CHARACTERISTICS ASSOCIATED
WITH RADIOGRAPHIC OSTEOARTHRITIS OF THE KNEE
S. M. Lingy, E. Dredgey, R. A. Conwitz, E. J. Mettery
y Clinical Research Branch, National Institute on Aging Intramural
Research Program, Baltimore, MD, USA
z National Institute of Neurological Diseases and Stroke, National
Institutes of Health, Bethesda, MD, USA
Background: Osteoarthritis of the knee is associated with impaired
quadriceps muscle function. Electromyography allows the study of
motor units, which comprises a single lower motor neuron and the
muscle ﬁbers it innervates.
Aim: We sought to test the hypothesis that motor unit (MU)
physiology measured by electromyography (EMG) differs by
radiographic severity of osteoarthritis of the knee.
Methods: We evaluated 39 participants (age 65G 3 years) in whom
weight-bearing knee X-rays were obtained and assigned a Kellgren-
Lawrence (KL) grade (0 to 4). Maximal isometric voluntary contraction
(MVC) for knee extension was measured by Kin-Com. EMG data
were collected from the vastus medialis muscle by needle and
surface electrodes during isometric knee extension approximating
10, 30 and 50% of MVC. Fifteen to 20 MUs were sampled at 10, 30
and 50%ofMVC.Decomposition-enhanced spiked-trigger averaging
was used to determine surface-detected motor unit potential (SMUP)(area, amplitude-indicators of MU size), and motor unit recruitment
index calculated (MURI Z proportion of rectiﬁed surface EMG
amplitude/[MU area! ﬁring rate]).
Results: EMG data were collected from 18 participants with KL Z
0, 4 with KLZ 1, 4 with KLZ 2, 9 with KLZ 3 and 4 with KLZ 4.
Knee extensor MVC and SMUP were inversely related to
radiographic severity. However, when adjusted for MVC, SMUP
area was signiﬁcantly larger in participants with KL gradesO0
compared to those with KL Z 0 (Fig. 1; P ! 0.01). MURI per unit
force was signiﬁcantly higher in participants with KL grade 4 OA
[Fig. 2(D)], and lower in participants with KL grades 1 or 2 [Figs. 2(A
and B)] than participants with KL Z 0 (P ! 0.01). Motor unit ﬁring
rate did not differ by OA grade.
Conclusions: These results suggest that adults with moderate to
severe symptomatic knee OA achieve a given level of knee
extensor force by activating larger MUs of greater number by MURI
than adults without OA of comparable age. In contrast, subjects
with early radiographic OA achieve a given force level by recruiting
larger but fewer MUs than subjects without OA. The EMG patterns
Fig. 1. Cumulative distribution of motor unit area per Newton force.Fig. 2. Motor unit recruitment index per Newton force by OA severity.
S18observed in association with advanced radiographic knee OA are
consistent with disuse. Other explanations should be sought for
the EMG patterns observed in association with early radiographic
OA.
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METABOLIC OBESITY, OSTEOARTHRITIS, AND PHYSICAL
FUNCTIONING
M. R. Sowers, A. F. Furniss, M. L. Jannausch
Epidemiology, University of Michigan, Ann Arbor, MI, USA
Aim: We evaluated the risk for having osteoarthritis of the knee and
diminished physical functioning with metabolic obesity.
Methods: A population based cohort of 531 women, aged 43–53,
was evaluated for metabolic obesity, deﬁned using body mass
index (BMI) cut points of!26, 26–34,O34 kg/m2 and the presence
of two or more of the following metabolic derangements: diabetes
or fasting glucoseO126 mg/dl, hsC-RPO2 mg/L, HDL cholesterol
!45 mg/dl, triglycerides O200 mg/dl, or waist–hip ratio (cm:cm)
O0.81. Osteoarthritis incidence and prevalence was deﬁned by
a Kellgren-Lawrence score O2 for either knee evaluated from X-
rays taken in the semi-ﬂexed position. Physical functioning included
gait velocity (cm/s) measured with an instrumented gait mat and
grip strength (nM) measured as the sum of three attempts with
a hand dynamometer. Additionally, measures included a timed 40
feet walk (seconds) and the time required to ascend and descend
three standardized steps (seconds).
Results: The third column of the table identiﬁes the frequency (%) of
women in each of the categories. Obesity deﬁned by BMI category
without the co-occurrence of other metabolic derangements
signiﬁcantly increased the odds of having prevalent OA of the
knee in women (far right column) who were classiﬁed as either
overweight/obese (ORZ 1.9) or very obese (ORZ 7.0) compared
to women who were not obese (reference group). However, the co-
occurrence of metabolic derangements with obesity was also
associated with a signiﬁcant increase in the odds of having
prevalent OA of the knee in women who were classiﬁed as either
overweight/obese (ORZ 3.3) or very obese (ORZ 9.0) compared
to women who were not obese (reference group). Further, there
were decrements in each of the four physical functioning measures
including velocity, grip strength, timed walk and stair climb, and the
decrements were signiﬁcantly greater among women classiﬁed as
obese and very obese when that obesity was accompanied by
metabolic derangements. The impacts of obesity and the co-
occurrence of metabolic derangements were more evident in the
measures of mobility than in the grip strength measure.
Conclusions: The added presence of metabolic derangements
exacerbates the impact of obesity as a risk factor for having OA
of the knee as well as less optimal physical functioning. This
indicates that the role of obesity with respect to OA and functioning
may extend, mechanistically, beyond that of joint loading. This
co-occurrence may also have implications for the types of
therapies used to treat both OA of the knee and conditions such
as diabetes that reﬂect the metabolic derangements being
evaluated.M43
OSTEOARTHRITIS MRI FEATURES ASSOCIATED WITH DIS-
CORDANT KNEE PAIN IN AN ELDERLY POPULATION
K. S. Wildyy, C. K. Kwohy, A. B. Newmany, R. M. Boudreauy,
C. P. Peterfyz, L. C. Carbonex, T. B. Harrisjj, M. C. Nevitt{
y Rheumatology, University of Pittsburgh, Pittsburgh, PA, USA
z Synarc, Inc, San Fransisco, CA, USA
x University of Tennessee, Memphis, TN, USA
jj National Institute of Aging, Bethesda, MD, USA
{ UCSF, San Francisco, CA, USA
Individuals with discordant knee pain (DKP) (pain in one knee,
absent in the other), allow study of MRI determinants of knee pain
controlling for subject-level confounding factors. We examined the
association between pain and key pathologic features of osteoar-
thritis (OA) on MRI in individuals with DKP.
In 3075 community-dwelling men and women, whites and African
Americans, aged 70–79, we evaluated bilateral knee MRIs of 263
participants reporting DKP. Knee pain was deﬁned as pain on most
days of a month in the past year or Rmoderate pain by WOMAC in
the past 30 days. MRIs were obtained on 1.5 T scanners (axial &
coronal T2 FSE, sagittal T2 FSE with fat sat) using lower resolution
scans, particularly in the axial plane, to minimize scanning time.
The WORMS method was used to score pathologic features of
knee OA: cartilage damage (CART), bone attrition (ATT), bone
marrow edema (BME), bone cysts (CYST), and osteophytes (OST)
in the medial tibiofemoral (MTF), lateral tibiofemoral (LTF),
patellofemoral (PF) compartments and in the total knee (TOTK),
plus meniscal damage (MEN) and synovitis (SYN) in the TOTK.
Matched analyses using McNemar’s test (presence C/), and
signed rank and forward step-wise conditional logistic regression
(CLR) with severity as a continuous variable were performed with
each individual’s nonpainful knee serving as control.
The association between the presence (score O0) of pathologic
MRI features and knee pain varied by compartment. In the MFT,
ATTO 0 and BMEO 0 were associated with knee pain, whereas in
the LFT, the presence of all features was associated with knee
pain. In the PF, no feature was associated with knee pain. For the
Table I
Conditional logistic regression
Compartment MRI feature Standardized
odds ratio
P-value
*MFT OST 2.13 0.04
BME 1.39 (!0.0001)
*LFT OST 1.72 (0.004)
CART 1.66 (0.02)
*PF OST 2.19 (!0.0001)
ATT 0.73 (0.04)
yTOTK OST 2.06 (0.007)
CART 1.7 (0.04)
SYN 1.46 (0.02)
*CLR starting with BME CART OST ATT CYST.
yCLR starting with BME CART OST ATT CYST SYN MEN.Table I
Means and odds ratio for functioning and OA of the knee according to metabolic obesity classification
Metabolic
derangement
BMI classiﬁcation (kg/m2) % Velocity Grip strength 40# walk Stair climb time Prevalent OAK (OR)
No BMI !26 34 119 30 8.0 18 Ref.
No 26–34 31 114 30 8.8 19 1.9
Yes 27–34 15 107 29 9.3 20 3.3
No O34 12 106 28 10.0 22 7.0
Yes O34 8 93 26 11.4 26 9.0
S19TOTK, CART O 0, ATT O 0, and BME O 0 were associated with
knee pain. Analyzed as continuous scores (signed rank), all
features in the MTF, LTF, and TOTK, along with OST severity in
the PF were associated with knee pain. Multivariate CLR results
utilized continuous scores (Table I). Interaction between features
revealed that the association of BME with pain is modiﬁed by the
presence of high CART (O15 in compartments, O20 in TOTK).
With high CART, BME had an ORZ 3.27 (PZ 0.003) in the MFT
and OR 2.0 (P Z 0.006) in the TOTK.
In summary, in the elderly with DKR, total knee severity of CART,
OST, and SYN were independently associated with knee pain.
BME, commonly noted in painful knees, was signiﬁcantly associ-
ated with knee pain when in the presence of high cartilage damage
in either the TOTK or MFT. Finally, increasing severity of OST in
any region measured was associated with knee pain.
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BIOMECHANICAL SIGNALING IN CARTILAGE: THE ROLE OF
THE PERICELLULAR MATRIX
F. Guilak, Ph.D.
Departments of Surgery and Biomedical Engineering, Duke
University medical Center, Durham, NC, USA
Chondrocytes in articular cartilage use signals from their bio-
mechanical environment in conjunction with other environmental
factors to regulate their metabolic activity. However, the sequence
of biomechanical and biochemical events involved in the trans-
duction of mechanical signals is not fully understood. A fundamen-
tal step in determining the role of physical factors in regulating cell
activity is to characterize the biophysical environment at the cellular
level under physiological conditions of mechanical loading. Here we
present theoretical and experimental studies of the micromechan-
ical behavior of chondrocytes in cartilage. Three-dimensional
ﬂuorescence microscopy has revealed that chondrocytes as well
as their nuclei undergo changes in shape and volume in a manner
that is coordinated with deformation of the tissue extracellular
matrix. The constitutive behavior and mechanical properties of
isolated chondrocytes were determined using micromechanical
methods such as micropipette aspiration and osmotic swelling,
showing that the chondrocyte behaves as a viscoelastic solid
material with a mechanical stiffness that is several orders of
magnitude lower than that of the cartilage extracellular matrix. The
mechanical and physicochemical properties of the chondrocyte
appear to arise primarily from the structure of the F-actin
cytoskeleton. Within the cartilage extracellular matrix, the cells
are surrounded by a narrow region of tissue termed the pericellular
matrix. The biphasic mechanical properties of the pericellular matrix
were found to signiﬁcantly differ from those of the chondrocyte and
the extracellular matrix, suggesting that this tissue region plays an
important role in deﬁning the mechanical environment of the
chondrocyte. Furthermore, deletion of the col6a1 gene in mice
resulted in accelerated osteoarthritis in the hip joints of mice and
was associated with a loss of pericellular matrix stiffness. The
experimentally measured values for chondrocyte, pericellular
matrix, and cartilage extracellular mechanical properties have been
used in combination with theoretical constitutive models to predict
the non-uniform and time-varying stress–strain and ﬂuid ﬂow
environment at the level of the cell. The ultimate goal of these
studies has been to elucidate the sequence of biomechanical and
biochemical events through which mechanical stress inﬂuences
chondrocyte activity in both health and in disease.
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DYNAMIC COMPRESSION COUNTERACTS IL-1b-INDUCED
INOS AND COX-2 ACTIVITY IN HUMAN CHONDROCYTES
CULTURED IN AGAROSE CONSTRUCTS
T. T. Chowdhury, D. L. Bader, D. A. Lee
Department of Engineering, Queen Mary, University of London,
Mile End Road, London, United KingdomIntroduction: The role of dynamic compression in the inhibition of
inﬂammatory mediators such as nitric oxide (.NO) and prostaglan-
din E2 (PGE2) has been previously demonstrated in interleukin-1b
(IL-1b) stimulated bovine chondrocytes cultured in agarose
constructs. It is unclear, however, whether dynamic compression
acts to abrogate IL-1b-mediated .NO and PGE2 release via iNOS/
COX-2 inter-dependent pathways in human chondrocytes.
Materials and methods: Human chondrocytes (Verigen, Germany)
were seeded in 3% agarose Type VII and cultured for 24 h.
Constructs were incubated for a further 48 h in radiolabelled
medium (1 mCi ml1 [3H]-thymidine and 10 mCi ml1 35SO4)
containing 0 or 10 ng ml1 of IL-1b C 1 mM L-NIO (NOS inhibitor)
or 0, 0.1, 1 and 2 mM 1400W (iNOS inhibitor) or 0.1, 1, 10 and 100
mM NS-398 (COX-2 inhibitor).
In a separate experiment, a fully characterised cell-straining system
(Zwick Testing Machines, UK) was used to apply 15% dynamic
compressive strain (1 Hz, 48 h) to constructs cultured in radio-
labelled medium supplemented with 0 or 10 ng ml1 IL-1b and/or 1
mM L-NIO or 2 mM 1400W or 100 mM NS-398. Nitrite was
measured using the Griess assay. PGE2 release was determined
using an EIA system. [3H]-thymidine and 35SO4 incorporation was
assessed by TCA and Alcian blue precipitation, respectively.
Results: IL-1b signiﬁcantly enhanced nitrite release, an effect which
was reversed by L-NIO and 1400W. IL-1b-induced PGE2 release
was abolished by NS-398 and could be partially reversed with
L-NIO or 1400W. In addition, the IL-1b-induced inhibition of
[3H]-thymidine and 35SO4 incorporation was partially reversed with
L-NIO or 2 mM 1400W. The inhibition, however, was not inﬂuenced
by NS-398.
The dynamic compression-induced inhibition of nitrite was signif-
icantly increased in the presence of IL-1b when compared to
untreated constructs. L-NIO and NS-398 reduced this effect,
a response abolished with 1400W. Dynamic compression did not
signiﬁcantly inﬂuence PGE2 levels in untreated constructs. How-
ever, IL-1b-induced PGE2 release was reversed by dynamic
compression. The response to dynamic strain was reversed in
the presence of L-NIO and abolished with NS-398 but was not
inﬂuenced by 1400W. The IL-1b-induced inhibition of [3H]-
thymidine incorporation was not inﬂuenced by L-NIO, 1400W or
NS-398. By contrast, strain-induced stimulation of 35SO4 incorpo-
ration in IL-1b stimulated constructs was reduced in the presence of
L-NIO and enhanced by 1400W.
Discussion: This study demonstrates that cytokine stimulation
enhanced .NO and PGE2 release via an iNOS-driven-COX-2
dependent pathway, a response that could be reversed by dynamic
compression. Inhibition of PGE2 with COX-2 inhibitor did not reduce
.NO levels but inhibition of .NO partially downregulated PGE2
release. The dynamic compression induced stimulation of cell
proliferation was not mediated by .NO whereas stimulation of
proteoglycan synthesis was .NO dependent. These data indicate
interactions exist between .NO and PGE2 pathways, a ﬁnding which
will provide new insights in the development of pharmacological or
biophysical treatments for cartilage disorders.
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RESPONSESOFOSTEOARTHRITIC ANDNORMALARTICULAR
CARTILAGEEXPLANTSTODYNAMICCOMPRESSION IN VITRO
A. M. Stoker, J. L. Cook, K. Kuroki, D. B. Fox
Comparative Orthopaedic Laboratory, University of Missouri
Columbia, Columbia, MO, USA
Study aim: To determine gene expression responses of normal and
OA cartilage explants to compressive load.
Methods
Tissue harvest and culture: For normal tissues, femoral heads were
obtained from adult dogs euthanatized for purposes unrelated to
this study. The femoral heads were stored overnight at 37(C in
culture media containing 10% FBS, and full-thickness 4-mm
articular cartilage (AC) explants were created the next day. OA
AC explants were obtained from the femoral heads of adult dogs
undergoing total hip replacement surgery, and full-thickness 4-mm
S20AC explants were created at the time of joint harvest. Explants were
cultured in ﬂexible-bottom plates for up to 14 days, and exposed to
biomechanical forces at either 0 or 2.0 MPa at 0.1 Hz for 20 min 3
times/day. Explants were collected at harvest and on days 0, 2, 7,
and 14 of culture.
Gene expression: Total RNA was analyzed by real time RT-PCR
analysis for GAPDH, COL 2, aggrecan, MMP-13, INOS, and COX-2
using a SYBR Green PCR assay.
Statistical analysis: Relative gene expression levels were de-
termined using Q-Gene, and differences in gene expression levels
among groups were determined using REST-XL with signiﬁcance
set at P ! 0.05.
Results
Gene expression (Table I): At the time of tissue harvest, normal AC
had signiﬁcantly higher Agg, COL 2, INOS, and COX-2 expression
compared to OA AC. COX-2 expression was signiﬁcantly higher in
loaded OA (LOA) compared to loaded normal (LNo) and unloaded
OA (NLOA) explants compared to unloaded normal (NLNo)
explants at day 2, and signiﬁcantly higher at day 14 in LNo
compared to LOA, and in NLNo compared to NLOA. MMP-13
expression was signiﬁcantly higher in LOA compared to LNo and in
NLOA compared to NLNo at day 14. Agg and COL 2 expression
was signiﬁcantly higher in LOA compared to LNo explants at days 7
and 14.
Discussion
This study indicates that harvesting and culturing signiﬁcantly alters
the gene expression of chondrocytes in normal AC explants but not
OA AC explants, indicating that the chondrocytes in diseased AC
may be more able to adapt to non-physiologic culturing conditions.
The loading proﬁle used in this study had little affect on OA
explants, but had a net negative affect on normal explants. These
data indicate that the harvest, culturing and loading conditions used
in this study may be an appropriate model for the study of disease,
rather than health, in normal AC explants. The results of this study
underscore the caution that must be used when applying results
obtained from in vitro articular cartilage explant culture to the in vivo
environment, and especially the clinical situation.
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RELATIVE EFFECTS OF CHONDROITINASE AND DECORIN
OVEREXPRESSION ON MECHANICAL PROPERTIES OF
NEOCARTILAGE
J. L. Lewisy*, D. A. Krawczaky, M. L. Hally, T. R. Oegemaz,
J. J. Westendorfy
y Orthopaedic Surgery, University of Minnesota, Minneapolis, MN,
USA
z Biochemistry, Rush Medical College, Chicago, IL, USA
Aim of the study: Determine the relative effects of decorin
overexpression and chondroitinase (cB and cAC) digestion on the
mechanical properties of tissue grown from chondrocytes in culture
(neocartilage).
Methods: Chondrocytes were isolated from cartilage in young
rabbits and cultured using established methods. Chondrocytes
Table I
Relative gene expression in OA and normal tissue explants
OA vs normal at Aggrecan Col 2 MMP-13 INOS COX-2
Harvest YY YY n.s.d. YY YY
Day 2L n.s.d. n.s.d. n.s.d. n.s.d. [[
Day 2NL n.s.d. YY n.s.d. n.s.d. [[
Day 7L [[ [[ n.s.d. n.s.d. n.s.d.
Day 7NL [[ [[ n.s.d. n.s.d. n.s.d.
Day 14L [[ [[ [[ n.s.d. YY
Day 14NL [[ n.s.d. [[ n.s.d. YY
[[ Z up in OA tissues, YY Z down in OA tissues, n.s.d. Z no
signiﬁcant difference.from Group I were transduced with a murine stem cell retrovirus
(MSCV) encoding human decorin, and a puromycin resistance
gene or with a control retrovirus lacking decorin. A second Group II
of tissue was grown in the standard fashion for 8 weeks and treated
with either chondroitinase B or chondroitinase AC1 (0.2 U/ml buffer
each for 24 h RT). After 8 weeks in culture, tissue layers of
approximately 150 mm in thickness were formed. The Group I
tissues were removed from the culture ﬂasks and tested for
mechanical properties, cell density, collagen structure, and pro-
teoglycan/protein content. Tensile strips 5 mm ! 20 mm were cut
and installed in a computer controlled tensile testing instrument
(MicroBionix, MTS, Inc.) with 5 N load cell. The test protocol was
designed to provide a preconditioning, and then a step-hold for
viscoelasticity characterization. For Group II, tissue was treated
with chondroitinase after 8 weeks and then tested as in Group I. For
Group I, displacement was increased to 1.5 mm at a rate of 16 mm/
s and held for 5 min as a preconditioning, unloaded to zero load,
held at zero load for 30 s, loaded to 0.5 mm at a rate of 16 mm/s,
and held for 5 min. For Group II, the last load was held for 20 min.
Total proteoglycans was measured in both the tissue and
supernatant for Group II.
Results: Immunoblots showed approximately three times as much
total decorin was produced in the transfected tissue as in the
controls. All other biochemical, structural, and mechanical proper-
ties, except relaxation function, were the same between decorin-
overexpressing tissues and control infected (no decorin) tissues in
Group I. The relaxation function of tissue expressing high levels of
decorin was slower to equilibrate, both in the short and long time.
Tissue digested with cB had slightly reduced total proteoglycans;
tissue digested with cAC had nearly all pg’s removed. Tissue
digested with cB had reduced maximum load, but otherwise
unchanged relaxation function. Tissue digested with cAC1 had
reduced maximum load and relaxation function with reduced
equilibrium time and increased equilibrium stiffness.
Conclusions: Tissue with overexpressed decorin had altered
relaxation function and no change in total proteoglycans, although
increased decorin was detectable by immunoblotting. Tissue with
cB digestion (dermatin sulphate, DS) had no change in relaxation
function, except lower maximum load. Tissue with cAC digestion
(chondroitin sulphate, CS) had a signiﬁcant change in relaxation
function, and near depletion of total proteoglycans. Although
opposite in effect, the addition of the decorin caused a change of
similar magnitude in the relaxation function to CS depletion. Both
decorin and CS inﬂuence the long term relaxation behavior of the
tissue.
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CATHEPSIN B AND NEUTROPHIL ELASTASE DEGRADE
BOVINE LUBRICIN AND INCREASE COEFFICIENT OF
FRICTION OF BOVINE SYNOVIAL FLUID
K. A. Elsaidy, G. D. Jayz, C. O. Chichestery
y Biomedical and Pharmaceutical Sciences, University of Rhode
Island, Kingston, RI, USA
z Emergency Medicine, Brown University, Providence, RI, USA
Aim: Lubricin and SZP are heavily glycosylated mucinous proteins
secreted by synovial ﬁbroblasts and superﬁcial zone articular
chondrocytes, and are responsible for lubrication of apposed
articular surfaces. The objective of this study is to examine the
effects of a time-dependent digestion of bovine synovial ﬂuid (BSF)
by cathepsin B (CB) and neutrophil elastase (NE), two proteases
implicated in rheumatoid arthritis pathogenesis, on the integrity of
lubricin and its relation to the in vitro lubricating ability of BSF.
Methods: BSF was aspirated percutaneously from the lateral
aspect of radiocarpal joints of freshly slaughtered cattle. Aliquots
of BSF (1 ml) were incubated with CB and NE at 0.05 U/ml for 24 h
at 37(C. Aliquots of digested BSF (200 ml) were removed after 6,
12, and 24 h, and the reaction was stopped by adding PMSF at
a ﬁnal concentration of 1 mM, and E-64 at a ﬁnal concentration of
100 mM. The integrity of lubricin band in BSF was analyzed by
SDS-PAGE, and Western blotting using PNA-peroxidase. The
S21Table I
Changes in m (Dm G S.D.) following time-dependent proteolytic digestion by 0.05 U/ml CB, NE, and chymotrypsin
Bovine synovial
ﬂuid (BSF)
BSF C CB
(0.05 U/ml) (n Z 8)
BSF C NE
(0.05 U/ml) (n Z 8)
BSF C Chymotrypsin
(0.05 U/ml) (n Z 8)
0 h 0.061 G 0.005 0.061 G 0.005 0.061 G 0.005 0.061 G 0.005
6 h 0.056 G 0.002 0.017 G 0.007 0.009 G 0.001 0.006 G 0.001
12 h 0.052 G 0.003 0.004 G 0.016 0.010 G 0.001 0.010 G 0.004
24 h 0.049 G 0.001 0.048 G 0.006 0.013 G 0.002 0.012 G 0.007friction assay of BSF aliquots was performed, and the change in
BSF coefﬁcient of friction (m) with reference to normal saline was
expressed as Dm. A negative Dm indicates lubrication and a positive
Dm indicates friction. The ability of CB and NE to degrade lubricin
and cause a loss of lubrication was compared to a-chymotrypsin,
previously shown to digest lubricin.
Results: CB and NE have exhibited an ability to degrade bovine
lubricin following their incubation with BSF as determined by
diminished lubricin band intensity in the digested BSF compared to
control. A loss of lubricating ability was observed for all enzymes.
The boundary lubricating ability of CB and NE-treated BSF (Table I)
deteriorated in a time-dependent manner, as demonstrated by aC
Dm, compared to control.
Discussion: CB and NE are involved in the pathogenesis of
a number of inﬂammatory arthritic conditions. These enzymes were
shown to degrade bovine lubricin resulting in an elevation in m of
BSF. The loss of BSF’s lubricating ability can increase the extent of
damage of articular cartilage through increased friction and wear.
Inhibition of the activities of CB and NE in arthritic disease states
may be beneﬁcial in restoring the chondroprotective properties
of SF.
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NONINVASIVE MEASUREMENT OF CARTILAGE BIOMECHAN-
ICS USING T1q MRI
A. J. Wheatonyz, M. T. Corboz, D. M. Elliotty, S. B. Nicolly,
G. R. Dodgex, R. Reddyz
y Department of Bioengineering, University of Pennsylvania,
Philadelphia, PA, USA
z Department of Radiology, Metabolic Magnetic Resonance Re-
search and Computing Center, University of Pennsylvania, Phila-
delphia, PA, USA
x Nemours Biomedical Research, Bone and Cartilage Research
Laboratory, A.I. duPont Hospital for Children, Wilmington, DE, USA
Aim: To correlate changes in cartilage biomechanical properties
with T1r in a cytokine-induced model of cartilage degeneration.
Methods
Explant culture: Cylindrical cartilage samples (nZ 36,/Z 1 cm)
were cored from individual bovine patellae. The samples were
separated into a control group bathed in only DMEM and a treated
group in DMEM with 30 ng/mL of IL-1b. The cytokine IL-1b served
as a physiologically relevant inducer of changes associated with
early OA, speciﬁcally PG loss. The samples were kept in an
incubator at 37(C. Every 3–4 days, six control and six treated
samples were removed and the media was refreshed for all
remaining samples.
MR imaging: A series of ﬁve T1r-weighted images were acquired on
a 4.7 T MR scanner using a spin-lock pulse sequence for spin-lock
pulse durations (TSL) of 10 to 90 ms. T1r maps were calculated by
ﬁtting the image data as an exponential function of TSL.
Mechanical testing: A core (/Z 4.7 mm) was punched from each
sample and placed inside a conﬁned compression chamber. The
sample was loaded using a porous indenter for four increments of
5% strain each. Between each strain increment, the sample was
allowed to relax for 50 min. The uniaxial aggregate modulus (HA)
and permeability (k) were calculated for each sample based on
a biphasic linear viscoelastic model of conﬁned compression.Results: T1r was increased by 8.2%, 18.8%, and 37.3% in the IL-
1b-treated samples compared to controls at days 3, 6, and 10,
respectively, as shown in the T1r maps (Fig. 1). The progressive
increase in T1r is indicative of a loss of PG content as corroborated
by previous studies using both animal and human cartilage. T1r
strongly correlated with both compressive stiffness (r2 Z 0.632)
and hydraulic permeability (r2 Z 0.667) (Fig. 2).
Discussion: A decrease in cartilage stiffness with depletion of PG,
measured indirectly in this study as an increase in T1r, is consistent
with previous reports. The loss of PG also results in a reduced
resistance to matrix ﬂuid ﬂow and a lower interstitial osmolarity
resulting in diminished ﬂuid pressurization. These PG-related
changes increase the hydraulic permeability which is reﬂected as
increased T1r. The T1r MRI technique has potential as a non-
invasive and quantitative indicator of changes in the mechanical
integrity of cartilage characteristic of OA.
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JOINT-SPECIFIC KNOCKOUT OF THE ANK GENE IS SUFFI-
CIENT TO CAUSE ANKYLOSIS IN MICE
H. Chen, C. A. Guenther, K. A. Gurley, R. B. Rountree,
D. M. Kingsley
Department of Developmental Biology, HHMI and Stanford
University School of Medicine, Stanford, CA, USA
S22Aim: To test whether the progressive ankylosis (ank) gene
functions systemically, or locally in articular regions, to protect
joints from ectopic mineralization and ankylosis.
Methods: A tissue speciﬁc recombination system was used to
inactivate the mouse ank gene speciﬁcally in articular regions. Mice
expressing Cre recombinase speciﬁcally in joints (Gdf5-Cre driver)
were ﬁrst crossed to animals heterozygous for an ank null allele.
Reporter mice were also created that carry a ﬂoxed ‘‘stop site’’
upstream of a lacZ cassette, and an ank ﬂoxed allele. The Cre driver
mice and the ﬂoxed reporter mice were then mated to generate
target mutant mice (ank ﬂox/null, loxP-STOP-loxP lacZ/C,
Gdf5-Cre/C) and control mice (ank ﬂox/C, loxP-STOP-loxP lacZ/
C, Gdf5-Cre/C). In target mice, the Cre mediated recombination
eliminated all ank activity in the Gdf5 expressing interzone cells. The
target mice of 4 months were subjected to range of motion test,
which measures the degrees of movement when a joint is forced
with a forcep, skeletal preparation, which stains cartilage with alcian
blue and bone with Alizarin red, von Kossa stain to study calcium
deposition, as well as X-gal stain to demonstrate sites of
recombination.
Results: We have previously positional cloned the product of the
progressive ankylosis locus in mice. Null mutations at the locus
lead to ectopic mineral deposition in both the limb joints and
vertebral column. The ank gene encodes for a novel trans-
membrane protein that regulates intra- and extra-cellular levels of
a small molecule inhibitor of mineralization (pyrophosphate). The
gene is expressed widely in most adult tissues, and it has not been
clear if the joint defects are due to systemic effects of mutations in
the gene, or because of a local requirement for ank activity in
articular regions. To study the question, we generated mouse
mutants with the ank gene speciﬁcally inactivated within the joint
region, as conﬁrmed by lacZ staining. Mice with joint-speciﬁc loss of
ank activity developed the same characteristic phenotypes seen in
classic progressive ankylosis mice, including swollen and fused
joints (whole mount skeletal preps), ectopic mineral deposition (von
Kossa stain), and loss of joint mobility (range of motion tests on
particular sets of limb joints). Recombination pattern revealed by
lacZ staining on knee sections demonstrated a strong correlation
between joint-speciﬁc recombination and appearance of pheno-
type. Only animals with strong recombination in articular cartilage
gave a limb phenotype, while animals with strong ectopic re-
combination in bone marrow and in muscles did not. Some animals
also showed a strong phenotype in only a subset of joints in the
limb.
Conclusions: Although the ank gene is normally expressed in
a broad range of adult tissues, our genetic studies suggest that
local expression of ank in articular regions is normally required to
protect articular cartilage and synovial ﬂuid from ectopic mineral
deposition, as opposed to a systemic requirement of ank function.
Furthermore, pyrophosphate level mediated by ank gene product in
articular regions is critical in protecting joint from calcium deposition
and arthritis.
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TGF-BETA OVEREXPRESSION IN MURINE KNEE JOINTS
DIMINISHES IL-1 CAUSED CARTILAGE DAMAGE. TGF-BETA
INDUCED SYNOVIAL FIBROSIS IS PREVENTED BY LOCAL
SMAD7 OVEREXPRESSION
E. N. Blaney Davidson, E. L. Vitters, P. M. van der Kraan,
W. B. van den Berg
Experimental Rheumatology and Advanced Therapeutics, Univer-
sity Medical Center, Nijmegen, Netherlands
Introduction: One of the main problems in OA is cartilage damage.
TGF-beta is known to induce proteoglycan (PG) production by
chondrocytes. TGF-beta could be used to stimulate damaged
cartilage. However, TGF-beta overexpression in knee joints results
in ﬁbrosis of the synovium. The objective of this study was to
investigate whether adenoviral overexpression of TGF-beta in knee
joints damaged by IL-1 can stimulate cartilage repair. In addition we
assessed whether unwanted TGF-beta induced ﬁbrosis could beblocked by simultaneous adenoviral overexpression of TGF-beta
and its inhibitor smad7.
Methods: Cartilage damage was induced by a single IL-1 injection
intra-articularly into murine knee joints of C57Bl/6 mice. After 2
days an adenovirus overexpressing either active TGF-beta or the
TGF-beta inhibitor LAP were injected intra-articularly. Four days
after IL-1 injection knee joints were isolated. Proteoglycan content
was measured in histological, safranin O stained, sections by
a computerized imaging system. Proteoglycan synthesis was
assessed by measurement of 35S-sulfate incorporation in patellar
cartilage.
For ﬁbrosis assessment, knee joints were intra-articularly injected
with Ad-TGF-beta combined with a control virus, Ad-smad7
combined with a control virus or a combination of Ad-TGF-beta
and Ad-smad7. After 2 weeks knee joints were isolated for
histology to investigate the effect of simultaneous overexpression
of TGF-beta and smad7 on ﬁbrosis. Fibrosis was quantiﬁed by
measuring synovial thickness in safranin O and fast green stained
sections and analyzing the number of procollagen type I positive
cells in the synovium.
Results: IL-1 induces an increase in proteoglycan synthesis on day
4 after exposure. Adenoviral TGF-beta overexpression further
elevated the proteoglycan synthesis. Elevated proteoglycan syn-
thesis was signiﬁcantly blocked by inhibition of endogenous TGF-
beta by adenoviral LAP overexpression. IL-1 signiﬁcantly reduces
the proteoglycan content of cartilage, which was even further
reduced after ad-LAP injection. Adenoviral overexpression of TGF-
beta after IL-1 exposure restored the proteoglycan content of
cartilage to normal levels.
Adenoviral TGF-beta overexpression induced an increase in
synovial thickness and number of procollagen type I positive cells.
By simultaneous overexpression with smad7 both synovial
thickness and the number of procollagen type I positive cells were
strongly reduced.
Conclusions: Adenoviral overexpression of TGF-beta strongly
stimulated articular cartilage repair as measured by proteoglycan
synthesis and content. Blocking endogenous TGF-beta reduced
proteoglycan synthesis. Fibrotic side effects of TGF-beta over-
expression in synovial tissue can be inhibited by co-transfection
with smad7. Our results indicate that overexpressing TGF-beta can
be a good candidate to stimulate cartilage repair and that side
effects can be blocked.
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COMPARING BODY MASS INDEX, BODY COMPOSITION, AND
BODY FAT DISTRIBUTION AS PREDICTORS OF RADIO-
GRAPHIC KNEE OSTEOARTHRITIS IN WOMEN AND MEN
L. M. Abbatey, J. B. Rennerz, G. Lutax, A. D. Dragomiry,
M. C. Hochbergjj, C. G. Helmick{, J. M. Jordan#
y Department of Epidemiology, University of North Carolina, Chapel
Hill, NC, USA
z Department of Radiology, University of North Carolina, Chapel
Hill, NC, USA
x Department of Biostatistics, University of North Carolina, Chapel
Hill, NC, USA
jj Department of Medicine, University of Maryland, Baltimore, MD,
USA
{ National Center for Chronic Disease Prevention and Health
Promotion, Centers for Disease Control and Prevention, Atlanta,
GA, USA
# Department of Medicine, University of North Carolina, Chapel Hill,
NC, USA
Purpose: Previous studies have shown that the effect of BMI on
radiographic knee osteoarthritis (rKOA) differs by gender, but these
effects have not been evaluated using measures of body fat
distribution or precise measures of body composition. We
examined these variables in African–American and Caucasian
women and men in the Johnston County Osteoarthritis Project.
Methods: The sample consisted of 849 women and 458 men
aged 45 and older with mean (SD) age 65.0 years (9.3). Body
S23composition (fat and lean masses and % fat and % lean masses)
was assessed using dual-energy X-ray absorptiometry, body fat
distribution was assessed using waist and hip circumferences, and
rKOA was deﬁned as Kellgren-Lawrence grade R2. Gender-
speciﬁc multiple logistic regression models were adjusted for age,
race, and prior joint injury.
Results: In women, mean (SD) BMI was 30.3 (6.4) and weight 77.3
kg (17.1), and in men, BMI was 29.3 (4.6), and weight 88.8 kg
(15.9). The adjusted odds ratios and 95% conﬁdence intervals [OR
(95% CI)] in models comparing the fourth to ﬁrst quartiles of BMI
and weight were 6.14 (3.65, 10.32) and 5.76 (3.43, 9.67) for women
and 1.60 (0.88, 2.94) and 2.11 (1.11, 4.02) for men, respectively. In
separate models, the body composition variables that were
associated with higher odds of rKOA for women were fat mass
[4.47 (2.64, 7.55)], % fat mass [3.25 (1.97, 5.34)], and lean mass
[3.18 (1.91, 5.28)], while only lean mass was associated with rKOA
in men [2.13 (1.05, 4.31)]. In both men and women, waist
circumference was highly associated with rKOA [women: 4.32
(2.62, 7.12), men: 2.47 (1.31, 4.67)]. In women, waist-to-hip ratio
was associated with rKOA [women: 1.57 (0.97, 2.55) and men: 1.22
(0.68, 2.19)]. The addition of weight or BMI to each of these models
attenuated all of the odds ratios in both genders. None of the
associations with body composition or body fat distribution
variables and rKOA in women, and only waist circumference in
men [3.45 (1.36, 8.73)], remained statistically signiﬁcant after
adjustment for BMI.
Conclusions: These ﬁndings suggest that the association between
rKOA and BMI or weight is stronger for women than for men. Total
mass, as measured by BMI or weight, is more highly associated
with rKOA than body composition variables, and waist circumfer-
ence may be an important risk factor for rKOA in men.
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A COMPARISON OF RISK FACTORS FOR TIBIOFEMORAL
AND PATELLOFEMORAL OSTEOARTHRITIS IN AN ETHNI-
CALLY DIVERSE STUDY POPULATION
G. Luta , A. D. Dragomir, A. L. Elliott, J. B. Renner, J. M. Jordan
Thurston Arthritis Research Center, University of North Carolina,
Chapel Hill, NC, USA
Purpose: Previous studies have compared risk factors for
radiographic tibiofemoral joint (TFJ) osteoarthritis (OA) and
patellofemoral joint (PFJ) OA in Caucasians or Caucasian women
only. We investigated differences in risk factors for these knee
compartments in a large, population-based sample of African–
Americans and Caucasians, using a novel statistical approach to
account for the correlation of the joint compartments within an
individual.
Methods: All participants with antero-posterior TFJ radiographs
from the Johnston County Osteoarthritis Project were included. TFJ
OA was deﬁned as a Kellgren-Lawrence grade of at least 2. For the
subset of the participants (the latest enrolled) for which sunrise PFJ
radiographs were also available, PFJ OA was deﬁned as the
presence of an osteophyte of grade 2 or greater. Using all available
radiographic data, we used generalized estimating equations
(GEE) methods to perform the simultaneous modeling of TFJ OA
and PFJ OA, and to test for outcome-speciﬁc effects of risk factors
of interest, while accounting for the correlation of the two knee OA
outcomes. The risk factors considered were age group (45–54, 55–
64, 65C years old), gender, ethnicity (African–American or
Caucasian), obesity (deﬁned as a body mass index (BMI) in kg/m2
greater than 30), previous knee injury, and clinical interphalangeal
OA.
Results: The sample (n Z 2802) was 61% female and 31%
African–American with mean (SD) age of 61 (10) and mean (SD)
BMI of 29 (6). For about a third (n Z 914) of the sample both TFJ
OA and PFJ OA data were available. This subset was 55% female
and 22% African–American with mean (SD) age of 59 (10) and
mean (SD) BMI of 29 (6). Isolated PFJ OA, isolated TFJ OA, and
their concomitant presence represented about 3%, 13%, and 7%,
respectively. The similar association of previous knee injury witheach outcome was characterized by a common odds ratio (OR) Z
2.21, 95% CIZ [1.78, 2.74]. The effect of obesity was stronger for
women than for men for both TFJ OA (P Z 0.015) and PFJ OA
(P Z 0.024). Gender-speciﬁc obesity effects were similar for
TFJ OA and PFJ OA (OR Z 3.00 [2.40, 3.74] for women, and
OR Z 1.75 [1.31, 2.34] for men). The effect of ethnicity was
different for the two compartments (P Z 0.007), with the effect
being conﬁned to PFJ OA (OR Z 2.08 [1.36, 3.17]). There was
borderline statistical evidence for different effects of clinical
interphalangeal OA (P Z 0.070) and age group (P Z 0.085).
Clinical interphalangeal OA was associated only with PFJ OA (OR
Z 1.57 [1.04–2.38]), and age was more strongly associated with
TFJ OA than PFJ OA.
Conclusions: The effects of gender, obesity, and previous knee
injury are similar for both TFJ OA and PFJ OA. Alternatively,
ethnicity, clinical interphalangeal OA, and age group may have
different effects upon TFJ OA and PFJ OA. These unique results
suggest that the etiologies of TFJ OA and PFJ OA may be different,
and further investigation to clarify the role of ethnicity and clinical
interphalangeal OA on PFJ OA appear warranted.
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CAN INTERVENTIONS TARGETING LOCAL FACTORS –
MALALIGNMENT, INSTABILITY, AND GAIT ABNORMALITIES
– DELAY PROGRESSION OF OA
K. Bennell
Centre for Health, Exercise and Sports Medicine, University of
Melbourne, Australia
Given that there is currently no cure for knee OA and the only
established treatment for end-stage OA is costly joint replacement,
slowing disease progression is essential to help reduce personal
and societal burden of knee OA. This presentation will cover the
evidence linking local factors to risk of progression and discuss
interventions that could potentially inﬂuence local factors and
prevent progression.
Evidence for a relationship between local factors and progression
(1) Malalignment: Static frontal plane alignment of the femur relative
to the tibia, known as the mechanical axis, inﬂuences load across
the tibiofemoral joint (Hurwitz et al., 2002). Knee joint malalignment
is correlated with disease progression measured radiologically
(Sharma et al., 2001; Cerejo et al., 2002) and by magnetic
resonance imaging (Cicuttini et al., in press). However, there is
conﬂicting evidence as to the role of malalignment on progression
with Miyazaki et al. (2002) and Dougados et al. (1992) both failing
to show a relationship.
(2) Laxity/instability: Knee laxity is seen as abnormal displacement
of the tibia with respect to the femur. In individuals with laxity,
research has shown that co-contraction of knee ﬂexors and
extensors is used. This general activation pattern ‘stiffens’ the joint
and provides stability against any external load but also increases
tibiofemoral compressive forces. High varus–valgus laxity has been
shown to be associated with greater progression particularly in the
presence of strong quadriceps (Sharma et al., 2003).
(3) Gait abnormalities: Repetitive impact loading leads to changes
consistent with joint degeneration in animal models (Radin et al.,
1971). Impact forces as seen in the heel strike transients in the
vertical ground reaction force directly following heel strike are
thought to be important in joint wear. However, no longitudinal
studies have directly assessed whether higher impact loading in
people with OA is a risk factor for disease progression. The
adductor moment during walking gait determines load distribution
across the tibial plateaus, with force across the medial compart-
ment almost 2.5 times that of the lateral [11]. Importantly, two
longitudinal cohort studies have shown a relationship between
higher adductor moment and disease progression measured using
X-rays (Miyazaki et al., 2002; Sharma et al., 2003).
(4) Muscle weakness/altered activation patterns: The primary role
of muscles is to move joints but in doing so they actually load the
joint articular surfaces. Intuitively one would expect muscle
weakness generally to unload the joint and therefore produce
S24reduced loading conditions compared to normal. However, quad-
riceps dysfunction could affect the ability to absorb impact forces at
heel strike (Jefferson et al., 1990; Mikesky et al., 2000). The role of
quadriceps strength in disease progression is currently controver-
sial. Brandt et al. (1999) found no difference in baseline quadriceps
strength between those with and without disease progression.
Sharma et al. (2003) found that the relationship between quads
strength and progression was mediated by the local environment.
Greater quads strength at baseline was associated with increased
likelihood of tibiofemoral OA progression in malaligned and lax
knees.
Potential interventions to address local factors
Unloader braces: Biomechanical evaluation shows that unloader
braces can reduce the knee adductor moment (Pollo et al., 2002)
and thus effects on disease progression may be feasible. Only one
clinical trial exists and results showed that the unloader brace
improves pain and function over 6 months in 119 patients with
varus knee OA (Kirkley et al., 1999). However, it did not assess
progression. Lateral wedges: Lateral wedges in the shoes can
reduce varus malalignment and the adductor moment in patients
with knee OA (Sasaki and Yasuda, 1987; Kerrigan et al., 2002).
However, only one randomised controlled trial has been conducted
to evaluate the clinical efﬁcacy of wedges (Maillifert et al., 2001;
Pham et al., 2003). In 156 patients with medial knee OA, lateral
wedges had no signiﬁcant effect on symptoms or radiological
disease progression over 2 years but patient selection criteria did
not consider knee joint alignment which may affect the outcome.
Gait retraining: It is suggested that increasing toe-out angle during
gait and shortening stride length are mechanisms to decrease the
knee adductor moment. Presumably an increased toe-out angle
would result in the ground reaction force being located closer to the
knee joint centre during the later part of stance and would thus
result in a lower second peak adduction moment but not
necessarily in the ﬁrst peak adductor moment. This was conﬁrmed
in a study by Hurwitz et al. (2002) in patients with knee OA as well
as in normal subjects (Andrews et al., 1996) although results are
inconsistent. The second adductor moment peak is generally
smaller than the ﬁrst and not all individuals have a deﬁnitive peak
(52% of OA patients do not have a second peak). The effect of
teaching a toe out gait on progression may therefore depend on the
size of the second peak and whether in fact that individual has
a second peak. The use of gait aids is designed to reduce the load
on the knee joint but effects have not been assessed. Weight loss:
In people with knee OA, being overweight increases the likelihood
of disease progression and this may be due to increased load on
the knee joint (Dougados et al., 1992). Theoretically weight loss
would reduce the adductor moment but might allow the person to
walk faster increasing the adductor moment. A recent single-blind
randomised controlled trial in 316 overweight and obese people
with knee OA showed that over 18 months, dietary weight loss
alone did not result in signiﬁcant improvements in pain and function
unless combined with exercise (Messier et al., 2004). No effect was
evident for joint space narrowing although the time frame and the
sample size may have prevented detection of meaningful differ-
ences. Specific exercise: The effect of exercise on pain and
function has been well documented but the effect of speciﬁc
exercise on the local factors discussed above and subsequently on
OA disease progression has not been well studied. Based on the
above literature, exercises may need to be tailored to speciﬁc
subsets of OA patients perhaps in combination with other
interventions that can stabilise the joint and alter alignment.
Selective muscle retraining rather than co-activation could be
attempted in order to minimise joint loads. The effect of pro-
prioceptive exercises has not been investigated.
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THE HIP ABDUCTION MOMENT AND PROGRESSION OF
KNEE OSTEOARTHRITIS (OA)
A. Changy, K. Hayesy, S. Cahuey, D. Hurwitzz, R. Gengez,
J. Songy, D. Dunlopy, L. Sharmay
y Rheumatology, Northwestern University, Chicago, IL, USA
z Rush Medical Center, Chicago, IL, USAFew modiﬁable risk factors for knee OA progression have been
identiﬁed. During level walking, hip abductor muscle weakness in
the stance-phase limb may cause a drop in the contralateral, swing-
phase hip. Such a drop shifts the center of mass towards the
swing-phase limb, thereby increasing forces across the medial
tibiofemoral compartment cartilage of the stance-phase knee. If this
is a clinically important effect, then a greater internal hip abduction
moment would protect against ipsilateral medial OA progression.
This has not been examined. We tested the hypothesis that
a greater internal hip abduction moment during gait at baseline is
associated with a reduced likelihood of ipsilateral medial tibiofe-
moral OA progression over the next 18 months.
Sixty-four persons with knee OA (by deﬁnite osteophyte presence
and symptoms) were evaluated. Baseline assessments included:
kinematic and kinetic gait parameters obtained with an optoelec-
tronic camera system and forceplate, with inverse dynamics used
to calculate 3-D moments at the hip, knee, and ankle joints; and
pain using a separate visual analogue scale for each knee. Semi-
ﬂexed knee X-rays with ﬂuoroscopic conﬁrmation of tibial rim
alignment were obtained at baseline and 18 months later. Disease
progression was deﬁned as worsening of medial joint space
narrowing grade. Logistic regression with GEE was used to
estimate odds ratios (OR) for progression per unit of internal hip
abduction moment, after excluding knees with the worst joint space
grade at baseline (which could not progress).
The 64 participants (63% women) with mild-moderate OA had
a mean age of 66, BMI 29, and mean internal hip abduction
moment of 4.19 (G0.92) %body weight! height. A greater internal
hip abduction moment during gait was associated with a reduced
likelihood of medial tibiofemoral OA progression, with OR/unit hip
abduction moment of 0.63, 95% CI (0.41, 0.98). This protective
effect persisted after adjustment for age, gender, walking speed,
and knee pain, with adjusted OR 0.52, 95% CI (0.30, 0.90).
A greater internal hip abduction moment during gait protected
against medial tibiofemoral OA progression in the ensuing 18
months in individuals with knee OA. These results suggest that
intervention to increase the internal hip abduction moment, such as
hip abductor muscle strengthening, may delay progression of
medial compartment knee OA.
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KNEE LAXITY INCREASES AFTER EXERCISE IN PATIENTS
WITH KNEE OSTEOARTHRITIS
T. Miyazakiy, M. Wadaz, K. Kamitanix, H. Babajj
y Orthopaedic Surgery, University of Fukui, Matsuoka, Fukui, Japan
z Orthopaedic Surgery, Tannan Hospital, Sabae, Fukui, Japan
x Orthopaedic Surgery, Izumigaoka Hospital, Tsuruga, Fukui, Japan
jj Orthopaedic Surgery, University of Fukui, Matsuoka, Fukui, Japan
Aim of this study: The purpose of this study was to test whether
dynamic knee laxity in patients with early-stage knee osteoarthritis
(OA) is much larger than that of non-OA subjects.
Methods: We studied 56 patients (112 knees) with bilateral primary
femoro-tibial knee OA. Age-matched 12 subjects were selected as
control. The patient group consisted of 24 knees with grade 1, 39
with grade 2, 32 with grade 3, and 21 with grade 4 OA according to
the criteria of Kellgren and Lawrence. Each subject was asked to
ascend and descend 8 steps repetitively for 10 min. Before and
after this exercise, we measured antero-posterior (AP) and varus–
valgus (VV) knee laxity. AP laxity was measured with KT 1000 knee
arthrometer. VV laxity was measured using radiographs applying
varus and valgus forces. The measured data were compared
among the non-OA, mild OA and advanced OA groups.
Results: Before the stepping exercise, the AP laxity was not
different among the three groups in both right and left knees.
However, the changes in AP laxity after exercise were signiﬁcantly
different among the three groups. The amount of change in AP
laxity was largest in mild OA and smallest in control group (P !
0.05 for right knee and P ! 0.01 for left knee). Similarly, the VV
laxity of the knee before exercise was statistically not different.
S25However, the amount of change after exercise in the mild OA group
was larger (left knee) and similar (right knee) than that of the
advanced OA group. In addition, the amount of change in the OA
group was signiﬁcantly larger than that of the control group (P !
0.05).
Conclusion: Dynamic knee laxity after physical exercise was
signiﬁcantly larger in the OA group than non-OA control.
The amount of change in laxity in the mild OA group was more
than that of the advanced OA group. Our results suggest the
development of knee laxity during repetitive physical exercise
may play a signiﬁcant role in the etiology and/or progression of
knee OA.
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IMPAIRED PROPRIOCEPTION OF BOTH KNEES AND
ELBOWS IN PATIENTS WITH KNEE OSTEOARTHRITIS
COMPARED TO HEALTHY PARTICIPANTS
H. Lund*y, B. Juul-Kristensenz, H. Christensenz, H. Bliddaly,
B. Danneskiold-Samsøey
y The Parker Institute, Frederiksberg Hospital, Frederiksberg,
Denmark
z National Institute of Occupational Health, Copenhagen ,
Denmark
Impaired proprioception is previously described in both the affected
and non-affected knee joint among patients with knee osteoarthritis
(OA), leading to the hypothesis that impaired proprioception might
be a general phenomenon, and not only a local phenomenon
caused by OA in the affected knee. Thus, the purpose of the
present cross sectional study was to test (1) whether proprioception
of the knees among patients with knee OA was different from
proprioception of the elbows and (2) whether proprioception of the
elbows among patients with knee OA differed from proprioception
of the elbows among healthy participants. Proprioception was
measured as joint position sense (JPS) and threshold to detection
of passive movement (TDPM). Eighteen female patients with knee
OA (mean (SD) age: 67.2(12.8) years) and 45 healthy female
(mean (SD) age: 45.1(16.4) years) participants had their JPS and
TDPM measured in both knees and elbows. JPS was measured as
the participant’s ability to actively reproduce an actively placed
position in the elbow and knee joints, measured 3 times. TDPM was
measured as the participant’s ability to recognize and respond to
a passive motion (1(s1) of the elbow and knee joints, measured 6
times. JPS was calculated as the mean difference (Absolute Error,
AE) and standard deviation (Variable Error, VE) (in degrees)
between target and estimated angle of the two differences that
were closest to each other. TDPM was calculated as the mean
difference and standard deviation (AE, VE) (in degrees) from the
onset of the passive movement to the participant’s recognition and
response to the movements. Student’s t test with P % 0.05 as
signiﬁcance level was used.
No difference was found between affected knee joint and healthy
knee joint for patients with knee OA for neither JPS nor TDPM. For
TDPM a signiﬁcant higher AE and VE were found over the knees
for patients compared to healthy participants (AE Z 2.66( vs
1.37(, P ! 0.0001; VE Z 0.97( vs 0.43(, P ! 0.0001). Further,
TDPM was signiﬁcantly higher in OA patients’ elbows compared to
healthy participants’ elbows (AEZ 2.75( vs 1.36( P ! 0.001; VE
Z 0.88( vs 0.48(, P ! 0.007). For JPS only VE showed
a tendency towards a difference between OA patient knees and
healthy participants knees (1.54( vs 0.87(, P Z 0.05). In
conclusion, the hypothesis that impaired proprioception is a general
problem and not a local phenomenon in knee OA patients, seems
to be supported. Longitudinal studies are needed in order to
evaluate whether a poor proprioception may increase the risk for
and aggravate the development of OA, or if OA leads to a poor
proprioception. Additionally, studies are needed to test whether
proprioceptive exercise may improve the impaired proprioception
and physical function in OA patients.M58
AN OPTIMAL DURATION OF INSOLE WITH SUBTALAR
STRAPPING WEAR EACH DAY FOR PATIENTS WITH VARUS
DEFORMITY OSTEOARTHRITIS OF THE KNEE
Y. Toda
Rheumatology, Toda Orthopedic Rheumatology Clinic, Suita,
Osaka, Japan
Aim of study: We assessed the optimal duration of laterally wedged
insole with subtalar strapping for medial compartment osteoarthritis
of the knee (knee OA) wear each day.
Method: Fifty eight patients with knee OA were prospectively ran-
domized according to birth date and instructed to wear a lateral
wedge with subtalar strapping for less than 5 h (the short group),
between 5 and 10 h (themediumgroup) andmore than 10 h (the long
group) each day, and placebo subtalar strapping bandwithout lateral
wedge (the placebo group) for 2 weeks. All patients recorded the
duration of wearing respective orthotic device each day in their diary
for 2 weeks. Standing radiographs were employed to analyze the
femorotibial angle for each subject, both with and without their res-
pective orthotic device. The remission scores of Lequesne index of
severity for knee OA were compared among the four groups at the
conclusion.
Results: All participants completed the study. There were 17
participants in the placebo group, 16 in the short group, 13 in the
medium group and 12 in the long group. The averages hours
wearing the insole with subtalar strapping were 3.1G 0.92 h in the
short group, 6.5G 1.5 h in the medium group and 14.7 G 3.2 h in
the long group. The short, medium and long groups demonstrated
a signiﬁcant greater valgus correction of the femorotibial angle than
the placebo group (P! 0.0001) (Table I). The remission score was
signiﬁcantly improved in the medium group compared to the
placebo (P Z 0.007) and long (P Z 0.025) groups (Table II).
Conclusion: There were time dependent effects from different
durations of an insole with subtalar strapping wear, which account
for changes in pain symptom of knee OA. An optimal duration of
insole with subtalar strapping wear for patients with varus deformity
knee OA may be between 5 and 10 h each day.
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PATHOGENESIS OF POST-TRAUMATIC OSTEOARTHRITIS
J. A. Buckwalter
University of Iowa, Iowa City, IA, USA
The pathogenesis of synovial joint degeneration following injuries of
articular surfaces, menisci and ligaments remains unknown. We
hypothesized that excessive loading of articular surfaces due to
acute joint trauma or post-traumatic joint malalignment, instability or
Table I
The changes of femorotibial angle (degree)
Placebo
group
Short
group
Medium
group
Long
group
Before device 180.5 (sd:3.6) 180.0 (sd:3.6) 180.5 (sd:4.6) 182.7 (sd:6.4)
With device 180.4 (sd:3.6) 177.6 (sd:3.0) 177.8 (sd:4.3) 180.1 (sd:5.3)
Correction angle 0.1 (sd:0.8) 2.4 (sd:1.3) 2.5 (sd:0.9) 2.7 (sd:2.3)
sd: standard deviation.
Table II
Remission score of severity index
Placebo group Short group Medium group Long group
Initial assessment 10.2 (sd:4.4) 9.7 (sd:3.9) 9.8 (sd:5.0) 10.0 (sd:4.7)
Final assessment 8.3 (sd:4.1) 5.0 (sd:4.1) 3.8 (sd:4.6) 7.7 (sd:4.1)
Remission score 1.9 (sd:3.7) 4.6 (sd:4.0) 5.9 (sd:4.1) 2.3 (sd:3.7)
The minus () value indicated an improvement.
S26incongruity increases release of reactive oxygen species that kills
chondrocytes and compromise the ability of the remaining cells to
maintain or restore the tissue. We tested the effects of high shear
stress as compared with compressive stress on human cartilage
explants. We also tested the effect of an antioxidant, n-acetyl
cysteine (NAC), to determine the role of antioxidants in preventing
shear stress effects. High shear stress (5 MPa axial compression)
stimulated release of oxygen free radicals and caused signiﬁcant
cell death as compared with compressive stress or moderate shear
stress. The greatest loss of chondrocytes occurred in the superﬁcial
zone, where viability was reduced to less than 75% of unstressed
controls. Pre-incubation of explants with NAC signiﬁcantly reduced
shear–stress-induced chondrocyte death in the superﬁcial zone.
NAC-treated explants exposed to high shear stress showedO85%
viability in the superﬁcial zone, which was not signiﬁcantly different
from the value for unstressed controls (93% viable) and signiﬁcantly
greater than in explants without NAC (!75% viable). We also
found that exposure of normal chondrocytes to high levels of
oxygen (21%) damages their nuclear DNA. These observations
support the hypothesis that oxidative damage mediates the effects
of shear stress on chondrocytes and suggest that excessive shear
stresses or due to articular incongruities, joint instability or
malalignment cause chondrocyte damage that leads to cartilage
degeneration. Strategies that may decrease the risk of post-
traumatic osteoarthritis include minimizing oxidative damage by
providing the optimal mechanical environment for restoration of
articular surfaces following injury and use of antioxidants, and
introducing new cell populations.
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QUADRICEPS FEMORIS STRENGTH, CROSS-SECTIONAL
AREA, AND MUSCLE ACTIVATION IN PATIENTS WITH KNEE
OSTEOARTHRITIS AND TOTAL KNEE ARTHROPLASTY
S. C. Petterson, R. L. Mizner, L. Snyder-Mackler
Physical Therapy, University of Delaware, Newark, DE, USA
Aim of study: To determine the contributions of muscle atrophy and
volitional activation (VA) to quadriceps weakness associated with
knee osteoarthritis (OA) and total knee arthroplasty (TKA).
Methods: Thirty patients with end-stage, unilateral knee OA were
tested a mean of 10 days before and 27 days after TKA.
Quadriceps strength and VA of the involved and uninvolved knee’s
quadriceps muscles were obtained using a burst superimposition
technique. A supramaximal burst of electrical stimulation is super-
imposed on a maximal volitional isometric contraction (MVIC). MRI
was used to determine maximal quadriceps cross-sectional area
(MCSA). MR images were digitized and intramuscular fat was
removed via custom-written software (ICC Z 0.99). VA was
calculated by dividing MVIC prior to the burst by the force output
with the burst. Differences in MVIC, VA, and MCSA were analyzed
using paired t tests. Linear regression was used to determine the
contributions of MCSA and VA to MVIC.
Results: Signiﬁcantly lower MVIC (P ! 0.001) and MCSA (P !
0.001) were found in the involved limb compared to the uninvolved
limb both before and after TKA. The interlimb difference in VA was
not signiﬁcant before TKA (PZ 0.225), however following TKA the
involved limb had greater activation failure (P ! 0.001). The
involved quadriceps was 24% weaker and 17% smaller before TKA
and 68% weaker and 26% smaller after TKA.
Compared to the preoperative values, involved MVIC decreased by
61%, MCSA decreased by 18%, and VA decreased by 13% (all
P ! 0.001). In the uninvolved limb after TKA, MVIC decreased by
5% (P Z 0.173), MCSA decreased by 8% (P ! 0.001), and there
was no change in muscle activation (P Z 0.774).
In the involved limb after TKA, VA accounted for the majority of the
variability in quadriceps MVIC (r2 Z 0.31, P Z 0.002), whereas
MCSA accounted for 22% of the variability (r2Z 0.22, PZ 0.009).
Together, VA and MCSA accounted for 50% of the variance of the
involved MVIC (R2 Z 0.50, P ! 0.001). MCSA, however,
accounted for the majority of the variability in MVIC (r2 Z 0.59,
P ! 0.001) in the uninvolved limb, whereas VA accounted for
considerably less of the variance (r2 Z 0.16, P Z 0.03).Collectively, VA and MCSA accounted for 78% of the variability in
the uninvolved quadriceps MVIC after TKA (R2Z 0.78, P! 0.001).
Conclusions: Patients with end-stage knee OA and concomitant
TKA have signiﬁcantly weaker quadriceps muscles and smaller
MCSA in the involved limb compared to the uninvolved limb,
whereas differences in muscle activation are only evident after
TKA. While MCSA explains the majority of the variability in the
uninvolved quadriceps MVIC after TKA, activation explains the
majority of the variability in the involved quadriceps MVIC after
TKA. Because muscle activation plays a large role in the
quadriceps weakness that develops following TKA, rehabilitative
measures during the acute postoperative stages should emphasize
techniques aimed to improve quadriceps muscle activation, such as
biofeedback and neuromuscular electrical stimulation. Improving
activation may lead to more dramatic strength improvements with
better long term postoperative outcomes.
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DOES OBESITY INFLUENCE CLINICAL OUTCOME AND
COMPLICATION RATES FOLLOWING TOTAL KNEE RE-
PLACEMENT FOR OSTEOARTHRITIS? A 5 YEAR ANALYSIS
A. K. Aminy, J. T. Pattony, R. E. Cookz, I. Brenkelz
y Orthopaedics, New Royal Infirmary, Edinburgh, United Kingdom
z Orthopaedics, Queen Margaret Hospital, Dunfermline, United
Kingdom
Aim: To assess the inﬂuence of obesity on clinical outcome and
complication rates 5 years following primary Total Knee Re-
placement (TKR) for osteoarthritis.
Methods: Three hundred twenty-eight primary TKRs (283 patients)
performed between 1995 and 1999 at a single institution, were
followed up prospectively at intervals of 6, 18, 36 and 60 months
following surgeryand the clinical outcomebasedon theKneeSociety
Clinical rating system (subdivided into a Knee Score (KS) and
Function score (FS)) recorded at each follow-up interval. The
following complications were also recorded: peri-operative mortality,
superﬁcial wound infection, deep wound infection, deep vein throm-
bosis, and revision rate. Three separate comparisons were un-
dertaken by subdividing the study sample into two sub-groups: (1)
GroupA comprised two sub-groups basedon bodymass index (BMI)
– ’Non-obese’ (BMI 15–30, 181 TKRs) or ‘Obese’ (BMI O 30, 147
TKRs). (2) Group B comprised only female patients divided into two
sub-groups based on BMI – ‘Non-obese females’ (BMI 15–30, 84
TKRs) or ’Obese females’ (BMIO 30, 87 TKRs). (3) Group C com-
prised two sub-groupsbasedonbodyweight alone–weight!100kg
(300 TKRs) or weight O100 kg (28 TKRs). A repeated measures
split-plot analysis of variance (SPANOVA) was used to evaluate the
difference in the clinical outcome at 5 years between the sub-groups
in Group A, B and C. The complication rates were also compared.
Results: There was no signiﬁcant difference in the KS at 5 years
between sub-groups in Group A (P Z 0.2), B (P Z 0.2) or C (P Z
0.3). There was a statistically signiﬁcant difference in the FS
between the sub-groups in Group A (P Z 0.01) and B (P Z 0.02)
but the effect size (relative magnitude of the difference between
means) was small (partial eta squaredZ 0.02 and 0.03, for Group
A and B, respectively). There was no signiﬁcant difference in the FS
between sub-groups in Group C (P Z 0.5). There was no
signiﬁcant difference in the complication rate between the sub-
groups in Group A, B or C (P > 0.2 for all complications).
Conclusion: Obesity does not inﬂuence clinical outcome, peri-
operative mortality and complication rates 5 years following TKR.
Further studies are required to determine the long-term success of
TKR in obese patients.
M62
INTRA-ARTICULAR OP-1 PROTECTS AGAINST OSTEOAR-
THRITIS AFTER CONTUSIVE IMPACT INJURY
M. B. Hurtig
Clinical Studies, University of Guelph, Guelph, ON, Canada
S27Aim of study: To determine whether OP-1 can modify the
progression of osteoarthritis (OA) created by a contusive impact
injury to the medial femoral condyle.
Methods: A model of progressive unicompartmental OA was
created by applying two 30 MPa impact injuries to both medial
femoral condyles of sheep. Treated limbs received 340 mg OP-1
implant (Stryker Biotech, Hopkinton, Mass) intra-articularly at the
time of injury and 1 week later, whereas control limbs received an
equal volume (0.3 ml) of vehicle alone. Synovial ﬂuid analysis was
done on day 0, 7 and at sacriﬁce 90 days postoperatively. India ink-
facilitated macroscopic assessment of the medial femorotibial joint,
creep indentation testing, and sulfated glycosaminoglycans con-
centration (DMMB method) were done. Histological sections were
used to score joint surfaces using the Modiﬁed Mankin and OARSI
systems, and TUNEL-positive cells were counted. A Students’ t test
or Wilcoxon Signed Rank test were applied as appropriate for each
data type.
Results: There was a strong statistical trend (P! 0.06) for reduced
leukocytes in synovial ﬂuid of OP-1 treated joints on postoperative
day 7. In control limbs irregular depressed areas were found in the
center of the medial femoral condyle with degenerating or eroded
cartilage extending centrifugally. In OP-1 treated joints, the impact
sites were reduced to an irregular, narrow ﬁssure 1–2 mm wide.
Cartilage sGAG content was signiﬁcantly higher (P ! 0.05) at the
impact site in OP-1 treated joints. Aggregate modulus was higher in
the cartilage surrounding the impact zone in OP-1 treated knees
(P! 0.01). Histological and macroscopic scores were improved by
OP-1 treatment (both P ! 0.05) (Tables I & II). OP-1 treated joints
had fewer TUNEL positive chondrocytes compared to vehicle-
treated control knees.
Discussion: This study indicates that two intra-articular injections of
OP-1 prevent the development of OA after mechanical injury.
Reduced TUNEL positive chondrocytes suggest that more chon-
drocytes survive the original injury in OP-1 treated knees and the
remaining cells may beneﬁt from the anabolic effect of OP-1 on
matrix synthesis. OP-1 may also reduce intra-articular inﬂammation
Table I
Percentage of abnormal cartilage in the medial femorotibial joints
Animal # Vehicle OP-1
28 20 5
29 40 20
30 60 0
31 50 20
32 70 10
33 25 10
Abnormal cartilage area was measured from India ink uptake on
scaled digital photographs using Northern Eclipse morphometry
software.
Table II
Histological scores using the modified Mankin and OARSI systems
Modiﬁed Mankin score OARSI scoreAnimal #
Vehicle OP-1 Vehicle OP-1
28 4 2 6 2
29 4 2 8 1.5
30 4 2 8 1
31 5 1 12 5
32 4 3 13.5 4
33 6 3 10 4
The modiﬁed Mankin score is 0–13 where 0 is normal. In the
OARSI system 0 is normal and scores are calculated by multiplying
the lesion stage (severity) by the area occupied. This system can
be open-ended because several lesions scores can be added
together.by reducing leukocyte migration or upregulation of hyaluronan
synthesis. OP-1 may have potential for treating acute sports-related
and traumatic injuries of the knee but more studies are needed to
elucidate this protective mechanism and determine optimum times
and dosage for such interventions.
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DISEASE MODIFYING EFFECT OF HYLAN G-F 20 IN OSTEO-
ARTHRITIS CORRESPONDS TO CHANGES IN GENE EXPRES-
SION PROFILES
P. Liy, M. Zhangz, D. Liux, M. Hawesy, P. DiBenedettojj, N. Morany,
L. DeNapoliy, F. Wang{, K. McHughy, J. Derryy, R. Davisy,
J. Herndony, S. Ryany, C. Wangx, S. Maddenz, C. Chu#,
A. Brooks#, M. O’Callaghany, G. Matthewsy
y Preclinical Biology, Genzyme Corporation, USA
z Gene Analysis, USA
x Bioinformatics, USA
jj Cell Biology, USA
{ Statistics Stability, Genzyme Corporation, Framingham, MA, USA
# Functional Genomics Center, University of Rochester, Rochester,
NY, USA
Hylan G-F 20 (HY) is the leading viscosupplement therapy for
knee pain in the US. The goal of this study was to evaluate the
efﬁcacy of HY in a rabbit model of osteoarthritis (OA) and
correlate its disease modifying effects with gene expression
alterations in articular cartilage using microarray technology.
Skeletally mature rabbits underwent either anterior cruciate
ligament transection (ACLT) to induce OA, or sham surgery. Four
weeks later, both groups were given 3 weekly intra-articular
injections of either HY (0.5 ml, 8 mg/ml) or Lactated Ringer’s
Solution (LRS), and then were sacriﬁced a week after the last
injection. Gross and histological assessment of the ACLT-LRS
knees revealed moderate OA development including ﬁbrillation,
clefts, cartilage thinning, and osteophyte formation, all of which to
varying degrees were less severe in the ACLT-HY knees. Mankin
scores were highest (worst) in the ACLT-LRS control group (6.54).
Scores for the remaining groups were: ACLT-HY, 5.29; sham-HY,
4.32; and sham-LRS, 3.62. The ACLT-HY group score was
signiﬁcantly lower than that for the ACLT-LRS group (P Z 0.02).
These ﬁndings were conﬁrmed using the Carlson scoring system,
and similar results were obtained: ACLT-LRS, 7.59; ACLT-HY,
5.30; sham-HY, 3.97; and sham-LRS, 3.09. To probe the
molecular mechanism of joint protection seen with HY treatment,
Affymetrix expression arrays were used to develop gene
expression proﬁles from total RNA isolated from cartilage of the
sham-LRS, ACLT-LRS, and ACLT-HY (8 per group). The initial
analysis focused on genes that were altered in the disease
(ACLT-LRS) compared with the control (sham-LRS) group, and
examined whether these OA altered genes were responsive to
HY. In the disease group, 166 genes were signiﬁcantly increased
(P ! 0.05) compared with sham controls. Among these 19
showed signiﬁcant reversal of this upregulation in response to HY.
Conversely, 6 out of 90 signiﬁcantly downregulated genes in
diseased vs sham controls showed reversal of downregulation in
response to HY. The HY responsive genes included those
involved in cell cycle regulation, cell differentiation, and matrix
metabolism. Among these genes, MMP-16, a member of the
matrix metalloproteinase family, was elevated in ACLT-LRS vs
sham-LRS and decreased in ACLT-HY vs ACLT-LRS. Another
interesting gene with a similar expression pattern was RANKL,
which is involved in bone remodeling and immune regulation.
Histological results of this study strongly support the conclusion
that HY, when administered in a course of 3 weekly injections,
has signiﬁcant disease modifying effects. The identiﬁcation of
treatment responsive genes supports the hypothesis that HY
ameliorates OA by affecting chondrocytes at the molecular level.
OA altered genes responsive to HY, such as MMP-16 and
RANKL, are likely involved in OA progression, and one of the
mechanisms of chondroprotection by HY may be via regulation of
these genes.
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REPAIR, REGENERATION, AND REPLACEMENT OF ARTICU-
LAR CARTILAGE
R. L. Sah
Department of Bioengineering, University of California-San Diego,
La Jolla, CA, USA
Articular cartilage normally functions as a remarkable low-friction,
wear-resistant, and load-bearing material. The spectrum of articular
cartilage damage and degeneration presents a variety of thera-
peutic challenges. Therapies may be guided by a biomimetic
approach, where the goal is to reestablish key biological and
biomechanical features of normal articular cartilage and joints. In
the mild stage of ﬁbrillation, surface treatments may restore
damaged superﬁcial cartilage tissue. In the moderate stage of
focal full-thickness chondral and osteochondral defects, cell-based
tissue replacement may ﬁll defects and restore local cartilage
function. In end-stage osteoarthritis, tissue-based biological organ
replacement may restore joint function. For effective therapies of
articular cartilage, there is a need to understand and control
dynamic biological processes to achieve the desired tissue or joint
properties in the bulk tissue and in the interface regions.
Both bulk and interface regions are important in repair, regenera-
tion, and replacement strategies. For example, in the case of an
osteochondral defect, a repair strategy such as microfracture,
a regeneration strategy such as cell transplantation, and a re-
placement strategy such as osteochondral grafting all face similar
challenges. Each of these strategies seeks to ﬁll the defect with
cartilaginous material that bears load in the bulk, a material that has
adhesive properties facilitating integration with the surrounding
articular cartilage and subchondral bone, and a material that has
anti-adhesive properties facilitating maintenance of a low-friction
surface. The development of these bulk and interface properties
may be desired in vitro, such as during fabrication of an
osteochondral implant, or in vivo, such as after implantation of
a formed construct.
The bulk biomechanical properties are central to the load-bearing
and wear-resistant functions of cartilage. The relationships between
poroelastic properties and cartilage composition and structure at
various stages of development and growth, at various depths from
the articular surface, and in various joint locations, provide
a blueprint for inducing repair tissue and fabricating replacement
cartilage tissue. The rapid maturation of articular cartilage
mechanical properties in the w8 week antenatal period suggests
that an immature cartilaginous tissue may be implanted and
expected, under appropriate and relatively short-term post-opera-
tive rehabilitation conditions, to deposit and remodel the pro-
teoglycan- and collagen-rich extracellular matrix to mature into
tissue with adult-like load-bearing properties. The growth of
cartilage appears mediated in part by a balance between
metabolism of molecules that contribute the swelling pressure of
cartilage and those that contribute to the restraining collagen
network.
Surface properties are critical to the low-friction behavior of articular
cartilage. While many lubrication mechanisms are operative in
articular cartilage and joints, boundary lubrication function and
failure may be critical to the damage that is evident at the articular
surface. Bioengineering cartilage tissue to be stratiﬁed and to
include appropriately localized cells that form a boundary lubrica-
tion layer, including lubricin/superﬁcial zone protein/proteoglycan 4,
may be needed to restore or achieve the low-friction articular
surface of cartilage. Also, cartilage resurfacing strategies may
utilize cells synthesizing PRG4. The role of PRG4 and other
proposed components of the boundary layer of cartilage remain to
be fully elucidated. However, the cells in the superﬁcial zone of
articular cartilage appear to be of particular interest since they have
properties of progenitor cells.
In other areas, the surface of an implant may form an interface with
host tissue that requires integration, both with the surrounding
articular cartilage and the subchondral bone. Integration of an
implant to the surrounding cartilage may be mediated by
metabolism of the cross-linked collagen network, driven by cellsin the local vicinity of the interface. Tailoring the cartilaginous
implant and host tissue may facilitate integration, recapitulating the
reparative milieu of immature cartilage. The integrity of the interface
with the subchondral bone is difﬁcult to analyze, and studies of the
native interface have utilized specialized fracture methods.
Appropriate formation of such an interface can occur in osteochon-
dral repair procedures, but directing this process to be consistent in
vivo and also in vitro are important for a number of treatment
strategies.
In most of the above processes, the organization of cells within
native, engineered, and implanted tissues is an important factor.
Such cells have a limited domain over which they typically inﬂuence
their surrounding. The chondrocytes of cartilage are initially at very
high density, and then become more dispersed as the tissue grows.
In the adult, chondrocytes are organized into oriented clusters and
columns in different regions of the tissue. 3-D histological-resolution
imaging methods have facilitated analysis of chondrocyte organi-
zation, effectively structural bioinformatics analysis of articular
cartilage at the cell scale. In engineered tissues, microscale
cell manipulation methods allow for controlling chondrocyte
organization and analyzing resultant effects. Appropriate cell
interactions, with deposition and remodeling of the appropriate
molecules in the local pericellular regions and at tissue interfaces is
needed for treating articular cartilage and for translating novel
tissue engineering approaches into successful in vivo models and
clinical practice.
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EVALUATION OF CARTILAGE REPAIR FOLLOWING TRANS-
PLANTATION OF GENE-ACTIVATED MESENCHYMAL CELLS
IN A RAT MODEL
K. Gelseyz, J. Parkz, K. von der Markz, T. Aignerx, H. Schneiderz
y Department of Surgery, Trauma Surgery Division, University of
Erlangen-Nuernberg, Erlangen, Germany
z Department of Experimental Medicine I, Nikolaus Fiebinger
Center of Molecular Medicine, University of Erlangen-Nuernberg,
Erlangen, Germany
x Department of Pathology, University of Erlangen-Nuernberg,
Erlangen, Germany
Aim of the study: To investigate the potential of mesenchymal cells
of different origin stimulated by growth factor gene transfer for the
repair of partial-thickness lesions in rat articular cartilage.
Methods: Mesenchymal cells were isolated from rib perichondrium,
fat stroma or bone marrow of rats. Following puriﬁcation and
propagation in vitro, each progenitor cell population was infected
with an adenoviral vector carrying bone morphogenetic protein-2
(BMP-2) cDNA. The infected cells were suspended in ﬁbrin glue
and applied to mechanically generated partial-thickness cartilage
lesions in the patellar groove of the rat femur, resembling the
ﬁssures and clefts seen in osteoarthritis. Quality and integration of
the newly formed tissues were assessed 8 weeks after the
transplantation by histochemical and immuno-histochemical meth-
ods. Non-infected cells or cells treated with a reporter gene vector
served as controls. A portion of the cells was also studied after
stimulation with an adenoviral vector carrying the insulin-like growth
factor 1 (IGF-1) gene.
Results: The transplanted cells were able to attach to the wounded
cartilage and resisted displacement by joint movement. AdBMP-2-
stimulated perichondrial cells produced repair cartilage of hyaline
morphology with a proteoglycan-rich, type II collagen-positive
matrix but only faint staining for type I collagen. Similar results
were obtained with perichondrial cells infected with AdIGF-1. The
repair tissue originating from AdBMP-2-infected bone marrow cells
showed less intensive type II collagen staining, although chondro-
genic differentiation of the cells was indicated by a proteoglycan-
rich matrix, only weakly positive for type I collagen. AdBMP-2-
infected fat stroma cells failed to form a hyaline repair tissue, but
produced rather ﬁbrous tissue mainly composed of type I collagen.
Non-infected perichondrium, fat stroma or bone marrow cells
formed only ﬁbrous tissue. Excessive cells, not protected from
S29mechanical wear, were partially dislocated to the joint margins,
leading to osteophyte formation there if AdBMP-2 had been used
for stimulation. This adverse effect, however, was not seen with fat
stroma cells or AdIGF-1-infected cells.
Conclusions: For the treatment of cartilage defects it may not be
necessary to obtain articular chondrocytes, because transplanta-
tion of mesenchymal cells that are more easily obtainable may
result in the formation of a hyaline repair tissue. Perichondrium-
derived mesenchymal cells were found to be superior to cells
isolated from bone marrow or fat stroma with respect to forming
a hyaline tissue. A chondrogenic stimulus, e.g., by transfer of BMP-
2 or IGF-1 cDNA, appears to be required for initiation or support of
a chondrogenic differentiation of the transplanted cells.
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FUNCTIONAL CHARACTERIZATION OF THE NOVEL GENE
HDACC-7 – A PROLOGUE FOR GENE THERAPY FOR REPAIR
OF ARTICULAR CARTILAGE
P. Ghosh, B. Shen, X. Wei
Institute of Bone and Joint Research, Royal North Shore Hospital,
St Leonards, NSW, Australia
Aims of study: The 17th century observation by John Hunter that
chondral injuries do not heal spontaneously is as true today as it
was then. However, within recent years surgical procedures, in
which autologous chondrocytes are transplanted into chondral
defects, have been reported to achieve repair in young adults but
the procedure is less successful in elderly patients due to the
decline in chondrocyte viability, their diminished response to growth
factors and loss of phenotype with aging. We undertook the present
study to determine if matrix biosynthesis and chondrocyte
phenotype could be preserved in ATDC5 pre-chondrocytes (APC)
or mesenchymal stem cells (MSC) by transfecting them with a novel
gene, DACC-7, initially derived from a deer antler cartilage gene
library (Roubin R and Ghosh P, Matrix gene expression in
chondrogenesis. Patent: PCT-Au 02-00163).
Methods: An expression vector containing the human (hDACC-7)
cDNA corresponding to the deer DACC-7 was constructed using
standard procedures. Mouse APC [RIKEN cell bank] and MSC
[isolated from bone marrow of NZ rabbits] were cultured in DMEM/
Ham’s F12 containing 5% FBS, transferrin and 3! 10–8 M sodium
selenite, at 37(C, 5% CO2. Using hDACC-7/pcDNA3.1/V5/His
expression vector or the vector alone (mock transfected) APC and
MSC were transiently transfected using Lipofectamine 2000 in Opti-
MEM I reduced serum medium. Stable transfection was achieved
using the same method but cells were further passaged at 1:30
dilution and cultured after 3 weeks in selective medium containing
100 mg/ml G418 [Geneticin]. RT-PCR was used to conﬁrm
transfection of cells and the expression of aggrecan (PG), Types
II and X collagens and SOX-9 relative to b-actin. In vitro isotope
labelling and standard bioassays were used to monitor DNA, PG
and Type II collagen synthesis. In all experiments the mock
transfected cells were used as the control.
Results: In the transiently transfected APCs, PGs and SOX-9 gene
expression were signiﬁcantly up-regulated and Type X collagen
down-regulated. Type II collagen expression was only marginally
increased. Isotope bioassays conﬁrmed these ﬁndings and also
showed that DNA synthesis was not changed. Transiently trans-
fected MSC cultured in monolayer or in alginate beads also
demonstrated enhanced PG synthesis using the bioassays. The
permanently transfected APCs exhibited substantially higher (2!)
PG synthesis than the transiently transfected APCs while DNA
synthesis was 4! the levels of the mock transfected cells.
Conclusions: The ﬁnding that transfecting the APCs or MSC with
hDACC-7 signiﬁcantly enhanced PG biosynthesis and cell division
while reducing expression of type X collagen suggests that this
gene could be implicated in maintaining the chondrocyte phenotype
during the growth and development of cartilage. Transfecting
chondrocytes or MCS cells with hDACC-7 prior to transplantation
into chondral defects could therefore improve production ofa hyaline matrix. Animal studies are in progress to examine this
hypothesis.
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THE TREATMENT OF DEEP OSTEOCHONDRAL DEFECTS
WITH A NEW GROWTH-FACTOR ENHANCED, CELL-FREE
COLLAGEN-TCP BIOIMPLANT – IN VIVO RESULTS
T. Gotterbarmy, S. J. Breuschz, S. Berardi Vileix, P. Mainil-Varletjj,
T. Yamashitajj, M. Jungy, W. Richtery
y Orthopedical Department, University of Heidelberg, Heidelberg,
Germany
z Orthopedical Department, University of Edinburgh, Edinburgh,
United Kingdom
x Zimmer Biologics Inc., Winterthur, Switzerland
jj Institute of Pathology, University of Bern, Bern, Switzerland
Aim of the study: The clinical treatment of deep osteochondral
cartilage defects is still a problem in joint surgery. The purpose of
this in vivo experiment was to study the histological and bio-
mechanical outcome of a new, cell-free, two-layered bioimplant.
The implant consisted of a collagenous layer as a replacement for
cartilage and a tri-calcium-phosphate (TCP) layer to replace
subchondral bone. To stimulate tissue differentiation a growth-
factor extract from bovine bone (Neosteoª, Sulzer Medica,
Winterthur, Switzerland) was added.
Methods: Twenty-seven Go¨ttinger Minipigs were used in this
experiment and randomized into three different treatment groups
to allow a strictly intra-individual comparison. An osteochondral
defect (/5, 4 mm) was drilled into the medial facet of the trochlear
groove of each knee. The defects were either left empty and served
as control (group C) or were treated with two different methods: in
group BI the bioimplant was press-ﬁtted into the standardized
osteochondral defect; in group GF after implantation, Neosteoª
was added on the top of the implant. The animals were killed after
6, 12 and 52 weeks. A non-destructive biomechanical test (stress-
relaxation test) of the repaired tissue was performed on all
specimens and histological evaluation was carried out by two
blinded observers (O’Driscoll- Score).
Results: Histological assessment showed that untreated osteo-
chondral defects (group C) only partially healed with biomechan-
ically insufﬁcient repair tissue. In contrast, the implantation of the
two-layered bioimplant (group BI and GF) improved subchondral
bone repair, superior to controls at 6 and 12 weeks follow-up (P!
0,005). The TCP was osseo-integrated after 6 and totally replaced
by cancellous bone at 52 weeks follow-up. The cartilage repair
tissue of the construct was mainly ﬁbrocartilaginous and showed
matrix producing cells, indicating that cell migration happened.
Tissue morphology and extracellular matrix staining was signiﬁ-
cantly better after growth-factor treatment at 6 and 12 weeks follow-
up (P! 0.005). Compared to controls, the bioimplant showed signs
of slight inﬂammation and the collagenous layer could be detected
up to 12 weeks. Biomechanical properties of the repair tissue
showed a maximum axial stiffness after 12 weeks but unequal to
healthy articular cartilage.
Conclusions: The use of a two-layered bioimplant seems to provide
a new promising treatment option for the clinical repair of deep
osteochondral defects in joint surgery.
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TIME-COURSE EVALUATION OF REPARATIVE CARTILAGE
WITH MR IMAGING AFTER AUTOLOGOUS CHONDROCYTE
IMPLANTATION
A. Watanabeyz, Y. Waday, T. Sashoy, N. Ochiaiy, T. Obataz,
H. Ikehiraz, T. Uedax, H. Moriyay
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Chiba, Japan
Aim of study: The aim of this study is to assess the qualitative
change of reparative cartilage after ACI by use of magnetic
resonance (MR) imagings.
Methods: Ten knees of 10 patients, on which ACI of the femoral
condyle was performed, were included. Time-course evaluation of
reparative cartilage was performed using fat-suppressed three-
dimensional spoiled gradient-recalled (3D-SPGR) MR imaging. To
compare the signal intensity of reparative cartilage with that of
normal cartilage, we deﬁned the signal intensity (SI) index (SI of
reparative cartilage divided by SI of normal cartilage; expressed as
a percentage), and the change of SI index was investigated. The
follow-up periods were 2 to 3 years after ACI surgery. A second
look arthroscopy was performed about 12 months after ACI, and
reparative cartilage as well as normal cartilage was obtained by
biopsy for qualitative evaluations. The histological evaluation was
made using the International Cartilage Repair Society (ICRS)
assessment form for repair of cartilage. For biochemical evaluation,
the concentration of glycosaminoglycan (GAG) in reparative
cartilage and in normal cartilage was evaluated with High
Performance Liquid Chromatography.
Results: In all cases, the SI index was at the lowest immediately
after the ACI, and it increased rapidly up to 9 months with time.
After 9 to 12 months, SI index had settled almost level and it was
maintained at least 2 to 3 years postoperatively. The average of SI
indexes after 12 months to last examination was 74.2 G 4.6 (%),
and this represent that the signal intensity of reparative cartilage
became constant with a value lower than that of normal cartilage.
The ICRS score of reparative cartilage was 11.6 G 2.3 (points,
normal cartilage is 18 points). The GAG concentration was 65.9G
9.4 (mg/mg) in reparative cartilage and 107.9 G 17.0 (mg/mg) in
normal cartilage. The ICRS score and the GAG concentration of
reparative cartilage were signiﬁcantly lower than those of normal
cartilage (P ! 0.05).
Conclusions: In strong T1 weighted imaging such as 3D-SPGR MR
imaging, the signal intensity is mainly determined by the tissue-
speciﬁc relaxation time. The time-course change in SI index may
have been caused by decrease in the tissue-speciﬁc T1 relaxation
time in the maturing process of the implanted chondrocytes from
the state of suspension to hard hyaline-like cartilage. Thus, as the
reparative cartilage becomes close to normal hyaline cartilage, the
SI index may increase. Our results might indicate that the major
maturation process of implanted chondrocytes had almost ﬁnished
up to 9 to 12 months, and although the quality of reparative
cartilage as a hyaline cartilage was inferior to that of normal
cartilage, identical condition had been maintained after that.
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REQUIREMENT OF REGULATORY AGENCIES FOR
DISEASE MODIFYING DRUGS IN OA: CONSENSUS AND
CONTROVERSIES
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A RANDOMISED, CONTROLLED TRIAL OF CORTICOSTEROID
INJECTION VS TIDAL IRRIGATION IN KNEE OSTEOARTHRI-
TIS: THE KIVIS STUDY
N. K. Ardeny, I. R. Readingy, K. M. Jordany, C. Coopery,
L. Thomasy, H. Platteny, A. Hassany, J. M. Ledinghamzy Rheumatology, Southampton University Hospitals NHS Trust,
Southampton, Hampshire, United Kingdom
z Rheumatology, Queen Alexandra Hospital, Portsmouth, Hamp-
shire, United Kingdom
Aims: To investigate the beneﬁts of intra-articular corticosteroid (IS)
and tidal irrigation (TI) in patients with knee osteoarthritis
Methods: A 6 month, randomised, single blind, parallel group,
clinical trial of patients recruited from Rheumatology clinics with
symptomatic knee OA. Patients aged 40–90 years with knee OA K/
L grade R 2 were randomised to IS with 40 mg triamcinolone
acetonide and 2 ml of 1% lignocaine or TI irrigating the knee with
500–1000 ml of normal saline through a 3 mm diameter trochar. In
patients with bilateral disease, the most symptomatic knee was
chosen as the index joint. The primary outcome measures were the
composite WOMAC pain score (WP) and composite WOMAC
function score (WF) measured by VAS; secondary outcome
measures included the patients’ overall assessment of treatment
(PAT) on a ﬁve point Likert scale. Patients were followed up at
2,4,12 and 26 weeks by a trained research nurse blinded to
treatment allocation. Analysis was by ITT.
Results: 150 subjects were randomised (65% women) and there
were 22 drop-outs (11 IS and 11 TI). The two groups (IS vs TI)
were well matched in terms of: mean age (68 vs 65 years); mean
height (166 vs 163 cm); mean weight (87 vs 83 kg); median
duration of symptoms (54 vs 60 months); percentage bilateral
knee pain (61 vs 63%) and baseline WP and WF. At 2 weeks, IS
and TI WP had improved signiﬁcantly from baseline but there was
no difference between treatment groups. At 26 weeks, this
improvement remained in the TI group alone and TI was
signiﬁcantly better than IS (P Z 0.01). A similar pattern was
seen for WF at 26 weeks.
Sixty-one percent of patients had an effusion. At 2 weeks, WP had
improved signiﬁcantly with no between group differences in any
group. At 26 weeks, only those who had TI had signiﬁcant
improvement and this was more marked in those without effusion
(P Z 0.009). A similar pattern was seen for WF.
There were no between treatment differences in PAT at 2 or 4
weeks, but signiﬁcant differences in favour of TI were seen at 12
and 26 weeks (P Z 0.002; P ! 0.001).
Table I
WOMAC pain and function
WP (mean (SD)) WF (mean(SD))Time
IS (n Z 77) TI (n Z 71) IS (n Z 76) TI (n Z 67)
Baseline 243 (96) 243 (91) 767 (360) 831 (340)
2 weeks 168 (111) 155 (117)
* !0.001 !0.001
26 weeks 232 (118) 173 (139) 769 (400) 632 (471)
* 0.6 !0.001 0.98 !0.001
*P value for change from baseline at given time point.
Table II
WOMAC pain and effusion
Effusion No Effusion
Time IS (n Z 50) TI (n Z 40) IS (n Z 27) TI (n Z 31)
Baseline 244 (87) 259 (91) 241 (113) 224 (90)
2 weeks 157 (97) 166 (119) 190 (131) 143 (116)
* !0.001 !0.001 !0.001 !0.001
26 weeks 214 (113) 180 (144) 262 (124) 164 (134)
* 0.18 0.002 0.15 0.01
*P value for change from baseline to given time point.
S31Conclusion: In knee OA patients, IS and TI treatment had
a signiﬁcant improvement on pain and function at 2 weeks. These
effects were maintained only in the TI group by 26 weeks and were
more marked in those without effusion.
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A COCHRANE REVIEW (UPDATE 2004): HYLAN G-F 20 VS
PLACEBO FOR KNEE OA
N. Bellamyy, J. Campbellz, V. Robinsonx, G. A. Wellsjj,
R. B. Bournez
y CONROD, University of Queensland, Brisbane, Queensland,
Australia
z Orthopaedics/Surgery, The University of Western Ontario, Lon-
don, ON, Canada
x Institute of Population Health, University of Ottawa, Ottawa, ON,
Canada
jj Epidemiology and Community Medicine, University of Ottawa,
Ottawa, ON, Canada
Aim of study: As part of a Cochrane review of viscosupplementation
in knee OA, randomised controlled trials (RCT) were reviewed to
evaluate evidence for the efﬁcacy of viscosupplementation with
Hylan G-F 20 compared to placebo.
Methods: Electronic searches were conducted of MEDLINE,
EMBASE, Premedline, Current Contents, and CENTRAL. Human,
RCT involving Hylan G-F 20 compared to placebo, published prior
to 1Q2004, were included. Trials were selected and data extracted
by two independent reviewers. Methodological quality was
assessed with the Jadad criteria by two reviewers. Data on the
OARSI and OMERACT core set clinical outcome measures were
extracted where possible. Weighted mean difference (WMD),
based on post-test scores, and 95% conﬁdence intervals (CI) werecalculated for continuous outcome measures and relative risk (RR)
for dichotomous outcome measures.
Results: Seven RCT met the inclusion criteria. Median methodo-
logical quality was 4 (range 1–5). A further two studies were only
reported in abstract form (Jadad score Z 1) and contained
insufﬁcient extractable data for inclusion in the analysis. Nine
RCT, which compared Hylan G-F 20 to other interventions such as
intra-articular corticosteroid, physiotherapy, NSAID, appropriate
care, intra-articular gaseous oxygen and other hyaluronan, are not
reported here. Twenty-three studies failed to meet inclusion criteria
and were excluded.
Hylan G-F 20 was more efﬁcacious than placebo at 1–4 weeks
post-injection for pain on weight-bearing WMD (random effects
[RE]) 13 mm on a 0–100 mm VAS (PZ 0.002) based on 6 RCT.
This difference was even greater at 5–13 weeks post-injection, 22
m (RE) (P Z 0.001) based on 5 RCT, and at 14–6 weeks post-
injection, 21 m (RE) (P Z 0.006) based on 4 RCT.
Hylan G-F 20 was more efﬁcacious than placebo at 1–4 weeks
post-injection for pain at night, WMD 7 mm on a 0–100 mm VAS
(P Z 0.003) based on 5 RCT. This difference was even greater at
5–13 weeks post-injection, 11 mm (PZ 0.008) based on 4 RCT,
and at 14–26 weeks post-injection, 17 mm (P ! 0.00001) based
on 3 RCT.
There was no signiﬁcant difference (WMD 8 mm) between Hylan
G-F 20 C oral placebo and arthrocentesisC oral placebo at 5–13
weeks post-injection for WOMAC Pain, but Hylan G-F 20 C oral
placebo was more efﬁcacious than arthrocentesis C oral placebo
for WOMAC Function, WMD 9 mm on a 0–100 mm VAS (P Z
0.01) (Dickson, 2001).
Hylan G-F 20 was more effective than placebo at 1–4 weeks post-
injection for the variable designed treatment efﬁcacy, WMD 22 mm
on a 0–100 mm VAS (P ! 0.00001) based on improvement in 4
RCT. This difference was even greater at 5–13 weeks post
injection, 35 mm (P ! 0.00001).
Conclusions: Evidence from this updated Cochrane review
supports the superior efﬁcacy of Hylan G-F 20 compared to
placebo on weight-bearing pain, night pain, function and treatment
efﬁcacy in the treatment of knee OA.
Poster SessionsP73
EFFECTS OF LONG-TERM ESTROGEN REPLACEMENT
THERAPY ON PERIARTICULAR TIBIAL OSTEOPHYTES IN
SURGICALLY POSTMENOPAUSAL CYNOMOLGUS MONKEYS
E. J. Olsony, B. R. Lindgrenz, C. S. Carlsony
y Department of Veterinary Population Medicine, College of
Veterinary Medicine, University of Minnesota, St. Paul, MN, USA
z School of Public Health, University of Minnesota, Minneapolis,
MN, USA
Epidemiologic evidence suggests that the risk of developing
osteoarthritis (OA) in postmenopausal women is reduced by
estrogen replacement therapy (ERT). We previously have demon-
strated that long-term ERT signiﬁcantly reduces the severity of
articular cartilage lesions of OA and reduces indices of subchondral
bone turnover in postmenopausal cynomolgus monkeys. The aim of
the present study was to assess the effects of long-term ERT on
osteophyte presence and size in these same animals. One hundred
ﬁfty-three (153) adult female cynomolgus monkeys were bilaterally
ovariectomized to simulate menopause and randomly divided into
three age- and weight-matched treatment groups for a 36 month
treatment period. Group 1 (Ovx control, n Z 52) received no
treatment, Group 2 (SPE, nZ 55) received soy phytoestrogens (at
129mg/day human equivalent), andGroup 3 (ERT, nZ 46) received
conjugated equine estrogens (at 0.625mg/day human equivalent) in
the diet. At necropsy, a midcoronal, toluidine blue-stained section of
the right proximal tibia fromeachanimalwas examined histologically.
The presence and size of periarticular osteophytes in the axial and
abaxial aspects of the medial and lateral tibial plateaus were
evaluated. The total area (mm2) of each abaxial osteophyte was
measured with a 2! objective using morphometry software.
Because of the difﬁculty in accurately determining axial osteophyte
margins, each axial osteophyte was measured twice: once using
a conservative measurement that included only clearly demarcated
osteophytes and once including measurement of any deviation from
the presumed normal articular surface of the joint. Axial osteophyte
presence was not affected by treatment. Abaxial osteophyte pre-
sence in the lateral tibial plateau and the sumof the lateral andmedial
abaxial osteophytes were signiﬁcantly affected by treatment (Chi-
square analysis, P! 0.01). The occurrence of lateral abaxial osteo-
phytes was signiﬁcantly lower in the ERT group than either the Ovx
control group (PZ 0.024) or the SPE group (P! 0.01). The sum of
lateral andmedial abaxial osteophytes was also signiﬁcantly lower in
the ERT group than the Ovx control group (P! 0.01) and the SPE
group (P! 0.01). Abaxial osteophyte area ranged from 0.06 to 3.51
mm2 for the lateral osteophytes and from 0.02 to 1.65 mm2 for the
medial osteophytes. Axial osteophyte area ranged from 0.10 to 1.94
mm2 for the lateral osteophytes and from 0.22 to 3.21 mm2 for the
medial osteophytes. There were no signiﬁcant treatment effects on
osteophyte size in any location, using either of the measurement
schemes. In thismodel of naturally occurringosteoarthritis, long-term
ERT reduces OA severity through effects on articular cartilage,
subchondral bone, and osteophyte occurrence, but has no effect on
osteophyte size.
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SITE SPECIFIC, AGE RELATED CHANGES AND THEIR
IMPLICATIONS FOR JOINT DISEASE
M. V. Branchy, R. C. Murrayy, S. J. Dysony, A. E. Goodshipz
y Centre for Equine Studies, The Animal Health Trust, Newmarket,
Suffolk, United KingdomS3z Musculoskeletal Pathobiology Research Group, The Royal
Veterinary College, Hatfield, Hertfordshire, United Kingdom
Aim: Osteoarthritis risk increases with age. Exercise and ageing
induce tissue interactions in the osteochondral unit, contributing to
joint degeneration. The horse is long lived and active providing
a ‘‘natural’’ model, for exploring the hypothesis that speciﬁc site and
tissue changes occur as a result of ageing.
Methods: Twenty-three cadaver tarsi from untrained, pasture
exercised ponies underwent magnetic resonance (MR) imaging
and histological processing of the distal tarsus. Subchondral bone
thickness was measured on the central tarsal (CT), third tarsal (T3)
and third metatarsal bones (MT3) on MR images at medial and
lateral sites. Hyaline, calciﬁed and total cartilage thicknesses were
measured on histological sections at identical sites. Tarsi were
grouped as 11 days (neonatal, minimal loading) (n Z 10); 6–9
months (loaded immature) (nZ 6); 3–6 years (loaded mature) (nZ
4); 16–24 years (loaded geriatric) (n Z 3). One-way ANOVA or
Friedman ANOVA was used to evaluate site differences. Multiple
comparisons of means using a paired Students t test or Wilcoxon
signed rank test determined which sites were different. To assess
differences between groups an independent samples Students
t test or Mann–Whitney U test were used.
Results: Comparing groups, mean lateral and medial hyaline
cartilage thickness decreased signiﬁcantly between 6–9 month
and 3–6 year groups (P % 0.04) at all sites. Mean medial calciﬁed
cartilage thickness increased signiﬁcantly between 6–9 month and
3–6 year groups on proximal MT3 (P Z 0.05). Subchondral bone
thickness increased signiﬁcantly between 11 day, 6–9 month and
3–6 year groups (P% 0.03) at all sites. In the 11-day group tissues
were uniform at all sites. By 6–9 months, medial total cartilage
thickness was greater than lateral on distal T3 (P Z 0.03). In the
3–6 year group medial calciﬁed cartilage thickness was greater
than lateral on distal CT (PZ 0.03). In the 6–9 month and 3–6 year
groups lateral subchondral bone thickness was signiﬁcantly
greater than medial on proximal and distal T3 (P % 0.03), and
distal CT and proximal MT3 (P % 0.02) respectively. This pattern
was retained in the 16–24 year group with no signiﬁcant site
differences.
Conclusions: Results show decreased hyaline and total cartilage
thickness with age at speciﬁc sites, but increased calciﬁed cartilage
and subchondral bone thickness, providing a potential mechanism
for increased osteoarthritis risk with age. Results support Little and
Ghosh’s ’blank joint’ hypothesis; there was no detectable topo-
graphical variation in osteochondral thickness in the neonatal
group, but a thickness pattern repeatable between sites was visible
after loading. Increased subchondral bone thickness at lateral sites
may reﬂect the location of peak strains across the joint. Rates of
change in articular cartilage and subchondral bone thickness with
age varied between sites. Although lateral subchondral bone
thickness was consistently greater than medial, the pattern across
the joint varied at different levels. Site-speciﬁc structural differences
could reﬂect site-speciﬁc differences in loading intensity predispos-
ing speciﬁc areas to injury.
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VALIDATION OF MRI CARTILAGE BIOMARKERS IN RAT KNEE
OSTEOARTHRITIS
J. D. Quirky, S. J. Baldwiny, M. P. Harmsy, F. Ecksteinzx,
M. Hudelmaierzx, S. Wrubelzx, E. C. Arnery, J. J. Kotyky
y Global Research and Development, Pfizer Inc., Chesterfield,
MO, USA2
S33z Institute of Anatomy and Musculoskeletal Research, PMU
Salzburg, Salzburg, Austria
x Chondrometrics GmbH, Munich, Germany
Aim of study: Magnetic Resonance Imaging (MRI) is gaining
acceptance as an endpoint for DMOAD clinical trials. A growing
need exists to translateMRI techniques to preclinical studies in order
to be able to test the efﬁcacy of drugs early in the drug development
process. In this context, the study of small animal models of OA with
MRI is attractive, though technically challenging, because of the
small dimensions of the joints. In the current work, we investigate
the reproducibility of several measures of cartilage morphology,
e.g., volume and thickness, for the rat medial tibial plateau.
Methods: All animal studies were approved by the Pﬁzer In-
stitutional Animal Care and Use Committee and the animal facilities
utilized were accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care, International. Five male
Sprague Dawley rats (350 g) received MRI scans of their right knee
on 5 separate days. Sagittal images of each knee were acquired at
4.7 T on a Bruker BiospecAvance MRI scanner. Each Magnevist-
enhanced 3D gradient echo image was collected in 28 min with an
in-plane image resolution of 29 ! 116 mm2 (interpolated to an
isotropic resolution of 29 mm) and a slice thickness of 234 mm. The
medial tibial cartilage plates in these images were segmented by
trained personnel with quality control by a single imaging expert.
Following segmentation, the cartilage volume, thickness, and bone/
cartilage interface area were measured. The ﬁve data sets of each
animal were segmented by the same observer (inter-scan, intra-
observer precision), and ﬁve data sets of one animal by four
different observers (inter-observer precision). Tibial cartilage
morphology in the rat was compared to results previously obtained
in other species.
Results: The quantitative measures of rat medial tibial cartilage
morphology are shown in Table I. The inter-scan precision error of
the different measures varied between 3.5% and 7.9%, and the
inter-observer error between 7.4 and 8.6%. Rats displayed
a cartilage volume of only 0.93 mm3, compared with previously
reported values of 25 mm3 in rabbits and 2500 mm3 in humans. The
mean cartilage thickness in rats was 150 mm, compared with 400
mm in rabbits and 1700 mm in humans.
Conclusions: The small dimensions of the rat knee joint make
detecting disease-related changes in cartilage morphology (e.g.,
volume and thickness) technically challenging. To our knowledge,
this is the ﬁrst study that looks at quantitative measures of cartilage
morphology in the rat using MRI. The CV values reported herein,
while larger than those typically reported in human studies, are
encouraging and suggest that MRI measurement of meaningful
changes in cartilage morphology is possible in the rat knee.
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DIETARY SUPPLEMENTATIONWITH CHONDROITIN SULFATE
AND GLUCOSAMINE HCL DOES NOT SLOW DOWN ARTICU-
LAR CARTILAGE EROSION IN BIGLYCAN/FIBROMODULIN
DEFICIENT MICE
Y. Henrotiny, M. Debergy, M. Oliveiraz, A. Labassey, E. Offordz,
J. M. Aeschlimannz, L. G. Ameyez
y Bone and Cartilage Research Unit, University of Liege, Liege,
Belgium
Volume
(mm3)
Mean
thickness
(mm)
Bone/Cartilage
interface
area (mm2)
Mean of 5 rats 0.93 0.15 6.
SD of 5 rats 0.09 0.03 1.
Intra-observer, inter-scan
precision (RMS CV)
6.1% 7.9% 3.5%
Inter-observer
precision (RMS CV)
7.4% 7.8% 8.6%z Nutrition and Health Department, Nestle Research Center,
Lausanne, Switzerland
Aim of the study: The effects of oral glucosamine/chondroitin
sulfate on preservation of articular cartilage in the biglycan/
ﬁbromodulin double deﬁcient mouse (DKO) were studied to
determine if this new animal model of osteoarthritis (OA) would
be suitable to test the in vivo efﬁcacy of structure modifying
compounds.
Methods: Two groups of 15 wild-type (WT) mice and two groups of
15 DKO were fed from weaning (day 21) with a regular diet,
supplemented or not with 1.2% chondroitin sulfate and 1.5%
glucosamine HCl. Serum levels of the C2C and coll2-1 type II
collagen biomarkers were determined at day 66 and 141 and at day
49, 81, 95 and 141, respectively. Mice were sacriﬁced at day 141
and preservation of the articular cartilage in the knees was
assessed by histology.
Results: Supplementation with glucosamine/chondroitin sulfate did
not slow down cartilage erosion in DKO. Articular cartilage was
similarly eroded below the tidemark in both DKO groups while being
intact in WT groups. This observation was conﬁrmed by measure-
ments of Coll2-1 and C2C biomarkers. The mean serum concen-
trations of Coll2-1 and C2C in control WT were signiﬁcantly lower
than in control DKO (see Table) but no differences were found
between treated and control groups except for higher coll2-1 levels
found in WT control group at day 81 (245 G 40 vs 204 G 37 nM,
P Z 0.007) and in DKO control group at day 95 (362 G 60 vs
293 G 55, P Z 0.007).
Conclusions: While glucosamine and chondroitin sulfate have been
shown to slow down cartilage erosion in chemically and surgically
induced OA in rabbits, this supplementation failed to show any
beneﬁt in the DKO suggesting that this animal model is inadequate
for in vivo tests of efﬁcacy of structure modifying compounds. The
higher serum levels of coll2-1 in DKO vs WT suggest that this new
biomarker, which is speciﬁc for a peptide of the a-helical region of
type II collagen, could be useful to monitor collagen degradation in
joint diseases.
Serum levels (mean G SD) of Coll2-1 and C2C biomarkers in
control WT and DKO groups
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THREE ANIMAL MODELS OF OSTEOARTHRITIS ARE CHAR-
ACTERIZED BY SIMILAR DISEASE MARKER EXPRESSION
PATTERNS DESPITE DIFFERENT DISEASE ETIOLOGY
U. H. Dietz, K. Rudolphi, N. Gerwin
Disease Group Osteoarthritis, Aventis Pharma, Frankfurt a.M.,
Germany
Aim of study: To compare the development of knee osteoarthritis
(OA) in three animal models based on expression patterns of
known human OA markers. We investigated STR/1N mice and
Dunkin Hartley guinea pigs (DHGP) with spontaneously developing
OA and rats with surgically induced OA [anterior cruciate ligament
transection combined with partial meniscectomy (ACLTpMx)].
Methods: STR/1N and C3H control mice age 0 (newborn)–18
weeks (wks) were sacriﬁced at weekly intervals. DHGP were
sacriﬁced at 3, 6, 9, 12 and 15 months (mo) of age. Twelve-wk-old
male Lewis rats underwent ACLTpMx or sham-operation and were
sacriﬁced 4, 8 and 12 wks later. Coronary sections of parafﬁn
coll2-1 (nM) C2C (ng/ml)
Ctl WT Ctl DKO P Ctl WT Ctl DKO P
Day 49 200 G 30 222 G 31 0.06 / / /
Day 66 / / / 32 G 16 52G14 0.001
Day 81 245 G 40 281 G 61 0.06 / / /
Day 95 305 G 32 362 G 60 0.005 / / /
Day 141 264 G 24 303 G 35 0.008 30 G 16 50G26 0.03
S34embedded knee joints were analyzed by immunohistochemistry
(IHC) and in situ hybridization (ISH). Histopathological OA changes
were scored semiquantitatively in H&E and SafraninO/fast green-
stained sections.
Results: OA histopathology of knee joints developed at different
rates in STR/1N mice, DHGP and ACLTpMx-rats: ﬁrst cartilage
lesions were detected at age 6 wks, 6 mo and 4 wks post surgery
(ps), respectively, while severe cartilage loss was observed by age
12 wks, 15 mo and 12 wks ps, respectively.
Whereas developmental collagen type X (ColX) RNA and protein
expression in STR/1N and C3H mice disappeared by 4 wks of age,
re-expression occurred in articular OA cartilage matrix of STR/1N
mice from 8 wks of age onwards and increased up to 18 wks. In
ACLTpMx-rats low levels of ColX protein were seen in calciﬁed and
non-calciﬁed cartilage matrix already 4 wks ps and expression
increased up to 12 wks.
The cartilage degrading protease cathepsin K (CathK) was ﬁrst
detected by IHC in 2-wk-old STR/1N and C3H mice in single deep
zone chondrocytes. Starting at 8 wks of age CathK protein was also
expressed in non-calciﬁed cartilage chondrocytes and surface
ﬁbrillations in STR/1N mice. In ACLTpMx-rats 4 wks ps CathK
protein was observed in few chondrocytes, while 8 and 12 wks ps it
was found in most chondrocytes in the non-calciﬁed cartilage and
ﬁbrillated surface areas. In DHGP CathK was ﬁrst detected from
age 6 mo onward, mostly in non-calciﬁed cartilage chondrocytes.
Collagen type II cleavage epitope COL2-3/4Cshort (COL2-3/4) was
detected at high levels in newborns and 1-wk-old STR/1N and C3H
mice, but was greatly reduced thereafter. Starting from age 5 wks
COL2-3/4 levels continuously increased up to 18 wks of age in
STR/1N mice. In 3-mo-old DHGP epitope staining was pronounced
in the entire cartilage matrix, at 6 mo it was barely detectable and
from 9 up to 15 mo of age it increased again continuously.
Conclusions: Our data indicate that the investigated OA markers
ColX, CathK, ADAMTS-4, -1, MMP-3, -13 (data not shown) and
COL2-3/4 were detected in all three models, in spite of different
rates of disease development and different etiology of OA in these
animals. Furthermore, the sequence of marker gene expression
was very similar in the three animal models and the time course
matched the appearance of histopathological OA lesions. There-
fore, all three models might be suitable tools for pharmacological
testing of potential OA treatments.
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CHARACTERIZATION OF THE MENISCECTOMIZED GUINEA
PIG MODEL OF OSTEOARTHRITIS – A LONG TERM STUDY
S. X Wang, R. Renlund, M. Dumitriu, R. Kandel, M. D. Grynpas
Samuel Lunenfeld Research Institute, Mount Sinai Hospital,
University of Toronto, Toronto, ON, Canada
The aim of this study is to characterize the changes in cartilage,
bone and serum biomarkers in a partial medial meniscectomized
guinea pig model of OA over a 6-month period and to correlate
these changes to the progression of the disease.
Material and methods: A partial medial meniscectomy was
performed on the right knees of 3-month old male Hartley-Dunkin
guinea pigs (n Z 60). Groups of 10 animals were sacriﬁced at 0,
10, 20, 30, 60, 90, and 180 days post-surgery. Serum samples
were collected before surgery and upon sacriﬁce. Cartilage was
harvested from the distal femur, and analyzed for glycosaminogly-
can, DNA, and collagen content. Bone mineral density (BMD) was
determined by DEXA at the distal femur, medial and lateral femoral
condyles, proximal tibia, medial and lateral tibial plateaus. Safranin-
O stained histological sections of proximal tibia were evaluated for
OA severity according to a modiﬁed Mankin scale. Trabecular bone
histomorphometric and connectivity parameters were analyzed on
undecalciﬁed sections from distal femurs. Bone mineralization was
assessed by backscatter electron microscopy (BSE). All data were
analyzed using SPSS statistical software.
Results
Histology: Cartilage erosions were observed as early as 10 days
post-surgery and these increased with time after surgery. TheMankin score was 4.2G 1.2 at 10 days and increased to 10G 1.3
at 180 days indicating progressive degeneration of cartilage in the
operated knee.
BMD: BMD decreased until 30 days after which it showed
a progressive increase up to180 days. The medial femoral condyle
showed the earliest and largest change in BMD.
Bone morphometry: Trabecular bone volume, thickness and
connectivity decreased up to 30 days and increased thereafter.
Bone formation showed an increase between 20 and 30 days and
then showed no further change. The subchondral bone plate
thickness increased between 10 and 30 days, and the percentage
of calciﬁed cartilage in the subchondral plate increased with time
after surgery in the operated knees, but not in the unoperated knee.
Cartilage biochemistry: GAG, DNA and collagen content decreased
in the ﬁrst 10 days after surgery, and then returned to baseline
levels between 20 and 30 days. This was followed by a gradual
decrease in GAG, DNA and collagen content.
Serum biomarker: CPII (a marker for type II collagen synthesis)
content was decreased signiﬁcantly in the serum at all time points
after surgery compared to baseline level.
Discussion: Bone changes parallel the cartilage deterioration at the
onset of OA in this model. The early bone loss and low
mineralization caused by high turnover are followed by compensa-
tory bone changes such as increased in BMD, trabecular bone
volume, and subchondral plate thickness. It is possible that these
bone changes may then contribute to further cartilage degenera-
tion. We observed severe cartilage damage and subchondral bone
thickening in the later stage of this model such as are present in
advanced or end stage human OA. The partial meniscectomy
accelerates the onset and progression of the spontaneous OA that
occurs in this model making it a useful model to study the
progression of the disease and to investigate new treatments.
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EXPRESSION OF TGF-BETA AND ITS SIGNALLING
MOLECULE SMAD-2P IN PATHOLOGICAL CHANGES IN
A SPONTANEOUS AND IN AN INSTABILITY OA MODEL
E. N. Blaney Davidson, E. L. Vitters, P. M. van der Kraan,
W. B. van den Berg
Experimental Rheumatology and Advanced Therapeutics, Univer-
sity Medical Center, Nijmegen, Netherlands
Aim of study: To investigate the role of TGF-beta in primary and
secondary OA model closely resembling human OA. Expression of
TGF-beta and the activated downstream signalling molecule smad-
2P were examined in both models.
Methods: Instability is induced in knee joints of Balb C mice by
intra-articular collagenase injection. After 1, 3, 7, and 14 days knee
joints were dissected and prepared for histology. STR/ort mice
develop OA spontaneously. Knee joints of mice aged 8 weeks, 6
months and 1 year were dissected for histology. All sections were
stained with safranin O and stained immunohistochemically for
TGF-beta3 and smad-2P.
Results: In the instability OA model a focal reduction in pro-
teoglycan staining in cartilage was observed which progressed
further in time. TGF-beta and smad-2P expression was reduced at
the sites of PG-depletion. In this model the synovium developed
ﬁbrosis which appeared to be associated with prominent TGF-
beta3 and smad-2P staining. A typical feature of the instability
induced OA is hypertrophy of the collateral ligament. All cells of the
hypertrophied ligament stained positive for both TGF-beta3 and
smad-2P. Osteophytes developed from day 7 and showed intense
staining for TGF-beta3 and smad-2P.
The cartilage of the spontaneous model showed a reduced staining
intensity for proteoglycans, accompanied by a decreased TGF-
beta3 and smad-2P immunopositivity. Cartilage of 6-month-old
mice contained clefts and was completely negative for TGF-beta3
and smad-2P. At 1 year of age some cartilage surfaces were
eroded. Those still present were completely negative for both TGF-
beta3 and smad-2P. The collateral ligaments of the STR/ort mice
S35showed chondrogenesis and bone formation. Sites of chondro-
genesis were TGF-beta3 and smad-2P positive. Osteophytes
developed in this model were positive for TGF-beta3 and smad-
2P in early stages. Later in development the TGF-beta staining
resided in the outer ﬁbrous layer of the osteophyte whereas smad-
2P expression was also found in chondroblasts more to the center
of the osteophyte.
Conclusions: TGF-beta3 and smad-2P expression is reduced in
damaged cartilage in both the spontaneous and instability induced
OA suggesting loss of the protective role of TGF-beta. TGF-beta
and smad-2P expression is upregulated in early stages of ﬁbrosis
and osteophytes formation. These results indicate that loss of
TGF-beta signalling is related to cartilage damage and that this
factor is important in early stages of ﬁbrosis and osteophyte
formation in OA.
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EFFECTS OF DIACERHEIN IN RAT MENISCAL TEAR OSTEO-
ARTHRITIS MODEL
J. Hoover, S. Chanrasekhar, R. L. Cain, Q. Zeng, Y. L. Ma
Bone and Inflammation Division, Lilly Research Laboratory, Eli Lilly
Company, Indianapolis, IN, USA
Aim of the study: To evaluate whether diacerhein is effective as
a disease-modifying agent in the rat meniscal tear model of
osteoarthritis (OA).
Methods: OA-like lesions were induced in male Lewis rats weighing
w300 g by surgical transection of the medial meniscus. Diacerhein
(10, 20 or 30 mg/kg/d) was administered by gavage once daily, for
3 weeks, starting immediately after the surgery.
Results: With the exception of mild diarrhea, the drug treatment
was well tolerated. There were no signiﬁcant changes in body
weight among the study groups during the duration of the study.Frontal planar parafﬁn sections (8 mm thick and up to 150 mm depth)
were prepared and evaluated by a semi-quantitative pathological
assessment (Bendele et al., JMNI 2001). Severe cartilage
degradation evidenced by the loss of proteoglycan, focal chon-
drocyte death, minimal to moderate cartilage lesions and ﬁbrillation
with large marginal osteophytes were seen in vehicle treated knee
joints of all the rats. Diacerhein treatment resulted in a slight non-
statistically signiﬁcant protective effect on cartilage degradation as
assessed by the total OA score. Interestingly however, the
diacerhein treatment signiﬁcantly reduced osteophyte size by
27–48%.
Conclusion: Our data suggest that a 3-week diacerhein treatment is
beneﬁcial in reducing osteophyte formation and protecting articular
cartilage degradation in the rat meniscal tear model. The relatively
poor efﬁcacy on cartilage endpoints in this study may be related to
the rapid progression of cartilage degradation in the rat meniscal
tear model.
P81
MARKERS OF MATRIX METABOLISM DIFFER BETWEEN THE
SERA OF MACAQUE AND SQUIRREL MONKEYS
P. A. Simkin, P. A. Kramer, L. Newell-Morris, M. H. Wener
Medicine, Anthropology, Orthopaedics, Laboratory Medicine, Uni-
versity of Washington, Seattle, WA, USA
In preparation for a longitudinal study of spinal osteoarthritis and
aging in Old World macaque (Macaca) and New World squirrel
(Samiri) monkeys, we invited providers of ELISA assays to send us
test kits for potentially useful serum markers of cartilage and/or
bone matrix metabolism. All assays were developed and marketed
for human use. The 13 plates received were used according to
manufacturer’s directions in stored sera from 29 Macaca (3
species) and 12 Samiri (2 subspecies). Table I displays mean
results with coefﬁcients of variation (CV Z SD/Mean). All plates
recognized target antigens and yielded useful data except for
laminin, which was off-scale high in all specimens. No interspeciﬁc
differences were signiﬁcant (by Kruskal–Wallis testing) except for
Col II 3/4 M in macaques (P Z 0.018, mulatta O nemestrina O
fascicularis). In contrast, intergeneric differences were apparent for
all markers except C2C and Col II 3/4 M, and most differences were
highly signiﬁcant (see Table I). No single marker correlated
signiﬁcantly with age, sex, or any other marker in either genus.
These differences (as well as those between these ﬁndings in
primates and those reported for the same assays in humans) are
unexplained and warant further study.
We are grateful to Ibex, Quidel, Ostex, Echelon, Anamar, and
Chemicon for providing the test kits and to the Squirrel Monkey
Breeding and Research Resource of the University of South
Alabama for providing Samiri sera.
Table I
Marker levels in two primate genera
MACACA SAMIRI IntergenericMarker Units
Mean CV Mean CV Probability
Bone Alk Phos U/L 73 0.47 124 0.20 0.0002
C2C ng/ml 109 0.92 64 0.79 0.17
C12C ng/ml 0.73 0.81 0.23 0.34 0.0001
Coll II 3/4 M ug/ml 3.9 0.12 4.1 0.21 0.74
COMP U/L 2.6 3.4 4.5 0.72 0.0004
CP II ng/ml 206 0.45 365 0.32 0.0001
CS 846 ng/ml 85 0.89 47 1.6 0.024
Hyaluronan ng/ml 259 0.69 1289 0.32 0.000l
Laminin ng/ml O3000 NA O3000 NA NA
NTx nM 24 0.37 17 0.37 0.012
Osteocalcin ng/ml 19 0.44 6.3 0.28 0.000l
PYD nM/L 3.4 0.69 2.0 0.19 0.020
YKL-40 ng/ml 377 1.3 31 2.1 0.0001
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MICROFRACTURE TECHNIQUE VS MOSAIC PLASTY IN
CARTILAGE REPAIR YIELDS NO DIFFERENCE IN THE RISK
OF OSTEOARTHRITIS
S. Heiryz, A. Aaroenyz, F. Reinholtx, L. Engebretseny
y Oslo Sport Trauma Research Center, NIH, Oslo, Norway
z Institute of Surgical Research, Rikshospitalet, Oslo, Norway
x Department of Pathology, Rikshospitalet, Oslo, Norway
Aim of study: This experimental study investigates the difference in
risk of long term osteoarthritis related to different surgical
techniques for repair of an experimental induced partial thickness
cartilage defect in the rabbit knee.
Methods: A partial thickness cartilage defect (diameter Z 4 mm)
was induced in the medial femur condyle of both knees of 14 adult
New Zealand rabbits at the age of 22 weeks. An operating
microscope was used to secure the preparation of the subchondral
bone plate and the rims of the defects. In one knee the defect was
treated by microfracture technique using an 0.6 mm awl and
a hammer creating 4 holes penetrating the subchondral bone plate.
In the other knee the defect was treated by mosaic plasty
harvesting three osteochondral grafts adjacent to the notch, press
ﬁt ﬁxating them in corresponding 1.3 mm holes drilled into the
subchondral bone of the defect. In addition 16 rabbit knees were
operated, inducing the defect in the medial femur condyle, leaving
them untreated as controls. Preoperatively, and prior to sacrifaction
at 58 weeks of age, washout samples of synovial ﬂuid were
collected. Degenerative changes were evaluated by macroscopical
grading and by analyzing the content of proteoglycans in the joint
synovial ﬂuid.
Results: Thirty-six weeks after inducing the cartilage defects the
proteoglycan content had rose from 4.7 mg/ml [3.2–9.7] to 7.0 mg/
ml [3.7–13.7] in the microfracture group (P Z 0.02) and from 5.2
mg/ml [2.2–8.3] to 8.1 mg/ml [4.6–11.9] in the mosaic plasty group
(P! 0.001). In comparison, the control group rose from 5.0 mg/ml
[2.2–8.0] to 7.3 mg/ml [2.5–15.4]. There was no signiﬁcant
difference in the rise of proteoglycan content in the three groups
(PZ 0.63). One of the knees in the microfracture group vs 5 of the
knees in the mosaic plasty group (P > 0.05) showed mild
degenerative changes to the cartilage adjacent to the defect. None
of the knees in neither groups showed grave osteoarthritis at the
time of sacrifaction.
Conclusion: Microfracture technique vs mosaic plasty in cartilage
repair yields no difference in the risk of long term knee osteoarthritis
in an experimental rabbit model.
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GENERATION OF A MOUSE MODEL TO ANALYSE THE ROLE
OF ADAMTS-5 IN THE PATHOGENESIS OF OSTEOARTHRISIS
J. Busch, C. Spangenberg, B. Zabel, C. Stelzer
Children’s Hospital, University of Mainz, Mainz, Germany
For proper maintenance of articular cartilage the dynamic pro-
cesses of matrix synthesis and degradation must be in balance. In
osteoarthritis (OA), the system is changed towards degradation
resulting in severe loss of matrix.
The unique characteristics of cartilage with its compressibility and
elasticity are essentially due to components like aggrecan and type
II collagen. The cleavage of cartilage aggrecan has been attributed
primarily to Aggrecanase-1 and Aggrecanase-2, two enzymes
which are metalloproteinases belonging to the ADAMTS family (a
disintegrin and metalloproteinase with thrombospondin motifs)
referred to as ADAMTS-4 and ADAMTS-5, respectively. It is
already known that ADAMTS-5 is an enzyme contributing to the
process of cartilage degradation in arthritic diseases but its exact
role in the pathogenesis of OA is not yet clariﬁed.
To investigate the role of Adamts-5 in cartilage matrix degradation
we are in the process of generating a transgenic mouse that
inducibly expresses this aggrecanase in the OA-relevant compart-ment (articular cartilage). The transgenic construct consists of the
reverse tetracycline-controlled transactivator (rtTA) that is driven by
the type II collagen promoter, to result in tissue-speciﬁc activity of
this promoter. Placed in cis-conﬁguration to the rtTA transcription
unit, the rtTA-inducible promoter directs the expression of the target
gene, in our case Adamts-5. Prior to the in vivo studies we
investigated the functionality of the construct in cell culture. After
transient transfection in suitable cell lines we observe that
tetracycline-administration induces expression of transgenic
Adamts-5. This construct now constitutes the starting point to
generate the transgenic mouse.
We anticipate that cartilage-speciﬁc overexpression of Adamts-5 in
mouse joints results in alterations of the articular cartilage similar to
those observed in human OA and that consequently this model will
provide a valuable tool to test new therapeutic strategies.
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DEVELOPMENT AND APPLICATION OF NOVEL MARKERS
OF COLLAGENASE ACTIVITY, POTENTIAL TO SUPPORT
PRECLINICAL AND CLINICAL STUDIES
T. Sunyery, O. V. Nemirovskiyy, M. A. Abramsy, L. E. Vickeryy,
D. R. Duﬁeldy, H. Fujiwaray, P. Aggarwaly, B. R. Bondy, K. L.
Dufﬁnz, D. J. Welschy
y PGRD, Pfizer Inc., Chesterfield, MO, USA
z Eli Lilly& & Co., Indianapolis, IN, USA
Osteoarthritis is a slowly progressing degenerative disease
characterized by the degradation and erosion of the articular
cartilage of synovial joints. The pathophysiologic OA process
typically proceeds to the appearance of signs and symptoms,
varying degrees of disability, and functional compromise. Current
treatments focus on increasing joint mobility and decreasing pain,
but are thought to be less effective in modifying the underlying
disease process. The identiﬁcation and development of agents that
attenuate the structural changes associated with disease pro-
gression has, to date, been limited by our inability to readily assess
small structural changes. The purpose of these studies was to
identify in biological ﬂuids, including urine and synovial ﬂuid,
speciﬁc type II collagen peptides resulting from collagenase
proteolysis and to develop analytical methods for the quantiﬁcation
of these peptides in preclinical and clinical samples. Peptides, that
ranged in size from 14 to 47 amino acids and contained 2 to 6
hydroxylations on proline and/or lysine residues, resulting from
collagenase cleavage of type II collagen at the 3/4–1/4 cleavage
site were identiﬁed in biological ﬂuids. Assays to quantify these
fragments were developed using LC/MS/MS and immunoassay
technologies. Levels of the most abundant collagenase-generated
type II collagen peptide in healthy adult (R35 years of age) urine
ranged from 0.2 to 3 nM. Using a human articular cartilage explant
assay, MMP inhibitors were shown to inhibit cartilage breakdown
and associated release of these type II collagen fragments into the
culture media. Furthermore, when measured in a rat adjuvant-
induced arthritis model, urinary levels of type II collagen fragments
were found to be increased with disease severity and were dose-
dependently inhibited by MMP inhibitors. Additionally, the concen-
tration of type II collagen degradation products was increased in the
synovial ﬂuid of dogs following ACL transection, a model intended
to mimic aspects of injury-induced OA in man. Importantly,
administration of an MMP inhibitor to naive dogs and healthy
human volunteers resulted in O90% reduction in urinary type II
collagen degradation products. The change in urinary peptide
levels was rapid and the effect was sustained over a 1-week dosing
period. In conclusion, this work describes the identiﬁcation and
development of methods for the quantiﬁcation of speciﬁc type II
collagen degradation peptides in biological ﬂuids and the applica-
tion of these methods to both preclinical and clinical samples.
Finally, the measurement of type II collagen peptide levels in
various species, disease states, and their response to inhibitor
suggest that collagen peptides may prove to be useful biomarkers
in monitoring disease, identifying target patient populations in need
of disease-modifying therapies, and monitoring drug effect.
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URINARY CTX-II AND GLUCOSYL-GALACTOSYL-PYRIDINO-
LINE ARE ASSOCIATED WITH BOTH PRESENCE AND
SEVERITY OF RADIOGRAPHIC KNEE OSTEOARTHRITIS
K. M. Jordany, H. E. Syddally, A. Aihie Sayery, E. M. Dennisony,
P. Garnerozx, P. D. Delmasz, C. Coopery, N. K. Ardeny
y Bone and Joint, MRC ERC, Southampton, Hampshire, United
Kingdom
z E Herriot Hospital, Lyons Cedex, France
x Molecular Markers, Synarc, Lyon, France
Aim: To investigate the association between biochemical markers
of bone, cartilage and synovial turnover and presence and severity
of knee osteoarthritis in men.
Methods: One seventy-six men aged 59–70 years who were born in
East Hertfordshire, UK were studied. Weight bearing AP and lateral
semi-ﬂexed radiographs were taken of both knees. A lifestyle
questionnaire including basic demographic details and a question-
naire detailing knee pain was completed. This stratiﬁed random
sample based on Kellgren Lawrence (K/L) score had analysis of the
following biochemical markers: serum osteocalcin, serum
C-telopeptide of type I collagen (CTX-I), urinary C-telopeptide of
type II collagen (CTX-II) and urinary glucosyl-galactosyl-pyridino-
line (Glc-Gal-Pyd), as speciﬁc indices of bone formation, bone
resorption, cartilage degradation and synovial tissue turnover,
respectively. Radiographs were graded at the tibio-femoral and
patello-femoral joints for joint space narrowing (JSN) and osteo-
phytes (OP) using a standard atlas (grade range 0–3); a grade of
R 2 was deﬁned as deﬁnite osteoarthritis and K/L score was also
determined.
Results: There was only one subject with grade 4 K/L score, who was
amalgamated with grade 3 subjects. The groups were well matched
for demographic details (age, BMI, social class, smoking, alcohol).
There was a strong statistically signiﬁcant association between
presence of knee osteoarthritis and urinary CTX-II and urinary Glc-
Gal-Pyd, which persisted after adjustment for age and BMI.
There was also a signiﬁcantly positive association between severity
of K/L grade and urinary CTX-II and urinary Glc-Gal-Pyd, which
again persisted after adjustment for age and BMI.
No associations between presence or severity of knee osteoarthri-
tis were found for serum CTX-I or serum osteocalcin.
Conclusions: Urinary CTX-II and Glc-gal-pyd, but not systemic
markers of bone turnover, are strongly associated with disease
Marker levels in two primate genera
Biochemical marker Knee K/L Grade P valuey
Mean
f*Geometricg(SD)
0/1 (n Z 97) 2–4 (n Z 79)
Osteocalcin (ng/ml)* 18.91 (1.43) 19.49 (1.36) 0.44
CTX-I (ng/ml)* 0.23 (1.69) 0.24 (1.61) 0.26
CTX-II (ng/mmol Cr)* 145.07 (1.58) 197.30 (1.71) !0.0001
Glc-gal-pyd
(nmol/mmol Cr)
4.0 (1.47) 4.57 (1.40) 0.02
yAdjusted for age and BMI.severity and presence of knee osteoarthritis and may be
clinically useful biochemical markers of radiographic knee osteo-
arthritis.
P86
CLINICAL CORRELATION OF SERUM COMP (CARTILAGE
OLIGOMERIC MATRIX PROTEIN) IN KNEE OSTEOARTHRITIS
F. A. Fernandes, M. L. Pucinelli, D. Feldman, N. P. Silva
Rheumatology, UNIFESP-EPM, Sao Paulo, Sao Paulo, Brazil
Background: Osteoarthritis (OA) has been deﬁned on the basis of
either clinical or radiological abnormalities, or both. These are
regarded as relatively late ﬁndings and research has focused on
several markers of cartilage breakdown as tools to diagnose the
disease in earlier stages and identify patients at high risk of OA.
Serum COMP levels have been shown to reﬂect processes of joint
cartilage in joint diseases. Most studies have been designed to
describe only radiological correlations, however, clinical correlation
would provide useful informations.
Aims: To study serum cartilage oligomeric matrix protein (COMP)
levels in a population with isolated knee OA and asymptomatic
controls, and to correlate these levels with clinical and radiological
abnormalities.
Patients and methods: Between January and October 2002, 272
patients with pain in the knees for at least 3 months duration were
invited to participate in this study. Anamnesis and clinical
examination were performed in all patients; patients with other
sources of pain in the knee and those with OA at other peripheral
locations were excluded; 86 patients fulﬁlled the ACR criteria for
knee OA and were included. Fifty-eight healthy individuals matched
for age and sex served as controls. All of the 144 individuals were
evaluated with the Lequesne and WOMAC questionnaires, VAS for
pain and standard knee X-rays. Blood samples were taken and
serum COMP levels were quantiﬁed by a sandwich-ELISA (AnaMar
Medical, Lund, Sweden). OA radiological analysis was performed
using the Kellgren and Lawrence (K/L) grading scale. After clinical
and radiographic analysis, four different groups of patients
emerged: symptomatic OA with a K/L grade 2, 3 or 4 (SOA),
symptomatic OA with a K/L grade 0 or 1(Pain), non-symptomatic
OA with a K/L grade 2 or 3 (NOA), and normal controls.
Results: We observed positive, statistically signiﬁcant correlation
between serum COMP levels and VAS, Lequesne and WOMAC
indexes (P ! 0.001). SOA group presented signiﬁcantly higher
serum COMP levels compared to controls and NOA groups
(P ! 0.001). No statistically signiﬁcant difference was found
between the groups NOA and controls (PZ 0.840). Pain group had
intermediate serum COMP levels, signiﬁcantly higher than those
observed in controls (P ! 0.03).
Conclusions: We observed increased serum COMP levels in
patients with symptomatic radiological knee OA. High serum
COMP levels may also suggest cartilage damage in well-selected
symptomatic patients without signiﬁcant radiological abnormalities.
We believe that the most important ﬁnding of our study was the
signiﬁcant correlation between serum COMP levels and pain and
other functional indexes, even higher than that observed between
COMP levels and X-ray abnormalities.Biochemical markers and severity of radiographic knee osteoarthritis
Biochemical marker Knee K/L Grade
Mean *fGeometricg (SD) 0 (n Z 48) 1 (n Z 49) 2 (n Z 49) 3/4 (n Z 30)
P value for trendy
Osteocalcin (ng/ml)* 19.1 (1.5) 18.8 (1.4) 20.7 (1.4) 18.4 (1.3) 0.90
CTX-I (ng/ml)* 0.25 (1.7) 0.21 (1.6) 0.26 (1.6) 0.22 (1.6) 0.93
CTX-II (ng/mmol Cr)* 146.8 (1.6) 143.4 (1.6) 194.3 (1.7) 206.8 (1.8) 0.001
Glc-gal-pyd (nmol/mmol Cr) 3.9 (1.1) 4.1 (1.8) 4.5 (1.6) 4.8 (1.2) 0.02
yAdjusted for age and BMI.
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BSP LEVELS IN SYNOVIAL FLUID RISE AFTER ANTERIOR
CRUCIATE LIGAMENT TRANSECTION IN THE RABBIT
E. Lindhorstyz, R. X. Raissy, N. Kimmigy, A. Theiseny,
F. Hentschely, T. Aignerx, L. Wachsmuthjj
y Surgery, Osteoarthritis Research Unit, Johann Wolfgang Goethe-
Universita¨t, Frankfurt/Main, Germany
z Surgery, Philipps-Universita¨t, Marburg, Germany
x Pathology, Friedrich-Alexander-Universita¨t, Erlangen-Nu¨rnberg,
Germany
jj Physics in Medicine, Friedrich-Alexander-Universita¨t, Erlangen-
Nu¨rnberg, Germany
Aim: Study of the potential of the molecular marker bone
sialoprotein (BSP) for indicating the onset and progression of
post-traumatic osteoarthritis (OA) in the rabbit model of anterior
cruciate ligament transection (ACLT).
Methods: Complete unilateral open anterior cruciate ligament
transection was performed in 32 adult male New Zealand white
rabbits. The left knees remained untreated intraindividual control
knees. Before sacriﬁce, lavages of the right and left knee joints
were performed with 1.5 cc of Ringer’s solution under anaesthesia.
The returned lavage volumes were recorded. Eight rabbits per
timepoint were sacriﬁced at 2, 4, 8, and 12 weeks after surgery.
Use of all animals had been permitted by the government
(Regierungspra¨sidium Darmstadt, Germany).
After sacriﬁce, macroscopic grading was performed on all right and
left knee joints by speciﬁcally evaluating 9 areas per each medial/
lateral tibia/femur and patella with a 8 point scale. Histologic
grading was performed with a dedicated grading system accounting
for proteoglycan content, matrix structure, cellularity, and osteo-
phyte formation.
Bone sialoprotein (BSP) levels were measured in the synovial ﬂuid
lavages with a radioimmunoassay (Immundiagnostik AG, Ben-
sheim, Germany). The distribution of synovial ﬂuid levels of BSP
was not normally distributed (Kolmogorov–Smirnov test). Conse-
quently, BSP values were log-transformed before analyses, which
resulted in normalization of the data. Differences between left and
right knees were statistically analysed by student’s t test.
Results: All 32 animals were free of signs of infection and had an
uneventful postoperative course. At 2 weeks after ACLT, macro-
scopically visible lesions were only detected at the medial femoral
site (P ! 0.05). With time, lesion size increased and lesions
appeared at more joint sites. At 12 weeks after ACLT, medial and
lateral tibiae as well as both femoral condyles showed statistically
signiﬁcant lesions. Histologic scores showed early OA after ACLT,
when compared with the unoperated contralateral side.
BSP levels in the synovial ﬂuid lavages of the operated knee joints
were increased at all timepoints (P ! 0.05) when compared to the
non-operated contralateral knees. The highest levels were mea-
sured at 2 weeks, followed by a gradual decrease.
Conclusions: To our knowledge, this is the ﬁrst study to evaluate
BSP in rabbit synovial ﬂuid samples. An acute increase was found
in rabbits for up to 3 months following ACL transection. BSP has
been shown to be present at the osseocartilagenous interphase.
Thus, the increase of BSP probably reﬂects subchondral bone
remodelling in the early phase of post-traumatic OA.
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AN ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY
TESTING AS A HELPFUL DIAGNOSTIC TOOL FOR DIFFER-
ENTIATION BETWEEN OSTEOARTHRITIS AND EARLY
RHEUMATOID ARTHRITIS IN ELDERLY
A. Tuchocka-Piotrowskay, M. Puszczewiczy, I. Zimmermann-
Gorskay, A. Piotrowskiz
y Department of Rheumatology, Rehabilitation and Internal Medi-
cine, University of Medical Sciences, Poznan, Poland
z Department of Anatomy, University of Medical Sciences, Poznan,
PolandAim of study: To evaluate a diagnostic usefulness of antibody
against cyclic citrullinated peptide (anti-CCP) testing for differenti-
ation between osteoarthritis and early stage of rheumatoid arthritis
in elderly.
Material and methods: We observed 62 patients, all over 60 years
old: 35 with osteoarthritis (OA) and 27 with rheumatoid arthritis (RA)
lasting less then 1 year (both diagnosed according to ACR
classiﬁcation criteria). Sex distribution (M/F) in these groups was
15/20 and 11/16, respectively. All the patients underwent a stan-
dardized evaluation including a physical examination and diagnostic
investigations. The patients with OA presented inﬂammation within
2 or more joints with duration less then 6 months, had elevated ESR
and CRP with or without leukocytosis, and no speciﬁc for RA
radiological changes on X-rays. Serum IgG anti-CCP antibodies
levels were tested by ELISA (Euroimmun) and compared in both
groups of the patients. Titers of serum rheumatoid factor (RF) were
measured by latex ﬁxation and Waaler-Rose method. Radiographs
of hands and feets and, in a case of effusion in some large joint –
additionally its X-ray was taken.
Results: In the OA group only two patients showed positive titers of
anti-CCP antibodies: 35 RU/ml and 47 RU/ml (cut off value was set
on 5 RU/ml). Ten of the OA patients and 15 of the RA patients had
positive rheumatoid factor (with unless one method). In the group
with RA 24 patients (88,89%) presented positive anti-CCP anti-
bodies, and in this group only 12 (50%) was RF positive. Five
patients with OA developed effusion of the knee joint – the synovial
ﬂuid examination revealed inﬂammatory pattern without presence
of rheumatoid factor. After a 6 months follow up the two patients
with positive anti-CCP values developed RA.
Conclusions: In the elderly patients the distinguishing process
between the recent oncet rheumatoid arthritis and exacerbation of
osteoarthritis with inﬂammatory reaction can provide difﬁculties
especially, when there is symmetrical hand joints swelling or large
joint effusion with moderate inﬂammatory changes in synovial ﬂuid,
or ﬁnally, the rheumatoid factor is absent. The accurate differential
diagnosis is important because of their therapeutic implications. A
simple and speciﬁc diagnostic test is needed for treatment to be
initiated at an early stage of RA. Although there is no speciﬁc
laboratory test to diagnose OA, it has been recently developed
a new, very speciﬁc assay for RA, the detection of a novel
autoantibody, directed to citrullinated antigens in the synovium –
anti-cyclic citrullinated peptide antibodies (speciﬁcity of 98–99%
and a sensitivity of 75–80%). Our study conﬁrms the high
diagnostic speciﬁcity of anti-CCP antibodies for rheumatoid
arthritis. Importantly enough, the lack of anti-CCP antibodies in
patients with the clinical suspicion of inﬂammatory exacerbation of
OA may be considered as a very helpful diagnostic tool to
discriminate from early RA in elderly.
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CHRONIC POSTTRAUMATIC KNEE SYNOVITIS: NITRIC OXIDE
SYNTHASE ACTIVITY AND APOPTOSIS
A. V. Cherepovskyy, A. I. Dubikovz, S. V. Nikuliny,
L. A. Belogolovyhz, E. E. Medvedz
y Department of Orthopedic Surgery, Vladivostok State Medical
University, Vladivostok, Primorsky region, Russian Federation
z Department of Rheumatology, Vladivostok State Medical Univer-
sity, Vladivostok, Primorsky region, Russian Federation
Aim of study: To study the role of nitric oxide (NO) derived from the
inducible nitric oxide synthase (iNOS) pathway in the induction of
apoptosis in the knee synovial membrane of patients with
posttraumatic knee instability.
Methods: Joint tissue was obtained from 20 posttraumatic knee
instability patients and 10 healthy men. Apoptotic cells were
identiﬁed in cryosections using the TUNEL (terminal dUTP nick
end labelling) assay (ApopTag Fluorescein In Situ Apoptosis
Detection Kit; CHEMICON International, USA & Canada).
Staining for iNOS was performed using a well-characterized
polyclonal rabbit anti-human iNOS antibody (Nitric Oxide Synthase
Detection Kit, Sigma Chemical Co., USA).
S39Results: Statistically signiﬁcant increase of nitric oxide synthase in
synovial cells was determined at the earliest period of trauma (after
one and a half month). An extensive number of apoptotic cells
appeared in the same zones at that time. These changes followed
picture of chronic proliferative synovitis. Moreover, the most pro-
liferative changes corresponded to synovial and subsynovial lining
cells that were positive for high nitric oxide synthase and apoptotic
activity. The increase of activity was accompanied with progressive
reduction of glycosaminoglycan in cartilage matrix. These changes
were illustrated with preserved structure of the cartilage matrix on the
earliest stage of posttraumatic knee instability.
Conclusion: The ﬁndings suggest that there is NOS-dependent
signal pathway to apoptosis which is thought to be cause of cell
death in chronic proliferative inﬂammation of synovium.
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TIBIAL CANCELLOUS BONE DIFFERENCES BETWEEN
OSTEOARTHRITIC (OA) AND NON-OA KNEE SUBJECTS:
A CROSS-SECTIONAL STUDY
E. A. Messent, J. C. Buckland-Wright
Applied Clinical Anatomy, King’s College London, London, United
Kingdom
Purpose: To quantify differences in cancellous bone structure in the
subchondral and subarticular regions of the tibia in knees with mild,
deﬁnite and advanced OA compared to a healthy reference group
using computerized method of fractal signature analysis (FSA) of
macroradiographs that separately quantiﬁes horizontal and vertical
trabeculae.
Methods: Patients with medial compartment OA (nZ 110; FZ 70),
mean (SD) age 57.2 (10.6) years, and non-OA reference subjects
(n Z 27; F Z 10) mean (SD) age 35.1 (11.2) years had x 4
macroradiographs that were digitised by laser scanner. Computer
measurement of minimum medial joint space width (JSW) sub-
divided OA knees into those with early (JSW O 3 mm, n Z 70),
deﬁnite (JSW% 3O 1.5 mm, nZ 52) and advanced OA (JSW%
1.5 mm, nZ 60). The non-OA group (nZ 49) had JSWO 4.5 mm.
FSA measured differences in cancellous bone structure between
OA and non-OA subgroups at four regions of interest (ROI) (size: 3/
4 tibial compartment width ! 6 mm height) placed at the medial
and lateral subchondral (Sc) and subarticular (Sa) sites.
Results
Medial compartment: Compared to non-OA, FSA of vertical trabe-
culae in all OA subgroups had increased signiﬁcantly (P! 0.05) at
all trabecular sizes (0.12–1.14 mm) in the Sc ROI and in deﬁnite
and advanced OA groups in the Sa ROI. Compared to early OA
group, FSA of vertical trabeculae had increased signiﬁcantly (P !
0.05) at most trabecular sizes (0.36–1.14 mm) in both the Sc and
Sa ROIs in knees with deﬁnite and advanced OA. FSA of horizontal
trabeculae had some differences between non-OA and OA groups
in the Sc region, but in the Sa region, FSA decreased signiﬁcantly
(P ! 0.05) at large sized horizontal trabeculae (0.60–1.14 mm) in
the advanced OA group.
Lateral compartment: Compared to non-OA, FSA of vertical
trabeculae in all OA subgroups had increased signiﬁcantly (P !
0.05) at most trabecular sizes (0.12–1.14 mm) in the Sc ROI, and
FSA of horizontal trabeculae increased signiﬁcantly (P ! 0.05) in
all OA subgroups in both Sc and Sa ROIs at some small to medium
sizes (0.12–0.78 mm).
Conclusion: The increase in FSA (consistent with increase in
trabecular number associated with thinning and fenestration at sites
of dense cancellous bone [Buckland-Wright et al., 1996; Ann
Rheum Dis 55:749]) of vertical trabeculae, showed osteoporosis to
be present in the Sc and Sa ROIs of both compartments. In the
medial Sc ROI, load-bearing led to the retention of most horizontal
trabeculae; the increase in vertical trabecular number was inversely
related to the degree of baseline JSW loss. With advanced OA,
fenestration of vertical and loss of horizontal trabeculae occurred in
the medial Sa ROI. Lateral compartment osteoporosis in the Sc
and Sa ROIs was due to unloading within joints with medial
compartment OA. Progressive bone loss in OA now requires
conﬁrmation from longitudinal studies.P91
CELLULAR PROLIFERATION OF OSTEOBLASTS FROM
OSTEOARTHRITIS PATIENTS IS SIGNIFICANTLY INCREASED
BY CXCL12 (SDF-1) AND CXCL13 (BCA-1) CHEMOKINES
F. Grassiy, S. Cristinoy, C. Cavalloy, A. Piacentiniy, A. Facchiniyz,
G. Lisignoliy
yLaboratorio di Immunologia e Genetica, Istituti Ortopedici Rizzoli,
Bologna, Italy
zDipartimento di Medicina Interna e Gastroenterologia, University
of Bologna, Bologna, Italy
Evidence indicates that the progression of joint cartilage de-
generation in osteoarthritis (OA) is associated with subchondral
bone modiﬁcation. In OA patients, the bone tissue is characterized
by areas of subchondral sclerosis, enhanced bone density,
increased subchondral bone metabolism, as well as increased
collagen type I synthesis and osteophyte formations. Different
soluble factors, as proinﬂammatory cytokines (IL1b and TNFa),
degradative enzymes (MMPs, b-N-acetylhexosaminidase) and
chemokines signiﬁcantly contribute to these modiﬁcations. Since
chemokines have been recently shown to modulate bone cell
metabolism and secretion of catabolic proteases, we wondered
whether CXC chemokines receptors were expressed in OBs and
whether their ligands modulated OB functions. Furthermore, we
tested the hypothesis that CXC chemokines may contribute to
modulating subchondral bone remodelling in OA Therefore, we ﬁrst
analysed the expression of CXC receptors and ligands on
osteoblasts (OBs) from OA patients and then we analysed how
OBs functions were modulated after in vitro stimulation with
chemokines. OBs isolated from trabecular bone tissue obtained
from OA and post traumatic (PT) patients were cultured and the
expression of CXC receptors/ligands (CXCR1/CXCL8, CXCR2/
CXCL8, CXCR3/CXCL10, CXCR4/CXCL12, CXCR5/CXCL13) was
analysed by ﬂow cytometry and immunohistochemistry or ELISA.
Functional assays on CXC chemokines-treated-OBs in the
presence or absence of their speciﬁc inhibitors were performed to
analyse cellular proliferation and the enzymatic response to
chemokine activation. The expression of chemokine ligands/
receptors was also conﬁrmed in bone tissue samples by
immunohistochemical analysis. OBs from both OA and PT patients
expressed high levels of CXCR3 and CXCR5 and lower amounts of
CXCR1 and CXCR4. CXCL12 and CXCL13, only in OBs from OA
patients signiﬁcantly induced cell proliferation. Both blocking
experiments, performed treating OBs with anti-CXCR4 and anti-
CXCR5, and inhibiting experiments, performed treating OBs with
Bordetella pertussis toxin, conﬁrmed a signiﬁcant speciﬁc reduction
of cell proliferation. Moreover, OBs from OA patients released
a higher amount of CXCL13 than PT patients and no differences
were found for CXCL12. In the remodelling area of bone tissue
samples, immunohistochemical analysis, revealed a high expres-
sion of CXCL12 by OBs and a low expression of CXCL13.
However, in the same area, the expression of CXCR4 was lower
than CXCR5. Moreover, we found in OA bone samples that when
bone remodelling occurred, a high number of growing OBs was
observed. These data suggest that CXCL12 and CXCL13 may be
directly involved in the remodelling process that occurs in the bone
of OA patients and their effects on cellular proliferation might favour
an increase in collagen deposition in OA bone.
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IGF-I STIMULATION OF CHONDROCYTE PROTEOGLYCAN
SYNTHESIS AND SURVIVAL REQUIRES ACTIVATION OF
THE PI-3 KINASE SIGNALING PATHWAY
B. Starkman, M. Del Carlo, C. Pacione, R. F. Loeser
Medicine (Rheumatology) and Biochemistry, Rush University
Medical Center, Chicago, IL, USA
Aim: Insulin-like growth factor (IGF-1) has been shown to promote
chondrocyte survival and proteoglycan (PG) synthesis but the cell
signaling mechanisms involved have not been well deﬁned. It is
S40important to deﬁne the IGF-I signaling pathway in chondrocytes
since studies have shown a reduced response to IGF-I in aging and
OA cartilage which could be due to altered cell signaling. The aim of
this study was to determine the role of the PI-3 kinase and MAP
kinase signaling pathways in IGF-I stimulation of both chondrocyte
survival and proteoglycan synthesis.
Methods: Chondrocytes were isolated from normal adult human
articular cartilage and cultured in high density primary monolayers
or in alginate beads. Monolayers were changed to serum-free
media after 5–7 days of culture and stimulated with 50–100 ng/ml of
IGF-I while alginate beads were maintained in serum-free media
supplemented with mini-ITS and stimulated with 100 ng/ml IGF-I.
Immunoblotting with phosphospeciﬁc antibodies was used to
determine the signaling proteins activated by IGF-I and speciﬁc
inhibitors to these proteins were used to determine which were
required for survival and PG synthesis. PG synthesis was
measured by sulfate incorporation in short-term stimulation studies
(16 h of IGF-I) and by DMB analysis in 21-day alginate cultures and
was corrected for cell numbers by a DNA quantiﬁcation assay. Cell
viability was measured using the LIVE/DEAD cell assay.
Results: Within 5–10 min of treatment, IGF-1 activated members of
both the PI-3 kinase pathway (IRS-I, Akt, p70S6 kinase, and GSK3)
and the ERK MAP kinase pathway (Shc, Ras, MEK, ERK) but not
JNK or p38. The PI-3 kinase inhibitor, LY294002 at 25 mM, blocked
IGF-1 stimulated Akt phosphorylation without blocking ERK
phosphorylation and this was associated with complete inhibition
of IGF-I stimulated PG synthesis in both short and long-term
cultures. The MEK inhibitor, PD98059 at 25 mM, blocked IGF-1
stimulated ERK phosphorylation but did not block phosphorylation
of Akt and did not decrease PG synthesis in short or long-term
cultures. In some alginate cultures, the MEK inhibitor resulted in
increased PG synthesis. Inhibition of IGF-1 stimulated PG synthesis
was observed upon inhibition of mTOR and p70S6 kinase, both of
which are downstream from Akt. None of the inhibitors caused cell
death in short-term cultures while the PI-3 kinase inhibitor blocked
the ability of IGF-I to promote survival in long-term cultures.
Conclusion: This is the ﬁrst study to demonstrate that IGF-I
stimulation of the PI-3 kinase signaling pathway is responsible for
the ability of IGF-I to regulate PG synthesis and promote survival.
Although IGF-I also activates the ERK MAP kinase pathway, it is
not required for PG synthesis and in some cases may be a negative
regulator. Activation of Akt resulted in activation of mTOR and
p70S6 kinase which were also required for PG synthesis, likely
through regulation of translational activity by p70S6 kinase.
Ongoing studies are determining how this signaling is disrupted
with aging in chondrocytes.
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HYALURONAN–CHONDROCYTE INTERACTIONS PROMOTE
CELL SURVIVAL VIA REDUCTION OF FAS MEDIATED
APOPTOSIS
M. Ohno-Nakahara*, W. Knudson, S. Ohno, C. B. Knudson
Biochemistry, Rush University Medical Center, Chicago, IL, USA
Aim of study: This study was initiated to investigate the relationship
of endogenous CD44-hyaluronan (HA) interactions in the pro-
motion of cell survival and to test whether the disruption of CD44–
HA interactions would increase the sensitivity of chondrocytes to
Fas ligand activation of apoptosis.
Methods: Bovine and human articular chondrocytes were treated
with either HA oligosaccharides or hyaluronidase to disrupt
endogenous HA–CD44 interactions. Normal human articular
cartilage was obtained through the Gift of Hope Organ & Tissue
Donor Network. Isolated chondrocytes were cultured in alginate
beads for 5 days for pericellular matrix assembly. Then, the
chondrocytes were pre-treated in DMEMC 10% FBS for 1, 7 or 14
days with 250 mg/ml HA oligosaccharides (containing HA4, HA6 and
HA8) or pre-treated with hyaluronidase (Sigma, H-1136) or cultured
untreated in control complete medium. The cells were released
from alginate beads, washed, seeded in monolayer culture and
then incubated for 17 h in the presence or absence of 7.5 mg/ml
anti-Fas antibody (clone CH-11; Upstate Biotechnology). Cellviability was determined after co-incubation with calcein AM and
ethidium homodimer-1 in PBS (Viability Kit, L-3224; Molecular
Probes) and is reported as % non-viable cells of the total. The
induction of apoptosis was conﬁrmed by Caspase-3 activity, which
was assayed by DEVD-p-nitroanilide cleavage by chondrocyte
lysates (CASP-3-C; Sigma).
Results: Both hyaluronidase and HA oligosaccharide treatment
disrupted pericellular matrix assembly and retention. Treatment of
normal human or bovine chondrocytes with HA oligosaccharides or
hyaluronidase for 1 or 8 days did not change cell viability; !3%
non-viable cells in all experiments. However, incubation of bovine
articular chondrocytes with HA oligosaccharides for 14 days
decreased cell viability to w55%. Anti-Fas antibody induced
a 2.6-fold increase in caspase-3 activity in human chondrocytes.
Cell viability was also decreased by Fas ligation of human
chondrocytes, to w11% non-viable cells. Pre-treatment of human
chondrocytes with HA oligosaccharides, followed by incubation with
the anti-Fas antibody decreased cell viability further tow23% non-
viable cells. Pre-treatment of human chondrocytes with hyaluron-
idase has a lesser effect, resulting in w17% non-viable cells after
incubation with the anti-Fas antibody.
Conclusions: Recent data are accumulating that high molecular
mass HA–CD44 interactions exhibit potent effects on promoting cell
survival and reducing cell sensitivity to apoptosis. In this study,
disruption of stable HA-cell interactions with HA oligosaccharides or
hyaluronidase treatment counteracted these effects. These results
suggest that the organization of the pericellular matrix may cluster
CD95/Fas on the cell surface and disruption of endogenous HA–
CD44 interactions may prime the cell surface for Fas ligand acti-
vation of CD95/Fas death pathways. Additionally, we have shown
activation of MMP-3, MMP-13 and iNOS following disruption of HA–
CD44 interactions, which may impact on these pathways.
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THE EFFECT OF PPAR g LIGAND ON CARTILAGE DEGENER-
ATION DURING THE DEVELOPMENT OF EXPERIMENTAL
OSTEOARTHRITIS IN THE RABBIT KNEE
H. Tonomura, K. A. Takahashi, Y. Arai, A. Inoue, R. Terauchi,
M. Saito, S. Fujita, T. Kubo
Department of Orthopaedics, Graduate School of Medical Science,
Kyoto Prefectural University of Medicine, Kyoto, Japan
Aim of this study: Natural prostaglandin 15-deoxy-delta12,14-
prostaglandin J2 (15d-PGJ2) known to be the most potent
endogenous ligand for peroxisome proliferator-activated receptor
g (PPAR g) was administered into joints of rabbit osteoarthritis (OA)
models and cartilage degeneration was investigated.
Methods: Twenty-two mature Japanese white rabbits underwent
unilateral anterior cruciate ligament transection (ACLT) and were
divided into two groups. The ﬁrst group (15d-PGJ2 group, n Z 12)
received intra-articular injections of 200 mg of 15d-PGJ2 into the
ACLT knee 3 weeks after transection, once a week for 7 weeks.
The second group (PBS group, n Z 10) was injected with PBS in
the same manner. All animals were sacriﬁced at 10 weeks following
surgery. At sacriﬁce, all ACLT knees were evaluated for gross
morphological changes of cartilage and classiﬁed into 6 grades
[Grade 1 (intact articular surface), 2, 3, 4a, 4b and 4c (severely
degenerated articular surface)] by using India ink and scored (0–5).
Results: Averaged scores were 4.5 G 0.9 in the 15d-PGJ2 group
and 2.7 G 2.1 in the PBS group. Severely damaged cartilage
(Grade 4a, 4b and 4c) was observed in 92% of the 15d-PGJ2
group, and in 44% of the PBS group. The extent and grade of
cartilage damage in the 15d-PGJ2 group were signiﬁcantly more
severe than the PBS group (P ! 0.05).
Conclusion: PPAR g is a member of the nuclear receptor
superfamily of ligand-activated transcription factors. Natural pros-
taglandin 15d-PGJ2 is a PPAR g ligand that modulates the
transcription of target genes. It is reported that 15d-PGJ2 has an
anti-inﬂammatory effect and ameliorates adjuvant-induced arthritis
in rats. In addition, previous in vitro study demonstrated that PPAR
g expressed in chondrocytes, and 15d-PGJ2 could suppress the
cartilage degeneration induced by inﬂammatory cytokines. Contrary
S41to our expectations, we found that intraarticular injection of 15d-
PGJ2 remarkably accelerated cartilage degeneration in ACLT
rabbit. These results are inconsistent with the previous studies
in vitro. High concentration of 15d-PGJ2 has been reported to
induce apoptosis in a variety of cells including chondrosarcoma
cells. The controlled release system which can maintain the low
concentration of 15d-PGJ2 might be necessary for the local
administration into joints in the treatment of OA.
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ROLE OF A COLLAGEN RECEPTOR, DISCOIDIN DOMAIN
RECEPTOR 2, IN PATHOGENESIS OF OSTEOARTHRITIS
L. Xuy, H. Pengz, D. Wux, K. Hux, M. B. Goldringz, B. R. Olsenyx,
Y. Lix
y Cell Biology, Harvard Medical School, Boston, MA, USA
z New England Baptist Bone & Joint Institute, Beth Israel
Deaconess Medical Center, Boston, MA, USA
x Oral and Developmental Biology, Harvard School of Dental
Medicine, Boston, MA, USA
The aim of this study was to investigate a possible role of a collagen
receptor, discoidin domain receptor 2 (DDR2), in pathogenesis of
osteoarthritis (OA). In this study, we found that the mRNA and
protein levels of Ddr2 were increased with age in the articular
cartilage of knee joints of heterozygous chondrodysplasia mice
(cho/C). These mice have hereditary OA as a result of a mutation
in type XI collagen. We also found that the destruction of articular
cartilage was associated with increased activities of matrix metal-
loproteinases (MMPs). The levels of Mmp-13 mRNA were
increased in knee joints by 6 months. To understand whether the
increased expression of Mmp-13 resulted from the upregulation of
Ddr2, we performed in vitro experiments. Studies with chondro-
cytes showed increased DDR2 and MMP-13 mRNA levels in an
immortalized human chondrocyte cell line and primary mouse
costochondral chondrocytes cultured on plates coated with native
type II collagen. This increase was not observed when the
chondrocytes were seeded on uncoated plates or on plates coated
with heat-denatured type II collagen. The levels of MMP-1, MMP-3,
MMP-8, ADAMTS-4, ADAMTS-5 and IL-1 mRNA in human
chondrocytes and Mmp-3, Mmp-8, Adamts-4, Adamts-5 and II-1
mRNA in mouse chondrocytes were not increased after culture on
plates with native type II collagen. In chondrocytes transfected with
full-length DDR2 cDNA and cultured on type II collagen-coated
plates, the levels of MMP-13 mRNA were also elevated, whereas
transfection with a truncated DDR2 cDNA, lacking the cytoplasmic
domain, reduced the MMP-13 mRNA level by 30%. Experiments
with speciﬁc inhibitors of intracellular signaling pathways demon-
strated that the Ras/Raf/MEK/ERK pathway was likely responsible
for the upregulation of MMP-13 in human chondrocytes cultured on
type II collagen-coated plates. Our data suggest that the levels of
expression and activity of DDR2 in chondrocytes depend on their
interaction with native type II collagen, and that DDR2-induced ex-
pression of MMP-13 represents a novel mechanism that may con-
tribute to the initiation or ampliﬁcation of cartilage damage in OA.
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GENE EXPRESSION PROFILES OF ISOLATED HUMAN CHON-
DRONS AND CHONDROCYTES—A COMPARATIVE cDNA
MICROARRAY STUDY
Z. Zhangy, J. Fanz, K. G. Beckery, R. D. Graffx, G. M. Leex,
C. A. Francomanoy
y National Institute on Aging/IRP, National Institutes of Health,
Baltimore, MD, USA
z Department of Medicine, The Johns Hopkins University, Balti-
more, MD, USA
x Thurston Arthritis Research Center, University of North Carolina,
Chapel Hill, NC, USA
Aim of study: A chondron, the biological unit of cartilage, includes
the chondrocyte and its pericellular matrix. This study was designedto investigate effects of the intact microenvironment on the gene
expression proﬁle of chondrocytes in chondrons.
Methods: In this study, chondrons and chondrocytes were
enzymatically isolated from human articular cartilage by following
previously established methods (Lee et al. 1997), and maintained in
pellet culture. Pellets of chondrons or chondrocytes were collected
at days 1, 3 and 5 for RNA isolation and cDNA microarray analysis.
RNA samples were then radiolabelled (a[33P]dCTP) and hybridized
according to protocols described at http://www.grc.nia.nih.gov/
branches/rrb/dna.htm. The human cDNA microarray (MGC1
6_10_03) has 8983 unique GenBank accesses or 6425 unique
genes. Raw intensity values of microarray were normalized using
Z-score transformation (Cheadle et al., 2003). In direct comparison
of the intensity of chondron genes with corresponding chondrocyte
genes, signiﬁcance was deﬁned as P ! 0.01 and z ratio O 2.0.
Signiﬁcant genes were clustered using GeneSpring software
(Silicon Genetics). The microarray data for genes of particular
interest were further validated with real time RT-PCR.
Results: In comparison with chondrocytes, 258 genes of chondrons
were either up- or down-regulated. Of these, 90 genes were of
unknown function. Genes functioning in signaling, protein assem-
bly/transportation and metabolism were the most common in
number. At day 1, there were 26 genes signiﬁcantly up-regulated
in chondrons and 4 down-regulated. At day 3, the number of up-
regulated chondron genes was 97 and 43 down-regulated. There
were more down-regulated genes (56) than up-regulated genes
(32) in chondrons at day 5. In chondrons, the largest cluster with 89
genes fell in a pattern that was unchanged at day 1, then up-
regulated at days 3 and 5. Consistent with real time RT-PCR
results, a group of genes in the heat shock protein 70 family were
up-regulated in chondrons: HSPA8 at day 1; HSPA1A, HSPA2,
HSPA8 at day 3 and HSPA1A at day 5.
Conclusions: (1) The retained chondrocyte microenvironment in
chondrons has a profound inﬂuence on chondrocyte gene
expression, affecting a large number of expressed genes over an
extended time course. (2) Heat shock proteins respond to cell
stress and promote cell survival. Up-regulation of the heat shock
protein 70 family may contribute to the reported characteristics of
chondrons such as robust mechanical properties, better tolerance
to osmolality challenges and more active matrix production.
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FLOW CYTOMETRIC MEASUREMENT OF MRNA IN LIVING
CELLS BY FISH
G. Verbruggen, J. Wang, P. Verdonk, D. Elewaut, E. M. Veys
Department of Rheumatology, Ghent University Hospital, Ghent,
Belgium
Objective: Flow cytometry (ﬂuorescence associated cell sorting;
FACS) has been successfully used to detect gene encoding at the
protein level while ﬂuorescent in situ hybridisation (FISH) is
a valuable research tool in molecular cytogenetics and gene
expression. We intended to evaluate the ﬂow cytometric enumer-
ation of mRNA by FISH in intact living chondrocytes.
Methods: Designed mRNA speciﬁc oligodeoxynucleotide probes
were synthesized and conjugated with FITC. Human chondrocytes
were obtained from normal cartilage and cultured as phenotypically
stable cells in 1% alginate beads for 1 week. The chondrocytes
were then isolated from the alginate and were incubated with
speciﬁc probes to hybridise the target mRNA molecules. FACS
detected ﬂuorescence intensity of probes in the intact living
chondrocytes. The Mean Fluorescence Intensity (MFI) of the cells
due to the presence of the speciﬁc FITC-conjugated mRNA probe
was then converted to number of mRNA molecules.
Results: Single-stranded oligonucleotides probes shorter than 30
bases freely entered intact living chondrocyte cytoplasm and
annealed with the target mRNA. Uncombined probes and negative
control probes were completely washed away. The use of a number
of supplementary probes linearly increased the ﬂuorescent intensity
of cells, but did not change the proportions of ﬂuorescent cells. As
each single oligonucleotide strand was labelled with one FITC
reporter molecule, the MFI of the labelled chondrocytes correlated
S42with the numbers of FITC-conjugated probes inside the cells and
allowed the copies of mRNA transcripts to be quantiﬁed. The
inﬂuence of IGF-1 and IL-1b on aggrecan and collagen gene
encoding was analysed by FACS dependent FISH. IGF-1
enhanced, and IL-1b depressed the transcription and the expres-
sion of both extracellular matrix compounds.
Conclusion: Flow cytometric analysis of mRNA by FISH is an
efﬁcient tool to quantify low numbers of copies of mRNA in intact
living chondrocytes. Proteins expressed on the cell surface have
been measured simultaneously.
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OSTEOARTHRITIC CARTILAGE CONTAINS INCREASED
LEVELS OF THE SERINE PROTEASE INHIBITOR, TRAPPIN-2
K. Jaovisidha, I. Masuda, A. K. Rosenthal
Medicine/Division of Rheumatology, Medical College of Wisconsin,
Milwaukee, WI, USA
Trappins are small serine protease inhibitors bound to extracellular
matrix through the actions of transglutaminase enzymes. Trappin-2
is one of the better characterized members of the trappin family. It is
also known as elaﬁn or SKALP and inhibits neutrophil elastase
and proteinase 3. In osteoarthritis, serine proteases contribute
to cartilage destruction, and extracellular activity of the protein-
crosslinking transglutaminase enzymes are increased. Yet, little is
known about extracellular matrix-bound protease inhibitors in
cartilage. The purpose of this work was to determine if trappin-2
is present in osteoarthritic cartilage and synovial ﬂuids.
Osteoarthritic cartilage was obtained from tissue discarded from
knee replacement surgeries. Osteoarthritic synovial ﬂuid was
from discarded ﬂuids from diagnostic or therapeutic arthrocenteses.
Normal cartilage sampleswere froma tissue bank. Articular cartilage
samples were assayed for trappin-2 protein by Western blotting,
ELISA, and immunohistochemistry. Trappin-2mRNAwasmeasured
by RT-PCR. The presence of trappin-2 in synovial ﬂuid was docu-
mented by Western blotting. The extracellular matrix components
bound to trappin-2 in osteoarthritic cartilagewere identiﬁedby2-Dgel
electrophoresis and peptide ﬁngerprinting.
Western blotting demonstrated trappin-2 in articular cartilage
extracts, cultured chondrocytes, and synovial ﬂuids from patients
with osteoarthritis. Osteoarthritic articular chondrocytes secreted
trappin-2 into conditioned media. A trappin-2 ELISA demonstrated
trappin-2 levels of 23.1 G 1.6 ng/mg cartilage in osteoarthritic
cartilage extracts (nZ 8) and 11.8G 3.2 ng/mg cartilage in normal
cartilage extracts (n Z 3) (P ! 0.004). Immunohistochemical
studies of osteoarthritic cartilage demonstrated trappin-2 protein in
chondrocytes. RT-PCR supported local trappin-2 production by
demonstrating the presence of trappin-2 mRNA in osteoarthritic
chondrocytes. Peptide mapping of proteins bound to trappin-2 in
osteoarthritic cartilage showed that ﬁbromodulin was one of several
protein partners of trappin-2.
We demonstrate the presence of trappin-2 in osteoarthritic cartilage
and synovial ﬂuid. Trappin-2 acts as a matrix-bound serine protease
inhibitor in the presence of extracellular transglutaminase activity.
Elevated levels of transglutaminase activity in degenerated cartilage
may aid repair processes by increasing levels of trappin-2 in matrix.
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NON-VIRAL GENE TRANSFER OF HYALURONIC ACID
SYNTHASE2 (HAS2) INTO THE PERIOSTEAL GRAFT FOR
DAMAGED ARTICULAR CARTILAGE
Y. Kawaguchi, Y. Wada, T. Yamashita, T. Sashou, M. Tahara,
S. Yamaguchi, H. Moriya
Orthopaedics, Chiba University, Chiba, Japan
Aim of this study: Recently it has been reported that Hyaluronan
accelerates the repair of cartilage damage. And gene gun system is
thought to be useful for gene transfer to limited area effectively and
safely. Aim of this study was to evaluate the effect of HyaluronicAcid Synthase 2 (HAS2) gene transfer into the periosteal graft for
articular cartilage defect using a gene gun system.
Methods: Fifteen adult New Zealand White rabbits were used.
Articular cartilage was excised from femoral component to create
a full thickness defect. Periosteal graft was harvested from proximal
tibia. The HAS2 plasmid was transfected to the cambium layer cells
of periosteal graft by a gene gun. And sutured on the defect with the
cambium layer facing up to the articular surface. Serial sections
were stained with H&E and toluidine blue at 2, 4 and 12 weeks after
the operation, and assessed by histological grading system (0–14
points) that consist of ﬁve categories including cell morphology,
matrix staining, surface regularity, thickness, and integration. And
RT-PCR analysis was performed to examine the gene expression
of HAS2 and type II collagen.
Result: At 4 weeks, the ﬁbrous tissue had been replaced by poorly
differentiated cartilage tissue that had metachromatic matrix and
better integration to the adjacent cartilage. The histological score of
integration to adjacent cartilage was signiﬁcantly better (P ! 0.05)
in the HAS2 group than that of control. At 12 weeks, the repair
tissue consisted almost entirely of hyaline cartilage, stained well
with toluidine blue. The score of surface regularity (P ! 0.01) and
total histological score (P ! 0.05) in the HAS2 group were
signiﬁcantly better than those of the control. RT-PCR analysis
revealed that the mRNA of HAS2 and Type II collagen of HAS2
group was expressed higher than control group at 2 weeks, 12
weeks after operation.
Conclusion: HAS2 gene transfer using a gene gun system might
have beneﬁcial effects to the surface matrix product of periosteal
graft transplanted on the articular cartilage defect. This easy and
safe method seemed to be useful for autologous chondrocyte
implantation to avoid hypotrophy of the periosteal grafts.
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REGULATORY FACTORS OF TIDEMARK PROGRESSION IN
ADULT HUMAN ARTICULAR CARTILAGE
R. C. Casey, C. L. Fhied, T. R. Oegema
Biochemistry, Rush University Medical Center, Chicago, IL, USA
Aim of study: Determine the ability of triiodothyronine (T3) and TGF-
b1, which control the progression of the tidemark in the developing
growth plate, to regulate hypertrophy in adult talar cartilage.
Methods
Cell culture: Full-thickness adult human talar cartilage, obtained
from donors free of symptomatic joint disease, was maintained as
explant or suspension cultures in DMEM, 5% FBS for up to 19 days
in the presence of 50 nM T3, 10 ng/ml TGF-b1, or neutralizing
antisera against TGF-b1.
Measurement of ALP activity: Suspension cultures were disaggre-
gated by sequential enzymatic digestion. Explant cultures were
frozen and sectioned. Both were stained with NBT/BCiP to
visualize alkaline phosphatase (ALP) activity and counterstained.
ALP activity was expressed as the percentage of ALP-positive cells
or as the distance of ALP-positive cells from the tidemark.
Results: T3 elicited ALP activity in the suspension cultures with
peak ALP activity observed at 11 days. This response was
signiﬁcantly inhibited by TGFb-1 and was enhanced by neutralizing
TGFb-1 antisera (Fig. 1).
T3 increased the wave of ALP activity to spread to additional cell
layers further away from the tidemark in the explant cultures
(Fig. 2). We also observed that this effect was much greater in 20–
30-year-olds than 60–80-year-olds. This suggests that T3 induces
adult chondrocytes in the early stages of hypertrophy to commit to
end-stage differentiation, although the response appears to
attenuate with age.
Conclusions: The growth plate contains an interactive set of regu-
latory factors that control the hypertrophic progression of chondro-
cytes. In the developing joint, the terminal differentiation of
chondrocytes to the hypertrophic phenotype regulates skeletal
growth. In adult articular cartilage, terminal differentiation is so tightly
regulated that mineralization (i.e., tidemark movement) almost
ceases. This report demonstrates that positive (T3) and negative
(TGF-b1) effectors still play a role in adult cartilage, although the
S43responses they elicit may attenuate with age. Dysregulation of these
elements may induce tidemark progression, a hallmark of osteoar-
thritis.
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and Tissue Donor Network and donor families for access to the
tissue.
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REGIONAL DIFFERENCES IN CHONDROCYTE METABOLISM
IN OSTEOARTHRITIC CARTILAGE
N. Fukuiy, L. J. Sandellz, Y. Ikeday, T. Ohnukiy, K. Tanakay,
S. Yamamotox, H. Ishibashix, M. Sawabex, R. Suzukiy, T. Ochiy
y Clinical Research Center, National Hospital Organization Saga-
mihara Hospital, Sagamihara, Kanagawa, Japan
z Department of Orthopaedics, Washington University School of
Medicine, St. Louis, MO, USA
x Departments of Orthopaedics and Pathology, Tokyo Metropolitan
Geriatric Hospital, Itabashi, Tokyo, Japan
Aim: Phenotypic change of chondrocytes in OA was evaluated by
the expression of ﬁve genes known to be induced in the disease,
correlating with the location in cartilage and the severity of cartilage
degradation.
Methods: OA cartilage was obtained from 11 knees at joint
replacement surgery, and the specimens were harvested from the
areas with various disease severity. Control cartilage was obtained
from 5 non-arthritic knee joints of the age-matched donors at
autopsy. Frozen sections were prepared, and the tissue was
obtained (1) by the severity of the disease and (2) by the cartilage
zones, using a laser captured microdissection device. RNA was
extracted, cDNA was synthesized, and the expression of Col a1(I),
Col a2(I), Col a1(II) (type A; type IIA collagen), Col a1(III), and Col
a1(X) were quantitatively evaluated by real-time PCR. In parallel,
the expression of Col a1(II) (types A and B; total type II collagen)
and aggrecan was evaluated as the indices for the metabolic
activity of the chondrocytes. The expression of the aberrant genes
Distance (mm)Age
Collins score Day 0 Day II Control
Day II T3
21 0–1 0 G 0 0 G 0 725 G 21
28 0–1 44 G 2 44 G 2 567 G 81
61 0–1 0 G 0 65 G 47 318 G 29
63 0–1 99 G 7 103 G 13 193 G 15
70 0–1 39 G 8 37 G 5 143 G 12
70 0–1 58 G 4 36 G 3 155 G 31
72 0–1 51 G 3 49 G 9 153 G 22
80 0–1 25 G 5 45 G 4 105 G 12
60 2 78 G 5 74 G 21 134 G 6
69 2 74 G 5 70 G 25 125 G 7
84 2 48 G 6 55 G 5 127 G 19was ﬁrst evaluated by the ratio against GAPDH, then by the ratio
against total type II collagen or aggrecan. Finally, the expression of
Sox9 was measured and compared with the aberrant gene
expression. A comparison between OA and control cartilage was
performed at each cartilage zone.
Results: The expression ratios against GAPDH showed that both of
the type I collagen genes and type III collagen gene tended to be
expressed at the upper areas of degenerative cartilage, while the
expression of type IIA and type X collagen were more abundant in
the deeper areas. In control cartilage, the expression of these
genes was negligible or very low throughout the three cartilage
zones. In contrast, the expression ratios against total type II
collagen or aggrecan, the values that take into account the
metabolic activity of the cells, clearly showed that the chondrocytes
close to the degenerated surface are expressing type I and type III
collagen at relatively higher levels. On the other hand, the
expression ratios for type IIA and type X collagen were still high
at deeper areas even when the cells’ anabolic activity was counted.
The expression of Sox9 was consistent between OA and control
cartilage throughout the three cartilage zones.
Conclusions: The result of this study revealed that different popu-
lations of the cells are responsible for the expression of speciﬁc
aberrant genes induced in OA. When the general anabolic activities
of the chondrocytes were considered, the induction of type I and type
III collagen occurred primarily at the cartilage surface in OA joints,
suggesting that the chondrocytes could undergo a speciﬁc pheno-
typic change there. On the contrary, the induction of type IIA and type
X collagen were observed independently at the middle and deep
cartilage zones, indicating that these genes could be induced by
different mechanisms. Thus, the quantitative investigation of gene
expression in speciﬁc regions of OA cartilage suggests that more
than one mechanism is responsible for altered gene expression.
P102
EXPRESSION OF FUNCTIONAL ADP-SELECTIVE
PURINOCEPTORS BY ARTICULAR CHONDROCYTES
R. D. Graffyz
yOrthopaedics, UNC School of Medicine, Chapel Hill, NC, USA
zThurston Arthritis Research Center, UNC School of Medicine,
Chapel Hill, NC, USA
Aim of study: Chondrocytes release ATP, a signaling molecule and
substrate for extracellular enzymes. Since extracellular ATP is
rapidly hydrolyzed in chondrocyte cultures, the aims of this study
were to determine whether articular chondrocytes possess recep-
tors speciﬁc for other nucleotides, and whether extracellular nucleo-
tides accumulate in sufﬁcient quantity to activate these receptors.
Method: Human articular cartilage was obtained as waste tissue
from total joint arthroplasty; porcine cartilage was harvested from
knee joints purchased commercially. Chondrons (chondrocytes
with their pericellular matrices intact) were enzymatically isolated
and maintained in pellet or multilayer culture. rt-PCR performed
using RNA was isolated from human chondron pellets and primers
speciﬁc for human purinoceptors. Extracellular adenine nucleo-
tides, and degradation of exogenous ATP, were measured by
reverse-phase HPLC. Multilayer cultures were treated with ATP,
ADP, or 2-Methylthio-ADP (2Me-S-ADP, a highly potent agonist of
ADP receptors), with or without varying purinoceptor antagonists,
prior to cell extraction with ice-cold lysis buffer. Cell extracts were
used for SDS-PAGE and western blotting for activated p42/44
MAPK (ERK1/2).
Results: rt-PCR analysis revealed that human chondrocytes
expressed mRNA for P2Y12 and P2Y13, both ADP receptors, but
not P2Y14, a recently described receptor for UDP-glucose.
Treatment of human and porcine chondrocyte cultures with either
ADP or 2Me-S-ADP caused activation of ERK1/2. 2Me-S-ADP
increased ERK1/2 activation in porcine chondrocytes at concen-
trations as low as 1 nM. In contrast, ERK1/2 activation by ATP
occurred only at 1mM or greater. ERK1/2 activation by 2Me-S-ADP
was unaffected by pretreatment with 10 mM MRS2179, a P2Y1
antagonist, or with 50 mM PPADS, a selective antagonist of P2Y1
S44and P2Y13, but having no effect on P2Y12. Di-adenosine
tetraphosphate (Ap4A), is an agonist at P2Y2 and P2Y12, but an
antagonist of P2Y13; 50 mM Ap4A activated ERK1/2 when added
alone, and its pretreatment did not affect ERK1/2 activation by 2Me-
S-ADP. HPLC analysis of extracellular adenine nucleotides
demonstrated that resting chondrocyte cultures accumulated ADP
and ATP at levels of approximately 2 and 4 nM, respectively.
Degradation of exogenous ATP resulted in an elevation of
extracellular ADP levels.
Conclusions: These experiments suggest that articular chondro-
cytes express functional receptors for ADP, in addition to previously
reported receptors for ATP and adenosine. The pattern observed
using pharmacological inhibitors is most consistent with expression
of P2Y12. In resting cultures ADP accumulation may be sufﬁcient to
activate its receptor. The elevation in ADP concentrations following
ATP hydrolysis is likely the result of an ecto-ATPase, or of ecto-
adenylatekinase,whichphosphorylatesAMP toADP in thepresence
of excessATP. Thephysiological role of ADP receptors in non-neural
cells is currently under investigation; P2Y12 activation decreases
adenylate cyclase activity, and could balance the response of
chondrocytes to ATP following its release and hydrolysis.
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INDUCTION OF AGGRECANASE-1 AND MATRIX METALLO-
PROTEINASE-13 BY PDGF AND IL-1 IN HUMAN ARTICULAR
CHONDROCYTES IS MEDIATED BY THE PI3-KINASE/PKB
PATHWAY
C. S. Kumary, B. J. Latarioy, S. Daoutiy, M. Lotzz
y Functional Genomics, Novartis Institutes for Biomedical Re-
search, Cambridge, MA, USA
z Division of Arthritis Research, The Scripps Research Institute, La
Jolla, CA, USA
Aims: To identify signaling pathways involved in the expression of
aggrecanase-1 (Agg-1) and matrix metalloproteinase-13 (MMP-13)
in human articular chondrocytes.
Methods: Agg-1 and MMP-13 expression in response to Platelet-
derived growth factor (PDGF) and Interleukin-1b (IL-1b) was
studied in ﬁrst passage monolayer cultures of normal human
articular chondrocytes. Signaling mechanisms were examined by
using speciﬁc pharmacologic inhibitors and by overexpressing
dominant negative and constitutively active genetic constructs of
selected kinases. Activation of kinases was analyzed by Western
blotting with phospho-speciﬁc antibodies.
Results: PDGF and IL-1b induced the expression of Agg-1 and
MMP-13 genes. This was associated with activation of the
phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) path-
way. The PI3K inhibitor LY294002 and the PKB dominant negative
mutant blocked this activation and prevented the induction of Agg-1
and MMP-13 expression in PDGF or IL-1b stimulated cells. In
addition, over-expression of the constitutively active forms of PI3K
and PKB in chondrocytes resulted in the induction of Agg-1 and
MMP-13. Over-expression of active PKB also increased phosphor-
ylation of the downstream forkhead transcription factor. The effects
of PDGF and IL-1b on mitogen-activated protein kinases (MAPK)
were not inhibited by PI3K inhibitor LY294002, indicating that the
PI3K and MAPK pathways are independently activated.
Conclusion: These ﬁndings suggest that the PI3K pathway plays
a key role in the induction of Agg-1 and MMP-13 by growth factors
and cytokines andmay contribute to cartilage degradation in arthritis.
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CHARACTERIZATION OF ARTICULAR CARTILAGE CALCIFI-
CATION IN HUMAN KNEES BY RADIOGRAPHIC IMAGING
H. Mitsuyama, R. M. Healey, T. Watanabe, R. D. Coutts, D. Amiel
Orthopaedics, University of California, San Diego, San Diego, CA,
USAThe aim of the present study is to investigate the relationship
between aging, body mass index (BMI), gender and the severity of
morphologic changes associated with cartilaginous calciﬁcation of
human knee joints.
Methods: Two hundred and forty-three human knee joints from 122
individuals (44 females, 78 males; avg. age 57.7 G 18.5 years,
range 16–91 years) were obtained. The surfaces of the articular
cartilage for both the femur and tibia were graded for gross
morphological changes using a 4-point grading scale (1 – normal to
4 – eroded). The lateral and medial femoral condyles were cut
along a sagittal plane and the tibia along a coronal plane to make
bone and cartilage slab specimens each about 7 to 10 mm thick.
The slabs were X-rayed on mammography ﬁlm. The radiographs
were scanned into a computer and assessed with image analysis
software (ImageJ 1.32). Quantitative measurements of the areas of
total cartilage and calcium depositions were performed.
Results: Calciﬁcation measurements were tabulated and assessed
by age group (young 11–40, middle 41–60 and aged 61–100
years). The results are graphed in Fig. 1. A signiﬁcant increase in
the percentage of calcium deposition was seen between the young
and middle-aged groups for all condylar sections. A signiﬁcant
increase was also seen between middle and aged groups for all but
the medial tibial plateaus. Similar results were observed when
‘‘normal’’ knees (graded 1 and 2) were assessed.
An assessment of calciﬁcation vs gross OA grade was made and
the results are presented in Fig. 2. Signiﬁcant changes in calciﬁcation
were seen primarily between grade 1 and grade 2 condyles.
There were no statistically signiﬁcant differences observed in the
comparison between BMI and calciﬁcation or between gender and
calciﬁcation of each condyle.
Discussion and conclusion: Calciﬁcation appears to be an early
phenomenon which occurs before evidence of cartilage break-
down. The amount of calciﬁcation increases with aging of articular
cartilage, yet this increase is independent of increasing severity of
cartilage breakdown. Cartilage calciﬁcation increases with age
even in the absence of degenerative change and regardless of
BMI. This would suggest that calciﬁcation is principally an effect of
aging.
Acknowledgement: Supported by NIH Grant AG07996.
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DETRIMENTAL EFFECT OF 3 T HIGH-FIELD MAGNETIC
RESONANCE TO CHONDROCYTE ACTIVITY
I. G. Sunk, W. B. Graninger, L. Amoyo, J. S. Smolen, K. Bobacz
Department of Internal Medicine III, Division of Rheumatology,
Medical University of Vienna, Vienna, Austria
Aim of study: Today magnetic resonance imaging (MRI) is a highly
sensitive method in the diagnosis of cartilage damage; however,
the effects of high magnetic ﬂux densities on cartilage metabolism
are currently unknown. In this study we investigated the effect of a 3
T MRI device on the biosynthetic activity of articular chondrocytes.
Materials: Metacarpophalangeal joints were obtained from 15, 3-
month old calves and divided into three groups. Group 1 was left
untreated and served as control. Group 2 was exposed to a static
magnetic ﬁeld (3 T), while group 3 was subjected to a pulsed
magnetic ﬁeld (constant 3 T, additional 0.0135 T pulsed ﬁeld, pulse
rate 0.5 s) for the duration of a standard knee-joint examination.
Directly after exposure cartilage was removed from the joints and
biosynthesis of extracellular matrix macromolecules was measured
by [35S]sulfate incorporation and values were normalized to
hydroxyproline content. Furthermore, to investigate a possible
differentiation towards osteogenesis, alkaline phosphatase (ALP)
activity was determined. Chondrocyte apoptosis was assessed by
Annexin V staining and TUNEL-FITC labelling using FACS analysis
24 h after exposure.
Results: The exposure to the magnetic ﬁelds, either static or
pulsed, resulted in a signiﬁcant decrease in cartilage macromole-
cule synthesis (control (mean G S.E.M. cpm/mg hydroxyproline):
6137.1 G 446.5 vs static ﬁeld: 3865.7 G 415.6, P ! 0.002; vs
pulsed ﬁeld: 3177.8 G 256.5, P ! 0.00002). The release of
proteoglycans into the supernatant remained unchanged when
compared to controls. Annexin V staining as well as TUNEL
labelling revealed no signiﬁcant increase in the number of apoptotic
cells in the static and pulsed magnetic ﬁeld group. There was no
difference in ALP activity between the three groups.
Conclusion: Although high-ﬁeld magnetic resonance provides
a better signal-to-noise ratio with the possibility to gain higher
spatial resolution, our data demonstrate reduced matrix synthesis
by articular chondrocytes under the inﬂuence of high magnetic ﬂux
densities. The 3 T MRI may mimic mechanical stress and induce an
inadequate movement of ﬂuid and electrolytes thereby compromis-
ing chondrocyte metabolism. Whether this detrimental effect is only
temporary has to be tested in further studies.
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REVERSIBLE EFFECTS OF HYALURONAN OLIGOSACCHA-
RIDE ON THE EXPRESSION OF MATRIX METALLOPROTEI-
NASES VIA IL-1 INDEPENDENT SIGNALING PATHWAY
S. Ohno, C. B. Knudson, W. Knudson
Biochemistry, Rush Medical College, Chicago, IL, USA
Aim of study: This study was conducted to clarify the size
dependent reversible effects of hyaluronan (HA) via CD44 on the
direct induction of matrix metalloproteinase-3 and -13 (MMP-3 and -
13) in articular chondrocytes.
Methods: Primary chondrocytes extracted from bovine and human
articular cartilages were treated with 250 mg/ml HA oligosaccharide
(Haoligo) for 12 h and washed excessively by fresh medium and
cultured for more 12 h with or without 500 mg/ml high molecular
weight HA (HMW-HA). The expression levels of MMP-3 and MMP-
13 mRNAs were assessed by quantitative real time RT-PCR.
Casein zymography was performed for conditioned medium of the
cultures. To investigate whether the effects of Haoligo on MMP
induction were related to the activation of IL-1-mediated signaling
pathways, the effects of Haoligo on AP-1 promoter activity were
examined in human immortalized chondrocytes using an AP-1promoter-reporter construct. Furthermore, changes in the accumu-
lation of released IL-1B protein were examined in the conditioned
medium of human chondrocyte by Western blot analysis. To
explore the involvement of CD44 in size dependent reversible
effects of HA on MMP expressions, we also used COS-7 cell which
does not express CD44, and examined the effects of HMW-HA on
Haoligo-induced MMP-13 expression in terms of its promoter
activity as well as caseinolytic activity.
Results: The expressions of MMP-3 and MMP-13 mRNAs were up-
regulated by the treatment of 250 mg/ml of Haoligo for 12–24 h, and
caseinolytic activities were also enhanced in the conditioned
medium of the cultures. Following wash-out of Haoligo at 12 h
and subsequent incubation in the presence of HMW-HA, the
expression of MMPs were again equivalent to control levels.
Furthermore, HMW-HA also had a reductive effect on the basal
MMPs expression levels and activities in articular chondrocytes.
Promoter analysis in immortalized chondrocytes shows that there
was no change in luciferase activity of AP-1 in response to Haoligo.
Chondrocytes from 4 different human donors exhibited release and
accumulation of IL-1B in the culture medium following 24 h
incubation, however, there was no change in the level of IL-1B
present in the medium following exposure of cells to Haoligo.
COS-7 cells transfected with pCD44H construct showed a higher
response to Haoligo treatment in the caseinolytic activation and
MMP-13 promoter activation than in control COS-7 cells (trans-
fected with empty vector). However, the reductive effect of HMW-
HA on MMP-13 promoter activity was not signiﬁcantly different
between control and CD44 transfected cells.
Conclusions: Our results suggest that MMP inductions by
Haoligo were exerted partly via CD44 signal pathway, and this
signal transduction is independent of IL-1 signal pathways. Our
results also suggest that HMW-HA has an ability to abrogate
the Haoligo-induced MMP expression, however, some receptors
other than CD44 may participate in the abrogation action of
HMW-HA.
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PHENOTYPIC AND MECHANOFUNCTIONAL CHARACTERISA-
TION OF HUMAN MENISCUS AND MENISCOCYTES
L. Fairbairn, A. Anand, K. J. Elliot, S. J. Millward-Sadler,
J. F. Keating, D. M. Salter
Osteoarticular Research Group, University of Edinburgh Medical
School, Edinburgh, Scotland, United Kingdom
Aim: To characterise human meniscus and meniscal cells, allowing
comparison with human articular cartilage and providing a standard
proﬁle for meniscal tissue against which engineered replacement
tissue can be evaluated.
Methods: Immunohistochemistry was undertaken on cryostat
sections of knee joint meniscus obtained from (1) individuals
undergoing above knee amputation or partial meniscectomy for
traumatic or degenerative tears and (2) normal and osteoarthritic
(OA) human articular cartilage (HAC) from patients undergoing
above knee amputation or joint replacement. Sections were
immunostained with a panel of antibodies against cell (integrins,
CD44, CD47, CD98, CD147, NG2, galectin-3, FAK, pyk-2) and
matrix (collagens I, II, III, IV, VI, ﬁbronectin, laminin, tenascin)
associated molecules and a series of neural related peptides
identiﬁed in human chondrocytes (S100, Substance P, NK1R,
NR1). Short term monolayer cultures of enzymatically extracted
meniscal cells were mechanically stimulated at a range of
frequencies following which changes in cell membrane potential
and tyrosine phosphorylation events were assessed.
Results: Meniscus, normal and OA cartilage showed strong
expression of a1, a5, aV, aVb5 and b1 integrin, CD44, CD47,
FAK and NG2, but no or minimal immunoreactivity for a2, a3, a4, a6
or b3 integrins. Positive immunoreactivity for CD98, CD147, pyk-2
and galectin-3 was identiﬁed in all zones of normal and OA HAC
whereas meniscus was negative. Collagen I was absent from HAC
S46but present in the meniscal matrix. Collagen II stained strongly in
HAC but was almost totally absent from meniscus. Collagen III was
absent from normal HAC, positive in small areas in the matrix of OA
HAC and positive throughout the majority of the meniscal matrix.
Collagen IV was completely absent from HAC however meniscus
positive staining was seen in the vascular and peripheral regions of
the matrix. Collagen VI was strongly expressed in HAC and
meniscus. Laminin was absent from both cartilage and meniscus.
Tenascin, absent in normal cartilage was strongly expressed in
OA cartilage and meniscus. Unlike chondrocytes in normal and
OA HAC which expressed the neural associated molecules
S100, substance P, NK1R and NR1 strongly, meniscus cells
showed no or minimal expression of these molecules. Signiﬁcant
frequency dependent differences were seen in the electrophysio-
logical response of meniscal cells and HAC to mechanical
stimulation.
Conclusions: Although meniscal cells and articular chondrocytes
show similar expression of integrins there are signiﬁcant differ-
ences in expression of a range of integrin-associated molecules,
neural peptides and matrix molecules and in responses to
mechanical stimulation. The differences in phenotype will relate to
the different function of meniscal cells and tissue in joints in
comparison to articular cartilage. Intuitively, it would be expected
that engineered meniscal tissue which shows phenotypic similarity
to native tissue, would have advantages for transplantation over
phenotypically divergent material.
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IL-1b DIMINISHES INTRACELLULAR ATP PRODUCTION IN
CULTURED HUMAN NORMAL CHONDROCYTES: THE ROLE
OF FACILITATIVE GLUCOSE TRANSPORTERS
M. C. De Andresy, C. Ruizy, E. Maneiroy, A. Bonillay, B. Rodriguezz,
I. Santamarinay, J. A. Pintoy, F. Galdoy, F. J. Blancoy
y Laboratory of Investigation, Rheumatology Division, C.H.U. Juan
Canalejo, A Corun˜a, Spain
z Genetic Division, C.H.U. Juan Canalejo, A Corun˜a, Spain
Introduction: Glucose is the main source of energy for articular
cartilage and entry into the cells via facilitative glucose transporters
(GLUT/SLC2A family). It has been showed that human chondro-
cytes express mRNA from GLUT1, GLUT3, GLUT5, GLUT9,
GLUT10 and GLUT11 using cDNA libraries. Likewise, it is known
that osteoarthritis (OA) is associated with the presence of pro-
inﬂammatory cytokines such as IL-1b.
Objective: To investigate the effect of IL-1b on ATP production and
expression of GLUTs in normal and OA chondrocytes.
Methods: Human normal (n Z 13) and OA (n Z 14) cartilage was
obtained from autopsies and patients with joint replacement
surgery. Chondrocytes were grown in DMEM medium supple-
mented with penicillin 100 U/ml, streptomycin 100 mg/ml and 10%
bovine serum. Cells were maintained in DMEM medium without or
with 25 mM glucose for 24 h at 37(C in 95% air–5% CO2 and
stimulated with IL-1b 1, 5 and 10 ng/ml (n Z 10) for 24 h. Total
chondrocyte RNA was extracted by TRIzol, then RT-PCR was
carried out. PCR products were resolved in 1.5% agarose gel
electrophoresis and stained with ethidium bromide. Proteins were
resolved by SDS-polyacrylamide gel electrophoresis, transpherred
onto PVDF membranes. Blots were incubated with anti-GLUT-1
and -2 antibodies for 1 h at RT. ATP Bioluminiscence Assay to
measure intracellular ATP, and the Lowry assay to determinate
protein concentration per sample. Statistical signiﬁcance was
determined by using an U Mann Whitney.
Results: Normal and OA chondrocytes with glucose produced
a similar amount of intracellular ATP (2.2 G 0.4 and 2.4 G 0.1
nmol/mg protein). Deprivation of glucose did not modify the ATP
production (2.3 G 0.4 and 2.3 G 0.1 nmol/mg protein). However,
IL-1b produced on normal chondrocytes (but not in OA cells)
a reduction of intracellular ATP (23.3% with glucose; 42% without
glucose). Normal chondrocytes in presence or absence of glucoseexpressed mRNA from GLUT1, -3, -4. -5, -8 and -9. Stimulation of
normal cells with IL-1 reduced the expression of GLUT-8 (70%) and
GLUT-9 (60%). OA cells vs normal cells showed a reduced mRNA
expression of only GLUT-8 (15%) and -9 (30%). Stimulation of OA
cells with IL-1 did not alter the mRNA expression of any GLUT
receptors. Protein analysis in normal cells showed a lower level of
GLUT-1 and -2 than OA chondrocytes.
Conclusion: These ﬁndings suggest that normal and OA chon-
drocytes show a different pattern of expression of GLUTs.
Modulation of mRNA GLUTs expression by IL-1 and glucose is
different in OA and normal chondrocytes.
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NORMAL AND OA CHONDROCYTES HAVE DIFFERENT SEN-
SITIVITY TO APOPTOSIS. THE ROLE OF GLUCOSE AND
MITOCHONDRIAL CHAIN COMPLEX ACTIVITY
E. Maneiroy, M. C. De Andresy, A. Bonillay, J. A. Pintoz, J. Arenasz,
M. A. Martinz, F. Galdoy, F. J. Blanco Garciay
y Laboratory of Investigation, Rheumatology Division, C.H.U. Juan
Canalejo, A Corun˜a, Spain
z Laboratory of Investigation, Hospital 12 Octubre, Madrid, Spain
Introduction: OA is characterized by an increase of matrix
degradation and chondrocyte death. Recent reports show that
OA chondrocytes in culture have inhibited complexes II and III and
they are depolarizated in a greater proportion.
Objective: To assess the role of glucose and mitochondrial chain
complex (MCC) activity on the apoptosis induced on OA and
normal chondrocytes.
Methods: Human OA cartilage (nZ 22) was obtained from patients
with joint replacement surgery and human normal cartilage (n Z
55) from autopsies. Chondrocytes were incubated (37(C, 5%CO2
and 95% air) in medium with and without glucose (4.5 mM). The
activity of the MCC was measured using spectrophotometer:
Complex I (NADH deshidrogenase), Complex II (succinate de-
hydrogenase), Complex III (decylubiquinol-ferricytochrome c oxi-
doreductase), Complex IV (cytochrome c oxidase), and the
appearance of free coenzyme A (citrate synthase). We used
rotenone, NPA, antimycin A, sodium azide and oligomycin to inhibit
the different MCC. Cells were analyzed by ﬂow cytometry using
probe JC-1 to measure the MMP and PI to quantify apoptosis.
Comparisons between groups were performed using U Mann
Whitney.
Results: Depletion of glucose caused a reduction of complex II
activity (45%) in normal chondrocytes. However, depletion of
glucose in OA did not alter the MCC activity. In addition deprivation
of glucose did not cause apoptosis in both normal and OA
chondrocytes. In presence of glucose, only, oligomycin induced
apoptosis at 24 h (10.5 G 2.5). In contrast, in absence of glucose,
all mitochondrial inhibitors induced apoptosis (sodium azide 45.6G
18.3%; NPA 8.5 G 6.9%; antimycin A 9.2 G 0.2%; oligomycin
14.6G 1.5%; rotenone 12.9G 5.2%). With regard to mitochondrial
potential, in normal chondrocytes cultured with glucose, none of the
inhibitors induced mitochondrial depolarization at 24 h. However,
rotenone increased mitochondrial depolarization in medium without
glucose (30.75G 3.71). In OA chondrocytes cultured with glucose,
only oligomycin induced apoptosis (9.13 G 2.8). However, in
absence of glucose, all mitochondrial inhibitors except NPA
induced apoptosis (oligomycin 38.6 G 7.9; rotenone 34.2 G 8.32;
sodium azide 30.9 G 13.5 and antimycin 23.9 G 7.31). Regarding
mitochondrial potential, only NPA and sodium azide did not cause
mitochondrial depolarization in OA chondrocytes cultured in
presence of glucose. However, in absence of glucose, all
mitochondrial inhibitors except oligomycin did not induce mitochon-
drial depolarization.
Conclusion: Inhibition of MCC induces apoptosis in both OA and
normal chondrocytes. Glucose protects human normal chondro-
cytes from apoptotic death. OA chondrocytes are more sensitive to
undergo apoptosis induced by the inhibition of MCC.
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HIGH SHEAR STRESS INDUCES p53 EXPRESSION AND
APOPTOSIS IN CARTILAGE EXPLANTS
J. A. Martin, A. D. Heiner, J. A. Buckwalter
Orthopaedics and Rehabilitation, The University of Iowa, Iowa City,
IA, USA
Articular surface incongruities can lead to excessive mechanical
shear stress, which promotes cartilage destruction and post-
traumatic osteoarthritis (OA). Here we test the hypothesis that
excessive mechanical shear stress induces chondrocyte stress
responses that lead to apoptosis. We cultured human cartilage
explants in a mechanically active bioreactor, the Triaxial Compres-
sion Vessel (TCV), which is capable of modulating shear stress
levels. This device was used to test the effects of shear stress on
viability, p53 levels, and apoptosis.
Methods: Cartilage explants harvested from non-osteoarthritic
ankle joints from two donors were placed in the TCV for
mechanical stress treatment. The TCV imposes variable shear
stress states at physiologic levels by applying transverse com-
pression and axial compression simultaneously. The interplay
between axial and transverse compression determines shear
stress levels. In this study, two different treatments (900 cycles,
1 Hz) were applied: (1) 5 MPa axial compression only (high shear
stress), (2) 5 MPa axial C 5 MPa transverse compression
(minimal shear stress). Treated explants were incubated overnight
in calcein AM to stain viable cells, then were cryoembedded.
Cryosections were mounted in DAPI to stain cell nuclei and%
viability was determined. Replicate cryosections were stained with
an anti-p53 antibody or stained for apoptosis by TUNEL assay
and mounted with DAPI. The superﬁcial, middle, and deep zones
of the cartilage were scored. Student’s t test was used to evaluate
statistical signiﬁcance.
Results: Chondrocyte viability in the superﬁcial and transitional
zones of cartilage explants declined from 89% in low shear stress
to 62% in high shear stress. Apoptosis increased from 2.4% in
low shear stress to 16.7% in high shear stress, while p53
expression increased from 23% to 48% (Fig. 1). Differences in
viability, apoptosis and p53 expression were signiﬁcant (P! 0.05).
No signiﬁcant changes were seen in the deep zone (data not
shown).
Fig. 1. Effects of high and low shear stress on cartilage explants.
Explants were exposed to high shear stress (A–C), or low shear
stress (D–F). (A,D) Calcein AM staining for viable cells (green).
(B,E) TUNEL reaction for apoptosis (red–orange). (C,F) Immuno-
staining for p53 (black). (G) Graph summarizing staining results
(mean and S.E.M.).Discussion: Exposure to high shear stress induced chondrocyte
death via apoptosis. High shear stress also induced p53
expression, indicating a strong cell stress response. This suggests
that high shear stress causes chondrocyte depopulation that could
contribute to cartilage degeneration in post-traumatic OA.
Supported by award 5 P50 AR048939, NIH Specialized Center of
Research for Osteoarthritis.
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CHARACTERIZATION OF THE HUMAN SOX9 PROXIMAL
PROMOTER REGION
S. Piera-Velazquez, D. F. Hawkins, M. K. Whitecavage,
S. A. Jimenez, D. G. Stokes
Department of Medicine, Division of Rheumatology, Thomas
Jefferson University, Jefferson Medical School, Philadelphia, PA,
USA
Aim of the study: The aim of this study was to determine the identity
and function of the proximal promoter regulatory elements involved
in the transcriptional control of the human SOX9 gene.
Methods: Segments of the human SOX9 promoter were cloned into
luciferase-reporter vectors and subjected to transient transfection
analysis in three chondrogenic cell lines: C3H10T1/2, ATDC5 and
RCS. Speciﬁc regions of the SOX9 promoter were deleted or
mutated followed by transient transfection analysis. DNase I
footprinting and electrophoretic mobility shift assays (EMSA) were
performed to determine the speciﬁcity of putative transcription
factor binding sites within the human SOX9 proximal promoter
region for DNA-binding activities in nuclear extracts from the
chondrogenic cell lines and from primary chondrocytes.
Results: A 5#-deletion-transient transfection analysis of the human
SOX9 proximal promoter region performed in C3H10T1/2, ATDC5
and RCS cells demonstrated that a segment from 123 bp to 219
bp, relative to the transcriptional start site, was responsible for
approximately 70% of promoter activity, corroborating previously
published results. DNase I footprinting analysis of this region of the
human SOX9 proximal promoter with nuclear extracts prepared
from the chondrogenic cell lines and also from primary chondro-
cytes revealed multiple protected regions. EMSA analysis demon-
strated DNA-binding activities in nuclear extracts from the
chondrogenic cell lines and also from human chondrocytes that
bound to a CCAAT box and to CREB and Sp1 sites. Mutation of the
CREB site and deletion of the Sp1 site reduced overall promoter
activity in ATDC5 cells by 40–50%.
Conclusions: The deletion analysis performed in this work
demonstrates that a region of approximately 100 bp in the human
SOX9 promoter harbors elements responsible for transcriptional
activity. Within or near this region there are predicted binding sites
for the CCAAT binding factor, CREB and Sp1. Mutation of the
CREB site and deletion of the Sp1 site reduced overall promoter
activity, indicating that these are functional sites. These studies
support the notion that Sp1 and CREB are important for the
transcriptional activity of the human SOX9 proximal promoter
region. (Supported by NIH/NIAMS grant AR039740.)
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CYCLIC CARTILAGE STRESS ELEVATIONS IN DYSPLASTIC
HIPS
D. R. Pederseny, K. H. Shivannaz, M. E. Russellz, N. M. Groslandyz
y Department of Orthopaedic Surgery and Rehabilitation, University
of Iowa, Iowa City, IA, USA
z Department of Biomedical Engineering, University of Iowa, Iowa
City, IA, USA
In the absence of trauma or surgical intervention, patients afﬂicted
with developmental dysplasia of the hip (DDH) tend to develop
S48osteoarthritis (OA) much earlier than the population norm. Over
a lifetime, chronic accumulation of locally elevated cartilage stress
exposure may mechanically trigger biologic pathways leading to OA.
Methods: We assembled 3-d nonlinear contact ﬁnite element (FE)
models of hip articulations from CT arthrograms. These voxel-
based, patient-speciﬁc, deformable-body models included the ‘stiff
membrane’ effects of an acetabular dome redirecting loads to the
lateral pelvic wing, thus retaining some subchondral bone
compliance likely present in deformed head on insufﬁcient
acetabulum articulations. The acetabulum and femoral head were
represented by 1 mm thick subchondral bone (E Z 2 GPa, n Z
0.3). Articular cartilage (EZ 12 MPa, nZ 0.42) extended from the
bone surfaces to the contrast ﬁlled joint space. Whole-gait-cycle
kinematics and kinetics were applied through the femoral head
center, at 0.04 ms intervals from heel-strike through toe-off and
swing phase. Articular cartilage stresses were reported during 32
increments of level walking. We also constructed a normal hip
model from the Visible Human Male.
Unique articular geometry compounded by dysplastic incongruities
necessitated meshing adaptability at a feature level, both to account
for surface topography and tomaintain suitable FE aspect ratios. The
acetabular cartilage horseshoe was ‘unfurled’ onto a 2-d surface,
seeded with regular quadrilateral elements of increasing reﬁnement
toward the acetabular rim, and remapped onto the acetabular dome.
Cartilage surfaces were smoothed to an unloaded ellipsoidal
shape, which described variable cartilage thickness over regional
subchondral bone irregularities consistent with histologic sections.
Results: Cartilage contact stresses did not exceed 2 MPa in the
congruous normal hip. Cyclic cartilage stresses approached 3 MPa
in a mildly dysplastic hip. Random bony incongruities elevated local
cartilage stresses beyond 5 MPa in more severely dysplastic hips
during some portions of the gait cycle. Articular cartilage stresses
rise in response to femoral bumps entering the acetabulum.
Discussion: From closed reduction in early infancy, we have
tracked hip development for more than four decades, providing
a natural history relationship between chronic cartilage stress
elevation and the development of OA, in actual human joints,
without surgical intervention.
This approach to modeling articular cartilage stresses enables the
move beyond typical snapshot FE analyses for two reasons.
Activities of daily living, such as normal level walking, provide
a dynamic view of changes in cartilage stresses as femoral and
acetabular bone incongruities move past each other. Additionally,
complete clinical histories enable single duty cycles to be combined
into each patient’s lifetime experience.
These new specially tailored tools provide the means to calculate
patient-speciﬁc cyclic stress elevations associated with moving
bony incongruities, measure chronic stress accumulations, and
compare them with individual patient’s OA histories.
Acknowledgements: Whitaker Foundation.
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THE ROLE OF THE PROTEOLYTIC ENZYME, CATHEPSIN B, IN
ARTICULAR CARTILAGE DEGRADATION FOLLOWING AN
IMPACT LOAD
J. E. Jeffrey, L. L. M. Li, R. M. Aspden
Department of Orthopaedic Surgery, University of Aberdeen,
Aberdeen, Scotland, United Kingdom
Aim of study: Joint impact injuries are known to increase the risk of
development of secondary osteoarthritis (OA). Cathepsin B is
a lysosomal cysteine protease which has potent matrix degrading
properties. Elevated levels of this enzyme have been found in both
cartilage and synovial ﬂuid of affected joints of patients with OA.
Our aim was to establish if cathepsin B is released following an
impact injury and whether inhibitors could prevent the enzyme’s
destructive activity. We studied cystatin C, a natural extracellular
inhibitor of cathepsin B found in many body tissues including
cartilage, and Ca-074Me, which is an intracellular inhibitor of
cathepsin B.Methods: Circular explants (5 mm diameter) were removed from the
underlying subchondral bone of human femoral heads (n Z 9)
using a cork borer and scalpel and cultured for 24 h. The explants
were then subjected to a single impact load using a 500 g mass
dropped from a height of 25 mm in a drop tower. The duration of
each impact was approximately 3 ms with an energy of 0.013 J.
Following impact, the loaded explants were cultured along with
unloaded controls, for 1, 3, 6, 9 or 15 days, in the presence of
selective cathepsin B inhibitors Ca-074Me (10–500 mM) or human
cystatin C (1–7.5 mg/ml). Explants were then removed, frozen in
liquid nitrogen and stored with their culture medium at 20(C.
Cathepsin B (both the pro and mature forms of the enzyme) and
cystatin C concentrations were measured in the explant culture
medium following impact using ELISA. The concentration of
glycosaminoglycans (GAGs), a measure of cartilage breakdown,
was determined in the culture medium using the dimethylmethylene
blue (DMMB) assay. Apoptotic cell death was evaluated in cartilage
sections using the TUNEL method.
Results: Cathepsin B levels were increased in the medium of
loaded explants at all time points and reached signiﬁcance at Day 6
(P Z 0.031) and Day 9 (P Z 0.024) for the proenzyme and Day 1
(PZ 0.001) for the mature enzyme. Culturing loaded explants for 6
days in the presence of Ca-074Me (500 mM), reduced the levels of
procathepsin B released by 94% (P ! 0.001) but did not reduce
GAG release. No increase in endogenous cystatin C was found in
the medium following loading. Addition of human cystatin C to the
culture medium lowered the levels of GAGs released from both
impacted and non-impacted explants at 3 days (P Z 0.024) and 6
days (PZ 0.013) post load but did not signiﬁcantly reduce the level
of procathepsin B in the medium in loaded explants. Neither Ca-
074Me nor cystatin C had any effect on reducing cellular apoptosis
in the loaded explants.
Conclusions: In this study, both active and pro-forms of cathepsin B
have been shown to be released following impact loading of
articular cartilage in vitro. Speciﬁc intracellular inhibition does not
prevent tissue breakdown whereas possibilities may exist for
extracellular inactivation and hence to slow down the development
of secondary osteoarthritis.
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VALIDATION OF AN IN VITROMODEL FOR THE INITIATION OF
OSTEOARTHRITIS FOLLOWING IMPACT
C. A. M. Huser, M. E. D. Davis
Clinical Veterinary Medicine, University of Cambridge, Cambridge,
Cambridgeshire, United Kingdom
Aim: The goal was to develop and validate paradigms of
experimental cartilage injury in vitro that model the molecular
processes involved in the initiation of osteoarthritis in vivo.
Methods: Full depth articular cartilage discs (7 mm diam.) were
obtained from the scapulohumeral joints (shoulder) of four healthy
horses and two affected with OA. Discs were subjected to a single
impact load of 500 g dropped from a height of 2.5 cm (0.175 J or
w8 MPa at 0.7 m/s) using a simple drop tower device. Unimpacted
cartilage discs from the same site served as controls. Cartilage
discs were then maintained in culture in sterile DMEM with 50 ml/ml
ascorbic acid at 37(C, 5% CO2 and 95% relative humidity for 0 to
30 days. Discs were removed from culture and processed for
histological and immunohistochemical assessment. Scoring scales
were developed, and each disc was assessed for cartilage
morphology and proteoglycan depletion, as well as cell death,
proliferation and cluster formation. In addition, changes in
collagens, ﬁbronectin and bFGF levels were compared to cartilage
obtained from the osteoarthritic joints. Experiments were repeated
at least three times for each horse, and results were compared
using unpaired Student’s t test.
Results
(i) A single impact creates cartilage damage similar to OA. When
compared, the scores of impacted and OA cartilage were not found
to be statistically different.
S49(ii) Culture induced progressive proteoglycan depletion, starting
from the articular surface. However, unlike reported in the
hock (tibiotarsal joint), proteoglycan depletion is not increased by
impact.
(iii) Culture post-impact induced OA-like changes, including in-
creased ﬁbrillation, cell death and ﬁbronectin expression at the sites
of damage. Some chondrocyte cluster formation and attempted
repair was also observed, although to a lesser extent than seen in
the hock.
Discussion: This study is the ﬁrst to directly compare results
from controlled, deﬁned loading and osteoarthritic cartilage. The
single impact model induced similar cartilage responses to those
seen in osteoarthritic cartilage from the same joint. However,
these were different from those reported in the hock, illustrating
the heterogeneic nature of articular cartilage. This study validates
the suitability of the single impact model in research
targeting molecular mechanisms and therapeutics of OA. It also
highlighted a different response to loading and injury in different
joints.
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NEW ANIMAL EXPLANT MODEL OF CARTILAGE DEGRADA-
TION IN OSTEOARTHRITIS
M. Ates, K. A. Rudolphi, M. Michaelis, H. Guehring
Disease Group Thrombosis/Osteoarthritis, Aventis Pharma Ger-
many, Frankfurt/Main, Germany
Aim: Before the experimental proof of concept in animal models of
osteoarthritis (OA), IL-1-stimulated explants from human articular
cartilage or explants from osteoarthritic human cartilage are often
used as secondary in vitro assays in the development of disease-
modifying drugs. These experiments frequently give highly variable
results because of the heterogenous quality of the explanted tissue.
Because it is technically very difﬁcult to obtain articular cartilage
explants from small rodents and rabbits we developed an
alternative assay using explants from mouse or rabbit Processus
xyphoideus.
Methods: Cartilage explants from the Processus xyphoideus of
rabbits and mice were transected and transferred into medium
(DMEM, 1% BSA). For compound testing the following time
schedule was used: 15 min pre-incubation with compounds, IL-
1beta (rabbit: 10 ng/ml, mice: 1 ng/ml) stimulation and termination
after 24 h. Aliquots of medium were analyzed by gelatin
zymography in 0.1% gelatin–8% acrylamide gels with subsequent
quantitative digital image analysis of the bands, and by measuring
the amount of released glycosaminoglycans (GAGs) in the medium
by photometry with dimethylene blue.
Results: In the xyphoid explants IL-1b concentration dependently
stimulated the proteolytic activity of Maxtrix Metallo Proteases-2, 9
and 13 (Pearson correlation r Z 0.8765; P ! 0.05) and enhanced
the GAG release (Pearson correlation r Z 0.826; P ! 0.05), as
shown for the mouse explants (see Table I; data shown as MeanG
S.E.M.; n Z 4/group). In rabbit xyphoid explants Ro 113–0830,
a broad spectrum matrix metalloproteinase inhibitor was able to
reduce the GAG release concentration dependently (IC50: 0.7 mM)
by lowering the activity of MMPs in the zymography. In contrast,
AVE1627 (a speciﬁc inhibitor of IkappaB kinase) decreased
the GAG release (IC50: 0.4 mM) by reducing the expression
of MMPs.Conclusions: These results suggest that the IL-1 beta-stimulated
Processus xyphoideus explants is a suitable in vitro test system for
compounds targeting cartilage breakdown.
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AGING-ASSOCIATED CHANGES IN BETA-ACTIN EXPRES-
SION IN CHONDROCYTES
K. Kuhn, M. Lotz
Division of Arthritis Research, The Scripps Research Institute, San
Diego, CA, USA
Aims: Cartilage aging is associated with changes in chondrocyte
biosynthetic functions, cell proliferation and survival. This study
analyzes protein expression proﬁles in chondrocytes to identify
mechanisms of chondrocyte aging.
Methods and results: Articular cartilage was obtained from knees of
young and old human tissue donors. Total cellular protein extracts
were prepared from ﬁrst passage monolayer cultures of chondro-
cytes. Proteins were analyzed by 2-D gel electrophoresis followed
by Sypro Ruby staining. Proteins showing differential expression in
young vs old donors were isolated and identiﬁed by LC-MS/MS.
b-actin was among the proteins with the largest aging-related
differences. Reduced levels of b-actin in chondrocytes from old
donors were conﬁrmed by Western blot analysis of additional cell
preparations. b-actin mRNA levels did not show aging-associated
differences.
Previous studies demonstrated aging-associated changes in the
chondrocyte response to growth factors such as TGFb. Stimulation
of cultured chondrocytes with TGFb increased b-actin expression
but under all conditions protein levels remained lower in cells from
older donors.
The microﬁlament-disrupting drugs cytochalasin B and jasplakino-
lide altered cell shape and led to disruption of stress ﬁbers in
cultured chondrocytes. These drugs induced low levels of cell
death and enhanced CD95-mediated chondrocyte apoptosis with
signiﬁcantly higher levels of apoptosis induction in chondrocytes
from older donors.
Conclusions: Chondrocyte expression of monomeric b-actin is
reduced in cartilage aging and is related to posttranscriptional
rather than differences in gene transcription. These differences in
chondrocyte microﬁlament organization can contribute to aging-
dependent changes in chondrocyte function and survival.
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TRANSFORMING GROWTH FACTOR-b SUPPRESSES NITRIC
OXIDE PRODUCTION IN MURINE H4 CHONDROCYTES BY
ENHANCING DEGRADATION OF INDUCIBLE NITRIC OXIDE
SYNTHASE PROTEIN
K. Vuolteenahoyz, T. Moilanenyx, R. Nieminenyz, E. Moilanenyz
y The Immunopharmacological Research Group, Medical School,
University of Tampere, Tampere, Finland
z Tampere University Hospital, Tampere, Finland
x Coxa, Hospital for Joint Replacement, Tampere, Finland
Nitric oxide (NO) is induced by proinﬂammatory cytokines IL-1 and
TNF-a in osteoarthritic (OA) cartilage and it partly mediates the
destructive effects of these cytokines. Along with proinﬂammatoryIL-1-stimulated GAG release and MMP activation
IL-1ß Naive 0.1 ng/ml 1 ng/ml 10 ng/ml Readout
GAG 17.2 G 2.4 30.5 G 3.7 47.3 G 13.6 93.0 G 12.3 mg/ml
MMP-2 2911.4 G 225.5 3126.1 G 184.5 5083.8 G 314.1 6707.4 G 437.3 Pixel intensity
MMP-9 29.9 G 6.5 42.8 G 5.8 128.9 G 13.8 1505.7 G 91.2 Pixel intensity
MMP-13 29.7 G 4.1 69.7 G 8.6 115.3 G 7.0 178.4 G 16.1 Pixel intensity
S50cytokines, anabolic and anti-inﬂammatory cytokine transforming
growth factor-b (TGF-b) is found in elevated levels in synovial ﬂuid
from OA patients. In the present study we investigated the effect
of TGF-b on IL-1b-induced NO production in H4 chondrocytes1
in vitro.
Results: TGF-b 1–3 (0.1–10 ng/ml) inhibited IL-1b-induced iNOS
protein expression and NO production in a concentration de-
pendent manner in murine H4 chondrocytes.
Real-time PCR was used to study the effect of TGF-b on iNOS
mRNA expression. In H4 chondrocytes IL-1b induced transient
iNOS mRNA expression, which peaked at 4 h. TGF-b 1–3 (10 ng/
ml) did not have any effect on IL-1b-induced iNOS mRNA levels
when measured 3 and 6 h after addition of IL-1b.
IL-b induced transient iNOS protein expression, which was at it’s
highest between 6 to 18 h after addition of IL-1b into the culture.
When measured 8 h after addition of IL-1b, iNOS protein levels
were similar in IL-1b- and IL-1b C TGF-b-treated cells. Whereas
at 12 and 24 h after addition of the cytokines, iNOS protein
levels were 50% and 80% lower in IL-1b C TGF-b- than in
IL-1b-treated cells. These results suggest that TGF-b enhances
the degradation of iNOS protein in chondrocytes exposed to
IL-1b.
Conclusion: TGF-b suppressed IL-1b-induced iNOS expression
and NO production in chondrocytes, probably by enhancing iNOS
protein degradation.
1Murine H4 chondrocyte cell line was kindly provided by Dr van
Beuningen from Laboratory of Experimental Rheumatology, Uni-
versity Medical Center Nijmegen, Netherlands.
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MECHANICAL TRAUMA RESULTS IN CHONDROCYTE CYTO-
SKELETAL DISRUPTION THAT CAN BE PREVENTED BY
CASPASE INHIBITION
D. D. D’Limayz, M. Lotzy
y Division of Arthritis Research, The Scripps Research Institute, La
Jolla, CA, USA
z Division of Orthopaedic Surgery, Scripps Clinic, La Jolla,
CA, USA
Aims: Mechanical injury induces chondrocyte apoptosis (pro-
grammed cell death) in which DNA fragmentation is mediated by
caspases. This study explores the effect of mechanical injury on the
cytoskeleton.
Methods: Chondrocyte/agarose gel constructs were subjected to
injury compression (40% strain) and cultured for varying intervals
up to 72 h after injury. Apoptosis was measured using TUNEL, and
detecting PARP cleavage. Correlation of apoptosis and changes in
actin organization was examined by dual staining with TUNEL and
FITC-labeled phalloidin. Constructs were also treated with caspase
inhibitors: pan-caspase inhibitor, caspase-3, -8, -9 inhibitors and
their combinations. The effect of caspase inhibition on prevention of
F-actin disruption was documented using three-dimensional con-
focal microscopy.
Results: The highest rates of apoptosis were seen 48 h after injury.
Actin ﬁlaments in uninjured chondrocytes had a more punctate
appearance. Actin ﬁlaments became more diffuse with time in
injured chondrocytes before ﬁnally disappearing, as the nuclei
became TUNEL positive. The number of TUNEL-positive chon-
drocytes was signiﬁcantly reduced by pan-caspase inhibitor z-
VAD.fmk, as well as by caspase-3, -8, and -9 inhibitors. Combined
caspase-3 and caspase-8 inhibition was most effective in reducing
apoptosis. The disruption of F-actin coincided with DNA frag-
mentation and was prevented by administration of caspase
inhibitors.
Conclusions: The results of this study indicate a caspase-mediated
cleavage of actin after mechanical injury. Caspase inhibition
appeared to prevent disruption of the cytoskeleton and concomitant
apoptosis. This opens potential for novel therapeutic approaches in
the prevention and treatment of cartilage trauma.P119
RESVERATROL EXERTS SALUTARY EFFECTS ON CARTI-
LAGE METABOLISM: A FRENCH PARADOX FOR OSTEOAR-
THRITIS?
M. N. Dave, M. G. Attur, J. N. Patel, S. B. Abramson
Division of Rheumatology, Department of Medicine, NYU-Hospital
for Joint Diseases, New York, NY, USA
Introduction: Red wine has been credited with protecting the
French from heart disease, which, given the rich food of their diet,
has been termed the French Paradox. Resveratrol, a polyphenolic
hydroxystilbene with anti-oxidant properties, is the proposed
active moiety. In mice, resveratrol has anti-carcinogenic and
anti-aging properties. In these studies we examined the effects of
resveratrol on the catabolic phenotype of human osteoarthritis
chondrocytes.
Methods: Nitric oxide and PGE2 production in human cartilage and
chondrocytes culture supernatants were estimated by the Greiss
assay and RIA, respectively. LTB4 released in culture supernatant
was estimated by ELISA. Proteoglycan synthesis in OA cartilage
was measured as 35S incorporation.
Results: We have demonstrated that OA chondrocytes spontane-
ously produce products of both the cyclooxygenase (predominantly
PGE2) and lipoxygenase (LTB4) pathways. We have also recently
shown that PGE2 and LTB4 independently inhibit proteoglycan
synthesis, and enhance the inhibition of proteoglycan synthesis
observed after exposure to IL-1. Resveratrol (10 mM) inhibited both
spontaneous (w15 ng/g cartilage) and IL-1 induced (w380 ng/g)
production of PGE2 by OA cartilage explants, reducing levels by
O50% and O90%, respectively. Similarly, resveratrol (10 mM)
signiﬁcantly inhibited both spontaneous (0.71 ng/g cartilage) and
IL-1 induced (2.8 ng/g cartilage) LTB4 production by O50% in OA
cartilage. The inhibition of PGE2 by resveratrol was not stimulus
dependent (i.e., comparable inhibition of IL-1b, LPS and TNFa);
resveratrol had no effect on nitrite production. Similar effects of
resveratrol were also observed in primary cultures of human
chondrocytes exposed to IL-1, where the IC50 for PGE2 and LTB4
inhibition was !10 mM. The addition of resveratrol (10 mM) to OA
explant cultures signiﬁcantly enhanced proteoglycan synthesis
(144% control). The addition of IL-1 signiﬁcantly inhibited pro-
teoglycan synthesis by OA explants (72% control); this IL-1 effect
was reversed by resveratrol (10 mM).
Conclusion: Resveratrol reduces eicosanoid production and en-
hances proteoglycan synthesis in OA cartilage. Red wine and
resveratrol may therefore have disease modifying properties in
osteoarthritis.
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PRODUCTION AND CATABOLIC EFFECT OF 4-HYDROXYNO-
NENAL IN OSTEOARTHRITIC CARTILAGE
B. Morquette, Q. Shi, P. Lavigne, J. C. Fernandes, M. Benderdour
Orthopaedics, Orthopaedics Research Laboratory, Sacre-Coeur
Hospital, Montreal, QC, Canada
Objective: To investigate the role of peroxidation end product,
4-hydroxynonenal (HNE), in the osteoarthritic cartilage (OA)
degradation.
Methods: Total HNE/protein adducts were quantiﬁed in synovial
ﬂuids or in cellular extracts of chondrocytes using a house Elisa.
OA cartilage and chondrocytes were incubated in the presence of
free radicals generators (H2O2, SIN) or HNE. The formation of
HNE/type II collagen adduct was analysed by immunoprecipitation.
Type II collagen synthesis was analysed by Western blotting. MMP-
13 activity and synthesis as well as TIMP-1 synthesis were mea-
sured by commercial kits.
Results: Our data show that the level of HNE/protein adducts
markedly increased in (1) OA synovial ﬂuids compared to normal
subjects and in (2) cellular extracts of OA chondrocytes treated with
S51H2O2 or SIN compared to untreated cells. Using an immunopre-
cipitation approach, we demonstrated the formation of HNE/type II
collagen adduct in OA cartilage and it’s increased level in the
presence H2O2 or SIN. Furthermore, we ﬁnd that HNE induces
MMP-13 activity and synthesis in a dose-dependent manner, but in
contrast, inhibits type II collagen and TIMP-1 synthesis. Interest-
ingly, HNE was proved to exert a dual effect in vitro, activating
proMMP-13 at low molar ratio (MR 100:1) and inhibiting active
MMP-13 at high molar ratio (MR O 1000:1).
Conclusion: The data generated in this study support the
hypothesis that HNE plays a dual role in OA cartilage degradation.
At posttranscriptional level, HNE promotes modiﬁcations of type II
collagen and MMP-13 by adducts formation. At transcriptional level,
HNE inhibits type II collagen and TIMP-1 synthesis, and induces
MMP-13 activity and synthesis.
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COXIBS (ROFECOXIB AND CELECOXIB) HAVE DIFFERENT
BIOLOGICAL EFFECTS ON HUMAN OA CHONDROCYTES
M. J. Lopez-Armaday, E. Maneiroy, M. C. De Andresy, A. Bonillay,
B. Caramesy, C. Ruizy, M. Lires-Deany, B. Cillero-Pastory,
I. Fuentes-Boquetez, F. Galdoy, F. J. Blanco-Garciay
y Laboratory of Investigation, Rheumatology Division, C.H.U. Juan
Canalejo, A Corun˜a, Spain
z Department of Medicine, University of A Corun˜a, A Corun˜a,
Spain
Introduction: Cyclooxygenase inhibitors are used widely in the
treatment of inﬂammatory arthropathies and represent the major
pharmacological intervention in OA. The anti-inﬂammatory effect of
classical NSAID may be related to inhibitory effect on IL-1, NO or
IL-1 Ra. The effect of COXIBs on this pro-inﬂammatory mediators is
unknown.
Aim: To study the effect of COXIBs (celecoxib and rofecoxib) on
NO, PGE2, IL-1 and IL-1 Ra synthesis in human OA chondrocytes.
Material and methods: OA cartilage samples were obtained from
autopsy and prosthetic-joint surgery. Chondrocytes were isolated
and cultured until used. Cells were placed into a well (250,000 cells
in a 24 well plate) with 0.5 ml of medium and incubated for 144 h
with three different stimuli: IL-1 (5 ng/ml), TNF-a (10 ng/ml), LPS
(100 mg/ml). Both COXIBs (rofecoxib 0.1; 1 and 10 mg/ml and
celecoxib, 1, 10 and 30 mg/ml) were added simultaneously to each
different concentration of stimuli. IL-1 Ra and IL-1 were measured
in supernatant by ELISA (R&D). Nitrites were quantiﬁed by the
Griess reaction and PGE2 level was measured by EIA (Amer-
sham).
Results: As expected both COXIBs at concentrations used inhibited
the PGE2 production on IL-1b stimulated chondrocytes. The results
did not show signiﬁcant differences between them. None of the
COXIBs studied modiﬁed the basal levels of NO. However both
COXIBs, celecoxib (30 mg/ml and rofecoxib 10 mg/ml, inhibited the
production of NO induced by IL-1 by 62% and 20%, respectively.
OA chondrocytes synthesise high levels of IL-1 Ra (108.5 G 6.5
pg/ml). None of the COXIBs tested were able to signiﬁcantly modify
the basal levels of IL-1 Ra produced by OA cells. In contrast,
the combination of IL-1 with rofecoxib or celecoxib caused around
30 fold increases in the basal production of IL-1 Ra. In addition,
combination of TNF-a with rofecoxib or celecoxib caused 15 fold
increase in the basal production of IL-1 Ra. The basal production
of IL-1 by human chondrocytes is very poor (0.12 G 0.21 pg/ml).
However, stimulation with LPS produces a signiﬁcant increase
of the IL-1 synthesis (18.81 G 2.2 pg/ml). None of COXIBs
tested were able to modify the basal levels of IL-1 produced by
OA cells. In contrast, only celecoxib (30 mg/ml) caused a signi-
ﬁcant decrement in the production of IL-1 induced by LPS (5.72 G
3.1 pg/ml).
Conclusion: In human OA chondrocytes, COXIBs are able to
inhibit PGE2, NO and IL-1 synthesis. In addition they increase
the production of IL-1 Ra induced by IL-1. Rofecoxib and celecoxib
show a different proﬁle of biological effect on OA chondrocytes.P122
OSTEOARTHRITIS AND CALCIUM PYROPHOSPHATE DIHY-
DRATE CRYSTAL ARTHROPATHY
K. P. H. Pritzker, P. So
Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto,
ON, Canada
Aim of study: To understand relationship of osteoarthritis to calcium
pyrophosphate dihydrate crystal arthropathy (CPPD) in surgically
removed knee joint tissues.
Methods: Using standard histologic methods, we examined 305
knee joints removed at arthroplasty for arthritis. In each case,
standard samples were taken of synovium, meniscus, femoral
condyle and tibial plateau for histopathology examination. CPPD
crystals were identiﬁed by characteristic positive birefringence
using compensated polarized light microscopy on undecalciﬁed,
unstained 5 mm sections.
Results: We found 149 cases with histologic criteria of osteoarthritis
without crystal deposition (47 males, 102 females; age M Z 70.4
years, F Z 69.3 years). CPPD crystals were found in 79 cases
(MZ 36; FZ 43, mean ageZ M 72.5 years, F 73.3 years). CPPD
crystals were found in 37 cases of degenerative arthritis (primary
CPPD) which did not meet histologic criteria for osteoarthritis. Of
these cases, in three patients CPPD crystals appeared in meniscus
only, whereas 34 cases (92%) involved meniscus and hyaline
cartilage. Fourteen of these patients (41%) had CPPD deposits in
synovium. CPPD crystal deposition and osteoarthritis occurred
together in 42 patients. All 42 patients had CPPD crystals involving
the meniscus. Five of these patients (11%) had synovial CPPD
deposition as well. Only two patients had involvement of both
meniscus and hyaline cartilage. No patients were found in either
osteoarthritis or the primary CPPD groups who had hyaline
cartilage CPPD without meniscal CPPD.
Conclusions: This data indicates that in CPPD crystal arthropathy,
meniscal ﬁbrocartilage is an early or preferential CPPD tissue
deposition site compared to hyaline articular cartilage or synovium.
In this aged population of patients with advanced osteoarthritis,
meniscal CPPD crystal deposition was found as commonly (21%)
as that reported in aged populations without clinical osteoarthritis.
Synovial CPPD deposition was seen less much frequently in
osteoarthritis than primary CPPD. This may reﬂect the pyrophos-
phatase activity present in osteoarthritic synovium. The observation
that CPPD crystals are very rarely found in hyaline cartilage (2 of
191) or synovium (5 of 191) of patients with osteoarthritis is further
evidence that CPPD crystal deposition arthropathy affecting hyaline
cartilage is a different disease process from osteoarthritis.
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EFFECTS OF INTERLEUKIN-1 BETA AND DEXAMETHASONE
ON THE EXPRESSION BY CHONDROCYTES OF ANTIOXI-
DANT ENZYMES
M. Mathy-Harterty, P. Devely, C. Sanchezy, M. Debergy, G. Deby-
Dupontz, Y. E. Henrotiny
y Bone and Cartilage Research Unit, University of Liege, Liege,
Belgium
z Center of Oxygen Research and Development, University of
Liege, Liege, Belgium
Aim of study: This work was designed to assess the effects of
interleukin (IL)-1b and dexamethasone (Dex) on the expression by
chondrocytes of the genes coding for copper–zinc (Cu/Zn)
superoxide dismutase (SOD), manganese (Mn) SOD, glutathione
peroxidase (GPX) and catalase (CAT).
Methods: Primary bovine chondrocytes in monolayer were cultured
for 24 h in the absence or in the presence of Dex (108 to 106 M)
and with or without IL-1b (1011 to 109 M). Cu/Zn SOD, Mn SOD,
GPX and CAT gene expression was quantiﬁed by reverse
transcription of mRNA followed by real time and quantitative
polymerase chain reaction.
S52Results: At 109 M, IL-1b decreased CAT, Cu/Zn SOD and Mn
SOD gene expression by 55, 77 and 49%, respectively. In contrast,
IL-1b did not modify GPX gene expression. Dex signiﬁcantly and
dose-dependently increased Mn SOD gene expression (0.01 P !
0.001) but had no effect on Cu/Zn SOD, CAT and GPX mRNA
levels. Further, Dex did not modify the IL-1b inhibitory effect on
CAT, Cu/Zn SOD and MnSOD.
Conclusion: This work shows that IL-1b down-regulates the
expression of genes coding for antioxidant enzymes indicating that
IL-1b contributes to decrease the cellular antioxidant defences. By
this way, IL-1b could promote the appearance of an oxidative stress
into the cells and consequently metabolic dysfunction. In contrast,
Dex increases SOD expression. By this way, Dex enhances the
antioxidant level into chondrocyte and then, reinforces the cellular
defences against the oxidative stress.
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MECHANOTRANSDUCTION VIA IL4 IN HUMAN ARTICULAR
CHONDROCYTES IS BY A STAT6-INDEPENDENT PATHWAY
S. J. Millward-Sadler, N. S. Khan, M. O. Wright, D. M. Salter
Osteoarticular Research Group, University of Edinburgh Medical
School, Edinburgh, Scotland, United Kingdom
Aim: To investigate the expression of STAT proteins in cultured
human articular chondrocytes, and assess the role of STAT6 in the
IL4-mediated mechanotransduction pathway.
Methods: Chondrocytes, extracted from macroscopically normal
and osteoarthritic human articular cartilage obtained from knee
joints following amputation, were grown in monolayer culture.
Whole cell lysates were subjected to SDS-PAGE, immunoblotted,
and probed with antibodies to STATs1-3, 5 and 6. Cells were
mechanically stimulated or stimulated by the addition of recombi-
nant human IL4 and protein was extracted at 1, 5, 10, 20 or 60 min
post-stimulation. Equal amounts of protein were subjected to SDS-
PAGE and probed for phospho-STAT6. Blots were stripped and
reprobed with total STAT6 antibodies.
Results: Human articular chondrocytes express STATs 1, 2, 3, 5
and 6 in culture, with no difference in expression between normal
and osteoarthritic cells. Following mechanical stimulation there is
no evidence of phosphorylation of STAT6 at any of the time points
examined. Stimulation of both normal and osteoarthritic chondro-
cytes with recombinant IL4 led to phosphorylation of STAT6 within
5 min of stimulation, with a peak in phosphorylation at 10 min in
normal cells, 20 min in osteoarthritic chondrocytes.
Conclusion: Both normal and osteoarthritic chondrocytes express
all STAT proteins in culture. Phosphorylation of STAT6, the IL4-
dependent STAT, could be induced by the addition of recombinant
IL4 to cells, but not following mechanical stimulation. This suggests
that chondrocyte mechanotransduction, which is mediated by IL4,
is a STAT6-independent pathway.
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MORPHOLOGY OF THE ANULUS FIBROSUS IN THE CERVI-
CAL INTERVERTEBRAL DISC
C. Poudersy, E. Barbaixy, M. De Maeseneerz, P. van Royy,
J. P. Clarysy
y Experimental anatomy, Vrije Universiteit Brussel, Brussels,
Brussels, Belgium
z Radiology, Vrije Universiteit Brussel, Brussels, Brussels, Belgium
Aim of study: To either conﬁrm or challenge the cervical disc model
proposed by Mercer and Bogduk regarding the discontinuation of
the anulus ﬁbrosus ﬁbers surrounding the nucleus pulposus. In
their model the anulus ﬁbrosus consists of a crescentic mass of
collagen which is thick anteriorly, tapering laterally toward theuncinate processes and reduced posteriorly to a thin layer of
paramedian, vertically orientated ﬁbers.
Methods: Whole cervical spinal columns were dissected out from
six human adult embalmed cadavers. The soft tissues, spinous
processes and posterior arches were removed. The specimens
were decalciﬁed and transverse sections were cut from levels C2-
C3 to C7-T1. Each level was cut into at least three transverse
sections: above and below the respective endplates and through
the middle of the disc. Sections with an intact IVD and clear anulus
ﬁbrosus were studied through a dissection microscope. A total of 27
discs were included.
Results: In most of the sections the anterior aspect of the annulus
ﬁbrosus was thicker than the posterior aspect. The posterolateral
ﬁbers were absent in only 11 out of 27 discs. In 10 discs we found
the outer ﬁbers of the anulus ﬁbrosus to taper laterally toward the
uncinate processes, whereas the inner ﬁbers of the anulus ﬁbrosus
curved posteriorly to complete the anular ring. In the remaining 6
discs degenerative signs prevented visualisation of the complete
ring, though the posterolateral anulus ﬁbers were clearly visible.
The presence of posterolateral anulus ﬁbers depended on the
height of the section in relation to the position of the uncinate
processes. The continuous lamellae were observed in the sections
below the tip of the uncinate processes.
Conclusions: We conﬁrm that the anulus ﬁbrosus is generally
thicker anteriorly than posteriorly and that the outer lamellae attach
to the anterior rim of the uncinate processes. However, we do not
agree that the anulus ﬁbrosus is always completely interrupted
posterolaterally: in sections below the tip of the uncinate processes,
the inner layer of the anulus ﬁbrosus may completely surround the
nuclear core.
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THE EFFECT OF PULSED ELECTROMAGNETIC FIELDS ON
PROTEOGLYCAN BIOSYNTHESIS OF ARTICULAR CARTI-
LAGE IS AGE-DEPENDENT
K. Bobacz, W. B. Graninger, L. Amoyo, J. S. Smolen
Department of Internal Medicine III, Division of Rheumatology,
Medical University of Vienna, Vienna, Austria
Aim of study: To investigate the effects of a pulsed electromagnetic
ﬁeld (EMF) on articular cartilage matrix biosynthesis with regard to
age and cartilage damage using a matrix-depleted cartilage explant
model.
Methods: Cartilage explants were obtained from metacarpopha-
langeal joints of calves and adult cows. After depletion of the
extracellular matrix by trypsin digestion, the samples were
maintained in serum-free basal medium with and without the
addition of chondroitin-sulphate or interleukin-1b. One half of the
samples was subjected to an EMF for 24 min daily, while the other
half was left untreated. Undigested, untreated explants served as
negative controls. After 7 days the biosynthesis of matrix macro-
molecules was assessed by 35[S]sulfate incorporation and values
were normalized to hydroxyproline content.
Results: The exposure to the EMF lead to an increase in matrix
macromolecule synthesis in the undigested, untreated explants
derived from both young and adult animals (P ! 0.009). In the
matrix-depleted samples the EMF had no stimulatory effect on
proteoglycan biosynthesis. While IL-1b signiﬁcantly decreased the
de novo synthesis of matrix macromolecules (P ! 0.00004) in
young and adult samples, EMF partly surpassed this catabolic
effect in cartilage samples derived from young animals, but it did
not counteract the IL-1b effect in old ones.
Conclusion: In the culture settings applied here, EMF promoted
matrix macromolecule biosynthesis in intact tissue explants but had
no stimulatory effect on damaged articular cartilage. The catabolic
effects of IL-1b were partially antagonized by EMF exposure and
that exclusively in cartilage derived from young animals. Our results
suggest age-dependent chondroprotective but no structure modi-
fying properties of the EMF in a condition of compromised cartilage
integrity.
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EFFECT OF TGF-b 1 ON THE TRANSCRIPTION AND EXPRES-
SION OF CARTILAGE OLIGOMERIC MATRIX PROTEIN IN
PRECHONDROGENIC AND CHONDROGENIC ATDC5 CELLS
F. Hanyz, R. Zakaz, Z. Taoy, N. J. Hickoky, C. J. Williamsz
y Department of Orthopedic Surgery, Thomas Jefferson University,
Philadelphia, PA, USA
z Division of Rheumatology/Department of Medicine, Thomas
Jefferson University, Philadelphia, PA, USA
Aim: To determine the effects of TGF-b 1 on the transcription and
expression of cartilage oligomeric matrix protein (COMP) in
prechondrogenic and chondrogenic cultures of ATDC5 mesenchy-
mal cells.
Methods: The cells were cultivated in either maintenance medium
lacking insulin (ITS), in order to maintain their prechondrogenic
state, or in chondrogenic medium containing insulin, transferrin,
and selenite (CITS) in order to effect their differentiation into
chondrocytes. Cells were transiently transfected with control
(pGL3) or COMP proximal promoter constructs containing a lucifer-
ase reporter, and were co-transfected with a lac Z construct in order
to assess efﬁciency of transfection. Cells were treated with medium
only, 1 ng TGF-b 1 or 10 ng TGF-b 1 per ml of medium. Forty-eight
hours after transfection, we measured luciferase activity in order
to determine the effect of TGF-b 1 on the transcription of COMP
and we used semi-quantitative RT-PCR to assess the impact of
TGF-b1 on expression of COMP.
Results: TGF-b 1 appeared to have an inhibitory effect on the
transcription and steady state expression of COMP in chondrogenic
cultures of ATDC5 cells, but had little or no effect on the
transcription and expression of COMP in prechondrogenic cells
cultivated in maintenance medium. These observations may reﬂect
the fact that a potential TGF-b 1 responsive element in COMP is not
included in the proximal promoter region used for our studies.
However, we also explored the possibility of a defect in TGF-b 1
signaling in the ATDC5 cells. We ﬁrst established by immunohis-
tochemistry that the cells expressed receptors for TGF-b 1 in both
prechondrogenic and chondrogenic culture conditions. We then
tested if ATDC5 cells responded to TGF-b 1 by activation of the
Smad2/3 pathway by transfecting the cells with a luciferase reporter
construct containing the JunB promoter. In maintenance medium,
TGF-b 1-mediated transactivation of the JunB promoter was
attenuated, suggesting that the cells have limited potential to
respond to TGF-b 1 stimulation. In chondrogenic medium con-
taining insulin, TGF-b 1 treatment of ATDC5 cells transfected
with the JunB-luciferase construct also showed responsiveness,
but to an even lesser extent than cells cultivated in the absence
of insulin.
Conclusions: Based on our data, COMP mRNA expression and
transcription are slightly suppressed by TGF-b 1. Studies utilizing
the JunB reporter construct suggest that these ﬁndings may reﬂect
the limited degree of responsiveness of ATDC5 cells to TGF-b 1.
(Supported in part by NIH AR39740.)
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ACCELERATION OF COLLAGEN SYNTHESIS IN BOVINE
CHONDROCYTES, TENOCYTES AND LIGAMENTS CELLS BY
EXPOSURE TO MICRO LEVELS OF GLUCOSAMINE HCL AND
CHONDROITIN SULFATE
L. Lippiello, A. Brudhomme
Research & Development, Nutramax Laboratories Inc, Edgewood,
MD, USA
Aim of study: To investigate whether the chondroprotective agents
glucosamine HCl (gln) and chondroitin sulfate (CS) stimulate
collagen synthesis in three connective tissue cell types: chondro-
cytes, tenocytes and ligament cells.Methods: All tissues were obtained from retired Holstein cows.
Articular chondrocytes from the metacarpal joints, tenocytes from
the extensor tendon adjacent to the metacarpals and ligament cells
from between the metacarpals were isolated by collagenase
digestion. Cells were expanded by culture in DMEM/F-12 C 10%
FCS, ascorbic acid and antibiotics and second to third passaged
cells used after plating at high density into 48 or 12 well multiculture
plates. All cells were acclimated to a metabolic steady state in
DMEM/F-12 C 1% FCS C ascorbic acid, Ab and 5 mM glucose.
Replicates (4–8) were exposed to varying dosages of Cosamin DS
(CDS; a 5:4:1 mixture of glucosamine HCl, LMW CS and Mn
ascorbate; Nutramax Laboratories Inc.) and 10 mCi/ml tritiated
proline for 24 h. Collagen synthesis was indexed by assay of label
into puriﬁed collagenase-sensitive material and by speciﬁc activity
of hydroxyproline (hyp) after separation from proline by HPLC (cpm
hyp/mg hyp). The data were compared to control cultures as well as
positive controls containing 50 ng/ml IGF-1 and signiﬁcance
determined by student’s t test and ANOVA.
Results: Twenty-four hour exposure of ligament cells, tenocytes
and chondrocytes to CDS elicited a dose-dependent statistically
signiﬁcant stimulation of collagen synthesis. Maximum effect (70–
80% greater than controls) was seen with 1–10 mg/ml CDS (equal
to 0.5–5 and 0.4–4 mg/ml gln and CS, respectively). Measurement
of the speciﬁc activity of hyp conﬁrmed these results. Higher levels
had minimal or no effect on metabolism.
Conclusion: Collagen synthetic activity of ligament, tendon and
articular cartilage cells is signiﬁcantly increased by exposure to gln
and CS. These data are the ﬁrst to demonstrate that these agents
increase collagen synthesis in chondrocytes equally as well as
proteoglycan synthesis. Surprisingly, very low levels, easily ob-
tained by the recommended oral dose, are required to elicit sig-
niﬁcant increases in anabolic activity. The physiological effect of
these responses under conditions of tissue trauma or injury remains
to be demonstrated. However, similar effects seen on cartilage in
animal models of OA suggest a protective effect on preserving
matrix integrity. Since tendon/ligament injuries constitute 30–50%
of sports injuries, application of gln/CS represents an important
extension of their application in the treatment of joint disorders.
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POSITION OF SINGLE AMINO ACID SUBSTITUTIONS IN THE
COLLAGEN TRIPLE HELIX DETERMINES THEIR EFFECT ON
STRUCTURE OF COLLAGEN FIBRILS
A. Steplewskiy, H. Itoy, D. E. Birkz, S. A. Jimenezx, A. Fertalay
y Dermatology and Cutaneous Biology, Jefferson Medical College,
Thomas Jefferson University, Philadelphia, PA, USA
z Department of Pathology, Anatomy and Cell Biology, Jefferson
Medical College, Thomas Jefferson University, Philadelphia, PA,
USA
x Division of Rheumatology, Department of Medicine, Jefferson
Medical College, Thomas Jefferson University, Philadelphia, PA,
USA
Collagen II ﬁbrils are a critical structural component of the
extracellular matrix of cartilage providing the tissue with its unique
biomechanical properties. The self-assembly of collagen molecules
into ﬁbrils is a spontaneous process that depends on site-speciﬁc
binding between speciﬁc domains belonging to interacting mole-
cules. These interactions can be altered by mutations in the
COL2A1 gene found in patients with a variety of heritable cartilage
disorders known as chondrodysplasias. Employing recombinant
procollagen II, we studied the effects of R75C or R789C mutations
on ﬁbril formation. We determined that both R75C and R789C
mutants were incorporated into collagen assemblies. The effects of
the R75C and R789C substitutions on ﬁbril formation differed sig-
niﬁcantly. The R75C substitution located in the thermolabile region
of collagen II had no major effect on the ﬁbril formation process
or the morphology of ﬁbrils. In contrast, the R789C substitution
located in the thermostable region of collagen II caused profound
changes in the morphology of collagen assemblies. These results
S54provide a basis for identifying pathways leading from single amino
acid substitutions in collagen II to changes in the structure of
individual ﬁbrils and in the organization of collagenous matrices.
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RISK FACTORS FOR IMMINENT PROGRESSION OF KNEE
OSTEOARTHRITIS
S. A. Mazzuca, K. D. Brandt, B. P. Katz, Y. Ding, K. A. Lane
Department of Medicine, Indiana University School of Medicine,
Indianapolis, IN, USA
Standardized protocols for knee radiography are more sensitive in
detecting progression of knee OA than conventional techniques.
We have prospectively evaluated risk factors for imminent
radiographic progression of knee OA using a standardized, ﬂuor-
oscopically assisted protocol for knee radiography.
Methods: Subjects were 319 men and women, R45 years of age,
with unilateral or bilateral knee OA who underwent a ﬂuoroscop-
ically standardized X-ray exam of the knees (semiﬂexed AP view),
a patellofemoral (PF) X-ray exam and an assessment with the
WOMAC OA Index at baseline and 16 months. WOMAC Pain and
Stiffness scales were administered separately for each knee. Joint
space narrowing (JSN) and osteophyte size were rated semi-
quantitatively by consensus of two readers who were blinded to
sequence, using a standard atlas. Ratings of tibiofemoral (TF) JSN
and osteophyte size in the semiﬂexed AP view were combined to
form an index of overall X-ray severity similar to a Kellgren and
Lawrence grade, which is based on the standing AP view. General
estimating equations (GEE) were used to calculate odds ratios and
P-values for risk factors for progression of medial TF JSN, growth of
TF osteophytes and overall X-ray severity. Knees with grade 4 OA
were excluded.
Results: The sample consisted of 84% females and 75% whites.
Mean age (GSD) was 60.0G 9.6 years and mean BMI 33.7G 7.7
kg/m2. Odds ratios (OR, change in likelihood of progression per unit
of variation in the independent variable) from logistic regression
models are presented below.
Conclusions: This investigation focused on JSN and osteophytosis
as features of TF knee OA, regardless of whether short-range
changes were evidence of incident or progressive OA. Notably, use
of a standardized X-ray protocol permitted identiﬁcation of signiﬁcant
risk factors for radiographic changes of knee OA within only
16 months. Rather than the classic risk factors of OA (e.g., age,
sex, BMI), those predictive of imminent change tended to be knee-
speciﬁc (i.e., presence ofPFOA, kneepain and stiffness at baseline).
Supported by NIH AR43370, AR43348 and AR20582.
Independent variable Medial
TF JSN
Growth of TF
osteophytes
Overall X-ray
severity
Odds
ratio
P Odds
ratio
P Odds
ratio
P
Age 1.01 0.59 1.00 0.80 1.00 0.72
Sex (male = 1) 0.78 0.52 1.16 0.60 1.53 0.14
Race (white = 1) 0.79 0.40 0.85 0.49 0.97 0.91
Body mass index (BMI) 1.03 0.08 1.02 0.12 1.02 0.21
Menopausal status 1.81 0.10 0.69 0.17 1.10 0.76
ERT (yes = 1) 0.80 0.50 0.74 0.22 0.87 0.62
Grade 2 X-ray severity
(c.f., grade 0–1)
1.86 0.09 0.61 0.15 0.92 0.80
Grade 3 X-ray severity
(c.f., grade 0–1)
1.46 0.20 0.96 0.87 0.33 0.00
Patellofemoral OA 1.76 0.04 1.58 0.04 1.65 0.06
Knee pain 1.07 0.01 1.05 0.04 1.08 0.00
Knee stiffness 1.14 0.03 1.18 0.00 1.20 0.00
Disability (function) 1.02 0.02 1.01 0.04 1.01 0.21P131
MINIMAL JOINT SPACE NARROWING IS A BETTER PRE-
DICTOR OF THE NEED FOR SURGERY THAN MEAN JOINT
SPACE NARROWING: AN 8-YEAR PROSPECTIVE FOLLOW-
UP STUDY IN KNEE OSTEOARTHRITIS
O. Bruyere, F. Richy, J. Y. Reginster
Public Health, Epidemiology and Health Economics, University of
Liege, Liege, Belgium
Background: To date, in the literature, few trials have evaluated the
effect of treatment on the structural progression of osteoarthritis
(OA). Some studies have shown an effect of drugs to delay the
natural joint space narrowing (JSN). However, the clinical
relevance of these results remains unknown. This relevance could
be shown by association between JSN and a relevant clinical
outcome (i.e., joint surgery).
Objective: To assess the clinical relevance of mean and minimal
femoro-tibial JSN to predict future OA-related surgery in patients
with knee OA.
Material and methods: One twenty-six subjects (77% women),
aged over 50 years, with primary knee OA (ACR criteria) were
followed for a mean period of 8 years. Minimal and mean joint
space width (JSW) were assessed from standard X-rays at
baseline and after a follow-up of 3 years. The rate of OA-related
surgeries (including total knee replacement, total hip replacement,
menisectomy and joint debridement) was recorded during the 8
years of follow-up.
Results: At baseline, age of the patients was 64.5 (6.9) years, body
mass index was 27.3 (2.8) kg/m2, minimal JSW was 3.9 (1.2) mm
and mean JSW was 5.4 (1.3) mm. After a mean follow-up of 8
years, 16 (12.7%) patients experienced OA-related joint surgery.
Logistic regression analysis including baseline JSW, body mass
index (BMI), age, sex, baseline WOMAC and 3-year changes in
WOMAC, identiﬁed 3-year changes in minimum JSW as predictor
of the need for future joint surgery (PZ 0.004). The cut-off for joint
space narrowing (JSN) maximizing sensibility and speciﬁcity to
predict future surgeries was a change of 0.6 mm or more in minimal
joint space width over a period of 3 years. However, no signiﬁcant
differences were observed between the predictive abilities of
thresholds from 0.3 to 0.8 mm. The relative risk (adjusted for age,
BMI, symptoms and baseline JSW) to experience OA-related
surgery during the 8 year of follow-up was 5.16 (95%CI 1.76–15.12,
P Z 0.003) in patients with a minimal joint space narrowing of 0.6
mm or more during the ﬁrst 3 years of the study. The areas under
the curves (AUC) resulting from the ROC curves analyses to predict
OA surgery were 0.73 (PZ 0.006) for minimal JSN and 0.55 (PZ
0.54) for mean JSN.
Conclusion: Minimal JSN seems to be more relevant to predict
knee OA surgeries than mean JSN. A cut-off of 0.6 mm in minimal
JSN reﬂects a clinically relevant progression in patients with knee
OA. However, larger studies should be conducted to validate our
results.
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ALTERED LEVELS OF SERUM CARTILAGE MARKERS IN
POSTMENOPAUSAL AFRICAN–AMERICAN AND CAUCASIAN
WOMEN ON CURRENT HORMONE REPLACEMENT THERAPY
A. D. Dragomiry, J. M. Jordany, V. B. Krausz, G. Lutay,
J. B. Rennery, A. R. Poolex
y Thurston Arthritis Research Center, University of North Carolina,
Chapel Hill, NC, USA
z Duke University Medical Center, Durham, NC, USA
x McGill University, Montreal, PQ, Canada
Purpose: Hormone Replacement Therapy (HRT) use may prevent
loss of knee articular cartilage. We have previously reported that
current HRT use is associated with lower levels of serum cartilage
oligomeric matrix protein (COMP), a marker of cartilage degrada-
tion. We investigated the associations of current HRT use with
S55serum biomarkers of cartilage type II collagen degradation (C2C),
types I and II collagen degradation (C1,2C), type II procollagen
synthesis (CPII), and chondroitin sulphate epitope 846 (CSE 846),
in an ethnically diverse study population. These associations have
not been previously investigated.
Methods: All postmenopausal women participating in a serum
biomarker sub-study of the Johnston County Osteoarthritis Project,
with data on current HRT use and serum biomarker levels were
included. All serum biomarker levels were measured using
commercial kits (Ibex). Current HRT use was deﬁned as self-
reported postmenopausal use of hormones pills, shots, or implants.
Separate Analysis of Covariance models were used to evaluate the
relationship between current HRT use and log-transformed (ln)
biomarker levels, controlling for ethnicity, age, BMI (kg/m2), and
radiographic knee OA status (affected: knee Kellgren-Lawrence
[K-L] grade R 2, unaffected: K-L grade 0 for both knees and both
hips).
Results: The sample consisted of 168 postmenopausal women.
Mean age (SD) was 62 (9) years; 49% were African–American,
23% were current HRT users, and 63% had knee OA. Both mean
ln C2C and mean ln CPII were lower in current HRT users
compared to non-users (P Z 0.032 and P ! 0.001, respectively).
After adjustment, only the reduction in mean ln CPII associated
with current HRT use remained statistically signiﬁcant (P !
0.001). There was also evidence of an interaction between
current HRT use and knee OA status for CSE 846, with HRT
users having higher levels of ln CSE 846 in the OA unaffected
group (P Z 0.008), and no HRT effect in the OA affected group
(P Z 0.957).
Conclusions: HRT users exhibit reduced type II collagen cleavage
as measured by C2C and reduced collagen II synthesis as
measured by CPII. Taken together, these results demonstrate
reduced collagen II turnover in HRT users, both OA and non-OA.
Current HRT use may increase aggrecan production in post-
menopausal women with no radiographic evidence of knee or
hip OA.
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SYMPTOMATIC KNEE OSTEOARTHRITIS: EVIDENCE FOR
INTRAUTERINE PROGRAMMING
K. M. Jordan, H. E. Syddall, A. Aihie Sayer, E. M. Dennison,
C. Cooper, N. K. Arden
Bone and Joint, MRC ERC, Southampton, Hampshire, United
Kingdom
Aims: To examine the association between birthweight, weight at 1
year and conditional growth and knee osteoarthritis in men.
Methods: We utilised directly recorded information on birthweight
and weight at 1 year in 498 men aged 59–70 years, born and still
resident in Hertfordshire, UK. We collected demographic details,
a questionnaire detailing knee pain and performed weight-bearing
antero-posterior and lateral semi-ﬂexed radiographs of both knees.
Radiographs were assessed for OA at the tibiofemoral and
patellofemoral joints for joint space narrowing and osteophytes
using a standard atlas and overall Kellgren and Lawrence score
(K/L) determined; a grade of R2 was deﬁned as deﬁnite
osteoarthritis. Clinical knee OA was deﬁned as pain in one or both
knees ‘‘on most days in the last month’’, and symptomatic knee OA
(SOA) as clinical knee OA plus K/L radiographic grade R 2.
Results: Overall prevalence of symptomatic OA was 11.3%,
radiographic knee OA K/L grade R2 18.8% and knee pain
37.4%. Mean age was 64.8 years, height 174.4 cm and weight 80.6
kg. There was no difference in mean age, weight, height, alcohol
consumption or smoking between symptomatic and non-symptom-
atic subjects. Symptomatic subjects were signiﬁcantly more likely to
be from a manual social class (15% vs 7%, P Z 0.03).
There were signiﬁcant associations between weight at 1 year and
symptomatic knee OA in adult life (PZ 0.02); this association was
strengthened after adjustment for adult BMI and age (P Z 0.01).The prevalence of SOA reached 15% (OR 2.6; 95% CI 1.15–6.0)
amongst those in the lowest third of the distribution of weight at
1 year which contrasts with a prevalence of 7% in those subjects in
the highest third of weight at 1 year. Association between SOA and
conditional growth in the ﬁrst year of life was also highly signiﬁcant
(P Z 0.01). There were no associations found between SOA and
birthweight.
Conclusion: These data suggest that weight in infancy is a de-
terminant of later risk of symptomatic knee osteoarthritis in men
and that this is mediated predominantly by growth during the ﬁrst
year of life.
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CO-MORBIDITY OF FOOT OSTEOARTHRITIS BY SITE
F. V. Wildery, J. P. Barrettz, E. J. Farinax
y Director of Research, The Arthritis Research Institute of America,
Inc., Clearwater, FL, USA
z Director, The Florida Knee and Orthopedic Institute, Clearwater,
FL, USA
x Director, Sarasota Therapy Center, Sarasota, FL, USA
Aim of study: To quantify the association between radiographic foot
osteoarthritis (OA) and radiographic OA at four other joints: second
DIP, third PIP, ﬁrst CMC, and the knee.
Methods: Data collected for the Clearwater Osteoarthritis Study
(COS) were analyzed (N Z 3436). The study outcome was OA
status (yes/no) of the ﬁrst metatarso-phalangeal joint (ﬁrst MTP).
The four study predictor variables were OA of the second DIP, third
PIP, ﬁrst CMC, and knee joints. The Kellgren and Lawrence scale
determined radiographic evidence of osteoarthritis. The strength of
the association between foot OA and OA at other sites was further
explored by unilateral and bilateral disease categories.
Results: For both genders, we found a signiﬁcant, positive
relationship between grade 2C foot OA and the presence of OA
of the second DIP, third PIP, ﬁrst CMC, and knee joints.
This relationship maintained its statistical signiﬁcance after
adjustment for age, body mass index, and occupational history.
Adjusted odds ratios ranged from 3.2 for the DIP joint (P! 0.0001)
and 3.7 for the knee joint (P ! 0.0001). Relative to unilateral joint
S56disease, co-existing bilateral disease yielded a signiﬁcantly elev-
ated risk for foot OA for all joints examined. While other studies
have not speciﬁcally examined co-morbidity with foot OA, our
ﬁndings are consistent with results from related, previous studies.
Conclusions: There is a veritable dearth of studies exploring OA
of the ﬁrst MTP joint. While the role of mechanical factors in
the pathogenesis of OA has compelling evidence, our current
ﬁndings support the theory of a systemic etiology involved in the
development of OA. Future epidemiological studies that further
distinguish the relationship between OA at differing sites will provide
an enhanced ability to describe the respective inﬂuences of
mechanical and systemic factors in the development of this disease.
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DISPARITIES IN UTILIZATION OF TOTAL KNEE ARTHRO-
PLASTY IN AFRICAN–AMERICAN MEN
A. C. Jonesy, C. K. Kwohyz, M. E. Kelleyz, M. J. Fineyz,
S. A. Ibrahimyz
y Medicine, University of Pittsburgh, Pittsburgh, PA, USA
z Center for Health Equity Research and Promotion, VA Pittsburgh
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Objective: Total knee arthroplasty (TKA) is a cost-effective option
for end-stage knee osteoarthritis (OA). Although the prevalence of
knee OA is similar among whites and African–Americans (AA’s),
studies using Medicare Administrative databases have demon-
strated marked racial disparities in the utilization of TKA. These
studies have several methodological problems, since 40% of
patients who undergo TKA are !age 65 and Medicare does not
fully cover the cost of post-surgery outpatient rehabilitation care
following TKA. Differences in economic status between AAs and
whites may play a role in the differences in utilization. Previous
studies have used the entire Medicare patient population, as
opposed to limiting the denominator to patients who are potential
candidates for the procedure, such as those with osteoarthritis. To
address these limitations, we utilized the VA National Patient Care
Database to determine if differences in the utilization of TKA exist
between AAs and whites.
Methods: This study sample included all VA patients during ﬁscal
year 1999 who were 50 years of age or older and had a ICD-9-CM
diagnosis of lower extremity OA (715.x). To improve the diagnostic
accuracy of this code, we also identiﬁed the subset of patients who
had been referred to either rheumatology or orthopedic surgery
clinic for specialty care. The primary outcome of the study was TKA
within 2 follow-up years (2000 and 2001). The primary predictor
variable was race deﬁned as AAs vs non-Hispanic white. The
primary outcome, TKA, was identiﬁed using ICD-9-CM code 81.54.
Data on co-morbidity was collected using the components of the
Deyo-Modiﬁed Charlson Index. We calculated the odds of each
race undergoing knee arthroplasty using a random effect logistic
regression with the hospital site as the random effect.
Results: The study population consisted of 223,604 whites (85.7%)
and 37,252 AAs (14.3%) with lower extremity OA. The sub-cohort
with specialty clinic visits included 39,488 (85.5%) whites and 6719
(14.5%) AAs.
For the larger OA sample the mean age was 66.95 years for whites
and 64.66 years for AAs. Overall, 3.2% of whites and 2% of AAswere female. Since the study population did not consist of
a sufﬁcient number of females for analyses, the results only pertain
to males. There were signiﬁcant differences in the prevalence of
comorbid conditions. Whites had higher rates of myocardial
infarction, congestive heart failure, peripheral vascular disease,
chronic lung disease, and rheumatologic disease, whereas
African–Americans had higher rates of diabetes with complications,
dementia, cancer, renal disease, and AIDS. After adjusting for age,
gender and co-morbidity, AAs were less likely to undergo TKA in
reference to white patients within 2 years in both the general OA
cohort and the sub-cohort (ORZ 0.72, 95% CI 0.65–0.80 and OR
Z 0.72, 95% CI 0.63–0.81).
Conclusion: When access to comprehensive care was equal in the
absence of ﬁnancial burden, African–American male veterans were
signiﬁcantly less likely than their white counterparts to undergo TKA
within the study period.
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SELF-REPORT OF A PHYSICIAN DIAGNOSIS OF ARTHRITIS
BY VETERANS IS INACCURATE
J. A. Singhy*, D. B. Nelsonz, K. L. Nicholy
y Department of Medicine, Minneapolis VA Medical Center,
Minneapolis, MN, USA
z Center for Chronic Diseases Outcomes Research, Minneapolis
VA Medical Center, Minneapolis, MN, USA
Objective: To determine the accuracy of patient self-report of
a physician’s diagnosis of arthritis in a cohort of Veterans.
Methods: We mailed a self-administered questionnaire to all
veterans who had at least one inpatient or outpatient encounter
between 10/1/1997 and 3/31/1998 at the Upper Midwest VA
Integrated Service Network. The survey included questions re-
garding self-report of physician-diagnosed comorbidities including
arthritis. We examined the computerized patient medical records for
presence of International Classiﬁcation of Diseases (ICD) code for
any type of arthritis in a 2-year period (a year before and after the
survey). We searched the pharmacy database for the same 2-year
period for prescription of two of more reﬁlls of Non-steroidal anti-
inﬂammatory drugs (NSAIDs) and Disease-modifying anti-rheumat-
ic drugs (DMARDs). Self-report of arthritis was compared to the four
database deﬁnitions derived from clinical and pharmacy databases
(gold standards): (1) ICD code; (2) use of medication; (3) ICD code
OR medication; and (4) ICD code AND medication. We assessed
the accuracy of the self-report by calculating sensitivity, speciﬁcity,
positive and negative predictive values (PPV and NPV), kappa
statistic and the area under the receiver operator characteristics
(ROC) curve.
Results: Of the 70,334 veterans surveyed, 40,508 responded
(response rate of 58%). Of these, 34,440 (49%) answered the
question regarding arthritis, and 18,464 (54%) subjects reported
arthritis. Review of patient’s computerized charts revealed that
14,378 (42%) had an ICD code for a diagnosis of arthritis.
Self-report of a physician’s diagnosis of arthritis had a sensitivity of
73–85%, speciﬁcity of 52–61%, a positive predictive value of 26–
56% and negative predictive value of 76–95% when compared to
the database deﬁnitions. The agreement between the database
deﬁnitions and self-report was poor (low kappa; Table I). The areaTable I
Accuracy of self-report as compared to the administrative and pharmacy databases
Self-report compared WITH Y Sensitivity
(95% CI)
Speciﬁcity
(95% CI)
PPV*
(95% CI)
NPVy
(95% CI)
Kappa
statistic
ROC curve
area (95% CI)
ICD code in 2-year period 78% (78–79%) 57% (56–57%) 43% (42–43%) 86% (86–87%) 0.28 (0.27–0.29) 0.67 (0.67–0.68)
Medication in a 2-year period 75% (74–75%) 55% (54–55%) 39% (39–40%) 85% (84–85%) 0.23 (0.22–0.24) 0.65 (0.64–0.65)
ICD code OR medication in
2-year period
73% (73–74%) 61% (60–61%) 56% (56–57%) 76% (76–77%) 0.32 (0.31–0.33) 0.67 (0.66–0.67)
Both ICD code AND
medication in 2-year period
85% (84–85%) 52% (52–53%) 26% (25–26%) 95% (94–95%) 0.19 (0.18–0.20) 0.69 (0.68–0.69)
*PPV, positive predictive value.
yNPV, negative predictive value; CI, conﬁdence intervals.
S57under ROC curve for self-report of arthritis was similar when
compared to various database deﬁnitions.
Conclusions: Self-report of a physician’s diagnosis of arthritis in
veterans is inaccurate when compared to the database deﬁnitions
for a diagnosis of arthritis.
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CONSERVATIVE TREATMENT PRESCRIPTION FOR PATIENTS
WITH OSTEOARTHRITIS
I. Shriery, D. Feldmanz, M. C. Gaudetz, M. Rossignoly, D. Zukor§,
M. Tanzer§, C. Graveljj, N. Newman{, R. Dumais#
y Lady Davis Institute for Medical Research, McGill University,
Montreal, QC, Canada
z Medecine Sociale et Preventive, Universite de Montreal, Mon-
treal, QC, Canada
xOrthopaedics, McGill University, Montreal, QC, Canada
jj Orthopaedics, Charles LeMoyne Hospital, Greenfield Park, QC,
Canada
{ Orthopaedics, Universite de Montreal, Montreal, QC, Canada
# Orthopaedics, Universite de Sherbrooke, Sherbrooke, QC,
Canada
Aim: Recent evidence suggests that there exist several effective
non-pharmacological conservative treatments for osteoarthritis
(OA), including the use of a cane, physiotherapy and exercises.
The objective of this study was to examine the proportion of
patients who received prescriptions for these treatments.
Methods: Patients from ﬁve different Quebec hospitals who were
scheduled to have THR for OA within the upcoming 1–4 weeks
completed a telephone interview questionnaire. Patients were
asked whether they had been prescribed a cane, strengthening or
stretching exercises, or physiotherapy at any time during their
medical treatment for OA.
Results: Of 164 patients approached, 161 agreed to participate. Of
the 123 patients (76.4%) prescribed a cane, 105 (85.4%) patients
used it. The reasons for not using a cane in the remaining 18
patients who were prescribed it were Not Needed (5), Vanity (8),
Difﬁcult to Use (4), and No Reason (1). Only 28.0% of patients were
prescribed physiotherapy. In total (with or without physiotherapy),
only 18.6% of patients were prescribed at least one strengthening
exercise (totals: 5.6% hip ext, 11.2% hip abduction, 11.2%
quadriceps), 18.0% at least one stretching exercise (totals: 7.5%
hamstrings, 7.5% back stretches, 5.0% quadriceps stretches) and
only 5.6% aerobic exercise (bicycling, swimming).
Conclusion: Our results suggest that patients with severe OA do
not recall being prescribed common effective non-pharmacological
conservative treatments during the entire course of their disease
and morbidity. These results suggest interventions must be
designed to improve non-surgery physician prescription of conser-
vative treatments in less severe cases of OA.
Acknowledgments: This study was carried out in part with funding
from the Fonds de Recherche en Sante´ du Quebec and the REPAR
network for musculoskeletal disorders.
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PHYSICAL ACTIVITY IN INDIVIDUALS WITH KNEE OSTEOAR-
THRITIS PRIOR TO PRIMARY TOTAL KNEE ARTHROPLASTY
D. L. Jonesy, C. K. Kwohz, J. J. Irrgangx, A. M. Kriskajj,
S. Weardeny, L. S. Crossett{
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z Rheumatology, University of Pittsburgh, Pittsburgh, PA, USA
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Aim: Few studies have quantiﬁed physical activity levels in
individuals with osteoarthritis (OA) of the knee prior to total kneearthroplasty (TKA). The aim of this study was to compare physical
activity levels in a cohort with knee OA undergoing primary TKA
(TKA cohort) with a comparison group with knee OA not undergoing
TKA (OA cohort) at baseline in a prospective cohort study
examining the natural history of physical activity after TKA.
Methods: The TKA cohort contained 74 patients, aged 45 years or
older, who were scheduled for elective primary TKA due to OA. The
OA cohort contained 66 patients, aged 45 years or older, with knee
OA and no prior TKA. Leisure activity, occupational activity, and
instrumental activities of daily living (IADLs) were assessed using
standardized physical activity questionnaires. Disease severity was
assessed using the Index of Severity for Knee Disease (ISK). The
Mann–Whitney test was used to compare total physical activity
(leisure and occupational activity combined) and IADLs between
the cohorts. An Analysis of Covariance was performed to control for
important sociodemographic and clinical factors when examining
the differences in activity between the cohorts.
Results: There were 37 males (23 TKA, 14 OA) and 103 females
(51 TKA, 52 OA) with a mean age of 66.9G 9.9 years (range, 45 to
88 years). Compared to the OA cohort, the TKA cohort was less
educated (P Z 0.03) and had more nonwhites (P Z 0.03), severe
OA (mean ISK G SD: TKA 13.9 G 3.2 vs OA 11.6 G 3.4, P !
0.001), WOMAC knee pain (TKA 10.3G 3.5 vs OA 7.7G 3.6, P!
0.001), and WOMAC stiffness (TKA 5.0 G 1.7 vs OA 4.2 G 1.6,
P Z 0.005); a higher body mass index (BMI) (TKA 32.6 kg/m2 G
7.1 vs OA 29.8 G 7.3, P Z 0.03); and lower WOMAC physical
functioning (TKA 34.2 G 11.5 vs OA 27.3 G 12.0, P Z 0.001).
Most of the reported activity was of low or moderate intensity in both
cohorts. The TKA cohort reported less total physical activity (mean
MET-hours/week G SD: TKA 31.5 G 31.4 vs OA 52.9 G 41.3,
medians: 21.8 vs 38.7, P ! 0.001) and IADLs (mean MET-hours/
week G SD: TKA 41.3 G 26.5 vs OA 68.9 G 55.4, medians: 37.2
vs 52.5, P Z 0.001) than the OA cohort. Signiﬁcant differences in
total physical activity between the cohorts remained after control-
ling for gender, BMI, and OA severity (adjusted mean G SD: TKA
37.5 G 36.3 vs OA 54.2 G 40.3, R2 Z 0.20), and for IADLs after
controlling for gender and BMI (adjusted meanG SD: TKA 40.3G
42.7 vs OA 61.0 G 42.7, R2 Z 0.19).
Conclusions: This study quantiﬁed the frequency, intensity, and
duration of physical activity in people with knee OA. Individuals
undergoing primary TKA reported less leisure, occupational, and
IADL activity than those not undergoing TKA. The goal of TKA is to
allow individuals to lead a more active life. Quantifying preoperative
activity levels is necessary to measure progress toward achieving
this goal. Further research is needed to prospectively determine the
effects of primary TKA on physical activity levels.
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TRENDS IN THE USE OF PATIENT REPORTED OUTCOMES IN
OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS CLINICAL
TRIALS AND SUBSEQUENT PRODUCT LABLES
M. L. Tany, J. H. Coombsz
y Institute of Social Research, University of Michigan and Pfizer
Outcomes Research, Ann Arbor, MI, USA
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Introduction: The Food and Drug Administration (FDA) has
released draft Guidance for Industry for the development of
osteoarthritis (OA) and rheumatoid arthritis (RA) products in 1998
and 1999, respectively. These Guidance documents provide
comments regarding endpoints, including patient reported out-
comes (PRO), in OA/RA clinical trials and labeling.
Aim of study: Identify trends in PRO measurement in clinical trials
and subsequent labeling claims for drug products indicated for OA/
RA before and after the draft Guidances.
Methods: The Physician Desk Reference (PDR) was searched for
‘Osteoarthritis’ and ’Rheumatoid Arthritis’ within the indication.
Summary Basis for Approvals (SBA) for OA/RA-indicated products
were obtained from the FDA. The FDA Draft Guidances were
reviewed for recommendations on the use of PROs. Product labels
S58and SBAs were evaluated chronologically based on the date of
approval and observed for trends in the use of PROs before and
after the release of the FDA guidances.
Results: Overall, 11 products were identiﬁed as indicated for OA
and 35 for RA. Review of SBAs for the six OA products approved
prior to the introduction of the OA Guidance revealed that four
products measured patient global assessment and two incorpo-
rated a patient assessment of OA activity. There were 27 RA
products approved prior to the RA Guidance, and eight measured
patient global assessment and four measured patient assessment
of RA activity.
After the introduction of the OA Guidance, ﬁve products were
approved, of which four included a patient global assessment,
patient assessment of pain, and the WOMAC in their pivotal trials,
coinciding with the Guidance’s recommendation for efﬁcacy
endpoints in OA clinical trials. All four of these products contained
PRO information in their labels. Similarly, seven drugs were
approved after the RA Guidance was introduced, ﬁve of which
were indicated for improvement in signs and symptoms based on
the ACR20 criteria – which includes patient ratings of pain, global,
and function – coinciding with the Guidance’s recommendation for
efﬁcacy endpoints in RA clinical trials.
Conclusion: Since the introduction of the FDA guidance for OA/RA
products, there has been an increase in proportion of OA/RA
products that describe PRO measurement in clinical trials and PRO
claims appearing in product labels.
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Aim of study: To create a long-term, decision-analytic model of
osteoarthritis (OA) disease progression and treatment for use in
cost-effectiveness analyses of new disease-modifying OA drugs
(DMOADs).
Methods: An Osteoarthritis Disease Progression and Treatment
(ODePT) model was designed using a semi-Markov, state-
transition structure, a tool commonly used to simulate the long-
term natural history of a disease and estimate the effect of an
intervention on the disease’s natural progression. The primary
health states and transition probabilities of the ODePT model reﬂect
the structural progression of OA based on the clinical understand-
ing of disease progression, data from the BOKS study (a
longitudinal cohort study of symptomatic knee OA), and published
epidemiological data. Symptom measures were overlaid onto the
structural model to capture treatment impact on signs, symptoms
and quality of life (QoL). The model is able to accommodate
alternative measures of structural and symptomatic progression.
Within a given cycle (year) of the model, patients remain in their
disease state, progress to a new state, transition to surgery and
a post-surgical state, or die of natural causes. Natural mortality was
incorporated as an absorbing state; patients could not transition out
of this state. Within the Markov structure, values representing the
cost and utility of spending one cycle in each health state were
assigned. The ODePT model uses Monte Carlo simulation (ﬁrst
order) to randomly select patients, one at a time, from a hypothetical
cohort, and transit them through the model independently. The
Monte Carlo approach allows all input variables to be varied
simultaneously, using the entire distribution of possible values for
each parameter. For each patient simulation, a value for each
variable is randomly selected from a distribution and the modelresults recorded. The process is repeated for a speciﬁed number of
simulations (e.g., 10,000) resulting in a distribution of model results,
given the variability in each of the input variables. Outputs of
the model include structural outcome (knee JSN), symptomatic
outcome (WOMAC), life years, deaths, frequency of surgery (TKR),
years spent in post-surgery, time to progression to ﬁnal structural
state (JSN Z 3), QALYs and costs, although the use of alternate
measures remains possible. All outcomes are summarized on an
annual basis and in aggregate and are displayed with and without
discounting. The ODePT model was constructed in Excel 2000 SP-
3 (Microsoft Corporation) as a series of worksheets. The Monte
Carlo portion of the model is handled by Crystal Ball (Decisioneer-
ing, Inc.), an Excel add-in for performing forecasting and risk
analysis. Visual Basic for Applications (VBA) macros initiate the
Monte Carlo simulation, perform model calculations and populate
the results.
Conclusions: Despite the signiﬁcant degree of heterogeneity
inherent in the disease process of OA, it remains possible to
create a long-term, probabilistic model of disease progression and
treatment. The present model provides a clinically relevant tool for
decision-makers and clinicians to assess the cost-effectiveness of
DMOADs in the treatment of OA.
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HEMOCHROMATOSIS HFE MUTATIONS IN OSTEOARTHRITIS
OF THE HAND AND KNEE
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Aim of study: Population based cross-sectional study to test the
hypothesis that primary osteoarthritis (OA) may be associated with
an increased prevalence of C282Y and/or H63D HFE gene
mutation.
Methods: Radiographic data were utilized from the St Thomas
UK Adult Twin Register (TwinsUk) and consisted of only white
women R55 years of age. HFE genotyping was performed on
subject DNA samples and the association of genotypes with
radiographic data from knee and hand joints were determined. The
analysis included 281 subjects that consisted of dizygotic twin pairs
and one member of a monozygotic pair. OA of the hand was
deﬁned as a Kellgren-Lawrence (K-L) grade of R 2 in at least 1 of
the second to fourth DIP, PIP, or MCP joints. Subjects without OA
served as controls. Severe OA was deﬁned as K-L grade of R 3.
Pearson Chi-Squared analysis was performed comparing HFE
mutation with the presence or absence of OA. Additional sub-
analysis was performed for the knee, speciﬁc hand joints and
chondrocalcinosis.
Results: The presence of H63D mutation was associated with
a decreased prevalence of OA of the hand with a P-value of
!0.018. C282Y mutation was associated only with a decreased
prevalence of severe OA of the CMC with a P-value of !0.017.
Presence of C282Y mutation was not associated with hand OA.
There were no signiﬁcant associations found for the presence of
either C282Y or H63D mutations with OA of other hand joints, knee
OA, or chondrocalcinosis. The same ﬁndings were present in
analysis of 151 subjects R age 60.
Conclusions: Homozygous C282Y HFE mutation accounts for 70%
of hereditary hemochromatosis cases and frequently results in an
aggressive form of OA. Heterozygous C282Y mutations are
common occurring in 8% of Caucasians and these heterozygous
mutations also result in elevated iron stores. However, this
study does not support the hypothesis that the presence of
C282Y and/or H63D HFE mutations are a predisposing factor in
the development of a osteoarthritis in females. The signiﬁcance of
the demonstrated inverse relationship of H63D mutation to hand
OA is unknown.
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Aim: (1) To identify common regulatory motifs in human using
differentially expressed transcripts in canine osteoarthritis (OA) as
a model. (2) To identify other transcripts containing the same
motifs. (3) To determine if those regulatory motifs are conserved in
canine, human, mouse and rat.
Methods: OA cartilage samples were obtained from the femoral
heads of clinically diagnosed canines undergoing total hip re-
placement. Differentially regulated transcripts in canine OA were
identiﬁed using a canine OA microarray previously described.
Canine transcripts were then mapped to the human transcript set
and the corresponding human transcripts were used to identify
common transcription factor binding sites 5 kb upstream of the
transcription start sites. We employed 20 human transcripts derived
from 19 genes that were up-regulated and 62 transcripts derived
from 60 genes that were down-regulated. After the promoter
models were developed, the human genome was scanned for other
genes likely to be regulated by the same promoter models, as
evidenced by the presence of potential binding sites, in any order or
orientation, in their upstream regions. Transcripts that displayed an
average cis-similarity distance (a measure of commonality between
the cis elements in the upstream of two genes) of 2 standard
deviations higher than above the mean when compared to all
transcripts comprising the model were retained. The 82 transcripts
and transcripts identiﬁed from the genome scan, including their 5
kbp upstream regions, were mapped to the genomic sequence of
canine, mouse and rat to evaluate the conservation of identiﬁed
regulatory motifs.
Results: One model was detected for up-regulated transcripts and
three models were detected for down-regulated transcripts. Each
model was based on the inclusion of 5–6 transcripts containing 5–8
common transcription factor binding sites. Common transcription
factors associated with these binding sites included AP-4, GATA-1
and -2, AP-2 alpha and gamma, cMyc/Max, E2F, among others.
Conclusions: The transcription factors associated with the identiﬁed
promoter motifs thus identiﬁed have previously been shown to be
involved in arthritis or chondrocyte biology. In addition, the
transcription factors and other identiﬁed transcripts driven by these
promoters may serve as new targets for the study of OA in higher
vertebrates.
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THE INCREASED FREQUENCY OF IL-1RN*2 ALLELE OF THE
INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RN) GENE IN
PATIENTS WITH PROGRESSIVE KNEE OSTEOARTHRITIS
K. Pavelka, L. Senolt, J. Vencovsky, S. Ruzickova
Department of Rheumatology, Institute of Rheumatology, Prague,
Czech Republic
Primary osteoarthritis (OA) is a common multifactorial disease with
not fully clariﬁed molecular factors inﬂuencing the development of
the disease. However, among factors maintaining the cartilage
integrity are such cytokines like IL-1 which can stimulate
proteinases resulting in the cartilage destruction. In this regard,
interleukin-1 receptor antagonist (IL-1RA) competing with IL-1 forbinding to its receptor may act as the inhibitor of cartilage
breakdown.
Aim of the study: To test the VNTR polymorphism in second intron
of IL-1RN gene as the putative factor of susceptibility to OA.
Methods: PCR using the primers ﬂanking VNTR region containing
variable number of 86 bp tandem repeat was employed to test the
hypothesis.
Results: Fifty patients with knee OA and 170 healthy controls were
included in the study. The patients with clinically symptomatic
primary knee OA were diagnosed according to ACR criteria with
annual JSN progression O0.2 mm. The increased frequency and
carriage rate of IL-1RN*2 allele were found in OA patients in
comparison with controls (28% vs 51%, P Z 0.0046, OR Z 2.20,
95% CI 1.30–3.74 for frequency; 50% vs 25.3%, P Z 0.0015, OR
Z 2.95, 95% CI 1.54–5.68 for carriage rate). In addition, the higher
frequency of genotype in OA patients was observed as compared
with controls (42% vs 20.6%, P Z 0.0032, OR Z 2.79, 95% CI
1.42–5.48).
Conclusions: These results suggest that IL-1RN*2 allele might
represent a factor of susceptibility to OA and/or a factor inﬂuencing
the severity and course of OA.
Acknowledgements: This work was supported by grant NK/5366-4
of the Ministry of Health of Czech Republic.
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COMPARISON OF SPGR AND SSFP SEQUENCES
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Purpose: To compare articular cartilage signal-to-noise (SNR),
contrast-to-noise (CNR), and thickness measurements on a 1.5 T
and a 3.0 T MR scanner using 3D spoiled gradient recalled echo
(3D-SPGR) and two steady-state free precession (SSFP) sequen-
ces.
Methods: Both knees of ﬁve volunteers were scanned at 1.5T and
at 3.0 T. Each examination consisted of a sagittal 3D-SPGR
sequence, a sagittal fat suppressed SSFP (FS-SSFP) sequence,
and a sagittal Dixon SSFP sequence. The 1.5 T scans used
a transmit–receive quadrature extremity coil. The 3.0 T scans used
a transmit–receive quadrature extremity coil. For quantitative
analyses, we compared cartilage SNR efﬁciency, CNR efﬁciency
between cartilage and ﬂuid and cartilage and its surrounding
tissues, and average cartilage thickness measurements.
Results: For 3D-SPGR, cartilage SNR efﬁciencies at 3.0 T
increased compared to a 1.5 T by a factor of 1.83 (range: 1.40–
2.09). The increased cartilage SNR efﬁciency of FS-SSFP at 3.0 T
was 2.13 (range: 1.81–2.39) times and for Dixon SSFP was 2.39
(range: 1.95–2.99) times better than those at 1.5 T. CNR
efﬁciencies between cartilage and its surrounding tissue increased
2.12 times for 3D-SPGR, 2.08 times for FS-SSFP and 2.41 times
for Dixon SSFP at 3.0 T. Cartilage signal at both ﬁeld strengths
varied with location, indicating coil sensitivity and location within the
joint is very important. Average cartilage thickness of load bearing
regions during walking did not differ at both ﬁeld strengths or
between sequences (P > 0.05).
Conclusion: Articular cartilage imaging of the knee on a 3.0 T MR
scanner shows increased SNR and CNR efﬁciencies compared to
a 1.5 T scanner, where SSFP based techniques show the highest
increase in SNR and CNR efﬁciency. There was no difference
between average cartilage thickness measurements performed at
the 1.5 T and 3.0 T scanner or between the three different
sequences. The improvement in SNR efﬁciency varies by location,
indicating the choice of coil and its sensitivity is crucial to beneﬁt
from the increase in ﬁeld strength.
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y Department of Clinical Physiology, Kuopio University Hospital,
Finland
z Department of Applied Physics, University of Kuopio, Kuopio,
Finland
x Department of Diagnostic Radiology, Oulu University Hospital,
Finland
Aims: MRI, ultrasound (US) and US indentation techniques have
been suggested for enhancing the diagnostics of OA. We further
analyzed data from our earlier experiments and compared the
ability of these techniques in the detection of OA.
Methods: Osteochondral plugs of bovine patellae with healthy and
degenerated cartilage (n Z 32) were studied. In US indentation,
cartilage was compressed with US transducer and US/mechanical
data collected. US reﬂection coefﬁcient of the cartilage surface (R)
and dynamic modulus (E) was measured with this instrument. US
attenuation, speed and reference E (E-ref) were determined with
mechano-acoustic material tester. From MRI, the superﬁcial value
of T2, bulk dGEMRIC (T1GD) values and Gd-DTPA2 concentra-
tion were quantiﬁed. Mankin score of the samples was evaluated
(0: normal, n Z 11; 1–3: early degeneration, n Z 11; O3:
advanced degeneration, nZ 10). Hydroxyproline (collagen), uronic
acid (PG) and H2O contents were determined. ROC analysis was
conducted to ﬁnd a cut-off value for each parameter where the sum
of speciﬁcity and sensitivity values was maximal.
Results: All diagnostic parameters showed signiﬁcant variation
(P ! 0.01, Kruskal Wallis H test) between the different stages of
degeneration. Several parameters revealed strong correlation with
the reference methods (Table I) and good speciﬁcity/sensitivity
values (Table II).
Table II
The specificity value indicates the part of healthy samples that were
correctly identified and sensitivity expresses the part of degen-
erated samples with correct identification with the mentioned cut-off
limit
Cut-off limit Speciﬁcity Sensitivity
E 2.5 Mpa 0.89 0.71
R 2.3% 0.89 0.91
US Speed 1576 m/s 0.82 0.91
US attenuation 2.47 dB/mm 0.82 0.95
T2 44 ms 0.73 0.81
T1GD 386 ms 0.73 0.81
[Gd-DTPA2] 0.54 mM 0.73 0.67
Table I
Individual and mean values of correlation coefficients between the
reference and diagnostic parameters of cartilage
Mankin
Score
PG
content
Collagen
content
H2O
content
E-ref
US indentation
E 0.74* 0.87* 0.86* 0.69* 0.98*
R 0.85* 0.83* 0.78* 0.66* 0.87*
US
US speed 0.76* 0.90* 0.86* 0.80* 0.90*
Attenuation 0.55* 0.65* 0.64* 0.65* 0.62*
MRI
T2 0.61* 0.36 0.33 0.34 0.30
T1GD 0.54* 0.62* 0.36 0.56* 0.50
[Gd-DTPA2] 0.54* 0.59* 0.35 0.55* 0.45**
n = 27–32, *P ! 0.01, **P ! 0.05.Discussion: US indentation results correlated strongly with the
histological, biochemical and biomechanical integrity of the tissue.
US indentation is feasible for arthroscopic use and it classiﬁed
sensitively and speciﬁcally samples into normal and degenerated.
Further, US speed in cartilage was an effective parameter for
evaluation of cartilage integrity. Although MRI showed weaker
correlation with the reference parameters, its diagnostic perfor-
mance was good as shown by speciﬁcity/sensitivity values. We
conclude that novel biophysical methods provide potential tools for
detecting signs of early OA, and may be useful in clinical practice.
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LINKS BETWEEN VARUS–VALGUS ALIGNMENT, CARTILAGE
MORPHOLOGY AND THREE-DIMENSIONAL PATELLAR KINE-
MATICS IN EARLY KNEE OSTEOARTHRITIS
E. J. McWaltery, J. Ciberey, S. Nicolaouy, F. Ecksteinz,
D. R. Wilsony
y Division of Orthopaedic Engineering Research, Rheumatology,
Arthritis Research Centre of Canada, Radiology, University of
British Columbia and Vancouver Coastal Health Research Institute,
Vancouver, BC, Canada
z Institute of Anatomy and Musculoskeletal Research, Paracelsus
Private Medical University, Salzburg, Austria
Aim: In this pilot study we studied possible links between varus–
valgus alignment, features of three dimensional (3D) patellar
kinematics and morphologic patellar cartilage parameters.
Methods: Ten individuals (4 males, 6 females, 73 G 8 years, BMI
26.6 G 3.7, WOMAC 26 G 12) with early OA in at least one
compartment of the knee and with varus or valgus alignment were
recruited. Each participant underwent an assessment of varus–
valgus knee alignment, patellar cartilage morphology and 3D
patellar tracking. We assessed varus–valgus alignment from
a weight-bearing AP radiograph. To assess global articular patellar
cartilage morphology (volume normalized to original bone cartilage
interface, mean cartilage thickness and% cartilage coverage) in the
medial and lateral compartments of the patella we used validated
quantitative MRI procedures. The patella was divided along the
median ridge. We used a novel, validated MRI-based method to
study 3D patellar tracking through approximately 40( of loaded
ﬂexion. We used a 2-way ANOVA to assess the relationship
between varus–valgus alignment and 3D patellar tracking param-
eters and between varus–valgus alignment and morphologic
cartilage parameters.
Results: We found statistically signiﬁcant differences between the
varus and valgus groups for patellar tracking parameters of ﬂexion,
spin, anterior translation and proximal translation (P! 0.001 for all
groups) for the ﬁrst 10( of tibiofemoral ﬂexion but not for tilt or
lateral translation. Patellae of the varus knee group tended to
display greater ﬂexion, external spin, a more anterior position and
a more distal position than the valgus knee group. A statistically
signiﬁcant difference was seen between the varus and valgus
groups for normalized cartilage volume (P ! 0.001) and mean
cartilage thickness (P ! 0.001). No statistically signiﬁcant
difference was seen between the medial and lateral cartilage
normalized volume, mean thickness or % coverage.
Conclusion: It is surprising that we found no difference in tilt
because tilt is a widely used parameter for assessing patellar
malalignment that is thought to be related to clinical symptoms such
as pain and cartilage degeneration. It is also surprising that we
found no correlation between tibiofemoral alignment and unequal
compartmental patellar cartilage deterioration. This suggests that
radiographic joint space narrowing observed in the lateral
compartment in valgus knees and the medial compartment in
varus knees in previous studies may not adequately reﬂect
changes in cartilage thickness. A key strength of our approach is
that we assessed patellar kinematics accurately in simulated
loaded ﬂexion. However, we cannot draw deﬁnitive conclusions
from this study due to the limited number of participants, and only
10( of tibiofemoral ﬂexion was studied due to one participant’s
limited range of motion. This work suggests that the links between
S61tibiofemoral alignment and patellar cartilage changes are not
simple. Assessing tibiofemoral alignment may not be sufﬁcient to
determine the mechanical causes of patellofemoral OA and guide
improved prevention and treatment.
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CARTILAGE T2 MAPPING OF STICKLER SYNDROME: AN MR
IMAGE MARKER FOR TYPE II COLLAGEN DEFICIENT CARTI-
LAGE
T. J. Moshery, Y. Liuy, S. A. Jimenezz
y Department of Radiology, Penn State University, Hershey, PA,
USA
z Department of Medicine, Division of Rheumatology, Thomas
Jefferson University, Philadelphia, PA, USA
Aim of study: To test the hypothesis that abnormal type II collagen
in the cartilage matrix resulting from mutations of the COL2A1 gene
will elevate Magnetic Resonance Imaging (MRI) T2 values of
articular cartilage.
Methods: Cartilage MRI T2 mapping was performed on two
patients diagnosed with Stickler Syndrome: a 27 year old male
with hearing loss and severe arthropathy, and a 55 year old female
with primarily visual symptoms, and mild arthropathy. Quantitative
cartilage T2 mapping was performed of both knees using a Bruker
3 T MR spectrometer, a 24 cm gradient insert, and 15 cm linear Litz
coil (Doty Scientiﬁc). Sagittal T2 maps of the femoral tibial joint
were calculated from a 6 slice, 12 echo sequence with TR/TE Z
1500/9–106 ms, 4 mm section thickness (ST), 384 ! 384 matrix
and a 12.75 cm ﬁeld of view (FOV). Axial T2 maps of the
patellofemoral joint were obtained from 5 sections with a 3 mm ST,
256! 256 matrix, and a 14.00 cm FOV. Cartilage T2 proﬁles were
compared to T2 proﬁles (mean G s.d.) from eight young normal
controls.
Results: Cartilage T2 maps of both Stickler syndrome patients
demonstrate signiﬁcantly elevated T2 compared to normal carti-
lage. Spatial variation in cartilage T2 as a function of depth from the
articular surface differs between the two Stickler syndrome patients.
For the male patient with severe arthropathy, T2 proﬁles of weight-
bearing femoral tibial cartilage demonstrates reversal of the normal
spatial dependency in cartilage T2 with lower values observed near
the articular surface. The female patient demonstrates spatial
variation in T2 similar to that seen in normal subjects.
Conclusions: Prior studies have demonstrated sensitivity of
cartilage T2 to content and orientation of Type II collagen ﬁbers
within the extracellular matrix. Abnormally high cartilage T2
observed in Stickler Syndrome is consistent with prior ex vivo
studies correlating elevated T2 with loss of type II collagen. The
pattern of T2 elevation differs between Stickler patients, and may
reﬂect differences in expression of the underlying genetic muta-
tions. In loaded femoral tibial cartilage of the Stickler syndrome
patient with severe arthropathy, T2 decreases linearly toward the
articular surface. We hypothesize this is due to lower water content
near the surface of the more compressible collagen deﬁcient
cartilage. The spatial variation of the female Stickler syndrome
patient suggests a more normal organization of the collagen
matrix. The sensitivity of cartilage T2 mapping to alteration of thecollagen matrix makes it a potential image marker to study the
phenotypic expression of different genetic mutations of the
COL2A1 gene.
Acknowledgements: Research support provided through grants
from the Arthritis Foundation and NIH/NIAMS.
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DGEMRIC AS A PREDICTOR OF OUTCOME AND RESPONSE
OF ARTICULAR CARTILAGE TO PERIACETABULAR OSTEOT-
OMY FOR HIP DYSPLASIA
R. Jessely, T. Cunninghamy, D. Zurakowskiy, M. Millisy,
D. Jaramillox, M. Grayjj, D. Bursteinz, Y. J. Kimy*
y Orthopaedic Surgery, Children’s Hospital, Boston, MA, USA
z Radiology, Beth Israel Deaconess Medical Center, Boston, MA,
USA
x Radiology, Children’s Hospital, Philadelphia, PA, USA
jj Harvard-MIT Division of Health Sciences and Technology, Cam-
bridge, MA, USA
Aim: To determine whether dGEMRIC (an MRI measure of
cartilage) is a predictor of outcome of periacetabular osteotomy
for hip dysplasia, and to follow cartilage response.
Methods: A patient cohort with developmental dysplasia of the hip
without prior acetabular osteotomies was recruited for this
longitudinal prospective study. Pre- and post-operative clinical
(WOMAC) and radiological (X-ray and MRI) data were collected.
JSW, center edge angle of Wiberg (LCE), and joint subluxation
were measured on standing AP pelvic radiograph. Radiographic
OA was graded using the To¨nnis grade (0, no arthritis; 1,
subchondral sclerosis; 2, mild joint space narrowing; 3, severe,
localized joint space narrowing). Congruency of the joint after
osteotomy was simulated using pelvic radiograph obtained with the
hip abducted and internally rotated. dGEMRIC is reported as the
average T1Gd of the weight bearing femoral and acetabular
cartilages. Failure after osteotomy: A hip was considered failed if
there was no improvement in WOMAC, continued joint space
narrowing, or underwent total joint replacement. Logistic regression
analysis was done to determine the pre-operative factors associ-
ated with failure. Response to osteotomy: The remaining non-failed
hips were followed using dGEMRIC. The importance of pre-
operative factors such as age, LCE, JSW, subluxation, To¨nnis
grade, joint congruency, and pre-operative dGEMRIC on the
change in dGEMRIC after surgery was assessed using multiple
regression analysis.
Results. Failure after osteotomy: Nine out of 52 hips failed.
dGEMRIC was 365 in hips that failed, relative to 496 in those that
did not. (Previously, we have measured dGEMRIC in hips with
normal morphology to be 570 G 90.) Univariate analysis demon-
strated that the presence of To¨nnis grade 2 or 3, low dGEMRIC,
severe dysplasia, and presence of subluxation were associated
with failure. Logistic regression analysis conﬁrmed that two factors,
dGEMRIC (likelihood ratio testZ 9.91, PZ 0.002) and subluxation
(likelihood ratio test Z 6.33, P Z 0.012) were associated with
failure. Response to osteotomy: Non-failed hips were followed after
surgery. Regression analysis demonstrated that only pre-op
S62dGEMRIC and To¨nnis grade were signiﬁcantly associated with the
change in dGEMRIC after osteotomy. Hips were stratiﬁed:
moderate OA (pre-op dGEMRIC ! 480) and mild OA (pre-op
dGEMRIC R 480); in the moderate OA group, an increase in
dGEMRIC was seen at 6 months and a further increase at
12 months. In the mild OA group, there was a drop in dGEMRIC at
6 months. These cases are being followed and hypotheses
generated as to the factors responsible for the observed changes
after surgery.
Conclusions: dGEMRIC appears to be a useful metric for identifying
hips that are poor candidates for osteotomy. Osteotomy is generally
effective in improving symptoms; however, the disease modifying
ability is unclear. dGEMRIC may be useful as a technique to better
understand what factors lead to improvement or further degener-
ation of cartilage post-intervention.
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VALIDATION OF QUANTITATIVE CARTILAGE MEASURE-
MENTS ON A 1 T EXTREMITY MRI SYSTEM
D. Inglisy, G. Ionnidisy, F. Ecksteinz, M. Puiy, P. Boulosy,
J. D. Adachiy, C. Webberx
y McMaster University, Hamilton, ON, Canada
z Institute of Anatomy & MSR, Salzburg, PU, Austria
x Hamilton Health Sciences, Hamilton, ON, Canada
Aim: Quantitative magnetic resonance imaging (qMRI) of articular
cartilage is typically performed using 1.5 T whole-body imaging
systems. As dedicated extremity MRI is relatively inexpensive and
more convenient than conventional whole-body MRI, there is
signiﬁcant merit in establishing the validity of qMRI using a 1 T
extremity scanner. The aims of this study were to: (1) examine the
short-term precision of qMRI on a 1 T extremity scanner, and (2)
establish the validity of the technique by comparing results with
those obtained using a previously validated MR sequence on a 1.5
T whole-body scanner.
Methods: Six normal subjects (2 males, 4 females: mean age (SD)
29.7 (5) years) and six with mild to moderate OA (6 females: 61.7
(10.4) years) were examined using a Siemens Magnetom (1.5 T)
whole-body scanner and an ONI Medical Systems, Inc., OrthOne (1
T) extremity scanner. Four 3D coronal acquisitions were obtained
of one knee for each subject: two at 1.5 T (FLASH we, TR Z 18.6
ms, TE Z 9.34 ms, FA Z 15o, resolution Z 0.31 ! 0.31 ! 1.5
mm3, scan timeZ 8:15 min) and two at 1 T (SPGRE fatsat, 59 ms,
10.9 ms, 37o, 0.31! 0.62 [interpolated to 0.31]! 1.5 mm3, 14:09
min) with repositioning between replicate scans. Imaging on the two
different systems was within 4 weeks. Propriety software was used
to segment the medial and lateral tibial and femoral cartilage plates
from which volume (ToVol), surface area (ToCrSf) and mean
thickness (ToThMea) measurements were obtained.
Results: The average precision errors (RMS CV%) reported are for
pooled normal and OA subjects. At 1 T, precision errors for ToCrSf
ranged from 1.7%, medial tibia (MT) to 2.8%, medial femur (MF)
and compared favourably with those at 1.5 T: 1.8%, MT to 2.1%,
MF. ToVol imprecision ranged from 3.6%, MT to 5.6% MF at 1 T
and was somewhat higher than at 1.5 T: 1.6%, lateral tibia (LT) to
3.4%, MF. ToThMea imprecision ranged from 2.9%, MT to 4.0%,
LT and lateral femur (LF) at 1 T and compared reasonably with that
at 1.5 T: 1.6%, MT to 3.2%, MF. High levels of agreement were
found between the two scanners over all plates for ToCrSf
(ICC(2,1) Z 0.997; 95% CI: 0.994, 0.998), ToVol (0.990; 0.982,
0.994) and ToThMea (0.982; 0.863, 0.961). Similar results were
found for analyses of individual plate and subject classiﬁcations. The
average over-underestimation at 1 T vs 1.5 T ranged from 1.0%
to 1.9% for ToCrSf, from 7.7% to 1.4% for ToVol, and from 9.7%
to 1.7% for ToThMea. With the exception of the LF in normal sub-
jects (ToVol, ToThMea), there was no statistically signiﬁcant syste-
matic bias in the data assessed with a Wilcoxon signed-rank test.
Conclusions: This is the ﬁrst study to establish the validity of qMRI
of articular cartilage using a 1 T extremity scanner and to examinethe short-term precision of the technique. The short-term precision
errors of the reported metrics were comparable to those at 1.5 T.
Measurements obtained at 1 T correlated highly with those
obtained at 1.5 T and, with few exceptions, were found to display
no signiﬁcant over- or underestimation. The results of this study
demonstrate that qMRI of articular cartilage can be reliably
performed using an OrthOne 1 T MRI scanner.
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EXAMINATION OF CARTILAGE SHAPE AND ITS RELATION
TO CHOICE OF SCAN PLANE IN MRI OF THE KNEE
J. A. Lynchy, M. Grigoryany, A. Guermaziz, C. G. Peterfyz,
H. K. Genanty
y Department of Radiology, University of California at San
Francisco, San Francisco, CA, USA
z Synarc Inc, San Francisco, CA, USA
Measurement of cartilage thickness from MRI of the knee is
problematic due to the curved nature of the thin sheets of articular
cartilage. Typically MRI scans are taken with in-plane resolution
typically 2–6 times the slice thickness. This causes partial volume
artefacts to obscure boundaries of cartilage when it intersects the
scan plane in a non-perpendicular manner. The aim of this study
was to determine which scan planes are optimal for imaging
different regions of the cartilage.
Methods: Five non-arthritic subjects had one knee imaged using
a fat-suppressed three-dimensional spoiled gradient echo MRI.
Scans were analysed using automated software to extract 3D
surfaces of subchondral bone and the articular surface of the
cartilage. The software output ﬁles deﬁned the 3D shape of these
surfaces using cubic B-splines, typically using upto 700 points. For
each of those points, the direction of the normal vector to the
surface was also recorded, along with the angle of this normal to
each of the three regular scanning planes (sagittal, coronal and
axial).
Results: More than 50% of the patella cartilage intersected axial
planes at an angle of 75( or more and 90% intersected at 55( or
better. For sagittal planes, these angles became 70( and 45(,
respectively. For 2/3 of patellar cartilage, axial planes had the least
partial volume problem, and for 1/3 sagittal was optimal.
For both sagittal and coronal planes, 50% of the tibial cartilage
surface intersected the scan plane at 75( or better, and 90% at 40(
or better. For 51% of tibial cartilage, sagittal planes would have
least partial volume artefact, with coronals best for 48%. Overall,
the only differences between sagittal and coronal planes were in
anatomical site, with the coronals being best for cartilage close to
the tibial spines, and sagittals best in the scoops of the tibial
plateau.
For femoral cartilage, 50% of surface intersected sagittal planes at
72( or higher, and 90% at 40( or higher. Due, in main, to the
orientation of cartilage at the posterior aspects of the femoral
condyles and at the patello-femoral articulation, more than 50% of
femoral cartilage intersected coronal planes at 40( or less, and only
20% at 70( of higher. Values for axial planes were similar to those
for coronal planes, except that it was the most superior portions of
the femoral cartilage that were close to parallel to axial planes.
Conclusions: Axial scan are optimal for imaging patellar cartilage
and would give the least amount of partial volume artefacts, but
were only slightly superior to sagittal scans. Partial volume artefacts
would affect tibial cartilage measurement to similar extents using
either sagittal or coronal scans, with the best scan plane being
determined by whether cartilage close to the tibial spines, or
cartilage in the scoop of the tibial plateau, needed to be well
imaged. For the latter, sagittal scans should be best. For femoral
cartilage, with both axial and coronal scans, less than 1/4 of femoral
cartilage would be likely to have low partial volume artefacts.
Sagittal scan planes will image most of the femoral cartilage with
low likelihood of partial volume errors.
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PROXIMAL TIBIAL BONE MINERAL DENSITY VARIES IN IN-
DIVIDUALS WITH DIFFERING DEGREES OF RADIOGRAPHIC
KNEE OSTEOARTHRITIS
L. E. Thorpy, J. A. Blockz, N. Shakoorz, D. R. Sumnery
y Anatomy and Cell Biology, Rush University Medical Center,
Chicago, IL, USA
z Section of Rheumatology, Rush University Medical Center,
Chicago, IL, USA
Aim of study: The purpose of this study was to investigate if
variations in local BMD exist in individuals with differing degrees of
radiographic knee osteoarthritis (OA).
Methods: Forty-three females with varying degrees of radiographic
knee OA, assessed by the modiﬁed Kellgren and Lawrence grading
scale, underwent dual X-ray absorptiometry (DXA) analysis to
determine areal bone mineral density (aBMD) of the proximal tibia
(Table I). aBMD of ﬁve tibial regions of interest (ROI), four condylar
and one diaphyseal, was measured by DXA (General Electric
Lunar Prodigy, Madison, WI) (Fig. 1). The proximal-to-distal aBMD
ratio in both the medial and lateral tibial condyles was determined
by the following formulae: (medial ratio Z ROI 1/ROI 3 and lateral
ratio Z ROI 2/ROI 4). aBMD of each region of interest and the
proximal-to-distal ratio of condylar aBMD were normalized to
account for the effect of body mass index (BMI) on aBMD. Data
were analyzed by repeated measures ANOVA and one-way
ANOVA with post hoc tests.
Results: The proximal-to-distal ratio of aBMD in the medial tibial
condyle was found to be signiﬁcantly greater in knees with grade 1
radiographic OA vs knees with grade 3 OA (P Z 0.044). A
signiﬁcant interaction was found between location (proximal vs
distal ROIs of the medial tibial condyle) and radiographic OA grade
(P Z 0.05). While no signiﬁcant differences were found between
speciﬁc proximal or distal condylar ROIs among any of the three
OA grades, as radiographic disease severity increased, aBMD in
the medial condyle tended to decrease proximally (by 11% from
grade 1 to grade 3) and increase distally (by 12% from grade 1 to
grade 3). No such trends were seen laterally. No signiﬁcant
differences in diaphyseal aBMD were found among the three OA
grades.
Discussion: The distribution of BMD in the medial tibial condyle was
shown to vary in individuals with differing degrees of radiographic
knee OA. The proximal-to-distal BMD ratio in the medial condyle
was signiﬁcantly less in individuals with grade 3 knee OA vs those
with grade 1 OA. Speciﬁcally, BMD just beneath the articular
Table I
n Avg. Age (GSD) Avg. BMI (GSD)
Grade 1 6 60.8 (G12.1) 26.8 (G4.1)
Grade 2 26 56.7 (G9.5) 28.7 (G4.1)
Grade 3 11 62.5 (G7.2) 30.4 (G3.2)surface of the medial tibial condyle may actually be decreasing and
BMD of bone more distal in the medial condyle may be increasing
as OA severity increases. No differences in BMD were noted in the
diaphysis based on radiographic OA grade, suggesting factors
other than disuse of the affected extremity, such as alterations in
bone remodeling or alterations in joint contact forces may be
responsible for the observed variations in condylar BMD.
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FUNCTIONAL MALCENTERING OF THE HUMERAL HEAD AND
ASYMMETRIC LONG TERM STRESS OF THE GLENOID IN
PATIENTS WITH GLENOHUMERAL OSTEOARTHRITIS
R. M. O. von Eisenhart-Rothey, K. H. Englmeierz, T. Voglx,
H. Graicheny
y Department of Orthopedic Surgery, JWG University of Frankfurt,
Stiftung Friedrichsheim, Frankfurt, Germany
z Institute for Medical Informatics, GSF Neuherberg, Neuherberg-
Munich, Germany
x Institute for Clinical and Interventional Radiology, JWG University
of Frankfurt, Frankfurt, Germany
Aim of the study: To apply 3D imaging techniques for simulta-
neously analyzing glenohumeral kinematics and long-term stress
distribution of the glenoid in patients with primary and secondary
(cuff-arthropathy) glenohumeral osteoarthritis (OA). Our hypothe-
ses were: (1) functional humeral head decentering occurs in
patients with shoulder OA; (2) the de-/centering of the humeral
head has a high correlation with subchondral bone density, as an
expression of the long-term stress distribution of the glenoid.
Methods: The shoulders of 28 healthy volunteers (24–39 years)
and 16 patients (51–82 years) with glenohumeral OA were
investigated. Eight patients demonstrated primary OA with no
signs of a rotator cuff tear, in the other eight extensive rotator cuff
lesions were found.
The shoulder joints were examined with an open MR system
(0.2 T). Images were obtained at 30( and 90( of abduction [neutral
and external rotation]. After segmentation and 3D reconstruction of
the bony structures, the 3D position of the humeral head and the
glenohumeral translation were calculated.
The distribution of subchondral mineralization in the glenoid cavity
was determined by CT osteoabsorptiometry. Transversal sections
were acquired with a CT scanner. After selective segmentation of
the subchondral plates, the 3D density distribution of the glenoid
was evaluated.
S64Results: At 30( of abduction, only four patients (25%) showed
a signiﬁcant posterior humeral head position (12.9G 2.8 mm, P!
0.01), all patients with cuff-arthropathy demonstrated superior
malcentering (6.6 G 2.7 mm; P ! 0.01). At 90( (with external
rotation), nearly all (87.5%) patients displayed signiﬁcant (P !
0.001) superior and posterior malcentering (functional malcenter-
ing) compared to the healthy shoulders. Only two patients showed
a centered head in both planes.
The patients yielded signiﬁcant changes of subchondral minerali-
zation patterns, the maxima being located in the direction of the
humeral head malcentering. Shoulders with a ﬁxed (functional)
posterior decentering yielded a monocentric [bicentric; Fig. 1(a)]
posterior mineralization pattern, in patients with cuff-arthropathy the
maxima were shifted superiorly [Fig. 1(b)]. Correlation between
position of the maxima and the humeral head was high (rZ 0.96).
Conclusions: We demonstrate that almost all patients with
glenohumeral OA display functional malcentering, which has
a relevant inﬂuence on long-term glenoid loading. This technique
helps to improve the understanding of pathomechanics and
implications of this disease. If this malcentering is not corrected
intraoperatively it might be responsible for postoperative glenoid
loosening and instability in shoulder arthroplasty.
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RADIOLOGICAL PROGRESSION IN PATIENTS WITH OSTEO-
ARTHRITIS AT MULTIPLE SITES IS INFLUENCED BY READ-
ING RADIOGRAPHS IN PAIRS OR IN CHRONOLOGICAL
ORDER
S. A. Botha-Scheepersy, I. Wattz, M. Kloppenburgy
y Department of Rheumatology, Leiden University Medical Center,
Leiden, Netherlands
z Department of Radiology, Leiden University Medical Center,
Leiden, Netherlands
Objective: To determine the inﬂuence of knowledge about the
chronological order of radiographs on radiological progression
scores in patients with well-documented OA at multiple sites.
Methods: In the GARP (Genetics, Arthrosis and Progression)
progression study, sib-pairs between 40 and 70 years of age with
OA at multiple sites were included. For the present study a random
sample of 20 participants was selected. Standardised radiographs
of the hand, hip and tibiofemoral joints and cervical and lumbar
spine were obtained at baseline and after 2 years and scored
according to the consensus of two experienced readers. Joint
space narrowing (JSN) and osteophytes in the DIP, PIP, MCP, IP,
ﬁrst CMC, STT, hip and tibiofemoral joints were graded (0–3) with
the help of the Altman atlas. The cervical (C2-7) and lumbar (L1-S1)
spine was graded (0–3) for disc space narrowing (DSN) and
anterior osteophytes using the Lane atlas. Films were read by two
different procedures. (1) Paired: all radiographs of the same patient
of both points in time presented together with the order in time
unknown to the readers. (2) Chronological: all radiographs of the
same patient of both points in time presented together in known
chronological order. Radiological progression was deﬁned as an
increase of at least one grade in JSN, DSN or osteophyte total
scores of the hands, hips, knees and spine. The standardised
response mean (SRM) was calculated for paired and chronological
reading procedures.
Results: Reading radiographs in pairs resulted in progression of
JSN or DSN scores in the hands, hips, knees and spine in
respectively 5, 5, 20 and 20% of the patients compared with
progression in 15, 10, 25 and 20% of the patients when read in
chronological order. Progression of osteophyte scores in the hands,
hips, knees and spine occurred in respectively 15, 10, 10 and 25%
of the patients according to the paired procedure compared with
progression in 15, 10, 25 and 35% of the patients with the
chronological procedure. The SRM for JSN or DSN progression
scores in the hands, hips, knees and spine were respectively 0.00,
0.00, 0.32, 0.13 and 0.38, 0.32, 0.56, 0.18 for the paired and
chronological readings. The SRM for osteophyte progression
scores in the hands, hips, knees and spine were respectively0.39, 0.20, 0.32, 0.38 and 0.41, 0.37, 0.56, 0.66 for the paired and
chronological readings.
Conclusion: When assessing radiological progression in OA, the
JSN, DSN and osteophyte progression scores are inﬂuenced by
the reading procedure. More patients showed progression of JSN,
DSN and osteophyte scores with the chronological than with the
paired reading procedure. Chronological readings are more
sensitive to change than paired readings when assessing
radiological progression in OA. These ﬁndings have implications
for the choice of reading procedure in OA progression studies.
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A STEREOPHOTOGRAPHIC STUDY OF ANKLE CARTILAGE
THICKNESS; DISTRIBUTION AND SURFACE TOPOGRAPHY
S. A. Millingtony, M. Grabnerz, S. R. Hurwitzx, J. R. Crandally
y Center for Applied Biomechanics, University of Virginia, Charlot-
tesville, VA, USA
z Department of Computer Graphic and Vision, Technical University
of Graz, Graz, Steiermark, Austria
x Department of Orthopaedic and Trauma Surgery, University of
Virginia, Charlottesville, VA
Aim of this study: To characterise the mechanical properties of
ankle articular cartilage; help improve ankle prosthesis design and
validate the accuracy of ankle cartilage MRI it is essential to have
accurate joint morphology and measurements of the articular
cartilage thickness and variation in thickness across the joint
surface. In this study we examine these parameters over the entire
ankle joint by using a high precision state of the art stereo-
photogrammetry system.
Method: Twelve male cadaveric lower leg specimens were
disarticulated at the ankle joint. The cartilage surfaces of each
ankle joint were imaged relative to photo targets which were rigidly
ﬁxed to the specimen. The stereophotogrammetry system (ATOS)
has a measurement noise (accuracy) of G2 mm and generated
a dense point cloud, typically on the order of 70,000 points per
cartilage surface. The cartilage was then dissolved using 5%
sodium hypochlorite solution to reveal the subchondral bone and
the process repeated for the subchondral bone surfaces. The photo
targets form a common reference system for the cartilage and bone
surfaces allowing the measurement projects to be combined to
generate a 3D model of the cartilage layer of the ankle. Cartilage
thickness was measured by performing an octree-based search for
every point on the cartilage surface to ﬁnd its nearest neighbour on
the corresponding bone surface. The mean and maximum thick-
ness and coefﬁcient of variation were calculated; the coefﬁcient of
variation provides a description of the variation of thickness within
a cartilage layer. Thickness distribution maps were also generated.
Results: The mean cumulative cartilage thickness of the ankle joint
(talus, tibia and ﬁbula combined) was 1.18 G 0.23 mm, the mean
maximum cumulative cartilage thickness of the entire ankle joint
was 2.17G 0.46 mm. When considering the cartilage layers of the
talus and the tibia–ﬁbula complex separately the mean and mean
maximum thickness for the talus were 1.17G 0.18 mm (0.85–1.40
mm) and 2.12 G 0.54 mm (1.52–3.43 mm), respectively. For the
tibia–ﬁbula complex the mean and mean maximum thickness were
1.18 G 0.28 mm (0.44–1.53 mm) and 2.3 G 0.57 mm (1.43–3.17
mm), respectively. The coefﬁcient of variation for cartilage layers
were 30.9G 5.1% (24.4–42.0%); 30.5G 11.7% (22.4–66.0%) and
30.4 G 9.0% (21.7–66.0%) for the talus, tibia–ﬁbula complex and
the cumulative cartilage of the entire ankle, respectively.
Conclusions: This study addresses a number of needs including;
quantiﬁcation of the cartilage thickness and thickness distribution
over the entire ankle joint including the malleoli, however, the most
important application of our technique is the development of a ’gold
standard’ for comparison and validation of the accuracy of MRI
scanning in the thin highly congruent cartilage layers of the ankle.
Additionally our models provide a quantitative database which may
assist in the development of ﬁnite element models for cartilage
stress and strain predictions, which may provide an insight to
mechanism for development of ankle OA.
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DIGITAL IMAGING OF STANDARDIZED RADIOGRAPHS DE-
FINES ALIGNMENT RISK FACTORS IN KNEE OSTEOARTHRI-
TIS (OA)
T. D. Cooke, R. A. Scudamore
School of Rehabilitation Therapy, Queen’s University, Kingston,
ON, Canada
Purpose: Digital analysis of bone geometry and joint space in Knee
OA of Canadians and Saudis was used to evaluate alignment risks
factors.
Summary of methods, results and discussion: Standardised Knee
Imaging (SKI) was used as a positioning frame that incorporated
reference markers and uniform set-up to obtain reliable frontal
(Hip–Knee–Ankle [HKA]) views. Digitized images of frame refer-
ence markers and bone landmarks were subject to electronic
manipulation to deﬁne geometric parameters (SD ! 2o) of each
bone’s and joint contribution to the HKA alignment (varus or valgus
deformity); data were stored and retrieved electronically.
Knee alignment of 119 healthy Canadian adults used for controls.
Alignment data of 167 Canadian OA (COA) was compared to 182
Saudi OA (SOA) cases. Pearson correlation coefﬁcient (P! 0.05)
was used in the analysis.
OA patterns were predominantly Varus. Valgus alignment was
identiﬁed in just 25% COA and in less than 5% SOA. SOA cases
exhibited overall more severe varus (P ! 0.001). Within all the
varus OA cases the femoral geometry (not tibial) was found to be
the signiﬁcant bone contributor to malalignment (SOAO COA, OA
O Healthy Adults at P! 0.001). Female SOA were much younger
than COA (P ! 0.001) with more severe arthritic damage in O50
years group. Greatest varus was found in older SOA and linked to
tibial plateau erosion evident in advanced disease.
Conclusions
(1) Femoral varus was identiﬁed as a novel alignment risk factor in
Varus knee OA.
The frequency of femoral varus questions the general use of tibial
realignment osteotomy for varus.
(2) Greater overall severity of varus OA in Saudis may relate to
culture (squatting and praying).
Severity of tibial erosion in older Female Saudi cases may relate to
bone weakness, lifestyle and obesity.
(3) Digital format of SKI alignment data was readily analysed for
bone and joint contributions to the deformity.
Significance: Digital applications of SKI were of great utility in
studying alignment in Knee OA. SKI reliably deﬁned the speciﬁc
contribution of bone angular features in the limb deformity. The data
support the use of femoral corrections in selected cases which may
improve osteotomy outcome in Varus knees. Digital processing
provided by SKI facilitated electronic access for collection and
analysis of the alignment data. Longitudinal studies of alignment
are indicated to deﬁne the source of the femoral varus. SKI may be
used in outcome studies of OA therapeutics for the role of bracing,
chondroprotective agents, and early speciﬁc realignment for cases
at risk.
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QUANTITATIVE MICRO-MORPHOMETRY OF ARTICULAR
CARTILAGE OF RABBIT KNEE JOINTS IN AN ANIMAL MODEL
OF OSTEOARTHRITIS – COMPARISON OF MAGNETIC RESO-
NANCE IMAGING AND MACROSCOPY
L. Wachsmuthy, S. Wrubelz, S. Chrubasikx, E. Lindhorstjj,
H. P. Juretschke{, F. Eckstein#
y Institute of Medical Physics, University of Erlangen, Germany
z Institute of Anatomy, University of Munich, Germany
x University of Freiburg, Germany
jj Klinikum Marburg, University of Marburg, Germany
{ Aventis Pharma Deutschland GmbH, Frankfurt a.M., Germany
# Institute of Anatomy and Musculoskeletal Research, University of
Salzburg, AustriaAim of the study: We investigated whether high-resolution 3D MRI
performed with a scan protocol that is suitable for continuous in vivo
imaging could allow for a precise qualitative and quantitative
analysis of cartilage morphology in a surgically induced OA rabbit
model.
Methods: Excised knee joints of skeletally mature New Zealand
White rabbits, sacriﬁced at 6 months after a combined unilateral
medial meniscectomy and transection of the anterior cruciate
ligament (nZ 8) were subjected to MRI at 7.1 T (Bruker, Karlsruhe,
Germany). A custom-built halfbirdcage coil (Center for Magnetic
Resonance, The University of Queensland, Brisbane, Australia)
was used to simultaneously image both, operated and contralateral
non-operated knees in the coronal plane. We used an optimized 3D
gradient echo protocol (TR 10.8 ms, TE 4.7 ms, ﬂipangle 5(, spatial
resolution 182 ! 182 ! 260 mm3, 4 acquisitions, scan time 50
min).
Analysis of 3D MRI and macroscopic appearance of tibia plateaus
was performed with one scoring system. Cartilage was graded on
a 4-point scale: 0: normal, 1: superﬁcial lesion/signal alteration,
contour abnormality, 2: cartilage loss !50%, 3: full thickness car-
tilage loss. Segmentation of tibia plateau cartilage was performed
on a section-by-section basis. We performed a systematic quan-
titative description of cartilage morphology by determining 3D para-
meters (mean/maximum thickness, volume, surface area, etc.).
We also determined the reproducibility of quantitative MRI
morphometry by calculating the coefﬁcients of variation (RMS
CV%) of repeated analyses in control knees from rabbits (nZ 6, 2
repetitions) without joint damage from an unrelated pharmacolog-
ical study, using the same imaging protocol.
Results: Within 6 month rabbits developed cartilage lesions being
most severe at the medial joint site. We observed contour
abnormalities, partial thickness loss, and focal areas with denuded
subchondral bone. Considering only the detection of macroscop-
ically conﬁrmed defects, sensitivity of MRI diagnosis was 92.7%. Of
the 137 (from 144) affected areas 59 (43.07%) were graded
identically. Thirty-three (24.09%) diagnoses differed by one grade,
and 45 (32.85%) diagnoses differed by two grades. Osteophytes
were detected by MRI with 100% accuracy.
Mean cartilage volume was signiﬁcantly reduced (18.54% G
17.02%) in operated knees when compared to the contralateral
non-operated knees (Students paired t test, PZ 0.013). The RMS
CV% of quantitative MRI based cartilage parameters of the medial
tibia plateau was 4.58% for cartilage volume, 7.10% for cartilage
thickness, and 4.20% for surface area. Precision errors in the
lateral tibia were in a similar range.
Conclusions: Within a scan time of less than 1 h, suitable for in vivo
examinations, MRI allowed for a comprehensive qualitative and
quantitative description of cartilage morphology in an OA rabbit
model. Accordance of MRI diagnosis with the gold standard
macroscopy and reproducibility of MRI based quantitative mor-
phometry is comparable to human studies.
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NORMAL VALUES OF MEDIAL TIBIOFEMORAL MINIMUM
JOINT SPACE WIDTH IN THE KNEES OF HEALTHY MEN
AND WOMEN
K. A. Beattiey, P. Boulosz, J. Duryeax, M. Puix, J. O’Neillz,
C. E. Webberjj, J. D. Adachiz
y Department of Medical Sciences, McMaster University, Hamilton,
ON, Canada
z Department of Medicine, McMaster University, Hamilton, ON,
Canada
x Department of Radiology, Brigham & Women’s Hospital, Boston,
MA, USA
jj Department of Nuclear Medicine, Hamilton Health Sciences,
Hamilton, ON, Canada
Aim: The purpose of this study was to evaluate and compare
‘‘normal’’ values of medial minimum joint space width (mJSW) in
S66the knees of healthy, Caucasian men and women over the age of
20 years.
Methods: Men and women without a history of knee pain, bone/joint
disease or knee injury were recruited to participate. All volunteers
underwent a single knee radiograph acquired using a ﬁxed-ﬂexion
protocol. Radiographs were graded by a radiologist according to
the Kellgren–Lawrence (K–L) scale. Those knees scoring R 2 on
the K–L scale were excluded. Films were digitized using a Vidar
Sierra Plus digitizer and analyzed for medial mJSW using an
automated computer algorithm.
Results: One hundred and seven healthy volunteers participated;
68 females and 39 males. The age distribution, mean age, body
mass index (BMI) and mJSW values for each sex and age group
are displayed in Table I.
A univariate ANOVA was performed to test for interaction between
sex and age as independent variables. With no signiﬁcant
interaction (P > 0.05), a linear regression analysis was performed
to determine whether sex and age are signiﬁcant predictors of
mJSW. Indeed, sex and age signiﬁcantly predicted mJSW in the
knees of these individuals (P ! 0.05). The comparison between
men and women revealed that healthy men have signiﬁcantly larger
mJSW values than healthy women of the same age group, by
a magnitude of R0.5 mm for most age groups, as shown in Fig. 1.
In addition, mJSW decreases signiﬁcantly, albeit slightly, with age
in both healthy men and women.
Conclusions: These data suggest that healthy Caucasian men
have larger mJSW values than healthy women of comparable
ages and that the magnitude of this difference appears to be
consistent (approximately 0.5 mm) across age groups. In addition,
even in healthy individuals it appears that mJSW decreases with
aging.
Table I
Mean age, body mass index and minimum joint space width values
for healthy males and females in different age groups
Sex Age group
(years)
N Mean age
(SD) (years)
Mean BMI
(SD) (kg/m2)
Mean mJSW
(SD) (mm)
Female 20–29 22 24.36 (2.40) 22.03 (1.90) 5.02 (0.54)
Female 30–39 11 33.33 (3.34) 22.73 (3.11) 4.49 (0.69)
Female 40–49 13 45.46 (2.60) 26.36 (5.46) 4.82 (0.71)
Female 50–59 17 53.18 (2.65) 27.60 (5.71) 4.75 (0.93)
Female 60–69 5 62.60 (3.13) 25.20 (5.59) 4.61 (0.44)
Male 20–29 15 23.62 (2.58) 24.38 (3.59) 5.58 (0.55)
Male 30–39 9 32.67 (2.83) 26.67 (4.35) 5.61 (0.68)
Male 40–49 8 44.75 (3.11) 26.89 (5.73) 5.34 (1.08)
Male 50–59 5 55.40 (2.41) 26.00 (2.01) 5.65 (0.53)
Male 60–69 2 66.00 (2.83) 29.48 (0.76) 4.72 (0.35)P158
A NEW METHOD OF HIGH RESOLUTION IMAGING FOR
ASSESSING OSTEOARTHRITIS IN JOINTS
M. Harmany, D. L. Stamperyz, S. B. Adamsy, B. Liuyz, S. Giattinay,
M. J. Robertsy, S. D. Martinyz, M. E. Brezinskiyz
y Department of Orthopedic Surgery, Brigham and Women’s
Hospital, Boston, MA, USA
z Harvard Medical School, Boston, MA, USA
Aim of study: To evaluate the efﬁcacy of optical coherence
tomography (OCT) to assess and monitor minor/subtle changes
in osteoarthritis (OA).
Methods: The OCT system used for this study utilized a light source
having a bandwidth (range of wavelengths within the beam) of
60 nm and a center wavelength of 1310 nm. The broader the
bandwidth used to image with OCT, the higher the resolution. The
axial resolution was measured to be 12 mm from the point spread
function off a mirror. A 30 mm focal length lens was used which
resulted in a transverse resolution of 10 mm. Images are generated
as one- and two-dimensional, cross-sectional images (4 mm ! 2
mm). A visible light guiding beam was used for registration.
The most important advantage of OCT is its high resolution of 4 mm
(up to 25! higher than anything in clinical medicine). In addition,
OCT imaging can be performed in real time with a high acquisition
rate, as well as through a small endo-catheter less than 0.017$ in
diameter and can be combined with a range of spectroscopic
techniques. We have examined cartilage (both normal and OA),
tendons, and ligaments with both structural OCT and polarization-
sensitive OCT (PS-OCT). Studies were performed both in-vivo and
in-vitro in both animal models and humans.
Results: Changes identiﬁed in OA cartilage include cartilage
thinning, micro-ﬁbrillation, and the disruption of the cartilage/bone
interface. In some cases, cartilage breakdown was identiﬁed prior
to cartilage thinning using PS-OCT demonstrating differences in the
rate of optical rotation measured both off A-scans and fast Fourier
transform (FFT). Similar observations were noted when comparing
healthy vs diseased tendons and ligaments. In addition, absorption
and dispersion OCT spectroscopy has yielded information on water
content, which is also relevant to OA.
Conclusion: This study demonstrates that OCT imaging provides
an excellent model for the sequential monitoring of OA. The high
resolution and polarization sensitivity of OCT allows the early
detection of surface ﬁbrillations, changes in cartilage thickness, and
changes in the bone/cartilage interface, providing a valuable tool for
the testing of therapeutics. In conclusion, OCT represents a
promising new technology for assessing early/subtle OA.
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THE ASSOCIATION BETWEEN PATIENT-REPORTED PAIN
AND MAGNETIC RESONANCE IMAGING (MRI) OF THE KNEE
P. Boulosyz, K. A. Beattiez, M. Puizx, G. Ioannidisz, A. Pathakz,
D. Inglisz, C. E. Webberzx, J. D. Adachiyz
y St. Joseph’s Healthcare, Hamilton, ON, Canada
z McMaster University, Hamilton, ON, Canada
x Hamilton Health Sciences, Hamilton, ON, Canada
Aim: To determine the association between patient-reported knee
pain and MRI ﬁndings.
Methods: Patients referred for knee pain were prospectively
enrolled into this study. Exclusions: (1) major trauma to the knee
and (2) conﬁrmed inﬂammatory arthritis. All patients completed
a set of questionnaires, had a full history and physical examination
performed. Knee pain was assessed by a 100 mm visual analog
scale (VAS) for severity of pain in the past 48 h and the presence of
‘knee pain today’. An MRI of the study knee, the most painful knee
at the time of the visit, was performed the same day using a 1 T
extremity scanner. Sequences included a sagittal T1-weighted,
3D spoiled gradient echo (SPGRE) with fat saturation, a sagittal
T1-weighted fast spin echo (FSE), a coronal T2-weighted FSE and
S67an axial FSE inversion recovery sequence. A radiologist read and
semi-quantitatively graded the MR scans for cartilage lesions,
subchondral cysts, bone marrow edema, osteophytes, meniscal
degeneration and tears, joint effusions and loose bodies. Statistical
analyses included multivariable linear regression and exact
multivariable logistic regression, adjusted for age, sex and body
mass index (BMI). Parameter estimates (PE), odds ratios (OR) and
P-values were calculated.
Results: Forty-ﬁve patients were enrolled into the study: 36 women,
mean age (SD) 64 (12) years and 9 men, 64 (10) years. The
average body mass index (BMI) was 30 (6) kg/m2 for women and
30 (5) kg/m2 for men. Mean duration of knee pain was 8.2 (8.4)
years. At the time of interview, 72% of patients had knee pain.
Higher VAS pain scores were associated with moderate bone
edema (1–2 cm) at the medial tibia (PE: 35.6; P Z 0.05) and low
signal intensity extending to the cartilage surface at the medial tibia
(PE: 54.6; PZ 0.02) and femoral trochlea (PE: 64.4; PZ 0.02) as
compared with those with no bone marrow edema or cartilage
abnormalities. A lower VAS pain score was associated with severe
bone marrow edema (O2 cm) at the lateral femur (PE: 51.3; PZ
0.04). There were no correlations between having ’knee pain today’
and the presence, location or severity of bone marrow edema,
osteophytes or cartilage defects; or the presence or size of knee
effusions; or the presence of subchondral cyst, meniscal de-
generation or tear on MRI.
Conclusions: Bone marrow edema has been found to be
associated with the presence of pain in knee OA. This pilot study
does support some association between MRI ﬁndings and VAS
report of pain. A larger sample size will be needed to draw deﬁnite
conclusions regarding these associations.
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COMPARISON OF CHANGES IN JOINT SPACE WIDTH MEAS-
UREMENTS USING MANUAL AND AUTOMATED SEGMENTA-
TIONS
M. Barbu-McInnisy, J. G. Tamez-Penay, T. Crillyy, S. Tottermany,
A. D. Saloz, A. L. Lernerz
y Research, VirtualScopics, LLC, Rochester, NY, USA
z Biomedical Engineering, University of Rochester, Rochester, NY,
USA
This work evaluates the performance of an automated method for
measuring the joint space width (JSW) on statically loaded knees
from 3-dimensional MRI data.
Ten healthy subjects, four males and six females, 26.8 years on
average, were scanned two times, ﬁrst under unloaded conditions
and secondly under axial load equivalent to one-half the body
weight. This protocol was repeated again for a total of 40 images.
The manual approach consisted of a statistical region growing
algorithm used to segment the tibia and femur in all unloaded and
loaded images. All segmentation errors were corrected by a trained
analyst resulting in 40 manual bone segmentations. For both scan
sets, the automated approach involved tracking the manual
segmentation of the unloaded knee to its corresponding axial
loaded case. Furthermore, the manual segmentation of the axial
loaded knee was tracked to its corresponding unloaded case for
one set of scans. The differences in overlap between the
automated and manual segmentations were assessed by measur-
ing the commonly classiﬁed voxels. At the same time, an
unsupervised algorithm that identiﬁes the medial and lateral
compartments of the knee joint was used to measure the average
JSW (AJSW) and minimum JSW (MJSW) on all manual and
automated unloaded and axially loaded data sets.
The manual and the automated processes result in similar
segmentations. On average, the difference in the volume between
the manual and automated segmentations is 2.0% G 1.7% for the
tibia and 1.5% G 1.1% for the femur. The nonoverlapping regions
are 2.7% G 1.4% for the tibia and 2.3% G 1.2% for the femur.
The manual and the automated processes predict similar JSW
changes due to the axial load. When using the manual process the
AJSW change due to loading ranged from 0.37 mm to 0.94 mm.Similarly, when the automated process was used the AJSW
differences due to loading ranged from 0.53 mm to 0.92 mm. At
the same time, the MJSW differences due to the axial load ranged
from 0.93 mm to 1.04 mm and from 1.05 mm to 1.09 mm for the
manual and automated processes, respectively. The correlation of
the AJSW differences due to loading between the manual and
automated scenarios was 0.85. Furthermore, when looking at the
MJSW measurements, both methods, the manual and automated,
predict similar changes between the unloaded and loaded knees
(RZ 0.89). At the same time, the manual MJSW measurements of
the unloaded knee are not statistically different from the automated
MJSW measurements of the same set (P Z 0.13).
In this work we have demonstrated that the automated approach
predicts similar changes in JSW to the manual technique, therefore
making the JSW measurement procedure less time consuming and
more reproducible. Aside from the static JSW measurements, this
approach enables for kinematics information resulting in a dynamic
image on how the tibia moves with respect to the femur.
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HOW TO SELECT RADIOGRAPHS FOR STRUCTURE-MODIFY-
ING-DRUGS TRIALS IN PATIENTS WITH KNEE OSTEOAR-
THRITIS? A LONGITUDINAL PROSPECTIVE STUDY WITH
LYON-SCHUSS RADIOGRAPHS OF THE KNEE
T. Conroziery, P. Mathieuy, M. Pipernoy, H. Favretz, M. Vignonz,
E. Vignony
y Service de Rhumatologie, Centre Hospitalier Lyon SUD, Pierre
Benite, France
z Laboratoire D’Exploration et de Morphometrie Articulaire (LEMA),
Centre Hospitalier Lyon SUD, Pierre Benite, France
Aim: To evaluate the inﬂuence of both the medial tibial plateau
(MTP) alignment and X-rays superimposition in the sensitivity to
change of the measure of the radiological joint space narrowing
(JSN) in patients with knee OA.
Methods: One hundred and six patients with knee pain. Knee
radiographs performed using a standardized radiographic pro-
cedure (Lyon schuss view) twice at 12 month intervals. Evaluation
of the quality of MTP alignment twice by two observers using
a 5 point scale (excellent, good, fair, poor, bad). Computerized
measurement of the distance between the MTP anterior and
posterior rims (DAPR). Computerized measurement of minimum
joint space width, at baseline (M0) and 1 year (M12). Assessment
of the sensitivity to change of JSN (Standard Response Mean –
RSM) according to the DAPR and the superimposition of the
images at M0 and M12.
Results: Scoring of MTP alignment was highly reproducible and
highly correlated to DAPR measurement (P ! 0.001). The DAPR
cut-off for satisfactory (excellent/good) alignment was !1.2 mm.
JSN [SD] and SRM were statistically higher (0.26 [0.45] mm/y and
0.58) in knees with DAPR! 1.2 mm at M0 and M12 than in those
with DAPRO 1.2 mm at M0 and/or M12. In patients with DAPRO
1.2 mm at M0 and M12 the mean JSW was 0.20 mm [0.55] with an
SRM of 0.36. In patients with DAPR O 1.2 mm only at M0 or M12
the mean JSW was 0.07 mm [0.52] with an SRM of 0.19.
Conclusion: Superimposition of radiographs and quality of the MTP
alignment highly inﬂuence the sensitivity to change of JSN mea-
surement. Radiographs with DAPR! 1.2 mm at baseline and end-
point only should be used in structure-modifying-drugs trials in OAs.
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TIME SAVING USING INTERACTIVE INPUT DEVICES FOR
CARTILAGE SEGMENTATION
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sheim, Germany
jj Department of Orthopaedics, University Frankfurt, Frankfurt,
Germany
{ Institute of Anatomy and Musculoskeletal Research, Paracelsus
Private Medical University Salzburg, Salzburg, Austria
Aim: To study the effect of new interactive computer input devices
on cartilage segmentation in terms of time, consistency between
input devices, and precision in quantitative magnetic resonance
imaging (qMRI).
Methods: MR images were obtained for 12 subjects, six with no
history of knee problems (3 females, 3 males, mean age 23.3G 2.1
years) and six with knee osteoarthritis (OA) (6 females, mean age
66.8 G 7.2 years). Axial and coronal images were acquired for
each subject using a T1-weighted fast low angle shot (FLASH) 3D
gradient echo sequence with water excitation. We compared two
novel input devices, an interactive digitizing tablet (Graphire3,
Wacom, Krefeld, Germany) and an interactive touch-sensitive
screen (Cintiq 18SX, Krefeld, Germany), to a traditional mouse
(Optical Mouse, Logitech, Fremont, California). The patellar
cartilage and medial tibial cartilage from the normal and OA
datasets were segmented manually using proprietary software. A
trainee was chosen to carry out the cartilage segmentation in order
to avoid bias towards one input device. The order each input device
was used in varied and each dataset was segmented twice with a 5
day interval. Quantitative assessment of cartilage volume was
carried out using an established technique. We tested the null
hypotheses that there was no signiﬁcant difference in segmentation
time, cartilage volume and precision errors between the input
devices.
Results: Segmentation using the interactive touch-sensitive screen
yielded signiﬁcant time saving on the order of 15% for three of the
four cartilage plates when compared to the mouse. No systematic
difference in volume was found between the different input
devices. No signiﬁcant difference was found in precision (re-
producibility) of the volume measurement for the different input
devices.
Conclusions: This study, to our knowledge, is the ﬁrst to evaluate
the use of novel input devices in the context of cartilage seg-
mentation. We found that using a touch-sensitive screen can
increase the speed of manual cartilage segmentation by approx-
imately 15% and does not affect the consistency or precision of
the results. Time saving was reported at the beginning and the
end of the study when the individual was considerably more
experienced. This suggests that time saving could also be
realized with an ‘experienced’ user. The demand for qMRI anal-
ysis of cartilage will likely increase in the coming years for
such applications as disease/structure modifying OA drugs
(D/SMOADS) clinical trials, making time saving an important
issue. It is also important that there was consistency between
input devices, which suggests that segmentation is related to what
the user sees rather than the input device he or she is using. A
previous study which looked at resegmentation with a time interval
similar to the one in this study reported similar precision errors.
We conclude that results of qMRI studies are dependent on the
morphology determined by the user and not on the choice of input
device, and using a touch-sensitive screen can reduce segmen-
tation time by approximately 15%.P163
THE ACCURACY OF DIGITAL PHOTOGRAPHY FOR THE
MEASUREMENT OF ANATOMICAL BONE SPECIMENS
A. J. Shyam Kumar, S. G. Haidar, R. Penematsa, R. Charity, A. B.
Tillu
Department of Orthopaedics, City Hospital, Birmingham, United
Kingdom
The use of digital photography in medicine is increasing rapidly. It is
cheap and quick, and allows images to be easily stored, retrieved
and transmitted over the Internet. Digital imaging software allows
the photographs to be manipulated and for measurements to be
taken on them. Various papers have been published in which digital
imaging has been used to make measurements of length and of
angles on gross anatomical specimens. However, the accuracy of
digital photography, over the current ‘‘gold-standard’’ – the vernier
calliper, has not been formally assessed. We attempted to
accurately measure the cortical thickness of 24 bone samples
using a vernier calliper and by digital photography using a 5-
megapixel camera and a standardized technique. Four indepen-
dent observers, using the two methods, measured each specimen
twice. The accuracy and repeatability of the two methods were
assessed using 95%-limits-of-agreement. We found that digital
imaging was not as accurate as the vernier calliper, and that its
repeatability was marginally lower than that of the vernier calliper.
We recommend that the process of making accurate distance
measurements using digital photography needs to be reﬁned
before it can be considered as a replacement for the current gold-
standard method.
P164
QUADRICEPS STRENGTH OF PATIENTS OF OSTEOAR-
THRITIS KNEE: RELATIONSHIPS TO PAIN AND DISABILITY
N. K. Multaniy, S. K. Vermaz
y Physiotherapy, Lyallpur Khalsa College, Jalandhar, Punjab, India
z Physiotherapy and Sports Sciences, Punjabi University, Patiala,
Punjab, India
Aim of study: To examine relationships between various compo-
nents of health related ﬁtness, pain, effusion and disability in
patients with osteoarthritis knee.
Methods: The study was conducted on 200 osteoarthritis knee
patients falling in the age range of 40–70 years. Isometric strength
of leg muscles was measured by using Back-Leg-Chest Dyna-
mometer whereas isotonic strength of quadriceps was measured
by using Delorme and Watkins method. The level of disability was
assessed by performing the classiﬁcation of functional status of
patients as per the 1991 revised criteria given by The American
College of Rheumatology. Pain, tenderness and joint effusion were
recorded depending upon the severity and graded as per criteria
laid by Livesley et al. (1991). Antero-posterior weight bearing X-
rays of both knees in extension and a lateral view in 40( of ﬂexion
were obtained. Radiographic classiﬁcation was performed to know
the stage of osteoarthritis knee according to an ordinal scale of 5
levels established by Kellgren and Lawrence (1957).Table I
Partial correlation coefficients derived from multiple regression analyses with fucntional status and radiological changes as the dependent
variables and age, body weight, body mass index, isotonic strength, isometric strength, knee extension, cardiovascular fitness,%fat, lean body
mass in 200 patients with osteoarthritis knee
Variables Age Body
weight
Body mass
index
Isotonic
strength
Isometric
strength
Knee
extension
Cardiovascular
ﬁtness
%Fat Lean body
mass
Functional status 0.037 0.128 0.119 0.440* 0.332* 0.352* 0.475* 0.172 0.004
Radiological changes 0.629* 0.128 0.143 0.364* 0.169 0.110 0.008 0.027 0.1705
*P ! 0.05.
S69Results: Multiple regression analyses were used to examine
relationships between the measured parameters, taking into
account the confounding effects of age, body weight and body
mass index.
Isotonic strength of quadriceps was found to be the most important
determinant of the disability (Rpartial Z 0.440, P ! 0.05) and
stage of osteoarthritis (Rpartial Z 0.364, P ! 0.05).
Pain and effusion were not associated with either disability or stage
of osteoarthritis.
Conclusion: Quadriceps strength is closely associated with
disability of the patients of osteoarthritis knee. Hence quadriceps
strengthening exercises may be used to reduce disability of such
patients.
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A MODERN PSYCHOMETRIC ANALYSIS OF THE KOOS
QUESTIONNAIRE
P. G. Conaghany, A. Sladez, E. M. Roosx, A. Careyy,
L. S. Lohmanderx, A. Tennanty
y Academic Unit of Musculoskeletal Disease and Rehabilitation,
University of Leeds, Leeds, United Kingdom
z Sheffield Hallam University, Sheffield, United Kingdom
x Department of Orthopaedics, Lund University Hospital, University
of Lund, Lund, Sweden
Aim: The KOOS is a self-administered questionnaire which was
developed as an outcome measure for knee injury potentially
resulting in post-traumatic osteoarthritis (OA) and based on the
WOMAC instrument. It comprises 42 items, with ﬁve subscales (9
pain, 7 symptoms, 17 activities of daily living, 5 sports and
recreational function and 4 quality of life items). The aim of this
project was to perform a modern psychometric analysis of the
KOOS by assessing ﬁt to the Rasch model, which formalises
desirable measurement characteristics such as unidimensionality.
Method: KOOS questionnaires were analysed from 380 Swedish
patients (279 men) with a variety of knee problems including
meniscal and anterior cruciate ligament tears, and primary and
secondary OA (cross-sectional study). Data were applied to the
Rasch model using a computer program RUMM 2020.
Results: Analysis of the ﬁve subscales generally demonstrated
good ﬁt to the model as represented by non-signiﬁcant deviation
Table II
Partial correlation coefficients derived from multiple regression
analyses with functional status and radiological changes as the
dependent variables and pain and effusion as the independent
variables in 200 patients with osteoarthritis knee
Variables Pain Effusion
Functional status 0.016 0.104
Radiological changes 0.321 0.039
*P ! 0.05.
Table 1
Sub-scale Item
mean
Item
SD
Chi sq
prob
Misﬁtting
items
Items
with DIF
Psi
Pain 0.074 1.326 0.108 * 3 0.922
Symptoms 0.134 1.081 0.355 * * 0.883
Activities of daily
living
0.212 1.527 0.431 2 1 0.973
Sport/recreation
function
0.362 0.496 0.840 1 * 0.918
QOL 0.315 1.638 0.149 1 * 0.877from model expectations expressed through a Chi-square inter-
action statistic (Table I). Some subscales, such as ADL, displayed
individual item misﬁt, but after removal, the remaining items formed
a Rasch scale. There was also some Differential Item Functioning
(DIF) present, but the effects of such bias can be removed at the
analytical stage. All subscales showed good person separation
index, (psi) indicating ability to discriminate groups of patients along
the construct. Finally, analysis of all the items as one summary
scale showed poor ﬁt to the model as identiﬁed by a signiﬁcant
item-trait interaction (PZ! 0.001), suggesting a lack of invariance
for the total set of items.
Conclusions: The KOOS subscales fulﬁl modern psychometric
criteria for an outcome tool with the deletion of a few items, and
appropriate adjustment for DIF.
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PREVALENCE OF PATIENTS WITH LOW INTENSITY
PAIN SYMPTOM SEVERITY STATES DURING TREAT-
MENT WITH ROFECOXIB AND IBUPROFEN FOR OSTEOAR-
THRITIS
N. Bellamyy, D. Krupaz, J. E. Markindz, A. S. Reicinz,
K. Malmstromz
y CONROD, The University of Queensland, Mayne Medical School,
Brisbane, Queensland, Australia
z Merck Research Laboratories, Rahway, NJ, USA
Aim of study: To examine the prevalence of low intensity symptom
severity states in patients taking placebo, rofecoxib 12.5 mg once
daily, rofecoxib 25 mg once daily, or ibuprofen 800 mg three times
daily using a post-hoc deﬁnition of low pain intensity states (BLISS
Index) based on the WOMAC Index.
Methods: Two 6-week, double-blind, parallel-group, placebo-
controlled, ibuprofen-comparator studies were conducted to mea-
sure the efﬁcacy of rofecoxib in patients with knee or hip
osteoarthritis. These studies employed a ﬂare design requiring
a minimum level of symptoms at entry following discontinuation of
prior analgesics. The WOMAC Pain subscale (100 mm visual
analog scale) was used as the pain measure. In separate analyses,
WOMAC pain subscale scores from each patient were compared to
ﬁve thresholds of pain:%5 mm,%10 mm,%15 mm,%20 mm, and
%25 mm. The percent of patients with BLISS states (1) on average
over 6 weeks, (2) at any time during the study, and (3) at week 6
was computed for each treatment group and threshold. The
treatment group percentages were compared using Fisher’s exact
test.
Results: During the study, patients received placebo (N Z 143),
rofecoxib 12.5 mg (N Z 461), rofecoxib 25 mg (N Z 459), or
ibuprofen (NZ 465). For each pain threshold and treatment group,
the percent of patients with BLISS states at any time (e.g., 50% for
rofecoxib 25 mg) exceeded the percentage at week 6 (e.g., 40% for
rofecoxib 25 mg) which, in turn, exceeded the percentage with
BLISS states on average (e.g., 32% for rofecoxib 25 mg). The
percentages of patients in the active treatment groups with BLISS
states on average were signiﬁcantly different than observed in the
placebo group at the%15 mm threshold (8–11% points vs placebo,
P ! 0.01), %20 mm level (10–15% points, P ! 0.01), and %25
mm level (14–17% points, P ! 0.001). Signiﬁcant differences
between the active treatments and placebo were also observed at
the%10 mm threshold (8–9% points, P! 0.05) for measurements
at week 6 and at the%10 (12–14% points, P! 0.001) and%5 mm
thresholds (5–7% points, P ! 0.05) for patients with BLISS states
at any time.
Conclusion: These measures of BLISS states differentiate all
three active treatment groups from placebo and further conﬁrm, at
an individual patient level, the clinical beneﬁt of rofecoxib in
the treatment of osteoarthritis. Furthermore, they provide informa-
tion on the prevalence of patients achieving low (%15 mm, %20
mm, %25 mm), and very low (%5 mm, %10 mm) pain severity
states.
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WOMAC 20, 50, 70 RESPONSE LEVELS IN PATIENTS
TREATED WITH ROFECOXIB FOR OSTEOARTHRITIS
N. Bellamyy, D. Krupaz, J. E. Markindz, A. S. Reicinz,
K. Malmstromz
y CONROD, University of Queensland, Mayne Medical School,
Brisbane, Quensland, Australia
z Merck Research Laboratories, Rahway, NJ, USA
Aim of study: The goal of this post-hoc analysis was to examine the
difference between treatment groups when varying the target
response level from at least a 20% improvement from baseline, to
at least 50% and 70% improvements in Phase III studies of
rofecoxib in patients with osteoarthritis.
Methods: The analysis focused on results from two 6-week,
placebo-controlled, ibuprofen-comparator, Phase III osteoarthritis
studies. These studies employed a ﬂare design requiring a minimum
level of symptoms at entry following discontinuation of prior
analgesics. Two deﬁnitions of ‘‘patient improved’’ from baseline
were used: (1) WOMAC-P: a reduction in the WOMAC pain score
and (2) WOMAC-PFS: a reduction in the WOMAC pain score and
either a reduction in the WOMAC stiffness or function score. The
improvement target was increased from 20% to 50% to 70%,
relative to baseline, to investigate how the increase affects the
ability to detect the differences between treatment groups.
Analyses were conducted on the average and last of all measure-
ments collected during a 6-week treatment period.
Results: In the ibuprofen-comparator studies, 1545 patients were
randomized to placebo, rofecoxib 12.5 mg once daily, rofecoxib 25
mg once daily, and ibuprofen 800 mg three times daily in a 1:3:3:3
ratio. The percentages of patients who met the improvement
targets decrease as the target increases from 20% to 50% to 70%.
There were meaningful differences between the active treatment
and placebo that were inversely related to the improvement target.
For example, there was a 31 (P! 0.001), 21 (P! 0.001), and 12
(P ! 0.001) percentage-point difference between rofecoxib 25 mg
and placebo for the 20%, 50%, and 70% targets for WOMAC-P.
For WOMAC-PFS, the differences between rofecoxib 25 mg
and placebo were 33 (P ! 0.001), 18 (P ! 0.001), and 9 (P !
0.01) percentage points for the 20%, 50%, and 70% improvement
targets.
Conclusions: Meaningful differences between active treatments
and placebo were detected at all three response levels associated
with the WOMAC-P and WOMAC-PFS endpoints. The differences
between groups were more dramatic at the 20% and 50% response
levels. The WOMAC (20,50,70)-P and WOMAC (20,50,70)-PFS
endpoints further conﬁrm, at an individual patient level, the clinical
beneﬁt of rofecoxib in the treatment of osteoarthritis that was
previously reported as a difference in means.
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INDUCTION OF OSTEOARTHRITIS IN RATS BY TRANSECTION
OF THE MEDIAL COLLATERAL LIGAMENT AND MEDIAL
MENISCUS RESULTS IN THE DEVELOPMENT OF BOTH
OSTEOARTHRITIS-LIKE JOINT PAIN AND SECONDARY
HYPERALGESIA
S. E. Bovey, K. D. Laemonty, B. M. Sanchezy, R. M. Brookery,
K. E. Hooky, J. R. Connorz, K. S. Kilgorey
y Inflammation Pharmacology, Pfizer Global R&D, Ann Arbor, MI,
USA
z Inflammatory Mediators, Pfizer Global R&D, Chesterfield, MO,
USA
Osteoarthritis (OA) is a progressive degenerative joint disease
characterized by loss of articular cartilage, changes to the
subchondral bone and subsequent, though not necessarily
correspondent, development of joint pain. In the absence of
effective pharmacologic interventions to prevent the structural
changes associated with OA, emphasis has been placed onattenuating the symptomatic aspects (joint pain and associated
referred pain and tenderness) of the disease. In the present study,
we characterize the pain proﬁle of a rat model of surgically induced
OA. Transection of the medial collateral ligament and the medial
meniscus of male Lewis rats resulted in increased change in hind
paw weight distribution and tactile allodynia that began within 3
days post surgery and was sustained through day 28. There was,
however, no appreciable effect on thermal hyperalgesia or
mechanical hyperalgesia. Treatment with a single dose of rofecoxib
(10 mg/kg, p.o., day 21 post surgery) or gabapentin (100 mg/kg,
p.o., day 21 post surgery) signiﬁcantly attenuated the change in
hind paw weight distribution, however, only gabapentin signiﬁcantly
decreased tactile allodynia (secondary hyperalgesia). It is conclud-
ed that the rat MMT model is a model of both nociceptive and
neuropathic OA pain that is responsive to both an NSAID
commonly utilized for OA pain (rofecoxib) and a widely prescribed
drug for neuropathic pain (gabapentin). The rat MMT model may
therefore represent a predictive tool for the development of
pharmacologic agents for the treatment of joint pain.
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THE USE OF SELF-ORGANIZING MAP TO RECOGNIZE
HUMAN MOVEMENT PATTERNS
Y. Li, R. Aissaoui, A. FuentesDupre,M.Charbonneau, J. A. deGuise
Department of Automated Manufacturing Engineering, Ecole de
Technologie Superieure, Montreal, QC, Canada
Aim of study: This study applies a neural network based on the
Kohonen’s self-organising maps (SOM) to the recognition human
movements.
Methods: Fourteen volunteer healthy subjects participated in the
experiment. The experimental protocol consisted of performing four
movements from the daily life: (1) walk on a treadmill at their own
preferred speed for 5 min; (2) stand with knee ﬂexion; (3) squat; and
(4) lunge. The subjects were asked to repeat each of the last three
movements 5 times. For the walking on the treadmill, the gait cycle
is computed as the time between two heel strikes. For knee ﬂexion,
squat and lunge motions, the cycle is computed as from the
beginning of the move to the end. An ensemble average of all
cycles for each movement was determined for each subject.
The movements of right or left leg in 3D were recorded using the
magnetic tracking device Fastrak (Polhemus Inc., Colchester,
Vermont, USA) at a frame rate of 60 Hz. A receiver was ﬁxed on
a harness that was clamped at femur epicondyle of left leg, and
another receiver was secured at the tibia level by straps. For each
subject, the 3D position and orientation of the two receivers were
parameterized to form a set of 4 training vectors, which were
corresponding to the four movements. Two subjects were excluded
from the squat motion for incomplete information. The variables
analysed in this study included the three components of the angles
and accelerations for the knee joint in the sagittal, frontal and
coronal plane. From each variable’s time course, 20 intervals were
taken per movement cycle. Normalization (with a mean of 0 and
a variance of 1) was applied to all data prior to analysis. Kohonen’s
SOM (Kohonen, 1997) was used for the classiﬁcation of human
movements. The SOM algorithm was applied to all parameters,
angle parameters, and acceleration parameters in order to ﬁnd
which parameters were better for identifying different movements.
Data from ﬁve men and two women were placed in one ﬁle as
training ﬁle and a second ﬁle contained data from the remaining
subjects as testing ﬁle. Then, the process was repeated with the
ﬁles reversed and the results pooled in order to test all subjects.
Results: For the walking, almost 100% of testing ﬁle is well
classiﬁed. The maximum misclassiﬁcation is reached when
classifying ﬂexion motion, where the misclassiﬁed moves are
mostly recognised as squat motion. When only using acceleration
parameters, the identiﬁcation of movements is the highest. An
increase of misclassiﬁcation is observed when all the parameters
are used. Therefore, the classiﬁcation of human movements by
means of using acceleration parameters shows good results.
However, the results also show that the identiﬁcation of movements
S71is sensitive to the selection of parameters used in the analysis.
Further study is necessary to investigate whether the parameters
relate to the sagittal plane provide enough movement information.
Conclusions: A new method for recognising different human
movements is proposed. Based on this method, the feasibility of
identiﬁcation of movements using the self-organising maps (SOM)
is demonstrated.
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CTGF OVEREXPRESSION INDUCES SYNOVIAL FIBROSIS
AND CARTILAGE DAMAGE IN MURINE KNEE JOINTS
E. N. Blaney Davidsony, EL Vittersy, FM Mooreny, N Oliverz, WB
van den Bergy, PM van der Kraany
y Experimental Rheumatology and Advanced Therapeutics, Uni-
versity Medical Center, Nijmegen, Netherlands
z FibroGen Inc., South San Francisco, CA, USA
Introduction: CTGF has been found highly expressed in osteoar-
thritic chondrocytes, but the role of CTGF in OA is still unclear.
CTGF is known to induce ﬁbrosis in a number of organs including
the lungs and kidney. CTGF is induced by TGF-beta, which has
been shown to induce synovial ﬁbrosis in experimental OA. To
investigate whether CTGF plays a role in OA pathophysiology, we
studied the effects of adenoviral CTGF overexpression in knee
joints on cartilage and synovial ﬁbrosis.
Materials and methods: CTGF was overexpressed in murine knee
joints of C57Bl/6 mice by intra-articular injection of an adenovirus
encoding rhCTGF. After 1, 3, 7 and 14 days, knee joints were
isolated and prepared for histology. Coronal sections were stained
with safranin O/fast green and immunohistochemistry was per-
formed with procollagen I antibody to measure collagen synthesis.
Procollagen I positive cells and extracellular matrix (ECM) were
measured with a computerized imaging system to asses ﬁbrosis.
Proteoglycan content of tibial cartilage was measured to investigate
CTGF-effects on cartilage. In addition, the chondrocyte cell line H4
cells was transfected with Ad-CTGF and after 6 and 24 h RNA was
isolated for quantitative alterations in gene expression by Q-PCR.
Expression of collagen type I, II and X, MMP-3, -9 and -13 and
ADAMTS-4 was analysed.
Results: Procollagen type I expression was increased in synovium
1, 7 and 14 days after CTGF overexpression by 88%, 138% and
106%, respectively compared to animals treated with control virus.
The amount of synovial ECM was signiﬁcantly increased on day 1
and 3 by 47% and 25%, respectively. Twenty-eight days after
CTGF overexpression ECM in synovial tissue had returned to
normal values. Proteoglycan content in tibial cartilage was reduced
after Ad-CTGF injection on all days compared to viral controls.
Maximal signiﬁcant reduction of proteoglycan content was ob-
served on day 7. Expression patterns of chondrocytes revealed that
only MMP-13 was signiﬁcantly up regulated (nearly three-fold) after
transfection with Ad-CTGF compared to viral controls.
Discussion: Our data show that adenoviral overexpression of CTGF
in murine knee joints induces ﬁbrosis and cartilage damage.
Cartilage damage could be mediated by activated ﬁbroblast butcould also be a result of direct effects of CTGF on chondrocytes. A
murine chondrocyte cell line showed clear elevation of MMP-13
expression after CTGF exposure. Our results indicate that CTGF
can contribute to pathology such as cartilage damage and ﬁbrosis
in osteoarthritic joints.
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LONG TERM CELECOXIB TREATMENT DECREASES COX-2
SYNTHESIS AND MACROPHAGE INFILTRATION IN OA SYNO-
VIAL MEMBRANE INDEPENDENTLY OF PGE2 INHIBITION
M. A. Alvarez-Soriay, R. Largoy, J. Santillanaz, O. Sanchez-
Pernautey, E. Calvoy, J. Egidoy, G. Herrero-Beaumonty
y Bone and Joint Research Unit, Rheumatology Department,
Fundacion Jimenez Diaz, Universidad Autonoma, Madrid, Spain
z Orthopaedic Surgery, Hospital Virgen de la Cinta, Tortosa,
Tarragona, Spain
Aim: To compare the effect of celecoxib with a classic NSAID on
the synovial inﬂammation, synovial membrane expression of proin-
ﬂammatory genes and its inﬂuence on cartilage damage on
patients with severe knee osteoarthritis.
Methods: Thirty patients with severe knee OA in the waiting list for
total knee replacement surgery were included in a 4 month,
controlled, open, randomised clinical trial. After 1 week of wash-out,
patients were randomly assigned to three groups: patients treated
with celecoxib (CBX) (200 mg/24 h), patients treated with
aceclofenac (ACF) (100 mg/12 h), and no anti-inﬂammatory
analgesic-treated patients (ANG). During knee replacement sur-
gery, synovial ﬂuid (SF), synovial membrane (SM) and articular
cartilage (AC) were processed for further studies. A piece of SM
and the macroscopically less damaged cartilage in the load area of
femoral condyle were ﬁxed and processed to be embedded in
parafﬁn. SM mRNA and total proteins were isolated to carry out
gene expression studies (by real time PCR and RT-PCR
techniques) and protein synthesis studies (by western blot).
Results: Five (17%) patients discontinued treatment owing to side
effects or other considerations. After 1 week wash-out period, no
differences in pain and knee function were observed between the
three groups, according to the WOMAC scale. At surgery, both
CBX and ACF treated patients showed a signiﬁcant improvement in
pain and joint function with respect to ANG group. SF PGE2
concentration was signiﬁcantly diminished both in CBX and ACF
treated patients in comparison to ANG patients. COX-2 expression
(real time PCR: Mean G S.E.M., CBX, 0.25 G 0.05*; ACF, 0.37 G
0.08; ANG, 0.53 G 0.07; n Z 7–9, *P ! 0.05 vs ANG) and
synthesis (western blot: Mean G S.E.M.: CBX, 0.30 G 0.08*; ACF,
0.39 G 0.06*; ANG, 1.16 G 0.07; n Z 7–9, *P ! 0.05 vs ANG)
were also signiﬁcantly inhibited in CBX and ACF patients when
compared to those taking ANG. However, SM macrophage
inﬁltration and the gene expression of proinﬂammatory mediators,
such as interleukin (IL) 1-b, tumor necrosis factor (TNF) a,
monocyte chemoattractant protein-1 (MCP-1) and IL-8, were only
decreased by CBX treatment. Furthermore, CBX treatment was
S72associated with a signiﬁcant less damage in the cartilage studied,
according to the Mankin scale.
Conclusions: Both treatments with CBX or ACF were able to im-
prove joint pain and function, to inhibit SF PGE2 concentration and,
unexpectedly, induced a decrease in SM COX-2 expression and
synthesis, which was not related to the tissue inﬂammatory status.
These data could indicate a new direct mechanism of action of
prolonged therapy with PGE2 blocking agents by which these
agents decrease PGE2 production not only by direct inhibition of
COX-2 activity, but also by a down-regulation in COX-2 expression
and synthesis. However, CBX and ACF seem to have different anti-
inﬂammatory proﬁle in controlling SM macrophage inﬁltration
and proinﬂammatory gene expression in the SM of patients with
knee OA.
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S-100 PROTEIN AND FGFR3 EXPRESSION IN RABBIT TEM-
POROMANDIBULAR JOINT BILAMINAR ZONE FOLLOWING
EXPERIMENTALLY INDUCED ANTERIOR DISC DISPLACE-
MENT
Y. Zhouy, Z. Gu, J. Zhan, S. Zhao
y Department of Oral and Maxillofacial Surgery, Hospital of
Stomatology, Zhejiang University, Zhejiang, China
Objective: To explore the possible mechanism of the adaptive
alteration in the bilaminar zone of temporomandibular joint following
anterior disc displacement.
Methods: The animal model of anterior disc displacement was
established in 20 Japanese rabbits. The expression of S-100,
FGFR3 and PCNA in the bilaminar zone of temporomandibular joint
was examined by immunohistochemical staining.
Results: (1) The mandibles of all ADD-induced animals deviated to
the left side to some extent with inclined attrition of incisors and the
joint disc was anterior displaced. (2) In the bilaminar zones of the
control group, no chondrocytes or S-100 expressed. However, in
the surgical group, there were more chondrocyte-like cells which
immunostaining for S-100 expressed positively with the disc
displacement going on. (3) In the surgical group, FGFR3 expressed
in the chondrocyte-like cell, and in the puerile chondrocyte-like cell,
PCNA expressed positively. But no FGFR3 or PCNA expressions
were found in the laminar zones of control animals.
Conclusion: (1) This animal model of temporomandibular joint disc
displacement is effective. (2) There were more and more
chondrocytes immunostained by S-100 and FGFR3 appeared in
the bilaminar zone after disc displacement, which were associated
with adaptive alterations of the BZ. This study was supported by the
grants from the Bureau of Science and Technology of Zhejiang
Province, P. R. China (G20030241).
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EFFECTS OF GINGER EXTRACT, ITS COMPONENTS, AND
NSAIDS ON CHEMOKINE EXPRESSION IN HUMAN SYNOVIO-
CYTES
P. V. Phany, A. Sohrabiy, A. V. Polotskyy, L. Lindmarkz, D. S.
Hungerfordy, C. G. Frondozay
y Orthopaedic Surgery, Johns Hopkins University, Baltimore, MD,
USA
z Research and Development, Ferrosan A/S, Soeborg, Denmark
Objective: The present study aims to compare the effect of a ginger
extract and its components to NSAIDs on chemokine expression in
human synoviocytes.
Methods: Human synoviocytes (5! 105 cells) were incubated with:
100 mg/ml of (1) Ginger extract (combination of Alpinia Galanga and
Zingiber Officinale), (2) Alpinia Galanga, (3) Zingiber Officinale, (4)
Aspirin, and (5) Ibuprofen, or control medium for 1 h at 37(C and
5% CO2. The cells were then re-incubated with control medium
alone, or 1 ng/ml TNF-a for 1 h. Cells were frozen for RNAextraction and subsequent Reverse Transcriptase Polymerase
Chain Reaction (RT-PCR) analysis.
Results: Ginger extract (Alpinia Galanga and Zingiber Officinale)
was more effective (O80%) in chemokine (MCP-1 and IP-10)
mRNA suppression than its individual components. It was also
more effective than Aspirin or Ibuprofen in chemokine suppression.
Conclusion: Ginger extract is a potent inhibitor of chemokine
expression in activated human synoviocytes. The inhibition of
chemokine expressions by Ginger extract may be mediated by
blockade of NF-kB activation and IkB-a degradation.
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THE ROLE OF ADHESIVE PROTEINS ON ENHANCEMENT OF
ARTICULAR CHONDROCYTE FUNCTIONS ON NAOH-TREA-
TED POLY(LACTIC-CO-GLYCOLIC ACID) SCAFFOLDS
G. E. Parky, T. J. Websteryz
y Biomedical Engineering, Purdue University, West Lafayette, IN,
USA
z Materials Science and Engineering, Purdue University, West
Lafayette, IN, USA
The purpose of this in vitro study was to determine the role of
adhesive proteins on the enhancement of chondrocyte functions on
NaOH-treated poly(lactic-co-glycolic acid) (PLGA) scaffolds. PLGA
scaffolds were synthesized by dissolving PLGA (50:50 wt. % PLA/
PGA) in chloroform and using salt-leaching techniques for the
creation of pores. Ten minute treatment of PLGA scaffolds with 1 N
NaOH induced nanometer surface roughness features. Previous
studies have shown increased chondrocyte functions on these
NaOH-treated PLGA scaffolds. To determine why, ﬁbronectin,
vitronectin, chondrocyte growth media, and serum-free media were
allowed to interact with the NaOH-treated and non-treated PLGA.
Fibronectin and vitronectin antibodies were utilized to spectropho-
tometrically determine the amount of these proteins that adsorbed
onto the scaffold surface. Results showed that the adsorption of
both ﬁbronectin and vitronectin onto the NaOH-treated PLGA was
greater than on the non-treated PLGA. Fibronectin adsorption was
higher than vitronectin, which implied that ﬁbronectin might be
involved in chondrocyte and substrate interactions to a greater
extent than vitronectin. To determine the relationship between the
adsorbed proteins on chondrocyte adhesion, human articular
chondrocytes (PNZ 6–9) were seeded at 50,000 cells per scaffold
and were cultured under standard conditions for 4 h. Results
showed that the number of cells that adhered to NaOH-treated
PLGA was greater compared to its counterpart for all protein
coatings (ﬁbronectin, vitronectin, media and serum-free media).
Cells incubated in growth media adhered at the highest numbers
whereas cells in serum-free media adhered minimally. In conclu-
sion, NaOH-treated PLGA may be a more promising alternative to
cartilage regeneration than non-treated PLGA and this study
provided the ﬁrst evidence why by elucidating initial protein
interactions.
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INTRA-ARTICULAR INJECTION OF HIGH DENSITY MESEN-
CHYMAL CELLS FOR CARTILAGE REPAIR
C. Nakamura, T. Kimura, S. Seki, K. Sugimori, I. Matsushita,
A. Sano
Department of Orthopaedic Surgery, Toyama Medical & Pharma-
ceutical University, Toyama, Toyama, Japan
In order to extend cell-based therapy for the repair of large cartilage
lesion, we have analyzed the effect of cell injection into joint. We
hypothesized that the injection of large number of mesenchymal
cells with certain differentiation stage would preferentially adhere to
damaged articular area and may contribute to repair.
Methods: Three types of cells were used for intra-articular injection
in this study; mouse embryonic stem cell (ES), undifferentiated
S73mesenchymal cells (MS), and partially differentiated mesenchymal
cell (dMS). As a source of MS cell, mouse N1511 cell line was
used. This cell line shows undifferentiated mesenchymal pheno-
type and can be differentiated to chondrocyte by BMP/insulin.
Articular cartilage defect was created in the femoral trochlea of the
nude rat (F344/Nrnu, 52 knees) with an 18# needle. Cells were
brieﬂy labeled with CellTracker and 50 ml of 1 ! 107/ml of each
cells were gently injected into the rat knees. The specimens were
evaluated histologically at 1, 2, 4, and 8 weeks.
Results: All three types of cells were detected within the rat knee
joints. Injected cells were mostly attached to the synovium and
were not detected on the surface of normal articular cartilage. Small
number of the injected ES cells or MS cell was found within and
around the cartilage defect, although they did not seem to
contribute to cartilage repair. dMS cells seemed to be more
preferentially remained within and around the cartilage defect. At 8
weeks, dMS cell group showed partial hyaline cartilage repair.
Histological score indicated that the dMS injection showed
signiﬁcantly better repair than ES, MS, and empty control. Osteo-
chondromatous or other tissue formation was not observed within
the synovium or joint space.
Conclusion: Most of the injected cells attached to the synovium. In
addition, some of the injected cells, especially dMS cells (cells
induced toward chondrogenic lineage) contributed to enhance the
cartilage repair. Therefore, intra-articular injection of large number
of cells with certain differentiation stage may be a potential cell-
based therapy for larger articular cartilage lesion.
P176
HYDROSTATIC PRESSURE INCREASES APOPTOSIS IN
TISSUE-ENGINEERED CARTILAGE-CONSTRUCTS
R. Wengery, J. F. Welterz, M. G. Hansy, C. J. Malemudx
y Orthodontics, Case Western Reserve University School of
Dentistry, Cleveland, OH, USA
z Orthopaedics, Case Western Reserve University School of
Medicine, Cleveland, OH, USA
x Medicine, Case Western Reserve University School of Medicine,
Cleveland, OH, USA
Mechanical stress, in the form of cyclic hydrostatic pressure (CHP)
may induce articular cartilage apoptosis in vivo. Intact cartilage
extracellular matrix (ECM) could potentially blunt the effects of
CHP. Previously, we showed (Islam N et al. J Cell Biochem
2002;87: 266–78) that CHP employed at 5 MPa for 4 h which
borders the mechanical interface between physiological and
injurious loading (Ferenbacher A et al. Arch Biochem Biophys
2003;410: 39–47) induced apoptosis in human chondrocyte
suspension cultures derived from the reduced weight-bearing
zones of ‘‘resident’’ osteoarthritic (OA) cartilage. We propose that
for tissue-engineered human cartilage-constructs (TEHCC) to be
successfully employed as transplants to weight-bearing areas of
OA cartilage, they must withstand deterioration in response to CHP
generated during continuous mechanical stress to the joint. Thus,
the present study was carried out to investigate the relationship
between newly created ECM in TEHCC and CHP-induced
apoptosis. Seventeen (17) human cartilage specimens (age 61 G
9.9, mean G SD) were obtained from the Cooperative Human
Tissue Network and individually analyzed. Chondrocytes liberated
by enzymatic dissociation (cell yield, 17.1 G 12.1 ! 106, meanG
SD) were expanded to produce high-density cultures which were
employed to seed hyaluronan-containing scaffolds (i.e., HYAFF-
11; Fidia) maintained in mini-bioreactors at 37(C. After 3 weeks,
harvested TEHCC still contained elements of HYAFF-11, but the
TEHCC ECM stained strongly metachomatic with Toluidine Blue O.
Moreover, TEHCC ECM reacted positively with anti-type II
collagen, but not anti-type I or anti-type X collagen antibodies.
TEHCC were subjected to CHP for 0–8 h at 5 MPa using a 1 Hz
continuous sinusoidal waveform. CHP (5 MPa, 4 h) induced
apoptosis. The percentage of monoclonal antibody F7–26
(i.e., mouse anti-single stranded DNA; Chemicon International)positive cells/DAPI-stained nuclei in CHP-treated TEHCC (i.e., fre-
quency of apoptosis) was 41 G 4.2% (mean G SD) compared to
control TEHCC, 28.5 G 8.4%; P ! 0.02. Thus, as in our previous
study, CHP increased apoptosis, but in this study we demonstrated
that cartilage-type ECM produced in TEHCC did not protect
TEHCC from the elevated frequency of apoptosis produced by
near-injurious levels of CHP in vitro.
P177
EFFECT OF BASIC FIBROBLAST GROWTH FACTOR ON THE
WOUND HEALING AND MATRIX SYNTHESIS OF CHONDRO-
CYTES IN VITRO
S. M. Li
Department of Orthopaedic Surgery & Traumatology, Guangzhou
No. 12 Hospital, Guangzhou, Guangdong, China
Aim of study: To investigate the roles of basic ﬁbroblast growth
factor (bFGF) in cartilage wound healing and matrix synthesis.
Methods: An in vitro wound closure model was established to study
the chondrocytes wound healing. Chondrocytes migration was per-
formed using Nucleopore blindwell chemotaxis chambers. Pro-
liferation and matrix synthesis of chondrocytes were also analyzed.
Results
Effect of bFGF on in vitro wound closure: The change in the wound
width of different treatments at 24-h incubation is shown in
Fig. 1.The wound in the presence of 50 ng/ml of bFGF closed
signiﬁcantly when compared with the control. The enhancement of
wound closure by bFGF was maximal in the presence of 50 ng/ml
of bFGF.
Effect of bFGF on cell chemotaxis: Basic ﬁbroblast growth factor, at
all concentration being tested, did not signiﬁcantly increase the
chondrocytes that migrated although the positive control BMP
showed threefold in crease compared with the control (Fig. 2).
Effect of bFGF on cell proliferation: Figure 3 shows the effect of
bFGF on chondrocytes proliferation. One ng/ml bFGF signiﬁcantly
increased the proliferation of chondrocytes in the second passage
but had no effect in the ﬁfth passage until the bFGF concentration
got to 10 ng/ml. Increasing the bFGF to 100 ng/ml did not show
additional improvement of proliferation in both passages.
Effect of bFGF on matrix synthesis: Figure 4 shows the effect of
bFGF on chondrocyte matrix synthesis. At all concentrations of
bFGF being tested, no stimulatory effects of bFGF on the matrix
synthesis were observed.
Conclusion: This study established an in vitro model for the
cartilage-healing assay. The wound width in the culture decreased
signiﬁcantly after bFGF was added to the in vitro wound closure
assay. The improved wound closure was mainly caused by
mitogenic effect of bFGF, but not chemotactic effect of bFGF. In
addition, bFGF has no effect on the matrix synthesis of
chondrocytes in vitro.
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ESTABLISHMENT AND ANALYSIS OF 3-D COLLAGEN GEL
CULTURES OF C-20/A4 CHONDROCYTES
A. Petsay, H. S. Chowdreyy, R. A. Knightz, A. N. Afokex,
I. C. Lockey
y School of Biosciences, University of Westminster, London, United
Kingdom
z Department of Cystic Fibrosis, Imperial College London, London,
United Kingdom
x Cavendish School of Computer Science, University of West-
minster, London, United Kingdom
Osteoarthritis (OA) is a degenerative disease of human articular
cartilage. Cartilage is the aneural and avascular tissue of
diarthroidal joints and comprises chondrocytes, which synthesise
and maintain an extracellular matrix (ECM) of mainly type II
collagen, proteoglycans and non-collagenous proteins. Although
S74the pathogenesis of OA remains unknown, loss of chondrocytes
due to apoptosis has been implicated. In order to better study
chondrocyte activity and survival in-vitro, we have developed a 3D
culture matrix based on a collagen type I gel and present here an
assessment of its viability. In this study test gels were populated
with the C-20/A4 human chondrocyte cell line and compared to
unpopulated control gels.
Control (no cells) and test gels (with 1 ! 106 cells/ml) gels were
prepared and cultured for 0, 1, 2, 4, 8 and 16 days at 37(C, 5%
CO2. Gel cultures of C-20/A4 cells were subjected to assessments
of cell viability by Trypan blue, early and late stages of cellular
apoptosis by annexin V-PI and TUNEL assays, respectively, and
necrosis by LDH assay. Gel structure was assessed for elastin and
collagen contents by EvG staining and immunohistochemistry and
Ca2C deposition by AAS. Differences in the mechanical properties
of control and test gels were assessed using a custom-built
apparatus to subject gels to mechanical compression.
C-20/A4 chondrocytes in 3-D collagen gel culture exhibited good
viability at culture intervals up to 4 days after which a decrease in
cell viability was noted with a corresponding increase in apoptotic
cells, particularly early apoptotic cells as demonstrated by Annexin
V/PI staining. Gel analysis did not demonstrate signiﬁcant Ca2C
deposition but a more ﬁbrous structure of elastin and collagen ﬁbres
developed from 4 days onwards with a corresponding decrease in
gel compressibility when tested mechanically.
C-20/A4 chondrocytes are viable in type I collagen gel cultures for 4
days, during which time the cells remodel their collagen environ-
ment resulting in an increased resistance to mechanical compres-
sion which is not a result of calciﬁcation.
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UPREGULATION OF ERK2 AND p38 GENE EXPRESSION IN
HUMAN CHONDROCYTES PROPAGATED IN MICROCARRIER
SPINNER CULTURE
P. S. Tsang, A. Polotsky, P. V. Phan, D. S. Hungerford,
C. G. Frondoza
Orthopaedic Surgery, Johns Hopkins University, Baltimore, MD
Aim of study: The present study aims to evaluate the role of ERK2
and p38 in the proliferation and phenotype expression of
chondrocytes propagated in microcarrier spinner culture.
Methods: Human chondrocytes were isolated and expanded in
monolayer culture and then seeded onto Cellagen microcarrier
beads. The cell-seeded microcarriers were propagated in bio-
reactor spinner culture for up to 2 weeks at 37(C, 5% CO2. Cells
were frozen for RNA extraction and subsequent Reverse Tran-
scriptase Polymerase Chain Reaction (RT-PCR) analysis.
Results: Chondrocytes propagated in microcarrier spinner culture
showed enhanced proliferation and phenotype expression: type II
collagen and aggrecan. This enhancement in proliferation and
expression of cartilage markers was paralleled by increased
expression for ERK2 and p38 signaling molecules.
Conclusion: Chondrocytes propagated in microcarrier spinner
culture showed upregulation of ERK2 and p38 gene expression.
ERK2 and p38 are mitogen activated protein kinases that have
been documented to play a role as signaling molecules in
mechanotransduction. Our observation suggests that these two
molecules may mediate the response of chondrocytes to the
mechanical stimulus provided by the spinner culture. Modulation of
these signaling molecules in cultured chondrocytes may provide
suitable cells for cartilage repair.
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GLUCOSAMINE SULFATE PREVENTS TOTAL JOINT RE-
PLACEMENT IN THE LONG-TERM FOLLOW-UP OF KNEE
OSTEOARTHRITIS PATIENTS
K. Pavelkay, J. Gatterovay, G. Giacovelliz, M. Olejarovay,
L. C. Rovatizy Department of Rheumatology, Institute of Rheumatology, Prague,
Czech Republic
z Department of Clinical Pharmacology, Rotta Research Laborato-
rium, Monza, Italy
Two recent randomised, placebo-controlled, double-blind, 3-year
clinical trials in knee osteoarthritis (OA) indicated that glucosamine
sulfate prevents radiographic joint space narrowing (JSN) and
relieves symptoms (Reginster et al. Lancet 2001;357:251–6;
Pavelka et al. Arch Intern Med 2002;162:2113–23). The aim of
this study was to assess the incidence of joint replacement after
a further long-term follow-up.
Methods: Systematic contact was attempted with all knee OA
patients from one of the previous studies (Pavelka et al., 2002),
who had been in the trial for at least 12 months and were then
followed by standard care after discontinuation of the study
medication. One thirty-six patients (67 formerly on placebo and
69 on glucosamine sulfate), i.e., 78.6% of the original cohort with
these characteristics, could be retrieved. They were administered
a standardised interview for the occurrence of total knee and/or hip
replacement, checked against patient medical records. Incidence of
surgery was compared by the chi-square test with calculation of
Relative Risk (RR). A subset of 101 patients (47 and 54 in the two
former groups, respectively) accepted to perform also a standing
antero-posterior knee radiograph according to the same stand-
ardised technique used in the trial, for measurement of medial
tibiofemoral minimum JSN with a magnifying glass by two readers,
randomising the sequence of trial enrolment, trial last and follow-up
radiographs; comparisons were performed by ANOVA. All assess-
ments were in double-blind.
Results: Median duration of follow-up after the trial was around
further 5 years (64 months, range 40–90 months) without differ-
ences in the former two groups, whose pre-trial characteristics were
also comparable. A total of 14 patients out of the 136 had
undergone knee replacement: 11/67 previously on placebo (16.4%)
and 3/69 on glucosamine sulfate (4.3%), with a 73% decrease in
risk with the latter (RR Z 0.27, 95% CI 0.08 to 0.91, P Z 0.021).
When hip replacements were also considered (four additional
patients), RR was still decreased after glucosamine sulfate: 0.37
(0.14 to 0.99), P Z 0.036.
The subset of glucosamine sulfate patients with X-rays at follow-up
had signiﬁcantly gained joint space during the trial [0.17 mm (0.03
to 0.31) (mean and 95% CI)] vs a slight loss with placebo [0.07
(0.19 to 0.07)] (PZ 0.17), and still tended to have a lower JSN on
the overall 8-year observation period: [0.47 mm (0.66 to 0.28)
vs 0.62 mm (0.82 to 0.41) with placebo (NS: P Z 0.30)],
despite a non-signiﬁcant trend for a greater loss during the follow-
up after drug withdrawal (P Z 0.53).
Conclusions: Treatment for up to 3 years with glucosamine sulfate
in knee OA prevented total joint replacement during a further follow-
up of 5 years after drug withdrawal, probably because of the effect
on joint structure achieved during treatment.
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IMPORTANCE OF EVALUATING COMMON INTERNAL CON-
TROLS WHEN ASSESSING THE RELATIVE EFFICACY OF
DIFFERENT PHARMACOLOGIC AGENTS THROUGH A META-
ANALYTIC APPROACH: A CASE STUDY OF COX-2-SELEC-
TIVE INHIBITORS IN THE TREATMENT OF OSTEOARTHRITIS
C. Leey, E. Hunschez, R. Balshawx, S. X. Kongz, T. Schnitzery
y Division of Rheumatology, Northwestern University Feinberg
School of Medicine, Chicago, IL, USA
z Merck & Co., Inc., Whitehouse Station, NJ, USA
x Department of Statistics & Actuarial Science, Simon Fraser
University, Burnaby, BC, Canada
Aim: To describe efﬁcacy differences of agents belonging to the
same class of drugs and common internal active controls when
performing a meta-analysis.
Methods: A meta-analysis of randomized controlled trials was
performed to assess efﬁcacy of Cox-2 selective inhibitors (coxibs)
S75in OA using data from 14 clinical trials identiﬁed via search of
MEDLINE and US FDA Electronic Database. Controls (naproxen,
non-naproxen NSAIDs) were also assessed. Main outcome
measure was effect size (ES) representing mean change from
baseline for WOMAC pain scores compared with placebo groups.
All analyses used random effects models to allow for the presence
of between-study heterogeneity. Heterogeneity was tested using
Cochran’s Q-statistic.
Results: ES for all coxibs was 0.44, but signiﬁcant heterogeneity
(P! 0.0001) was found. Exploring the basis for this heterogeneity
showed that coxib type was an important factor: rofecoxib (ES Z
0.68) and etoricoxib (ESZ 0.73) had similar ES, but comparatively
greater than either celecoxib (ES Z 0.26) or valdecoxib (ES Z
0.16). ES for common active controls showed NSAID groups in
rofecoxib/etoricoxib trials to have greater ES than those in
celecoxib/valdecoxib trials (ES Z 0.59 vs ES Z 0.26). Also, ES
for a single NSAID, naproxen, was greater in the etoricoxib/
rofecoxib than celecoxib/valdecoxib trials (ES Z 0.60 vs ES Z
0.22). Trial design and patient characteristics (age, sex, OA site)
were similar across trials. Further exploration of trial charac-
teristics, which may have accounted for observed ES differences,
was limited by the absence of publicly available study-speciﬁc
information.
Conclusions: Marked differences in ES were present for both
coxibs and common active internal controls. Methodologic differ-
ences between trials may be an important confounder. Thus,
comparisons across trials, even in meta-analyses, may not
accurately reﬂect true differences. Use of a common active control
is essential when comparing different agents across trials.
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COLLAGEN HYDROLYSATE (CH) IN KNEE OSTEOARTHRITIS
(OA): POPULATION-RELATED RESPONSES
H. K. Selbmanny, I. Fischery, R. W. Moskowitzz
y Department of Medical Statistics and Information Processing,
University of Tubingen, Tubingen, Germany
z Department of Medicine, Case Western Reserve University,
Beachwood, OH, USA
Table I
Effect size estimates for coxibs and common internal controls
(NSAID and naproxen) vs placebo
Comparisons Effect Size Heterogeneity
(Mean change from base-
line)
(95% CI) (P-value*)
All coxibs vs placebo 0.44 (0.33, 0.55) !0.0001
Celecoxib & valdecoxib vs
placebo
0.25 (0.18, 0.31) ns
Etoricoxib & rofecoxib vs
placebo
0.70 (0.55, 0.84) ns
NSAID vs placebo 0.37 (0.26, 0.49) 0.007
NSAID in celecoxib valde-
coxib trials vs placebo
0.26 (0.17, 0.34) ns
NSAID in rofecoxib & etor-
icoxib trials vs placebo
0.59 (0.45, 0.73) ns
Naproxen vs placeboy 0.30 (0.18, 0.43) 0.04
Naproxen in celecoxib val-
decoxib trials vs placebo
0.22 (0.13, 0.31) ns
Naproxen in rofecoxib &
etoricoxib trials vs placebo
0.60 (0.36, 0.84) ns
*ns denotes P O 0.06.
yIdentical dose of naproxen (1000 mg/day) in all coxib trials.Background: Collagen hydrolysate increases chondrocyte collagen
biosynthesis in vitro, and is associated with preferential localization
of CH-derived 14C-labeled proline into cartilage. Clinical studies
with CH have suggested efﬁcacy in reducing symptoms and
increasing joint function.
Aim: To assess CH efﬁcacy in a large randomized, double-blind,
placebo-controlled multinational study.
Methods: Three hundred eighty-nine patients with ACR criteria
knee OA, ages 45–80, pain score of 30–90 mm (0–100 mm scale)
on the WOMAC pain item ‘‘walking on a ﬂat surface’’ and/or
‘‘descending and/or ascending stairs’’ at screening and baseline
were randomized in 20 sites; 6 rheumatology in the United States
(US), 3 rheumatology in the United Kingdom (UK), and 11
orthopaedic in Germany (GER). Baseline patient global was mild
or greater, with symptoms at least 1 year and a K-L grade II, III.
Standard inclusion and exclusion criteria for knee OA studies were
applied. Patients randomly received either identically packaged
10 g Pharmaceutical Collagen Hydrolysate (PCH) or 12 g lactose
(placebo) for 24 weeks. Acetaminophen (Acet) rescue up to 4 g/day
was allowed. Primary efﬁcacy measures were WOMAC pain;
WOMAC function; and Patient Global. Randomization within sites
allowed a by-country analysis. Modiﬁed ITT, and per protocol
analyses were performed.
Results: Demographic characteristics (gender, race, age) were
similar in treatment and placebo groups. Mean age was 63.1 and
63.7 years respectively, female:male was approximately 62%:38%.
Baseline pain and function were lower in GER vs US, UK sites. No
statistically signiﬁcant differences between treatments were ob-
served for the total study group in the ITT or per protocol analyses.
Examination of individual countries, however, revealed a statistically
signiﬁcant treatment advantage of PCH over placebo in all three
primary efﬁcacy variables in German (P ! 0.05), but not in US or
UK sites (Table I). Drop-out rates were: Germany 6.2%, US 42%,
and UK 35%. Acet intake and protocol violations were lowest in
GER sites. Adverse events, primarily GI, were mild.
Conclusions: PCH was more effective than placebo in all three
primary efﬁcacy variables in the German sites. Differences between
sites in drop-out rate; acetaminophen intake; protocol violations;
baseline pain/function parameters; principal investigators (rheum
vs ortho); and cultural differences in patient response expectation
are possible explanations. Geographic considerations may have
a signiﬁcant impact on clinical trial results.
P184
SUPPRESSION OF CYTOKINE AND CHEMOKINE ACTIVATION
BY GINGER EXTRACT AND CURCUMIN IN HUMAN MACRO-
PHAGE-LIKE THP-1 CELLS
S. C. Lombardiy, P. V. Phany, R. Grzannaz, M. Polotskyy,
H. Khalsay, L. Lindmarkx, C. G. Fronzdoza§
y Orthapedic Surgery, Johns Hopkins University, Baltimore, MD,
USA
z RMG Biosciences, Baltimore, MD, USA
x Research and Development, Ferrosan A/S, Soeborg, Denmark
Aim of study: The present study aims to deﬁne the mode of action
of Ginger extract and curcumin on the surrogate human macro-
phage THP-1 model.
Methods: Human macrophage-like THP-1 cells (5 ! 105 cells)
were incubated with: (1) 1–100 mg/ml of Ginger extract from Alpinia
galanga and Zingiber officinale, (2) puriﬁed 1–100 mM curcumin, or
Table I
% Mean differences, baseline to 24 weeks, GER sites
PCH Placebo
WOMAC pain 35 (CI 44, 25) 18 (CI 28, 8)
WOMAC function 26 (CI 34, 18) 8 (CI 16, 8)
Patient Global 21 (CI 28, 13) 9 (CI 16, 2)
S76control medium for 1 h at 37(C and 5% CO2. The cells were then
re-incubated with control medium alone, 1 ng/ml TNF-a or 20 ng/ml
LPS for 1 h. Cells were frozen for RNA extraction and subsequent
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
analysis. We evaluated the effect of these two preparations on
the expression of pro-inﬂammatory mediators: TNF-a, IL-1b, COX-
2, IL-8 and MIP-1b.
Results: There was a dose dependent suppression of pro-
inﬂammatory mediators: TNF-a, IL-1b, COX-2, IL-8 and MIP-1b
expression by Ginger extract and curcumin in human macrophage
surrogate THP-1 cells. Maximum suppression of O80% was
observed with 100 mg/ml of Ginger extract and 100 mM curcumin.
In contrast, control medium had no suppressive effect.
Conclusion: Ginger extract and curcumin effectively suppressed
the expression of several pro-inﬂammatory mediators including
cytokines, chemokines and COX-2, a regulatory enzyme of the
arachidonic acid metabolism. Active components of Ginger extract
may be more effective than the puriﬁed curcumin if compared on
a per molar basis. Our observation suggests that these herbal
extracts exert their biologic activity by inhibition of the inﬂammatory
cascade possibly by disruption of the NF-kB signaling pathway.
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THE NATURAL PRODUCT NR-671 STIMULATES PROTEOGLY-
CAN PRODUCTION IN BOVINE CARTILAGE BY UPREGULAT-
ING CHONDROCYTE TGF-b2 SYNTHESIS
A. Hartog, J. Garssen, H. F. Smit, M. A. Hoijer
Biomedical Research, Numico Research BV, Netherlands
Aim: Limitations in the conventional medical management of
arthritis indicate a need for safe and effective prevention and
treatment measures of osteoarthritis.
In this study a standardized extract of a natural product (NR-671)
was evaluated using bovine cartilage under control and inﬂamma-
tory conditions.
Methods: Primary bovine chondrocytes were cultured in alginate
beads and incubated for 5 days with NR-671 (0–100 mg/ml) in the
absence or presence of recombinant human TGF-b1 latency
associated peptide (rh-LAP). Proteoglycan synthesis and pro-
liferation were studied by [35S] and 3H-thymidine incorporation,
respectively. The amount of TGF-b1, 2 and 3 released into the
culture medium was measured by ELISA. Inﬂammatory conditions
were induced by adding 10 ng/ml interleukin-1b (IL-1b) to the
culture medium at the start of the experiment.
Bovine articular cartilage explants were cultured for 7 days with
various concentrations of NR-671 (0–75 mg/ml). Proteoglycan (PG)
synthesis was measured by [35S] incorporation; PG release and
content were detected by dimethylmethyleneblue assay (DMB).
Results: NR-671 dose-dependently increases TGF-b2 levels in the
culture medium under control and inﬂammatory conditions to 253%
(P! 0.006) and 124% (P! 0.007), respectively. No effects of NR-
671 were seen on TGF-b1 production whereas TGF-b3 levels were
not detectable. No changes were seen on chondrocyte pro-
liferation.
PG synthesis in alginate cultures and cartilage explants was
stimulated dose-dependently by NR-671 to 190% (P ! 0.0001)
and 150% (P ! 0.001), respectively. Under inﬂammatory con-
ditions the effect on PG synthesis was less pronounced.
After 7 days of incubation with NR-671 (50 mg/ml) in the absence of
IL-1b the PG content of the explants was increased to 128% of the
starting value (P ! 0.001). No effects were seen on PG release
from explants compared to control.
Conclusion: In the present study we have shown that NR-671 can
increase PG synthesis as well as PG content in bovine chondrocyte
explants. The up-regulation of TGF-b2 production by NR-671 is
directly proportional to the stimulation of PG synthesis of the
chondrocytes cultured in alginate. This data indicate that
the anabolic effect of NR-671 can at least partly be explained by
the ability of the natural product to enhance TGF-b2 production
by the chondrocytes.P186
15-DEOXY-D12,14-PROSTAGLANDIN J2 INHIBITS IL-1b-IN-
DUCED CYCLOOXYGENASE-2 EXPRESSION IN HUMAN
SYNOVIAL FIBROBLASTS THROUGH A HISTONE DEACETY-
LASE-INDEPENDENT MECHANISM
K. Farrajota, X. Li, H. Aﬁf, J. Martel-Pelletier, J. P. Pelletier,
H. Fahmi
Osteoarthritis Research Unit, Notre-Dame Hospital, Centre Hospi-
talier de L’universite de Montreal (CHUM), Montreal, QC, Canada
Objective: 15-Deoxy-d12,14PGJ2 (15d-PGJ2) has been reported to
inhibit the expression of a number of genes involved in the
pathogenesis of osteoarthritis. However, its effects on cyclo-
oxygenase-2 (COX-2) remain controversial. Here, we investigated
the effects of 15d-PGJ2 on interleukin-1b (IL-1b-induced COX-2
expression in human synovial ﬁbroblasts (HSFs).
Methods: HSFs were treated with IL-1b in the absence or presence
of 15d-PGJ2 and the level of COX-2 protein and mRNA expression
were evaluated using Western blotting and real-time reverse-
transcription polymerase chain reaction, respectively. The COX-2
promoter activity was analyzed in transient transfection experi-
ments. Chromatin immunoprecipitation (ChIP) assays were per-
formed to evaluate the level of histone acetylation and the
recruitment of histone deacetylase (HDAC)1, 2, 3 and histone
acetylase (HAT) p300 to the COX-2 promoter.
Results: 15d-PGJ2 inhibited IL-1b-induced COX-2 protein and
mRNA expression, as well as COX-2 promoter activation. The
suppressive effect of 15d-PGJ2 was abrogated by the PPARg
antagonist, GW9662, suggesting that this effect is mediated by
PPARg. 15d-PGJ2 selectively blocked IL-1b-induced histone H3
acetylation. The reduction of histone H3 acetylation did not
correlate with the recruitment of HDAC to the COX-2 promoter.
Also, treatment with the speciﬁc HDAC inhibitor, trichostatin A, did
not relieve the suppressive effect of 15d-PGJ2, indicating that
HDACs are not involved in the inhibitory effect of 15d-PGJ2.
Furthermore, 15d-PGJ2 blocked IL-1b-induced recruitment of p300
to the COX-2 promoter, which may be the mechanism for
decreased histone H3 acetylation and COX-2 expression. In line
with this, overexpression of p300, but not of a mutant p300 lacking
HAT activity, relieved the inhibitory effect of 15d-PGJ2 on COX-2
promoter activation.
Conclusion: Our data suggest that 15d-PGJ2 can inhibit IL-1b-
induced COX-2 expression in a PPARg-dependent, HDAC-in-
dependent mechanism, probably by interfering with the HAT p300.
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RESPONDERS TO GLUCOSAMINE SULFATE IN KNEE OSTE-
OARTHRITIS
O. Bruyerey, K. Pavelkaz, F. Richyy, G. Giacovellix, L. C. Rovatix,
J. Y. Reginstery
y Public Health, Epidemiology and Health Economics, University of
Liege, Liege, Belgium
z Department of Medicine, Charles University, Prague, Czech
Republic
x Department of Clinical Pharmacology, Rotta Research Laborato-
rium, Monza, Italy
Background: The assessment of ‘‘responders’’ or ‘‘failures’’ is
recommended as a secondary end-point in the evaluation of
structure modifying drugs in osteoarthritis (OA) (Abadie et al.
Osteoarthrtis Cartilage 2004;12:263–68). A ‘‘failure’’ may be
deﬁned as a subject either reaching a signiﬁcant threshold of joint
space narrowing (JSN) or lacking a clinically relevant improvement
in symptoms.
Objective: To look at the prevalence of ‘‘failures’’ and ‘‘responders’’
in two long-term studies evaluating the effects of glucosamine
sulfate in knee osteoarthritis progression.
Material and methods: Patients with knee OA (ACR criteria) were
included in two randomised, double-blind, 3-year studies of
S77glucosamine sulfate vs placebo. Joint space width (JSW) at the
narrowest point of the medial tibiofemoral compartment was
assessed at baseline and after 3 years, from standing anteropos-
terior knee radiographs. Symptoms were scored by the algo-
functional WOMAC index at baseline and after 3 years. A
responder was deﬁned either as a patient who experienced
a JSN below 0.5 mm and as having an improvement in symptoms
of at least 20% in WOMAC total or in WOMAC pain).
Results: Out of the 414 patients included, 259 completed the study
(133 in the glucosamine sulfate group and 126 in the placebo
group). In the glucosamine sulfate group, 71 patients (53%) were
considered responders (JSN ! 0.5 mm and at least 20%
improvement in total WOMAC) compared to 41 patients (32%) in
the placebo group (P Z 0.0007). When considering changes in
WOMAC pain and JSN, the number of responders were 67 (50%)
in the glucosamine sulfate group and 48 (38%) in the placebo group
(PZ 0.04). The relative risk (RR) to experience a ‘‘failure’’ (JSNO
0.5 mm or improvement in total WOMAC!20%) was decreased by
32% in the glucosamine sulfate group compared to the placebo
group (RR 0.68; 95%CI 0.54 to 0.84).
Conclusion: Glucosamine sulfate meets the newly recommended
secondary end-points for structure modifying drugs in OA.
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PREDICTORS OF OSTEOARTHRITIS (OA) IMPROVEMENT IN
PATIENTS TREATED WITH HYLAN G-F 20 FOR KNEE OA
C. H. Goldsmithy, N. Bellamyz, D. Pericakx, G. W. Torrancex,
J. P. Raynauldjj, M. Bell{, R. Polissonyy
y Department of Clinical Epidemiology and Biostatistics, McMaster
University, Hamilton, ON, Canada
z CONROD, Faculty of Health Sciences, The University of Queens-
land, Brisbane, Queensland, Australia
x Health Economics and Outcomes Research, Innovus Research
Inc., Burlington, ON, Canada
jj Montreal Institute of Rheumatology, University of Montreal,
Montreal, QC, Canada
{ Rheumatology and Clinical Epidemiology, Sunnybrook & Wom-
en’s Health Science Centre, University of Toronto, Toronto, ON,
Canada
# Centre for Global Health, Institute of Population Health, University
of Ottawa, Ottawa, ON, Canada
yy Genzyme Corporation, Cambridge, MA, USA
Aim of study: Different criteria for treatment response were explored
to identify predictors of OA improvement. Analyses were based on
data from a previously reported 1-year randomized controlled trial
of appropriate care with or without hylan G-F 20 in patients with
knee OA.
Methods: Five deﬁnitions of ‘‘patient responder’’ from baseline to
month 12 were examined: at least 20% reduction in WOMAC pain
score; at least 20% reduction in WOMAC pain score and at least
20% reduction in either the WOMAC stiffness or function score;
OARSI responder criteria (Propositions A and B) for intra-articular
drugs; and OMERACT-OARSI responder criteria (Proposition D).
As an a posteriori analysis, multivariable logistic regression models
for each deﬁnition of patient responder were developed using
a forward selection method. The following variables were deﬁned
prior to modeling and considered in the model along with two-way
interactions: age (O65 years), BMI, gender, X-ray grade (0, I, II vs
III, IV), co-morbidity (1 or 2 conditions vs 3 or more), duration of OA
in study knee (years), previous surgery of study knee, hylan G-F 20
injection technique, WOMAC pain, stiffness and function, and
treatment group.
Results: Hylan G-F 20 was a predictor of improvement for all patient
responder deﬁnitions P! 0.001; odds of improvement were 2.7 or
higher for patients in the hylan G-F 20 group compared to
appropriate care without hylan G-F 20. For three of the ﬁve patient
responder deﬁnitions, X-ray grade was a predictor of improvement
(P! 0.10; lower X-ray grade increased the odds of improvement).
For four of the ﬁve patient responder deﬁnitions, duration of OA wasa predictor of improvement (P ! 0.10; shorter duration of OA
increased the odds of improvement).
Conclusion: Analyses showed that appropriate care with hylan G-F
20 is the dominant predictor of patient improvement. While high
grade structural damage does not preclude a response, patients
who are targeted early in the disease process when less structural
damage has occurred, may have a greater chance of improvement.
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A NOVEL GLYCOSAMINOGLYCAN POLYPEPTIDE COMPLEX,
PEPTACAN, SUPPRESSES JOINT INFLAMMATION AND PRE-
SERVES CARTILAGE IN RAT MODELS OF ARTHRITIS GIVEN
ORALLY EITHER AS A TOLERAGEN OR AS A THERAPEUTIC
AGENT
P. Ghoshyz, S. Shimmonyz, M. Whitehousex
y Institute of Bone and Joint Research, Royal North Shore Hospital,
Sydney, NSW, Australia
z Pharmacology, Institute of Nutraceutical Research, Sydney, NSW,
Australia
x Medicine, University of Queensland, Brisbane, Queensland,
Australia
Aims of study: Molecular fragments derived from the proteolysis of
joint cartilage are antigenic and can trigger an autoimmune
response leading to cartilage destruction in both rheumatoid arthritis
(RA) and osteoarthritis. Oral tolerisation of arthritic animals or RA
patients with type II collagen (Col-II), may attenuate joint inﬂam-
mation and disease progression. However, similar studies on the
anti-arthritic activities of cartilage proteoglycan (PG) fragments have
not been previously described. Peptacan, isolated from bovine
tracheal cartilage is a PG fragment and contains glycosaminoglycan
peptides which was shown to increase chondrocyte and synovial
ﬁbroblast anabolism and attenuate the suppressive effects of IL-1
on chondrocytes in vitro, suggesting its use as a disease modifying
anti-arthritic agent. In the present study we compared the anti-
arthritic and chondroprotective effects of Peptacan in two rat models
of arthritis with three related anti-arthritic agents, chondroitin sulfate
(ChS), glucosamine sulfate(Gln) and bovine Col-II.
Methods: Collagen-induced arthritis (CIA) and adjuvant-induced
arthritis (AIA) were established in Wistar rats (6–8 per group) using
the established procedure. Drugs were administered orally (10–200
mg/kg) either for 7 days prior to disease induction (tolerogenic
protocol) or continuously for 15 days after injecting the arthritogen
(prophylactic/therapeutic protocol). Joint swelling and arthritis
scores were determined on days 15–18 and H&E and toluidine
blue stained histological sections of rear and front paw joints were
assessed post-necropsy for inﬂammatory cell inﬁltratation, cartilage
and bone erosion using published techniques.
Results: Peptacan at 20 mg/kg and above prevented arthritis,
synovial inﬂammation and joint cartilage breakdown in the rat CIA
using the tolerogenic or prophylactic protocols but was only
effective prophylactically in the AIA at 100 mg/kg. In contrast, pure
ChS or Gln at doses up to 200 mg/kg were inactive in both arthritis
models. Col-II was tolerogenic at 10 mg/kg for the CIA, but unlike,
Peptacan, it was also arthritogenic in these animal models.
Conclusion: This study has identiﬁed the potential of Peptacan, as
a safe, structurally modifying anti-arthritic agent, which could be
used to delay the onset of disease or slow its rate of progression by
preserving joint cartilage integrity and thus its function.
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MUSCLE RESPONSES TO VALGUS PERTURBATIONS AFTER
ANATOMIC TIBIAL REALIGNMENT
D. K. Ramsey, M. D. Lewek, K. S. Rudolph, W. Newcomb,
L. Snyder-Mackler
Physical Therapy, University of Delaware, Newark, DE, USA
Opening wedge high tibial osteotomy (OW-HTO) is used to realign
the knee and reduce damaging joint moments in patients with
S78Fig. 1. Group reﬂex and volitional muscle response during perturbations.medial compartment knee osteoarthritis (MKOA). The purpose of
this study was to determine whether knee realignment alters
muscle responses that could inﬂuence disease progression when
exposed to a rapid valgus perturbation.
Methods: Nine subjects with MKOA and genu varum were tested
prior to (PRE) and 1 year following OW-HTO (POST). Nine healthy
age and gender-matched control subjects with neutral alignment
(CONT) were compared. Alignment and joint laxity were measured
from radiographs and quadriceps strength tested with a KinCom.
Kinematic, kinetic, and reﬂexive muscle responses were assessed
with subjects standing on a moveable platform that induced a rapid
valgus motion at the knee. Muscles included medial (MH) and
lateral hamstrings (LH), vastus medialis (VM), and vastus lateralis
(VL), and lateral (LG) and medial gastrocnemius (MG). Co-
contraction indices were derived during long loop reﬂex (40–175
ms during plate movement) and volitional responses. Signiﬁcance
was set at P ! 0.05.
Results: Following OW-HTO, the weight-bearing line shifted laterally
(P Z 0.000) medial laxity was reduced (P Z 0.024) and was
equivalent to the healthy group (P Z 0.394) but quadriceps
weakness persisted (P ! 0.05). Knee function improved (P Z
0.002) but was still lower than healthy controls (PZ 0.045). Dynamic
knee stability improved after realignment (P Z 0.056) and was
equivalent to controls (P Z 0.176). Reﬂex latencies in the medial
muscles were no different from controls, either preoperatively or
postoperatively (PO 0.05) and realignment did not change the level
of medial muscle co-contraction during the reﬂex interval (PO 0.05).
medial contraction found during the volitional interval was lower
postoperatively and equivalent to controls (PO 0.05) (see ﬁg. 1).
Negative correlations were found between quadriceps strength and
the levels of co-contraction in VLLH and VMMH in the reﬂex and
volitional intervals.
Conclusion: After OW-HTO varus malalignment was corrected and
patients had reduced medial laxity, higher dynamic knee instability
and higher overall function. However, the quadriceps weakness that
persisted after realignment could lead to less joint motion during
dynamic activities that would reduce shock absorption that would
allow joint degeneration to continue despite realignment. The higher
co-contraction could increase joint compression that would further
exacerbate joint destruction. The robust relationship between
quadriceps strength and medial muscle co-contraction suggests
that improving quadriceps strength could reduce medial muscle co-
contraction and both might slow the progression of MKOA.P191
EFFICACY AND SAFETY OF 40 mg/4 ml OF HYALGAN BY
ULTRASOUND-GUIDED INTRA-ARTICULAR INJECTION IN HIP
OSTEOARTHRITIS PATIENTS: PILOT STUDY
A. Migliorey, S. Tormentaz, U. Massafray, C. Valentey, A. Alimontiy,
L. S. Martinx
y Department of Internal Medicine, S.Pietro-FBF Hospital, Centro
Ricerche S.Pietro AFaR, Rome, Italy
z Department of Radiology, S.Pietro-FBF Hospital, Rome, Italy
x Department of Internal Medicine, Regina Apostolorum Hospital,
Albano, Rome, Italy
Aim of the study: Pilot investigation into the safety and the duration
of beneﬁt after ultrasound-guided intra-articular injections of
Hyalgan in patients with hip OA.
Materials and methods: Adult, ambulatory patients suffering from
hip OA grade 2 to 3 according to Kellgren and Lawrence were
selected for the Study. Two syringes of 20 mg/2 ml (equal to 40 mg/
4 ml) of Hyalgan, were injected twice with ultrasound guidance by
an anterior parasagittal approach in each symptomatic hip; the
second injection was given 30 days after the ﬁrst one. A 7 MHz
linear or 3.5 MHz convex transducer was used with a sterilised
biopsy guide attached. The efﬁcacy of the injection was assessed
by using the Lequesne index, taking into account previous monthly
Table 1
Results at 3 and 6 months (mean values and% variation vs
baseline)
Baseline 3 months 6 months
Lequesne Index 10.64 4.59 (56.9%)*** 5.04 (52.6%)**
Pain 6.50 4.54 (30.2%)*** 4.73 (27.2%)**
Global patient
evaluation
5.82 4.18 (28.2%)* 4.36 (25.1%)*
Physician global
evaluation
5.91 4.14 (29.9%)* 4.13 (30.1%)*
NDAIDs consumption 6.90 2.27 (67.1%)* 2.18 (68.4%)*
*P ! 0.02; **P ! 0.002; ***P ! 0.001.
S79NSAIDs consumption, VAS pain score, global patient evaluation
and global physician evaluation at baseline and then 3 and
6 months after the injections of Hyalgan. Any adverse events
during the follow-up period were reported.
Results: Eleven patients (3 M–8 F) were enrolled in the study, ﬁve
had bilateral hip OA. A total of 16 hips were treated and 32
injections were performed. After treatment, values showed a statis-
tically signiﬁcant reduction vs baseline both at 3 and 6 months in
the Lequesne index, pain (rating scale 0–10), global patient
evaluation and global physician evaluation (both assessed by
rating scale 0–10). Average NSAIDs intake (days/month) de-
creased signiﬁcantly during the study.
No infectious or systemic complications were reported.
Conclusions: In summary, Hyalgan at the proposed regimen
(2 doses of 40 mg injected at 30 days each to the other) seems
to be a safe and efﬁcacious treatment improving pain and function
at least up to 6 months in hip OA patients. The reduction in
NSAID consumption may also reduce the costs associated with
disease management. The injection volume of 4 ml is well
tolerated in hip joints. Further studies in a larger series of patients
and with a control group are warranted in order to conﬁrm these
results.
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EFFECTS OF LATERALLY WEDGED INSOLES ON JOINT
MOMENTS IN PEOPLE WITH AND WITHOUT KNEE OSTEO-
ARTHRITIS
W. Kakihanay, M. Akaiy, K. Nakazaway, T. Takashimay, Kenji
Naitoz, Suguru Toriiz
y Department of Rehabilitation for Movement Functions, Research
Institute of National Rehabilitation Center for Persons with
Disabilities, Tokorozawa, Japan
z Graduate School of Human Sciences, Waseda University,
Tokorozawa, Japan
Aim of study: To assess frontal plane kinematic and kinetic effects
of wearing a lateral wedge on the knee joint varus moment during
gait in elders with and without knee osteoarthritis (OA).
Methods: Crossover design: Subjects walked under two different
insole conditions: a 0( control wedge and a 6( lateral wedge. Forty
elderly females (20 healthy elders and 20 osteoarthritic patients
with a varus deformity of the knee) participated in the experiments.
The inclusion criteria for OA patients were: 50 years of age or older,
knee pain for at least 6 months, and bilateral knee OA with
a deﬁnite osteophyte indicated by the radiograph. Three-dimen-
sional gait analyses were conducted with a motion analysis system
(Vicon 512 System) operating at 60 Hz with 12 infrared cameras
and 8 force platforms operating at 60 Hz. Frontal plane angles and
moments at the knee and subtalar joints, ground reaction forces
and center of pressure were investigated for not changed right
side of healthy elders and for more affected side of OA patients.
Moments were derived using a three-dimensional inverse dynam-
ics model of the lower extremity. A comparison of each parameter
was performed using a 2 (groups: healthy elders and OA
patients)!2 (conditions: 0( control wedge and a 6( lateral wedge)
analysis of variance (ANOVA) with repeated measures on the last
factor.
Results: The 6( lateral wedge signiﬁcantly reduced knee joint varus
moment (a 9.4% reduction for the healthy elders and a 5.6%
reduction for the OA patients; P!.001) and increased subtalar joint
valgus moment (a 33.3% increase for healthy elders and a 10.5%
increase for OA patients; P !.001) when compared to no wedge.
The most remarkable difference between the insole conditions was
the shift of the center of pressure location: The center of pressure
location was always parallel to the subtalar joint axis but shifted
more laterally when wearing 6( lateral wedge. Consistent with this
difference, the valgus moment arm of the subtalar joint for 6( lateral
wedge was signiﬁcantly greater compared with no wedge (a 33.9%
increase for healthy elders and a 12.3% increase for OA patients;
P ! 0.001), and hence produced a signiﬁcantly smaller knee jointvarus moment than no wedge. There was a reversed correlation
between the subtalar joint valgus moment and the knee joint varus
moment in all healthy elders (nZ 20) and in 75% of the OA patients
(n Z 15). But in ﬁve OA patients, there were diverse, sometimes
reversed effects with the 6( lateral wedge.
Conclusion: The 6( lateral wedge did not consistently reduce the
knee joint varus moment in knee OA patients. The biomechanical
indications and limitations of laterally wedged insoles should be
conﬁrmed by a larger study.
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SUPPRESSION OF HUMAN RHEUMATOID SYNOVIAL FIBRO-
BLAST MMP-2 EXPRESSION AND MATRIX INVASION BY
NUTRIENT SYNERGY
M. W. Roomi, V. Ivanov, A. Niedzwiecki, M. Rath
Research, Matthias Rath Inc, Santa Clara, CA, USA
Objective: In patients with rheumatoid arthritis and other inﬂamma-
tory diseases, MMPs are expressed in synovial membranes and
have been implicated in synovial tissue invasion into adjacent
cartilage and bone. We investigated the effect of Nutrient Synergy
(NS), a unique nutrient mixture containing ascorbic acid, lysine,
arginine, and epigallocatechin gallate on human synovial ﬁbroblast
growth, MMP expression, and invasive potential.
Materials and methods: Human synovial ﬁbroblasts were grown in
DME medium supplemented with 10% FBS, penicillin (100 U/ml)
and streptomycin (100 mg/ml) in 24-well tissue culture plates. At
near conﬂuence, the cells were treated with Nutrient Synergy (NS)
dissolved in media and tested at 0, 10, 100, 500, and 1000 mg/ml in
triplicate at each dose. Cell proliferation/cytotoxicity was evaluated
by MTT assay, MMP expression by gelatinase zymography, and
invasion through Matrigel.
Results: NS demonstrated dose-dependent inhibition of synovial
ﬁbroblast growth with maximum inhibition of 49% at 1000 mg/ml
(P ! 0.0001). NS was found to inhibit synovial ﬁbroblast ex-
pression of MMP-2 in a dose-dependent manner, with complete
inhibition at 500 mg/ml. The synergistically acting nutrient mixture
signiﬁcantly reduced the invasion of human synovial ﬁbroblasts
through Matrigel in a dose-dependent fashion, with 89% inhibition
at 100 mg/ml and 100% at 500 mg/ml NS (P Z 0.01). H&E staining
demonstrated no major changes, even at the highest concentration
of NS.
Conclusion: Our results suggest that NS has excellent potential as
an anti-inﬂammatory agent to suppress synovial cell MMP-2 activity
and tissue invasion.
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CHONDROITIN SULFATE REDUCES NUCLEAR TRANSLOCA-
TION OF TRANSCRIPTION FACTOR NF-kB AND DOES NOT
MODIFY THE ACTIVATION STATE OF ACTIVATING PROTEIN-1
(AP-1)
J. Vergesy, E. Montelly, G. Martinezy, L. Herouxz, P. du Souichz
y Clinical Research Unit, Scientific Medical Department, Bioiberica
Farma, Barcelona, Spain
z Pharmacology Department, Faculty of Medicine, University of
Montreal, Quebec, QC, Canada
Aim: To study the effect of chondroitin sulfate (CS) on the activation
of (Activator Protein-1 (AP-1) and Nuclear Factor–kB (NF-kB)
transcription factors.
Methods: Chondrocytes from rabbit knees were treated with 200
mg/ml of CS or the corresponding vehicle for 24 h. Afterwards, the
cells were stimulated with IL-1b (5 ng/ml) for another 48 h. Nuclear
translocation of AP-1 and NF-kB proteins, determined by immuno-
ﬂuorescence, was expressed as the ratio between the number of
nuclei stained with secondary antibodies with regard to the total
number of nuclei. This parameter was quantiﬁed by means of the
S80nucleic acid staining technique with the blue ﬂuorescent DAPI
probe. In parallel, nitric oxide (NO) concentrations were determined
in cell culture supernatant.
Results: The obtained data show that IL-1b induces nuclear
translocation of NF-kB. Thus, the ratio NF-kB/DAPI increases in
cells incubated with IL-1b (0.870G 0.035) as opposed to untreated
chondrocytes (0.013G 0.003) (P! 0.05). CS reduces said ratio in
cells stimulated with IL-1b (0.771G 0.032; P! 0.05). IL-1b-treated
chondrocytes show a higher activation of protein AP-1 with regard
to control cells (the ratio AP-1/DAPI increases from 0.18G 0.12 to
0.55G 0.12; P! 0.05). However, when simultaneously incubating
chondrocytes with CS and IL-1b, said ratio does not decrease,
ranging from 0.48 G 0.15. NO concentration in IL-1b-treated
chondrocytes (8.49 G 2.20 mM/mg of protein) is much higher than
that observed in control cultures (0.47 G 0.13 mM/mg of protein)
(P ! 0.05). CS treatment does not prevent the increase of NO
levels induced by IL-1b (9.60 G 2.18 mM/mg of protein).
Conclusions: The present study evidences that CS reduces the
activation of transcription factor NF-kB, which could partially
account for its clinical efﬁcacy. This effect on NF-kB is not
associated to a reduction in NO production, although the activation
of NF-kB induces the expression of the enzyme nitric oxide
synthase-2 (NOS-2). This apparent contradiction could be ex-
plained by the regulation of the NOS-2 enzyme by other
transcription factors apart from NF-kB. In summary, the decrease
of nuclear translocation-transactivation of NF-kB induced by CS
could constitute a new mechanism of action for CS.
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A HERBAL REMEDY, MADE FROM A SUBSPECIES OF ROSE-
HIP ROSA CANINA, REDUCES SYMPTOMS OF KNEE AND HIP
OSTEOARTHRITIS
E. Reiny, A. Kharazmiz, G. Thamsbprgx, K. Wintherjj
y Institute for Clinical Research, Clinical Research, Torskinsvej,
Egtved, Denmark
z Department of Clinical Microbiology, Rigshospitalet, Copenhagen,
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x Department of Rheumatology, County Hospital, Glostrup, Copen-
hagen, Denmark
jj Department of Biochemistry, County Hospital, Gentofte, Copen-
hagen, Gentofte, Denmark
Aim of the study: The objective of this study was to test if a herbal
remedy made from a subspecies of rose-hip (Rosa canina) might
reduce symptoms of osteoarthritis and consumption of rescue
medication in patients suffering from osteoarthritis of the hip or
knee.
Methods: Ninety-four patients with osteoarthritis of the hip or knee
were enrolled in a randomized, placebo-controlled, double blind
cross-over trial. Forty-seven patients were given 5 g of the herbal
remedy daily for a period of 3 months and the remaining patients
were given a similar amount of identical placebo. The group initially
treated with placebo was then changed to rose-hip and vice versa
for another three months period. Upon inclusion and after 3 weeks
and 3 months of each treatment period pain, stiffness, disability and
global severity of the disease was scored on a WOMAC
questionnaire. After 3 weeks of treatment patients, if possible,
were allowed to reduce their consumption of ‘‘rescue medication’’.
Data were analyzed on the basis of intention to treat.
Results: Rose-hip treatment resulted in a signiﬁcant reduction in
WOMAC pain (P ! 0.013) as compared to placebo, when testing
after 3 weeks of treatment. The consumption of ‘‘rescue medica-
tion’’, signiﬁcantly declined as a result of active treatment (P !
0.0137). WOMAC disability, stiffness and global assessment of
severity of the disease was not altered by 3 weeks, but decreased
signiﬁcantly (P ! 0.0183, P ! 0.0378 and P ! 0.0349), res-
pectively, after 3 months treatment.
Conclusion: The present data suggest that the herbal remedy rose-
hip can alleviate symptoms of osteoarthritis and reduce the
consumption of ‘‘rescue medication’’.P196
CHONDROITIN SULFATE (CS) AND HYALURONIC ACID (HA)
(500–730 KDA) INHIBIT STROMELYSIN SYNTHESIS (MMP-3) IN
HUMAN CHONDROCYTES
J. Monforty, M. Nacherz, E. Montellx, J. Vilaz, J. Vergesx, P. Benitoy
y Rheumatology Service, Hospital del Mar, Autonomous University
of Barcelona, Barcelona, Spain
z Institut Municipal d’Investigacio Medica, Pompeu Fabra Univer-
sity, Barcelona, Spain
x Clinical Research Unit, Scientific Medical Department, Bioiberica
Farma, Barcelona, Spain
Aim: To analyze in vitro the effect of CS and HA (500–730 kDa) on
MMP-3 synthesis induced by IL-1b in chondrocytes from patients
with primary osteoarthritis.
Methods: The in vitro cellular model used were cartilage chon-
drocytes obtained from patients with hip osteoarthritis subject to
arthroplasty. Chondrocyte cultures (nZ 3) were used in the second
subculture and were incubated for 48 h with IL-1b (2.5 ng/ml) in
absence or presence of different concentrations of HA 500–730
kDa (Hyalgan, Bioiberica Farma), or alternatively, CS
(Condrosan, Bioiberica Farma) (10, 50, 100, 150, 200 and
1000 mg/ml). Expressed MMP-3 levels were determined in cell
supernatant by means of the ELISA technique.
Results: The obtained data reveal that both CS and HA inhibit
MMP-3 synthesis induced by IL-1b. Speciﬁcally, CS reduces the
expression of MMP-3 in all tested concentrations (P ! 0.05), with
the values being 2092 G 546 ng/105 cells in absence of CS and
HA, and in presence of CS: 1686 G 89 ng/105 cells (10 mg/ml of
CS), 1544G 420 ng/105 cells (50 mg/ml of CS), 1511G 314 ng/105
cells (100 mg/ml of CS), 1492G 392 ng/105 cells (150 mg/ml of CS),
1535G 314 ng/105 cells (200 mg/ml of CS) and 1611G 209 ng/105
cells (1000 mg/ml of CS). Chondrocytes treated with HA also
present inhibition of stromelysin synthesis at different HA concen-
trations (P ! 0.05): 1526 G 339 ng/105 cells (50 mg/ml of HA),
1602 G 365 ng/105 cells (100 mg/ml of HA), 1601 G 668 ng/105
cells (150 mg/ml of HA), 1560G 349 ng/105 cells (200 mg/ml of HA)
and 1490 G 145 ng/105 cells (1000 mg/ml of HA).
Conclusion: The present work evidences that CS and HA inhibit the
synthesis of MMP-3 (proteolytic enzyme, which induces cartilage
destruction) in chondrocyte cultures from patients with primary
osteoarthritis. This effect provides new data about the mechanism
of action of said drugs, which could contribute to explain its clinical
effect in osteoarthritic patients.
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EVALUATION OF THE EFFICACY AND SAFETY OF ETORI-
COXIB 60 MG VS ROFECOXIB 25 MG IN ADULT INDIAN
PATIENTS WITH OSTEOARTHRITIS
A. A. Desaiy, G. Bhatiaz, S. B. Sarvagodx, C. C. Ballaryy,
A. S. Gawdey, V. P. Baligay
y Medical Services Department, Glenmark Pharmaceuticals Ltd.
22, Bhulabhai Desai Road, Mumbai, Maharastra, India
z Orthopedic Department, Inlaks and Mukat Hospital, Chandigarh,
Chandigarh, India
x Orthopedics Department, Mumbai Medical Centre, Thane, Maha-
rastra, India
Aim: To evaluate the efﬁcacy and safety of etoricoxib and rofecoxib
in patients with osteoarthritis (OA).
Methods: This prospective randomized, double-blind 4 week study
compared the efﬁcacy and safety of once daily doses of Etoricoxib
60 mg and Rofecoxib 25 mg in 80 Indian patients with osteoarthritis
after obtaining their informed consent. Efﬁcacy was assessed by
analyzing the changes in Western Ontario and Master Universities
(WOMAC) Osteoarthritis Individual and Composite Indices, Pa-
tients’s and Physician’s Assessment of Arthritis. Safety was
evaluated by monitoring treatment-emergent adverse events,
physical examination and laboratory tests.
S81Table I
Effect of therapy with etoricoxib and rofecoxib on mean scores of pain, VAS, Stiffness, physical function and Total WOMAC Index
Parameter Etoricoxib
60 mg OD
(n = 40)
(Baseline)
Etoricoxib
60 mg OD
(n = 40)
(Week 2)
Etoricoxib
60 mg OD
(n = 40)
(Week 4)
Rofecoxib
25 mg OD
(n = 40)
(Baseline)
Rofecoxib
25 mg OD
(n = 40)
(Week 2)
Rofecoxib
25 mg
OD (n = 40)
(Week 4)
Mean scores of pain (GSD) 13.45 G 4.84 *4.83 G 2.51# *1.06 G 0.98# 13.23 G 4.39 *5.82 G 3.25 *1.80 G 2.05
Mean scores of VAS (GSD) 7.81 G 3.26 *3.49 G 2.48# *0.49 G 0.76# 7.82 G 3.61 *4.96 G 3.04 *1.12 G 1.04
Mean scores of stiffness (GSD) 5.47 G 2.39 *1.88 G 1.97# *0.63 G 0.82# 5.50 G 2.40 *2.52 G 2.11 *1.25 G 0.97
Mean scores of physical function (GSD) 37.61 G 9.11 *19.68 G 8.05# *4.72 G 2.84# 37.41v9.64 *24.03 G 7.96 *6.14 G 2.60
Mean Total WOMAC Index score (GSD) 56.53 G 12.84 *26.39 G 8.57# *6.41 G 3.46# 56.14 G 13.61 *32.37 G 9.77 *9.19 G 3.75
Within group *P ! 0.05, by Wilcoxon Sign Rank test; between groups #P ! 0.05, by Mann Whitney U test.Results: Etoricoxib demonstrated clear improvements for all the
endpoints, viz. WOMAC Osteoarthritis Individual and Composite
Indices, Patient’s Assessment of Arthritis, Pain-Visual Analogue
Scale (VAS) and Patient’s and Physician’s Global Assessment of
Arthritis. At the recommended doses of 60 mg Etoricoxib was found
to be superior to Rofecoxib 25 mg in the symptomatic relief of OA.
Starting from the second week of initiating therapy, the improve-
ment in the symptom scores was signiﬁcantly greater in the
Etoricoxib group than in the Rofecoxib arm. More number of
patients in the Etoricoxib group expressed greater satisfaction with
their study medication than those in the Rofecoxib group. The
incidence of adverse events in the groups was similar: in the two
groups. The nature of the adverse events was mild in severity and
did not result in discontinuation of therapy. There were no
statistically signiﬁcant changes in the laboratory tests at the end
of the study in both the groups.
Conclusion: Consistent with its greater selectivity for COX-2
enzyme, etoricoxib demonstrated faster and greater pain relief
compared to rofecoxib and thus represents a superior alternative to
rofecoxib in the symptomatic relief of osteoarthritis.
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THE PHARMACOKINETICS OF ORAL CRYSTALLINE GLU-
COSAMINE SULFATE IN MAN SUPPORT ITS MECHANISM OF
ACTION AND CLINICAL EFFECTS
S. Persianiy, L. C. Rovatiy, V. Foschiniz, G. Giacovelliy,
M. Locatelliz, A. Rodaz
y Department of Clinical Pharmacology, Rotta Research Laborato-
rium, Monza, MI, Italy
z Department Pharmaceutical Sciences, University of Bologna,
Bologna, Italy
Aim of study: The original glucosamine sulfate oral formulation
(crystalline glucosamine sulfate, 1500 mg once-a-day soluble
powder – Dona, Viartril-S, Xicil, or other Rottapharm Group trade-
marks) (CGS) was shown to be a symptom- and structure-modifyingdrug in knee OA long-term trials (Reginster et al. Lancet
2001;357:251; Pavelka et al. Arch Intern Med 2002;162:2113). To
date the pharmacokinetics (PK) of glucosamine (G) have not
been elucidated due to the lack of suitable bioanalytical
methods, limiting the understanding of CGS mechanism of action
and clinical effects. In addition, the impossibility to demonstrate
bioequivalence favoured the appearance on the parallel dietary
supplementmarket of several undocumentedGsalts and derivatives
(e.g., G-HCl,
N-acetyl-G, etc), formulations and dose regimens, thus creating
a major public health concern. The study aim was therefore to
describe the PK of G after administration of CGS to humans.
Methods: A Liquid Chromatography with Mass Spectrometry
detection (LC-MS/MS) method for the determination of G in human
plasma was validated with a quantitation limit of 6.25 ng/ml. Twelve
healthy volunteers received 3 consecutive once daily oral admin-
istrations of the CGS original formulation at the doses of 750, 1500,
and 3000 mg, in a randomised, cross-over, open fashion. G PK
were determined by non-compartmental methods.
Results: Endogenous G was detected in plasma (10.4–204 ng/ml)
with low intra-subject variability and was subtracted. After 3
consecutive administrations, the PK of G were at steady state
indicating an elimination t1/2 of approximately 15 h. G was rapidly
bioavailable and its plasma PK were linear in the dose range 750–
1500 mg (Table). At the dose of 3000 mg, a deviation from linear
kinetics was observed, as the dose-normalised AUCt and AUCss
values were lower than the corresponding values at the dose of 750
mg (P! 0.05). G was still measurable in plasma 48 h after dosing,
and its PK indicates that G distributes to both the vascular and
extravascular compartments.
Conclusions: G is bioavailable after oral CGS and the Css,max at the
dose of 1500 mg is in line with the concentrations effective in
inhibiting IL-1 intracellular signalling pathway, that may mediate the
drug clinical effects (Letari et al. Arthritis Rheum 2003;48
Suppl:664). G distribution is in agreement with its action at the
level of the joint, whereas its disposition supports once daily dosing.
Doses higher than 1500 mg afford less than dose-proportional
plasma concentrations. Other G salts, derivatives, formulations or
regimens must ﬁrst show to be bioequivalent to CGS 1500 mg once
daily, before they can be considered for comparison as therapeutic
alternatives.Parameter 750 mg 1500 mg 3000 mg
Tmax [h]y 3 (0.56) 3 (1.54) 4 (34)
Css,max [ng/ml]z 1069.2 G 675.30 1601.9 G 424.85 2503.1 G 1835.3
AUCss [ng h/ml]z 9696.67 G 4214.75 14563.7 G 4138.16 22094.6 G 6984.08*
AUCt [ng h/ml]z 14323.0 G 5582.4 20216.4 G 5021.27 27990.5 G 8034.69*
*P ! 0.05 vs 750 mg when dose-normalised (ANOVA).
yMedian and range.
zMean G SD.
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INVESTIGATING CHRONIC ABERRANT STRESS EXPOSURE
FOLLOWING INTRA-ARTICULAR FRACTURE AS A PREDIC-
TOR OF POST-TRAUMATIC OSTEOARTHRITIS
D. D. Anderson, N. M. Grosland, T. D. Brown
Orthopaedics and Rehabilitation, The University of Iowa, Iowa City,
IA, USA
Aim: Using ﬁnite element (FE) computer models of intact and
fractured ankles from patients, we aim to characterize chronic
aberrant stress exposure as a predictor of post-traumatic OA
following intra-articular fracture.
Methods: Two different ankles were studied, one from an intact
cadaver, the other from an intra-articular fracture patient. FE
models were created from CT scans using techniques previously
described. Subchondral bone surfaces were segmented to deﬁne
rigid bodies over which articular cartilage layers were meshed.
Apposing cartilage surfaces were deﬁned as deformable contact
pairs with a frictionless interface, and large displacement simu-
lations were utilized. Starting from a neutral ankle posture,
a sequence of 13 loading conditions taken from literature were
applied to simulate the stance phase of gait.
Computed contact stress values were summed at each surface
node across discrete instances in the simulation. This exposure
Fig. 1. Schematic of intact ankle FE model taken through loading
sequence from the stance phase of gait. The tibia is rotated about
a ﬂexion/extension axis located in the talus.measure was then compared between the intact and fractured
models.
Results: Intuitively credible solutions were obtained with both
models.
Coupled talar rotations were observed during the simulation. The
peak cumulative local stress for the fracture case was 28% higher
than in the intact ankle, and it was located distant from the
incongruity near the posterior margin of the joint. This is in contrast
to the intact case, where the maximal contact stress exposure was
centrally located.
Conclusions: These patient-speciﬁc computer models of ankle
loading provide insight into the contact stress histories which
articular cartilage experiences over many cycles each day. The
long-theorized chronic aberrant stress exposure following intra-
articular fractures healed with residual incongruity may now be
studied in the living ankle. This opens new avenues to study the link
between chronic stress exposure and the onset of post-traumatic
OA. The contact stress exposures, appropriately scaled across
a period of service, might logically be compared to previously
published values for chronic stress tolerance in human articular
cartilage. Using this approach, predictions of the likelihood of post-
traumatic OA occurring in a given ankle can be made. Prospective
clinical evaluations of outcomes must necessarily be used to
establish the validity of such predictions, and we are currently
performing just such studies.
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VISCOSEAL AIDS RECOVERY AFTER ARTHROSCOPY –
A SINGLE BLIND, RANDOMISED, MULTICENTRE STUDY
A. Villamor1, J. Lloveras2, L. Camacho3, A. Ojeda4, A. Alonso5,
J. Cami6, L. Alcocer7, A. Perez8, M. A. Herrador9, F. J. Vaquero10,
J. Cabot11, C. Justribo12, F. Dachs12, F. Macule13, J. M. Aguilera14,
X. J. Segarra15, A. Salvado16, A. Fraguas17, A. Puig-Adell18,
J. Azofra19, M. Sanchez19, F. Ayerbe20, L. Varela21
1Orthopedic Surgery, Clinica IQTRA Medicina Avanzada, Madrid,
Spain
2Orthopedic Surgery, C Salus Infirmorum, Girona, Spain
3Orthopedic Surgery, HS Juan de Dios, Mallorca, Spain
4Orthopedic Surgery, IATMED, Sevilla, Spain
5Orthopedic Surgery, H C U, Salamanca, Spain
6Orthopedic Surgery, H Manresa, Barcelona, Spain
7Orthopedic Surgery, Asepeyo, Madrid, Spain
8Orthopedic Surgery, C La Milagrosa, Madrid, Spain
9Orthopedic Surgery, C Cemtro, Madrid, Spain
10Orthopedic Surgery, Fremap, Madrid, Spain
11Orthopedic Surgery, Artrosalud, Barcelona, Spain
12Orthopedic Surgery, C Sagrado Corazon, Barcelona, Spain
13Orthopedic Surgery, H Clinic, Barcelona, Spain
14Orthopedic Surgery, Asepeyo, Barcelona, SpainFig. 2. In these anterior views of the tibial plafond, plots of contact stress exposure (effectively time integrals of instantaneous contact stress
summed over the stance phase of gait) demonstrate contact stress aberration following a healed intra-articular fracture.
S8315Orthopedic Surgery, C Verge del Pilar, Barcelona, Spain
16Orthopedic Surgery, C Plato, Barcelona, Spain
17Orthopedic Surgery, C Teknon, Barcelona, Spain
18Orthopedic Surgery, C Tres Torres, Barcelona, Spain
19Orthopedic Surgery, UPS Esperanza, Vitoria, Spain
20Orthopedic Surgery, H S Eloy, Bilbao, Spain
21Scientific Department, Masterfarm, S.L., Barcelona, Spain
Aim: To assess the safety and efﬁcacy of Viscoseal (TRB
Chemedica AG, Germany), a synovial ﬂuid substitute containing
0.5% hyaluronan for use after arthroscopy, on symptoms in the 4
week post-surgery period compared to standard procedure.
Methods: Patients (18–60 years old), requiring partial meniscec-
tomy and/or osteochondral debridment were recruited after giving
written informed consent and were randomised after conﬁrmation of
inclusion/exclusion criteria during arthroscopy. Those in the control
group (CG) underwent standard arthroscopy while the other group
(VG) received 10 ml Viscoseal into the joint through the contro-
lateral portal after ﬁnal joint lavage. No other intra-articular
treatment was allowed. Only diclofenac 50 mg tablets were
available as escape medication. From Days 1 to 7, patients
recorded pain and diclofenac intake daily in a diary and returned on
Days 7, 12 and 28 (end of study) for assessments. The Mann–
Whitney U test was used for the primary endpoint while the non-
parametric Mann–Whitney U test and Mantal–Haenszel test were
used for secondary endpoints.
Results: Niety-three patients (66 males; mean age: 44.7 G 12.75
years) were recruited and completed the study (CG: n Z 45; VG:
n Z 48). Pain, which was similar in both groups at Day 0,
decreased more rapidly in VG being signiﬁcant (P! 0.01) at Day 7
compared to CG. This was maintained until Day 28 (P ! 0.05).
AUC for pain (VAS) was 39% lower in VG than in CG (CG: 496.22;
VG: 301.22) (P ! 0.01). At Day 0, all patients had mild to severe
pain on squatting. On Day 28, 53.3% in VG and 32.2% in CG had
no pain on squatting. Diclofenac use was lower in VG on Day 1
post-surgery (1.6G 1.1 tablets vs 1.9G 1.0 in CG) and decreased
daily to Day 6 (0.9 G 1.0 vs 1.3 G 1.1 in CG) and Day 28 (0.2 G
0.5 vs 0.7 G 1.0 in CG) indicating Viscoseal had an NSAID-
sparing effect. By Day 28, 53.3% patients in VG returned to work
compared to 32.4% in CG. By Day 28, 20% of the patients in VG,
compared to 13.5% in CG, were able to practice sport. On Day 7
there was a 57% reduction in the sum of point scores for secondary
efﬁcacy parameters (meniscal examination, effusion, pain on
squatting, Lachman test, knee rotation, MCL, LCL, etc.) in VG
compared to a 49% reduction in CG. On Day 28, reductions were
similar in both groups (73%). No adverse events were reported.
Conclusion: Viscoseal was safe and effective in decreasing pain
and improving function when used post-arthroscopy and resulted in
an earlier return to work and sports practice.
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THE EFFECT OF 15-MONTH LOW INTENSITY EXERCISE
THERAPY ON THE FUNCTIONAL CAPACITY OF THE LOWER
EXTREMITIES IN 35–54-YEAR OLD WOMEN WITH KNEE
SYMPTOMS
A. E. Tamm, U¨. Hansen, M. Viil, L. Laurson, A. O. Tamm
Faculty of Medicine, University of Tartu, Tartu, Tartu, Estonia
ulle Hansen Family Practice, Elva, Tartu, Estonia
Faculty of Mathematics and Informatics, University of Tartu, Tartu,
Tartu, Estonia
Faculty of Sport Sciences, University of Tartu, Tartu, Tartu, Estonia
Faculty of Medicine, University of Tartu, Tartu, Tartu, Estonia
Aim: To study the applicability and effect of long-term low intensity
exercise therapy (ExT) on the functional capacity of the lower
extremities in 35–54 years overweight women with knee com-
plaints.
Methods: All subjects were selected from the symptomatic cohort of
a study of knee osteoarthritis from the community of Elva. Theinclusion criteria for ExT were the following: complaints according
to KOOS, BMIO 27, abnormal results in 2 out of 4 functional tests
and/or radiographic OA. To 36 subjects, meeting the criteria, ExT
was proposed. Nine of them passed the course of 15-month ExT
(group I), the 11 who did not agree with ExT (group II) served as the
controls, while they matched the ExT subjects regarding sex, age,
BMI, level of hs-CRP, radiographic OA. The status of the subjects
of group I was tested monthly using the KOOS and VAS scales,
and 5 times per 18 months using functional tests. The subjects of
group II were checked before and after the ExT period. For
statistics, the Mann–Whitney test, the Spearman rank correlations
and time series analysis were used.
Low intensity ExT consisted of aerobic, isometric and stretching
exercises for 60 min twice per week in the gym-hall. The 15-month
ExT period (6 C 9 months) had 3-month summer interval.
Results: Among several tests performed during the 15-month ExT,
improvements were observed in four tests. The women of group I
showed more capacity to climb stairs (CCS) (P Z 0.002–0.003),
separately with the left and the right foot, than the women of the
non-exercise group. The women of group I were quicker (P Z
0.023) in Up & Go test and capable of rising from the chair (P Z
0.003) compared with the women of group II. Signiﬁcantly better
ﬂexion of the left (PZ 0.007) and the right (PZ 0.026) knees were
noted of group I women in comparison with controls.
During the ﬁrst 6 months of ExT, improvement, but also
deteriorations were observed in stepping up with both legs in
about half of the subjects. Therefore, individual approach is needed
in the use of ExT. Repeated measurements revealed two sub-
groups among the women passing ExT: the group with (IA) and
without (1B) improvement of the quality of life. The women of the IA
group demonstrated signiﬁcant correlations between CCS test and
ADL (R Z 0.767, n Z 14, P Z 0.0014), QL (R Z 0.744, P Z
0.0023) and knee pain (R Z 0.623, P Z 0.017). In the IB group
no correlations were detected between the results of the functional
tests and the KOOS.
Conclusions: (1) During 15 month low intensity ExT there was
observed a signiﬁcant improvement in stair climbing, in rising from
the chair, in up & go test and in the ﬂexion of the knees. However,
there may occur reductions in capacity during ExT. (2) For
monitoring the status during long-term ExT, it is expedient to use
both the KOOS and VAS scales in order to assess individually the
patients’ status. (3) Reduced capacity in using the lower extremity
was primary revealed in the tests performed with one leg, e.g., stair
climbing. Such a change seems to be frequent already in early
knee OA.
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LONG TERM STUDY OF CHONDROPROTECTIVES IN O.A.
KNEE
C. L. Kanth, K. H. Hussain, S. Sulochana
Rheumatology, Sai Rheumatology Centre, Hyderabad, AP, India
Aim of study: To evaluate the structure modifying effects of
chondroprotectives glucosamine hydrochloride and glucosamine
hydrochloride C chondroitin sulfate.
Methods: Glucosamine hydrochloride is an early symptom and long
term structure modifying agent. Chondroitin sulfate is also
a symptom and structure modifying drug.
This was a randomized study, a continuation of early study of 7210
patients with O.A knee, 1991 were males and 5219 were females
(3988 out of them were post menopausal), who were divided into 2
groups, ﬁrst group with glucosamine hydrochloride 500 mg I.T.I.D.
and second group with glucosamine hydrochloride 750 mgC
chondroitin sulfate 600 I.T.I.D. for a period of 2 years. Weight
bearing antero-posterior radiographs of each knee were taken at
enrolment and at yearly intervals standardizing patient positioning
and radiographic procedure. Joint space width (JSW) at the
narrowest point was measured visually by a 0.1 mm graduated
magnifying glass according to a validated technique. The clinical
efﬁcacy was evaluated by assessing Lequesne index, spontaneous
S84pain using the (Huskisons visual analog scale), pain on load (using
4 point ordinal scale) and paracetamol consumption.
Results: The results quite convincingly depict the structure
modifying both drugs on clinical and radiological mapping with
some varied efﬁcacy variation.
Conclusion: The structure modifying effects of both drugs glucos-
amine hydrochloride and glucosamine hydrochlorideC chondroitin
sulfate are well established by measuring the height of the cartilage
by standard radiograph. The symptom free interval after stopping
the drug is also well plotted for comparison. This study concludes
both drugs are deﬁnitely structure modifying but combination
seems to be better option than used individually.
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INTRA-ARTICULAR HYALURONATE (MW 500–730 KDA)
THERAPY AND CONCOMITANT HOME EXERCISE
STRENGTHENING: AN EFFECTIVE ADDITIVE THERAPEUTIC
ALGORITHM FOR OSTEOARTHRITIS OF THE KNEE
T. P. Stitik, P. M. Foye, D. M. Stiskal, S. F. Nadler, B. Chen,
L. Schoenherr
Physical Medicine & Rehabilitation, University of Medicine &
Dentistry of New Jersey-New Jersey Medical School, Newark,
NJ, USA
Purpose: Intra-articular (IA) hyaluronan therapy (viscosupplemen-
tation) and strengthening of the quadriceps in knee osteoarthritis
(OA) have been independently shown to improve pain and function
in patients with mild to moderate OA. Since the beneﬁts of adding
a home exercise program (HEP) of quadriceps strengthening to
weekly IA injections in alleviating symptoms of OA is unknown, this
study was undertaken.
Methods: An active controlled, parallel-design, blinded-observer
study was initiated using three treatment groups, and a total of 60
patients with painful OA (Kellgren-Lawrence grade II or III on X-ray)
with follow-up out to 12 months. Patients were randomized to
receive weekly Hyalgan (sodium hyaluronate, MW 500–730 kDa)
injections (IA-HYL) as follows: 3 weekly IA-HYL (3HYL), 3 weekly
IA-HYLC HEP (3HYLC HEP), or 5 weekly IA-HYL (5HYL). A total
of ﬁve follow-up visits were completed post-injection (7, 11, 26, 39
and 52 weeks). The primary efﬁcacy measure was VAS pain (100
mm) after a 50 ft walk, and secondary measures included WOMAC,
Range of Motion (ROM), patient’s categorical pain score, patient’s
global assessment, and various isokinetic quadriceps strength
measures.
Results: Patient demographics between groups were not statisti-
cally different at Baseline (average age 64 G 9.2, average weight
of 217 G 49.1 and 70% were female). The% improvement from
Baseline at 3, 6, 9 and 12 months using the VAS pain score were
49%, 46%, 22% and 34% (3HYL); 59%, 58%, 51% and 56%
(3 HYL C HEP); and 48%, 45%, 53% and 71% (5HYL), res-
pectively, and all were statistically improved from baseline at each
follow-up (P ! 0.01). Using a mixed effect model with all follow-up
visit assessments after the IA-HA, the 3HYL C HEP group was
statistically superior to the 3HYL treated patients (PZ0.04), but
there was no signiﬁcant difference between the 3HYL C HEP and
5HYL. WOMAC function subscore signiﬁcantly improved for all
groups through 12 months compared to baseline (not statistically
different from each other). The quadriceps strengthening (average
peak torque) did not signiﬁcantly change from the baseline, even in
the HEP group. Although there was no discernable improvement in
quadriceps strengthening between treatment groups, HEP had
a signiﬁcant impact on improvement of pain assessments following
IA-HYL. HEP beneﬁts seemed to be manifested very early following
the injections (7 weeks), and were maintained through 12 months.
Conclusions: Although the current indication for Hyalgan is after
non-pharmacologic intervention and simple analgesics have failed,
it is suggested that early intervention and concomitant quadriceps
strengthening is clinically beneﬁcial.
Key words: Rehabilitation; Strengthening; Viscosupplementation;
QuadricepsP204
LONG-TERM USE OF ACETAMINOPHEN IN PATIENTS WITH
OSTEOARTHRITIS PAIN
A. R. Templey, G. D. Bensonz, J. R. Zinsenheimy, J. E. Schweinley
y Research and Development, McNeil Consumer & Specialty
Pharmaceuticals, Fort Washington, PA, USA
z Department of Medicine, UMDNJ-Robert Wood Johnson Medical
School, Camden, NJ, USA
Aim: This study assessed the safety and efﬁcacy of acetaminophen
(APAP) 4000 mg/d when used for up to 1 year to treat osteoarthritis
(OA) pain of the hip or knee. Naproxen (750 mg/day) served as an
active control treatment.
Methods: This was a multi-center, randomized, double-blind,
parallel group study of up to 12 months duration. Subjects 40 to
75 years of age with mild to moderately severe pain secondary to
OA of the hip or knee were randomized to treatment with APAP
4000 mg/day or naproxen 750 mg/day for up to 6 (n Z 102) or 12
months (n Z 469). Assessments were conducted after 1, 3, and 6
months (6-mo group) or 1, 3, 6, 9 and 12 months (12-mo group).
Efﬁcacy was evaluated using WOMAC pain, stiffness, and physical
function subscales. Safety evaluations included a physical exam-
ination and study joint assessment at each visit, and specimens
were collected for laboratory evaluations. Reports of adverse
events were recorded at each visit.
Results: A total of 581 subjects were enrolled; 551 were included in
the intent-to-treat population for efﬁcacy analysis and 571 were
included in the safety population. In the APAP group (nZ 290), 174
completed 3 months of treatment, 129 completed 6 months, 72
completed 9 months, and 60 completed a full 12 months. Similar
completion rates were observed for the naproxen group. The
median dosing adherence ranged from 95.5 to 98.6% over the
period of the trial (average APAP doseO100 gm/month). The least
square mean change from baseline to Month 12 (or end of study) in
WOMAC pain, stiffness, and physical function subscales did not
differ signiﬁcantly between the APAP and naproxen groups.
Adverse events were reported by 206 subjects in the APAP group
and 209 in the naproxen group. No adverse event reported in the
APAP group was considered ‘‘serious’’ and ‘‘related’’ to study drug.
One subject in the naproxen group had a ‘‘serious’’ and ‘‘related’’ GI
bleed. No APAP subjects had AST or ALTO3X ULN, or creatinine
O1.5X ULN.
Conclusion: Continuous use of APAP for up to 12 months at
recommended doses of 4000 mg/day reduced WOMAC pain,
stiffness, and physical function scores to a similar extent as
naproxen without evidence of clinically important adverse effects.
These results indicate that with appropriate physician supervision
APAP can be used to safely and effectively treat OA pain of the hip
or knee for periods of up to 12 months.
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LONG-TERM EFFICACY OF LUMIRACOXIB IN OSTEOARTHRI-
TIS DEMONSTRATED USING THE OMERACT-OARSI CRITE-
RIA
J. P. Ouellety, J. Zacherz, A. Moorex, A. Leejj, V. S. Sloan{
y Medical Director, Q&T Research, Sherbrooke, Canada
z Orthopa¨dische Klinik, HELIOS Klinikum, Berlin, Germany
x Biostatistics and Statistical Reporting, Novartis Pharma AG,
Basel, Switzerland
jj Clinical Team – CRD Europe, Novartis Pharma AG, Basel,
Switzerland
{ Senior Director, Arthritis, Novartis Pharmaceuticals Corporation,
East Hanover, NJ, USA
Aim: To investigate the efﬁcacy of lumiracoxib over 52 weeks in
patients with knee osteoarthritis (OA) using OMERACT-OARSI
criteria, which provide a single measure of OA treatment response
incorporating pain, functional status and patient’s global assess-
ment of disease activity.
S85Methods: After a 3–7-day washout of NSAIDs, 1702 patients with
knee OA were enrolled into a 13-week core study and randomized
to lumiracoxib 200 mg qd (n Z 487), lumiracoxib 400 mg qd (n Z
491), celecoxib 200 mg qd (n Z 481) or placebo (n Z 243).
Patients completing the core could enter a 39-week extension.
Patients on active drug continued on the same treatment
(lumiracoxib 200 mg qd, n Z 352; lumiracoxib 400 mg qd, n Z
358; celecoxib 200 mg qd, n Z 348). Patients on placebo in the
core were re-randomized to active treatment. For the extension,
results are presented only for patients receiving active treatment
throughout the 52-week study. Efﬁcacy was assessed using
OMERACT-OARSI criteria at Weeks 2, 13 and 52 (end of study).
Patients were considered responders using these criteria if they
had a reduction of: R 50% from baseline and an absolute reduction
of R 20 in either pain intensity or the WOMAC Difﬁculty in
Performing Daily Activities [DPDA] subscale (rescaled to 0–100);
or R20% from baseline and an absolute reduction of R10 in R 2
of the following: pain intensity, WOMAC DPDA subscale
(rescaled to 0–100) or patient’s global assessment of disease
activity.
Results: After 52 weeks of treatment, 66.2% of patients in the
lumiracoxib 200 mg qd group were responders according to
OMERACT-OARSI criteria. This was not signiﬁcantly different from
celecoxib (71.8%). During the placebo-controlled core study,
lumiracoxib 200 mg qd was superior to placebo at Week 2
(50.2% vs 35.1%, respectively; P! 0.001) and Week 13 (64.3% vs
52.9%, respectively; P ! 0.01). The proportion of responders for
celecoxib 200 mg qd (49.0% and 66.1% at Weeks 2 and 13,
respectively) was similar to lumiracoxib 200 mg qd. No signiﬁcant
differences were observed between celecoxib 200 mg qd and
lumiracoxib 200 and 400 mg qd at any timepoint (data not shown).
Conclusions: Lumiracoxib 200 mg qd was an effective long-term
treatment for OA, similar to celecoxib 200 mg qd using OMERACT-
OARSI criteria, encompassing pain, functional status and patient’s
global assessment of disease activity.
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COST-EFFICACY OF JOINT LAVAGE VS NSAID’S IN THE
TREATMENT OF KNEE OSTEOARTHRITIS
A. R. De la Serna, A. A. Pereira, M. A. Moreno, I. J. Gich,
M. I. Caeiro
Rheumatology, Sant Pau Hospital, Barcelona, Spain
Objectives: To evaluate the cost-efﬁcacy and tolerance of joint
lavage (AL) vs NSAID’s in knee osteoarthritis.
Methods: In this open, observational and prospective study the
sequences of cases, 283 patients affected with knee osteoarthritis
(ACR criterion) treated with AL, was compared with 54 patients with
knee osteoarthritis treated with NSAID’s in a double-blind,
comparative study with other NSAID’S. The NSAID’s used was:
diclofenac, naproxyn, piroxicam, rofecoxib and tenidap.
A comparison response rates between two groups be made using
a Student’s t test and ANCOVA model. The comparison is
signiﬁcant at the 0.05 level.
Results: Both treatment groups were comparable except to age
(the mean age for AL was 68.5 years vs NSAID’s group 65.3 years;
P ! 0.0002).
The efﬁcacy to treatment was similar for both group and was
a signiﬁcant improvement compared to baseline at the 3 months
assessment (P ! 0.0005), but no statistically signiﬁcant difference
between the groups (for the variables: pain on a visual analogue
scale (VAS) from 0 to 100 mm; joint effusion and pain to joint
pressure).
The patient opinion for efﬁcacy of treatment was better for AL (P!
0.005) compared with NSAID’s, but was similar for physician
opinion (P ! 0.764).
Tolerance: The drop-out for AL was 7.42% vs 11.11% for NSAID’s.
Adverse events was seen in four patients for AL (2.06%) vs 9
patients in NSAID’s group (16.6%); P ! 0.0005.
Cost: The material cost of AL was 6$. The mean cost on NSAID’s
therapy during 3 months was 243.68$ (range 16.98 to 134.04 $).Conclusion: Treatment with AL is safe and comparable to NSAID’s
in knee osteoarthritis, in the short term (3 months). The AL was
more cost efﬁcient and present less adverse events.
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BAND OF 6–8 KDA DETECTED BY ANTIBODIES TO SYNVISC
(HYLAN G-F 20): IMMUNE MECHANISM FOR PSEUDOSEPSIS?
M. Hamburger, M. Settles, J. Teutsch
TGA Sciences Inc, Medford, MA, USA
Two hyaluronans (HA), hylan G-F 20 (Synvisc), SYN, and sodium
hyaluronate, MW 500–730 kDa (Hyalgan), HYL are approved to
treat osteoarthritis knee pain. Numerous case reports and clinical
studies have documented pseudoseptic reactions or Severe Acute
Inﬂammatory Reactions (SAIRs) and occasionally chronic granu-
lomatous reactions, CGR, (Chen et al. JBJS 2002;84:1142)
following SYN administration but not HYL. SAIRs normally require
prior exposure, and incidence increases following repeat treatment
(Leopold et al. JBJS 2002;84:1619). Components of chicken combs
(HA source) that are chemically cross-linked during the manufactur-
ing of SYN may be responsible. We demonstrated that rabbits
immunized with the commercially available SYN elicit an antibody
response to chicken proteins present in crude chicken comb
preparations (CCCP). Conversely, rabbits immunized with HYL
mounted antibody response. None of the rabbits immunized with
either product developed antibodies to puriﬁed HA. We have
conducted a Western blot analyses of the chicken proteins
contained in CCCP using the rabbit sera previously mentioned.
Three prominent bands between 48 kDa and 54 kDa, and a diffuse
band at approximately 6–8 kDa are observed using anti-CCCP
rabbit sera. A 6–8 kDa protein band was also observed in the blots
developed with anti-SYN sera, suggesting that these protein bands
may be responsible for the immunological response to SYN. We
are optimizing and validating these assays using samples from
patients following an SAIRs or CGR to SYN. Such an assay could
be used as an early diagnostic test to distinguish SYN reactions
from true joint sepsis.
P208
GLUCOSAMINE SULFATE AT GONARTHRITIS TREATMENT
N. P. Prodanovic, B. D. J. Bozic, I. Zgradic
Military Medical Academy, Military Medical Academy, Belgrade,
Serbia, Yugoslavia
Aim of study: Osteoarthritis (OA) represents the destruction of
articular cartilage and subchondral bone. OA is induced by
interaction of several factors including the biomechanical status of
joint, genetic factors, cellular and biochemical processes induced
by inﬂammation. Today there are more and more trials of applying
supportive therapy for treating many diseases, including osteoar-
thritis. The aim of this work was to estimate the inﬂuence of
glucosamine sulfate for pain reduction with patients with gonar-
thritis.
Methods: In the period from October 2002 to January 2004, we
carried out an investigation which included 61 women with
gonarthritis in the third stage with an average age of 64 years.
Radiographic stages have been determined on the basis of
Kellegren-Lawrence scale. Patients were required to have a rate
of at least 40 mm on a 100 mm VAS of knee pain. They were
divided into two groups. The ﬁrst group included 35 patients treated
with diclofenac duo 75 mg twice, oral during 12 weeks. The second
group included 26 patients treated with glucosamine sulfate 1500
mg/day, oral during 12 weeks. Efﬁciency was estimated using
a visual analog scale (VAS) for pain.
Results: According to the above mentioned, a therapy effect was
noticed after 8 weeks for 17 (48.57%) patients treated with
diclofenac duo, and after 12 weeks for 18 (51.43%) patients. The
S86symptoms of illness were reduced for 18 (69.23%) patients treated
with glucosamine sulfate after 8 weeks, evidenced by the decrease
in VAS score, and after 12 weeks for eight (33.77%) patients.
Conclusion: Our study showed that the glucosamine sulfate was
more effective in relieving the pain from gonarthritis and in
controlling the other symptoms of gonarthritis during 8 or 12 weeks
of treatment than diclofenac duo.
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HYALURONIC ACID VS DEXAMETHASONE FOR THE LOCAL
TREATMENT OF RHIZARTHROSIS: A PROSPECTIVE RAN-
DOMIZED STUDY
A. R. De la Serna, R. C. Gelabert, M. A. Moreno, A. A. Pereira
Rheumatology, Hospital Sant Pau, Barcelona, Spain
Objectives: To evaluate the efﬁcacy and safety on intra-articular
injections of hyaluronic acid vs dexamethasone on the trapezio-
metacarpal joint in patients suffering from rhizarthrosis.
Methods: In this prospective comparative study, 51 patients
affected by rizarthrosis and diagnosed by clinical and radiological
examinations were treated in one or both hands (total hands: 60).
The main inclusion criterion was a minimum pain score of 50 mm
on a visual analogue scale (VAS) from 0 to 100 mm. The patients
were randomized into two groups. The ﬁrst group received one
injection of dexamethasone (4 mg/1 ml) whereas the second group
received 4 weekly injections of hyaluronic acid (5 mg/0.5 ml). Both
groups were evaluated at baseline, 1 month and 6 months after the
ﬁrst injection. The primary endpoint was the efﬁcacy on the pain
level as measured by the VAS scores and the secondary endpoints
were the treatment tolerance and the overall treatment evaluation
by the patient and physician.
Results: Both treatment groups were comparable at baseline as
the hyaluronic acid group had a VAS score of 30.7 and the
dexamethasone group had a VAS score of 36.7. There was
a signiﬁcant improvement in the VAS score (P ! 0.0001)
compared to baseline at the 1-month assessment but no
statistically signiﬁcant difference between the groups. The ﬁnal
evaluation at 6 months showed a sustained improvement in the
hyaluronic acid group as the VAS score was 30.6 (vs 30.7 at the 1
month evaluation). The dexamethasone group demonstrates the
fading of the positive effect with a VAS score of 48.6 (vs 36.7 at the
1 month evaluation). The difference between the two groups at 6
month evaluation was statistically signiﬁcant (P Z 0.0001).
Tolerance results showed no severe adverse events in either
group. There were three minor local reactions at the injection site:
one patient in the hyaluronic acid group ant two in the
dexamethasone group.
Conclusion: Treatment with hyaluronic acid injections in the
trapeziometacarpal joint is safe and comparable to dexamethasone
in the treatment of rizarthrosis in the short term (1 month) but is
superior in the long term (6 months).
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EVALUATION OF SAFETY AND EFFICACY OF HYLAN GF-20
IN OSTEOARTHRITIS OF THE ANKLE: AN OPEN MULTI-
CENTRIC STUDY
V. Legre-Daumeny, T. Pham, P. Lafforgue, Reseau Rhumato Study
Group
Rheumatology, CHU Conception, Marseille, France
Osteoarthritis of the ankle is rare, and usually post-traumatic.
Hyaluronic acid injections, which are used in the treatment of knee
and hip osteoarthritis, could be an alternative treatment for ankle
OA.
Objectives: To evaluate the safety and efﬁcacy of intra-articular
Hylan GF-20 injections in patients with painful osteoarthritis of the
ankle.Methods: Eighteen patients with ankle pain and radiological ankle
osteoarthritis, were given 1 to 3 intra-articular injections of 2 ml
Hylan GF-20 under ﬂuoroscopy at 2 weeks interval, in a 6 months
follow-up prospective open study. The occurrence of adverse
effects and clinical outcome (100 mm pain visual analog scale
(VAS), Kitaoka functional score, 5 points satisfaction scale) were
evaluated at baseline, ﬁnal injection, week 4 and week 24.
Results: Tolerance of the injections was excellent in 15/18 patients.
Local ﬂare reaction occurred in one patient. Transient ankle pain
was recorded in two patients, with discontinuation of the treatment
in one case. Sixty-six percent of patients had signiﬁcant improve-
ment of pain and function (P ! 0.02) at 1 month and 6 months
evaluation, using a Wilcoxon test.
Conclusion: Hylan GF-20 ankle injections are well tolerated. This
study suggests some beneﬁcial clinical effects of hylan GF-20
injections in osteoarthritis of the ankle. A double blind study should
be performed to conﬁrm efﬁcacy of the treatment.
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TOLERABILITY OF ROFECOXIB 12.5 MG AND CELECOXIB 200
MG IN OSTEOARTHRITIS PATIENTS
G.Ruoffy, C. Birbaraz, A. Rodgersx, C. Valenzuelax, R. Petruschkex,
A. Tershakovecx
y Clinical Research, Westside Family Medical Center, Kalamazoo,
MI, USA
z Clinical Research, Clinical Pharmacology Study Group, Worcester,
MA, USA
x Clinical Development, Merck & Co., Inc., West Point, PA, USA
Aim of study: Selective cyclooxygenase (COX)-2 inhibitors dem-
onstrated improved gastrointestinal tolerability compared to non-
selective COX-1 and COX-2 inhibiting NSAIDs. The two most
frequently used COX-2 inhibitors are rofecoxib (ROF) and
celecoxib (CEL). Two studies were conducted to evaluate the
efﬁcacy and safety of the recommended starting osteoarthritis (OA)
dose of ROF 12.5 mg daily and the recommended OA dose of CEL
200 mg daily. Combined analyses of safety data from the studies
were performed to evaluate overall tolerability of ROF 12.5 mg
compared to CEL 200 mg.
Methods: Patients had clinically diagnosed OA of the knee for at
least 6 months that required regular treatment with an NSAID or
acetaminophen. Eligible patients were randomized to ROF 12.5
mg, CEL 200 mg, or placebo (PBO) for 6 weeks. The primary
objective was to demonstrate comparable efﬁcacy with ROF 12.5
mg and CEL 200 mg, based on patient global assessment of
response to therapy (PGART) over 6 weeks on a 5-point
categorical scale (0 Z none, 1 Z poor, 2 Z fair, 3 Z good, and
4 Z excellent) and a prespeciﬁed comparability bounds of G0.5
points. Combined analyses of prespeciﬁed adverse experiences
(AEs) were performed and included drug-related and serious AEs,
discontinuations due to AEs, as well as hypertension and edema
AEs leading to discontinuation, CHF, and GI AEs. Additional
combined hypertension- and edema-related AEs were evaluated.
Results: The two studies included: 413 patients (ROF N Z 159,
CEL NZ 169, and PBO NZ 85) and 395 patients (ROF NZ 160,
CEL NZ 157, and PBO NZ 78), respectively. ROF 12.5 mg was
comparable to CEL 200 mg on the primary endpoint of PGART over
6 weeks in both studies. For combined analyses, ROF and CEL
had similar overall AE rates, with no signiﬁcant differences
compared to PBO for any prespeciﬁed AEs. There were no
signiﬁcant differences in drug-related AEs, serious AEs, discontin-
uations due to AEs, hypertension and edema AEs leading to
discontinuation, CHF, and GI AEs. A greater number of serious
AEs were noted with CEL, 6 (1.8%) (P! 0.05) than ROF, 0; none
of which were considered drug-related. There were no serious
cardiovascular AEs in any treatment group. There were no
signiﬁcant differences between treatments in incidence of the
hypertension-related AEs (e.g., blood pressure increased, hyper-
tension, or hypertensive crisis) or the edema-related AEs (e.g.,
edema, peripheral edema, or ﬂuid retention).
S87Conclusions: Rofecoxib 12.5 mg daily and celecoxib 200 mg were
both generally well tolerated with an incidence of AEs similar to
placebo in this analysis of 6 week studies. No difference was
observed in hypertension- or edema-related AEs, with no serious
cardiovascular adverse experiences reported in any treatment group.
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THE MOLECULAR WEIGHT DEPENDENT INFLUENCE OF
HYALURONIC ACID ON HUMAN CHONDROCYTES
D. Wohlrab, W. Hein
Department of Orthopedics, Martin Luther University Halle Witten-
berg, Halle, Germany
Introduction: Osteoarthritis occurs as a consequence of patholog-
ical changes of synovial hyaluronic acid (HA). To date, the effect of
the HA is thought to be caused exclusively by its rheologic features.
The impact of cell biological features by HA has only been partially
investigated. In this study, the concentration-dependent inﬂuence
of ﬁve HA preparations with different molecular weights (0.5–6.0
million Dalton) on chondrocytes have been investigated under in
vitro conditions. Comparatively, both the inﬂuence of HA on cell-
biological features and differences in the effectiveness of the
several preparations were estimated.
Methods: The investigations were performed on human chondro-
cytes isolated from osteoarthritic knee joint cartilage. Chondrocytes
were cultivated for 14 and 28 days. Three different concentrations
of each HA preparation were applied (5 ! 105, 3 ! 105, 1 !
105 mmol). At the end of the culture duration, cells were counted in
a Fuchs Rosenthal counting chamber. Flow cytometry was used to
determine the DNA synthesis capacity and the cell cycle
distribution.
Results: Under the inﬂuence of HA, a considerable increase in the
cell number and of the DNA synthesis capacity together with
a displacement of the cell cycle phases, occur in human
chondrocytes. Particularly, the DNA synthesis capacity increased
with high molecular weight HA (6.0 million Dalton) by up to 70%. In
chondrocytes cultivated with another HA preparation the increase
of the DNA synthesis capacity was only up to 35%.
Conclusion: HA leads to a modulation of the proliferation of human
chondrocytes. The increase of chondrocytes proliferation depends
on the HA molecular weight and is most distinct under the inﬂuence
high molecular weight HA (6.0 million Dalton).
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WEATHER CONDITIONS CAN INFLUENCE RHEUMATIC
DISEASES
I. Mollery, N. Martiy, J. Vergesz, E. Montellz, E. Tomasz,
G. Cumellesz, G. Castan˜edaz
y Rheumatology Department, Instituto Poal de Reumatologia,
Barcelona, Spain
z Joint Health Unit, Scientific Medical Department, Bioiberica
Farma, Barcelona, Spain
Aims: The objective of this study was to evaluate the effect of
climatic conditions in rheumatic patients.
Methods: The present work was carried out with patients attending
the Instituto Poal de Reumatologia of Barcelona and the data were
analyzed by Bioiberica Farma (Spain). It was a prospective, double-
blind study including 92 patients with rheumatic disorders (80 with
osteoarthritis, 12 with rheumatoid arthritis) compared to a control
group of 42 subjects. The evaluation of pain (Huskisson VAS) and
functional capacity (Health Assessment Questionnaire –HAQ-)
were determined daily during 1 month and the climatic variables
studied were temperature, humidity and barometric pressure.
Results: The results obtained have been subject to binary
regression analysis. Our data demonstrate that osteoarthritic
patients experience increased joint pain in response to a decreasein pressure, indicating that low atmospheric pressure conditions
exacerbate joint pain in these patients. Our work also suggests that
some meteorological variables affect the occurrence of pain in
rheumatoid arthritis, since we have found that low temperatures
increase the risk of joint pain.
Conclusion: Therefore, these data suggest that in the future it may
be possible to modulate pharmacological and non-pharmacological
treatments for some osteoarthritic patients depending on the
predictable weather conditions in order to avoid, as much as
possible, the disease-associated joint pain and functional in-
capacity, thus improving patients’ quality of life.
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TRANSFERSOME CARRIERS FOR THE TRANSDERMAL
TARGETED DELIVERY OF NSAID INTO MUSCLE AND KNEE
JOINT – PRECLINICAL RESULTS WITH IDEA-033
S. Mazgareanu, U. Vierl, M. Rother
Preclinical R&D, IDEA AG, Munich, Germany
One major challenge in developing topical NSAID formulations is
that dermally applied drugs in conventional formulations are
transported across the skin by diffusion and are rapidly locally
cleared by the cutaneous microcirculation. Diffusion is usually
supported by penetration enhancing excipients causing a consider-
able level of skin irritation. In contrast, drugs applied dermally with
Transfersome carriers effectively accumulate in subdermal target
areas. The basis is activation of intercellular pathways into
transdermal passages allowing the drug-carrier-associate to cross
the skin spontaneously in a non-diffusive fashion and to bypass the
cutaneous microcirculation. An NSAID affecting the COX/LIPOX
pathway was chosen to investigate this novel drug delivery
approach (IDEA-033).
IDEA-033 showed superior targeted drug delivery into different
structures of subdermal pig tissue as compared to conventional oral
and topical (gel, patch) products. Additional studies indicate that
IDEA-033 is transported directly into the knee joint and accumu-
lates in the synovial ﬂuid of the targeted vs non-targeted joint.
Plasma concentrations for IDEA-033 were by a factor of about 100
lower as for the orally applied drug. Dermal tolerance studies in
rabbits indicate good skin tolerability of IDEA-033.
Preclinical ﬁndings prove the feasibility of the Transfersome-
mediated transdermal targeted delivery of NSAID and indicate
a highly efﬁcient and well-tolerated therapeutic concept for the
treatment of pain and inﬂammation associated with osteoarthritis.
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TREATMENT OF OSTEOARTHRITIS PATIENTS WITH ROFE-
COXIB 12.5 MG AND CELECOXIB 200 MG: A RANDOMIZED,
PLACEBO-CONTROLLED TRIAL
G. Ruoffy, L. Gildermanz, S. Cohenx, C. Valenzuelajj, A. Rodgersjj,
R. Petruschkejj, A. Tershakovecjj
y Clinical Research, Westside Family Medical Center, Kalamazoo,
MI, USA
z Clinical Research, University Clinical Research, Pembroke Pines,
FL, USA
x Clinical Research, Radiant Research, Dallas, TX, USA
jj Merck & Co., Inc., West Point, PA, USA
Aim of study: Osteoarthritis (OA) patients generally seek treatment
for pain. Options include acetaminophen, nonselective cyclo-
oxygenase (COX)-1 and -2 inhibiting NSAIDs, and selective
COX-2 inhibitors. Rofecoxib (ROF) and celecoxib (CEL) are the
most frequently used COX-2 inhibitors in this population. In
a previous 6-week OA study, ROF 25 mg demonstrated superior
efﬁcacy to CEL 200 mg, with ROF 12.5 mg and CEL 200 mg having
similar efﬁcacy and safety. The present comparability study was
conducted to evaluate efﬁcacy and safety of the minimum
S88recommended OA dose of ROF 12.5 mg qd and the maximum
recommended OA dose of CEL 200 mg qd.
Methods: Eligible patients had clinically diagnosed knee OA for at
least 6 months that required regular treatment with an NSAID or
acetaminophen. Patients were randomized to ROF 12.5 mg, CEL
200 mg, or placebo (PBO) for 6 weeks. Patient global assessment
of response to therapy (PGART) over 6 weeks on a 5-point
categorical scale (0 Z none to 4 Z excellent) was the primary
endpoint. The primary objective was to demonstrate comparable
efﬁcacy with ROF 12.5 mg and CEL 200 mg, and superior efﬁcacy
of ROF 12.5 mg compared to PBO, based upon prespeciﬁed
comparability bounds of G0.5 points. WOMAC pain and physical
function subscales [0–100 mm VAS (0 Z no pain to 100 mm Z
extreme pain and 0 Z no difﬁculty to 100 Z extreme difﬁculty,
respectively)], were included as secondary endpoints with prespe-
ciﬁed comparability bounds of G10 mm. Adverse experiences
(AEs) were recorded and drug-related and serious AEs, discontin-
uations due to AEs, as well as hypertension and edema AEs
leading to discontinuation, CHF, and GI AEs were prespeciﬁed
categories for comparison.
Results: Four hundred and thirteen patients (ROF N Z 159, CEL
NZ 169, and PBO NZ 85) were treated. ROF 12.5 mg (2.3) was
comparable to CEL 200 mg (2.3) on the primary endpoint of
PGART [ROF minus CEL (95% CI) Z 0 (0.20, 0.24)]. Both were
signiﬁcantly more efﬁcacious than PBO (1.6, P ! 0.001). For
improvement on pain and physical function on the WOMAC
subscales, ROF also demonstrated comparable clinical efﬁcacy
to CEL; difference of ROF minus CEL (95% CI) 1.7 (6.69, 3.29)
for pain and 1.9 (6.71, 2.93) for physical function. For both
WOMAC endpoints, both active drugs were signiﬁcantly superior to
placebo (P ! 0.05). ROF and CEL had generally similar AE rates.
ROF (13.8%) had signiﬁcantly (P ! 0.05) more drug-related AEs
thanCEL (7.1%),with numerically less seriousAEs (ROF, 0; CEL, 3).
There was a similar incidence of discontinuations due to AEs, dis-
continuation due to hypertension and edemaAEs, CHF, andGI AEs.
Conclusions: Rofecoxib 12.5 mg daily and celecoxib 200 mg daily
provided comparable efﬁcacy in the treatment of patients with OA.
In this study, both drugs were well tolerated with an incidence of AE
similar to placebo.
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EVALUATION OF THE EFFICACY AND SAFETY OF ETORI-
COXIB 60 MG IN ADULT INDIAN PATIENTS WITH OSTEOAR-
THRITIS
A. A. Desaiy, S. A. Jagtapz, S. Ramx, G. Bhatiajj, S. B. Sarvagod{,
S. Shah#, C. C. Ballaryy, A. S. Gawdey, V. P. Baligay
y Medical Services Department, Glenmark Pharmaceuticals Ltd.,
Mumbai, Maharastra, India
z Department of Orthopedics, Grant Medical College and Sir J J
Hospital, Mumbai, Maharastra, India
§ Department of Orthopedics, Kumaran Hospital, Chennai, Tamil
Nadu, India
jj Department of Orthopedics, Intas Hospital and Mukat Hospital,
Chandigarh, Chandigarh, India
{ Department of Orthopedics, Mumbai Medical Centre, Thane,
Maharastra, India
# Department of Orthopedics, M R Medical College, Gulbarga,
Karnataka, India
Aim: To evaluate the efﬁcacy and tolerability of etoricoxib, a COX-2
selective inhibitor in patients with osteoarthritis (OA).
Methods: This 5-week, assessor-blind, prospective, non-compara-
tive, single-group multicenter study was conducted in eligible
osteoarthritis patients. Patients were treated with Etoricoxib 60 mg
once daily after obtaining their informed consent. Efﬁcacy was
assessed by analyzing the changes in the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC), Visual
Analogue Scale (VAS), patient’s and Physician’s Global Assess-
ment of Therapy. Safety of etoricoxib was evaluated by monitoring
the incidence of treatment-emergent adverse events, physical
examination and the laboratory parameters.Results: Following therapy with Etoricoxib 60 mg once daily, in
patients with osteoarthritis, there was a clinical and statistically
signiﬁcant improvement in the mean pain scores, VAS, stiffness
score, physical function, composite and WOMAC index score.
Patient’s and Physician’s Assessment of response to therapy was
good to very good in 90.8% and 91.6%, respectively at the end of
the study. None of the patients reported gastrointestinal adverse
events like dyspepsia, bleeding or ulceration. Thus, there was
improved gastrointestinal tolerability following therapy with etor-
icoxib. Furthermore, none of the patients reported any renal
adverse events.
Conclusion: The present study shows that therapy with Etoricoxib
60 mg once daily for 4 weeks is effective in the symptomatic
treatment of osteoarthritis and is well tolerated.
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INHIBITION OF BONE RESORPTION REDUCES DEGENERA-
TIVE OSTEOARTHRITIS OF THE HIP SECONDARY TO EX-
PERIMENTAL OSTEONECROSIS OF THE FEMORAL HEAD
J. G. Hofstaetter, J. Wang, M. J. Glimcher
Laboratory for Skeletal Disorders, Department of Orthopedic
Surgery, Children’s Hospital and Harvard Medical School, Boston,
MA, USA
Osteonecrosis of the femoral head can lead to structural failure and
hip joint destruction. We evaluated the effects of bisphosphonate-
mediated inhibition of bone resorption on the repair of osteonecrotic
bone and the development of secondary osteoarthritis of the
ipsilateral acetabulum. Osteonecrosis of the femoral head was
induced surgically in 60 adult, male New Zealand White Rabbits.
Rabbits were randomized and treated either with Alendronate
(ALN) (150 mg/kg/day, S.C., 3! per week) or saline starting 1
month post-surgery. Rabbits were sacriﬁced 6 and 12 month post-
surgery and contralateral hips of the saline groups served as
controls. Femoral heads and acetabuli were analyzed using Micro-
QCT (16microns), DEXA, digital radiography and histology. Two
osteonecrotic femoral heads from the saline group were collapsed
at 12 months, whereas no collapse was observed in the ALN-
groups. Osteonecrotic femoral heads from the saline groups
showed signiﬁcant increases in aBMD, vBMD and BVF with distinct
changes in micro-architecture at 6 and 12 months when compared
to their contralateral side. ALN-treatment further increased aBMD,
vBMD and BVF in the trabecular region of the osteonecrotic femoral
heads when compared to saline treated. Porosity was signiﬁcantly
increased and vBMD was signiﬁcantly decreased in the subchon-
dral region of the saline-treated osteonecrotic femoral head. ALN-
treatment resulted in increased vBMD and decreased porosity of
the subchondral osteonecrotic bone. Osteoarthritic changes were
seen on radiographs of all acetabuli ipsilateral to the osteonecrotic
femoral heads. Osteoarthritic acetabuli had a signiﬁcantly higher
aBMD than their contralateral healthy side. ALN-treated osteoar-
thritic acetabuli had a similar aBMD as the saline-treated
Table II
Effect of therapy on various efficacy parameters in patients with
osteoarthritis
Parameter Baseline Week 2 Week 4
Mean pain score
(GSD)
13.33 G 4.04 *4.91 G 2.27 *1.09 G 0.83
Mean VAS score
(GSD)
7.73 G 2.66 *3.36 G 2.30 *0.47 G 0.72
Mean score of
stiffness (GSD)
5.30 G 2.07 *1.84 G 1.43 *0.66 G 0.70
Mean score of
physical function
(GSD)
38.10 G 8.99 *19.37 G 6.96 *4.58 G 2.25
Mean Total WOMAC
Index score (GSD)
64.46 G 13.39 *29.79 G 9.11 *6.80 G 3.21
*P ! 0.05 by ANOVA (Kruskal Wallis).
S89osteoarthritic acetabuli at 6 months, and a lower aBMD at 12
months. Subchondral bone in osteoarthritic acetabuli was thicker,
but had a lower vBMD, a higher porosity and was less mineralized.
ALN-treatment resulted in signiﬁcant increases in vBMD and
mineralization and in a signiﬁcant decrease in porosity of the
osteoarthritic subchondral bone when compared to the saline-
treated osteoarthritic acetabuli. In the saline group, vBMD and BVF
were signiﬁcantly increased in the trabecular region of the
acetabulum when compared to the contralateral control side.
Histological evaluation of articular cartilage in the acetabulum
using the Mankin-Score showed a signiﬁcant reduction of cartilage
degeneration in the ALN-treated groups at 6 and 12 months. We
have demonstrated that alendronate effectively inhibits resorption
of dead trabecular and subchondral bone during the repair of the
osteonecrotic femoral head. Hence, alendronate may prevent
weakening of the structural properties of the subchondral bone
that occurs during the repair phase of osteonecrosis and decreases
the incidence of subchondral bone collapse. Moreover, prophylactic
alendronate therapy of the early stages of osteonecrosis signiﬁ-
cantly reduced subchondral bone resorption in the osteoarthritic
acetabulum and reduces hip joint degeneration secondary to
osteonecrosis of the femoral head.
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REGIONAL ANALYSIS OF GENE EXPRESSION IN EARLY
OSTEOARTHRITIS USING THE POND-NUKI MODEL IN DOGS
A. M. Stoker, J. L. Cook, K. Kuroki, D. B. Fox
Comparative Orthopaedic Laboratory, University of Missouri
Columbia, Columbia, MO, USA
Study aim: The aim of this study was to determine changes in gene
expression early in the development of OA.
Methods
Pond-Nuki model: The ACL in one stiﬂe (ACL-X) of two adult
mongrel dogs (mean weight 26.2 kg) was completely transected
through a lateral parapatellar arthrotomy. The dogs were allowed
unrestricted use of the limb for 2 weeks, and then euthanatized and
evaluated. The contralateral stiﬂe of each dog was used as the
nonoperated control.
Tissue harvest: Cartilage samples were collected from the cranial
medial femoral condyle (CrMF) and tibial plateau (CrMT); caudal
medial femoral condyle (CaMF) and tibial plateau (CaMT); cranial
lateral femoral condyle (CrLF) and tibial plateau (CrLT); and caudal
lateral femoral condyle (CaLF) and tibial plateau (CaLT) of both stiﬂes.
Gene expression: Total RNA was analyzed by real time PCR for
GAPDH, COL 1, COL 2, aggrecan, TIMP-1, MMP-3, MMP-13,
ADAMTS 5, INOS, and COX-2 using a SYBR Green PCR assay.
Biochemical and histological evaluation: AC from each region from
both ACL-X and control stiﬂes were analyzed by subjective
histologic evaluation using toluidine blue and H&E stains; total
sulfated GAG content using the DMMB assay; and total collagen
content using a hydroxyproline assay.
Statistical analysis: Relative gene expression levels were de-
termined using Q-Gene, and differences in gene expression among
groups were determined using REST-XL. Biochemical data were
analyzed by ANOVA with signiﬁcance at P ! 0.05.
Results
Biochemical and histological: Signiﬁcant differences were not
observed between control and ACL-X tissues by histologic
assessment or in total GAG or HP content.
Gene expression (Fig. 1): Signiﬁcant differences in gene expres-
sion between ACL-X and control stiﬂes were observed in every
region analyzed, and each region exhibited a unique gene
expression proﬁle.
Discussion: To the authors’ knowledge, the results presented in this
study represent the ﬁrst report of regional analysis of gene
expression in dogs this early in the course of ACL-X induced OA.
The regional analysis used for this study revealed changes in gene
expression 2 weeks after ACL transection indicative of the focal
nature of the development of OA. Importantly, these changes in
gene expression were detected prior to gross, histologic, orbiochemical evidence for OA, and indicate a shift towards
a degradative phenotype. The consistent increased expression of
COL 1, MMP-13, and COX-2 in the ﬁve regions that showed the
highest number of differentially expressed genes provides impetus
for investigation of the utility of this combination as a diagnostic
marker in early OA.
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HISTOPATHOLOGICAL CHANGES IN RELATION TO PRO-
TEOGLYCAN DEGRADATION IN ARTICULAR CARTILAGE OF
DISPROPORTIONATE MICROMELIA MICE AS A PREDISPOS-
ING FACTOR LEADING TO OSTEOARTHRITIS
B. D. Bomstay, L. M. Gessely, L. C. Bridgewaterz, R. E. Seegmillery
y Physiology and Developmental Biology, Brigham Young Univer-
sity, Provo, UT, USA
z Microbiology and Molecular Biology, Brigham Young University,
Provo, UT, USA
Aim of study: In the present study we examined knee-joint articular
cartilage of heterozygous Disproportionate micromelia (Dmm/C)
mice which carry a dominant-negative mutation in the C-propeptide
region of the Col2a1 gene for type II collagen. The aim of this study
was to determine the existence of a temporal relationship between
histological changes in the articular cartilage and the occurrence of
enzymatic degradation of matrix proteoglycan. Such analysis is
important in light of the role played by type II collagen as a major
contributor to cartilage matrix ﬁbrils, and in view of our un-
derstanding that enzymatic degradation of proteoglycan is a key
step in the mechanism of osteoarthritis (OA).
Methods: With wild-type (C/C) mice of the C3H strain serving as
controls, knee joints from 3, 6, 9, 12, and 15 month old Dmm/C
were examined histologically to compare structural changes, and
immunohistochemically to analyze the extent of degraded aggre-
can as detected by antibodies speciﬁc to the NITEGE and VDIPEN
neo-epitopes.
Results: Relative to control, a signiﬁcantly increased number of
chondrocytes was observed in articular cartilage of the experimen-
tal group at 3 months of age. The change in cell number was
observed in the transitional and deep zones. Cartilage erosion was
not seen in any of the control mice; however, 100% of the
experimental animals at 9 months of age had severe cartilage
erosion, particularly in the region of the medial tibial plateau. The
occurrence of proteoglycan degradation in correlation with this
Fig. 1. Differential gene expression in ACL-X compared to control
articular cartilage by region. Genes with signiﬁcantly (P ! 0.05)
higher levels of expression in ACL-X compared to controls are
listed in standard font below each region heading. Darker shading
in a region indicates that a larger number of genes showed
differential expression in that region.
S90histopathology has been veriﬁed through immunohistochemical
analysis, in particular with localization of degraded aggrecan stain
at sites of cartilage erosion.
Conclusions: These results suggest that the Dmm/C dominant-
negative effect predisposes these mutants to early-onset OA by
compromising the integrity of the matrix structure, subjecting the
cartilage to a cascade of degenerative events that lead to OA. This
study adds to the mounting evidence that the Dmm mutant can
serve as an animal model for the study of early-onset OA in the
human chondrodysplasia syndrome.
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DIFFERENTIAL ROLE FOR INTERLEUKIN-1 IN INDUCED
INSTABILITY OSTEOARTHRITIS AND SPONTANEOUSLY
OCCURRING OSTEOARTHRITIS IN MICE
A. B. Blom, P. L. van Lent, P. M. van der Kraan, L. A. Joosten,
W. B. van den Berg
Experimental Rheumatology and Advanced Therapeutics, Univer-
sity Medical Center Nijmegen, Nijmegen, Netherlands
Interleukin (IL)-1 is thought to be involved in several rheumatic
disorders. It can mediate inﬂammation and cartilage catabolism.
However, lately there is much controversy about the role of this
cytokine in osteoarthritis (OA). The involvement of IL-1 may be
dependent on the mechanism through which the (experimental)
disease is caused.
Aim of study: To identify the role of IL-1 in cartilage damage that
occurs in two separate experimental models for OA.
Methods: Experimental instability OA was induced by intra-articular
injections of collagenase in knee joints of IL-1b/ mice (n Z 10)
and wild-type controls (WT; n Z 10). Knee joints were isolated 42
days after induction. Expression of IL-1b in synovium and cartilage
was determined at day 7 and day 35. Also in these strains, the
occurrence of spontaneous OA was studied in 12 (respectively, n
Z 20 and n Z 34) and 20 months old mice (n Z 43 and n Z 30).
Cartilage damage was scored using a 0–6 scale.
Results: In 12 months old mice we observed spontaneous OA-
lesions, both in IL-1b/ and wild types, but these were not
signiﬁcantly different between both groups. However, in 20 months
old IL-1b/ mice, an increase with 20% (P ! 0.03) in cartilage
pathology at the lateral tibia was seen. Severe cartilage damage
occurred in 62% of control animals, whereas 93% of IL-1b/ mice
showed severe cartilage damage, indicating that IL-1b plays
a protective role in aging cartilage. This is in line with recent
observations by K. Clements et al. who demonstrated a protective
role for IL-1 in murine aging OA. The absence of an effect on
cartilage damage at tZ 12 months suggests that the cartilage of IL-
1b/ mice is not different at younger age. In the experimental
instability model of OA, IL-1b expression in the synovium was
upregulated, both at early (day 7; DDCtO 3) and at late time points
(day 35; DDCtZ 2), whereas in the cartilage a slight but consistent
downregulation was observed (DDCt Z 1.3), early in the disease.
In contrast to the spontaneous OA, cartilage damage was
decreased in IL-1b/ mice, 6 weeks after induction of instability.
On the medial tibial plateau OA pathology was signiﬁcantly reduced
with 25% (P ! 0.03), indicating a catabolic role for IL-1b in this
model. We have suggestive evidence for reduced joint instability in
IL-1b/, since at tZ 6 weeks dislocations were reduced with 60%
in IL-1b/ mice. This implies impaired restoration of stability by
expression of IL-1b in the soft tissues in this model. Although IL-1b
is involved, it may not be a dominant mediator since signiﬁcant
effects were found on one joint surface only and severe cartilage
lesions were found in IL-1b/ mice.
Conclusions: This study indicates that the role of IL-1b in OA is
complicated and depends on the etiology of the experimental OA.
In spontaneous OA, characterized by limited inﬂammation, IL-1b
seems to reduce cartilage damage. In contrast, during experimental
OA that is caused by induction of instability by ligament damaging
enzymes, IL-1 is involved in causing cartilage damage. This
suggests that the success of anti-IL-1 therapy in OA may depend
on the etiology of OA in each individual patient.P221
TYPE IX COLLAGEN DEFICIENCY CAUSES OSTEOARTHRITIS-
LIKE CHANGES IN KNEE AND TEMPOROMANDIBULAR
JOINTS IN MICE
K. Huy, L. Xuz, J. Brussiauy, K. Hoy, B. R. Olsenyz, Y. Liy
y Oral and Developmental Biology, Harvard School of Dental
Medicine, Boston, MA, USA
z Cell Biology, Harvard Medical School, Boston, MA, USA
Mutations in type IX collagen result in early-onset osteoarthritis
(OA) in humans, but the underlying pathogenetic mechanism is
largely unknown. The aim of this study was to examine the effect of
type IX collagen deﬁciency on knee and temporomandibular (TM)
joints in mice. Five knee and ﬁve TM joints were obtained from type
IX collagen-deﬁcient mice and their wild-type littermates at the ages
of 3, 6, and 9 months. Serial 8-mm sections were cut and stained
with Safranin-O and Fast Green. The histopathological condition
of the joints was evaluated. We also examined matrix metal-
loproteinase (Mmp) 3 and Mmp 13 in knee joints of type IX
collagen-deﬁcient mice at the ages of 3 and 6 months by
immunohistochemistry. OA-like changes including chondrocyte
clustering and diffuse staining proteoglycans in the articular
cartilage were observed in type IX collagen-deﬁcient mice at the
age of 3 months. The severity of these pathological changes
progressed with age, as shown by proteoglycan depletion,
ﬁbrillation and loss of the articular cartilage. The expression of
Mmp 13 was signiﬁcantly increased in knee joints of type IX
collagen-deﬁcient mice at both 3 and 6 months compared with wild-
type littermates. However, there was no difference in Mmp 3
expression between the mutant and wild-type mice. Recently, we
found that a collagen receptor, discoidin domain receptor 2 (Ddr 2),
is up-regulated in knee joints of another mouse OA model,
heterozygous chondrodysplasia (cho/C) mice, in which collagen
XI is reduced 50%. Interestingly, the expression of Ddr 2 was also
increased in knee joints of type IX collagen-deﬁcient mice. We also
generated compound mutant mice in which both type IX and XI
collagen were reduced 50%, to ﬁnd out whether a reduction in type
IX collagen accelerates progression of OA in cho/C mice.
Histological analysis indicated that this was not the case. This
suggests that the pathogenetic OA pathway may be the same in
collagen IX deﬁcient and cho/C mice. Increased expression of
Mmp 13, due probably to increased expression of Ddr2, may
represent a common downstream pathogenetic factor, resulting in
articular cartilage destruction, eventually leading to OA.
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DISEASE PROGRESSION IN SURGICALLY INDUCED MURINE
OSTEOARTHRITIS IS STRAIN DEPENDENT
H. L. Ma, T. J. Blanchet, D. Peluso, B. Hopkins, E. A. Morris,
S. S. Glasson
Womens Health and Bone, Wyeth Research, Cambridge, MA, USA
Aim of study: Osteoarthritis (OA) is a slowly progressing chronic
joint disease. Studies have demonstrated that many factors such
as genetic background can contribute to the development of OA.
Accelerated development of OA in mice knee joint can be induced
by surgical destabilization of medial meniscus. Using this model
system we studied whether genetic background inﬂuences OA
progression in mice.
Methods: Surgical instability was induced in three different strains
of 10-week-old male mice (129/SvEv, FvB/N and C57Bl/6). The
progression of OA in these mice was scored histologically at 4 or/
and 8 weeks post-operatively using a published grading system
with slight modiﬁcation.
Results: The OA lesions were most severe in 129/SvEv mice;
statistically (P! 0.05) less severe in C57Bl/6 at 8 weeks and least
severe in FvB/N mice at 4 and 8 weeks post-operatively (Fig. 1).
Un-operated knee showed little or no histopathologic evidence of
OA at these time points (data not shown).
S91Conclusions: Our result suggests the genetic background of mice
signiﬁcantly inﬂuenced the severity and progression of osteoarthri-
tis. As genetically engineered mice are frequently used to dissect
genes or signaling pathways that are important for the progression
of OA, our results strongly indicate that the genetic backgrounds of
murine models must be taken into consideration when designing
experiments and interpreting results.
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MEASUREMENTOFSUBCHONDRALBONEMINERALDENSITY
IN AN EXPERIMENTAL MODEL OF OSTEOPOROSIS IN
RABBITS
R. Largoy, S. Castan˜edaz, E. Calvoy, F. Rodriguez-Salvanesz,
M. E. Marcosy, G. Herrero-Beaumonty
y Bone and Joint Research Unit, Rheumatology Department,
Fundacion Jimenez Diaz, Universidad Autonoma, Madrid, Spain
z Rheumatology, Hospital de la Princesa, Madrid, Spain
Subchondral bone may play a central role in the initiation and
development of osteoarthritis. It has been suggested that alterations
in subchondral bone could be associated with subsequent cartilage
deterioration. To study subchondral bone mineral density (BMD)
and its modiﬁcations should be of paramount importance in OA.
Aim: To speciﬁcally assess by dual energy X-ray absorptiometry
(DXA) the bone mass loss induced at subchondral bone in an
experimental model of rabbit osteoporosis (OP); and to compare it
to trabecular and cortical bone mass loss.
Methods: OP was induced by combined bilateral ovariectomy (OVX)
plus methylprednisolone hemisuccinate (MPH) i.m. administration
during 6 weeks. Twenty-eight 10-month old and 3.8–4.8 kg body
weight skeletally mature female rabbits were divided into four
experimental groups: (1) OVXC 0.5 mg/kg/dayMPH (n: 4); (2) OVX
C 1 mg/kg/day of MPH (n: 7); (3) 1.5 mg/kg/day MPH without OVX
(n: 5); (4) healthy rabbits (n: 7). In all rabbits, BMD was measured at
sacriﬁce at the following target areas: lumbar spine (L3–L4), global
knee, subchondral bone of the knee and upper cortical tibia with
a Hologic QDR-1000 employing a speciﬁc software for small
animals. Group effect of the different interventions was studied by
ANOVA of repeated measures with SPSS 10.0.
Results: The in vivo mean intraindividual coefﬁcient of variation
(CV) in our experience was 3.8 for lumbar spine, 2.6 for global
BMD measurements at sacrifice (mean G SD mg/cm2)
Group L3–L4 Global
knee
Subchondral
bone
Cortical
tibia
Healthy 285 G 20 458 G 42 637 G 32 555 G 233
OVX + MPH 0.5 273 G 22 352 G 37* 484 G 83* 540 G 50
OVX + MPH 1 245 G 22* 384 G 32* 533 G 43* 456 G 248
MPH 1.5 256 G 29 371 G 89* 506 G 166* 266 G 75*
*P ! 0.05 vs healthy animals.knee, 3.6 for subchondral knee and 3.1% for upper cortical tibia.
The interindividual CV ranged from 7 at global knee to 24% at
upper cortical tibia of the knee. BMD values were:
Conclusions: These results demonstrate that osteoporosis in
subchondral bone parallels to that seen in other bone areas such
as vertebra and cortical locations, although more similarities were
found with bone loss observed in trabecular bone, probably
reﬂecting the mixed haversian and trabecular bone nature
characteristic of this area. These results demonstrate that the
combination of ovariectomy and low doses of corticosteroid
treatment produces a rapid trabecular and probably cortical bone
loss as shown by BMD in vertebrae, subchondral bone and cortical
tibia. This combined model, useful for sparing corticosteroids, could
be employed to detect changes in subchondral BMD both in OA
development and response to therapy.
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THE EFFECT OF GLUCOSAMINE ON THE TEMPOROMANDIB-
ULAR JOINT DISC OF RATS WITH OSTEOARTHRITIS
A. V. Joaquim, O. A. Mora, M. S. Galhardo, S. Figueroba,
E. S. Kanehisa, O. S. Toledo
Morphology, Federal University of Sa˜o paulo, Sa˜o Paulo, Sa˜o
Paulo, Brazil
Osteoarthritic changes appear in the articular cartilage of tempo-
romandibular joint in rats aged 7 months and older. In osteoarthritic
cartilage the normal collagen network that ensure a high pro-
teoglycan concentration is damaged and a severe loss of
proteoglycans associated with reduced rate of their synthesis
leading to the articular cartilage destruction. Glucosamine is an
amino-monosaccharide and one of the basic constituents of the
disaccharide units of the articular cartilage glycosaminoglycans.
Aim of study: Examine and compare the ultrastructural differences
in the temporomandibular joint disc of rats with osteoarthritis under
no treatment and rats with osteoarthritis treated with glucosamine.
Methods: Sixteen male Wistar rats aging 16 months old (32 discs)
were divided in two groups. The experimental group received daily,
oral 18 mg/ml glucosamine for 21 days and the control group
received the same volume of water only. After 21 days the animals
were killed and the discs were dissected and processed for
transmission electron microscopy.
Results: Transmission electron microscopy observations revealed
signiﬁcant differences in the central part of the disc between the
groups. The control group showed the disc less thick and the
orientation of the collagen ﬁbrils running in all directions and very
compact. The cells of this group showed poor in organelles with
a heterochromatic core. The experimental group showed the disc
thicker and more uniform. A better organisation of the collagen ﬁbrils
with a transversal orientation was evident. The disc cells of the
experimental group showed a euchromatic core with a big mitochon-
drial concentration and a prominent endoplasmic reticulum rough.
Conclusion: The oral administration of glucosamine can stimulate
the synthetic activity of the disc cells, increasing the synthesis of
extracellular matrix elements and reorganising the collagen ﬁbrils.
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THE INTRA-ARTICULAR LOCATION OF A PARTIAL THICK-
NESS CARTILAGE DEFECT DOES NOT INFLUENCE THE RISK
OF LONG TERM OSTEOARTHRITIS
S. Heiryz, A. Aaroenyz, S. Lokenyz, S. Sulheimy, F. Reinholtx,
L. Engebretseny
y Oslo Sport Trauma Research Center, NIH, Oslo, Norway
z Institute of Surgical Research, Rikshospitalet, Oslo, Norway
x Department of Pathology, Rikshospitalet, Oslo, Norway
Aim of study: This experimental study investigates the difference in
risk of long term osteoarthritis related to the intra-articular location
of an experimental induced partial thickness cartilage defect in the
rabbit knee.
S92Methods: A partial thickness cartilage defect (diameter Z 4 mm)
was induced in both knees of 16 adult New Zealand rabbits at the
age of 22 weeks. In one knee the defect was induced in the patella,
whereas in the other on the medial femur condyle. An operating
microscope was used to secure the preparation of the subchondral
bone plate and the rims of the defects. Preoperatively, and prior to
sacrifaction at 58 weeks of age, washout samples of synovial ﬂuid
was collected. Degenerative changes were evaluated by macro-
scopical grading and by analyzing the content of proteoglycans in
the joint synovial ﬂuid.
Results: Thirty-six weeks after inducing the cartilage defects the
proteoglycan content had rose from 5.1 mg/ml [2.2–9.4] to 6.5 mg/
ml [1.4–16.2] in the patella group (P Z 0.16) and from 5.0 mg/ml
[2.2–8.0] to 7.3 mg/ml [2.5–15–4] in the femur condyle group (P Z
0.03). There was no signiﬁcant difference in the rise of proteoglycan
content in the two groups (P Z 0.39). Three of the knees in the
patella group vs 1 of the knees in the femur condyle group (P >
0.05) showed mild degenerative changes to the cartilage adjacent
to the defect. None of the knees in neither groups showed grave
osteoarthritis at the time of sacrifaction.
Conclusion: The intra-articular location of a partial thickness
cartilage defect does not inﬂuence the risk of long term knee
osteoarthritis in an experimental rabbit model.
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ROLE OF KNEE ALIGNMENT IN ANIMAL MODEL OF OSTEO-
ARTHRITIS
Y. Okaday, M. Watanabez, Y. Kanemotox, Y. Yoshihirox
y Physical Therapy, Japanese School of Technology for Social
Medicine, Koganei, Tokyo, Japan
z Rehabilitation, Koseikai Hospital, Mitaka, Tokyo, Japan
x Applied Protein Chemistry, Tokyo University of Agriculture and
Technology, Fuchu, Tokyo, Japan
Aim of study: To investigate the mechanism of osteoarthritis (OA),
several spontaneous animal models have been used. Dunkin-
Hartley guinea pig models have been frequently described, but rat
models are not popular. In the present study, we tested the
hypothesis that differences in knee alignment between guinea pigs
and rats reﬂect disparities in the onset of OA.
Methods: The knee joints were harvested from 14-month-old
Dunkin-Hartley guinea pigs and Wister rats. They were processed
for histological examinations, and scored by the Mankin’s criteria.
Six-week-old male guinea pigs and rats were used for the knee
alignment evaluation. The range of motion (ROM) in knee joints
was measured by goniometer. After removal of the biarticular
muscle, gastrocnemius, the knee ROM was measured again.
Results: Histological ﬁndings showed 14-month-old rats have no
osteoarthritic symptoms, but in guinea pigs the degeneration of
cartilage was observed. By alignment analysis, the maximum knee
extention range in guinea pigs was smaller than in rats. Without
gastrocnemius muscle, the knee ROM has changed. The maximum
knee extention mobility in guinea pigs increased by 30(, but in rats
only 20( increased. In guinea pigs, the proportion of myogenic
restriction is greater than in rats. The weight ratio of gastrocnemius
to the whole body in guinea pigs was smaller than in rats.
Conclusion: Limited joint mobility in knees is a phenomenon
occurring in guinea pig model. Knee structure and muscle stiffness
in guinea pigs is different from that in rats, which may be attributed
to the onset of OA. These facts suggest the clinical approach for
OA in the provision of rehabilitation.
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MACROPHAGES MEDIATE CARTILAGE DAMAGE IN EXPER-
IMENTAL ARTHRITIS THROUGH PRODUCTION OF MATRIX
METALLOPROTEINASES IN THE SYNOVIUM
A. B. Blomy, P. L. van Lenty, S. F. Libregtsy, P. M. van der Kraany,
N. van Rooijenz, W. B. van den Bergyy Experimental Rheumatology and Advanced Therapeutics, Uni-
versity Medical Center Nijmegen, Nijmegen, Netherlands
z Molecular Cellbiology, Vrije Universiteit Medical Center, Amster-
dam, Netherlands
Synovial macrophages have been shown to be very important in
mediating inﬂammation and cartilage damage during murine
experimental models for arthritis. Also in osteoarthritis (OA) recent
studies suggest that synovial cells may be involved in the etiology
of the disease. Recently we have shown that macrophages from
the synovial lining are involved in generation of OA-like pathology,
e.g. matrix metalloproteinase (MMP) mediated cartilage damage,
during experimental OA.
Aim of study: To further elucidate the mechanism via which
synovial macrophages are involved in the generation of MMP-
mediated OA-like pathology.
Methods: OA was induced in knee joints from which macrophages
had previously been depleted using liposomes containing clodro-
nate. Induction of OA was performed by two intra-articular
injections of collagenase on alternate days. At days 3 and 7 after
induction of OA, synovial tissue and cartilage was isolated and
processed for RT-PCR. mRNA for MMP-2, MMP-3, MMP-9, MMP-
12 and TIMP-1, -2 and -3. At days 7 and 14, whole knee joints were
isolated and processed for histology. Immunohistochemistry for F4/
80 and Saf-O staining was performed and scored.
Results: At t Z 7 and t Z 14 days the amount of macrophages in
the synovial lining of osteoarthritic knee joints that had previously
been injected with clodronate-liposomes was strongly diminished.
However, no signiﬁcant effect of clodronate treatment was
observed on macrophages in deeper layers of the synovium. The
decreased presence of macrophages correlated well with the
described amelioration of MMP-mediated cartilage damage (Blom
et al. 2004). At day 3 after induction of OA, expression of several
MMPs and MMP-inhibitors in the synovium was tested, but no
signiﬁcant differences were found comparing MMP/TIMP expres-
sion in control OA synovium and macrophage depleted synovial
tissue. However, at day 7 after induction, a strong upregulation of
MMP-12 (200-fold) and MMP-3 (60-fold) was found in OA tissue of
control joints, whereas expression in synovium of macrophage
depleted joints was not signiﬁcantly different from naive controls.
Also MMP-2 and -9 were upregulated in control OA synovium
(respectively, 16- and 4-fold). In contrast, in macrophage depleted
synovium, MMP-2 was not upregulated and MMP-9 was even
slightly downregulated (2-fold). The inhibitors of MMP, TIMP-1and -
2, were upregulated (30- and 6-fold) in the control OA synovium
and in macrophage depleted synovium TIMP-1 was also increased
(8-fold), whereas TIMP-2 was not upregulated. TIMP-3 remained
unchanged in both groups. This indicates a more protective
phenotype in synovium of knee joint from which the macrophages
had been depleted. In contrast, in the cartilage of both groups no
differences in regulation of MMPs or TIMPs were found.
Conclusions: These results point out an important role for macro-
phages in early cartilage damage that occurs during experimental
OA. This involvement of macrophages is probably due to (induction
of) MMP production, or MMP-activating mediators, by the synovium
itself, and not by induction of MMP expression by chondrocytes.
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CROSS SECTIONAL EVALUATION OF BIOCHEMICAL
MARKERS OF BONE AND CARTILAGE METABOLISM IN
SIBLING PAIRS WITH FAMILIAL OA AT MULTIPLE SITES.
THE GARP STUDY
I. Meulenbelty, G. Kloppenburgz, J. Miny, E. Pickeringx, M. P. Hellio
Le Graverandx, J. Grootjj, P. E. Slagboomy
y Molecular Epidemiolgy, Leiden University Medical Centre, Leiden,
Netherlands
z Rheumatology and Clinical Epidemiology, Leiden University
Medical Centre, Leiden, Netherlands
x Global Research & Development, Pfizer, Croton, NY, USA
jj Biomedical Research, TNO Prevention and Health, Leiden,
Netherlands
S93Aim of the study: To assess the relationship between the urinary
levels of type I collagen C-telopeptide (UCTXI), type II collagen C-
telopeptide (UCTXII) and the serum levels of cartilage oligomeric
matrix protein (COMP) and osteocalcin as markers of cartilage and
bone metabolism with joint destruction in sibling pairs with
radiographic (ROA) and symptomatic osteoarthritis (SOA) at
multiple sites, the GARP (Genetics Osteoarthritis and Progression)
study.
Methods: Levels of UCTXII, UCTXI, COMP and osteocalcin were
measured in probands aged 40 to 70 with their siblings. Pairs had
primary OA in multiple joint sites (knee, hip, hand and spine). The
diagnosis of symptomatic OA (SOA) was based on a combination of
pain or stiffness on most days of the last month and the presence of
osteophytes or joint space narrowing on X-ray. Hand OAwas deﬁned
by the American College of Rheumatology criteria. Data was
analyzed using mixed model regression analyses with the bio-
chemical marker level as dependent variable and as co-variable the
presence of either ROA or SOA as a quantitative measure of joint
sites with OA as assessed in knee (0–2), hip (0–2), hand/spine (0–3),
with a total scale of 0–7. Family numbers are added as random effect
variables to adjust for the family relationship between siblings.
Results: In 381subjects themedian (range) number of thequantitative
measure of joint siteswithROAwas3 (0–7) andwithSOA2 (0–7). The
mean (sd) levels of UCTXI, UCTXII, COMP and osteocalcin were,
respectively, 170 (100) mg/mmol Creat, 253 (165) ng/mmol Creat, 12
(3) U/L, and 22 (9) mg/L. Among subjects of the GARP study, the
UCTXII level was signiﬁcantly associated with a quantitative measure
of both ROA and SOA (P-valueZ 0.0001). Adjusting for age or BMI
did not change this effect. COMP, osteocalcin and UCTXI levels were
not associated by this measure of ROA or SOA.
Conclusion: UCTXII levels as marker of cartilage degradation are
associated with a quantitative measure of both ROA and SOA as
assessed in knee, hip, hand and spine among subjects of the
GARP study.
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URINARY TYPE II COLLAGEN NEOEPITOPE (uTIINE): A
MARKER OF OSTEOARTHRITIS ACTIVITY
E. Pickeringy, G. Szekely-Klepserz, O. Nemirovskiyx, W. Liz,
R. Brownz, T. Sunyerx, M. Abramsx, L. Vickeryx, D. Welschx,
W. Mathewsx, M. P. Hellio Le Graverandz
y Pfizer Global Research & Development, Clinical R&D, Groton,
CT, USA
z Pfizer Global Research & Development, Ann Arbor, MI, USA
x Pfizer Global Research & Development, Saint Louis, MO, USA
Objective: The objective of this study was to compare the levels of
type II collagen neoepitopes in the urine of patients with
symptomatic osteoarthritis compared with subjects with radiograph-
ic osteoarthritis and subjects with no radiographic signs of OA.
Methods: Urine samples from men and women over 55 years of
age were collected and submitted to a technically validated
antibody capture LC/MS/MS assay to measure the levels of a 45-
mer peptide resulting from the collagenase cleavage of type II
collagen at the 3/4–1/4 cleavage site. Urine samples from a total of
54 subjects were analyzed.
Results: All subjects were characterized for the presence of joint
pain and radiographic signs of osteoarthritis (KL R 1). Four groups
were determined including symptomatic OA (SOA) patients (ACR
criteria), asymptomatic subjects with radiographic OA (ROA) of the
hip(s) and/or knee(s); asymptomatic subjects with radiographic OA
of the hand(s)/spine (i.e., cervical C lower lumbar) and asymp-
tomatic subjects with no radiographic signs of OA (Non-OA) in the
hips/knees/hands and spine (i.e., cervical C lower lumbar).
The creatinine normalized uTIINE levels in the symptomatic OA
group were 46% greater compared to the mean uTIINE levels in the
hip(s)/knee(s) ROA group (P Z 0.0068) (Table I). Mean uTIINE
levels were similar in the hip(s)/knee(s) ROA, hand(s)/spine ROA,
and Non-OA group (Table II).
Conclusion: This novel, technically validated urine LC/MS/MS
assay measures a peptide resulting from the collagenase cleavageof type II collagen at the 3/4–1/4 collagenase cleavage site that can
differentiate symptomatic OA patients from both asymptomatic
ROA subjects and age-/sex-matched Non-OA subjects.
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ADIAGNOSTIC ALGORITHMTO IDENTIFY AN INFLAMMATORY
SUBSETOFPATIENTSWITHKNEEOSTEOARTHRITIS:APILOT
STUDY
C. Wu, S. Lee, R. Terkeltaub, K. C. Kalunian
Center for Innovative Therapy, UCSD, La Jolla, CA, USA
Purpose: The presence of synovial inﬂammation in a percentage of
patients with knee osteoarthritis (OA) has recently been well
described. In a prior arthroscopic irrigation trial, we retrospectively
identiﬁed clinical features associated with arthroscopic evidence of
synovitis. Herein we sought to prospectively correlate clinical and
laboratory features indicative of an inﬂammatory phenotype of OA
with ultrasonographic evidence of synovitis.
Methods: Ten patients who fulﬁlled the 1986 ACR criteria for OA of
the knee were enrolled into this cross-sectional, prospective study.
Patients who carried any coexisting inﬂammatory condition were
excluded. Data on demographics, clinical symptoms of inﬂamma-
tion, physical exam ﬁndings, and laboratory data (i.e., CRP) were
collected. We subsequently performed US examinations of the
suprapatellar fossa, medial and lateral recesses, and posterior
fossa using a Sonosite Titan machine with a 10 MHz linear probe.
On US, knees were graded for the presence of effusion, pannus,
and ﬂow using a semi-quantitative (0–3) scale. US synovitis was
recorded as the presence of pannus O2 mm or Power Doppler
evidence of hypervascularity.
Results: Patients were 90% females with a mean age of 63 G 11
years, a patient VAS pain severity of 58.5 G 21, WOMAC
composite score 50.6 G 18.2 and a CRP mean of 1.08 G 0.72.
Any combination of two of the following: morning stiffnessO10 min,
night painO 4 on a 10 point scale, and the physical exam ﬁndings of
effusion or joint line tenderness had an ICCZ 0.76 (PZ 0.01) with
US synovitis. Interestingly, the association of patient complaint of
knee swelling more than once a month (7/10 patients) and US
synovitis had an ICC Z 1.0 (P !0.05). WOMAC stiffness and
composite scores highly correlated with US synovitis (ICCZ 0.80,
PZ0.005 and ICCZ 0.764, PZ0.01, respectively). CRP and US
synovitis did not reach a signiﬁcant correlation. Two of the patients
with US synovitis had subsequent arthroscopy, both demonstrated
gross villous synovium with macroscopic crystals.
Conclusions: Despite the small cohort of knee osteoarthritis
patients studied, the clinical characteristics of night pain, morning
stiffness, knee effusion and joint line tenderness had a signiﬁcant
association with ultrasonographic evidence of knee synovitis.
Table I
Mean uTIINE levels (ng/mM)
N Mean (ng/mM)
SOA 38 0.122
Knee/Hip ROA 27 0.083
Hand/Spine ROA 17 0.063
Non-OA 11 0.062
Table II
Differentiation of populations, statistical comparison (one-way
ANOVA)
P-value
SOA vs Knee/Hip ROA 0.0068
SOA vs Hand/Spine ROA 0.0001
SOA vs Non-OA 0.0012
Knee/Hip ROA vs Hand/Spine ROA 0.0965
Knee/Hip ROA vs Non-OA 0.1623
Hand/Spine ROA vs Non-OA 0.9572
S94Patient report of knee swelling greater than once a month also
demonstrated high correlation with US synovitis. Identiﬁcation of
these clinical features should be considered in patients with OA of
the knee and may warrant therapy that speciﬁcally targets
inﬂammation. We plan to study at least 60 patients and will offer
diagnostic arthroscopy to those who show US synovitis.
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INCREASE IN DEGRADED COLLAGEN TYPE II IN SYNOVIAL
FLUID EARLY IN THE RABBIT MENISCECTOMY MODEL OF
OSTEOARTHRITIS
E. Lindhorstyz, L. Wachsmuthx, N. Kimmigy, R. X. Raissy,
T. Aignerjj, L. Atleyx, D. Eyre{
ySurgery, Osteoarthritis Unit, Johann Wolfgang Goethe-Universita¨t,
Frankfurt/Main, Germany
zSurgery, Philipps-Universita¨t, Marburg, Germany
xPhysics in Medicine, Friedrich-Alexander-Universita¨t, Erlangen-
Nu¨rnberg, Germany
jjPathology, Friedrich-Alexander-Universita¨t, Erlangen-Nu¨rnberg,
Germany
{Orthopaedics and Sports Medicine, Orthopaedic Research
Laboratories, University of Washington, Seattle, WA, USA
Aim: To determine whether collagen type II breakdown products in
synovial ﬂuid, detected by an enzyme-linked immunoassay,
represent a useful marker for early events in osteoarthritis in the
rabbit medial meniscectomy model.
Design: Complete medial meniscectomy was performed on the
right knee joints of 32 rabbits. Balanced groups of rabbits were then
sacriﬁced at 2, 4, 8, and 12 weeks post-surgery. An additional eight
unoperated and 11 sham operated animals served as controls.
Synovial ﬂuid lavages were performed on right and left knee joints
of the same animals at sacriﬁce. The proteolytic epitope of type II
collagen was measured in synovial ﬂuid lavage samples using an
enzyme-linked immunoassay. The ELISA uses the antibody 2B4
raised against the ‘‘EKGPDP’’ amino acid sequence and which
recognizes a proteolytic epitope in the C-telopeptide cross-linking
domain of type II collagen.
Results: Macroscopically, visible surface ﬁbrillations and focal
erosions appeared as early as 2 weeks after meniscectomy in the
femorotibial joint (P ! 0.01). Osteoarthritis developed gradually
during the later observation period, and then predominantly on the
medial tibial plateau and medial femur.
Signiﬁcant histological alterations in cartilage, including a loss of
proteoglycans, surface irregularities, and clefts, were detected at 2
weeks after meniscectomy (P ! 0.01). Collagen type II epitope
levels in synovial ﬂuid lavage samples were elevated peaking at 2
weeks after meniscectomy (P ! 0.02). Levels decreased at later
time points, but they were still raised at 12 weeks (P % 0.05).
Highly signiﬁcant correlations were found between the synovial ﬂuid
collagen type II epitope levels and the macroscopic and micro-
scopic scoring results for the operated knee (P % 0.01).
Conclusion: In this rabbit model of complete medial meniscectomy,
levels of type II collagen fragments in synovial ﬂuid were a useful
marker of early events in osteoarthritis development.
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DETERMINATION OF MOLECULAR INDICATORS OF CON-
NECTIVE TISSUE CHANGES IN SYSTEMIC AND DEGENERA-
TIVE RHEUMATIC DISEASES
M. Braun, H. Hulejova, P. Spacek, M. Adam, S. Forejtova,
L. Senolt, K. Pavelka
Department of Bone and Cartilage Metabolism, Institute of
Rheumatology, Prague, Czech Republic
Aim: In this study we focused on determination and comparison of
selected indicators of metabolic changes of connective tissues in
systemic and/or degenerative chronic rheumatic diseases with
different etiopathogenesis.Methods: Markers of bone and cartilage turnover like collagen cross-
links – pyridinoline (PD) and deoxypyridinoline (DPD), bone alkaline
phosphatase (BAP) and osteocalcin (OC) were determined as well
as pentosidine (PEN) – potential indicator of glycoxidation loading of
the organism and general collagen breakdown. Body ﬂuids of
patients with osteoarthritis (OA), rheumatoid arthritis (RA), diffuse
idiopathic skeletal hyperostosis (DISH), ankylosing spondylitis (AS)
and healthy controls were used as samples and their levels were
compared in the studied groups to demonstrate the inﬂuence of in-
ﬂammation, glycoxidation, ossiﬁcation and degenerative processes
on concentration of measured indicators in body ﬂuids. The mea-
surements were performed by utilization of either sensitive HPLC
methods with ﬂuorescence detection (for PEN, PD and DPD) or
immunochemically by means of speciﬁc ELISA kit (for BAP) or using
IMMULITE (DPC, Los Angeles, CA, USA) for OC and free DPD
determination.
Results: PEN levels are higher in both RA and in OA comparing to
controls, but in RA systemic inﬂammation and oxidative stress plays
the key role, while in OA combination of mechanical stress leading
to damage of cartilage and subchondral bone, synovitis, formation
of granulation tissue and other processes in joint compartment are
responsible for PEN elevation. Slightly increased PEN was found
also in AS (due to inﬂammation) and DISH patients where frequent
association with diabetes could be the main reason. Urinary
excretion of PD and DPD as well as serum levels of markers of
osteoblastic activity (BAP and OC) were markedly elevated in those
pathological states too in comparison with healthy subjects.
Conclusions: In the study we described analytical methods used for
determination of important indicators of bone and cartilage
metabolism which were applied on body ﬂuid samples of patients
with RA, OA, DISH and AS. Quantiﬁcation of these indicators in the
studied groups may contribute to elucidation of those pathological
states caused by processes like inﬂammation, glycoxidation, cross-
linking of collagen, bone resorption or ossiﬁcation. Obtained levels
could be a useful tool in the assessment of main risk factors in
chronic rheumatic diseases, their activity and progression.
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TOTAL ANTIOXIDANT STATUS IN PATIENTS WITH KNEE
OA – A PILOT STUDY IN SOUTHWESTERN NIGERIA
T. O. Alonge, A. N. Sulaiman, O. M. Akinosun, S. O. Ogunlade
Surgery, College of Medicine, University of Ibadan, Ibadan, Oyo,
Nigeria
Chemical Pathology, College of Medicine, University of Ibadan,
Ibadan, Oyo, Nigeria
Aim of study: To establish a relationship if any between the total
antioxidant status and the prevalence of primary osteoarthritis of
the knee among Nigerians.
Patients and method: Thirty-ﬁve consecutive patients with clinical
and radiological evidence of knee OA (average age of 58.8 years)
seen at the orthopaedic outpatient clinic over a 6 months period
were recruited into the study. Patients with hypertension, diabetes,
patients on vitamin supplements and those with other intercurrent
and infectious diseases were excluded from the study. Twenty
patients’ average age was 53.3 years who had no clinical evidence
of knee OA were used as controls. Informed consent was obtained
from all the patients prior to the commencement of the study. Five
milliliters of venous blood obtained from the ante-cubital fossa and
analysed for total antioxidan status (TAS) using the technique
described by Koracevic et al.
Results: The mean TAS in the osteoarthritic patients was 1.09 G
0.38 mmol/l while the value for the control was 1.6 G 0.09 mmol/l
(P ! 0.05). The arthritic patients also had a higher body mass
index compared to the controls.
Conclusion: The TAS values obtained in this study are a dynamic
equilibrium of the antioxidative defence system of the body and not
a simple sum of the activities of the various antioxidants. In this
study, lower TAS that was observed in the patients with knee OA
may be due to the increased utilisation of the antioxidants in the
presence of free radicals which may be incriminated in the
S95pathogenesis of osteoarthritis in our environment. To our knowl-
edge there has been no study of this nature in Nigeria even in the
presence of an increasing aged population and a rise in the
prevalence of osteoarthritis particularly knee OA. The lower TAS
values may in addition be due to lower dietary intake of these
antioxidants bearing in mind the cost of the prepared formulations
and poverty which limits the purchase of fruits and vegetables that
are natural sources of some of these protective chemical agents.
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HUMAN OSTEOCLASTS SECRETE MCSF IN RESPONSE TO
RANK-LIGAND, IL1-a AND TNF-a TREATMENT
A. Regmi, R. J. S. Galvin
Bone and Inflammation, Eli Lilly and Company, Indianapolis, IN,
USA
Xu et al. have reported that locally produced MCSF at the
periprosthetic tissue interface in total hip replacement contributes
to osteoclast activation leading to periprosthetic loosening. MCSF is
a cytokine involved in the development and proliferation of cells of the
monocyte/macrophage cell lineage. The essential role for MCSF in
osteoclast differentiation has been demonstrated both in vitro and in
vivo. Mice (op/op) and rats (tl/tl) deﬁcient in MCSF are osteopetrotic
due to a decrease in osteoclast differentiation and the bone
phenotype can be restored by MCSF replacement. MCSF gene
regulation has been previously shown in ﬁbroblasts and osteoblasts.
Both TNF-a and IL1-a have been reported to increase MCSF in ST2
bone stromal cells as well as, in 10T1/2 murine ﬁbroblasts. MCSF
production by human osteoclasts has not been reported. Our
objective was to determine if osteoclasts produced MCSF and
whether it was regulated by TNF-a, IL1-a and Receptor Activator of
Nuclear Factor Kappa B Ligand (RANKL). Human osteoclasts
(hOCS) derived from umbilical cord blood cells were differentiated
for 9–13 days in the presence of RANKL (50 ng/mL) and MCSF (50
ng/mL). The osteoclasts were washed thrice with PBS and treated
with RANKL (3–300 ng/mL), TNF-a (0.3–100 ng/mL) or IL1-a (0.3–
100 ng/mL) in 200-mL media containing 0.5%-charcoal stripped heat
inactivated fetal bovine serum. Media was collected after 24 or 48 h
and MCSF was assayed using Quantikine human MCSF ELISA kit
(R&D Systems). Cells were lysed using 0.1% Triton-X100 /PBS and
tartrate resistant acid phosphatase (TRAP) enzyme activity was
measured for all samples. Since TRAP is an osteoclast marker, the
ﬁnding that TRAP was similar in all wells suggested similar
differentiation between wells. MCSF’s role in osteoclast survival
was determined by measuring caspase-3 activity using Ac-DEVD-
Amc peptide cleavage (Biosource International). IL1-a, TNF-a and
RANKL increased MCSF in the media in a concentration dependent
manner (EC50Z 13, 7 and 8 ng/mL, respectively) and themagnitude
of MCSF secretion by RANKL (300 ng/mL) was 3-fold, IL1-a (100 ng/
mL) was 10-fold and TNF-a (100 ng/mL) was 7-fold over untreated
control. MCSF also inhibited caspase activity in osteoclasts (IC50Z
18 ng/mL) in a dose dependent manner validating the anti-apoptotic
activity of MCSF in osteoclasts. Bone destruction in arthritis and
orthopedic implant loosening may be in part attributed to local
secretion of MCSF by osteoclasts in response to pro-inﬂammatory
cytokines and RANKL. Since MCSF also increases osteoclast
survival, this further aggravates bone resorption. Thus, blockage of
MCSF activity could be a potential therapeutic target in arthritis and
orthopedic joint loosening.
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GENE EXPRESSION OF OSTEOBLAST FROM SUBCHON-
DRAL BONE IN OSTEOARTHRITIS
K. Sakao, K. A. Takahashi, H. Tonomura, A. Inoue, T. Kunitomo,
S. Nakamura, A. Hiraoka, T. Kubo
Department of Orthopaedics, Graduate School of Medical Science,
Kyoto Prefectural University of Medicine, Kyoto, JapanAim of this study: To investigate cytokine gene expressions in
human osteoblasts from subchondral bone of osteoarthritis (OA) to
elucidate the role of subchondral bone in the pathogenesis of OA.
Methods: Subchondral bone was harvested from the loaded area in
the femoral head at the time of total hip arthroplasty for eight
patients (3 men and 5 women; mean age 66.5G 7.6 years) with hip
OA. Osteoblasts were isolated and cultured. Total RNA was
extracted and analyzed by RT-PCR method for IL-1b, IL-6, IL-8 and
TNF-a mRNA. Osteoblasts isolated from femoral neck trabecular
bone were used as controls.
Results: IL-1b, IL-8 and TNF-a mRNA expressions were higher in
100% (8/8), 62.5% (5/8) and 12.5% (1/8) of subchondral bone
osteoblasts than controls. IL-6 mRNA expression were detected at
the same level as control in all samples.
Conclusion: In the pathogenesis of OA, various inﬂammatory
cytokines produced by chondrocytes and synoviocytes lead to
degeneration and destruction of articular cartilage. Subchondral
bone sclerosis is a well-recognized phenomenon in OA. However,
the biological role of subchondral bone has not been fully elucidated.
This study showed that IL-1b and IL-8 mRNA expressions were
increased in the subchondral bone osteoblasts. These results
suggest that osteoblasts from subchondral bone could release
IL-1b and IL-8 and contribute to the pathogenesis of OA. Especially
about IL-8, we previously reported that excessive mechanical
stress accelerates IL-8 production in human osteoblasts cell line.
Our ﬁndings indicate that mechanical stress could stimulate the
expression of IL-8 in subchondral bone and induce inﬂammation
during the development of OA.
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REGULATION OF THE HUMAN AGGRECANASE-1 (ADAMTS-4)
GENE PROMOTER BY NFATP AND RUNX2
K. Thirunavukkarasu, Y. Pei, X. P. Yu, S. Chandrasekhar
Bone & Inflammation, Eli Lilly and Company, Indianapolis, IN, USA
Objective: To understand the transcriptional regulation of the
aggrecanase-1 gene and analyze the role of chondrocyte ex-
pressed transcription factors on aggrecanase-1 expression.
Methods: A 4.5 kb human aggrecanase-1 promoter (4109 to
C406) was cloned by genome walking PCR and random 5#-
deletions were generated using PCR to obtain a total of six
promoter fragments (4.5, 3.5, 2.0, 1.6, 1.15 and 0.8 kb). The
fragments were inserted into pb-gal-Basic vector (Clontech) to
generate promoter-reporter constructs. The reporter constructs
were transiently cotransfected along with an expression construct
for NFATp, Runx2 or a control vector into mesenchymal (C3H10T1/
2), chondrocytic (SW1353, IRC) and ﬁbroblastic (COS-1) cell lines.
b-gal activity in cell extracts was measured 36–48 h after
transfection using a luminescent b-gal assay kit (Roche).
Results: Sequence analysis of the 4.5 kb promoter revealed the
presence of two putative binding sites for the Nuclear Factor of
Activated T cells (NFAT) family of transcription factors, of which one
member (NFATp) has been shown to function as a repressor of
cartilage growth and differentiation. Treatment with cyclosporin A,
an inhibitor of NFAT function has been shown to inhibit aggrecanase
expression and matrix degradation in bovine cartilage explants. In
order to analyze whether NFATp could regulate aggrecanase-1
promoter activity, we cotransfected the promoter along with an
NFATp expression construct into C3H10T1/2, SW1353, IRC and
COS-1 cells. Overexpression of NFATp resulted in a signiﬁcant
increase in reporter gene expression (w25-fold in C3H10T1/2 and
COS-1 cells, and w4-fold in SW1353 and IRC cells), suggesting
aggrecanase-1 as a potential downstream target for NFATp. To
determine whether one or both of the NFAT-binding elements
(NBEs) are involved in mediating NFATp effects, we performed co-
transfection studies using the full-length or 5#-deletion constructs in
C3H10T1/2 and COS-1 cells. Deletion of the upstream NBE
containing region resulted in a substantial loss of induction by
NFATp implicating the distal region to be more important for
mediating NFATp effects. Promoter analysis also revealed the
presence of eight putative binding sites (OSE2) for the transcription
S96factor Runx2 that plays a role in chondrocyte maturation and
osteoblast differentiation. The functionality of these elements was
demonstrated by the observation that overexpression of Runx2
resulted in aw25-fold increase in promoter activity in SW1353 cells
and a 13-fold increase in COS-1 cells. 5# Promoter deletions
resulted in some decrease in promoter activity, but the shortest
promoter fragment (0.8 kb:405 toC406) was still inducedw8–10
fold by Runx2, suggestive of the functional importance of the
proximal OSE2 containing region for Runx2 stimulation.
Conclusions: We have cloned a functional human aggrecanase-1
promoter and have demonstrated the potential involvement of
NFATp and Runx2 in aggrecanase-1 gene regulation. This
promoter would serve as a valuable mechanistic tool to better
understand the regulation of aggrecanase-1 expression at the
transcriptional level and may suggest novel ways for inhibiting
cartilage degradation seen in joint diseases.
P237
UPREGULATION OF ADAMTS-7B, A NEWLY IDENTIFIED
COMP-DEGRADING ENZYME, BY IL-1b AND BMP-2
C. Liu, M. Fajardo, P. E. DiCesare
Department of Orthopaedic Surgery, Musculoskeletal Research
Center, NYU-Hospital for Joint Diseases, New York, NY, USA
Study aim: ADAMTS-7B is the ﬁrst physiological enzyme found to
degradeCOMP. The purpose of this investigationwas to examine the
regulation of ADAMTS-7B expression by cytokines in chondrocytes.
Methods: Cell culturedHuman primary chondrocytes and rat
chondrosarcoma (RCS) cells were treated with 10 ng/ml IL-1b,
IL-6, noggin, follistatin, TGF-b, TNF-a or 300 ng/ml BMP-2, BMP-4,
BMP-7, BMP-12, BMP-13. Cells were also treated with IL-1b or
BMP-2 to generate dose–response data.
RT-PCRdthe ADAMTS-7B-speciﬁc primers were used: 5#-
gagcctgtctggatccagctgctgttc-3# and 5#-tgcacacctctgccgcaggt-
gactgtg-3# for human ADAMTS-7B; 5#-gcaacgctattgatgaggaa-
gacc-3# and 5#-ttgggaagggcaggtgatgtagga-3# for rat ADAMTS-7B.
The PCR product was analyzed by 1% agarose gel. Western
blotdCells lysates was resolved on SDS-PAGE and detected with
antiserum to ADAMTS-7B.
Results: IL-1b and BMP-2 upregulate the mRNA level of ADAMTS-
7B in RCS cellsdAs shown in Fig. 1(A), IL-1b, BMP-2, and BMP-4signiﬁcantly increased ADAMTS-7B mRNA expression, whereas
BMP inhibitors, follistatin and noggin, downregulated it. Other
factors had little effect on ADAMTS-7B mRNA expression.
IL-1b and BMP-2 induce the expression of ADAMTS-7B in
a dosage-dependent manner in human chondrocytesdWe then
treated primary human chondrocytes with various amounts of IL-1b
or BMP-2 and examined ADAMTS-7B gene expression using RT-
PCR. As shown in Fig. 1(B, C), the upregulation effects of IL-1b and
BMP-2 are dose-dependent.
IL-1b and BMP-2 increase the protein level of ADAMTS-7B in
human chondrocytesdA western blot analysis was done to test
their effect on ADAMTS-7B protein levels. As with the pattern of
mRNA expression, IL-1b and BMP-2 signiﬁcantly increased the
ADAMTS-7B protein level in human chondrocytes (Fig. 2).
Conclusion: We examined the regulation of ADAMTS-7B expres-
sion at both the mRNA and protein levels by several cytokines in
both RCS and human primary chondrocytes. The proinﬂammatory
factor IL-1b and the anabolic factor BMP-2 were potent stimulators
of ADAMTS-7B expression. ADAMTS-7B expression can therefore
be modulated by both catabolic and anabolic factors in chondro-
cytes.
Supported by NIH grant R01 AR45612-01A2.
Fig. 2. Western blotting for examining the regulation of ADAMTS-
7B protein by cytokines.Fig. 1. Regulation of ADAMTS-7B mRNA by cytokines, assayed by RT-PCR.
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RELIEF OF EPIGENETIC CYCLIN D1 SUPPRESSION ENHAN-
CES THE PROLIFERATIVE CAPACITY OF ARTICULAR CHON-
DROCYTES
M. C. Stewart, A. A. Stewart, Y. Geng
Veterinary Clinical Medicine, University of Illinois at Urbana-
Champaign, Urbana, IL, USA
Aim: To identify the mechanism(s) by which cyclin D1 expression
and associated proliferative activity are constrained in articular
chondrocytes.
Methods: Human articular cartilage was obtained from total joint
replacement procedures: The cartilage was pulverised under liquid
nitrogen and used for RNA or protein isolation, using standard
protocols. ‘In vivo’ expression of the D type cyclins was assessed
by gel-based RT-PCR and Western blot analyses. For in vitro
experiments, articular cartilage was collected from equine femo-
rotibial joints. The cartilage was maintained as explants, or articular
chondrocytes were isolated by collagenase type II digestion and
cultured as non-adherent aggregates. Both explants and aggre-
gates were maintained in deﬁned, serum-free medium supple-
mented with antibiotics and ascorbic acid. Where indicated,
chondrocytes were treated with FBS or bFGF. Direct cyclin D1
expression was induced with a cyclin D1-expressing adenoviral
vector. Gene expression was assessed by Northern blot analyses.
Proliferative activity was monitored by measurements of total DNA,
using the Pico green assay, and thymidine incorporation rates.
Results: Of the D type cyclins, only cyclin D2 was consistently
expressed in human articular cartilage samples. However, cyclin D1
was the ‘mitogen response’ cyclin when articular chondrocytes were
exposed to soluble mitogens. Cyclin D2 expression did not change in
these experiments. In in vitro cultures, both basal and inducible cyclin
D1 expression decreased over time, independent of mitogenic
stimulation. Treatment with the DNA demethylating agent, 5-
azacytidine (5-AZA), blocked the loss of cyclin D1 expression. In
contrast, the histone acetylation inhibitor, trichostatin A, had no effect
on cyclin D1 expression. Both agents blocked collagen type II
expression completely. After removal of the 5-AZA, basal cyclin D1
expression remained elevated for at least 7 days, while collagen type
II levels rapidly returned to control levels. The elevated level of basal
cyclin D1 expression was functionally signiﬁcant, since the treated
chondrocytes showed increased inducible cyclin D1 expression and
increased thymidine incorporation rates, in comparison to untreated
controls. The effects of 5-AZA on cyclin D1 expression and
associated proliferative activity were also evident in articular cartilage
explants, indicating that the cartilaginous ECM does not preclude
modulation of epigenetic gene regulation. DNA demethylation must
activate other critical cell cycle regulatory factors, since adenoviralexpression of cyclin D1, at MOIs up to 100/cell, did not increase
proliferative activity above that of controls.
Conclusions: These results indicate that cyclin D1 expression by
articular chondrocytes and, more generally, cell cycle progression
in these cells, is suppressed by DNA methylation events. Removal
of this suppression elevates both basal and inducible proliferative
activity. These ﬁndings suggest strategies for modulating the
proliferative activity of resident articular chondrocyte populations
in vivo, and are also relevant to the issue of scaffold colonization by
transplanted chondrocytes for tissue engineering applications.
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ADAMTS-12 PHYSICALLY ASSOCIATES WITH AND
DEGRADES COMP
C. Liu, W. Kong, M. Fajardo, P. E. Dicesare
Department of Orthopaedic Surgery, Musculoskeletal Research
Center, NYU-Hospital for Joint Diseases, New York, NY, USA
Study aims: Structure analysis revealed that ADAMTS-12 pos-
sesses similar domain organizations to ADAMTS-7, the ﬁrst
COMP-degrading enzyme. The purpose of this investigation was
to determine whether ADAMTS-12 also associates with COMP and
acts as another COMPase.
Methods: Coimmunoprecipitation (Co-IP)dCell lysates prepared
from COMP stable lines transfected with pcDNA3-HA-ADAMTS-12
plasmid were incubated with anti-COMP, anti-HA, or control rabbit
IgG antibodies and the bound proteins were examined by western
blotting with anti-COMP antibodies.
Assay of protein–protein interactions by yeast two-hybrid
assaydThree independent colonies were analyzed for the in-
teraction in yeast between two proteins and published procedures
of Liu et al. (2001, 2003) were followed.
In vitro digestion assaydCOMP was incubated with the lysates
prepared from Cos-7 cell lines transfected with either pcDNA3,
pcDNA3-HA-ADAMTS-12, or pcDNA3-ADAMTS-12mut in a diges-
tion buffer and the resulted fragments were detected by western
blotting with anti-COMP antiserum.
Results: ADAMTS-12 associates with COMP in vivodA Co-IP
assay was performed in order to determine whether ADAMTS-12
associates with COMP in vivo [Fig. 1(A)]. A speciﬁc COMP band
was present in the immunoprecipitated complexes brought down by
anti-COMP (lane 3) and anti-HA (lane 4), but not control IgG (lane
2) antibodies, demonstrating that ADAMTS-12 speciﬁcally asso-
ciates with COMP in vivo.
Selective association of ADAMTS-12 with the EGF-like domain of
COMPdTo determine the functional domains of COMP that bind
to ADAMTS-12, ﬁlter-based beta-galactosidase assays wereFig. 1. ADAMTS-12 binds to and cleaves COMP. (A) Co-IP assay. (B) Yeast two-hybrid assay. (C) In vitro digestion assay.
S98performed. As shown in Fig. 1(B), ADAMTS-12 selectively interacts
with the EGF-like domain of COMP among the four functional
domains tested.
Cleavage of COMP by the recombinant ADAMTS-12 in vitrodAs
shown in Fig. 1(C), cell extracts transfected with either empty vector
(lane 1) or mutant ADAMTS-12 (lane 3) did not cleave hCOMP, but
wild-type ADAMTS-12 (lane 2) digested COMP and produced two
major fragments (large arrowhead) and a minor fragment (small
arrowhead), demonstrating that ADAMTS-12 can degrade COMP.
Conclusion: ADAMTS-12 physically binds to the EGF domain of
COMP and is able to digest the latter in vitro. COMP is the ﬁrst
identiﬁed substrate for ADAMTS-12. Following ADAMTS-7B,
ADAMTS-12 is the second physiological enzyme found to bind to
and cleave COMP, raising the possibility that both ADAMTS-7B
and 12 are responsible for endogenous COMP degradation in OA.
This study was supported by NIH R01 AR45612-01A2.
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INTERLEUKIN-1, INTERLEUKIN-6 AND ONCOSTATIN M STIM-
ULATE NORMAL SUBCHONDRAL OSTEOBLASTS TO INDUCE
CARTILAGE DEGRADATION
C. Sanchezy, M. A. Debergy, N. Piccardiz, P. Msikaz, J. Y. L.
Reginstery, Y. E. Henrotiny
y Bone and Cartilage Research Unit, University of Liege, Liege,
Belgium
z Research and Development, Expanscience Laboratories, Cour-
bevoie, France
Aim of study: To determine the effects of osteoarthritic subchondral
osteoblasts on the metabolism of human chondrocytes in alginate
beads.
Methods: Human chondrocytes were isolated from osteoarthritic
(OA) cartilage and cultured in alginate beads for 4 days in the
absence or in the presence of normal or OA subchondral
osteoblasts in monolayer (co-culture system). Before co-culture,
osteoblasts were cultured for 72 h with or without 1.7 ng/ml
interleukin (IL)-1b, 100 ng/ml IL-6 with its soluble receptor (IL-6sR;
50 ng/ml) or 10 ng/ml oncostatin M (OSM). Aggrecan and matrix
metalloproteases (MMP) -3 and -13 mRNA levels in chondrocytes
were quantiﬁed by real time polymerase chain reaction. Aggrecan
production was assayed by a speciﬁc enzyme ampliﬁed sensitivity
immunoassay (EASIA).
Results: OA, but not normal, osteoblasts signiﬁcantly decreased
(28%, P ! 0.001) aggrecan production and aggrecan gene
expression and signiﬁcantly increased by human OA chondrocytes
in alginate beads MMP-3 and MMP-13 gene expression (1.65 and
2 times, respectively, P ! 0.001). When they were pre-incubated
with IL-1b, IL-6 or OSM, normal osteoblasts inhibited aggrecan
synthesis and increased MMP-3 and -13 gene expression by
chondrocytes in alginate beads in the same order of magnitude of
that of OA osteoblasts.
Conclusions: These results demonstrate that OA subchondral
osteoblasts could contribute to cartilage degradation by stimulating
chondrocytes to produce more matrix metalloproteases and by
inhibiting aggrecan synthesis. IL-1b, IL-6 and OSM may stimulate
normal osteoblasts to induce chondrocyte metabolic dysregulation
similar to those observed in OA cartilage, suggesting that these
cytokines play an important role in the phenotype shift of
subchondral osteoblasts in OA.
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TRANSCRIPTIONAL COACTIVATOR PGC-1A PROMOTES
CHONDROGENESIS VIA INTERACTION WITH SOX9
M. Tsuday, N. Taniguchiy, T. Furumatsuy, S. Takahashiz,
K. Yoshiday, T. Itoy, M. Hashimotox, S. Miyakix, T. Yokoyamax,
Y. Kawakamijj, H. Asaharay
y Molecular and Experimental Medicine, Division of Arthritis, The
Scripps Research Institute, La Jolla, CA, USAz Life Science, Tokyo University of Pharmacy and Life Science,
Hachioji, Tokyo, Japan
x Department of Regeneration Surgery, National Center of Child
Health and Development (NCCHD), Setagaya-ku, Tokyo, Japan
jj Gene Expression Laboratory, The Salk Institute for Biological
Studies, La Jolla, CA, USA
Purpose: Chondrogenesis is a multi step pathway during which
multi-potential mesenchymal stem cells differentiate into chondro-
cyte. The Sox9 high-mobility group (HMG) domain transcription
factor regulates chondrocyte differentiation and cartilage-speciﬁc
expression of genes such as Col2a1. However, Sox9 expression is
not only restricted to cartilage, suggesting the existence of
molecular partners of Sox9 that are required for expression of
cartilage-speciﬁc genes. Here we report the identiﬁcation of PPAR
gamma-coactivator (PGC-1) as a coactivator for Sox9 during
chondrogenesis.
Methods: In situ hybridization was performed to PGC-1 expression
in mouse development. Immunoprecipitation and GST Pull-down
assay was used to detect interaction. Chromatin immunoprecipita-
tion and Luciferase reporter assay was performed to analyze
activity on gene expression. Chicken embryos and human
mesenchymal stem cell (MSC) were infected with adenovirus to
examine the effect of PGC-1 in chondrogenesis.
Results: Expression of PGC-1 is induced at chondrogenesis sites
during mouse embryonic limb development. PGC-1 forms complex
with Sox9 and CBP/p300. Sox9 dependent transcriptional activity is
enhanced by co-expression of PGC-1, suggesting the role of PGC-
1 as a transcriptional coactivator for Sox9. Consistent with this,
PGC-1 disruption in MSC by siRNA inhibits chondrogenesis.
Furthermore, overexpression of both PGC-1 and Sox9 induced
ectopic chondrogenesis in the developing chicken limb.
Conclusion: These results suggest a previously unknown PGC-1
coordinated transcriptional mechanism for chondrogenesis.
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REGULATION OF TGF-b SIGNALING BY PROINFLAMMATORY
CYTOKINES IN HUMAN CHONDROCYTES
J. A. Roman-Blas, S. A. Jimenez, D. G. Stokes
Division of Rheumatology, Thomas Jefferson University, Philadel-
phia, PA, USA
Purpose: Proinﬂammatory cytokines IL-1b and TNF-a and
TGF-b family growth factors play critical roles in articular
chondrocytes metabolism and differentiation and in OA pathogen-
esis. TGF-b generally exerts an anabolic or repair response from
articular cartilage; in contrast IL-1b/TNF-a exerts a strong catabolic
effect. Recent evidence has shown that IL-1b/TNF-a and the
TGF-b signaling pathways share an antagonistic relationship.
The aim of the study was to determine whether the modulation of
the response of human articular chondrocytes to TGF-b by IL-1b/
TNF-a signaling pathways occurs through regulation of activity and
availability of Smad proteins.
Methods: Articular cartilage was obtained from the tibial plateaus
and femoral condyles of patients undergoing knee-replacement
surgery. Chondrocytes were isolated by overnight digestion with
collagenase, and cultured in suspension in 60 mm2 polyHEMA
coated plastic dishes at a density of 5! 106 cells/dish. Twenty-four
hours before treatment the FBS in the media was reduced to 1%.
The cells were cultured without cytokines or were treated with 10
ng/ml IL-1b/ TNF-a for 2 h. Nuclear extracts were then prepared by
standard methods. Electrophoretic mobility shift assay (EMSA)
were carried out with probes speciﬁc for NF-kB and Smad 3/4.
Nuclear extracts were then subjected to the TranSignal Protein/
DNA array (Panomics, Redwood City, CA) enabling the detection of
the DNA-binding activity of 57 different transcription factors.
Another set of cultures was treated with 10 ng/ml IL-1b or 10 ng/
ml TNF-a for 1 h and then total RNA was prepared. RT-PCR
analyses of Smad 6 and 7, COL 2A1, aggrecan and GAPDH were
performed at low cycle number (18–22), and samples were
S99electrophoresed on 10% polyacrylamide gels and then stained with
Syber Green I.
Results: EMSA analysis showed a clear increase in the DNA-
binding activity of NF-kB in response to cytokine treatment. The
DNA-binding activity of Smad 3/4 in the TranSignal Protein/DNA
array was found down-regulated (46%) in three out of three
samples by TNF-a treatment and in two out of three samples by IL-
1b. Further EMSA analysis showed a consistent reduction in the
Smad 3/4 DNA-binding activity in human articular chondrocytes
treated with either IL-1b or TNF-a. RT-PCR analysis of Smad 6 and
7 mRNA levels showed lack of induction by either IL-1b or TNF-a,
whereas COL2A1 and aggrecan mRNA levels were strongly
decreased verifying the effect of both cytokines.
Conclusion: We observed a suppressive effect on Smad 3/4 DNA-
binding activity in response to either IL-1b or TNF-a in human
articular chondrocytes. No change in mRNA levels of inhibitory
Smad 6 and 7 was observed, indicating that alternative mecha-
nisms are involved in the suppression of TGF-b signaling induced
by IL-1b or TNF-a. The balance between these two signaling
pathways is crucial for maintenance of articular cartilage homeo-
stasis and its disruption likely plays a substantial role in the
pathogenesis of OA.
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TRANSCRIPTIONAL REGULATION OF ADAMTS-5 (AGGRECA-
NASE 2)
M. R. Heming, S. D. Wainwright, B. Caterson, C. E. Hughes
Connective Tissue Biology Laboratories, Cardiff University, Cardiff,
Wales, United Kingdom
Aim: Using the Luciferase Assay System (Promega, Madison, WI)
the project aim is to identify regulatory elements in the 5# non-
coding region that regulates ADAMTS-5 expression. In addition the
effect of catabolic stimulants on that regulation will be studied.
Methods: A 3 kb fragment containing the 5# ﬂanking region of
ADAMTS-5 was subcloned into pGL3-Basic (Promega), a luciferase
reporter vector lacking a eukaryotic promoter. Truncations were
made to the full-length construct using the Erase-a-Base System
(Promega, Madison, WI) at restriction enzyme sites SacI at 11 bp
from the origin, and NheI at 21 bp from the origin, resulting in
200–2300 bp deletions on the TS-5 full-length vector. Bovine
articular chondrocytes were obtained from the metacarpophalan-
geal joints of 18 month old bovine sources. Cells were isolated by
enzymatic digestion and seeded at 0.64! 106 cells per well (12 well
plates) in Dulbecco’s modiﬁed Eagle’s medium (DMEM) (Gibco Life
Technologies) containing: 50 mg gentamicin/ml and 5% Fetal Bovine
Serum. Cells were maintained for 24 h at 37(C, 5% CO2. The next
day serum media was removed and DMEM free of serum or
antibiotics was added. Transfection complexes were prepared by
mixing 97 ml of serum free medium, 3 ml of Fugene-6 transfection
agent, and 2 mg of DNA from Control, Basic, TS-5 full-length
construct and seven deletion fragments (numbering downstream
from the ATG start codon) spanning the 5# non-coding region: 3b.4
(2322 bp), 4a.5 (2110 bp), 5a.2 (1810 bp), 4a.2 (1427 bp),
t3a.3 (718 bp), 2a.1 (433 bp), 4a.1 (278 bp). One hundred
microliters of the complex was pipetted directly into each well. Plates
were incubated for 48 h at 37(C, 5% CO2. The addition of catabolic
stimulants followed with 3! 10 min washes and direct pipetting of
IL-1a (10 ng/ml), TNFa (50 ng/ml), RA (106 M), or OSM (10 mg/ml)
into the wells for a further 48 h. Cells were harvested, washed twice
in PBS, and resuspended in 1! Passive Lysis Buffer. Twenty
microliters of the cell lysate was assayed for luciferase activity as
described in the manufacturers protocol (Promega, Madison, WI).
Results and discussion: In comparison to ADAMTS-4, it is clear that
IL-1a is not involved in the up-regulation/induction of ADAMTS-5.
Evidence shows that IL-1a clearly increases the relative luciferase
activity of ADAMTS-4 parent vector, but not that of ADAMTS-5,
indicating IL-1a has no effect on the transcriptional regulation of
ADAMTS-5 within the 5# non-coding region. This suggests that
transcriptional regulation of TS-5 cannot be responsible for the
reported induction of message by IL-1a in articular explant cultures.Similarly TNFa also does not visibly increase the luciferase activity
of ADAMTS-5 suggesting it has no effect on transcriptional
regulation. However, signiﬁcant increases in luciferase activity
were seen with the addition of RA, OSM, and OSM/IL-1a in
combination. A 10 fold increase in luciferase activity occurred with
the addition of OSM and a 16 fold increase when in combination
with IL-1a, suggesting IL-1a may indirectly regulate ADAMTS-5
activity. Further investigations into relative changes in luciferase
activity between the deletion fragments will help to identity the
regulatory elements involved in these processes.
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TRANSCRIPTIONAL REGULATION OF MPGES-1 GENE IN
PRIMARY CULTURED ARTICULAR CHONDROCYTES: ROLE
OF C/EBP FACTORS
P. Bauseroy, C. Salvaty, V. Meynier de Salinellesy, A. Pigeneyy,
M. Raymondjeany, F. Berenbaumz
y CNRS/Paris 6, UMR7079, Paris, Metropolitan, France
z UFR Saint-Antoine, UMR7079 CNRS/Paris 6, Paris, Metropolitan,
France
Healthy cartilage is maintained in a state of dynamic equilibrium by
matrix synthesis and matrix degradation by the chondrocytes. Any
dysregulation with increased degradation and/or inadequate
synthesis leads to loss of tissue structure and function, as in
osteoarthritis (OA). The pro-inﬂammatory cytokine interleukin-1 (IL-
1) plays a major role in this phenomenon. IL-1 acts on
chondrocytes in part by stimulating the release of prostaglandin
E2 (PGE2) at the sites of inﬂammation. Recently, a human
membrane-associated prostaglandin E2 synthase-1 (mPGES-1)
was cloned. This enzyme catalyzes the conversion of PGH2 to
PGE2. We previously demonstrated that mPGES-1 mRNA is
induced by IL-1 and regulated by MAP kinases in chondrocytes, in
a dose and time-dependent manner (Arthritis & Rheum, in press).
In order to study the transcriptional regulation of mPGES-1 in
articular chondrocytes, we have cloned its promoter upstream of the
CAT ORF (vector pCAT3-basic, Promega). We show by transient
transfection experiments in primary rabbit articular chondrocytes
that the mPGES-1 promoter is stimulated by IL-1beta (w2-fold). A
close examination of putative bindings sites has revealed the
presence of two C/EBP binding sequences (TTNNGNAAT) located
between 548 to 558 and 610 to 619. Co-transfections of
expression vectors encoding the two different isoforms of C/EBP
(beta and delta) strongly stimulate (w4–6-fold) the promoter activity.
To further study the role of C/EBP in mPGES-1 expression, we
performed gel shift experiments on wild type and mutated
oligonucleotides derived from the mPGES-1 sequence. These
experiments conﬁrm the speciﬁc binding of C/EBP on the
mPGES-1 promoter. Taken together, our results suggest that
C/EBP factors indeed bind and regulate the mPGES-1 promoter in
articular chondrocytes. Since these factors are also implicated in
the gene regulation of other enzymes involved in PGE2 syn-
thesis by chondrocyte (type II secreted phospholipase A2 and
cyclooxygenase-2), we postulate that C/EBP factors should be
considered as potential targets for the treatment of OA.
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SUBCHONDRAL BONE OSTEOBLASTS INDUCE
PHENOTYPIC CHANGES IN HUMAN OSTEOARTHRITIC
CHONDROCYTES
C. Sanchezy, M. A. Debergy, N. Piccardiz, P. Msikaz, J. Y. L.
Reginstery, Y. E. Henrotiny
y Bone and Cartilage Research Unit, University of Liege, Liege,
Belgium
z esearch and Development, Expanscience Laboratories, Courbe-
voie, France
S100Aim of study: To determine the inﬂuence of osteoarthritic (OA)
subchondral osteoblasts on the phenotype of human chondrocytes.
Methods: Human chondrocytes were isolated from OA cartilage
and cultured in alginate beads for 4 days in the absence or in the
presence of normal or OA human subchondral osteoblasts in
monolayer. Sox-9, type I, II and X collagen (COL1, COL2, COL10),
osteoblasts stimulating factor (OSF)-1, parathyroid hormone related
peptide (PTHrP) and its receptor (PTHR), and bone alkaline
phosphatase (ALP) mRNA levels in chondrocytes were quantiﬁed
by real time polymerase chain reaction.
Results: In co-culture with OA or normal subchondral osteoblasts,
chondrocytes expressed signiﬁcantly less sox-9 and COL2 mRNA
compared to chondrocytes cultured alone. The decrease of sox-9
andCOL2geneexpressionwas signiﬁcantlymore pronounced in the
presence of OA than in the presence of normal subchondral osteo-
blasts (OA vs normalP! 0.001). OSF-1mRNA level in chondrocyte
was increased by both normal and OA osteoblast, but to a larger
extent by OA osteoblasts (OA vs normal P ! 0.001). PTHrP gene
expression by chondrocytes was 20-fold increased by normal osteo-
blasts but 4-fold inhibited by OA osteoblasts. OA, but not normal
osteoblasts, induced a signiﬁcant decrease of PTHR gene expres-
sion. In our experimental conditions, chondrocytes did not express
COL1, COL10 or ALP, even after 4 days of co-culture with
osteoblasts.
Conclusions: In co-culture with OA subchondral osteoblasts,
chondrocytes initiated a dedifferentiation process, characterized
by a decrease of sox-9 and COL2 gene expression, and initialize
hypertrophic differentiation as indicated by an increase of OSF-1
expression and a decrease of PTHrP gene expression. These
ﬁndings suggest that OA osteoblasts could initialize chondrocyte
phenotype shift occurring in OA cartilage.
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HYALURONAN-CELL INTERACTIONS INFLUENCE THE TRAN-
SCRIPTIONAL REGULATION OF CD44 BY BMP-7
R. A. Andhare, C. B. Knudson
Biochemistry, Rush Univerity Medical Center, Chicago, IL, USA
Aim: This study aims to identify potential BMP-7 promoter/enhancer
elements within the human CD44 gene and to test if hyaluronan-cell
interactions inﬂuence the BMP-7 response on the CD44 gene.
Methods: Four different CD44 promoter/enhancer constructs were
generated to elucidate the regulation of CD44 expression. The
different regions of CD44 were ampliﬁed by PCR from genomic
DNA and cloned into the Kpn-1 and Nhe-1 sites of the PGL3 Basic
vector (Promega). PGL3ti(SBE)4 (from Dr Bart Eggen, University of
Groningen) a Smad element driven luciferase reporter construct
was used as a positive control for BMP-7 activity. Cells were
transfected using lipofectamine 2000 (Invitrogen) reagent and after
treatment they were lysed and luciferase activity measured using
the luciferase assay system.
Results: The 0.5 kb CD44 construct contains the promoter region.
This region has binding sites for transcription factors, e.g., Smad-4,
AP-1, SP-1, Egr-1 and p300. At short time points (1, 2, 4 h) in HeLa
cells, treatment with 100 ng/ml BMP-7 almost doubled the luciferase
activity with a similar increase in bovine chondrocytes. However, in
HeLa cells BMP-7 treatment for 24 h resulted in slight decrease
(w0.7!) in luciferase activity whereas in chondrocytes elevated
luciferase persisted. Treatment with 10 ng/ml of IL-1 also increased
the luciferase activity by 2.5 fold. A 1.35 kb construct containing the
promoter region, exon-1 and part of intron-1 of CD44 exhibited a 3-
fold increase in luciferase activity with BMP-7 treatment and a 2.5
fold increase in activity with IL-1 stimulation. Streptomyces
hyaluronidase is an enzyme that speciﬁcally degrades hyaluronan.
The 0.5 kb CD44 plasmid transfected articular chondrocytes
displayed luciferase activity that either decreased or remained the
same upon treatment with Streptomyces hyaluronidase or with
Streptomyces hyaluronidase pre-treatment followed by BMP-7
stimulation. A BMP-7 responsive PGL3ti(SBE)4 plasmid was
expressed well over the empty vector in C28/I2 cells (human
immortalized chondrocytes) and the luciferase activity doubled with2 h of BMP-7 treatment. In parallel, the PGL3ti(SBE)4 luciferase
activity either decreased or remained the same upon treatment with
BMP-7 in the presence of Streptomyces hyaluronidase.
Conclusion: CD44 on articular chondrocytes bind to hyaluronan
and maintain cartilage homeostasis by retaining and anchoring the
proteoglycan aggregates in the pericellular matrix. CD44 expres-
sion is upregulated by growth factors, e.g., BMP-7 or cytokines,
e.g., IL-1. The 0.5 kb CD44 promoter construct was responsive to
BMP-7. IL-1 validated the functionality of the CD44 0.5 kb
construct. Removal of the cell–matrix interactions resulted in
a diminished BMP-7 response in both the articular chondrocytes
and C28/I2 cells using the CD44 promoter or PGL3ti(SBE)4
constructs. This suggests that hyaluronan-cell interactions augment
the BMP-7 response. A link between hyaluronan–CD44 interac-
tions and signal transduction cascades implicates that modulation
or disruption of hyaluronan-cell interactions during development;
tissue remodeling or degeneration may change the growth factor
responsiveness of that cell and/or affect cartilage homeostasis.
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THE REGULATION OF HUMAN METALLOPROTEASE-13 BY
LICOFELONE, AN INHIBITOR OF CYCLOOXYGENASES AND
5-LIPOXYGENASE, IN HUMAN OSTEOARTHRITIC CHONDRO-
CYTES IS MEDIATED BY THE INHIBITION OF THE p38
MITOGEN-ACTIVATED PROTEIN KINASE SIGNALING PATH-
WAY
C. Boileauy, J. P. Pelletiery, F. Mineauy, G. Tardify, H. Fahmiy,
S. Lauferz, M. Lavignex, J. Martel-Pelletiery
y Osteoarthritis Research Unit, University of Montreal Hospital
Centre, Notre-Dame Hospital, Montreal, QC, Canada
z Department of Pharmaceutical/Medicinal Chemistry, Eberhard-
Karls University Tu¨bingen, Tu¨bingen, Germany
x Department of Orthopedics, Maisonneuve-Rosemont Hospital,
Montreal, QC, Canada
MMP-13 is one of the most important metalloproteases (MMP)
involved in osteoarthritis (OA). Licofelone, a novel dual inhibitor of
cyclooxygenases (COX) and 5-lipoxygenase (5-LOX), has been
shown in vivo in animal models to positively affect OA articular
tissue structural changes. We evaluated the effect of licofelone on
MMP-13 production in human OA chondrocytes by analyzing its
impact on this enzyme’s expression/production, promoter, and on
the major MAP kinase signaling pathways and transcription factors.
Human OA chondrocytes were stimulated with interleukin (IL)-1b
for 24–96 h, and treated with or without therapeutic concentrations
of licofelone (0.3, 1, 3 mg/ml), NS-398 (10 mM), a speciﬁc COX-2
inhibitor, or BayX-1005 (10 mM), a speciﬁc 5-LOX inhibitor. MMP-13
synthesis was determined by a speciﬁc ELISA, and expression by
quantitative PCR. Effect of licofelone on the MMP-13 promoter was
studied on OA chondrocytes transiently transfected with three
constructs (-1599, -183 and -133Luc), stimulated with PMA (100
ng/ml) and treated with licofelone at 3 mg/ml; dexamethasone at
107 M was used as the comparator. The effect of licofelone on IL-
1b-induced MMP-13 signaling pathways was determined with the
use of the speciﬁc phosphorylated ELISA for mitogen-activated
protein (MAP) kinases and transcription factors.
Data showed that licofelone signiﬁcantly reduced, in a dose-
dependent manner, the IL-1b-stimulated production and expression
of MMP-13. NS-398 and BayX-1005 had a very slight effect.
Licofelone also signiﬁcantly inhibited MMP-13 transcription on all
the promoter constructs used; the maximal effect was obtained with
the smaller construct containing only the AGRE, PEA-3 and AP-1
sites. The licofelone inhibition was comparable to that obtained with
dexamethasone. Licofelone had no effect on phospho-44/45,
JNK1/2, decreased c-jun and signiﬁcantly inhibited phospho-p38
and CREB.
In this study, we demonstrated on human OA chondrocytes, the
inhibitory effect of licofelone on MMP-13 production under
proinﬂammatory conditions; this occurs via inhibition of the
activation of the p38 pathway, then of the transcription factor
CREB, which indirectly inhibits the AP-1 activation.
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b1 INTEGRIN REGULATES AGGRECAN GENE EXPRESSION
BY OSTEOARTHRITIC HUMAN ARTICULAR CHONDROCYTES
K. J. Elliot, D. M. Salter
Osteoarticular Research Group, University of Edinburgh Medical
School, Edinburgh, Scotland, United Kingdom
Aim: To establish whether manipulation of integrin receptors
inﬂuences aggrecan gene expression of osteoarthritic (OA) human
articular chondrocytes (HAC) in the presence or absence of
a potentially anabolic mechanical stimulus.
Methods: Primary monolayer cultures of OA HAC were incubated
with function blocking anti-integrin antibodies [avb5 integrin (P1F6),
b1 integrin (PC410, P5D2 or JB1a)] for 30 min prior to mechanical
stimulation (MS) by a regime which has been previously shown to
increase aggrecan expression when applied to normal HAC (20
min, 0.33 Hz, 4000 microstrain). RNA was extracted from cells
untreated or treated with antibody, at rest and at 24 h post MS and
aggrecan mRNA levels assessed by semi-quantitative RT-PCR.
Results: Preincubation with the function blocking anti-integrin
antibodies for 30 min did not alter aggrecan mRNA levels.
However, following 24 h antibody incubation signiﬁcant decreases
in aggrecan mRNA levels were seen with the b1 integrin antibodies
PC410 and P5D2 but not with JB1a or the avb5 integrin antibody
P1F6. Following MS there was no signiﬁcant alteration in aggrecan
mRNA levels in untreated OA cells or cells treated with P1F6 and
mechanical stimulation had no effects on the down-regulation of
aggrecan gene levels seen with PC410 and P5D2. OA HAC
preincubated with b1 integrin antibody (JB1A) prior to mechanical
stimulation showed a signiﬁcant increase in aggrecan mRNA levels
at 24 h when compared to cells treated with JB1a for 30 min or
untreated cells which have been mechanically stimulated.
Conclusions: We have previously demonstrated that mechanical
stimulation at 0.33 Hz results in an RGD dependent increase of
aggrecan mRNA in normal but not OA HAC 1–3 h post stimulation.
The present study conﬁrms that 0.33 Hz stimulation does not
inﬂuence levels of aggrecan mRNA in mechanically stimulated
untreated OA cells upto 24 h post stimulation. The results suggest
that aggrecan mRNA expression in OA chondrocytes can be
manipulated by function modifying anti-b1 integrin antibodies either
adversely or, in conjunction with a mechanical stimulus, in a positive
manner raising the possibility that anti-integrin therapy may be used
to alter the balance between catabolic and anabolic activity in
osteoarthritis.
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PROSTAGLANDINS AND LEUKOTRIENE B4 ARE OVEREX-
PRESSED BY AND EXERT CATABOLIC EFFECTS IN OA
CARTILAGE
M. G. Attur, M. N. Dave, J. N. Patel, P. Gomez, S. B. Abramson
Division of Rheumatology, Department of Medicine, Hospital for
Joint Diseases, New York, NY, USA
Introduction: We have previously reported that OA cartilage
explants spontaneously produce multiple cyclooxygenase products
(including PGE2 and PGD2) and express the terminal enzymes
mPGHS and brain PGDS. Similarly, leukotriene products LTB4 and
lipoxin were also produced. However, the effects of PGEs and
LTB4 which act via four G-protein coupled receptors (EP1–EP4)
and BLT1 and BLT2, respectively, on cartilage metabolism,
remains poorly understood. In these studies we investigated the
expression of EP and LTB4 receptors and effects of PGE2 and
LTB4 on chondrocyte metabolism.
Methods: Cartilage explants were prepared from OA patients
undergoing joint replacement surgery. In selected experiments
chondrocytes were isolated using collagenase digestion and
cultured in alginate beads. Proteoglycan synthesis was estimated
using 35S incorporation. Gene expression studies were performed
by Real Time PCR (SYBER Green I detection system).Results: The expression of PGE2 receptors (EP) was analyzed
using RT-PCR. All four EP receptors were expressed in both
normal and OA chondrocytes. However, EP4 receptor was
differentially expressed in OA cartilage compared to normal (2–3
fold increase). LTB4 receptors BLT1 and BLT2 were both
expressed in normal and OA chondrocytes. Addition of PGE2
and LTB4 (0.1–10 mM) inhibited proteoglycan synthesis by
chondrocyte cultures to levels of 75% control (P ! 0.01). The
potency of inhibition was comparable to that observed in the
presence of IL-1beta, and the inhibitory effects of the combination
of IL-1 plus PGE2 or LTB4 (10 mM) were additive. We next
analyzed the effect of various COX inhibitors on both constitutive
and IL-1 induced inhibition of proteoglycan (PG) synthesis in
immobilized chondrocytes in alginate beads. COX-2 selective
inhibitors, celecoxib (2 mM) and rofecoxib (2 mM) did not alter
constitutive proteoglycan synthesis whereas, aspirin (1 mM)
reduced proteoglycan synthesis to 58% control values (P !
0.01). IL-1 induced inhibition of proteoglycan synthesis (78%
control) was signiﬁcantly reversed by both celecoxib (101% control)
and rofecoxib (133% control). In contrast, the non-selective COX
inhibitors indomethacin and aspirin did not reverse the IL-1 effects.
Additional experiments revealed that the treatment of chondrocytes
with PGE2 and LTB4 signiﬁcantly induced (P ! 0.01) the
production of LTB4 or PGE2, respectively, and the chemo/
cytokines, IL-6 and IL-8.
Conclusion: Prostaglandins, perhaps acting via the EP4 receptor,
and LTB4 via BLT receptors exert catabolic effects on chondrocyte
metabolism. These effects can be reversed by the coxibs, but not
by aspirin or indomethacin. Upregulation of COX-2, 5-LO and EP4
receptor in OA cartilage may participate in disease progression,
and strategies that examine the speciﬁc antagonism of EP4 or
LTB4 receptor signaling are warranted.
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ROLE OF PHOSPHATASE -1 AND -2A IN CHONDROCYTE
SURVIVAL
B. Caramesy, M. J. Lopez-Armaday, B. Cillero-Pastory, M. Lires-
Deany, I. Fuentes-Boquetez, C. Ruiz-Romeroy, B. Lemay,
J. A. Pinto-Tasendey, F. Galdoy, F. J. Blancoy
y Unidad de Investigacion, Servicio de Reumatologia, Complejo
Hospitalario Juan Canalejo, A Corun˜a, Spain
z Department of Medicine, Universidad de A Corun˜a, A Corun˜a,
Spain
Objective: It is clear that chondrocyte death may contribute to the
progression of osteoarthritis (OA). Reversible phosphorylation is
a key mechanism for regulating the biological activity of many
human proteins that affect a diverse array of cellular processes,
including apoptosis. In this study we characterised the role of the
phosphatase 1 and 2 (PP1/2A), in the modulation of apoptosis in
human OA chondrocyte.
Methods: Human OA chondrocytes were isolated from cartilage
obtained from the femoral heads of patients undergoing joint
replacement surgery. Cell viability was evaluated using a colorimet-
ric assay based on the MTT assay. A colorimetric assay with
methylene blue incorporation into cells was used to determine cell
proliferation. Apoptosis was quantiﬁed by ﬂow cytometry and by
using an ELISA that quantiﬁes DNA fragmentation. Protein
synthesis and the expression of mRNA for the caspases and poli-
ADP-ribosa (PARP) were analyzed by Western-blot and the
ribonuclease protection assay, respectively. Nitric oxide (NO)
production was evaluated by the Greiss method and inducible
Nitric Oxide Synthase (iNOS) protein synthesis was studied by
Western-blot.
Results: The inhibition of PP1/2A by the speciﬁc inhibitor okadaic
acid (OKA) dose- and time-dependently caused a reduction in
chondrocyte proliferation (50 nM OKA: a reduction of 28% and 46%
at 48 and 72 h, respectively) and in cell viability (50 nM OKA:
a reduction of 31% and 53% at 48 and 72 h, respectively). Genomic
DNA from chondrocytes treated with OKA at 50 and 100 nM for 48
h displayed increases in inter-nucleosomal DNA fragmentation by
S10211 and 13 ﬁelds, respectively. Furthermore, the quantiﬁcation of
apoptosis by ﬂow cytometry analysis demonstrated the presence of
a hypodiploid peak (100 nM OKA: 40% at 48 h). In addition, 100 nM
OKA at 72 induced PARP cleavage. Different concentrations of
OKA (10, 20, 50, and 100 nM) for different time intervals (6-, 24-,
and 48-h) caused, in a time-dependent manner, the up-regulation
of the executioner of mRNA and protein caspase-3 and -7. To
analyze the functional role of caspases on the apoptosis induced by
OKA, experiments with caspase inhibitors were performed. The
pan-caspase inhibitor Z-VAD-FMK reduced the apoptosis induced
by 50 nM OKA by 77%. Finally, at any dose tested, OKA did not
increase iNOS protein synthesis or NO production.
Conclusion: These results suggest that apoptosis induced in human
OA chondrocyte is caspase dependent and NO-independent.
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INTEGRIN-MEDIATED MECHANOTRANSDUCTION IN IL-1b
stimulated chondrocytes
T. T. Chowdhuryy, R. N. Applebyz, D. M. Salterz, D. L. Badery,
D. A. Leey
y Department of Engineering, Queen Mary, University of London,
Mile End Road, London, United Kingdom
z Department of Pathology, Edinburgh University Medical School,
Teviot Place, Edinburgh, United Kingdom
Introduction: The current study tests the hypothesis that IL-1b
modulates the response of bovine chondrocytes to the application
of dynamic compression via an integrin-mediated mechanotrans-
duction process.
Materials and methods: Bovine chondrocytes were seeded in
agarose gel (3%, Type VII) and cultured for 24 h. Constructs were
incubated for a further 48 h in radiolabelled medium (1 mCi ml1
[3H]-thymidine and 10 mCi ml1 35SO4) containing 0 or 10 ng ml
1
of IL-1b C 100 mg ml1 GRGDSP (competitive ligand for a5b1
integrin) or 100 mg ml1 GRADSP (non-binding control peptide).
In a separate experiment, a fully characterised cell-straining system
(Zwick Testing Machines, UK1) was used to apply 15% dynamic
compressive strain (1 Hz, 48 h) to constructs cultured in labelled
medium supplemented with 0 or 10 ng ml1 IL-1b C 100 mg ml1
GRGDSP or 100 mg ml1 GRADSP. Nitrite was measured using the
Griess assay. PGE2 was determined using an EIA system. [
3H]-
thymidine and 35SO4 incorporation was assessed by TCA and
Alcian blue precipitation, respectively.
Results
Effect of RGD peptides in untreated and IL-1b stimulated
constructs: In the absence of IL-1b, similar levels of nitrite and
PGE2 release,
35SO4 and [
3H]-thymidine incorporation were found
for constructs cultured for 48 h in medium supplemented with either
GRGDSP or GRADSP. In the presence of IL-1b, the cytokine-
induced nitrite and PGE2 release was not affected by GRGDSP or
GRADSP. Similarly, the IL-1b-induced inhibition of 35SO4 and [
3H]-
thymidine incorporation was not inﬂuenced by either peptide.
Effect of RGD peptides in mechanically stimulated constructs: The
relative compression-induced inhibition of nitrite was enhanced by
IL-1b. This effect was not inﬂuenced by GRADSP but was reversed
with GRGDSP. In the absence of IL-1b, dynamic compression did
not signiﬁcantly inﬂuence PGE2 levels in the presence and absence
of GRADSP. Dynamic strain enhanced PGE2 release in the
presence of GRGDSP. Furthermore, the IL-1b-induced PGE2
release was reversed by dynamic compression in the presence
and absence of GRADSP, a response abolished with GRGDSP. In
the presence and absence of IL-1b, dynamic compression-induced
stimulation of [3H]-thymidine incorporation was not inﬂuenced by
GRADSP but was abolished with GRGDSP. Similarly, strain-
induced stimulation of 35SO4 incorporation was not inﬂuenced by
GRADSP, but was reversed with GRGDSP in the presence and
absence of IL-1b.
Discussion: The current study demonstrates that the dynamic
compression-induced changes in cell metabolism, in the presence
and absence of IL-1b, were integrin-mediated. These ﬁndings are
similar to a previous study utilizing human chondrocytes2. Furtherwork will determine the beneﬁcial effects of mechanical stimuli and
its interactions between compression, .NO and other inﬂammatory
mediators.
References
1. Lee and Bader. J Orthop Res 1997;15:181–8.
2. Chowdhury et al. Biochem Biophys Res Commun 2004;318:
873–81.
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THE TYROSINE KINASE PYK-2 IS REQUIRED FOR CHON-
DROCYTE ACTIVATION BY INTERLEUKIN-1
T. Olee, J. Valbracht, M. Lotz
Division of Arthritis Research, The Scripps Research Institute, La
Jolla, CA, USA
Aims: Identiﬁcation of signaling pathways that are involved in
chondrocyte activation by Interleukin-1 (IL-1) has the potential to
generate new targets for pharmacological inhibition of cartilage
degradation. The objectives of the present study were to
determine the role of tyrosine kinases in the IL-1 response of
chondrocytes.
Methods: Differential expression of tyrosine kinases in normal vs
OA cartilage was analyzed with DNA arrays and immunohisto-
chemistry. Inhibitors of tyrosine kinases were tested for effects on
IL-1-induced gene and protein expression in cultured chondrocytes.
Activation of tyrosine kinases and mitogen-activated protein
kinases (MAPK) was analyzed by Western blotting with phospho-
speciﬁc antibodies.
Results: Expression of pyk-2 mRNA was increased in OA
cartilage. Analysis of chondrocyte by immunocytochemistry
showed that the majority of chondrocytes were positive for pyk-2
protein. Phosphorylated pyk-2 was detectable in cultured chon-
drocytes and increased in response to stimulation with IL-1. The
pyk-2 speciﬁc kinase inhibitor AG-17 completely inhibited IL-1
induced nitric oxide and IL-6 production in chondrocyte monolayer
and in cartilage explant cultures. Pharmacologic inhibitors of other
tyrosine kinases such as FAK and Src did not signiﬁcantly affect
these IL-1 responses. In a subset of chondrocyte preparations
AG-17 and pyk-2 siRNA prevented IL-1-induced MAP kinase
activation.
Conclusions: IL-1 activates pyk-2 and this is required for IL-1
induced expression of NO and IL-6. These results identify pyk-2 as
a new component of IL-1 signaling in chondrocytes.
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TRANSCRIPTIONAL REGULATION OF HYALURONIDASE-2:
CHARACTERIZATION OF THE PROMOTER REGION OF HU-
MAN HYALURONIDASE-2
G. Chow, W. Knudson
Biochemistry, Rush Medical College, Chicago, IL, USA
Introduction: Maintaining a steady state in the hyaluronan content
(HA) is important as it plays an integral role in the extracellular
matrix of cartilage. Little is known about the lysosomal hyaluroni-
dase(s) involved in HA degradation or how the enzyme is
regulated. In this initial promoter analysis study hyaluronidase-2
promoter region was examined to identify possible elements critical
to the regulation of its expression.
Methods: A series of 5# and 3# deletion hyaluronidase-2 promoter
constructs were generated by cloning ampliﬁed human DNA into
a promoterless vector, pGL3-Basic. To assess for transcriptional
activity of these constructs each was transfected into immortalized
human chondrocytes, C-28I2 (a gift from Dr Mary Goldring) at 1 mg
using FuGene 6 and assayed for luciferase activity at 48 h and
compared with empty pGL3-Basic vector. In addition, the transcrip-
tional start site was determined by RACE ampliﬁcation using
human placenta as the template.
Results: Both 5# and 3# deletion promoter constructs were generated
to determine the promoter activity for the hyaluronidase-2 gene.
S103The 5# deletion constructs (C1 to C4) are located in the 5#-ﬂanking
region of Exon 1 varying in length from 65 bp to 1051 bp. The 3#
deletion constructs (C5 to C7) are also within the 5#-ﬂanking region
with the exception of C5 that also spans both Exon 1 and part of
Intron 1 ranging in length from 734 bp to 2822 bp. Of the 5#deletion
constructs, C3 shows the highest luciferase activity (!14) over the
empty vector while the rest showed a moderate increase of 2 to 6
fold. With the 3# deletion constructs, C5 shows a moderate increased
(!6) while C6 and C7 inhibited the luciferase activity by 9- and 1-
fold, respectively. We have also determined the transcriptional start
site of hyaluronidase-2 using human placenta RNA and found that it
extends 57 bp upstream of Exon 1.
Discussion: By 5#RACE, we have identiﬁed a transcription start site
that is located an additional 57 bp beyond the published
hyaluronidase-2 cDNA sequence. Of the 5# deletion constructs
examined, a proximal 257 bp fragment (C3) exhibited the highest
transcriptional activity that seems to suggest the proximal promoter
activity is located in this region. Inspection of the sequence
revealed no TATA-box or CCAAT box but has features character-
istic of eukaryotic promoters such as a high GC content (63%) and
also showed the presence of sites for transcription factors like
AP-4, USF, GATA and Ets-1. In addition, a strong repressor
element was located in C6 and its identity is yet to be determined.
Thus, the hyaluronidase-2 gene could be negatively modulated by
the region found in C6.
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HETEROGENEITY OF SHEAR STRESS MODULATION IN TRI-
AXIAL COMPRESSION OF CARTILAGE
N. Vosy, N. Groslandyz, D. Pedersenz, J. Martinz, A. Heinerz,
T. Brownyz
z Department of Biomedical Engineering, University of Iowa, Iowa
City, IA, USA
y Department of Orthopaedics and Rehabilitation, University of
Iowa, USA
A poroelastic ﬁnite element (FE) model of a cylindrical cartilage
specimen in triaxial compression was developed to quantify shear
stress heterogeneity, and to explore the inﬂuence of peripheral
buttressing in forestalling progressive compaction of test speci-
mens.
An FE model of a cartilage explant (d Z 4 mm, t Z 1.5 mm) and
containment sheath (t Z 0.0254 mm) was created to replicate
triaxial testing conditions. The specimen was modeled using
axisymmetric, poroelastic (8-noded bi-quadratic) elements. The
sheath was modeled using 2-noded shell elements. The cartilage
was modeled as having an initial void ratio of 4.0, nZ 0.1667, EZ
15 MPa, and void ratio-dependent permeability. Properties of the
sheath were E Z 5.5 GPa and n Z 0.4. The explant was
compressed between two rigid porous platens (d Z 4 mm). The
interstitial ﬂuid was free to ﬂow in/out of the surfaces adjacent to the
platens. Transverse ﬂuid ﬂow was restricted by the impermeable
sheath. Eight hundred cycles (1 Hz) of trapezoidally modulated
loading were applied for three loading conditions: (1) 2 MPa axial
pressure alone, (2) 2 MPa axial plus 1 MPa transverse pressure,
and (3) 2 MPa axial plus 2 MPa transverse pressure. The
transverse load was applied to the circumferential surface of the
specimen using a distributed load on the sheath.
As transverse pressure was increased, both the cycle average and
peak-to-peak range of axial strain decreased, in effect buttressing
the cartilage (Fig. 1). As may be expected intuitively, shear stresses
were highest for axial pressure alone (Condition A, Fig. 2). Stresses
were inhomogeneous throughout the explant, with localized regions
of shear stress concentration near the upper and lower perimeters.
Progressive specimen compaction is a problem in unconﬁned
compression testing, and is likely responsible for artifactual matrix
damage and chondrocyte mechanostimulus effects not present in
vivo. In triaxial compression, the buttressing effect seen for
increasing transverse pressure better represents cartilage loading
in vivo than do conﬁned or unconﬁned compression. Triaxial testing
allows the effects of shear stress to be parametrically isolated atphysiologically relevant stress levels. Hence, a detailed stress
analysis of this novel testing regimen is an important foundation for
helping interpret in situ experiments exploiting this modality.
Funded by NIH AR 48939.
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NOTCH SIGNALING IN CHONDROGENIC DIFFERENTIATION
OF HUMAN MESENCHYMAL STEM CELLS
K. Hiraoka, M. Lotz
Division of Arthritis Research, The Scripps Research Institute, La
Jolla, CA, USA
Aims: The transmembrane receptor Notch-1 regulates cell fate and
differentiation. The present study analyzed expression and function
of Notch-1 during chondrocytic differentiation of human mesenchy-
mal stem cells (MSC).
Methods: MSC were isolated from human bone marrow aspirates
and expanded in monolayer culture. Chondrogenesis was induced
by transfer of MSC from monolayer to pellet culture and stimulation
with TGFb and bFGF. Notch expression was analyzed by ﬂow
cytometry. Notch activation is associated with the proteolytic
Fig. 1. Peak-to-peak axial strain.
Fig. 2. r–z plane shear stress (Mpa) at 300 cycles.
S104release of the Notch intracellular domain (NICD) that was detected
by Western blotting. The role of Notch in regulating chondrogenesis
was analyzed by using the gamma secretase inhibitor L,685,458
that prevents Notch activation.
Results: Notch-1 was expressed on O70% of MSC in early
passage monolayer culture. During serial passaging Notch
expression decreased and this was associated with a reduced
differentiation potential. In early passage MSC, Notch-1 expression
was reduced from O70% in low density culture to !30% upon
transfer to high cell density culture. In MSC monolayer culture
Notch signaling was activated as indicated by the proteolytic
release of the NICD. TGFb reduced levels of NICD in monolayer
culture. Following transfer of MSC from monolayer to pellet culture
Notch-1 expression and activation decreased in a time-dependent
patter to undetectable levels by 96 h. The gamma secretase
inhibitor L,685,458 suppressed glycosaminoglycan and type II
collagen production in chondrogenesis cultures.
Conclusions: These results suggest Notch-1 expression on MSC as
a marker of MSC differentiation potential. Notch activation appears
to be required during the early phase of chondrogenesis.
P256
TUMOUR NECROSIS FACTOR a (TNFa) AND INTERLEUKIN-1b
(IL-1b) CYTOKINES DIFFERENTIALLY REGULATE THE ACTI-
NOMYCIN D-INDUCED APOPTOSIS IN CULTURED HUMAN
CHONDROCYTES
M. J. Lopez-Armaday, B. Caramesy, M. Lires-Deany, B. Cillero-
Pastory, C. Ruiz-Romeroy, I. Fuentes-Boquetez, B. Lemay,
J. C. Fernandez-Lopezy, F. Galdoy, F. J. Blancoy
y Unidad de Investigacion, Servicio de Reumatologı´a, Complejo
Hospitalario Juan Canalejo, A Corun˜a, Spain
z Universidad de A Corun˜a, A Corun˜a, Spain
Objective: Death of chondrocyte cells by apoptosis is a hallmark of
degenerative joint diseases such as osteoarthritis (OA). Interleukin-
1b (IL-1b) and tumour necrosis factor a (TNFa) have been
demonstrated to play a pivotal role in the development of OA
disease. However, the role of IL-1b and TNFa in chondrocyte
survival is not totally known. In this work, we studied if TNFa and IL-
1b cytokines differentially regulate the actinomycin D (ActD)-
induced apoptosis in cultured human chondrocytes.
Methods: Human chondrocytes were isolated from cartilage
obtained from the femoral heads of patients undergoing joint
replacement surgery. Cell viability was evaluated using the MTT
assay. Apoptosis was quantiﬁed by ﬂow cytometry. Protein
expression for caspases-7 and -3, the poli-ADP-ribosa (PARP),
and the anti-apoptotic proteins Bcl-2 and mcl-1 were analyzed by
Western-blot. Nitric oxide (NO) production was evaluated by the
Greiss method and prostaglandin E2 (PGE2)by ELISA.
Results: Cultured chondrocytes were resistant to apoptosis by
TNFa (10 ng/ml) or IL-1b (5 ng/ml) alone, but combined treatment
of TNFa with ActD (1 mg/ml) increase cell death in a dose- and time-
dependent manner. Interesting, IL-1b, unlike TNFa, not showed this
synergistic effect with ActD. After 72 h of incubation, TNFa
increased the loss ActD-induced cell viability in a dose-dependent
manner (ActD: 62.3 G 4% vs basal; ActD/TNFa: 47.8 G 2.8% vs
basal, nZ 4, P! 0.05), unlike IL-1b that did not modify the loss of
ActD-induced viability (ActD/IL-1b: 73.5 G 1.7% vs basal, n Z 4,
P ! 0.01 vs basal and vs TNF/ActD). These results are in
agreement with apoptosis studies, by ﬂow cytometry, which
demonstrated that the increase of hypodiploid peak induced by
ActD was ampliﬁed by TNFa, but not by IL-1b (ActD: 18.4 G 1.8%
vs basal, P ! 0.01; ActD/TNFa: 29.3 G 2.6% vs basal P ! 0.01
and vs ActD; ActD/IL-1 b: 17.2G 2.3% vs basal, P! 0.01 vs basal
and vs ActD/TNF). Furthermore, when levels of procaspase-7 and -
3 activation was evaluated, it was found that the combination ActD/
IL-1b not induced an increase in the activation of caspases-7 and -3
observed in a time- and dose-dependent manner by the incubation
with ActD/TNFa (nZ 4, P! 0.05). In relation, no PARP cleavage
could be detected when ActD/IL-1b incubated for 6, 36 or 72 h, but
PARP cleavage did occur within 36 or 72 h after ActD/TNFatreatment. On the other hand, treatment with ActD/TNFa or ActD/IL-
1b decreased in the same manner the Bcl-2 and mcl-1 production
induced by TNFa or IL-1b alone. The analysis of NO and PGE2
demonstrated that neither NO nor PGE2 mediate the differential
interaction of IL-1b and TNFa with the death stimuli ActD.
Conclusion: These results show that IL-1b and TNFa differentially
regulate machinery apoptotic activation in human chondrocyte
cells. These data could be important for a better understanding of
the participation of IL-1b and TNFa in the pathogenesis of cartilage
degradation.
P257
PROTEOGLYCAN AGGREGATE OF VERSICAN/PG-M IN CAR-
TILAGE
K. Matsumotoyz, K. Kamiyax, F. Atsumiy, K. Shimizuy, Y. Yamadajj,
K. Kimatay, H. Watanabey
y Institute of Molecular Science of Medicine, Aichi Medical
University, Nagakute, Aichi, Japan
z Department of Orthopaedic Surgery, Matsunami General Hospi-
tal, Gifu, Japan
x Department of Orthopaedic Surgery, Gifu University School of
Medicine, Gifu, Japan
jj Craniofacial Developmental Biology and Regeneration Branch,
National Institute of Dental and Craniofacial Research, Bethesda,
MD, USA
Aim of study: To elucidate the role of versican in the cartilage as the
proteoglycan aggregate with both link protein (LP) and hyaluronan
(HA).
Methods: Immunostaining of aggrecan, versican, LP, and detection
of HA by HABP in tissues of the aggrecan-null cartilage matrix
deﬁcient (cmd) and LP-null mice. We performed a density gradient
ultracentrifugation to identify the proteoglycan aggregate of
versican using the cartilage of mice with cmd. Transfection and
immunostaining of chondrocytic N1511 cells were performed. At
day 13 after induction by dexamethasone and rat parathyroid
hormone, whole-mount cultures were rinsed with PBS, ﬁxed with
10% formalin/PBS, and then stained with 0.5% alcian blue
overnight. Immunostaining of versican was performed. The area
stained with alcian blue was measured using NIH Image version
1.63. For analysis of aggrecan or versican transcription in cartilage,
we obtained cartilage from C57/Bl6 mice at day 0 and 2 and at 8
weeks. Real-time quantitative PCR was performed using the
TaqManTM 7700.
Results: By immunostaining, versican was mainly present in the
interterritorial zone of the articular surface, whereas aggrecan was
mainly in the pericellular zone of prehypertrophic and hypertrophic
cells of the growth plate, suggesting distinct function of versican in
cartilage. Biochemical analysis of the aggrecan-null cartilage
revealed that versican is present as the proteoglycan aggregate
with both LP and HA. Overexpression of LP in chondrocytic N1511
cells at an early stage of differentiation with versican expression
enhanced versican deposition in the matrix, and suppressed further
chondrocyte differentiation. Versican transcription levels rapidly
diminished during growth.
Conclusions: Our results strongly suggest important roles of the
versican aggregate, which maintains chondrocytes at resting stage
and provides the extracellular matrix with appropriate texture for
articular surface.
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INHIBITIONOFCOX-2 EXPRESSION BYANTI-INFLAMMATORY
STEROIDS. ROLE OF HISTONE DEACETYLATION
R. Nieminenyz, K. Vuolteenahoyz, H. Kankaanrantayz,
E. Moilanenyz
y The Immunopharmacological Research Group, Medical School,
University of Tampere, Tampere, Finland
z Tampere University Hospital, Tampere, Finland
S105Aim of the study: Inducible prostaglandin synthase (cyclooxyge-
nase-2, COX-2) is expressed in osteoarthritic cartilage and
produces high amounts of proinﬂammatory prostanoids in the joint.
Anti-inﬂammatory steroids suppress COX-2 expression but the
mechanisms of action are not fully known. In the present study we
investigated the effects of glucocorticoids on COX-2 expression in
IL-1b -treated H4 chondrocytes1.
Results: Dexamethasone and a dissociated glucocorticoid, RU
24858, inhibited COX-2 protein and mRNA expression in a dose-
dependent manner in murine H4 chondrocytes exposed to IL-1b. In
the presence of a glucocorticoid receptor (GR) antagonist
mifepristone, dexamethasone and RU 24858 had no effect on
COX-2 expression. In the further mechanistic studies, the effects of
glucocorticoids through histone deacetylation were studied by
using inhibitors of histone deacetylases (HDACs). Interestingly,
neither dexamethasone nor RU 24858 had any effect on COX-2
expression in the presence of a non-selective HDAC inhibitor
(trichostatin A or M344) or a selective HDAC1 inhibitor (MC1293).
Conclusions: The present results suggest that glucocorticoids
inhibit IL-1b induced COX-2 expression in chondrocytes by a GR-
mediated and glucocorticoid responsive element (GRE)-indepen-
dent manner possibly through histone deacetylation and transcrip-
tional silencing.
1Murine H4 chondrocyte cell line was kindly provided by Dr van
Beuningen from Laboratory of Experimental Rheumatology, Uni-
versity Medical Center Nijmegen, Netherlands.
P259
NITRIC OXIDE DONOR COMPOUNDS DIFFERENTIALLY REG-
ULATE CHONDROCYTE VIABILITY
B. Caramesy, M. J. Lopez-Armaday, M. Lires-Deany, B. Cillero-
Pastory, C. Ruiz-Romeroy, I. Fuentes-Boquetez, B. Lemay, J. A.
Pinto-Tasendey, F. Galdoy, F. J. Blancoy
y Unidad de Investigacion, Servicio de Reumatologia, Complejo
Hospitalario Juan Canalejo, A Corun˜a, Spain
z Department of Medicine, Universidad de A Corun˜a, A Corun˜a,
Spain
Background: It has to be pointed out that last year a big controversy
emerged about the possible function protective of nitric oxide (NO)
under certain conditions of oxidative stress. This controversy has
emerged with the employment of the new NO donor compounds,
the ‘‘NOCS’’ (diazeniumdiolates).
Objectives: In this work, we compared the effects of the new NO
donor compound NOC12 with the classical NO donor SNP (sodium
nitroprusside) on NO production, viability, expression of Bcl-2
family components and caspases activation.
Methods: Human chondrocytes were isolated from cartilage
obtained from the femoral heads of patients undergoing joint
replacement surgery. Cell viability was evaluated using a colorimet-
ric assay based on the MTT assay; as a control, cell death was
induced by staurosporine (1 mM). Protein synthesis and the
expression of mRNA for Bcl-2, caspases family and poli-ADP-
ribosa (PARP) were analyzed by Western-blot and the ribonucle-
ase protection assay, respectively. NO production was evaluated
by the Greiss method.
Results: Firstly, we evaluated the synovial ﬂuid NO levels in
patients with different inﬂammatory arthropathies. The levels of NO
found in the synovial ﬂuid were 829 G 232 mM. Secondly, we
compared the total NO produced by a classical NO donor (sodium
nitroprusside, SNP) with the new NO donor NOC12. The results
indicated that, after 48 h of incubation, lesser molar concentrations
of NOC12 produce even bigger amounts of NO than SNP [NOC12
(0.1 mM): 263G 11 mM vs SNP (2 mM): 51G 4.3 mM, nZ 4, P!
0.05]. Thirdly, we assessed cell viability and we found that NOC12
neither reduced signiﬁcantly cell viability at any time (24, 48 and 72
h) nor dosage (0.05, 0.1 and 0.5 mM) employed, unlike SNP which
induced loss of cell viability in a dose- and time-dependent manner
[NOC12 (0.5 mM): 93 G 7% vs SNP (2 mM): 33 G 5.5%, n Z 4,
P ! 0.05). We also explored the caspases’ protein activation and
we found that NOC12 did not activate caspases and subsequentlyno PARP cleavage could be detected, unlike SNP which induced
the activation of caspases-7 and -3 in a time- and dose-dependent
manner. When Bcl-2 was assessed it was found that NOC12 (0.5
mM) increased Bcl-2 synthesis in a time-dependent manner, unlike
SNP which reduced the levels of Bcl-2. Finally, neither Bcl-2 nor
caspases family mRNA showed modulation in relation to basal
levels after incubation with NOC12.
Conclusion: These results show that NO donors’ compounds have
different biological effects on chondrocyte. These results are not
correlated with the concentration of NO released by NO donors.
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ICRS SCORE AND STIFFNESS REDUCTION OF CARTILAGE IN
THE OSTEOARTHROTIC KNEE
R. U. Kleemann, A. Cedro, D. Krocker, J. Tuischer, G. N. Duda
Center for Musculoskeletal Surgery, University Medicine Berlin,
Free and Humboldt-University, Berlin, Augustenburger Platz 1,
Germany
Aim of study: Substantial changes in articular cartilage composition
and mechanical properties occur in the development of OA. While
there is agreement that the severe stage of OA provides
mechanical softening of articular cartilage, there is a lack of data
describing the relation between stiffness reduction and visual
appearance in the mild and moderate stage of OA. The objective of
the study was to quantify the loss of stiffness of arthrotic articular
cartilage in each stage of degeneration. Knowledge about the
mechanical quality is important for diagnostic reasons and for the
understanding of the process of degeneration and regeneration.
Methods: Human tibia plateaus were taken from patients following
total knee arthroplasty (n Z 21, age Z 70 G 13). The cartilage
areas were classiﬁed using the International Cartilage Repair
Society (ICRS) score. Osteochondral plugs (n Z 42, 6 mm in
diameter) were taken from each specimen and divided for
mechanical and histological tests.
A custom made high-precision material testing device was used to
determine the biphasic material properties of the cartilage using
unconﬁned compression. After equilibration, stepwise loads of
0.019 N were applied up to 25% strain, and the creep relaxation
behaviour was recorded. Histological analysis used HE-staining for
morphological measurements and safranin-O-staining for proteo-
glycan content.
Results: Cartilage degeneration and abrasion was evident in all
specimens. The original contact area of the cartilage was
dramatically reduced. In most cases, a varus-gonarthrosis was
prominent. Values obtained from the mechanical tests showed
a relation between increasing ICRS grade and stiffness reduction
(rZ 0.69, P! 0.03). Stiffness values were E1Z 0.50G 0.14 MPa
for ICRS Grade 1, E2Z 0.37G 0.13 MPa for ICRS Grade 2 and E3
Z 0.28G 0.12 MPa for ICRS Grade 3. The histological evaluation
showed a clear matrix degradation of the more degenerated
cartilage. The superﬁcial and intermediate layer showed deteriora-
tion by means of ﬁssures and cracks, hypercellularity and
a decrease of Safranin-O and Collagen-II stainability. Together
with cloning of chondrocytes, the cracks reached the middle zone in
Grade 2 of degeneration. The clefts and disruption increased to
Grade 3 – both chondrocyte cloning and hypocellularity were
present, and the tidemark was crossed by blood vessels. The visual
grading to ICRS classes was conﬁrmed by histological evaluation.
Conclusions: The deteriorated cartilage areas of the tibia plateaus
in OA knees showed 25% reduction of Young’s modulus with each
increasing ICRS Grade. In the progression of osteoarthrosis, the
integrity of the extracellular matrix (ECM) is disrupted, causing
ﬁssures and clefts, and in consequence, a reduction in stiffness.
The signiﬁcant correlation between mechanical properties, visual
and histological results suggest that mechanical based testers may
be useful tools in clinical diagnostics. Stiffness determination may
be a potential replacement for biopsies. However, it appears
questionable if clinically ICRS Grade 1 may be depicted by pure
mechanical stiffness measurements due to the minor stiffness
decrease for ICRS Grade 1 in respect to intact cartilage.
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MODULATION OF CHONDROGENESIS BY BMP-2, TGF-b1 AND
IGF-1 IN HIGH DENSITY MICROMASS CULTURES OF
C3H10T1/2 CELLS
R. Modarresiy, K. G. Danielsonz, S. A. Jimenezy,
M. R. Seghatoleslamiy
y Medicine, Thomas Jefferson University, Philadelphia, PA, USA
z Orthopaedic Research, Thomas Jefferson University, Philadel-
phia, PA, USA
Aim: This study was conducted to examine the potential differential
effect of individual or combination of the growth factors, BMP-2,
TGF-b1 and IGF-1 on chondrogenesis of C3H10T1/2 cells.
Methods: For alcian blue staining, C3H10T1/2 cells were seeded as
1! 105 cells/10 ml in duplicate in F12 medium containing 10% fetal
bovine serum and antibiotics. After 2.5 days incubation, the cultures
were ﬁxed and stained. Total RNA from duplicate micromass
cultures containing 5 ! 105 cells/50 ml were isolated using Trizol
reagent. cDNA synthesis was performed using superscript III cDNA
synthesis kit. Ampliﬁed transcripts of the genes of interest (20
cycles) and normalizing b-actin (15 cycles) were separated on 8%
non-denaturing poly-acrylamide gels and stained with SYBR green I
dye. For proliferation assays, 2.5 day cultures initially seeded at 5!
105 cells/50 ml were incubated with WST-1 reagent (Roche Applied
Science) and colorimetric assays were performed according to the
provided protocol. Cultures were supplemented with 0.5–8 ng/ml of
TGF-b1, 100 ng/ml of BMP-2 or 100 ng/ml of IGF-1.
Results: Previous observations indicate that C3H10T1/2 cells in
high density culture shortly detach from a plastic substrate as
a condensed ﬂoating aggregate when maintained in the presence
of 10 ng/ml TGF-b1. Such aggregates stain intensely with alcian
blue and histological examination of these cultures indicates
induced matrix deposition of type II collagen and link protein
(Denker et al., 1995). In this study we have examined the effect of
lower concentrations of TGF-b1 on cellular morphology and
proliferation, chondrogenesis related gene regulation, alcian blue
staining, and attachment characteristics of C3H10T1/2 micromass
cultures. Our ﬁndings indicate that low concentrations of TGF-b1 (2
ng/ml) maintain micromass attachment for 3–5 days and induce
collagen type IIB gene expression. However, TGF-b1 does not
induce aggrecan gene expression even at high concentrations (8
ng/ml) although an increase in sulfated macromolecules was
detected by alcian blue staining. When micromass cultures were
treated with 100 ng/ml BMP-2 a marked up-regulation of both
aggrecan and collagen type IIB expression was detected as
determined by RT-PCR analysis. The dual treatment with BMP-2
and TGF-b1 or BMP-2 and IGF-1 or BMP-2 individually caused
a three-fold induction of extracellular matrix in the micromass
cultures as detected by alcian blue staining. In contrast, treatment
with IGF-1, a reported chondropromoter factor, conferred a negative
effect on alcian blue staining and transcriptional activity of the
collagen type IIB and aggrecan genes. Combination of the growth
factor treatments mentioned above resulted in minimum changes in
growth of the C3H10T1/2 cultures.
Conclusions: The above results indicate that BMP-2 was more
effective than either TGF-b1 or IGF-1 in promoting chondrogenesis
of C3H10T1/2 cells and the increase in alcian blue staining induced
by TGF-b1 was not linked to aggrecan gene expression. Promotion
of chondrogenesis by TGF-b1 and BMP-2 was not due to
a signiﬁcant change in cellular growth.
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MATRIX TURNOVER IN FOCALLY DAMAGED HUMAN ANKLE
CARTILAGE: EVIDENCE FOR A GENERALIZED RESPONSE
AND ACTIVE MATRIX REMODELLING
M. Aurichyz, J. O. Andersz, R. A. Fuhrmannz, J. A. Mollenhaueryz,
K. E. Kuettnery, A. Reinerx, A. R. Poolex, A. A. Coley
y Department of Biochemistry, Rush Medical College, Chicago, IL,
USAz Department of Orthopedic Surgery, University of Jena, Waldk-
rankenhaus ‘‘Rudolf-Elle’’, Eisenberg, Germany
x Joint Diseases Laboratory, Shriners Hospitals for Children,
Departments of Surgery and Medicine, Montreal, QC, Canada
Aim: To examine the very early development of cartilage lesions in
vivo concerning collagen and proteoglycan turnover.
Methods: Full depth early cartilage lesions exhibiting only super-
ﬁcial ﬁbrillation from the talar dome of the ankle were isolated as
well as cartilage from sites adjacent to and remote from these
lesions. Cartilages were graded histologically using Mankin grading
system. For type II collagen, the tissue was processed for in situ
hybridization to detect mRNA of type IIB collagen (COL2A1B). The
C-propeptide (CPII), a measure of synthesis, the collagenase-
generated intrahelical cleavage neoepitope (COL2-3/4Cshort or
C1,2C) and the intrachain epitope (COL2-3/4m) which deﬁnes
denaturation of the triple helix were determined by immunohisto-
chemistry and immunoassays. To study proteoglycan metabolism,
assays were performed to detect total glycosaminoglycan (GAG)
content and the 846-epitope of aggrecan, a marker for turnover of
aggrecan.
Results: In early cartilage lesions we observed increased cleavage
of type II collagen, denaturation, expression and synthesis. These
increases in turnover were observed within the lesion as well as in
sites adjacent to and remote from these lesions. Proteoglycan
content was increased remote from the lesion (not within it) but 846
epitope was increased in the lesion and elsewhere in the joint. The
Mankin grade and DNA content were also elevated in the lesion site
and elsewhere as compared to the normal control.
Conclusions: The upregulation of matrix turnover in minor cartilage
lesions may indicate a physiologic response to an insult and an
attempt to repair the damaged matrix. The increased turnover at the
lesion site also occurred both adjacent to and remote from the
lesion, compared to normal cartilage. The data suggest a general-
ized response of the entire cartilage in the talar dome and may in
part relate to the low prevalence of osteoarthritis in the ankle joint.
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FRESHLY ISOLATED OSTEOARTHRITIC CHONDROCYTES
ARE CATABOLICALLY MORE ACTIVE THAN NORMAL CHON-
DROCYTES, BUT LESS RESPONSIVE TO CATABOLIC STIM-
ULATION WITH IL-1b
S. J. Soeder, Z. Fan, B. Bau, H. Yang, T. Aigner
Osteoarticular and Arthritis Research, Department of Pathology,
University of Erlangen-Nu¨rnberg, Erlangen, Germany
Aim of study: IL-1 is thought to be one of the most important
cytokines relevant not only to rheumatoid arthritis, but also to
osteoarthritic joint disease. The aim of this study was to investigate
whether there are different effects of low and high concentrations of
IL-1b on the expression level of anabolic and catabolic genes as
well as cytokines and whether there is any difference in reactivity of
normal and osteoarthritic chondrocytes.
Methods: Gene expression levels (collagen type II, aggrecan,
MMP-1, MMP-2, MMP-3, MMP-13, ADAMTS-4, IL-1b, IL-6, LIF)
were detected by real-time PCR in (non-passaged) primary human
articular chondrocytes (normal (nZ 6); osteoarthritic (nZ 7)) after
stimulation with 0.01 ng, 0.1 ng, 1 ng and 10 ng/ml IL-1b in high-
density short-term monolayer cultures.
Results: Primary adult articular chondrocytes showed a moderate
expression of collagen type II and aggrecan. They expressed very
abundantly MMP-3 and only to a minor extent MMP-1, -2, -13 and
hardly any ADAMTS-4. Il-1b, IL-6 and LIF were basically not
expressed at all.
In normal adult articular chondrocytes the expression of aggrecan
and collagen type II genes were both signiﬁcantly down-regulated
by IL-1b. In contrast, matrix degrading proteases – except MMP-2 –
as well as the investigated cytokines II-1b, II-6, and LIF were
induced by IL-1b dose-dependently. The strongest regulation was
found for IL-6 and LIF.
S107Osteoarthritic chondrocytes, showed strongly increased basal
levels of catabolic enzymes and mediators investigated, but
appeared to be less responsive to further stimulation with IL-1b.
The responsiveness of chondrocytes to IL-1b was not age-related
in our samples for any of the genes tested neither in normal nor in
osteoarthritic chondrocytes.
Conclusion: Our study conﬁrms that IL-1b activity is critically
dependent on the applied concentration and the reactivity of the
cells stimulated. The responsiveness appears to be signiﬁcantly
reduced in late stage osteoarthritic chondrocytes. However, these
cells appear to show high levels of basic stimulation at least as far
as catabolic enzymes and mediators are concerned. From our
study, it remains open whether this indicates that osteoarthritic
chondrocytes are hardly inﬂuenced by IL-1 or are already so
strongly stimulated during the disease process that they are
refractory to further stimulation with IL-1b.
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A CRH FAMILY PEPTIDE PROTECTS A HUMAN CHONDRO-
CYTE CELL LINE AGAINST APOPTOSIS
N. Y. Intekhab-Alamy, H. S. Chowdreyy, R. A. Knightz, I. C. Lockey
y School of Biosciences, University of Westminster, London, United
Kingdom
z Department of Cystic Fibrosis, Imperial College London, London,
United Kingdom
Chondrocyte apoptotic death has been implicated in the patho-
genesis of osteoarthritis (OA). Recent reports have demonstrated
increased levels in OA cartilage of the pro-apoptotic stimuli Nitric
Oxide (NO) and TNF-a and these stimuli may contribute to
accelerated damage of articular tissue and to ampliﬁcation of the
inﬂammatory response.
C-20/A4 cells treated with SNAP (NO donor) and TNF-a demon-
strated a dose dependent increase in apoptosis as assessed by
Fig. 1. Quantiﬁcative TAQMAN-analysis for mRNA expression
levels of MMP-13 in normal articular chondrocytes with and without
stimulation with IL-1b (a) as well as the ratios of stimulation/control
(b) of 6 (normal) and 7 (osteoarthri t ic) independent
experiments each. Signiﬁcance levels vs control: *P ! 0.05;
**P ! 0.01; ***P ! 0.001.both TUNEL and Annexin V/PI assays and little necrosis indicated
by low LDH release. The application of a-helical CRH (108 M)
alone and in the presence of SNAP and TNF-a resulted in a high
level of apoptosis. Endogenous Urocortin (UCN) expression was
established by RT-PCR and the addition of an anti-UCN antibody
resulted in an increased level of apoptosis, higher than that seen
with a-helical CRH treatment. Addition of an anti-albumin isotype
control antibody did not result in this high level of apoptosis. With
the application of exogenous UCN (108 M) apoptotic levels
decreased signiﬁcantly in SNAP treated cells, but not in TNF-a
treated cells suggesting a different mechanism may be involved in
the pro-apoptotic properties of these two stimuli.
In conclusion, endogenous expression of UCN in human chon-
drocytes has been demonstrated and the existence of a CRH
peptide mediated protective mechanism against apoptotic cell
death has been established. It is postulated therefore that UCN
may be acting as a protective agent in these cells.
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CYCLICAL MECHANICAL STIMULATION (CMS) DECREASES
INDUCIBLE NITRIC OXIDE SYNTHASE (INOS) LEVELS
THROUGH A b1-INTEGRIN INDEPENDENT PATHWAY IN
PRIMARY OSTEOARTHRITIC (OA) HUMAN ARTICULAR
CHONDROCYTES (HAC)
J. E. Johnstony, S. J. Millward-Sadlery, N. Boughton-Smithz,
D. M. Saltery, G. Nukiy
y Osteoarticular Research Group, University of Edinburgh Medical
School, Edinburgh, Scotland, United Kingdom
z Research and Development, Astrazeneca, Charnwood, Lough-
borough, Leicestershire, United Kingdom
Aim: CMS has been shown to inﬂuence IL-1 mediated NO
production in cartilage explants and isolated chondrocytes. Experi-
ments have been undertaken to try to elucidate how CMS
modulates cytokine stimulated iNOS and NO production in OA
HAC.
Methods: Primary HAC isolated from OA articular cartilage were
cultured in monolayer. Conﬂuent cultures were stimulated with
a pro-inﬂammatory cytokine cocktail (IL-1b 0.5 ng/ml, TNFa 5
ng/ml, IL-6 1 ng/ml, IFNg 10 ng/ml) or IL-1b (0.5 ng/ml) and
subjected to CMS (0.33 Hz and 30,000 mstrain) for 4 and 12 h.
iNOS mRNA was measured by Taqman Real Time PCR, iNOS
protein by Western Blotting and nitrite release into the medium with
a Griess Assay. Cells were pre-incubated with a b1-integrin
blocking antibody and an IL-4 neutralizing antibody.
Results: IL-1b and the cytokine cocktail induced signiﬁcantly
increased iNOS mRNA, protein and nitrite levels in the OA HAC.
CMS partially inhibited this response in the cytokine cocktail
stimulated OA HAC, with 7-fold, 4-fold and 2-fold decreases in the
levels of mRNA, protein and nitrite detected, respectively. This was
not inﬂuenced by the b1-integrin blocking and IL-4 neutralizing
antibodies. Similar results were seen in the IL-1b stimulated OA
HAC.
Conclusions: We have previously shown that CMS is associated
with a5b1 integrin and IL-4 dependent increases in aggrecan
mRNA and relative decreases in MMP3 mRNA in normal but not
OA HAC. The current studies have demonstrated IL-1 and pro-
inﬂammatory cytokine mediated stimulation of iNOS mRNA, protein
and nitrite production in OA HAC can be inhibited by CMS through
a b1-integrin independent and IL-4 independent mechanotrans-
duction pathway.
P266
EXTRACELLULAR COLLAGEN HYDROLYSATE MODULATES
THE METABOLISM OF CHONDROCYTES
S. Oessery, J. Seifertz
y CRI, Collagen Research Institute, Germany
z Surgical Research University of Kiel, Kiel, Germany
S108In recent years, a variety of substances have been identiﬁed to
inﬂuence chondrocyte metabolism and thus alter matrix turnover.
The objective of this study was to investigate the effect of
hydrolyzed collagen fragments on the biosynthesis of articular
cartilage cells.
Methods: For the investigation, a primary cell culture model of
porcine chondrocytes and a cartilage explant model, respectively,
were used. Mature porcine chondrocytes were isolated from
articular cartilage and cultured under oxygen reduction. Collagen
hydrolysate (CH) with a mean MW of 3.3 kDa was obtained by
enzymatic degradation of type I collagen. The collagen fragments
were added to the culture medium of the isolated chondrocytes and
the cartilage explants. At the end of the culture period, type II
collagen biosynthesis was quantiﬁed by means of ELISA tech-
nique. The results were conﬁrmed by immunocytochemical
detection of type II collagen and by analyzing the incorporation of
14C-proline into matrix proteins. Moreover, pericellular proteogly-
cans were determined by colorimetric assay and immunoassay,
respectively. In additional experiments, protease activity in the
culture media was evaluated.
Results: The presence of extracellular CH led to a signiﬁcant
(P ! 0.01), dose-dependent increase of type II collagen bio-
synthesis in chondrocytes. After the supplementation of the culture
medium with 0.5 mg CH/ml, the determined amount of type II
collagen was almost doubled compared to the untreated cells.
Native collagen and collagen-free hydrolysate failed to stimulate the
production of type II collagen in chondrocytes. The amount of
pericellular proteoglycans was also signiﬁcantly (P ! 0.05)
increased after CH treatment. In contrast, the presence of CH had
no signiﬁcant effect on the protease activity of cartilage cells.
Conclusion: These results clearly indicate a stimulatory effect of CH
on type II collagen biosynthesis of chondrocytes. Moreover, the
cells seem to synthesize enhanced amounts of a complete
extracellular matrix after CH treatment, whereas protease activity
of the cartilage cells was not affected by extracellular CH.
Based on these data, we have provided evidence that collagen
fragments may be involved in the regulation of cartilage tissue
turnover.
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THE MEVALONATE PATHWAY PLAYS A CRITICAL ROLE
IN VITRO IN THE BIOLOGY OF THE CHONDROSARCOMA
CELL LINES LTC AND C422
A. Arı´n-Martı´nez, O. Herna´ndez-Perera, N. E. Cabrera-Benı´tez,
R. G. Dı´az-Pen˜ate, I. Cabrera-De´niz, R. Pe´rez-Machı´n, J. M.
Garcı´a-Castellano
Laboratory of Molecular Oncology, Research Unit, Hospital Dr.
Negrı´n, and Canary Institute for Cancer Resarch (ICIC), Servicio
Canario de Salud, Las Palmas, Las Palmas de G.C., Spain
Aim of study: Statins are lipid-lowering agents, with pleiotropic
effects on the mevalonate pathway, the products of which are vital
for a variety of key cellular functions affecting membrane integrity,
cell signaling, protein synthesis, and cell cycle progression. These
drugs have been tested as anti-inﬂammatory agents in different
models. However, there are no sufﬁcient evidences of its basic
mechanism in chondrocytes. The aim of this study is to evaluate in
vitro the role of statins in chondrocytes cell biology.
Methods: Rat chondrosarcoma cell lines (LTC and C422, a kindly
gift of Dr John Kimura and Dr Jeff Stevens) were grown under
conventional conditions. The following parameters were studied
after administration of simvastatin at different doses (vehicle, 0.1,
0.3, 1.0, 3.0 and 10 mM) and during different times (24, 48 and 72
h): cell growth rate by cell counting; cell viability by Trypan blue cell
exclusion assay and by MTT; morphologic changes; apoptotic
response studied by DAPI, ﬂow cytometry with propidium iodide/
annexine V and by DNA laddering; cell cycle alterations were
analyzed by ﬂow cytometry with propidium iodide; and cell motility
was studied by cell wound assay. Data was presented as meanC
S.E.M. of at least three different experiments. A rejection level of P!
0.05 will be considered signiﬁcant.Results: It was observed that statins induced: (1) cell rounding and
decreased ability of cell adhesion to the substrate; (2) decreased
cell viability, assessed by MTT assay, with IC50 between 1 and 2
mM; (3) induction of time- and dose-dependent cell apoptosis; (4)
cell growth arrest in G1 and G2/M phases with decreased S phase;
and, (4) alteration of cell motility.
Conclusions: The present work studied the effect of interruption of
the mevalonate pathway on cell viability, cell cycle, apoptosis, and
cell migration in a model of immortalized chondrocytes. In the best
of our knowledge, this is the ﬁrst reference about the effect of
statins on cartilage. Further studies are necessary to study how
statins can affect normal cartilage biology or under degenerative
processes. At present we are evaluating the in vitro and in vivo
effects of these drugs in normal and osteoarthritic cells.
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GLUTAMINE PROTECTS CHONDROCYTES FROM HEAT
STRESS AND NO-INDUCED INJURY
H. Tonomura, K. A. Takahashi, R. Terauchi, Y. Arai, A. Inoue,
S. Ohashi, T. Morihara, T. Kubo
Department of Orthopaedics, Graduate School of Medical Science,
Kyoto Prefectural University of Medicine, Kyoto, Japan
Aim of this study: To investigate the efﬁcacy of glutamine (Gln) in
protecting chondrocytes against heat stress and NO-induced injury.
Methods: Primary chondrocytes cultures were established from
rabbit joints. The cells were pretreated with Gln-10 mM containing
medium for 12 h. In control experiment, the cells were pretreated
with Gln-free medium. Heat stress (45(C) was applied to the cells
for 2 h using circulatory hot water bath. At 24 h after heat stress
loading, cell viability was estimated by cell count reagent SF. Cells
were also injured using sodium nitroprusside (SNP) dihydrate that
generates nitric oxide (NO). At 12 h after adding 0.5 mmol/l of SNP,
cell viability was estimated by lactate dehydrogenase (LDH) assay.
Results: Absorbance levels at 45(C were 1301.2 G 79.5 in the
controls while 1685.6 G 21.8 in the Gln-treated cells and there is
a signiﬁcant difference (P ! 0.05). With 37(C treatment, no
signiﬁcant difference was observed. The release of LDH from
chondrocytes after NO-induced injury in the Gln-treated cells
(22.0 G 0.6) was signiﬁcantly lower than in the controls (91.0
G 14.4) (P ! 0.05). These data indicated Gln-treated cells aquire
resistancy to both heat stress and NO-induced injury.
Conclusion: Osteoarthritis (OA) is associated with degeneration of
articular cartilage. Various biologic and chemical stress factors are
thought to be involved in the occurrence and progression of OA,
including heat stress and reactive oxygen species (ROS) such as
NO. Previously we showed that heat shock protein 70 (HSP70)
expression increases along with the severity of OA and that HSP70
protects chondrocytes from heat stress and apoptosis induced by
NO. Gln, a nonessential amino acid, has been reported to enhance
HSP 70 expression under the stressed conditions in some organs
and to have therapeutic effect on oyher diseases. Gln may confer
protection against stress in chondrocytes through HSP 70 in-
duction. Although Gln has not been applied to the ﬁeld of joint
disease, present data showed the possibility to use Gln as
a therapeutic agent for OA therapy.
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FURANIC AVOCADO/SOYBEAN UNSAPONIFIABLES PRE-
VENT OSTEOARTHRITIC SUBCHONDRAL OSTEOBLASTS-
INDUCED CARTILAGE DEGRADATION
C. Sanchezy, M. A. Debergy, N. Piccardiz, P. Msikaz, J. Y. L.
Reginstery, Y. E. Henrotiny
y Bone and Cartilage Research Unit, Univeristy of Liege, Liege,
Belgium
z Research and Development, Expanscience Laboratories, Cour-
bevoie, France
S109Aim of study: To determine the effects of furanic avocado/soybean
unsaponiﬁables (FASU) on osteoarthritic osteoblasts-induced
chondrocyte metabolism dysregulation.
Methods: Human chondrocytes were isolated from OA cartilage
and cultured in alginate beads for 4 days in the absence or in the
presence of OA subchondral osteoblasts in monolayer (co-culture
system). Before co-culture, OA osteoblasts were incubated or not
with 10 mg/ml FASU for 72 h. Aggrecan (AGG), type II collagen
(COL2), matrix metalloproteases (MMP) -3 and -13 mRNA levels in
chondrocytes were quantiﬁed by real time polymerase chain
reaction. Aggrecan production was assayed by a speciﬁc enzyme
ampliﬁed sensitivity immunoassay (EASIA).
Results: OA osteoblasts induced a signiﬁcant inhibition of AGG
production (27%, P ! 0.001) and AGG (36%, P ! 0.001) and
COL2 (78%, P ! 0.001) gene expression but signiﬁcantly
increased MMP-3 and MMP-13 gene expression by chondrocytes
in alginate beads (1.65 and 2 times, respectively, P! 0.001). Pre-
treatment of OA osteoblasts with FASU fully prevented the
inhibitory effects of OA osteoblasts on AGG production (P !
0.01), and increased by 2-fold the COL2 expression by chondro-
cytes (P ! 0.001). The treatment of OA osteoblasts with ASU did
not modify the expression of MMPs by chondrocytes.
Conclusions: These results demonstrate that OA subchondral
osteoblasts could contribute to cartilage degradation by stimulating
chondrocytes to produce more matrix metalloproteases and by
inhibiting their production of AGG. FASU prevent osteoblasts-
induced matrix molecules inhibition, suggesting a new mechanism
of action for this drug.
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VOLTAGE-GATED POTASSIUM CURRENTS OF HORSE AND
ELEPHANT CHONDROCYTES
R. Barrett-Jolleyy, M. D. Womacky, P. D. Cleggz, A. Mobasheriy
y Department of Veterinary Preclinical Sciences, Faculty of
Veterinary Science, University of Liverpool, Liverpool, Merseyside,
United Kingdom
z Department of Veterinary Clinical Science, Faculty of Veterinary
Science, University of Liverpool, Neston, Cheshire, United
Kingdom
Aim of study: The importance of chondrocyte ion channels is
becoming increasingly apparent. Many electrophysiological studies
of these proteins have, however, been conducted on tertiary cultures
of chondrocytes from small mammals. An interesting recent paper,
however, examined the properties of delayed rectiﬁer potassium
channels in freshly dissociated canine chondrocytes. In this study,
we compare the steady-state activation properties of delayed rectiﬁer
potassium channels in freshly dissociated chondrocytes, taken from
the healthy joints of horses and elephants to those of dogs.
Methods: Equine cartilage was routinely obtained from a local
abattoir. Elephant cartilage was obtained from two female
elephants that were euthanased for unrelated clinical reasons.
Cartilage shavings were rinsed with phosphate-buffered saline
(PBS), cut into small slices and incubated overnight with type I
collagenase (EC 3.4.24.3 from Clostridium histolyticum) (approxi-
mately 100 collagen digestion units mL1) in Dulbecco’s modiﬁed
Eagles medium (DMEM) supplemented with 1000 mg L1 glucose,
10% fetal calf serum and 1% antibiotic/antimycotic solution. The
ﬁltered cell suspension was washed three times in fresh DMEM and
the cells were grown in monolayer culture with 4% fetal calf serum
for no more than three passages. Electrophysiological studies were
carried out using freshly isolated, ﬁrst and second passage cells.
Chondrocytes were transferred to a recording chamber and
superfused with the following bath solution [mM] NaC 150, KC 2,
Mg2C 1.4, HCO3
 26, glucose 10, KH2PO4 1.2, 5%CO2/95% O2.
Patch pipettes were fabricated from Clark GC150F capillary glass
and had resistances of 5 MU when ﬁlled (pipette solution [mM]: KC
150, Mg2C 1.4, Cl 142.8, EGTA 5, HEPES 10, pH 7.2).
Results: Maximum conductance of horse chondrocytes (0.13 G
0.03pS/pF) was very similar to that of the dog (0.12 pS/pF,
calculated from Wilson et al., 2004), whereas that of elephantchondrocytes was somewhat larger (0.8G 0.4 pS/pF). Conversely,
steady-state activation parameters of elephant chondrocytes (V1/2
26.6 G 6.7 mV, k 13.6 G 3.18 mV, n Z 4) were more similar to
that of the dog (V1/2 25 mV, k 6.3 mV) than those of horse
chondrocytes (V1/2 0.6 G 6.0 mV, k 16.3 G 1.9 mV, n Z 4).
Conclusions: Kv currents from equine and elephant chondrocytes
appear broadly similar to those of dogs both in terms of their size
and steady-state activation parameters. Molecular techniques will
be required to determine if the potassium channel proteins are
identical across these species.
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REGULATION OF CARTILAGE OLIGOMERIC MATRIX PRO-
TEIN EXPRESSION IN HUMAN ARTICULAR CHONDROCYTES
IN VITRO
T. Matsumoto, M. Osaki, C. Miyamoto, K. Sakimura, H. Shindo
Orthopaedic Surgery, Nagasaki University, School of Medicine,
Nagasaki, Nagasaki, Japan
Cartilage oligomeric matrix protein (COMP) is an abundant non-
collagenous component of articular cartilage, and being used as
a marker of cartilage metabolism.
Aims: To know the regulation of COMP synthesis by several factors
known to be related to cartilage metabolism.
Methods: Normal adult human articular chondrocytes (purchased
from CAMBREX) were cultured with or without 10–1000 ng/ml
insulin-like growth factor (IGF)-I, 0.1–10 ng/ml transforming growth
factor (TGF)-beta1, 1! 108–1! 106 M dexamethasone or 0.1–
10 ng/ml interleukin (IL)-1beta for 24 to 48 h. After extraction of total
RNA, the expression of COMP mRNA was quantiﬁed by real-time
polymerase chain reaction (PCR). The concentration of COMP in
culture medium was also measured by ELISA.
Results: The expression of COMP mRNA was stimulated by TGF-
beta1, but not by IGF-I, dexamethasone or IL-1 beta. Further, the
stimulatory actions of TGF-beta1 were almost completely blocked
by IL-1beta. TGF-beta1 also increased the concentration of COMP
in a dose dependent manner, however, neither IGF-I, dexameth-
asone, nor IL-I beta increased them.
Conclusion: TGF-beta1 is a potent inducer of COMP in articular
chondrocytes, and which is in part regulated by IL-I beta.
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EFFECTS OF RADIAL SHOCK WAVES ON EQUINE CARTI-
LAGE EXPLANT MORPHOLOGY, CHONDROCYTE MEM-
BRANE PERMEABILITY, AND CHONDROCYTE VIABILITY
C. R. Byron, B. M. Benson, A. A. Stewart
Veterinary Clinical Medicine, University of Illinois, Urbana, IL, USA
Aim of study: To investigate potential effects of radial shock waves
on chondrocyte membrane permeability, chondrocyte viability, and
articular cartilage morphology in equine cartilage explants in vitro.
Methods: Equine cartilage explants were subjected to radial shock
waves. Treatment groups consisted of a negative control, 500,
2000, and 4000 pulses with the Radial ESWT handpiece (convex
applicator head), and 500, 2000, and 4000 pulses with the FOCUS
ESWT handpiece (concave applicator head). Treated explants
were cultured for 48 h. Effects on explant structure were evaluated
via environmental scanning electron microscopy. Plasma mem-
brane viability was determined by lactate dehydrogenase release
into the culture medium. Chondrocyte viability was assessed via
vital cell staining with calcein-AM and EthD-1 and confocal laser
scanning electron microscopy imaging with computer image
analysis. Comparisons of lactate dehydrogenase activity levels
were performed with two-way ANOVA and comparisons of
nonviable cell percentages were performed with Kruskal–Wallis
ANOVA. A P value !0.05 was considered signiﬁcant.
Results: Cell membrane permeabilization increased signiﬁcantly at
the 2000 and 4000 pulse levels with both the Radial and the
S110FOCUS handpieces. A statistically signiﬁcant decrease in cell
viability was observed for the 4000 pulse Radial handpiece group.
There was no detectable damage to cartilage explant morphology
in any treatment group as evaluated by environmental scanning
electron microscopy.
Conclusions: Radial shock waves do not damage the morphology
of equine articular cartilage explants, but do increase chondrocyte
permeability and decrease chondrocyte viability. Caution should be
exercised when using radial shock wave therapy at high
periarticular pulse doses until further studies can further deﬁne
the impact on chondrocytes and the cartilage matrix.
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LIMB POSITION SENSE ERROR IN A DYNAMIC LIMB-LOAD-
ING TASK
D. Brown, V. Cohen, A. Fong, S. Luu, A. Chang, L. Sharma
Rheumatology, Northwestern University, Chicago, IL, USA
Proprioceptive signals that originate from the lower limbdvia joint
loading, muscle stretch, and cutaneous inputdare important for
locomotor control because they trigger onset and offset of muscle
activity during different phases of the locomotor cycle. Limb position
sense is assessed to determine the degree to which proprioceptive
signals from the limbs can be accessed by the brain. However,
position sense in studies of OA has typically been assessed in
a single joint during non-functional movements. Therefore, we
developed a new approach to assess limb position sense during
a locomotor pedaling task that allows different levels of limb-
loading. The purpose of this study was to examine the effect of
dynamic limb-loading on limb position sense error (LPSE) in
persons with and without knee OA.
Eight persons with knee OA (K/L R 2) and 13 persons of
comparable age without knee symptoms, knee injury, any arthritis
or musculoskeletal problemwere studied. Subjects pedaled a bicycle
ergometer while leaning against a sliding backboard and a motor
moved the crank at a constant rate of 20 rpm. LPS was evaluated in
an unloaded (seated) and limb-loaded condition at 50%, 75%, and
100% of maximal tolerated load. Absolute mean LPSE was
measured using the difference between the targeted position and
the subject’s verbally recorded response of perceived leg position
during the task. The change in LPSE with load was also examined,
i.e., the difference between the limb-loaded absolute LPSE and
unloaded absolute LPSE. Reliability for LPSE measurement was
high [ICC (1,1) 0.85–0.99 for persons with and without OA].
Absolute LPSE in those with OA was higher than in the control
group (33.4G 18.2 vs 21.9G 16.5(, P! 0.01). Also, variability in
error values was greater in the OA group (ratio of control to OA
variance 0.69). With greater load, the OA group had a greater
increase in LPSE than the control group (11.9 vs 0.8, P ! 0.01).
The normalized peak force production was greater in the OA than in
the control group (1.9 G 0.1 vs 1.7 G 0.1 peak force to average
force ratio, P ! 0.05), and these higher forces occurred at an
earlier point in the cycle compared with controls (127 vs 151( past
top dead center). High peak forces correlated with greater absolute
LPSE, R Z 0.70.
During a dynamic, locomotor task, individuals with knee OA had
worse proprioceptive acuity than similarly aged controls, and acuity
was made worse by the addition of body load. Such a deﬁcit may
impair load-attenuating muscle activity, leave the knee vulnerable
to injurious loading during locomotion, and contribute to disease
progression.
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MORPHOLOGICAL DIFFERENCES BETWEEN CHINESE AND
CAUCASIAN HIPS
Y. J. Kimy, Y. Zhangz, L. Xux, M. C. Nevittjj, N. E. Lanejj, M.
Doherty{, D. Felsonz
y Department of Orthopaedic Surgery, Children’s Hospital, Boston,
MA, USAz Boston University Medical Center, Boston, MA, USA
x Peking Union Medical College Hospital, Beijing, China
jj University of California, San Francisco, San Francisco, CA, USA
{ University of Nottingham, Nottingham, United Kingdom
Aim: Morphological differences may explain the markedly lower
prevalence of hip OA in Chinese compared to Caucasian.
Background: It has been postulated that acetabular deformity such
as acetabular dysplasia is a major cause of OA in women, while,
femoral abnormalities such as pistol grip deformity is a major cause
of OA in men. We compared the radiographic measurements of
acetabular and femoral morphology in these two populations with
markedly different rates of OA.
Methods: Fifty pelvic radiographs from older men without OA were
selected from a population based British Study, similar Caucasian
female radiographs were obtained from the Study of Osteoporotic
Fractures (SOF). Comparable radiographs of unaffected male and
female hips in the Beijing Osteoarthritis Study (BOA) were selected.
These were intermingled and read by a single reader (YJK) using
a standard protocol. The femoral head ratio (FHR) of Murray
(assesses pistol grip deformity), and two measures of acetabular
dysplasia, the center-edge angle (CE) of Wiberg and acetabular
slope of To¨nnis were measured. Additionally, the presence of
acetabular retroversion was noted when the cross-over sign was
present. We compared the mean of CE angle, acetabular slope,
and FHR using Student’s t test and tested the equality of variances
of each measurement with F test. The proportion of cross-over sign
was tested using chi-square test between two racial groups.
Results: The intraobserver reliability was high for all measurements
(ICC’s from 0.84–0.97). The mean femoral head ratio was modestly
increased in the Caucasian males (1.10) compared to the Chinese
(1.04) (P Z 0.07), suggesting possible increase in pistol grip
deformity in the Caucasian male group. Additionally, the proportion
of retroverted acetabulum in the Caucasians (28%) is also higher
than that in Chinese males (13%) (P Z 0.01). The CE angle was
smaller in the Chinese female (P ! 0.001) but the variance was
borderline increased (P Z 0.06). Both mean and variance of the
acetabular slope in the females were signiﬁcantly different (P !
0.001). Additionally, the Caucasian females had a signiﬁcantly
more acetabular retroversion than Chinese (P ! 0.05).
Conclusions: Subtle morphologic abnormalities of the hip joint have
been postulated to cause osteoarthritis. We found that Caucasian
male hips may have more femoral head deformity and acetabular
retroversion. While the Caucasian female hips have increased
variability in their acetabular morphology.
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RAPID RADIOGRAPHIC PROGRESSION OF KNEE OSTEOAR-
THRITIS IS ACCOMPANIED BY AN INCREASE IN SYMPTOMS
S. A. Mazzuca, K. D. Brandt, B. P. Katz, K. A. Lane
Department of Medicine, Indiana University School of Medicine,
Indianapolis, IN, USA
It has been suggested that radiographic progression of knee
osteoarthritis (OA) is unrelated to progression of symptoms.
However, previous studies that have failed to show a signiﬁcant
association between radiographic and symptomatic progression
Summary of data
CE angle Slope Retroversion FHR
Caucasian
female
26.6 G 6.5 3.4 G 4.7 16% 0.91 G 0.29
Chinese
female
23.0 G 5.4 6.0 G 3.7 6% 0.89 G 0.24
Caucasian
male
31.6 G 5.2 3.6 G 3.7 28% 1.10 G 0.22
Chinese
male
31.1 G 4.7 3.8 G 3.9 13% 1.04 G 0.22
S111also suffer limitations with respect to their cross-sectional design
and the limited capacity of conventional radiographic methods to
detect joint space narrowing (JSN), the surrogate for loss of articular
cartilage. The present study compares rapid radiographic pro-
gressors with non-progressors, based on highly standardized X-ray
examinations, with respect to concurrent clinical indicators of OA.
Methods: Subjects were 113 obese 45–64 year old women with
unilateral knee OA who were assigned to the placebo group of
a randomized controlled trial of a disease-modifying OA drug. Fifty-
seven exhibited rapid progression of JSN (i.e., mean JSN Z 1.18
mm or 0.47 mm/yr) in ﬂuoroscopically standardized semiﬂexed
anteroposterior radiographs obtained 30 months apart; in the
remaining subjects (N Z 56), mean JSN was 0.006 mm over 30
months. A clinical assessment of OA severity [WOMAC OA Index
(Likert scales), visual analog scale (VAS) of pain after a 50-ft walk,
and semiquantitative 5-pt global assessments (patient and physi-
cian)] were obtained every 6 months. General health status (SF-36)
was measured every 4 months. Group comparisons were
performed with Student’s t test and Wilcoxon two-sample test, as
appropriate.
Results: Rapid progressors and non-progressors did not differ at
baseline with respect to age, body mass index (BMI), VAS pain or
WOMAC function scores. The mean of WOMAC Pain scale was
marginally higher at baseline among progressors than non-
progressors (11.5 G 4.9 vs 10.0 G 3.6, possible range: 5–25,
P Z 0.06). Progressors were no more likely to have experienced
weight gain during the study than non-progressors. Nor did they
differ from non-progressors with respect to changes in mean pain,
disability and SF-36 scores over 30 months. However, the mean
percentage (GSD) of follow-up pain assessments (maxZ 100% of
5 assessments) during which subjects reported an increase
R20% in 50-ft walk pain relative to that reported 6 months earlier
(with minimum VAS increase Z 1 cm) was 42% greater among
progressors than non-progressors (27.7 G 22.7 vs 19.5 G 20.7,
P Z 0.048). In addition, increases in global disease activity were
more frequent among progressors than non-progressors, whether
rated by the patient or the physician (P Z 0.046 and P Z 0.022,
respectively).
Conclusions: These data may have limited generalizability, due to
the homogeneity of the sample with respect to sex and obesity.
Nonetheless, subjects undergoing rapid JSN reported clinically
important increases in walk pain more frequently than non-
progressors. Radiographic progressors also were distinguishable
from non-progressors on the basis of changes in global assess-
ment of disease activity.
Supported by NIH AR43348, AR48870 and AR20582; OA-
Doxycycline Study Group: J. D. Bradley, S. T. Hugenberg,
L. Heck, S. Manzi, L.W. Moreland, C. V. Oddis, L. Sharma, T. J.
Schnitzer, F. Wolfe, D. E. Yocum.
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CARTILAGE THICKNESSES OF THE LOWER LIMB JOINTS OF
AN INDIVIDUAL ARE CORRELATED. ‘‘INDIVIDUAL CARTI-
LAGE THICKNESS’’, A NEW CONCEPT?
T. Armingeaty, T. Phamy, P. Champsaurz, P. Lafforguey
y Department of Rheumatology, Hoˆpital la Conception, Marseille,
France
z Laboratory of Anatomy, Faculte´ de Me´decine de Marseille,
Marseille, France
Aim of study: To look for a correlation between the cartilage
thicknesses of the various joints of individuals.
Background: Cartilage thickness has been widely studied in various
human joints, especially hip and knee joints. For a given joint, there
is a high inter-individual variability in cartilage thickness. However,
there is few or no information whether the cartilage thicknesses of
various joints are correlated within an individual, i.e., whether
persons may have globally thick or thin cartilages.
Material and methods: Cartilage thickness of the six major lower
limbs joints (hips, knees, ankles) was measured in human
cadavers. Only healthy cartilage (i.e., with a macroscopic normal
appearance) was analyzed. Measurements were performed bya single observer using a 1/10( mm scale magniﬁer in osteochon-
dral biopsies taken at deﬁnite sites in each joint (98 biopsies per
subject). Correlation between the cartilage thicknesses of various
joints (hip vs knee for example) was assessed using linear
regression. In a second approach, the individual cartilage thick-
nesses were compared to a ‘‘standard individual’’ (deﬁned as
means of the cartilage thicknesses of each of the 98 biopsied sites)
using a Fisher’s test. Finally, the inﬂuence of sex, age and height
was checked with a Bonferroni test.
Results: Sixteen cadavers (9 females, 7 males, mean age 83
years) were analyzed, corresponding to 1568 biopsies. As pre-
viously known, cartilage was thicker at the tibiofemoral joint (2.1G
0.5 mm) followed by hip (1.5G 0.3 mm) and ankle (1.2G 0.3 mm).
A strong correlation was found between the cartilage thicknesses of
different joints of a single individual (P ! 0.001). The comparison
with the ‘‘standard individual’’ also conﬁrmed a signiﬁcant differ-
ence between subjects (P ! 0.001), which persisted after
adjustment for the demographic variables (P ! 0.001).
Conclusion: This study shows that there is a strong correlation
between the cartilage thicknesses of various lower limbs joints of an
individual. It supports the concept of an ‘‘individual cartilage thick-
ness’’, with subjects having more or less thick/thin cartilage as
awhole. The determinants of this individual cartilage thickness are to
establish.
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A PALEOPATHOLOGIC STUDY OF ARTICULAR SURFACE
PITTING
L. Shepstoney, P. A. Dieppez
y School of Medicine, Health Policy and Practice, University of East
Anglia, Norwich, United Kingdom
z Social Medicine, University of Bristol, Bristol, United Kingdom
Aim: To investigate the prevalence and pattern of articular surface
pitting in a skeletal collection and to examine its relationship with
eburnation.
Methods: Data for this study came from the ‘Barton-on-Humber’
skeletal collection, a large collection of human skeletal remains
excavated from a single site in England. Skeletal material lends
itself well to the study of OA and this collection has been used
previously for this purpose. A total of 563 skeletons were used, on
the basis of bones available, in this study. Pitting and eburnation
(indicating full-thickness cartilage loss) of the articular surfaces
were recorded as either present or absent by a single experienced
paleopathologist. The joint groups of interest were the shoulder,
elbow, wrist, hand, hip, knee, ankle and foot. Not all joint surfaces
were available for examination in all skeletons. The prevalence of
pitting within each joint group (left and right combined) was
calculated with 95% conﬁdence intervals. Odds ratios were
calculated to quantify associations between joint groups and
between pitting and eburnation within joints. McNemar’s test was
used to test for a difference between the prevalence of lone pitting
and the prevalence of lone eburnation within joint groups.
Results: The prevalence of pitting differed across joints. The most
commonly affected joint was the hip and the least commonly
affected the ankle.
There were strong and statistically signiﬁcant associations between
pitting at different joints (ORs typically O4.0). Within joint groups,
Table I
Prevalence of surface pitting for different joint groups
Joint group Positive/Present Prevalence (%) 95% C.I.
Shoulder 5/375 1.3 0.4–3.1%
Elbow 13/532 2.4 1.3–4.1%
Wrist 6/514 1.2 0.4–2.5%
Hand 11/501 2.2 1.1–3.9%
Hip 37/513 7.2 5.1–9.8%
Knee 18/536 3.3 2.0–5.3%
Ankle 1/478 0.2 !0.1–1.2%
Foot 24/429 5.6 3.6–8.2%
S112there were again strong and signiﬁcant associations between the
presence of pitting and eburnation (ORs typically O10). An
analysis of discordant pairs highlighted differences across joints.
In the hip, for example, pitting was more likely to occur without
eburnation than eburnation without pitting. In the hand the converse
was true and in the knee the two were equally likely.
Conclusions: Overall, pitting of articular surfaces appears as
common as, and strongly associated with, eburnation suggesting
that pitting is characteristic of osteoarthritis. Pitting rarely occurred
in the joints of the upper limb without eburnation (most strikingly the
hand) suggesting it is a relatively late phenomenon in those joints.
This was less the case in weight-bearing joints, particularly at the
hip where pitting was common without eburnation, indicating
a typical occurrence prior to full-thickness cartilage loss.
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RISK FACTORS IN FAMILIAL OSTEOARTHRITIS. THE GARP
SIBLING STUDY
N. Riyaziy, F. R. Rosendaalzx, E. Slagboomjj, F. C. Breedveldy,
M. Kloppenburgyz
y Rheumatology, Leiden University Medical Center, Leiden, Nether-
lands
z Clinical Epidemiology, Leiden University Medical Center, Leiden,
Netherlands
x Hematology, Leiden University Medical Center, Leiden, Nether-
lands
jj Molecular Epidemiology, Leiden University Medical Center,
Leiden, Netherlands
Aim: Osteoarthritis (OA) is a complex disease with a multicausal
etiology. We investigated whether environmental factors contribute
to OA susceptibility in patients with a familial predisposition for OA,
the GARP (Genetics, ARthrosis and Progression) study.
Methods: The GARP study consists of probands aged 40 to 70 and
their siblings with primary OA at multiple sites. The diagnosis of
knee, hip and spine OA was based on a combination of pain or
stiffness on most days of the last month and the presence of
osteophytes or joint space narrowing on X-ray. Hand OA was
deﬁned by the American College of Rheumatology criteria. The
controls consisted of 345 individuals recruited by random sampling
of the population by telephone, matched to the probands for age,
sex and geographical region. Data on demographics, anthropo-
metrics, metabolic disorders and hormonal risk factors were
collected by questionnaires. Odds ratios (OR) were adjusted for
sex, age and when appropriate for additional confounders and 95%
conﬁdence intervals were computed using robust standard errors
that take into account the intra-family effect.
Results: The 191 affected sibpairs (n Z 382) consisted of 82% of
women with a mean age of 60 years (43–79). OA was present in
the spine (80%), hands (72%), knees (34%) and hips (24%). The
controls consisted of 64% of women with a mean age of 57 years
(40–76). A higher risk of OA was observed with increasing body
mass index (BMI) (kg/m2): BMI 25–30, OR: 1.8 (1.3–2.6) and BMI
O30, OR: 2.0 (CI95 1.3–3.2) in reference to BMI of !25. In
reference to a height of!160 cm, the risk of OA decreased with an
Table II
Relationships within joint groups with eburnation
Joint
group
Pitting positive/
Eburnation
negative
Pitting negative/
Eburnation
positive
Ratio McNemar’s
test
Shoulder 3 5 0.6 P = 0.480
Elbow 5 15 0.3 P = 0.025
Wrist 2 16 0.1 P = 0.001
Hand 5 47 0.1 P ! 0.001
Hip 28 4 7.3 P ! 0.001
Knee 12 17 0.7 P = 0.353
Ankle 0 0 – –
Foot 13 14 0.9 P = 0.847increase in height: 160–170 cm, OR: 0.51 (CI95 0.3–0.9), 170–180
cm, OR Z 0.47 (CI95 0.2–0.9) and O180 cm, OR Z 0.33 (0.1–
0.8). Physically demanding jobs were associated with an increased
risk of OA in men, OR Z 2.6 (CI95 1.3–5.3). OA was associated
with a married status, ORZ 2.1 (CI95 1.3–3.4) and was unrelated
to years of formal education or smoking. Metabolic disorders such
as diabetes mellitus, hypertension, hyper/hypothyreoiditis and
hypercholesterolemia were not associated with OA. In women
hormonal factors were associated with OA. An early natural
menopause before the age of 45 years, was associated with the
risk of familial OA in relation to the reference category 45–52 years,
ORZ 3.1 (1.6–6.3). In addition, a history of ovariectomy, ORZ 1.9
(CI95 1.0–3.6) and a short duration of fertile years calculated as
age at natural menopause  age at menarche (!30 years),
showed a trend of an association with OA, ORZ 1.9 (CI95 0.9–3.9)
in reference to 30–40 fertile years. Use of hormone supplements
and number of children were not associated with OA.
Conclusions: This study shows that environmental factors are
important in OA susceptibility, even in patients with a familial
predisposition for OA, underscoring the multicausal etiology of this
disease.
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A WALKING MODEL TARGETING ACUTE PAIN IN KNEE
OSTEOARTHRITIS
M. M. Hooper, R. W. Moskowitz
Department of Medicine, Case Western Reserve University,
Cleveland, OH, USA
Objective: To evaluate a walking model that provokes acute pain in
a way that would permit the evaluation of agents speciﬁcally
targeted to treat acute knee OA pain.
Methods: Ten women and six men, mean age 61 G 4 years with
knee OA by ACR clinical criteria, had baseline 48 h walking VAS
pain scores R40 mm. In this crossover trial, subjects completed
two 20-min walks, separated by a rest of at least 1 h or until their
pain had returned to baseline. At the onset of the walk, their pain
level could be no greater than mild. In the self-paced walk (SP),
subjects walked at a pace they considered brisk. In the coordinator-
paced (CP) walk, the coordinator set as fast a pace as the subject
could tolerate. During the walks, time, and pace to onset of slight,
mild, moderate and severe pain were recorded. Seven subjects
started with a self-paced walk (SP1) followed by the coordinator-
paced walk (CP2). Nine subjects walked in the reverse order (CP1,
SP2). Paired t tests were used to compare mean changes in times,
rates and distances between the ﬁrst and second walks. Students’ t
test was used to compare the means between SP1 and SP2, and
CP1 and CP2.
Results: See Table I: 15/16 subjects achieved a level of moderate
pain in all walks (one drop out due to dyspnea in CP1, SP2). Time
to onset of moderate pain was faster in the second walk than the
ﬁrst. Four of seven achieved a level of severe pain in the SP1 walk
and 7/7 did in the CP2 walk. Five of nine subjects achieved a level
of severe pain in either the CP1 or the SP2 walk (2, no severe pain;
2, stopped because of dyspnea). Time to onset of moderate or
severe pain was always shorter in the CP2 sequence compared to
SP1, but was not signiﬁcantly different in the SP2 sequence
compared to CP1. The CP1 and CP2 rates were very consistent.
Although SP2 rates appeared faster than SP1, the difference was
not statistically signiﬁcant.
Conclusions: As the rates of walking were consistent between the
SP and CP walks, the shortened time to onset of pain indicates
a period effect in which the ﬁrst walk enhanced the pain of the
second walk, contributing to the reproducibility of the model. The
SP pace allowed a warm up for subjects for the CP walk and was
tolerated; starting with a CP walk seemed too demanding for some
subjects. The observed pain enhancement phenomenon gives
insight into clinically relevant pain avoidance strategies. Testing of
comparator therapies using an SP1, CP2 paired walk sequence in
OA patients provides a new model for speciﬁc study of the OA pain
response.
S113Table I
Mean times and rates to pain for self- and coordinator-paced walks
SP1 (sd) CP2 (sd) P value CP1 (sd) SP2 (sd) P value
Time (min)
Severe 18 G 4 12 G 5 !0.01 14.5 G 7 14.5 G 7 NS
Moderate 13 G 2 6 G 3 !0.001 9 G 7 8 G 7 NS
Rate
(ft/mi)
Severe 224 G 52 262 G 35 !0.01 263 G 29 236 G 32 !0.01
Moderate 221 G 63 258 G 29 NS 263 G 29 230 G 44 NSP280
LONG TERM OUTCOME FOLLOWING JOINT ARTHRO-
PLASTY: A CONTROLLED LONGITUDINAL STUDY
J. Cushnaghany, I. Readingy, P. Dieppez, P. Croftx, D. Coggony,
P. Byngy, K. Coxy, C. Coopery
y MRC Epidemiology Resource Centre, Southampton University,
Southampton, Hampshire, United Kingdom
z MRC Health Services Research Collaboration, Bristol University,
Bristol, South Glos, United Kingdom
x Primary Care Sciences Research Centre, Keele University,
Keele, Staffordshire, United Kingdom
Aims: Osteoarthritis (OA) of the hip is a major cause of pain and
disability and accounts for a large number of total joint replace-
ments each year. This study aimed to test the hypothesis that
obesity and radiographic severity at baseline are associated with
a poor long term functional outcome of total hip arthroplasty and to
relate patient centred outcomes to baseline assessments of
radiographic severity and risk factors for the development of OA.
Methods: A cohort of subjects from two towns in the United
Kingdom (Portsmouth and Stoke-on-Trent), aged 45 years and
over, placed on a waiting list for hip arthroplasty were studied. At
baseline data were collected on age, gender, body mass index,
radiographic ﬁndings, risk factors for OA and functional status. A
control subject, without OA, was selected for each case, of the
same age and sex, attending the same General Practice. Identical
data were obtained for the control subjects, but no radiographs
were studied. All subjects have been followed up, where possible,
and data obtained on pain, functional status and health-related
quality of life. Comparisons between cases and controls at baseline
and follow-up were made using Kruskal–Wallis test of equality
(non-parametric).
Results: At baseline 643 matched case control pairs were identiﬁed
(MZ 219, FZ 424, totalZ 1286). Mean age at baseline was 68.3
years (males) and 72.2 years (females). Three hundred twenty-four
cases (MZ 112, FZ 212), and 305 controls (MZ 106, FZ 199)
were followed up (response rate 82.2%). One hundred fourty cases
and 124 controls had died. Mean length of follow-up was 8.5 years
for cases and 8.1 years for controls. Mean age at follow-up was
73.1 years (males) and 77.7 years (females). One hundred sixteen
cases and 141 controls could not be traced. At baseline controls
had signiﬁcantly higher SF-36 physical function scores (median 85,
IQR 55–95) compared to cases (median 20, IQR 7.5–35, P Z
0.0001). After 8 years, controls had deteriorated signiﬁcantly
(median 65, IQR 27.8–85.7, P! 0.001), whilst cases had improved
signiﬁcantly (median 30, IQR 10–56.3, P ! 0.001), however, the
SF-36 physical function scores for cases remained signiﬁcantly
lower than those of the controls (P Z 0.001). SF-36 mental health
and global scores showed no signiﬁcant differences between cases
and controls at baseline or follow-up. In a regression model age and
gender (female) were predictors of functional decline but BMI was
not. Higher Kellgren and Lawrence grade predicted a signiﬁcantly
greater improvement in SF-36 physical function, at follow-up, in the
cases (P Z 0.008).
Conclusions: In this population based, long term, controlled follow-
up study we have shown that physical function following hip
replacement substantially improves. The considerable rate of
physical deterioration in the age-matched controls led to a smallerdisparity between cases and controls at follow-up. Cognitive and
global assessments of quality of life were similar in both cases and
controls.
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DETERMINATES OF ARTHRITIS-RELATED HEALTH BELIEFS
AMONG MALE VETERANS WITH OSTEOARTHRITIS
C. J. Appelty, S. A. Ibrahimyz, C. J. Burantx, L. A. Siminoffx,
C. K. Kwohyz
y Center for Health Equity Research and Promotion, Pittsburgh
Veterans Administration Healthcare System, Pittsburgh, PA, USA
z Medicine, University of Pittsburgh, Pittsburgh, PA, USA
x Bioethics, Case Western Reserve University, Cleveland, OH, USA
Objectives: Since patients’ health beliefs may impact their
perceptions of the efﬁcacy of various treatment options, we
examined health beliefs relevant to arthritis in a cohort of older
African–American’s (AA’s) and whites with knee or hip osteoarthri-
tis (OA).
Methods: We performed a cross-sectional survey of 596 elderly
patients with symptomatic osteoarthritis of the knee and/or hip who
were recruited from the primary care clinics at a VAMC. Participants
were asked about their health beliefs relevant to the following: four
questions on arthritis as part of the aging process; ﬁve questions on
the affect of weather conditions on arthritis; and two questions on
the affect of weight gain or exercise on arthritis. Bivariate analysis
was conducted using Chi-square or Fisher’s exact test. Due to the
small number of females, they were excluded from the analysis.
Results: The mean age of this cohort of male veterans was 66G 10
years and 39% were over age 70; 56% were white and 44% were
African–American; 34% had ! high school (HS) education and
48% had graduated from HS; and 56% had a household income of
$15,000. Veterans with OA over 70 years of age compared to those
ages 60–69 and !60 were more likely to believe that ‘‘arthritis is
a natural part of growing old’’ (71% vs 55% and 54%, respectively,
PZ 0.001); they should ‘‘expect to live with pain as they grow old’’
(76.2% vs 52.7% vs 58%, respectively, P ! 0.001); they expect
that ‘‘they won’t be able to walk as well’’ as they get older (81.1% vs
68.4% vs 66.3, respectively, PZ 0.001). White male veterans with
OA were more likely than AA’s to believe that they would
‘‘experience more pain and stiffness due to a humid climate’’
(62.7% vs 46.1%, respectively, P ! 0.001) and that they would
‘‘experience more pain and stiffness due to weight gain’’ (94.3% vs
88.4%, respectively, P ! 0.02). Male veterans with OA who had
! than high school education were less to likely believe that they
would ‘‘experience more pain and stiffness due to weight gain’’
compared to high school graduates or those with O than high
school education (86.3% vs 94.4% and 94.3%, respectively, P !
0.01). Veterans with OA who had high school education or were
high school graduates were more likely to believe that they
will ‘‘experience more pain and stiffness due to damp climate’’
compared to those withOhigh school education (91.9% and 91.2%
vs 80.7%, respectively, P ! 0.01). No signiﬁcant differences were
found in health beliefs by income level.
Conclusion: Health beliefs about arthritis vary by age, ethnicity and
education level. Clinicians should consider these differences when
discussing treatment strategieswith their patientswithkneeorhipOA.
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DETERMINANTS OF ACTIVITY LIMITATION IN VETERANS
WITH SELF-REPORT OF A PHYSICIAN DIAGNOSIS OF
ARTHRITIS
J. A. Singhy, D. B. Nelsonz, K. L. Nicholyz
y Department of Medicine, Minneapolis VA Medical Center,
Minneapolis, MN, USA
z Center for Chronic Diseases Outcomes Research, Minneapolis
VA Medical Center, Minneapolis, MN, USA
Objective: To study factors associated with limitation of activities of
daily living (ADLs) in Veterans with self-report of physician-
diagnosed arthritis.
Methods: All veterans receiving health care at Upper Midwest
Veterans Integrated Service Network with an inpatient or outpatient
encounter between 10/1/1997 and 3/31/1998 were mailed a self-
administered questionnaire, which included questions related to
limitation of six ADLs (bathing, dressing, eating, getting in or out of
chairs, walking, and toileting), demographics, current smoking
status, % Service connection (veterans who have disabilities
resulting from or beginning during active military duty get service
connection from 0 to 100%) and self-report of physician-diagnosed
comorbidities. This data was supplemented by demographic and
health care utilization data from the clinical patient database. In
subjects with self-reported physician-diagnosed arthritis, we per-
formed multivariable logistic regression analyses with ADL limitation
as outcome (any difﬁculty vs no difﬁculty) to determine factors asso-
ciated with each ADL limitation. Odds ratio (OR) with a 99% con-
ﬁdence interval (CI) excluding unity was considered signiﬁcant (P!
0.01).
Results: Of the 70,334 eligible veterans, 34,440 (48.9%) subjects
answered the arthritis question and 18,464 (53.6%) reported
physician-diagnosed arthritis. Mean age of subjects with arthritis
(GSD) was 65.4 years (G12.5), 96% were males and 91% were
Caucasians.
In patients with arthritis, the following categories of patients had
signiﬁcantly higher odds of each ADL limitation: education level
lower than high school (OR, 1.2–1.7); unemployed or retired (OR,
1.1–1.5); higher % service connection (OR, 1.0–2.5); those with
asthma (OR, 1.2–1.5), diabetes (OR, 1.7–2.5); and those with one
or more hospitalizations in the year prior to the survey (OR, 1.0–
1.4). Veterans who were married had higher odds of limitation of
bathing and eating (OR, 1.1–1.2) than unmarried veterans, and
those who were current smokers had more difﬁculty with eating and
walking (OR, 1.2–1.3) than non-smokers. Veterans with depression
had higher odds of difﬁculty with bathing, walking and getting in and
out of chair (OR, 1.2–1.4) and those with heart disease walking and
getting in and out of chair (OR, 1.2–1.4), compared to veterans
without depression and heart disease, respectively. Age was
associated with an OR of 1.01 with bathing, but had no signiﬁcant
association with other ADL limitations.
Table I
Association of arthritis with ADL limitation in regression analysesz
Unadjusted
odds ratio
(95% CI)
Age-adjusted
odds ratio
(95% CI)
Multivariablex-
adjusted odds
ratio (95% CI)
Bathing 2.0 (1.9–2.2)* 2.0 (1.9–2.1)* 1.6 (1.5–1.7)*
Dressing up 2.2 (2.1–2.4)* 2.2 (2.1–2.4)* 1.8 (1.7–2.0)*
Eating 1.3 (1.2–1.4)* 1.4 (1.3–1.5)* 1.1 (1.0–1.2)y
Getting in/out
of chair
3.3 (3.2–3.5)* 3.3 (3.1–3.4)* 2.8 (2.6–2.9)*
Walking 3.2 (3.1–3.4)* 3.1 (3.0–3.3)* 2.6 (2.5–2.8)*
Using toilet 1.9 (1.8–2.1)* 1.9 (1.8–2.1)* 1.6 (1.5–1.7)*
*P ! 0.001, yP = 0.048. zReference category: subjects
without arthritis. xAdjusted for the following variables: age,
gender, race and education level; marital, employment, VA
eligibility and smoking status; presence of asthma, depression,
diabetes, heart disease, hypertension; inpatient and outpatient
health care utilization in the prior year and multi-site use.Gender, race, presence of hypertension and number of outpatient
visits in the prior year were not signiﬁcantly related to any ADL
limitation in multivariate analyses.
Conclusions: Socio-demographic factors, presence of some co-
morbidities and certain health care utilization parameters were
associated with functional limitation in veterans with arthritis.
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VETERANS WITH SELF-REPORTED ARTHRITIS HAVE SIG-
NIFICANT FUNCTIONAL LIMITATION
J. A. Singhy, D. B. Nelsonz, K. L. NichoLyz
y Department of Medicine, Minneapolis VA Medical Center,
Minneapolis, MN, USA
z Center for Chronic Diseases Outcomes Research, Minneapolis
VA Medical Center, Minneapolis, MN, USA
Objective: To describe functional limitation in veterans with self-
reported arthritis.
Methods: All veterans receiving health care at Upper Midwest
Veterans Integrated Service Network with an inpatient or outpatient
encounter between 10/1/1997 and 3/31/1998 were mailed a self-
administered questionnaire, which included questions related to
functional limitation as measured by limitation of six Activities of
Daily Living (ADLs; bathing, dressing, eating, getting in or out of
chairs, walking, and toileting), demographics, current smoking
status, and self-report of physician-diagnosed comorbidities. This
data was supplemented by demographic and health care utilization
data from the clinical patient database. Using logistic regression,
we compared patients with and without arthritis with regard to each
ADL limitation, with ADL limitation as the outcome and calculated
unadjusted, age-adjusted and multivariable-adjusted odds ratios.
Odds ratio (OR) with a 95% conﬁdence interval (CI) excluding unity
was considered signiﬁcant.
Results: Of 70,334 eligible veterans, 34,440 (48.9%) subjects
answered the arthritis question and 18,464 (53.6%) reported
arthritis. Compared to subjects without arthritis, those with arthritis
were signiﬁcantly older, less educated and more likely to be
unemployed or retired, married, males, and multiple medical site
users. Subjects with arthritis had signiﬁcantly higher number of
mean ADL limitation as compared to those without arthritis (1.94G
1.88 vs 1.06 G 1.69).
Unadjusted regression analyses showed that the individuals with
arthritis had signiﬁcantly higher odds of each ADL limitation as
compared to those without arthritis (Table I). These differences
persisted even after adjusting for age and other variables in
multivariable analyses. In the multivariable-adjusted model, sub-
jects with arthritis had 2.6–2.8 times higher odds of difﬁculty with
getting in or out of the chair and walking as compared to subjects
without arthritis (Table I).
Conclusions: Signiﬁcant limitation of ADLs was found in veterans
with self-reported physician-diagnosed arthritis as compared to
veterans without a self-report, which persists even after adjusting
for socio-demographic, comorbidity and health care utilization
factors.
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FRACTURE ENERGY AS A PREDICTOR OF POST-TRAUMATIC
OA: ENERGY MEASURES AGREE WITH CLINICAL INJURY
SEVERITY SCORING IN COMMINUTED INTRA-ARTICULAR
FRACTURES
D. D. Anderson, V. L. Muehling, J. L. Marsh, T. D. Brown
Orthopaedics and Rehabilitation, The University of Iowa, Iowa City,
IA, USA
Aim: Using CT-based analyses of intact and fractured ankles, we
inferred the initial cartilage insult as a predictor of post-traumatic OA
following intra-articular fracture. Fracture energy measures were
S115used to quantify injury severity in a series of 11 tibial pilon fracture
cases, and these measures were compared to the judgment of an
experienced orthopaedic surgeon.
Methods: Bone free surface area measurements were extracted
from patient CT datasets using validated digital image analyses.
The difference between free surface areas measured on fractured
and intact tibias of each patient yielded the de novo surface area
liberated during fracture. Bone densities, regressed from CT
intensities, were incorporated into a formal fracture energy
measure. The clinical cases were rank ordered by an experienced
orthopaedic traumatologist, who was blinded to the surface energy
data, in terms of injury severity using plain radiographs. A
Spearman rank order analysis compared fracture energy measures
with the clinical rank ordering.
Results: Bone free surface areas measured in intact tibias ranged
from 8577 to 25,059 mm2, with the relatively large variability
attributed to calculations spanning different segmental tibial
lengths. Among fractured tibias, surface areas ranged from 8722
to 30,826 mm2, yielding net liberated surface areas from 2 to 75%
of the intact side. Plotted alongside scout images of the distal tibias,
these bone surface areas show variation in the degree of proximal
to distal fragmentation, and reﬂect the proximity of a given fracture
to the articular surface. The Spearman analysis comparing clinical
rank ordering with the fracture-liberated surface area ranking
yielded an R value of 0.72. Incorporating local bone densities into
Fig. 1. These two cases show the comminution spectrum. Note the
small number (4) of fragments in the case to the left, and the large
number (O30) of small bone fragments in the tibial pilon fracture
case to the right (coventional unsegmented surface rendering from
radiologic workstation shown to far right, no fragments enumerated).a formal fracture energy measure increased the correlation to an
R Z 0.90.
Conclusions: We have developed estimates of the liberated bone
surface area associated with a series of clinical pilon fractures.
Because mechanical fracture toughness is bone density-depen-
dent, we have incorporated local material variability, available in the
form of CT Hounsﬁeld values, into a formal fracture energy
measure. The energy measures here calculated agree favorably
with the clinical impression of the treating surgeon, in terms of
a rank ordering of injury severity.
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THE GENETICS OF GENERALIZED OSTEOARTHRITIS (GOGO)
STUDY: PATTERNS OF HAND OSTEOARTHRITIS
V. B. Krausy, J. M. Jordanz, M. M. Cranex, J. B. Rennerz,
M. Dohertyjj, A. G. Wilson{, R. Moskowitz#, M. Hochbergyy,
R. Loeserzz, M. Hooper#, P. Hastiex, S. Versanix, D. Noelx, U. Atifx
y Medicine, Duke U
z UNC
x GlaxoSmithKline
jj Sheffield
{ CWRU
# U MD-Baltimore, USA
yy Rush Med Ctr
zz Nottingham
Aim of study: The GOGO study is conducted by a consortium of
seven clinical research sites in US and UK to identify genes
associated with generalized OA. Participants in the GOGO study
were screened on the basis of clinical hand OA. The patterns of
radiographic OA (rOA) of the hands resulting from this strategy are
described below.
Methods: Participants meeting clinical GOGO criteria (bony
enlargement of R 3 joints distributed bilaterally and including at
least one distal interphalangeal joint-DIP) were invited to participate
along with at least one clinically affected sibling as well as other
siblings when available. Gold standard criteria for a qualifying
family consisted of at least two siblings affected with radiographic
OA (rOA) of the hand, deﬁned by Kellgren Lawrence grade of R2
involving R 3 joints, distributed bilaterally, of the DIP, proximal
interphalangeal (PIP), or carpometacarpal (CMC) joint groups, and
self-reported Caucasian ethnicity. The rOA grade of the metacarpal
phalangeal (MCP) joints was also scored. Participants were
excluded on the basis of X-ray evidence of rheumatoid arthritis
and X-ray and serological evidence of hemochromatosis.Fig. 2. A plot of bone surface areas along two fractured distal tibias (same cases as above) shows the unique traits of different fractures. Cyan/
white curves are intact areas, red are fractured.
S116Results: A total of 2747 participants from 1148 families were
enrolled into the GOGO study (65% through the ﬁve US sites and
35% through the two UK sites). A total of 2599 participants were
affected by clinical hand criteria while 1962 were affected by the
radiographic criteria. The rOA hand affected sample had a mean
age of 68.6 years, was 80.3% females, 34.5% met BMI criteria for
obesity (BMI R 30.0 kg/m2), and 72% met BMI criteria for
overweight (BMI R 25.0 kg/m2). A total of 706 families had at least
two siblings that met the case deﬁnition of hand rOA. Clinical and
radiographic determinations of affected status were discordant in
752 participants. Rarely was a participant affected radiographically
without meeting clinical criteria of affection status (2.6% of all
participants). More commonly, individuals meeting clinical hand
criteria did not meet the deﬁnition of a radiographic case (24.8% of
all participants). The most frequent hand rOA phenotypes were
DIP/PIP/CMC (34.7%), followed by DIP/PIP/CMC/MCP (28.9%)
and DIP/PIP (28.6%). The overall frequency of MCP rOA was
36.2%. CMC disease almost always occurred in combination with
DIP/PIP involvement and rarely with DIP disease alone (0.4%) or
DIP/MCP disease (0.2%). The mean self-reported ages of onset of
these various phenotypes were: DIP/PIP/CMC (54.7G 11.7 years),
DIP/PIP/CMC/MCP (56.3G 11.7 years), and DIP/PIP (54.1G 10.4
years).
Conclusions: The involvement of MCP rOA was surprisingly
common in this cohort. Using the GOGO clinical screening strategy,
61.5% of families had at least one hand rOA affected sib pair.
Because multiple family members were ascertained when avail-
able, this strategy yielded 1129 sibling pairs with rOA of the hand.
This sample should provide great power to detect linkage to OA
associated genes.
This study was supported by a grant from GlaxoSmithKline.
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ALLELIC POLYMORPHISMS OF VITAMIN D RECEPTOR GENE,
TYPE I COLLAGEN GENE, OSTEOCALCIN GENE AND CALCI-
TONIN RECEPTOR GENE IN PATIENTS WITH IDIOPATHIC
KNEE OSTEOARTHROSIS IN RUSSIAN FEDERATION
N. N. Kornilovy, M. V. Aseevz
y Department of the Experimental and Clinical Knee Surgery,
Russian Research Institute of Traumatology and Orthopaedics n.a.
RR Vreden, St. Petersburg, Russian Federation
z Laboratory of Prenatal Diagnostic, Research Institute of Obstetrics
and Gynaecology n.a. DO Ott, St. Petersburg, Russian Federation
Aetiology and pathogenesis of osteoarthrosis (OA) are still poorly
understood despite a lot of studies dedicated to this frequent cause
of musculoskeletal disability. We have investigated the association
between polymorphisms of vitamin D receptor gene (VDR), type I
collagen gene (COL1A1), osteocalcin gene (BGLAP), calcitonin
receptor gene (CALCR) and idiopathic knee osteoarthrosis (OA) in
90 patients (76 (84.4%) females and 14 (15.6%) males), living in
the North-West region of Russian Federation, who were hospital-
ised in our clinic for the surgical or conservative treatment during
the last 4 years. All patients satisﬁed OA diagnostic criteria of
American College of Rheumatology and had a duration of
symptoms more than 1 year. Individuals with secondary gonarth-
rosis were excluded from the survey. In the control group were
randomly included 138 healthy Caucasian volunteers living in the
same area.
There was no signiﬁcant difference between frequencies of
COL1A1, BGLAP, and CALCR genes polymorphisms in knee OA
group in comparison with population of the North-West region of
Russian Federation. The frequency of functionally defective allele t
of VDR gene was signiﬁcantly higher among patients with end-
stage knee OA (46.14%) in comparison with population (32.7%)
(c2 Z 4.7; df Z 1, P ! 0.05). The frequencies of VDR genotypes
TT, Tt and tt in the group of patients with severe OA of the knee
were 23.7%, 60.5% and 15.8% and differed signiﬁcantly from the
population (53.7%, 39.2% and 7.1%) (c2 Z 12.7; df Z 2, P !0.01). The odds ratio (OR) for homozygous (tt) subjects was 2.5
(95% CI, 1.01–6.03).
Therefore certain VDR genotypes are associated with the de-
velopment of severe idiopathic knee OA in Russian population.
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IDENTIFICATION OF DIFFERENTIALLY EXPRESSED TRAN-
SCRIPTS IN CANINE OSTEOARTHRITIS
R. P. Middletony, J. Holzwarthz, R. Nelsony, W. Staerkery,
J. Labuday, Q. Liy, S. S. Hannahy
y Basic Research, Nestle Purina Research, St. Louis, MO, USA
z Bioinformatics, Nestle Research Center, Lausanne, Switzerland
Aim of study: To identify differentially expressed chondrocyte
transcripts involved in canine osteoarthritis (OA).
Methods: Microarray analysis of canine osteoarthritis was carried
out using a canine OA microarray developed from differential
display (previously described). Canine osteoarthritic cartilage
samples were obtained from the femoral heads of clinically
diagnosed canines undergoing total hip replacement (n Z 8).
The microarray data were normalized using the quantile normali-
zation method and a Welch modiﬁed t test was used to determine
differentially expressed transcripts. Annotation of clones was
determined via direct BLAST (E value less than 0.002, covering
50% of the sequence) and by ﬁrst extending the sequences using
the 1.5! coverage of the canine genome, and then BLASTing, as
above. In addition, RT-PCR was carried out to validate microarray
results as well as to determine if other transcripts known to be
involved in OA, not represented on the microarray, were
differentially expressed in canine OA.
Results: Of the approximately 1750 clones represented on the
microarray, 321 were identiﬁed as being differentially expressed
(P ! 0.05). These included interleukin-8, thrombospondin-1,
insulin-like growth factor II (IGF-II), as well as others with no
signiﬁcant homology to other known transcripts or with no known
functional annotation associated with them. Included is the gene Va
(Geneva) gene, which was highly down-regulated in OA. It has
some sequence homology to a low density lipoprotein receptor-
related protein binding protein, but does not share homology with
the perlecan gene. RT-PCR analysis conﬁrmed six out of seven
differentially expressed transcripts (P ! 0.05) and seven out of
seven directionally. In addition, matrix metalloproteinases-2 and -
13, procollagen IIA, interleukin-6 and tumor necrosis factor-alpha
were up-regulated in OA.
Conclusion: Transcriptional proﬁling of canine OA has led to
a better understanding of the disease at the molecular level. The
transcriptional characterization of canine OA is very consistent with
that found in human OA with an exception being IGF-II. This study
has also identiﬁed new OA targets such as the Geneva gene. In
addition, there are unidentiﬁed differentially expressed transcripts
which, once annotated, will further our understanding of the
disease.
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SEVERITY OF PAIN AND JOINT TISSUE LESIONS IN KNEE
OSTEOARTHRITIS
L. Torresy, C. Peterfyz, A. Guermaziz, P. Prasady, S. Cahuey,
D. Dunlopy, J. Songy, L. Sharmay
y Department of Rheumatology, Northwestern University, Chicago,
IL, USA
z Imaging, Synarc Inc, San Francisco, CA, USA
Joint tissue sources of pain in knee OA are not well understood.
MRI affords a means to examine the relationship between tissue
status and pain severity. MRI lesion scores may be summed for all
compartments. However, pain may be driven by the lesions of the
most diseased compartment. We tested whether tissue lesion
severity is related to pain severity, examining both: sum of scores
for a tissue in all compartments; score for that tissue in the most
diseased compartment.
One hundred forty-four individuals with knee OA (K/L R 2 and
symptoms) had MRI of both knees using a commercial knee coil
and one of two whole-body scanners (1.5 T and 3 T). The protocol
included coronal T1-weighted spin-echo (SE), sagittal fat-sup-
pressed dual-echo turbo SE, and axial and coronal fat-suppressed,
T1-weighted 3D-fast low angle shot (FLASH) sequences. Applying
the whole organ semi-quantitative scoring system (WORMS),
cartilage morphology (CM), osteophytes (O), bone edema (BE),
bone cysts (BC), bone attrition (BA), and menisci (M) were scored
for each surface. Ligaments and synovial ﬂuid (presence/absence)
were characterized. The worst compartment was that with poorest
cartilage morphology. Pain was assessed with separate visual
analogue scales for each knee. We graphically examined lesion
score by pain group (VAS 0–5, 6–20, 20–50, O50 mm). Next,
polynomial regression and GEE were used to model pain as
a function of lesion score. For each feature, both sum of scores and
worst compartment score were analyzed.
One hundred forty-four persons (mean age 70 G 10, BMI 30.6 G
6.0, pain severity 29G 26 mm, 78% women) were evaluated (266
knees without MRI exclusion). Worst compartment was medial
tibiofemoral in 94 knees, lateral tibiofemoral in 65, and patellofe-
moral in 107. The ﬁgure depicts the mean lesion score (BE, BC, BA
and M as examples, worst compartment) for each pain group (each
bar). With the worst compartment approach, there was a signiﬁcant
increase in pain with an increase in MRI score for CM, BE, BC, BA,
OC, and M (i.e., evidence of linear relationship). Additionally, for
BE, BC, BA, and O, as MRI score rose, the rate of pain worsening
signiﬁcantly increased (evidence of a quadratic relationship). With
the sum approach, a signiﬁcant quadratic relationship was detected
for BE and O.
These results suggest that in knee OA bone pathologydedema,
cysts, attrition, osteophytesdstrongly relates to pain severity (vs
ligaments, menisci, effusion), in keeping with a prior report linking
bone edema to knee pain presence. Treatment targeting these
sources of pain should be developed. A focus on the most diseased
compartment was more sensitive in revealing these relationships.P289
DIFFRACTION ENHANCED X-RAY IMAGING OF MUSCULO-
SKELETAL LESIONS
C. Muehlemany, J. Liz, K. E. Kuettnerz, Z. Zhongx
y Anatomy and Cell Biology, Rush University Medical Center,
Chiago, IL, USA
z Biochemistry, Rush University Medical Center, Chicago, IL, USA
x NSLS, Brookhaven National Laboratory, Upton, NY, USA
Aim of study: To demonstrate the ability of Diffraction Enhanced X-
Ray Imaging (DEI) to radiograph the soft tissues, including articular
cartilage, of synovial joints, as well as to identify lesions within.
Methods: Intact cadaveric human knee and ankle joints were DEI
imaged at 40 keV at the X-15 beamline at the NSLS, Brookhaven
National Laboratory. A collimated fan beam of X-rays is prepared
by a silicon [3,3,3] double crystal monochromator. When this beam
passes through the subject, a matching analyzer placed between
the subject and the detector converts the angular changes in the
beam into intensity changes, giving rise to enhanced contrast. The
angular sensitivity of DEI allows measurement of the gradient of
the X-ray index of refraction, and of ultra-small-angle scattering of
the subject, besides the X-ray attenuation obtained through
conventional radiography. The image is then recorded on a detector
or image plate. Thus, absorption or refraction images can be taken
depending upon the rotation of the analyzer, which, thus, captures
different X-ray properties.
Results: Articular cartilage and surrounding soft tissues such as
tendons and ligaments were visible within DEI images of the joints.
It was found that the refraction images, especially, were effective in
rendering views of cartilage, even when superimposed by bone. In
particular, cartilage displaying signs of degeneration could be
detected and correlated to gross morphology. Concerning other
soft tissues, transections of the calcaneal tendon were readily
observed within their DEI images.
Conclusion: Since the DEI contrast mechanism does not rely
simply on the absorption of the subject, it is ideally suited to image
bone, cartilage and other soft tissues simultaneously. Here we have
shown that DEI allows the radiographic imaging of cartilage,
tendons, and other soft tissues as well as lesions within. DEI
refraction images, as compared to DEI absorption images render
soft tissue morphology with edge enhancement, a feature that is
particularly useful in determining the intactness of a tissue surface
such as for articular cartilage. Since DEI is not intrinsically tied to
a synchrotron, we are optimistic about the utility of this novel
imaging technique in the clinical setting.
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MR-TECHNIQUE FOR ASSESSMENT OF CARTILAGE CON-
TACT AREAS IN PATIENTS WITH PATELLAR SUBLUXATION
H. Graicheny, S. Hinterwimmeryz, R. von Eisenhart-Rothey,
F. Ecksteinx
y Orthopaedic Department, University of Frankfurt, Frankfurt,
Germany
z Department of Surgery, Ludwig Maximilians Universita¨t, Munich,
Germany
x Institute for Anatomy and Muskuloskeletal Research, Paracelsus
Private Medical University, Salzburg, Austria
Aim of the study: Ex vivo studies have suggested that changes of
cartilage contact areas and contact pressure are of high clinical
relevance in the etiology of osteoarthritis in particular in patients
with patellar subluxation. Recent studies have shown that closed
(1.5 T) MR-systems are able to quantify cartilage contact areas
accurately, however, showing the limitation that the clinically
relevant higher ﬂexion angles cannot be assessed due to scanner
construction. The aims of this study were therefore (1) to develop
an open MR imaging technique that allows assessment of the
cartilage contact areas at different ﬂexion angles, (2) to validate this
technique with closed MR (1.5 T) and (3) to study the alterations of
S118knee joint contact areas in patients with patellar subluxation at
different angles of knee ﬂexion in comparison with healthy subjects.
Methods: 3D-MR image data sets of 12 healthy volunteers and
eight patients with patellar subluxation were acquired using
a standard clinical closed (1.5 T) and an open (0.2 T) MRI scanner.
After data transfer, semiautomatic segmentation and 3D recon-
struction, validation of the different open MR sequences
[dual-echo-steady-state (DESS) and fast-low-angle-shot (FLASH)
sequences] was performed by comparing femoro-patellar and
femoro-tibial contact areas with those derived from standard clinical
1.5 T MRI (Gold-Standard). We then analyzed differences in joint
contact areas between healthy subjects and patients with patellar
subluxation at 0(, 30( and 90( of knee ﬂexion using open MRI.
Results: The correlation of the size of contact areas from open MRI
with standard clinical MRI data ranged from rZ 0.52 to 0.92. Open-
MRI DESS displayed a smaller overestimation of joint contact areas
(C21% in the femoro-patellar, C12% in the medial femoro-tibial,
and C19% in the lateral femoro-tibial compartment) than FLASH
(C40%, C37%, C30%, respectively). The femoro-patellar contact
areas in patients were signiﬁcantly reduced in comparison with
healthy subjects (47% at 0(, 56% at 30(, and 42% at 90( of
ﬂexion; all P ! 0.01), whereas no signiﬁcant difference was
observed in femoro-tibial contact areas.
Conclusions: Open MRI allows one to quantify joint contact areas of
the knee with reasonable accuracy, if an adequate pulse sequence
is applied. The technique permits one to clearly identify differences
between patients with patellar subluxation and healthy subjects at
different ﬂexion angles. This effect could be shown by the closed as
well by the open MR technique with comparable accuracy. In our
patients we found a signiﬁcant reduction of 50% and a lateralization
of contact areas in patients. In the future, application of this new in
vivo technique is of particular interest for monitoring the efﬁcacy of
different types of surgical and conservative treatment options for
patellar subluxation.
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QUANTITATIVE MEASUREMENT OF ANKLE CARTILAGE
USING AN ISOTROPIC MRI SEQUENCE AND A DIRECTIONAL
GRADIENT VECTOR FLOW SNAKE
S. A. Millingtony, J. Tangz, S. R. Hurwitzx, S. T. Actonz,
J. R. Crandally
y Center for Applied Biomechanics, University of Virginia, Charlot-
tesville, VA, USA
z Computer & Electrical Engineering, University of Virginia,
Charlottesville, VA, USA
x Department of Orthopaedic Surgery, University of Virginia,
Charlottesville, VA, USA
Aim of study: Appropriate MRI sequences combined with the latest
image analysis techniques can be used to reproducibly measure
quantitative cartilage parameters hence, offering a tool for
monitoring and detecting degenerative change non-invasively at
an earlier stage than previously possible. In this study we assess
the performance of a directional gradient vector ﬂow (dGVF) snake
segmentation algorithm for segmenting an isotropic sequence
which allows segmentation of the full articular surfaces (including
malleolar surfaces) of the ankle joint. Comparison is made with
a previously reported non-isotropic sequence which provides
limited surface data.
Methods: Eight cadaveric ankles were imaged at 1.5 T using an
isotropic 3D T1 weighted FLASH sequence with water excitation
(WE), resolution 0.3 ! 0.3 ! 0.3 mm, scan time 17 min 14 s. In
a subset of ﬁve ankles four data sets were acquired with
repositioning and re-shimming between acquisitions. For compar-
ison ﬁve ankles were imaged with a previously reported non-
isotropic sagittal 3D T1 weighted FLASH sequence with WE (NEX
Z 2), resolution 1! 0.25! 0.25 mm, scan time 19 min 40 s. The
image data was linearly interpolated and then segmented using
a semi-automated dGVF snake algorithm. Following 3D recon-
struction of the segmented data normal thickness was calculated at
each voxel on the surface. Coefﬁcients of variation (CV) were
calculated for the repeated data set.Results: In the eight ankles imaged using the isotropic sequence
the mean thickness (GS.D.; median) was 1.80 mm (G0.05 mm,
1.81 mm); 1.83 mm (G0.07 mm, 1.83 mm) and 1.81 mm (G0.07
mm, 1.83 mm) for the talus, tibia and cumulative ankle cartilage,
respectively. In the ﬁve ankles imaged using the non-isotropic
sequence the mean thickness (GS.D.; median) was 2.18 mm
(G0.07 mm, 2.20 mm); 2.19 mm (G0.09 mm, 2.15 mm) and 2.19
mm (G0.08 mm, 2.19 mm) for the talus, tibia and cumulative ankle
cartilage, respectively. The mean coefﬁcients of variation (min–
max) from the four repeated measurements in ﬁve ankles were
1.74% (0.69%–3.57%); 1.20% (0.26%–3.06%) and 1.52% (0.26%–
3.57%) for the talus, tibia and cumulative ankle cartilage,
respectively. The ratio between inter-subject variability and
technical precision provides an assessment of the ability to
distinguish individuals with high or low cartilage thickness. In the
ﬁve ankles imaged four times the ratios ranged from 1.47 in the
talus to 3.81 for the cumulative ankle cartilage. The ratio was
relatively low for the talus due to low inter-subject variability for the
talus.
Conclusions: The low CVs from the repeated data sets demon-
strate the precision of the dGVF snake algorithm for segmenting
thin highly congruent cartilage layers. Using an isotropic sequence
allows the whole joint surface including malleoli to be segmented
from one data set by multi-planar reconstruction. The reported
image sequence and segmentation is a valid tool for quantitative
assessment of the entire ankle joint. A possible application is the
early detection of surface injury and/or degenerative change.
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MAGNETIC RESONANCE IMAGING IN KNEES OF PATIENTS
WITH OSTEOARTHRITIS AT MULTIPLE SITES: ASSOCIATION
WITH CLINICAL FINDINGS
P. R. Kornaaty, J. L. Bloemy, R. Y. T. Ceulemansy, N. Riyaziz,
F. R. Rosendaalx, R. G. Nelissenjj, W. O. Carter{, M. Helio
Le Graverand{, G. Kloppenburgz
y Radiology, Leiden University Medical Center, Leiden, Netherlands
z Rheumatology, Leiden University Medical Center, Leiden, Nether-
lands
x Clinical Epidemiology, Leiden University Medical Center, Leiden,
Netherlands
jj Orthopaedic Surgery, Leiden University Medical Center, Leiden,
Netherlands
{ Pfizer Groton, Groton, CT, USA
Background: Traditionally, radiographs are used to assess osteo-
arthritic changes in the knee and to associate osteoarthritic
changes with clinical ﬁndings such as knee pain. Only a poor
association between osteoarthritic changes seen on radiographs
and clinical ﬁndings was found. Magnetic resonance (MR) imaging
allows another perspective on structural abnormalities secondary to
OA. These structural abnormalities seen on MR imaging have been
associated with clinical ﬁndings including knee pain. However,
a controversy about the cause of knee pain remains.
Objective: To determine the association between a spectrum of
structural abnormalities found on MR imaging of the knee and
clinical ﬁndings in patients with familial OA.
Methods: MR images of the knee were obtained in 105 sib-pairs
(210 patients) diagnosed with symptomatic OA at multiple sites. MR
images were analyzed for the presence and severity of cartilagi-
nous lesions, osteophytes, subchondral cysts, bone marrow
edema, meniscal abnormalities, effusion and Baker’s cysts. All
patients were interviewed concerning the presence or absence of
pain or stiffness in the imaged knee during the month prior to MR.
Patients were randomized into two groups. Imaging ﬁndings with an
odds ratio (OR) for pain or stiffness greater than 2 were identiﬁed in
one group and subsequently ORs of these parameters were
determined in the second group.
Results: Patient ranged from 40 to 75 years in age, 83% of the
patients were females, average body mass index was 26 and 51%
of the patients had radiographic femorotibial OA. Cartilage defects
and osteophytes are the most commonly seen defects on MR
S119images of the knee in the studied population. Marked joint effusion is
associated with pain (OR: 6.9; CI: 0.8–57) and stiffness (OR: 6.8; CI:
0.8–60). Presence of O5 osteophytes in the entire knee (OR: 3.6;
CI: 1.5–9.1) andO2 osteophytes at the patellofemoral compartment
alone (OR: 3.0; CI: 1.1–8.3) are associated with pain. Bone marrow
edema at the femorotibial compartment (OR: 2.9; CI: 0.8–11) and
presence of a central osteophyte (OR: 3.0; CI: 1.1–8.3) were
associated with stiffness. All other imaging ﬁndings including
cartilage destruction were not associated with pain or stiffness.
Conclusion: Only marked joint effusion, presence of O5 osteo-
phytes in the entire knee, presence of central osteophytes and
bone marrow edema in the femorotibial compartment were
associated with pain and/or stiffness in the knee.
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AUTOMATED HISTOMORPHOMETRIC ANALYSIS OF JOINT
DAMAGE IN A MOUSE MODEL OF OSTEOARTHRITIS
H. Guehringy, T. Jensenz, J. Dorez, M. Grunkinz, K. A. Rudolphiy
y Disease Group Thrombosis/Osteoarthritis, Aventis Pharma
Germany, Frankfurt/Main, Germany
z Image Analysis, Visiopharm ApS, Horsholm, Denmark
Aim: Morphometric analysis of histological sections of the knee is
essential for quantifying the degree of joint damage and drug efﬁcacy
in animal models of osteoarthritis (OA). It is of particular interest to
measure the number of cells and the area of the cartilage lesions as
they are manifested in the histological sections. Manual counting of
cells is very time consuming, and scoring of cartilage loss is
qualitative and subject to grader variability. The aim of the work
presented here was to develop image analysis software capable of
performing a fully automated segmentation of Hematoxilin/Eosin
(H&E) stained histological knee sections, thus allowing for measuring
various morphometric variables, including cellularity and lesion area.
Methods: Two hundred twenty light microscopy images were of
H&E stained histological knee sections obtained from 50 male
STR/1N mice, a strain which develops OA spontaneously, were
used for developing the software algorithms. In order to develop
a method which is robust towards variation in staining intensity,
knowledge about the anatomy of the knee, was incorporated into
the algorithm. This allows for an automated localization of regions
for training the chosen pixel classiﬁer for recognizing bone matrix,
cartilage, cells (and lacunae), and background. The automated
training is repeated for each individual image. Position and shape of
the cartilage areas are exploited to perform correct delineation, of
the femoral and tibial cartilage. Objects that are irrelevant for
morphometric measurements, such as, e.g., the meniscus, is
automatically excluded, an iterative local curve ﬁtting approach.
Cells inside the cartilage areas are segmented using a special type
of ﬁlters giving a strong response, wherever small rounded objects
are present. An iterative method, locating local maxima allows for
correct counting even when cells are partly overlapping.
Results: A novel image analysis method was developed, capable of
performing and automated segmenting of H&E stained histological
knee sections spatially into anatomically correct areas of bone,
cartilage, cells (chondrocytes), lacunae, and background. Based on
this segmentation, the system is capable of measuring cell number,
cartilage area, surface length, and a number of other morphometric
variables that can be deﬁned by the scientists using the software,
for developing and testing scientiﬁc hypotheses.
The user interface for the system allows the scientists to inspect
each image for correctness of the computerized segmentation as
well as the measurements. It is simple and intuitive to perform
corrections in those cases where corrections may be deemed
necessary.
The developed method is ﬂexible enough to allow for different
staining methods.
Conclusions: If the promising ﬁrst results of this automated image
analysis method can be veriﬁed on a larger test set, a new and
powerful research tool will be available to scientists for performing
histomorphometric measurements much faster, and most likely with
a higher degree of reproducibility.P294
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Aim of the study: Quantitative magnetic resonance imaging (qMRI)
of articular cartilage has become a powerful tool in cartilage and OA
research. The precision (reproducibility) of the technique plays
a pivotal role in longitudinal studies, e.g., when trying to identify the
effectiveness of a drug in preventing structure modiﬁcation of
cartilage. Here we test the hypothesis that the precision of these
measurements can be improved by imaging cartilage at 3 T (T), due
either to an enhanced signal- and contrast-to-noise or to an
improved spatial resolution at 3 T.
Methods: We examined 30 subjects, 15 normal (age 62.3 G 11.5
years, Kellgren Lawrence grade Z 0) and 15 with early OA (age
63.7 G 9.6 years, Kellgren Lawrence grade Z 2 to 3) using
a Siemens Magnetom (1.5 T) and Trio (3 T) scanner and circularly
polarized birdcage knee coils. Six coronal scans were obtained in
each subject, two at 1.5 T with a slice thickness (ST) of 1.5 mm
(FLASH we, 20 ms, 7.6 ms, 20(), two at 3 T with an ST of 1.5 mm
(FLASH we, 20 ms, 7.6 ms, 12(), and two at 3 T with an ST of 1.0
mm (other parameters identical). The joints were repositioned in
between replicated scans. Cartilage volume (ToVol), cartilage
surface areas (ToCrSf), and mean cartilage thickness (ASThMea)
were quantiﬁed in the medial tibia, the lateral tibia, the medial
femoral condyle, and the lateral femoral condyle, using proprietary
software (Chondrometrics GmbH, Germany).
Results: When summarizing all plates, the average precision error
(RMSCV%) for ToVol and ASThMeawas 2.9% and 2.6%at 1.5 T/1.5
mm ST, respectively. The error was smaller at 3 T/1.5 mm (2.6%/
2.5%) and still smaller at 3 T/1.0 mm (2.1%/2.0%). This trend was
seen in all four cartilage plates. At 3 T/1.0 mm the precision errors for
ToVol and ASThMean were !2.5% for the femoral condyles and
!2.0% for the tibiae. Average precision errors for surface areas
amounted to between 1.3 and 1.4% with all protocols. Precision
errors did not differ between non-OA and OA subjects. Measure-
ments at 3 T correlated highly with those at 1.5 T (rZ 0.99 for volume,
rZ 0.95 for thickness, and r > 0.94 for surface areas). ASThMeawas
observed to be somewhat higher at 3 T, the systematic difference
ranging from 0.6% (P Z 0.7) in the medial femoral compartment to
5.2% (P! 0.001) in the lateral femoral compartment.
Conclusions: This is the ﬁrst study to examine the precision of qMRI
at 3 T. Our results show that measurements display a very high
linear relationship with previously validated measurements at 1.5 T
and that at 3 T the precision of the measurements can be improved
vs 1.5 T. In addition, decreased slice thickness (1.0 vs 1.5 mm) at 3
T made a greater contribution to improvements in reproducibility
than a gain in signal- and contrast to noise. We thus recommend
a maximum slice thickness of 1 mm for coronal FLASH images of
the knee acquired at 3 T.
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S120Aim: There are limited data on the quantiﬁcation or scoring of all the
structural pathologies visualised by MRI in the OA joint. Several
summative scoring methods have been proposed for the WORMS,
a whole-organ MRI scoring method that evaluates 14 features at
multiple intra-articular sites using scales ranging from 0–1 to 0–7.
Our aim was therefore to evaluate the WORMS using modern
psychometric approaches.
Methods: MR images from 336 knee assessments with WORMS
recorded by three readers were included in the analysis. The four
proposed scoring systems: (1) combined total score for all
abnormalities; (2) combined score of individual feature for all sites,
(3) combined scores for surface (cartilage and bone) features by
compartment, and (4) each feature by compartment were tested
against the expectations of the Rasch measurement model.
Results: (1) Substantial re-scoring of items was required for all
individual feature subscales. Using a total combined score, there
was no ﬁt to the Rasch model. (2) Bone marrow edema (BME) and
sub-articular cysts showed adequate ﬁt to the model (P > 0.003),
although the former had one site score removed. Bone attrition also
demonstrated adequate ﬁt, following the removal of four (of 14) site
scores. For osteophytes, collapsing categories (recoding) into a 0–
2 scale demonstrated a hierarchical response, but still the subscale
still failed to ﬁt the model. Substantive problems remained with
cartilage morphology and cartilage signal subscales. (3) Aggregat-
ed compartment speciﬁc scores for surface features again needed
re-scoring and did not ﬁt the model. (4) For those sites that could be
evaluated, BME in the medial and lateral compartments, medial
sub-articular cysts and medial menisci all ﬁtted the model, however,
the cartilage and osteophyte subscales remain problematic.
Conclusions: Applying this strict measurement model suggests that
care should be taken if considering use of the currently proposed
WORMS recommendations for summating the total knee or speciﬁc
compartment scores. However, individual subscales such as BME
and cysts appear to be working and there is opportunity for re-
developing other subscales.
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Aims: During routine arthroscopy surface of the articular cartilage is
evaluated visually and with manual probing, but possible de-
generation of the deep cartilage and subchondral bone remains
undetected. Ultrasound imaging is one of the advanced cartilage
evaluation methods which could even be adapted to arthroscopic
use. We characterized spontaneous repair of porcine cartilage in
situ with quantitative 2D-ultrasound imaging.
Methods: At the age of 7–8 months, a cartilage lesion (dia. 6 mm,
not penetrating into subchondral bone) was created on the lateral
patello-femoral groove of right porcine knee (n Z 8). The porcines
were sacriﬁced after 3 months follow-up. The lesion site, adjacent
cartilage and the corresponding control area (nZ 5, at the left joint)
were 2D imaged with 20 MHz ultrasound instrumentation.
Ultrasound reﬂection coefﬁcients were determined from the
cartilage surface (R) and from the cartilage bone interface (R–
bone). Further, microtopography of the surface was quantiﬁed by
calculating the ultrasound roughness index (URI) parameter from
the ultrasonically detected surface proﬁle. Kruskall–Wallis post hoc
test was used for statistical analyses.Results: Lesion site was spontaneously ﬁlled with visually cartilage-
like soft tissue with smooth surface. However, ultrasonic images
(and histology) revealed erosion of subchondral bone under the
lesion site. Tissue thickness was highest in the lesion site.
Reﬂection from the surface (R) was signiﬁcantly decreased at the
lesion site as compared to control cartilage. At the lesion site R–
bone was signiﬁcantly lower than at the adjacent cartilage area.
Cartilage surface roughness, as indicated by URI, was higher
(P ! 0.01) at the lesion site than at the control area.
Conclusions: In this study, quantitative ultrasound was used for the
evaluation of cartilage repair for the ﬁrst time. Along with qualitative
ultrasound imaging information, R, R–bone and URI offered critical
data about the status of the lesion site and adjacent cartilage.
Immature cartilage showed signiﬁcant capability for self-repair.
Hence, young porcine may not provide an optimal model for
cartilage repair techniques such as ACT or microfracture. However,
ultrasound analyses revealed that the subchondral bone was
eroded and there were minor changes in the adjacent cartilage.
These changes would not be detectable by traditional arthroscopic
means. We have previously demonstrated that ultrasound re-
ﬂection (R) and surface roughness (URI) will decrease and
increase, respectively, after enzymatic degradation of collagens.
In this study, at the lesion site, these parameters were affected
similarly, indicating that the structural integrity of the spontaneously
repaired cartilage was inferior.
Arthroscopy is a routine procedure in the evaluation of joint status.
More quantitative, yet simple, arthroscopic methods should be
developed for the follow-up of surgical cartilage repairs and
diagnosis of OA. Quantitative ultrasound imaging may provide
a means for grading of cartilage and subchondral bone structural
integrity.
P297
THE ASSOCIATION BETWEEN PHYSICAL EXAMINATION AND
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Aim: To determine the association between MRI ﬁndings and
physical examination of the knee in individuals referred for knee
pain.
Methods: Patients were prospectively enrolled if they had a physical
examination and an MRI performed on the same knee on the same
day. The study knee was the most painful knee at the time of the
visit. Exclusions: (1) major trauma to the knee and (2) conﬁrmed
inﬂammatory arthritis. All patients completed a set of question-
naires. A rheumatologist performed a knee examination document-
ing pain, warmth, ﬂuid, crepitus, range of motion, ligament stability
and alignment. MRI was performed using a 1 T extremity scanner.
Sequences included a sagittal T1-weighted, 3D spoiled gradient
echo with fat saturation, a sagittal T1-weighted fast spin echo
(FSE), a coronal T2-weighted FSE and an axial FSE inversion
recovery. A radiologist semi-quantitatively graded the MR scans for
cartilage lesions, subchondral cysts, bone marrow edema, osteo-
phytes, meniscal degeneration and tears, joint effusions and loose
bodies. Statistical analyses included exact multivariable logistic
regression (adjusted for age, sex and body mass index (BMI)) and
kappa correlation. Odds ratios (OR) and P-values were calculated.
Results: The 45 patients enrolled included 36 women, mean age
(SD) 64 (12) years and mean BMI (SD) 30 (6) kg/m2, and 9 men, 64
(10) years and 30 (5) kg/m2. Mean duration of knee pain was 8.2
(8.4) years. At the time of interview, 72% of patients had knee pain;
72% had pain in one of their other joints in the past; 42% had
a family history of OA and 16% of patients were not aware of their
family history. Large osteophytes (at all sites), R0.5 cm, were
positively associated with restricted range of motion on knee
examination, including medial femur (MF: OR Z 10.8; P Z 0.05),
lateral femur (LF: ORZ 20.2; PZ 0.002), medial tibia (MT: ORZ
S12122.8; P Z 0.008), lateral tibia (LT: OR Z 7.7; P Z 0.02), femoral
trochlea (FT: ORZ 12.6; PZ 0.02) and patella (P: ORZ 9.2; PZ
0.05). Large osteophytes on the LF were also positively associated
with pain on examination (OR Z 8.9; P Z 0.02). No signiﬁcant
associations were identiﬁed between crepitus on knee examination
and the presence, location or severity of osteophytes or cartilage
defects on MRI. No correlation was found between pain on
examination of the knee and the presence, location or severity of
bone marrow edema, osteophytes (except LF) or cartilage defects;
or the presence or severity of knee effusions; or the presence of
subchondral cysts, meniscal degeneration or tear on MRI. The
McMurray test could not be evaluated due to a low number of
positives in this population. The kappa correlation between the
presence of ﬂuid on MRI vs physical examination was poor at 0.22.
Conclusions: Restriction of knee range of motion on physical
examination was signiﬁcantly correlated with the presence of large
osteophytes on MRI evaluation of the same knee. Otherwise
physical examination did not correlate well with MRI ﬁndings of
cartilage defects, bone marrow edema, subchondral cysts, menis-
cal degeneration, meniscal tears or joint effusions.
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Aim: This study was aimed to evaluate the association between
chondral defects utilizing near infrared spectroscopy (NIR).
Materials: Osteochondral samples from the lateral femur condyle
(areas with normal cartilage, chondral damage of degree II and III
according to Outerbridge) were obtained during knee arthroplasty.
There were a total of 31 patients (10 males, 21 females; age 71.1
G 5.1 years).
For NIR-investigation a ﬁber optic micro-spectrometer with a spec-
tral range of 1100 nm to 1700 nm and spectral resolution of 10 nm
was used. A ﬁber optic surface probe was used for light delivery
and collection.
Data preprocession was performed using custom software written
in MATLAB (MathWorks). Absorption spectra in relative absorption
units [AU] were calculated from the reﬂection spectra of the
samples and a spectrum of a gold reﬂection standard. The mean
spectrum from both measurements of each sample was calculated.Baseline effects were removed by vector normalization. The
biggest variance in the spectra was found in the region from
the 1430 nm to 1510 nm (around a peak at 1470 nm) and therefore
the mean absorption in this area was used as signal for statistical
evaluation. Figure 1 shows full spectra of all samples after
normalization.
Statistical analysis: After testing for normal distribution and variance
homogeneity, a One-Way Analysis of Variances (ANOVA) and
post-hoc pairwise comparison of means were preformed by
applying a 2-sided Dunnet’s t test with the porcine as the control
group.
Results: Healthy cartilage produces a meanly relative absorption of
0.055 G 0.008 AU around 1470 nm (group a). In specimens with
a higher degree of chondral damage (group c, degree III according
to Outerbridge) we measured a signiﬁcant higher relative absorp-
tion (0.062G 0.007 AU). In tendency the relative absorption (0.058
G 0.006 AU) in chondral damage of degree II (group b) was higher
than in healthy and lower than in case of higher damage (Fig. 2).
Conclusions: Damaged cartilage samples absorbed differently
around 1470 nm than healthy samples. This absorption wavelength
corresponds mainly to the water content. The relative absorption
increases in cases of chondral damage. The measurement of these
changes may be a possibility to discriminate chondral damages
intraoperatively in future.
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Purpose: The natural history of osteoarthritis (OA) often includes
painful episodes probably related to synovial inﬂammatory reaction
and probably correlated to the severity of chondropathy and of
S122subsequent chondrolysis. Nevertheless the prevalence of synovitis
and effusion, their correlation, as well with clinical parameters has
not been shown. The study objectives were: the assessment of
prevalence of synovitis and effusion in patients with chronic painful
knee OA, using ultrasonography (US) ﬁndings as gold standard;
and the evaluation of correlation between synovitis, and effusion,
and clinical parameters in order to propose a decisions rules for
recognize an inﬂammatory episodes of painful knee OA.
Patients and methods: Study design: Cross-sectional, multi-center,
European study (Belgium, France, Germany, Italy, Spain, Switzer-
land, UK) conducted under aegis of EULAR. Patients: Primary knee
OA (ACR criteria) with painful episode (VAS pain R 30 mm). Data
collected: (1) A rheumatologist collected the clinical data: (pain after
daily activities, sudden change in the pain level, night pain, morning
stiffness, knee effusion at physical examination). (2) A radiologist or
a rheumatologist experienced in musculoskeletal ultrasound
performed the US of the study knee and collected speciﬁc data
(knee synovitis R 4 mm, effusion R 4 mm). Statistical analysis:
Univariate, multivariate, CART.
Results: Six hundred patients were included, 72.5% were females.
In the total population, 53.6% of patients with painful knee OA had
no objective signs of inﬂammation. However, the prevalence of an
inﬂammatory episode (synovitis and effusion) at US was important
46.4%; and the correlation between these variables was statistically
signiﬁcant (P ! 0.0001). Patients (37.3%) had at least 2/4 of
clinical signs suggestive of an inﬂammatory ﬂare. Nevertheless only
52.5% of these had objective inﬂammatory signs at US. Patients
with a more severe radiological grade (Kellgren-Lawrence score R
3), and moderate or important joint effusion at clinical examination
had an increase probability to detect synovitis at US examination,
with an OR of 2.20 and 1.97, respectively. In patients with a less
severe Kellgren-Lawrence score (%2), the probability to detect
synovitis at US was related to the presence of a sudden
aggravation of pain, with an OR of 1.83. A second multivariate
analysis consisting in building a decision tree was conducted to
look for a possible extrapolation of these results to an individual
level. This analysis did not improve the sensitivity and speciﬁcity
(LR ! 2).
Conclusions: This ﬁrst multi-center US study permitted the
evaluation of prevalence of an inﬂammatory episode in painful
knee OA. These results suggest that US might be used as an
effective tool in detecting synovitis and effusion in clinical daily
practice.
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Aim: The aim was to evaluate ‘‘normal’’ ranges of medial minimum
joint space width (mJSW) in the knees of healthy women and to
compare these values with those in women with osteoarthritis (OA).
Methods: Women in the ‘‘healthy’’ group included 20–69 year olds
with no knee pain, no bone/joint disease and no knee injury. Those
in the OA group included 30–89 year olds who had been clinically
diagnosed with knee OA. All volunteers consented to have a single,ﬁxed-ﬂexion knee radiograph acquired of her non-dominant knee.
Radiographs were graded by a radiologist according to the
Kellgren-Lawrence (K-L) scale. Films were then digitized using
a Vidar Sierra Plus digitizer and analyzed for medial mJSW using
an automated computer algorithm.
Results: Of 87 females who participated, 62 were healthy and 25
had knee OA. The mean (SD) age and BMI of the healthy group
were 39.1 (13.6) years and 24.2 (4.3) kg/m2, respectively. K-L
grading revealed 43 ﬁlms were grade 0 and 19 were grade 1,
conﬁrming no individuals showed radiographic evidence of OA.
There were no signiﬁcant differences in mJSW between knees
graded 0 and those graded 1 on the K-L scale (P > 0.05). The
number of healthy women and their mean mJSW values per
decade are displayed in Table I. The mean (SD) age and BMI of the
OA group were 62.2 (11.7) years and 28.0 (5.8) kg/m2, respectively.
K-L grading of radiographs revealed three grade 0, four grade 1,
nine grade 2, three grade 3 and four grade 4. Thus, seven women
with clinically diagnosed OA had no radiographic evidence of
disease (K-L scores %1). The age distribution and results of the
mJSW analyses for each age group are also displayed in Table I. A
graphical representation of the the comparison between healthy
and OA data is shown in Fig. 1.
Conclusions: These data suggest a ‘‘normal’’ range of mJSW for
healthy females likely lies between 4.55 and 5.00 mm with a slight
decrease in mJSW over time. However, mJSW appears to
decrease by a much greater magnitude over time in those with
OA. Minimum joint space width values in OA patients are smaller
than healthy women in the same age group. As expected, mJSW
values decrease with increasing K-L grade, although there is no
difference in mJSW values between those graded 0 and 1 as these
grades are considered to be ‘‘normal’’.
Table I
Age and mJSW distribution in healthy and osteoarthritic women
Decade N
Mean (SD)
mJSW (mm)
Healthy 20–29 21 5.00 (0.54)
Healthy 30–39 11 4.49 (0.69)
Healthy 40–49 12 4.82 (0.74)
Healthy 50–59 13 4.57 (0.76)
Healthy 60–69 5 4.61 (0.44)
OA 30–39 1 5.75
OA 40–49 2 4.43 (0.28)
OA 50–59 9 4.12 (1.22)
OA 60–69 6 3.07 (2.18)
OA 70–79 5 1.85 (1.83)
OA 80–89 2 0
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Aim of the study: To investigate quantitatively the changes in
ultrasound backscattering from the cartilage–bone interface during
spontaneously developed osteoarthritis (OA) in vitro. Ultrasound
attenuation in the overlying cartilage was also measured, and its
effect on the backscatter results was investigated.
Methods: Osteochondral samples were prepared from the bovine
patellae with normal (n Z 13) or degenerated (n Z 19) cartilage
surface appearance. Quantitative ultrasound 2D-images were
acquired for all samples. Ultrasound reﬂection and backscattering
from the cartilage–bone interface was quantiﬁed by calculating the
ultrasound reﬂection coefﬁcient in time-domain (R (%)) and
integrated reﬂection coefﬁcient in frequency domain (IRC (dB),
frequency band 8–12 MHz). Subsequently, small cartilage plugs
were detached from the subchondral bone, and ultrasound
attenuation was measured for those samples using a mechano-
acoustic material testing instrument. Attenuation in the cartilage
samples was calculated both in time-domain (amplitude attenua-
tion) and in frequency domain (integrated attenuation, frequency
band 5–9 MHz), and the backscattering results were corrected for
the variations in attenuation. Finally, the degenerative grade of the
each sample was histologically determined using the Mankin
scoring method, and the samples were divided into two groups
according to their Mankin score: intact (Mankin scoreZ 0, nZ 11)
and degenerated (Mankin score Z 1–10, n Z 21).
Results: An increase in echogenicity from the cartilage–bone
interface and a decrease in echogenicity from the cartilage surface
were visually observed in ultrasound 2D-images of degenerated
samples as compared to intact ones. A statistically signiﬁcant
increase (P ! 0.05, Mann–Whitney U test) in ultrasound
backscattering from the cartilage–bone interface was determined
between intact and degenerated sample groups. Furthermore,
correlations between the Mankin score and R or IRC were
statistically signiﬁcant (r Z 0.37 and 0.40 for R and IRC,
respectively, P ! 0.05). After correcting the results for backscat-
tering from the cartilage–bone interface with the attenuation of the
overlying cartilage (as well as with cartilage surface reﬂection),
signiﬁcant increase in absolute values of ultrasound backscattering
parameters was observed, however, correlations between the
Mankin score and R or IRC remained unchanged.
Conclusions: In this study it was quantitatively demonstrated, for
the ﬁrst time, that ultrasound backscattering from the cartilage–
bone interface increases in spontaneously developed OA. Further-
more, it was revealed that ultrasound attenuation in the overlying
cartilage has a signiﬁcant effect on the measured backscattering
values from the cartilage–bone interface. In summary, quantitative
ultrasound enables detection of subchondral changes known to
represent one of the ﬁrst signs of osteoarthritis. These changes are
currently impossible to diagnose during arthroscopy. For these
purposes, an arthroscopic ultrasound instrument with acceptable
measurement reproducibility is needed.
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Osteoarthritis of the knee and hip is sometimes treated with
realignment surgery (e.g., high tibial osteotomy) in an effort to delay
the progression of the disease. It is not clear whether these
operations slow or reverse the degeneration of cartilage. Delayed
Gadolinium-Enhanced MRI of Cartilage (dGEMRIC) has recently
been developed and validated to non-invasively assess concen-
tration of glycosaminoglycan (GAG), a macromolecule related to
the material strength of cartilage. It is not clear whether dGEMRIC
can be used to assess the effectiveness of realignment surgery
because it is not known how the hardware implanted during surgery
will affect the scan.
Our objectives were: (1) to assess the dGEMRIC procedure in the
presence of surgical hardware, and (2) to optimize its performance
in the presence of surgical hardware.
We assessed two subjects with metal plates (stainless steel and
titanium) in the proximal tibia after high tibial osteotomy. The subjects
were scanned using the standard dGEMRIC protocol, which involves
a series of inversion recovery (IR) scans used to calculate T1,
a surrogate for GAG concentration. We then tested modiﬁcations to
the dGEMRIC protocol with a phantom. The phantom consisted of
nested bottles with gadolinium-doped salt solutions of different
concentrations. It was scanned with and without metal (titanium
osteotomy plate) placed in contact with the outer bottle.
We scanned the phantom using a standard dGEMRIC protocol (IR
series) as well as a modiﬁed protocol using a saturation recovery
(SR) series.
The subject with a stainless steel plate did not produce viable
images for analysis due to distortion. The subject with a titanium
plate produced images which appeared to have no distortion in the
cartilage area. When analyzed, however, there were signiﬁcant
problems in the cartilage T1 curves that made it impossible to
estimate GAG concentration accurately. The single pixel curves did
not follow a standard T1 curve and were often nearly ﬂat.
For the phantom images, distortion in the proximity of the plate was
evident in IR images with shorter TIs, but not in longer TI images. As
we analyzed T1 curves pixel by pixel from outside the distortion
toward the plate, the null point of the T1 curve appeared to shift left,
implying decreasing T1within the homogeneous liquid. Eventually the
null point shifted below 50ms, and the curves began to look like those
seen in the subject with titanium. The result on the T1 map is an area
of altered T1 values. Using the SR series on the phantom eliminated
the T1 distortion but produced a noisier image than the IR series.
The distortion of the T1 map in the vicinity of surgical hardware
found using the standard dGEMRIC protocol with an IR series
appears to be related to radiofrequency ﬁeld inhomogeneity
introduced by the titanium plate. Using a SR series with the
protocol eliminated the distortion likely because it is more robust
than the IR sequence for T1 measurements in inhomogeneous
ﬁelds. We conclude that dGEMRIC can be used to assess cartilage
GAG concentration in 3 T studies after surgery, provided titanium
hardware and a SR series are used.
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ASSESSMENT AND A DEFINED SLICE ANALYSIS OF SYNO-
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S124Aim: Assessing synovitis in osteoarthritis (OA) is useful for studies
of pain pathogenesis or treatment response. The aim of this study
was to provide a method of deﬁned slice analysis for the volume of
synovitis without the necessity for full regional analysis, thereby
providing a simple measure of synovitis volume.
Methods: Thirty-ﬁve patients with ACR OA of the knee were
assessed with MRI using a 1.5 T scanner with a dedicated knee
coil. Quantitative assessment of synovial volume was performed
using the axial T1-weighted post-Gd-DTPA FS images and image
analysis software with manual outlining. Four anatomical sites were
evaluated: medial and lateral recesses, suprapatellar pouch and
intercondylar notch. The number of enhancing pixels within each
region of interest was calculated in each slice and converted to an
area measurement. The volume of synovitis in each anatomical site
was calculated using the following formula VolsynvolZ S(Arsynvo!
ST), where ST represents the sum of the slice thickness and the
slice gap and Arsynvol represents the area of the synovial volume in
each slice. Using the same techniques, four methods of deﬁned
slice analysis were tested using the same MR images; (1) volume
of synovitis in the most inferior slice of the ROI, (2) sum of the
volumes of synovitis in the inferior and superior slices of the ROI,
(3) sum of the volume of synovitis in the inferior, mid and superior
slices of the ROI and (4) the volume in the mid slice of the ROI. The
volume of synovitis within one slice was calculated using Volsynvol
Z Arsynvo ! ST. In order to determine the predictive capacity of
each of the slice analysis methods with the overall synovial volume
measurement, linear regression analysis was performed.
Results: The best slice analysis predictor of total synovial volume
measurement was (3). This slice analysis method predicted 82% of
the volume in the medial recess (r2 Z 0.818, P Z 0.000), 73% of
the total volume in the lateral recess (r2 Z 0.732, P Z 0.000) and
just under 65% of the total volume in the intercondylar notch (r2 Z
0.643, P Z 0.000). As full coverage of the SPP was not always
achieved (only nine evaluable subjects), a correlative relationship
between each analysis method and the overall synovial measure-
ment was undertaken. Again method (3) demonstrated the
strongest correlation with total volume measurement (r Z 0.917,
P Z 0.000).
Conclusions: This data suggests that a 3-slice analysis on axial
post-Gd sequences provides a simple surrogate measure of
synovial volume.
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NEW COMPUTER SOFTWARE TO ASSESS SEVERITY OF
MEDIAL-TYPE OSTEOARTHRITIC KNEE ON MRI
N. Ochiaiy, T. Sahoy, Y. Waday, M. Taharay, Y. Kawaguchiy,
A. Watanabey, R. Muratay, S. Yamaguchiy, K. Nakagaway,
H. Moriyay, Y. Miyakez, T. Nakaguchiz
y Department of Orthopaedic Surgery, Chiba University, Graduate
School of Medicine, Chiba, Chiba, Japan
z Research Center for Frontier Medical Engineering, Chiba
University, Chiba, Chiba, Japan
Purpose: The purpose of this study is to develop a new computer
software that can measure the irregularity of contour of medial
femoral condyle (MFC) on MR imaging automatically which might
serve as an index that can show the severity of medial-type
osteoarthritic knee (OA) objectively. We then validated its relations
between clinical severity of OA and the index, and conﬁrm the
reliability of the index.
Material and method: Thirty knees with medial-type OA were
involved (mean age: 72.5 years old). None of them had received
surgical treatment beforehand. Their Japanese Orthopedic associ-
ation score (JOA score) were recorded. This score becomes 0–100
according to OA symptoms and knee function. The lower score
means the severer symptoms and dysfunctions of affected knee
joint. All patients underwent MR imaging of the knees on a 1.5-T
unit (Signa, GE medical systems) and proton-weighted sagittal
images were used for this study. Parameters for the proton-
weighted sequence were 2000/16 ms (TR/TE). The ﬁeld of view
was 14 ! 14 cm, matrix 512 ! 256, number of excitations 2, andslice thickness 3 mm without an interslice gap. Irregularity of MFC
was calculated by a newly developed computer software. This
software was programmed in MATLAB6.5. This software can use
DICOM data directly. (1) At ﬁrst, we determined the objective image
that represented the center of medial compartment. (2) The
objective image was made into a black-and-white image. Threshold
between black and white was determined by the software. (3) Then
the contour of MFC was extracted and two parameters were
calculated automatically: (a) the area of the subchondral bone
(Area: tentative units) and the ratio of the length of upper surface
and the length of lower surface (Ratio). The more the OA was
severe, the more the area of the subchondral bone became larger
and the ratio became bigger. Correlation of those data and knee
score were examined.
Results: The area of the subchondral bone ranged from 572 to 1780
(Area: ave. 1200.9). The ratio ranged from 0.976 to 1.442 (ave.
1.143). The JOA score ranged from 30 to 80 (Ratio: ave. 56.4). The
area of the subchondral bone negatively correlated with knee score
with correlation coefﬁcient of –0.56. The ratio also negatively
correlated with knee score with correlation coefﬁcient of –0.48.
Conclusion: We previously indicated that the specimens retrieved
at the time of TKA revealed irregularly described MFC had many
pseudo-cysts in its subchondral plate. We also indicated the
correlation between irregularly described contour and disease
severity of OA. The computer software was useful and easy to
assess the irregularity of MFC. We suggest that the area and the
ratio could serve as an objective index that indicating disease
severity of OA.
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ULTRASOUND PATTERN IN A COHORT OF 170 PATIENTS
SUFFERING FROM HIP OSTEOARTHRITIS
S. Tormentay, A. Migliorez, P. Nardisy, U. Massafraz, A. Alimontiz,
C. Valentez, G. Garlaschix
y Radiology, S.Pietro-FBF Hosp., Rome, Italy
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Aim: To describe the ultrasound (US) patterns of a large number of
patients suffering from symptomatic hip osteoarthritis (OA).
Patients and methods: Patients affected by symptomatic OA of the
hip according to the ARA criteria with Kellgren-Lawrence II and III
radiological degree undergoing intra-articular US guided injection
with hyaluronic products were studied. Before performing the
injection they have been submitted to US examination of the
affected hip. Patients were examined supine with the hip in internal-
rotation of 15–20(. Hip joint was scanned by means of an anterior
parasagittal approach, lateral to the femoral vessels. A 7.5 MHz
linear or 3.5 MHz convex transducer was aligned with the long axis
of the femoral neck, including the acetabolum and the femoral
head. All images were archived and then examined and compared
with normal hip US image.
Results: One hundred seventy patients were studied. The main US
patterns were: (1) normal femur head proﬁle (44.1%); (2) leveling of
a regular femur head proﬁle (11.2%); (3) increase of the angle of
the femur head-neck junction proﬁle caused by initial deformity of
head femur (23%); (3) irregular femur head proﬁle by osteophytes
and/or bone erosions (18.8%); (4) Acetabulum prominence (2.4%).
There are also three subsets: (a) synovial proliferation (8.2%); (b)
joint effusion (3.5%); (c) ileopsoas bursitis (2.4%). These ﬁndings
may be found alone or associated. Loose joint bodies were not
found.
Conclusions: US scanning of the hip may give useful information
about the state of synovial membrane, synovial ﬂuid, articular
cartilage, joint margins, bone proﬁle, bursae presence also in hip
OA. Further studies are needed to evaluate their prevalence in hip
OA symptomatic and not-symptomatic patients and their correlation
to X-ray ﬁndings, severity disease and treatment outcome. Hip
sonography might be useful to monitor OA hip progression with
accuracy.
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TRAVELLING-WAVE CALIBRATION OF INTRA-ARTICULAR
SHEET ARRAY PRESSURE SENSORS
T. E. Baer, D. R. Pedersen, M. J. Rudert, N. A. Vos,
N. M. Grosland, T. D. Brown
Orthopaedic Surgery and Rehabilitation, University of Iowa, Iowa
City, IA, USA
Abnormal mechanical stress distributions, particularly those arising
from joint incongruities, are a signiﬁcant precursor of secondary
osteoarthritis. Techniques for accurate measurement of intra-
articular pressures are important to elucidating OA pathogenesis.
Sheet array pressure sensors have come into increasing use in
biomechanical research to measure transient contact stress
distributions in articular joints, but are notoriously difﬁcult to
calibrate. A novel device and concomitant software are here
reported to efﬁciently calibrate sheet array pressure sensors on
a junction-by-junction basis and to correct for intra-experimental
deviations from their original responses.
Sensor response is highly non-linear, and the even application of
the high loads required for calibration is difﬁcult to achieve.
Furthermore, localized compressive and shear stresses generated
in gait-cycle loading, especially in the presence of incongruities,
tend to exacerbate existing disparities within the array and make
the ability to efﬁciently perform frequent sensor recalibrations
during the course of an experiment highly desirable.
A ‘‘wringer’’ device was built to apply a known force transiently to
subset rows of junctions in turn as the sensor is passed between
a pair of rollers that distribute the load over multiple rows of
Fig. 1. Calibration device with Tekscan ankle sensor inserted
between the rollers.junctions while concentrating force on the center row of the contact
patch (Fig. 1). Gears constrain the rollers to rotate at the same
velocity (but in opposite directions) to minimize shear forces.
Raw data were captured using the sensor manufacturer’s software
and processed using Matlab. The pressure history at each
junction was assumed to follow the stress distribution for a ﬁnite
element model of two parallel cylinders in contact. The instanta-
neous load on each sensor row as it traveled through the device
was calculated, and calibration curves were ﬁt correlating raw
output to stresses for each individual junction.
The result was a full set of algebraically consistent calibration
curves that yield accurate location-speciﬁc pressure readings
across the entire area of the sensor.
Sensor response is highly dependent on the compliance of the
mating surface materials. At the beginning of each testing session,
the system was tuned by applying known static loads across the
joint. The integrated loads reported by the sensor were then
adjusted to the speciﬁc test environment.
The resulting joint- and sensor-speciﬁc calibration curves accu-
rately converted the raw data to corresponding physical pressure at
each individual junction. Subsequent roller-based recalibrations
allowed monitoring of sensor performance and correction for
localized changes to ensure the integrity of the data as local stress
concentrations induced change in individual junction responses.
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INCREASED TIBIAL PLATEAU BONE MINERAL DENSITY
ASSOCIATED WITH PAIN
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Introduction: The ratio of medial vs lateral tibial plateau bone
mineral density (M:L BMD) is correlated with dynamic loading of the
knee (which is difﬁcult to assess clinically) with an increased M:L
BMD reﬂecting increased medial loading. If increased loading is
associated with pain, then in those with medial OA, higher medial
tibial bone density should be associated with more pain. Therefore,
we hypothesized that in medial OA, higher M:L BMD would be
associated with more pain.
Methods: We examined the Framingham OA Study Cohort,
a population-based cohort. All participants had knee BMDs, and
weight-bearing PA semi-ﬂexed knee X-rays (2002–2004). Femoral
neck BMDs were also measured. M:L BMD ratios were calculated
using a previously developed customized BMD region of interest
from medial and lateral regions in the tibial plateau (repeat
acquisition, ICC Z 0.96). Knee X-rays were read for K/L grade,
osteophytes, and joint space narrowing (JSN) using the OARSI
scoring system by a bone and joint radiologist. Subjects were
classiﬁed as having medial OA if they had either (1) K/L R 2 and
medial JSN R 1; or (2) a medial osteophyte with no lateral
osteophyte, and no lateral JSN. Subjects were assessed for pain
on most days in each knee.
Spline curves were created to obtain more detail regarding the
dose–response relation between M:L BMD and pain. We selected
referent groups based on the spline curves. We performed a logistic
regression in subjects with medial OA, with pain as the dependent
variable and quartiles of M:L BMD ratio as independent variables,
using GEE to adjust for correlation between knees. We also
adjusted for age, sex, body mass index, and femoral neck BMD. As
sex was a signiﬁcant confounder in the logistic regression, sex-
speciﬁc analyses were also performed.
Results: Mean age of 236 subjects (339 knees with medial OA) was
68.7 (SD G 8.7), with 50% women, and mean BMI 30.7 (SD G
5.9). Based on the J shaped sex-speciﬁc spline curves, referent
groups were assigned as the second quartile for men and the third
quartile for women.
S126Conclusions: Differences in nadir of pain prevalence based on M:L
BMD quartiles in the sex-speciﬁc curves suggest a difference
between sexes in loading within the knee. In those with medial OA,
people in the highest quartile of M:L BMD were the most likely to
report pain. These ﬁndings support the relation between the
presence of knee pain and increased loading as indicated by
increased local bone density. Thus, unloading the knee could
potentially alleviate OA-related pain.
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THE RELATIONSHIP BETWEEN RADIOGRAPHIC STATIC
ALIGNMENT AND DYNAMIC KNEE VARUS MOMENT IN
HEALTHY SUBJECTS AND PATIENTS OF KNEE OSTEOAR-
THRITIS
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y Graduate School of Human Sciences, Waseda University,
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Aim of this study: The difference of walking mechanism between
Osteoarthritis (OA) patients and healthy elder is still unclear. The
aim of this study was to draw a comparison between normal healthy
subjects and patients of knee OA about the relationship between
static lower leg alignment and dynamic knee external varus
moment during level walking.
Methods: The study design was cross-sectional group comparison
study between symptomatic subjects group and control subjects
group. Thirteen symptomatic OA subjects and 20 healthy subjects
participated in this study. All of them were elderly woman aged from
50 to 70 years. Their static alignment of lower legs by whole leg
radiograph and dynamic varus moment of the knee during stance
phase of level walking were measured. The radiographs were taken
in double legs standing position. The static lower limb alignment
was assessed by Hip–Knee–Ankle (HKA) angle. The kinetic data
was sampled with VICON512 motion analysis system and force
platform. The subjects were asked to walk through the 10 m
walkway with bare feet. The walking speed was self-paced decided
by subjects. The knee varus moment were calculated with our own
program. Pearson correlation coefﬁcients were used to determine
signiﬁcant correlations between HKA angle and dynamic knee
varus moment.
Results: The HKA angle was 1.56 G 3.62( in healthy elder
subjects and 3.38G 4.25( in OA subjects. Also, the dynamic knee
Table I
M:L BMD quartiles
1
(lowest ratio)
2 3 4
(highest ratio)
Overall
Men
Crude pain
prevalence
10/42 7/42 13/42 21/42 51/168
Adjusted pain
prevalence
ratio (95% CI)
1.3
(0.6–1.3)
1.0
(reference)
2.1
(1.0–4.3)
2.9
(1.4–6.0)
M:L BMD
range
0.72–1.15 1.16–1.26 1.26–1.35 1.35–1.61
Women
Crude pain
prevalence
13/42 15/43 8/43 26/43 62/171
Adjusted pain
prevalence
ratio (95% CI)
1.7
(0.8–3.9)
1.9
(0.9–3.9)
1.0
(reference)
3.2
(1.6–6.4)
M:L BMD Range 0.90–1.13 1.13–1.20 1.20–1.31 1.32–1.92varus moment was 0.32 G 0.07 Nm/kg in healthy elder subjects
and 0.36 G 0.11 Nm/kg in OA subjects. Both of these parameters
were higher in OA subjects. However, the difference between
groups was not signiﬁcant. There was signiﬁcant positive correla-
tion between HKA angle and dynamic knee varus moment during
gait in healthy subjects (r Z 0.71, P ! 0.001). But, there is no
correlation in OA patients (r Z 0.24, P > 0.05).
Conclusions: It is concluded that there is different relationship
between lower leg alignment and dynamic knee varus moment
between normal subjects and OA subjects. In the OA patients,
dynamic knee loading were not affected by static loading axis
directly. We speculated that the compensation to reduce knee pain
affects the different mechanism of symptomatic OA group.
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SYNOVIAL FLUID REPLACEMENT IN ARTHROSCOPIC
SHOULDER SURGERY – A RANDOMISED, PROSPECTIVE,
CONTROLLED TRIAL
L. Funk, P. R. Wykes
Orthopaedic Surgery, Hope Hospital, Manchester, Lancashire,
United Kingdom
Introduction: Shoulder arthroscopy has become a widely used
procedure for both diagnosis and treatment. It offers less surgical
insult than a traditional open approach, with a correspondingly
quicker recovery. However, it is not an absolutely benign pro-
cedure, due both to the effects of the irrigation solution on articular
cartilage metabolism as well as post-operative pain, subsequent
joint immobilization & secondary stiffness.
Viscoseal (TRB Chemedica, AG) is a 0.5% isotonic solution of 1.2
Million Dalton molecular weight hyaluronan. Hyaluronans are
a normal proteoglycan component of hyaline cartilage and synovial
ﬂuid, and play an important role in joint lubrication and metabolism.
Hyaluronan has been proven to have short-term beneﬁts in
reducing joint pain and swelling whilst increasing mobility following
knee arthroscopy.
The aim of this study was to assess the effect of Viscoseal on the
short-term outcomes of shoulder arthroscopy.
Materials and methods: Fifty-eight adult patients of the senior
author undergoing arthroscopic subacromial decompression were
randomised into two groups. The ﬁrst group received 10 ml of
Viscoseal and 10 ml of 0.5% bupivicaine (local anaesthetic)
injected into the subacromial bursa via the arthroscope at
completion of the procedure (n Z 28). These patients were
controlled by a matched group of patients who received 20 ml of
0.5% bupivicaine only (n Z 30). All procedures were performed or
supervised by the senior author.
S127Results: The mean age of the viscoseal group was 50.5 years (24–
74) and in the control group 48.9 (31–80).
The early post-operative data shows that the Viscoseal group
experienced less severe pain 4 h post-operatively than the control
group, with 3.5% of the Viscoseal group experiencing severe pain
compared to 23% of the control group. Twenty-nine percent of the
patients in the Viscoseal group felt no pain at 4 h post-operatively,
while none of the patients in the control group had no pain (Fig. 1).
The Viscoseal group also required less analgesia post-operatively
than the control group. Twenty-ﬁve percent of the Viscoseal
required no analgesia, whilst all patients in the control group
required analgesia. The percentage of control group that required
opiates was 33.3% compared to 10.7% in the Viscoseal group (Fig.
2).
The time to discharge from hospital for the Viscoseal group was 5.2
G 13 h, and for the control group 9.6G 5.3 h. This was signiﬁcantly
earlier (P Z 0.0001).
There were no adverse events in either group.
Conclusions: Patients receiving injections with Viscoseal felt less
post-operative pain and required less post-operative analgesia.
They were discharged twice as early as those not getting Viscoseal
injections.
Viscoseal seems to have a useful role to play in improving early
outcomes after shoulder arthroscopic surgery.
Fig. 1. Pain level at 4 h post-op.
Fig. 2. Strong analgesia required 4 h post-op.P310
EFFECTIVENESS AND SAFETY OF RETREATMENT WITH
HIGH MOLECULAR WEIGHT HYALURONAN (HMWH; ORTHO-
VISC): RESULTS FROM AN EXTENSION OF A RANDOMIZED
CONTROLLED TRIAL
C. A. Birbaray, M. Bellz, J. R. Caldwellx
y Associate Professor of Medicine, UMass School of Medicine,
Worcester, MA, USA
z Department of Medicine, Division of Rheumatology, Sunnybrook
and Women’s College Health Sciences Centre, Toronto, ON, Canada
x Medical Director, Radiant Research, Daytona Beach, FL, USA
Aim: The OAK0101 (‘‘extension study’’) objective was to assess the
effectiveness and safety of a repeat course of three injections of
intra-articular HMWH for treatment of joint pain in knee OA patients
(pts) who had completed OAK2001 (‘‘original study’’) and were still
experiencing some pain (WOMAC R 200 and!400 mm for index
knee) at ﬁnal follow-up 28 weeks (wks) after the ﬁrst injection.
Methods: The extension study was a multi-center open-label
extension of the original study. Of the 372 pts randomized in the
original study, 190 (51%) had knee pain of sufﬁcient degree at Wk
28 to qualify for enrollment in the extension study, which called for
an arthrocentesis procedure plus an HMWH injection for 3
consecutive wks. The ﬁrst injection (Wk 0) was designed to occur
within 4 months of Wk 28 of the original study, in which pts were
randomized either to 4 HMWH injections, 4 arthrocentesis
procedures, or 3 HMWH injections C 1 arthrocentesis procedure.
The primary outcome measures of the extension study were the
rate of adverse events (AEs) and effectiveness as assessed by the
proportion of pts achieving a 20%, 40%, and 50% improvement in
WOMAC pain score at wks 1, 2 and 6. Further effectiveness
analyses summarized the ‘‘best response’’ (lowest post-baseline
value) in WOMAC pain and Investigator Global Scores for both
studies for pts who enrolled in the extension study.
Results: The intent-to-treat population (n Z 188) was 51.6% male,
with a mean age of 59.5 years, mean baseline WOMAC pain score
of 288.2, and mean baseline Investigator Global Score of 59.6.
There were no differences among the 3 original study randomiza-
tion groups for any baseline factor. The AE proﬁle was similar for
the two studies in terms of both incidence and severity. AEs
occurring in O5% of pts in the original or extension study were as
follows: arthralgia, 3.7 vs 5.3%, headache, 14.2 vs 3.7%, and
nasopharyngitis, 6.8 vs 1.6%, respectively. Device-related AEs
(including nausea, dysgeusia, injection site events, joint swelling,
arthralgia and effusion) were noted at rates similar to the original
study. In terms of effectiveness, 78% of pts achieved a 20%
improvement in WOMAC pain score at 6 wks, and 48% a 50%
improvement. In terms of WOMAC pain score best response, the
mean percent change from baseline was comparable between the
two studies (57.1% for original vs 52.9% for extension).
Similarly, the mean change from baseline in Investigator Global
Score best response was comparable for the original and extension
studies (31.9 and 33.7, respectively).
Conclusions: Extension study pts achieved clinically meaningful
improvements for both WOMAC pain and Investigator Global
outcomes, with pain improving to levels consistent with those seen
in the original study, demonstrating that a second course of
treatment with HMWH is equally effective as the ﬁrst. The
incidence, severity and proﬁle of AEs were comparable to those
observed in the original study, indicating that retreatment with
HMWH is safe.
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PATIENTS WITH KNEE OSTEOARTHRITIS
L. A. Mendozay, R. Quiney, J. A. Roman-Blasz
y Musculoskeletal & Pain Management Department, National Re-
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z Division of Rheumatology, Thomas Jefferson University, Phila-
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S128Objective: We examined the relationship between pain and
disability in patients with symptomatic knee OA and its correlation
with age (elderly and middle-age).
Methods: Thirty out-patients with knee OA treated at the
Musculoskeletal Disorders & Pain Management Department of
the National Rehabilitation Institute in Lima-Peru, during July 2000
to June 2001, were selected by inclusion and exclusion criteria. We
used self-reported measures for pain and disability, a Spanish
version of the WOMAC index (Battle-Gualda & Esteve-Vives1) and
a pain numerical scale (numerical rating scale; NRS). The variables
age, NRS, WOMAC total score, WOMAC pain, stiffness and
function subscale scores were analyzed by Pearson correlation
and multivariable analysis, regression analysis, and Z test to
determine the difference between the two age groups.
Results: The relationship between NRS and WOMAC function
subscale was linear (P Z 0.00008), as well as the one between
WOMAC pain and WOMAC function subscales (P Z 0.0000039).
The relationships between NRS and WOMAC score total and pain
subscale were also linear (P Z 0.00011, P Z 0.00386, re-
spectively). The correlation coefﬁcients for the relationships
between NRS and WOMAC pain, stiffness and function subscale
scores and WOMAC total score were 0.51, 0.43, 0.66 and 0.65,
respectively. In addition, the coefﬁcients among WOMAC subscale
scores were also positive, the highest one being between pain and
function scale scores (0.74). There was no statistically signiﬁcant
difference in all variables analyzed between patients!60 years old
and R 60 years old, although a numerical difference was found.
Conclusions: In this sample of Peruvian patients with knee OA,
using a Spanish WOMAC version (Batlle-Gualda & Esteve-Vives1),
NRS and WOMAC function subscale displayed positive linear
relationship, not due to random association, as well as the one
between WOMAC pain and WOMAC function subscales. There
was not a statistically signiﬁcant difference in these relationships
between elderly and middle-age patients, even though there was
a numerical difference.
References
1. Escobar A. et al. Validation of the Spanish Version of the Womac
Questionnaire for patients with hip or knee osteoarthritis. Clin
Rheumatol 2002;21:466–71.
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EFFECT OF TREATMENT WITH ROFECOXIB COMPARED TO
OXYCODONE/ACETAMINOPHEN ON ACUTE PAIN SEVERITY
AND PATIENT FUNCTION EVALUATED WITH THE BRIEF PAIN
INVENTORY
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USA
Aim of study: Patients with osteoarthritis and other rheumatic
conditions often require treatment for ﬂares of acute pain.
Rofecoxib (ROF) 50 mg has demonstrated efﬁcacy in treatment
of acute pain using a validated dental pain impaction model
compared to NSAIDs and opioids. The pharmacokinetics of ROF
are consistent with once daily dosing, while NSAIDs and opioid
analgesics generally require multiple daily dosing to provide 24 h
pain relief. A recently completed double-blind, 24 h, randomized
study compared total pain relief with a single 50 mg dose of ROF
and multidose oxycodone/acetaminophen (OXY/ACET). We further
examined the effect on pain severity and patient function with ROF
and OXY/ACET.
Methods: Two hundred seventy-one patients underwent surgical
extraction of R2 third molars and were randomized to single-dose
ROF 50 mg (N Z 121), OXY/ACET 10/650 mg followed by 5/325
mg every 6 h as needed (NZ 120), or placebo (PBO) (NZ 30) for
24 h. The primary endpoint was total pain relief over 6 h (TOPAR6)
(comparability boundsG2.5). Sum of pain intensity difference over
24 h (SPID24) (comparability boundsG10) was the key secondaryendpoint. Patients were evaluated 24 h post initial dose for pain
severity and patient function using the Brief Pain Inventory (Short
Form) ‘‘Severity’’ and ‘‘Interference’’ scales (0 ‘‘best’’ to 10 ‘‘worst’’).
Results: ROF and OXY/ACET were comparable based upon
TOPAR6 [12.9 vs 11.3; difference Z 1.6 (95% CI: 0.1, 3.2;
P Z 0.059)] and SPID24 [21.9 vs 18.1; difference Z 3.9 (95% CI:
1.0, 8.8; P Z 0.122)] scores that were within predeﬁned bounds.
Among the four Severity questions assessed at 24 h, ‘worst pain’
(6.9 vs 7.4, P ! 0.050), ‘least pain’ (1.2 vs 1.7, P ! 0.050),
‘average pain’ (3.1 vs 4.3, P ! 0.001), and ‘pain right now’ (2.1 vs
3.4, P ! 0.001) were all signiﬁcantly less with ROF than OXY/
ACET. Least pain (1.2 vs 1.9, P! 0.050) and average pain (3.1 vs
4.3, P ! 0.001) were also signiﬁcantly less with ROF than PBO,
with no signiﬁcant differences between OXY/ACET and PBO.
Among Interference questions, signiﬁcant (P ! 0.001) improve-
ment was achieved with ROF compared to OXY/ACET for all seven
endpoints (general activity, mood, walking ability, normal work,
relations with other people, sleep, and enjoyment of life). ROF
demonstrated signiﬁcant improvement compared to PBO in general
activity (P! 0.001), mood (P! 0.001), and enjoyment of life (P!
0.050). Walking ability was signiﬁcantly (P ! 0.050) worse with
OXY/ACET than PBO, with no other signiﬁcant differences between
OXY/ACET and PBO.
Conclusions: In this study of acute pain, a single dose of ROF 50
mg demonstrated total pain relief comparable to multidose OXY/
ACET over 24 h. ROF patients responded signiﬁcantly better on
Brief Pain Inventory Severity and Interference scales than OXY/
ACET patients, corresponding to less pain and better function after
24 h of treatment.
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DEVELOPMENT OF CORE SETS FOR OSTEOARTHRITIS TO
APPLY THE INTERNATIONAL CLASSIFICATION OF FUNC-
TIONING DISABILITY, AND HEALTH (ICF) IN CLINICAL PRAC-
TICE AND RESEARCH
K. E. Dreinhoefery, A. Ciezazx, G. Stuckix
y Department of Orthopaedic, Ulm University, Ulm, Germany
z ICF Research Brand, WHO FIC Collaborating Center,
Ludwig-Maximilians-University, Munich, Germany
x Department of Physical Medicine and Rehabilitation, Ludwig-
Maximilians-University, Munich, Germany
Aim of study: The purpose of this study was to establish an ICF
Core Set (list of ICF categories relevant to most patients with
a health condition) for clinical practice (Comprehensive ICF Core
Sets) and for research (Brief ICF Core Sets) for osteoarthritis (OA).
Methods: A formal decision-making and consensus process
integrating evidence based on the results of preliminary studies
using empirical data from patients, international Delphi surveys,
and systematic reviews was initiated. After training in the ICF and
based on these preliminary studies relevant ICF categories were
identiﬁed in a formal consensus process by international experts
from different backgrounds.
Results: The preliminary studies identiﬁed a set of 388 ICF
categories at the second, third and fourth ICF levels with 144
categories on ‘‘body functions’’, 49 on ‘‘body structures’’; 165 on
‘‘activities and participation’’ and 43 on ‘‘environmental factors’’.
Altogether 55 second-level categories were included in the
Comprehensive ICF Core Set with 13 categories from the
component ‘‘body functions’’, 6 from ‘‘body structures’’, 19 from
‘‘activities and participation’’ and 17 from ‘‘environmental factors’’.
The Brief ICF Core Set included a total of 13 second-level
categories: three on ‘‘body functions’’, three on ‘‘body structures’’,
three on ‘‘activities and participation’’ and four on ‘‘environmental
factors’’.
Conclusion: A formal consensus process integrating evidence and
expert opinion based on the ICF framework and classiﬁcation led to
the deﬁnition of ICF Core Sets for osteoarthritis. These ICF Core
Sets are both intuitive and practical and link the ICF to the
condition-oriented perspective.
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ELEVATED CRP LEVELS IN OSTEOARTHRITIS ARE ASSOCI-
ATED WITH LOCAL INFLAMMATION
A. D. Pearle, C. R. Scanzello, N. Scallet, T. P. Sculco, M. K. Crow
Orthopedic Surgery, Hospital for Special Surgery, New York, NY,
USA
Purpose: Previous studies have demonstrated an association
between osteoarthritis (OA) progression and inﬂammation as
measured by systemic CRP levels. We hypothesize that CRP
levels in patients with OA are pathogenically linked to synovial
membrane inﬂammation. This study investigated the relationship
between CRP, synovial histology, and synovial ﬂuid IL-6 levels.
Methods: Patients with idiopathic OA undergoing either total hip or
knee arthroplasty or knee arthroscopic debridement were identiﬁed.
Synovial membrane inﬂammation was graded by histologic
examination of samples obtained from standardized locations.
Synovial ﬂuid IL-6 levels and plasma CRP levels were measured
using ELISA.
Results: Fifty-nine patients with idiopathic OA were identiﬁed. CRP
levels were elevated in OA patients with synovial membrane
inﬂammatory inﬁltrates compared to OA patients without histologic
inﬁltrates (4.7 mg/L vs 1.7 mg/L, PZ 0.003). CRP levels correlated
with the degree of synovial membrane inﬂammatory inﬁltrate (r Z
0.42, P Z 0.0015), but not with histologic vascularity or synovial
lining hyperplasia. OA patients were then dichotomized into two
groups: high CRP (CRP level O3 mg/ml) and low CRP (CRP !3
mg/ml). The high CRP group demonstrated elevated synovial ﬂuid
IL-6 levels compared with the low CRP group (193.3 pg/ml vs 35.1
pg/ml, P ! 0.001). There was a good and highly statistically
signiﬁcant correlation between synovial ﬂuid IL-6 levels and
systemic CRP levels (r Z 0.63, P Z 0.005). In a multivariate
regression model including BMI, synovial ﬂuid IL-6, degree of
inﬂammatory inﬁltrate, and age, synovial ﬂuid IL-6 and degree of
inﬂammatory inﬁltrate were independent predictors of CRP (P Z
0.02 and P Z 0.04, respectively).
Discussion: We have demonstrated an association between CRP
and local histologic synovial inﬂammation and synovial ﬂuid IL-6
levels in patients with idiopathic OA. The more aggressive disease
seen in OA patients with elevated CRP levels may be mechanis-
tically linked to a more inﬂammatory synovial response in the
diseased joint.
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PROSTAGLANDIN E2-DEPENDENT TRANSCRIPTIONAL SUP-
PRESSION OF TUMOR NECROSIS FACTOR-a IN HUMAN
MACROPHAGES AND RHEUMATOID ARTHRITIS-AFFECTED
SYNOVIAL FIBROBLASTS IS MEDIATED BY EARLY GROWTH
RESPONSE FACTOR-1/KROX-24
W. H. Faoury, D. Jovanovicz, A. Mancinix, Q. W. Hez,
J. A. Di Battistaz
y Molecular Biology, University of Montreal, Montreal, QC, Canada
z Medicine, McGill University, Montreal, QC, Canada
x Anatomy and Cell Biology, McGill University, Montreal, QC,
Canada
Aim: To investigate the immunomodulatory properties of prosta-
glandin E2 (PGE2) by examining the molecular mechanism by
which the eicosanoid suppresses TNF-a mRNA expression and
protein synthesis in human macrophages and rheumatoid arthritis-
affected synovial ﬁbroblasts (RASFs).
Methods and results: PGE2 rapidly and dose-dependently induced
egr-1 mRNA expression and protein synthesis in RASFs (obtained
from RA arthroplasty patients diagnosed based on criteria de-
veloped by the American College of Rheumatology Diagnostic
Subcommittee for arthritis) by restricted SAPK2/p38 MAP kinase-
dependent ATF-2/ATF-2 or ATF-2/CREB-1 transactivation of the
egr-1 promoter, as judged by studies using wild-type (wt) and
deletion mutant egr-1 promoter constructs, northern and westernblotting and standard and super-shift electrophoretic mobility shift
analysis (EMSA). Using THP-1 cells stably transfected with wt and
dominant-negative mutant expression constructs of Egr-1, we
observed that PGE2 inhibition of IL-17-stimulated TNF-a mRNA
expression was dependent on Egr-1 expression, as mutants of Egr-
1, alone or in combination, markedly abrogated any inhibitory effect
of PGE2. When NIH-3T3 stable transfectants were co-transfected
with a wt TNF-a promoter construct, PGE2-dependent suppression
of IL-17 up-regulated promoter activity, largely dependent on ATF-
2/c-Jun transactivation, was blocked in transfectants harboring
mutants of Egr-1. However, the mutation of the Egr-1 site rendered
induced promoter activity partially refractive to either PGE2 treat-
ments or over expression of Egr-1. Subsequent analyses revealed
that PGE2 suppression of IL-17-induced TNF-a mRNA expression
was dependent on Egr-1 and on Egr-1-mediated inhibition of
induced c-Jun expression.
Conclusions: We conclude that egr-1 is an immediate-early PGE2
target gene that may be a key regulatory factor in mediating
eicosanoid control of genes involved in the immune and in-
ﬂammatory response.
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THE EFFECTS OF PULSED SIGNAL THERAPY (PST) ON
SYNOVIAL FLUID MATRIX PARAMETERS, AS WELL AS
MATRIX METALLOPROTEINASES AND THEIR INHIBITORS,
DURING JOINT REMODELING
D. M. Da Silva Ferreira, R. Markoll
Research, Infinomed – Institute for Innovative Medicine, Munich,
Bayern, Germany
Aim: To correlate the clinical effects of Pulsed Signal Therapy
(PST) with synovial ﬂuid matrix parameters and their inhibitors,
during joint remodeling.
Methods: Twenty-one patients with Gonarthrosis stage II and III
were subjected to PST for 1-h, on 9 consecutive days (allowed
interruption over 2 days). synovial ﬂuid (1.5–2.0 ml) was aspirated
from the arthrotic knee(s), pre- and post-PST treatment and frozen
at70(C for subsequent analysis. In cases where ﬂuid could not be
aspirated, 20 ml NaCl was ﬁrst injected into the joint space, the joint
carefully manoeuvered, and thereafter, 1.5–2.0 ml aspirated. Since
the protein concentrations in each synovial sample varied, the
concentration of each matrix parameter measured was normalized
to protein content. MMP-2 and -9, tenascin-C, collagens IV and VI,
and the MMP inhibitor, TIMP, were quantiﬁed using monoclonal
antibodies in sandwich immunoassays. Immune complexes were
separated from serum using magnetic particles covered with
monoclonal anti-ﬂuoresceine. Hyaluronan was determined with
biotin-labeled cartilage link protein and alkaline phosphatase-
labeled streptavidine. The assays were developed for the BAYER
IMMUNO 1 immunoassay system and validated in a large cohort
of liver patients and healthy subjects. MMP-1 and -3 were measured
using commercially available kits. All samples were assayed in
batches, with appropriate quality controls (sera from three healthy
and two pathological joint ﬂuids were used to calibrate), and intra-
and interassay variation kept below 10%. The level of matrix
parameters was correlated to changes in clinical parameters such
as performance, pain intensity and activities of daily living (ADL).
Results: Two-tailed paired t test showed statistically signiﬁcant (P!
0.05) differences between pre- and post-PST treatment for
tenascin-C/protein, MMP-1/protein, MMP-9/collagen IV and MMP-
9/TIMP, in general, suggesting a regulated proteolysis as a pre-
condition for favourable remodeling of joint structures, as opposed to
uncontrolled MMP-release and high levels of matrix fragments (such
as collagen IV and VI) in active RA. Such t tests were also used to
evaluate pain intensity and ADL (on awakening in the morning, at
night during rest, on ascending and descending stairs, standing for
15 min, and descending stairs alone). In all cases, a statistically
signiﬁcant improvement (P ! 0.05) was obtained post-PST
treatment. The positive results obtained post-PST in OA joint
remodeling and its clinical signiﬁcance in improving both pain and
ADL, were conﬁrmed by Pearson’s correlation (P! 0.05).
S130Conclusion: The clinical signiﬁcance of PST for the treatment of
musculoskeletal disorders, including OA, is supported by its
(controlled) release of MMP, and other matrix parameters, during
joint remodeling, and its improvement in both pain intensity and ADL.
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DIFFERENTIAL EXPRESSION OF RUNX2 AND OSTERIX IN
MOUSE AND HUMAN BONE MARROW CELLS IMPACTS
CHONDROGENIC POTENTIAL
C. R. Chuy, H. H. Fuz, M. B. Patily, T. McNelisz, N. J. Izzoy, K.
Hayashiy, J. O. Hollingerz
y Orthopedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA
z Bone Tissue Engineering Center, Carnegie Mellon University,
Pittsburgh, PA, USA
Aim: The aim of this study is to assess the chondrogenic potentials
of mouse and human bone marrow stromal cells.
Methods: Bone marrow stromal cells (BMSC) isolated from adult
mouse (C57BL/6) and adult human femurs using similar techniques
were cultured in DMEM with 20% FBS to passage 1. Human tissues
were obtained in accordance with IRB approved protocols. Total
RNA of mouse and human BMSC and of reference cells (mouse
ﬁbroblast cell line C3H10T1/2) were extracted using TRIZOL
reagent. Quantitative PCR was performed using Runx2, osterix,
osteocalcin and GAPDH speciﬁc primers by ABI Prism 7000
Sequence Detection System with SYBR Green ﬂuorescent dye.
Data was normalized to that of the endogenous reference gene
GAPDH using the comparative Ct (Cycle of threshold) method.
Mouse and human BMSC were harvested and prepared into pellet
cultures (250,000 cells per pellet). Pellets were cultured in Insulin,
Transferrin, Selenium (ITS) media with ascorbate, glucose and 10
ng/ml of TGF-b1 for 2 weeks. Pellets were analyzed by gross
inspection, histology and immunoﬂuorescence for type II collagen.
Results: Both mouse and human BMSC expressed Runx2 mRNA
that were at least 10-fold higher than reference ﬁbroblasts. Mouse
BMSC expressed similarly high levels of osterix and osteocalcin.
No detectable expression of osterix or osteocalcin was seen in
human BMSC or in reference ﬁbroblasts. All mouse pellets
disintegrated during the 2-week culture period. All human BMSC
formed pellets exhibiting chondrogenic differentiation as deter-
mined by the presence of large, chondrocyte-like cells surrounded
by alcian blue stained matrix by histological analysis. Immunoﬂu-
orescence conﬁrmed the presence of type II collagen in the human
pellets.
Conclusions: Differential expression of Runx2, osterix and osteo-
calcin were found between mouse and human BMSC. Runx2
increases both bone and cartilage formation and is considered to be
upstream of osterix. Osterix induces osteocalcin, a deﬁnitive marker
of osteogenesis. Our results indicate that adult mouse BMSC are
further differentiated towards osteogenesis than similarly cultured
adult human BMSC. Pellet cultures of human BMSC stimulated with
TGF-b1 underwent consistent chondrogenesis while apparent
culture failure was seen in mouse BMSC under identical culture
conditions. The failure of our group and others to achieve consistent
in vitro chondrogenesis of adult mouse BMSC may be explained by
osteogenic differentiation of these cells. Demonstration of a relatively
undifferentiated state in adult human BMSC further support
continued efforts to harness the chondrogenic potential of these
cells for articular cartilage repair and regeneration. The role of
Runx2 in this process deserves further study.
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THE EFFECT OF FIBROBLASTIC GROWTH FACTOR ON
MONOLAYER STEM CELL EXPANSION AND SUBSEQUENT
CHONDROGENESIS
A. A. Stewart, M. C. Stewart, H. Pondonis
Veterinary Clinical Medicine, University of Illinois, Urbana, IL, USAAim of study: MSC-based therapies for articular cartilage repair
minimize donor morbidity, are autogenous, and avoid disease
transmission. MSC expansion may be enhanced with basic
ﬁbroblastic growth factor (bFGF) supplementation. This study was
performed to determine whether bFGF treatment of MSCs during
the expansile monolayer phase enhances subsequent chondro-
genesis in a 3-dimensional culture system.
Methods: Bone marrow-derived MSCs were obtained from six
horses. MSC’s monolayers were seeded at 10,000 cells/cm2, and
supplemented with medium containing 0, 1, 10, or 100 ng/ml of
bFGF. After 6 days, MSCs were transferred to pellet cultures
(200,000 cells/pellet) and supplemented with chondrogenic medi-
um. Pellets were collected after 15 days. The pellets were analysed
for collagen type II by ELISA, total glycosaminoglycan content
using the dimethymethylene blue (DMMB) dye-binding assay and
DNA content using ﬂuorometric quantiﬁcation. Semi-quantitative
RT-PCR was performed to assess relative levels of collagen type II
and aggrecan mRNAs.
Results: All three doses of bFGF signiﬁcantly increased DNA and
collagen type II content. Total GAG content was also increased with
bFGF treatment in ﬁve of six horses, but pooled differences did not
reach statistical signiﬁcance due to considerable interanimal
variability. Collagen type II and aggrecan RT-PCR data indicated
a dose-dependent increase in collagen type II and aggrecan
transcripts with bFGF treatment. Of note, the untreated control
group showed minimal evidence of collagen type II and aggrecan
transcripts after 35 rounds of ampliﬁcation. Subjectively, the pellets
treated with bFGF showed more toluidine blue staining for
proteoglycan retention within the pellets, consistent with the DMMB
and RT-PCR data.
Conclusions: These results indicate that bFGF treatment during
the monolayer expansion phase had signiﬁcant effects on
subsequent MSC chondrogenesis during the pellet phase of this
model. bFGF increased pellet DNA content and also increased
collagen type II and total GAG content. When the matrix
component data were normalized for DNA content, statistical
signiﬁcance was not present, suggesting the primary effect of
bFGF was to increase cell number in each pellet. In conclusion,
bFGF should be considered for expansion of bone marrow-
derived MSC monolayers for subsequent chondrogenic differen-
tiation.
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MOLECULAR CHARACTERIZATION OF HUMAN CARTILAGE
BIOPSIES AFTER AUTOLOGOUS CHONDROCYTE TRANS-
PLANTATION
L. De Franceschiy, L. Rosetiy, A. Piacentiniy, M. Manfrediniz,
R. Facciniz, A. Facchiniyx, B. Grigoloy
y Laboratorio di Immunologia e Genetica, Istituti Ortopedici Rizzoli,
Bologna, Italy
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x Dipartimento di Medicina Interna e Gastroenterologia, Universita`
di Bologna, Bologna, Italy
Aim of study: The aim of this study was to quantify the expression of
genes encoding extracellular matrix (ECM) proteins and regulatory
factors essential for cell differentiation in human cartilage biopsies
of patients who underwent autologous chondrocyte transplantation
(ACT) 2 years previously.
Methods: Two cartilage biopsies from each of patients who had
been treated by ACT and from multiorgan donors (controls) were
used. Real-Time Reverse Transcriptase Polymerase Chain Re-
action (RT-PCR) analysis was performed to evaluate the expres-
sion of types I, II and X collagen, aggrecan, cathepsin B, early
growth response protein-1 (Egr-1) and Sry-type high-mobility-group
box transcription factor-9 (Sox-9) mRNAs. Immunohistochemical
analysis for ECM proteins and regulatory proteins was carried out
on parafﬁn embedded sections.
S131Results: Type I collagen mRNA was expressed in all the samples
evaluated. Type II collagen was present in ACT samples, but at
lower levels compared with controls. Type X collagen messenger
was undetectable. Aggrecan mRNA was present in all the samples
at lower levels in the controls while cathepsin B messenger levels
were higher, and Egr-1 and Sox-9 mRNAs were expressed at lower
levels. The immunohistochemical analysis showed slight positivity
for type I collagen in all the sections. Type II collagen was found in
all the samples with positivity conﬁned inside the cells, while the
controls displayed a positivity which was diffuse in the ECM.
Cathepsin B was slightly positive in all the samples while the
controls were negative. Egr-1 protein was particularly evident in
the areas negative for type II collagen. Sox-9 was positive in all the
samples, with evident localization in the superﬁcial layer.
Conclusion: In biopsies of ACT at 2 years, there is evidence of the
formation of a new tissue which displays varying degrees of
organization with some ﬁbrous and ﬁbrocartilaginous features.
Long-term follow-up investigations are needed to verify if, once all
the remodelling processes are completed, the formed tissue will
acquire the more typical features of articular cartilage. The data
obtained with our study give evidence of a sophisticated gene
expression machinery which is addressed to new hyaline cartilage
formation.
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PROLIFERATION AND CHARACTERISATION OF MENISCAL
CHONDROCYTES ON COLLAGEN BEADS
T. A. Tebby, J. A. Werkmeistery, S. W. Tsaiz, J. F. Whitey,
V. Glattauery, W. B. Tsaiz, J. A. Ramshawy
y CSIRO Molecular Science, CSIRO, Parkville, Victoria,
Australia
z Biomedical Engineering Center, ITRI, Hsinchu, Taiwan
The meniscus only exhibits a very limited capacity to repair, which
is usually restricted to the vascular zone at the peripheral edge. If
damage to the meniscus is not repaired, it invariably leads to the
development of arthritis. A range of permanent and biodegradable
materials has been proposed as scaffolds to bridge tears in the
tissue and allow healing. The use of collagen in tissue
engineering strategies is attractive since this natural ﬁbrous
network is known to serve as a scaffold for many types of tissue
repair. Most studies have examined only two-dimension growth on
collagen templates under static conditions. The aim of this study
was to evaluate the growth and type of matrix generation of
meniscal cells cultured in dynamic conditions on collagen bead
systems. Fresh chondrocytic cells were isolated from ovine
menisci by digestion using combinations of trypsin or bacterial
pronase and bacterial collagenase and/or hyaluronidase. Growth
of cells was studied using a spinner culture system. Cells were
cultured at various densities on different types of collagen and
gelatin-based beads in 50 ml DMEM/F12/10% FBS containing
100 mg/ml penicillin and streptomycin at 37(C with 5% CO2 in 125
ml spinner bottles. Cultures were supplemented with daily
additions of ascorbate for 10 days prior to matrix analyses. Cell
phenotype was monitored using a variety of histochemical and
immunohistochemical markers, including Alcian Blue and Masson
Trichrome stains and speciﬁc antibodies against collagens types I,
II, III and VI, and to keratan sulfate. To study proliferation rates,
cells were passaged and counted at days 7, 15 and 21. The
growth rates were signiﬁcantly higher on all bead types than was
seen in control monolayer cultures. Cells migrated and proliferated
over the entire surface of beads, as well as into the porous beads.
For all beads, a range of collagen types consistent with the native
meniscal environment was produced, and ﬁrm cartilage like
tissue, resistant to trypsin degradation, was formed. Collagen
types II and III were readily detected and evenly distributed
throughout the neomatrix. Collagen type I expression appeared
lower. Keratan sulfate was expressed as intense discrete patches
in all cases. Collagen type VI was predominant at the leading
edge of cellular growth.P321
A NOVEL TREATMENT OF ARTICULAR CARTILAGE DEFECTS
K. F. Almqvisty, P. Verdonky, R. Verdonky, K. Verstraetez,
E. M. Veysx, G. Verbruggenx
y Department of Physical Medicine and Orthopaedic Surgery,
Ghent University Hospital, Gent, Belgium
z Department of Radiology, Ghent University Hospital, Gent,
Belgium
x Department of Rheumatology, Ghent University Hospital, Gent,
Belgium
Aim of the study: To produce tissue-engineered cartilage by human
articular chondrocytes cultured in a biocompatible, biodegradable
matrix in vitro, for subsequent use in in vivo manipulations for the
treatment of (osteo)chondral lesions.
Materials and methods: Earlier studies have shown that chondro-
cytes proliferate in alginate, and synthesize a cartilage-like matrix
for up to 8 weeks.
Allogenic human chondrocytes were cultured in 1.0% alginate
beads for 2 weeks before implantation into cartilage defects of the
knee joint. Prior to the surgical intervention the cultured chondro-
cytes were tested for their phenotypical stability. The (osteo)chon-
dral lesion of the femoral condyle in 10 patients (2 lateral–8 medial)
was debrided, and covered by an autologous periosteal ﬂap.
Subsequently the defect was ﬁlled with the alginate beads
containing the chondrocytes. The cartilage lesion was ﬁnally
injected with 0.5% ﬁbrin gel. Parameters that were followed pre-
and postoperatively, were the Lequesne index, the WOMAC and
VAS-score, gait analysis and Gd-DTPA MRI. A follow-up arthros-
copy to assess the macroscopic aspect and the integration of repair
tissue into surrounding native cartilage was performed at 6 and 12
months postoperatively, with a biopsy at 12 months.
Results: Clinically, immediate or short-term adverse reactions to the
alginate/ﬁbrin matrix seeded with the allogenic cartilage cells, were
not observed. The results of the short-term (three patients more
than 12 months) clinical examination of the involved joint as well as
the functional scores improved with time. Follow-up arthroscopy at
6 months showed an intact though slightly smoother articular
surface, with good integration into the surrounding cartilage. At 12
months a practically normal indentation was felt on palpation. The
biopsies showed a hyaline-like cartilage, and the Gd-DTPA MRI
images a progressively ﬁlling of the treated defects with cartilage
tissue.
Conclusion: This surgical procedure is performed in one step.
Biodegradable, biocompatible scaffolds could be used in the
treatment of cartilage defects, with the advantage that the artiﬁcial
matrix provides an initial support to the chondrocytes, making the
implant initially biomechanically superior to the model in which cells
are injected as a suspension under a periosteal ﬂap.
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CULTIVATION OF HUMAN TENOCYTES IN HIGH-DENSITY
CULTURE
G. Schulze-Tanzily, A. Mobasheriz, P. D. Cleggz, J. Sendziky,
T. Johnx, M. Shakibaeiy
y Institute of Anatomy: Cell and Neurobiology, Charite´ Medicine
University Berlin, Berlin, Germany
z Department of Veterinary Preclinical, Faculty of Veterinary
Science, University of Liverpool, Liverpool, Merseyside, United
Kingdom
x Department of Veterinary Clinical Science, Faculty of Veterinary
Science, University of Liverpool, Liverpool, Merseyside, United
Kingdom
Aim of study: Limited supplies of tendon tissue for use in
reconstructive surgery require development of phenotypically
stable tenocytes cultivated in vitro. Tenocytes in monolayer culture
display an unstable phenotype and tend to dedifferentiate but those
in three-dimensional culture may remain phenotypically and
S132functionally differentiated. In this study we established a high-
density three-dimensional culture system for cultivation of human
tenocytes for tissue engineering.
Methods: Human tenocytes were expanded in monolayer culture
before transfer to high-density culture. The synthesis of major
extracellular matrix proteins and the ultrastructural morphology of
the three-dimensional cultures were investigated for up to 2 weeks
by electron microscopy, immunohistochemistry, immunoblotting
and quantitative, real time PCR.
Results: Differentiated tenocytes were able to survive over a period
of 14 days in high-density culture. During the culture period
tenocytes exhibited a typical tenocyte morphology embedded in an
extensive extracellular matrix containing cross-striated collagen
type I ﬁbrils and proteoglycans. Moreover, expression of the
tendon-speciﬁc marker scleraxis underlined the tenocytic identity of
these cells.
Conclusions: We conclude that the three-dimensional high-density
cultures may be useful as a new approach for obtaining
differentiated tenocytes for autologous tenocyte transplantation to
support tendon and ligament healing and to investigate the effect of
tendon affecting agents on tendon in vitro.
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CLINICALLY SIGNIFICANT PLACEBO IMPROVEMENT
OCCURS BY 6 MONTHS AND IS MAINTAINED THROUGH 24
MONTHS IN A STUDY OF KNEE OA PAIN AND FUNCTION
C. Bingham, J. Beary, S. Adami, D. Clauw, S. Cohen,
M. Dougados, G. Cline, J. Meyer
Rheumatology, NYU-Hospital for Joint Diseases, New York, NY,
USA
Arthritis Research, Procter and Gamble Pharmaceuticals, Mason,
OH, USA
Rheumatology, University of Verona, Verona, Italy
Rheumatology, University of Michigan, Ann Arbor, MI; Rheumatol-
ogy, St. Paul Medical Center, Dallas, TX, USA
Rheumatology, Hopital Cochin, Paris, France
Purpose: Pain in osteoarthritis (OA) is not constant over time, and
long term studies of analgesics in OA were typically conducted for
safety purposes rather than to prove chronic efﬁcacy. The placebo
effect is known to be robust in analgesic studies. A large placebo-
controlled clinical trial of knee OA was analyzed in order to better
understand the role of the placebo symptom beneﬁt in multiyear
studies of OA.
Methods: North American subjects (1232) with symptomatic knee
OA and a medial compartment JSW of 2–4 mm (Buckland-Wright
method) were randomized to receive placebo, risedronate 5 mg/
day, 15 mg/day, or 50 mg/week. WOMAC pain, function and
stiffness were assessed at baseline, and every 6 months. To
facilitate subject retention, analgesics and NSAIDS were permitted
as needed between assessments, which were preceded by a 5 day
medication stepdown and washout.
Results: No drug treatment effect was seen in the primary
radiographic or symptom endpoints of the study. All dose groups
showed a signiﬁcant improvement from baseline in total WOMAC
and all subscales at 6 months. The placebo effect persisted
throughout the study. When data from all dose groups were pooled,
the total WOMAC score (100 mm VAS) fell from a baseline of 38.2
mm to 30.0 mm at 6 months and 29.3 at 24 months (P ! 0.05 for
BL to 24 months comparison). Results were consistent when dose
groups were analyzed separately, and the same placebo beneﬁt
was seen in WOMAC subscales. These results were conﬁrmed in
a separate study of 1251 European subjects conducted under
a similar protocol.
Conclusions: This is the ﬁrst large, long term randomized clinical
trial to report a clinically relevant placebo improvement in
a population with chronic knee OA, detectable at 6 months and
continuing for an additional 18 months. The magnitude of the
apparent placebo beneﬁt should be taken into consideration in
designing future studies to assess long term symptomatic and
structural improvements in OA.P324
SELECTIVE COX-2 INHIBITORS ROFECOXIB AND ETORICOX-
IB DECREASE SERIOUS LOWER GI CLINICAL EVENTS AS
COMPARED TO NONSELECTIVE NSAIDS: A META-ANALYSIS
L. Lainey, A. S. Reicinz, Q. Yuz, I. Fearenz, J. A. Bolognesez,
E. S. Mallerz
y Department of Medicine, U.S.C. School of Medicine, Los Angeles,
CA, USA
z Merck Research Laboratories, Rahway, NJ, USA
Aim of study: NSAIDs can cause both lower gastrointestinal (LGI)
clinical events as well as upper gastrointestinal (GI) clinical events.
Initial reports from the VIGOR GI outcomes trial suggest that use of
COX-2 selective inhibitors (coxibs) decreases the risk of these LGI
events. We determined the incidence of LGI events with non-
selective NSAIDs and assessed whether the incidence was
decreased with coxibs in a meta-analysis of double-blind random-
ized controlled trials of rofecoxib (ROF) and etoricoxib (ETOR).
Methods: The data sets included the 20 double-blind trials
comparing ROF (12.5 mg–25 mg–50 mg) with nonselective
NSAIDs (6–156 weeks; N Z 17,072), the VIGOR GI outcomes
trial (ROF 50 mg vs naproxen 500 mg bid; N Z 8076), and the 10
double-blind trials comparing ETOR (60 mg–90 mg–120 mg) with
nonselective NSAIDs (12–190 weeks; N Z 5441). Serious LGI
events were deﬁned as gross rectal bleeding (other than melena)
with hospitalization or a temporally related hemoglobin drop R 2 g/
dL: positive test for fecal occult blood with hemoglobin drop R 2 g/
dL and negative upper endoscopy; or hospitalization for intestinal
perforation or obstruction. Independent post hoc adjudication of LGI
events was performed by three authors blinded to treatment group.
Secondary analyses were also done for the subset of serious LGI
bleeding and for all investigator-reported LGI bleeding (including
conﬁrmed and unconﬁrmed serious and non-serious events).
Zelen’s exact test or a variance-weighted chi-square test was used
to examine heterogeneity for combining results across all three
coxib datasets. The Mantel-Haenszel or Cox proportional hazards
model methods, depending on the assessment of proportionality
assumption, were used to estimate a common RR across the three
coxib datasets.
Results: The rate of serious LGI events with nonselective NSAIDs
was 0.5 per 100 patient-years, with approximately 75% due to LGI
bleeding. Use of ROF or ETOR led to a signiﬁcant 45% relative risk
reduction in serious LGI events and any LGI bleeding, and
a signiﬁcant 52% risk reduction in serious LGI bleeding. These
post hoc analyses show consistent RR estimates across the three
LGI endpoints examined in favor of use of ROF and ETOR.
Conclusions: The COX-2 selective inhibitors rofecoxib and etor-
icoxib decrease serious lower GI clinical events in addition to their
previously demonstrated ability to decrease upper GI events.
Treatment Events/
patient-
years
Rate per 100
patient-
years (95% CI)
RR (95% CI) [P-value
for heterogeneity
test]
Serious
conﬁrmed
LGI events
ROF or
ETOR
31/12,551 0.25
(0.17, 0.35)
0.55 (0.34, 0.88)
NSAIDs 39/7815 0.50
(0.35, 0.68)
[P = 0.193]
Serious
conﬁrmed
LGI bleeding
ROF or
ETOR
20/12,555 0.16
(0.10, 0.25)
0.48 (0.27, 0.86)
NSAIDs 30/7816 0.38
(0.26, 0.55)
[P O 0.200]
All reported
LGI bleeding
ROF or
ETOR
43/12,551 0.34
(0.25, 0.46)
0.55 (0.36, 0.84)
NSAIDs 54/7811 0.69
(0.52, 0.90)
[P O 0.200]
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GLUCOSAMINE AND CHONDROITIN SULFATE REGULATE
INFLAMMATORY MEDIATORS
P. S. Chany, J. P. Caronz, M. W. Orthy
y Department of Animal Science, Michigan State University, East
Lansing, MI, USA
z Large Animal Clinical Sciences, Michigan State University, East
Lansing, MI, USA
Aim: To evaluate the effectiveness of pharmacologically relevant
concentrations of glucosamine (GLN) and low molecular weight
chondroitin sulfate (CS), both individually and in combination, on
inhibiting IL-1 stimulation of inﬂammatory mediators.
Methods: Cartilage explants (6 mm diameter) were obtained from
the carpal joint of a mature Holstein steer. After 48 h serum free
equilibration, non-control explants received 10% FBS, 15 ng/ml
IL-1 and treatments for 24 h. GLN concentrations tested were 0,
1, 5, 10 and 20 mg/ml. Concentrations tested for CS were 0, 5,
20, 50 and 100 mg/ml. The concentrations of GLN and CS chosen
for the combination experiments were 10 and 20 mg/ml, re-
spectively. RNA was isolated from explants collected 24 h after
treatment and reverse transcribed to give cDNA. cDNA was
subjected to the relative quantitative real-time PCR (Q-RT-PCR)
procedure using ABI PRISM 7000 and species speciﬁc primers
for inducible nitric oxide synthase (iNOS), cyclooxygenase-2
(COX-2) and microsomal prostaglandin E synthase (mPGE
synthase). Replicated Q-RT-PCR data were normalized with
GAPDH and gene expression relative to control was calculated
with the delta delta cycle to threshold (ddCt) method. Media were
collected 24 h post stimulation and assessed for nitric oxide (NO)
and prostaglandin E2(PGE2) content. Each experiment wasrepeated a total of 3 times, each time using tissue from a different
steer.
Results: GLN and CS alone had no effect on NO release. Cytokine
induced PGE2 release were signiﬁcantly (P ! 0.05) decreased by
66, 74 and 73% with 5, 10 and 20 mg/ml GLN, respectively and by
45 and 50% with 50 and 100 mg/ml CS, respectively. GLN (10 mg/
ml) and CS (20 mg/ml) reduced NO and PGE2 release at 24 h post
IL-1 stimulation by about 57% and 41%, respectively (Table I).
Inhibition of biochemical parameters associated with inﬂammatory
mediators by GLN and CS correlated with the suppression of iNOS
and COX-2 transcript levels (Fig. 1). GLN and CS had no effect on
mPGE synthase gene expression although the pattern was similar
to COX-2 (Fig. 1).
Conclusion: Pharmacological concentrations of GLN and CS can
inhibit gene expression and synthesis of inﬂammatory mediators in
cartilage explants.
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GLUCOSAMINE AND CHONDROITIN SULFATE REGULATE
IL-1 INDUCED GENE EXPRESSION
P. S. Chany, J. P. Caronz, M. W. Orthy
y Department of Animal Science, Michigan State University, East
Lansing, MI, USA
z Large Animal Clinical Sciences, Michigan State University, East
Lansing, MI, USA
Aim: To determine the effect of pharmacologically relevant
concentrations of glucosamine (GLN) and low molecular weight
chondroitin sulfate (CS) on the regulation of IL-1 induced gene
expression in cartilage explants.Fig. 1. Gene expression at 24 h post stimulation. Different superscripts for values within a gene denote a signiﬁcant difference (P ! 0.03)
between treatments.
Table I
The effect of GLN and CS combination on NO and PGE2 release into conditioned media of cytokine stimulated explants
Variable Treatment
Ctrl IL-1 IL-1 +GLN +CS
NO (mM) G SE 8.04 G 0.94 a 52.60 G 5.55 b 22.54 G 2.31 c
PGE2 (pg/ml) G SE 70.03 G 9.11 a 1159.16 G 248.09 b 675.29 G 106.84 c
Ctrl Z FBS control, GLN Z 10 mg/ml glucosamine, CS Z 20 mg/ml chondroitin sulfate, IL-1 Z 15 ng/ml human recombinant interleukin-
1, NO Z nitric oxide, PGE2 Z prostaglandin E2. Different letters for values within a variable indicate a signiﬁcant difference (P ! 0.02)
between treatments.
S134Fig. 1. Gene expression at 24 h post-stimulation. Different superscripts for values within a gene denote a signiﬁcant difference (P ! 0.05)
between treatments.
Fig. 2. Gene expression at 48 h post-stimulation. Different superscripts for values within a gene denote a signiﬁcant difference (P ! 0.05)
between treatments.Methods: Cartilage explants (6 mm diameter) were obtained from
the carpal joints of three mature Holstein steers. Two discs were
cultured per well of a 24-well plate. After 48 h serum free
equilibration, non-control wells received 10% FBS and 50 ng/ml
IL-1 to induce cartilage catabolism. There were ﬁve treatments per
experiment, an FBS control (Ctrl), IL-1, IL-1 C GLN (5 mg/ml), IL-1
C CS (20 mg/ml) and IL-1 C GLN C CS (5 mg/ml, 20 mg/ml,
respectively). Twelve wells (24 discs) received each treatment at
each time point (24, 48 h) for each of three replicates. RNAwas isolated from the tissue and reverse transcribed to
cDNA. cDNA was subjected to the relative quantitative real-time
PCR (Q-RT-PCR) procedure using the ABI PRISM 7000 and
SYBR green detection and species-speciﬁc primers for MMP-1, 2,
3, 9, 13, 14, aggrecanases 1 and 2, TIMP-1, 2 and 3, aggrecan
and type II collagen. Replicated Q-RT-PCR data were
normalized with GAPDH and gene expression relative to control
was calculated with the delta delta cycle to threshold (ddCt)
method.
S135Results: Only signiﬁcant (P ! 0.05) changes in gene expression
among treatments are shown. GLN and CS alone repressed IL-1
stimulation of MMP-13 at 24 h (Fig. 1). The combination of GLN and
CS repressed IL-1 induced expression of MMP-3 at 24 h and
suppressed the MMP-13 induction at both time points (Figs. 1, 2).
Cytokine induced aggrecanase-1 (Agg-1) expression was reduced
by GLN alone and by the combination (Fig. 1). Aggrecanase-2
(Agg-2) gene upregulation by IL-1 was inhibited by GLN at 24 h
(Fig. 1), GLN and CS alone and in combination at 48 h (Fig. 2). GLN
and CS in combination reduced the MMP-14 transcript at 48 h (Fig.
2). TIMP-3 mRNA expression with the combination was signiﬁ-
cantly greater than CS given alone (Fig. 1).
Conclusions: Relevant concentrations of GLN and CS can repress
expression of genes encoding proteolytic enzymes involved in
cartilage degradation. The combination of GLN and CS was more
effective in antagonizing some gene expression than when used
individually.
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THREE-MONTH EFFICACY AND SAFETY OF ACETAMINO-
PHEN FOR OSTEOARTHRITIS PAIN OF THE HIP OR KNEE
R. D. Altmany, J. E. Schweinlez, J. R. Zinsenheimz, A. R. Templez
y David Geffen School of Medicine, University of California, Los
Angeles, Los Angeles, CA, USA
z Research & Development, McNeil Consumer & Specialty
Pharmaceuticals, Fort Washington, PA, USA
Aim: To examine the efﬁcacy and safety of acetaminophen
extended-release (APAP ER) caplets in the treatment of moderate
to moderately severe pain associated with osteoarthritis (OA) of the
hip or knee.
Methods: This was a multicenter, randomized, double-blind, 12-
week, parallel-group study involving patients R 40 years of age
with moderate to moderately severe OA pain. After an initial
washout period (baseline), patients (n Z 483) were randomized to
treatment with APAP ER 1950 mg/day, APAP ER 3900 mg/day, or
placebo. Primary efﬁcacy endpoints were changed from baseline at
12 weeks in the WOMAC VAS pain and physical function
subscales, and in patient global assessments (5-point Likert scale).
Safety assessments included monitoring vital signs, adverse
events, study joint assessments, and clinical laboratory results at
each study visit. The intent-to-treat analysis included all random-
ized subjects.
Results: All groups were similar with respect to baseline de-
mographics. Patients in the APAP ER 3900 mg/day group
experienced signiﬁcant improvements in all three primary efﬁcacy
variables compared with patients in the placebo group (see Table
I). There were no signiﬁcant group differences in the overall
numbers of adverse events (AE), percentages of subjects with AEs,
serious AEs, or subjects who discontinued because of an AE.
There also were no serious AEs or deaths considered by
investigators to be related to treatment. Three subjects in the
3900- mg/day group had elevations of ALT and/or AST O3! the
upper limit of normal; two returned to normal or near normal while
Table I
Mean change from baseline at week 12
APAP ER
3900 mg/day
APAP ER
1950 mg/day
Placebo
WOMAC painz 25.87 (1.77)** 22.49 (1.77) 19.81 (1.74)
WOMAC physical
function
24.17 (1.80)y 19.02 (1.80) 18.22 (1.77)
Patient global
assessment
2.11 (0.09)y 2.09 (0.09)y 1.81 (0.09)
*P = 0.01 vs placebo;
yP ! 0.02 vs placebo.
zLeast squares mean (standard error).continuing APAP (one with documented cholecystitis) and one after
discontinuing APAP.
Conclusion: APAP ER 3900 mg/day was superior to placebo in
treating moderate or moderately severe chronic OA pain, even in
the presence of a sizable placebo response. APAP ER was well
tolerated, and the overall incidence of AEs was similar among
treatment groups.
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MIXTURES OF GLUCOSAMINE AND CHONDROITIN SULFATE
REVERSE FIBRONECTIN FRAGMENT MEDIATED DAMAGE TO
CARTILAGE MORE EFFECTIVELY THAN EITHER AGENT
ALONE
L. M. Ray, D. Guo, G. A. Homandberg
Biochemistry and Molecular Biology, University of North Dakota,
Grand Forks, ND, USA
Aim of study: The effectiveness of glucosamine and chondroitin
sulfate in blocking or reversing damage in cartilage exposed to
ﬁbronectin fragments (Fn-f), an exposure known to enhance levels
of catabolic cytokines and matrix metalloproteinases (MMPs) and
to enhance degradation of the matrix, was tested.
Methods: Pharmacologic formulations from Nutramax Laboratories,
Inc., glucosamine hydrochloride (FCHG49) and chondroitin
sulfate (TRH122), were tested singly or in combination at 1, 10
or 100 mg/ml ﬁnal concentration in the presence of 0.1 mM Fn-f. To
test for blocking damage in short term cultures in the absence of
serum growth factors or proteinase inhibitors, bovine cartilage
explant cultures were established in DMEM. Explants were then
adjusted to Fn-f with agents and proteoglycan (PG) content of
media assayed to obtain rate constants for PG degradation/
release. Long term (21 day) cultures in 10% serum were also
studied, conditions with greater anabolic potential. To test for
effects on steady state PG content, Fn-f and agent were added and
every 7 days cartilage removed and PG content measured. To test
for repair in 10% serum, cartilage was ﬁrst damaged in the
presence of 0.1 mM Fn-f for 7 days, Fn-f removed and media
adjusted to test compounds. Every 7 days, the remaining PG
content was measured. MMP expression was tested by western
blotting of media.
Results: In serum-free conditions, neither of the agents singly nor in
combination decreased rates of Fn-f mediated PG depletion. When
tested in 10% serum, lower concentrations of glucosamine alone
had no signiﬁcant effect on PG content in the absence of Fn-f.
However, glucosamine at 100 mg/ml decreased PG depletion
caused by Fn-f by 49% (P! 0.0001) from days 7 to 21. Chondroitin
sulfate alone showed a trend of enhancing PG content and at 1–
100 mg/ml and at 7 days, decreased PG loss by up to 50% (P !
0.001) and slowly restored PG. Combinations of both agents at all
concentrations decreased PG loss dose dependently from 49% to
89% (P ! 0.0005). Cartilage ﬁrst damaged with Fn-f and then
treated with 100 mg/ml glucosamine showed 55% restoration of PG
(P ! 0.0005) by day 21. Chondroitin sulfate caused a trend of
faster and higher PG restoration activity than glucosamine.
Combinations from 1 to 100 mg/ml showed much greater than
additive effects with signiﬁcant effects in restoration of PG by day 7
with 100 mg/ml restoring PG to above normal levels.
However, neither agent alone nor in combination decreased
MMP-1, -3 or -13.
Conclusions: While the effects of these agents have been tested in
in vitro models and in terms of effects on numerous pathways and
measurable outcomes, there are few studies of direct effects on
cartilage tissue PG content in a well deﬁned cartilage damage
model, such as that involving Fn-f. We report that glucosamine and
chondroitin sulfate appear to act synergistically in reversing
damage and likely do not do so by affecting MMP levels. We
propose that these agents enhance anabolic effects, such as PG
synthesis, which compensates for matrix damage. Reported
observations of effects of these agents on PG synthesis or IGF-1
activation are consistent with our proposal.
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EXPRESSION AND REGULATION OF MICROSOMAL PROSTA-
GLANDIN E SYNTHASE-1 IN HUMAN OSTEOARTHRITIC
CARTILAGE AND CHONDROCYTES
X. Li, H. Aﬁf, J. Martel-Pelletier, J. P. Pelletier, H. Fahmi
Osteoarthritis Research Unit, Notre-Dame Hospital, Centre Hospi-
talier de l’universite de Montreal, Montreal, QC, Canada
Objective: Elevated production of prostaglandin E2 (PGE2) plays
an important role in the pathogenesis of osteoarthritis. Recently, an
inducible microsomal prostaglandin E synthase-1 (mPGES-1) was
identiﬁed. This enzyme is functionally coupled with cyclooxyge-
nase-2 (COX-2) and converts the COX product PGH2 to PGE2. In
the present study we analyzed the expression of mPGES-1 in
human normal and osteoarthritic (OA) cartilage and determined the
effect of different inﬂammatory agonists on the expression of
mPGES-1 in OA chondrocytes.
Methods: Expression of mPGES-1 mRNA and protein in cartilage
were determined by quantitative real-time reverse transcriptase-
polymerase chain reaction and immunohistochemistry, respec-
tively. OA chondrocytes were treated with different inﬂammatory
agents and mPGES-1 protein expression was evaluated by
Western blot. Activation of the mPGES-1 promoter was assessed
in transient transfection experiments.
Results: Levels of mPGES-1 mRNA and protein were markedly
elevated in OA vs normal cartilage. Treatment of chondrocytes with
interleukin-1b (IL-1b) induced the expression of mPGES-1 protein
in a dose- and time-dependent manner. This appears to occur at
the transcriptional level as IL-1b induced the expression of
mPGES-1 mRNA and the activity of this gene promoter. Tumor
necrosis factor-a (TNF-a) and IL-17 also up-regulated the
expression of mPGES-1 protein and displayed a synergistic effect
with IL-1b. 15-Deoxy-d12,14-prostaglandin J2 inhibited IL-1b-in-
duced mPGES-1 protein expression, an effect that was reversed by
exogenous PGE2.
Conclusion: This study shows for the ﬁrst time that mPGES-1
expression is up-regulated in OA vs normal cartilage and that pro-
inﬂammatory cytokines increased mPGES-1 expression in chon-
drocytes. These data suggest that mPGES-1 may prove to be an
interesting therapeutic target for controlling PGE2 synthesis.
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PREDICTORS OF STRUCTURAL PROGRESSION IN KNEE
OSTEOARTHRITIS OVER 24 MONTHS
C. Bingham, G. Cline, S. Adami, C. Buckland-Wright, S. Cohen,
P. Conaghan, M. Dougados, V. Strand, D. Wenderoth, J. Beary,
J. Meyer
Rheumatology, NYU-Hospital for Joint Diseases, New York, NY,
USA
Arthritis Research, Procter and Gamble Pharmaceuticals, Mason,
OH, USA
Rheumatology, University of Verona, Verona, Italy
Radiology, Kings College, London, United Kingdom
Rheumatology, St. Paul Medical Center, Dallas, TX, USA
Rheumatology, Leeds General Infirmary, Leeds, United Kingdom
Rheumatology, Hopital Cochin, Paris, France
Rheumatology, Stanford University, Palo Alto, CA, USA
Purpose: The objective of this analysis was to examine the
predictors of joint space narrowing (JSN) in patients with knee
OA over a 2-year period.
Methods: Patients (2483) were randomized [1232 patients in North
America (NA) and 1251 patients in Europe (EU)] in a 2 year
randomized placebo-controlled study of mild-moderate knee
osteoarthritis. Entry criteria and study medication doses are
reported elsewhere in this abstract series. Study patients qualiﬁed
by fulﬁlling ACR criteria for knee OA and by having a medial
compartment knee joint space width (JSW) of 2–4 mm using the
ﬂuoro-positioned standardized radiographic method of Buckland-Wright (mean of 7( ﬂexion). To measure JSW, radiographs of the
signal knee were taken at baseline and at 12 and 24 months
utilizing the ﬂuoroscopic semi-ﬂexed (Fluoro) technique. Minimum
medial compartment JSW was measured by computer and is used
in these summaries. Detectable progressors were deﬁned as
patients with a change in JSW outside of the measurement error of
the radiographic technique (JSN R 0.6 mm) at any time post-
baseline.
There was no treatment effect observed on the radiographic
endpoint between groups, so the three risedronate treatment arms
from NA and EU were combined with placebo for the analyses. We
evaluated the relationship between detectable progression and the
following baseline variables included in the table below using
a multiple logistic regression model. All patients (2153 of which 285
(13.2%) were progressors) with observations were included in the
analysis.
Results:
Conclusions: This study importantly demonstrates that only a small
number of patients with knee OA progress over a 2 year period. We
showed that elevated CTXII, increased BMI, male gender, pain,
absence of hip OA, and knee crepitus are predictors for pro-
gression.
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THE INFLUENCE OF EXERCISE ON PAIN, MUSCLE
STRENGTH, AND PROPRIOCEPTION IN KNEE OSTEOAR-
THRITIS (OA)
N. Shakoory, D. Nelsonz, Y. Lix, J. Blocky
y Section of Rheumatology, Rush Medical College, Chicago, IL,
USA
z College of Nursing, Rush Medical College, Chicago, IL, USA
x Rush Institute for Healthy Aging, Rush Medical College, Chicago,
IL, USA
Introduction: OA of the knee has been associated with signiﬁcant
pain and disability as well as with deﬁcits in quadriceps muscle
strength and knee proprioception. Muscle strength and propriocep-
tive deﬁcits may be related in knee OA. Studies suggest that
exercise can lead to signiﬁcant improvements in both pain and
muscle strength in subjects with knee OA. However, the effects of
exercise and muscle strengthening on proprioceptive function are
not clear. The aims of this investigation were to evaluate the effects
Parameter/outcome Baseline
mean (SD)
or proportion
(N = 2483)
Odds ratio
(N = 2153)
95% CI P
Value
CTX II Q2 1.63 1.1, 2.5 0.02
CTX II Q3 2.38 1.6, 3.5 !0.01
CTX II Q4 2.29 1.5, 3.5 !0.01
Gender (male) 30% 1.86 1.4, 2.5 !0.01
WOMAC pain 40(22) 1.2 per
10 mm
1.1, 1.3 !0.01
Knee crepitus 83% 1.59 1.1, 2.3 0.02
BMI (kg/m2) 30(4.5) 1.03 1.0, 1.1 0.03
Hip OA 17% 0.67 0.5, 1.0 0.04
Baseline JSW 2.97(0.59) 0.81 0.7, 1.0 0.07
WOMAC function 44(23) 0.92 per
10 mm
0.8, 1.0 0.10
Non-Caucasian 10% 1.37 0.9, 2.1 0.13
Alcohol previous
use
6% 1.50 0.9, 2.6 0.14
Age 62(8.7) 1.01 1.0, 1.0 0.46
Previous smoker 31% 1.09 0.8, 1.5 0.57
Estrogen/SERM Use 18% 0.91 0.6, 1.4 0.65
Alcohol current use 65% 0.99 0.7, 1.3 0.94
Current smoker 11% 0.99 0.6, 1.6 0.95
Hand OA 40% 0.99 0.8, 1.3 0.95
S137of an 8-week home-based muscle strengthening program on pain,
muscle strength, and knee proprioception in subjects with
symptomatic knee OA and to examine relationships between pain,
muscle strength and proprioception in these subjects.
Methods: Thirty-eight subjects with symptomatic knee OA were
enrolled in the study. A home exercise program was developed in
consultation with the medical center’s physical therapy department.
Subjects were taught three standard quadriceps strengthening
exercises which were to be performed daily at home using a 5-lb
ankle weight. Subjects recorded daily exercise performance in
a diary. Pain, muscle strength and proprioceptive function were
measured at baseline and after 8 weeks of exercise therapy. Pain
was assessed with the Western Ontario MacMasters Universities
Osteoarthritis Index (WOMAC) visual analog scale. Isokinetic
quadriceps muscle strength and passive-active replication pro-
prioceptive testing were performed using a Biodex isokinetic
dynamometer. Paired t tests were used to examine changes in
pain, strength and proprioception at baseline and post-intervention.
Relationships between the factors were evaluated using Pearson
and Spearman correlations.
Results: Signiﬁcant improvements in pain (42%, P ! 0.001) and
quadriceps muscle strength (23%, P ! 0.001) were noted after 8
weeks of home exercise therapy. Concomitant improvements in
proprioception were not observed. There were signiﬁcant negative
correlations between baseline pain and both baseline muscle
strength (SpearmanZ 0.35, PZ 0.03) and proprioceptive acuity
(SpearmanZ0.35, P Z 0.03). There were also signiﬁcant
associations between improvements in pain with exercise and
improvements in muscle strength (Spearman Z 0.42, P Z 0.008)
and proprioception (Spearman Z 0.41, P Z 0.01). Subjects with
more severe pain and muscle strength deﬁcits at baseline achieved
the greatest improvement in pain and muscle strength, respec-
tively, with the intervention.
Conclusions: An 8-week home exercise program resulted in
signiﬁcant improvements in pain and muscle strength in subjects
with symptomatic knee OA. The fact that concomitant improve-
ments in proprioceptive acuity were not observed in this study may
suggest that proprioceptive deﬁcits are independent of muscle
strength deﬁcits in knee OA or that alternatively, 8 weeks is not
a sufﬁcient period of time in which to achieve improvements in
sensory deﬁcits. Nevertheless, poorer proprioceptive acuity was
found to be associated with increased pain at baseline and
improvements in pain with exercise were associated with signiﬁcant
improvements in proprioceptive acuity.
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BRADIKININ-RECEPTOR-INHIBITION – A THERAPEUTIC
OPTION IN OSTEOARTHRITIS?
J. Flechtenmachery, M. Talkez, D. Veithx, K. Heiljj, A. Gebauer{,
M. Schoenharting{
y Ortho, Praxis, Karlsruhe, Germany
z Ortho, Praxis, Berlin, Germany
x Ortho, Praxis, Emmendingen, Germany
jj Ortho, Praxis, Tuttlingen, Germany
{ Aventis, Pharma GmbH, Frankfurt, Germany
In humans the most relevant effects of bradikinin (BK) are thought
to be mediated through B2 receptors, while the role of B1 receptors
still remains obscure and is possibly induced during chronic
inﬂammation. In numerous in vitro and preclinical in vivo studies,
icatibant (ITB) has been shown to be a potent inhibitor of BK
effects, with high metabolic stability in different organ systems. This
suggests ITB as an appealing therapeutic option, administered by
intra-articular injection.
Aim of the study: (1) To compare the extent and course of pain
relief in the affected knee joint between ITB and placebo using
a visual analogue scale (VAS). (2) To compare ITB and placebo for
safety and the efﬁcacy variables: time until need of rescue
medication; WOMAC index; and patient’s global assessment
(PGA).Methods: This was a randomised, double-blind, placebo-controlled,
parallel, multi-centre study.
At the screening visit, out-patients with symptomatic knee OA were
supplied with an electronic patient diary (LogPad) for daily
assessments of pain, intake of rescue medication and PGA.
After a 1-week washout period, subjects returned for the baseline
visit, were randomised, and received, after removal of the
excessive synovial ﬂuid, an intra-articular single-dose of 90 mg
ITB diluted in 1.0 mL buffered saline, or respective placebo, into the
affected knee joint.
Pain intensity was followed several times per day, and PGA and
intake of rescue medication were followed once daily, for a total
period of 6 weeks. Subjects returned for follow-up visits after 1, 3
and 6 weeks. Functional assessment of the affected knee joint was
performed by answering a WOMAC questionnaire at these visits.
Statistical analysis included the Chi-square test, differences in
means, Wilcoxon-test, the trapezoid rule and Kaplan–Meier curves.
Results: One hundred ﬁfty-nine subjects were screened and 113
were randomised and treated: 55 with placebo and 58 with ITB.
Treatment emergent adverse events were experienced by eight
subjects (14.5%) treated with placebo and six subjects (10.3%)
treated with ITB. Responder rates for mean pain reduction of at
least 21 VAS units were consistently higher during the ﬁrst week
after single-dose injection, for the ITB treatment group compared to
the placebo treatment group, for both pain at rest and pain during
activity. The reduction in WOMAC scores was similar in both
groups.
PGA for both groups decreased, with a greater decrease observed
for subjects treated with ITB compared to placebo.
Conclusion: Here we present the ﬁrst evidence of a therapeutic
effect of ITB in the treatment of symptomatic knee OA. ITB
administered as a single intra-articular dose was safe and well
tolerated. Intra-articular administration of ITB was shown to result in
higher responder rates for mean pain reduction. It is interesting to
note that the bigger effect of ITB regarding pain during activity as
compared to pain at rest was due to a lower change from baseline
in the placebo group rather than to an increased change from
baseline in the active treatment group. Consumption of rescue
medication was correspondingly reduced in subjects treated
with ITB.
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THE EFFECT OF ARTHROSCOPIC DEBRIDEMENT, MICRO-
FRACTURING, AND HIGH TIBIAL OSTEOTOMY IN THE
TREATMENT OF VARUS GONARTHROSIS
G. Spahn, S. Kirschbaum, R. Wittig
Department of Arthroscopy and Joint Surgery, Clinic of Traumatol-
ogy and Orthopaedic Surgery, Eisenach, Thuringia, Germany
Aim: The goal of this prospective study was to determine the effect
of chondral debridement vs microfracturing and the effect of an
additional high tibial osteotomy (HTO) in case of varus gonarthrosis
(VGA) of the knee.
Methods: A total of 210 patients who were suffering from VGA
underwent operative treatment.
The patients underwent arthroscopic debridement (group A, n Z
61), arthroscopic microfracturing (group B, n Z 39), chondral
debridement and HTO (group C, n Z 44) or microfracturing and
HTO (group D, n Z 34).
The HTO was performed as opening-wedge osteotomy by using an
internal ﬁxation (c-plate).
The Lysholm score and the level of pain (visual analogous scale
ranging from 0 to 100) were determined preoperatively and at the
time of follow-up after 48.5 G 5.6 [range 34–60] months.
A total of 22 patients (group A: n Z 15, group B: n Z 4, group C:
nZ 3) required alloarthroplasty, one patient from group A died and
a total of nine patients were not available.
Finally, a total of 178 patients were available for a follow-up
(Table I).
Results: In tendency, patients from groups A and B had an
increased Lysholm score, and the intensity of pain was reduced.
S138In groups C and D, the patients had a signiﬁcant improvement of
their symptoms. The results are shown in Figs. 1 and 2.
Conclusions: Arthroscopic debridement in case of VGA produces
only small improvement. The results are better after microfractur-
ing. In case of combination from arthroscopic procedure with an
HTO, it suggests, that the patients mostly proﬁt.
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Table I
Follow-up of a total of 178 patients
Group A Group B Group C Group D
Debridement Microfracturing Debridement
+ HTO
Microfracturing
+ HTO
N 61 39 44 34
Male/Female 23/38 26/13 26/18 17/17
Age (years) 53.9 G 10.6 50.3 G 9.9 49.3 G 8.9 47.1 G 4.9
Follow-up
(months)
50.7 G 2.3 49.7 G 1.9 49.2 G 6.1 42.1 G 7.4Aim: To assess the efﬁcacy and safety of lumiracoxib 100 mg qd vs
placebo and celecoxib over 13 weeks in patients with knee
osteoarthritis (OA).
Methods: Following a 3–7-day washout for NSAIDs, 1684 patients
with symptomatic knee OA from multiple centers, including Europe,
were randomized to lumiracoxib 100 mg qd (nZ 420), lumiracoxib
200 mg qd for 2 weeks then 100 mg qd (200/100 mg qd; nZ 420),
celecoxib 200 mg qd (nZ 420) or placebo (nZ 424). Patients had
to have pain intensity in the target knee R 40 mm on a 100 mm
visual analog scale. The primary efﬁcacy variables (assessed at
Week 13) were pain intensity in the target knee, patient’s global
assessment of disease activity and functional status (WOMAC
Total score). These variables were also assessed by visit. Safety
and tolerability were assessed with standard measures.
Results: Lumiracoxib provided signiﬁcant improvements compared
with placebo in primary efﬁcacy variables. In terms of pain intensity
in the target knee, the mean reductions from baseline to Week 13
were 26.8, 26.2 and 26.6 mm for lumiracoxib 100 mg qd, 200/100
mg qd and celecoxib, respectively (all P ! 0.01 vs placebo). The
patient’s global assessment of disease activity improved from
baseline to Week 13 by 25.1, 21.9 and 22.9 mm for lumiracoxib 100
mg qd, 200/100 mg qd and celecoxib, respectively (all P! 0.05 vs
placebo).
The mean reductions from baseline to Week 13 in the WOMAC
Total score were 15.2, 14.8 and 14.7 for lumiracoxib 100 mg qd,
200/100 mg qd and celecoxib, respectively; all P ! 0.01 vs
placebo.
All active groups were superior to placebo from the ﬁrst assessment
(Week 2) for all three variables. No signiﬁcant differences were
seen between lumiracoxib groups, or between either lumiracoxib
group or the celecoxib group for any variable at any timepoint.
Lumiracoxib and celecoxib were well tolerated. The incidence of
adverse events (AEs), serious AEs and discontinuations due to
AEs was similar across groups.
Conclusions: Lumiracoxib 100 mg qd was an effective therapy
for OA, with efﬁcacy superior to placebo and similar to celecoxib
200 mg qd, and a safety/tolerability proﬁle comparable with
placebo.
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LUMIRACOXIB 100 MG ONCE DAILY IS AN EFFICACIOUS AND
WELL-TOLERATED THERAPY FOR KNEE OSTEOARTHRITIS
A. Beaulieuy, E. Sheldonz, Z. Pasterx, D. Duttajj, S. Yu{,
V. S. Sloan#
y Centre Hospitalier de l’Universite´ Laval Research Centre, Ste-
Foy, Canada
z Miami Research Associates, Miami, FL, USA
x Principal Research – Dean Foundation, Dean Medical Center,
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jj Clinical Trial Leader, Novartis Pharmaceuticals Corporation, East
Hanover, NJ, USA
{ Biostatistics and Statistical Reporting, Novartis Pharmaceuticals
Corporation, East Hanover, NJ, USA
# Senior Director, Arthritis, Novartis Pharmaceuticals Corporation,
East Hanover, NJ, USA
Aim: To compare the efﬁcacy and safety of lumiracoxib 100 mg qd,
placebo and celecoxib in a 13-week study of patients with knee
osteoarthritis (OA).
Methods: Patients (n Z 1551) at centers in the US and Canada
with primary knee OA and pain intensity in the target knee R40
mm on a 100 mm visual analog scale after a 3–7–day washout for
NSAIDs were randomized to lumiracoxib 100 mg qd (n Z 391),
lumiracoxib 200 mg qd for 2 weeks then 100 mg qd (200/100 mg
qd; nZ 385), celecoxib 200 mg qd (nZ 393) or placebo (nZ 382).
Three co-primary efﬁcacy variables were assessed at study end:
pain intensity in the target knee, patient’s global assessment of
disease activity and functional status (WOMAC Total score).
Secondary variables included by-visit assessment of these vari-
ables. Safety/tolerability was assessed with standard measures.
S139Results: Lumiracoxib was superior to placebo in all primary
variables. Reductions in pain intensity in the target knee were
similar for lumiracoxib groups at Week 13 (est. treatment  placebo
differences in least square means [LSMs]: 6.7 and 8.1 mm for
lumiracoxib 100 mg qd and 200/100 mg qd, respectively; both P!
0.001) and both were non-inferior to celecoxib (5.7 mm; P !
0.001). For patient’s global assessment of disease activity at Week
13, all active treatments were superior to placebo (est. treatment 
placebo differences in LSMs: 9.1, 10.1 and 6.7 mm for
lumiracoxib 100 mg qd, 200/100 mg qd and celecoxib, respectively;
all P ! 0.001).
Lumiracoxib signiﬁcantly improved the WOMAC Total score at
Week 13 vs placebo (est. treatment  placebo differences in LSMs:
7.4 and 7.8 for lumiracoxib 100 mg qd and 200/100 mg qd,
respectively; both P! 0.001). Lumiracoxib was similar to celecoxib
(est. treatment  placebo difference in LSM: 6.4; P ! 0.001).
Signiﬁcant differences vs placebo were seen from Week 2 for all
active treatments in all variables. No signiﬁcant differences were
seen between lumiracoxib groups for any variable at any timepoint.
Both lumiracoxib groups were numerically better than celecoxib for
all three variables.
Lumiracoxib and celecoxib were well tolerated with adverse event
incidence similar to placebo.
Conclusions: Lumiracoxib 100 mg qd demonstrated efﬁcacy similar
to celecoxib 200 mg qd in patients with knee OA, with tolerability
comparable with placebo.
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ARTICULAR CARTILAGE PASTE GRAFTING: A 2 TO 12 YEAR
FOLLOW-UP
K. R. Stoney, A. W. Walgenbachy, M. D. Hilly, D. P. Speerz
y Research, The Stone Foundation for Sports Medicine and
Arthritis Research, San Francisco, CA, USA
z College of Medicine, University of Arizona, Tucson, AZ, USA
Background: Isolated chondral defects are treated by various
chondroplasty and replacement procedures. However, no cartilage
replacement procedure is indicated for the treatment of arthritic
defects. To treat arthritic knee joint surfaces a single step
arthroscopic cartilage repair technique was designed.
Method: The paste graft steps require the harvest and mixture of
articular cartilage and bone from the intercondylar notch, crushed
into a paste, and impacted into a morselized arthritic area. This
prospective longitudinal study presents the results of a 2-to-12-year
follow-up of 125 patients (134 procedures) with Grade III or IV
arthritis receiving a paste graft. Of 145 patients who received this
procedure, 10 underwent subsequent joint arthroplasty and were
considered failures, 18 patients were lost to follow-up and two are
deceased; therefore, 125 patients (82 males, 43 females) of 145
(86%) were evaluated. Of the 125 patients, 93 (74.4%) had
undergone previous procedures to the affected knee with a mean
number of past surgeries of 1.70 (range, 1 to 7). The remaining 32
patients failed to respond to non-operative care. Average age was
46 years old. Lesions grafted included 76 medial femoral condyles,
23 lateral femoral condyles, 24 trochleas and 11 tibial plateaus. The
average lesion size was 289 mm2 (range, 24 mm2 to 1400 mm2).
Statistical power, with a two-sided a Z 0.05, and an effect size Z
1.05 and n Z 125, was O90%.
Results: WOMAC pain and functioning measures improved
signiﬁcantly (P! 0.001). Eight (5.5%) patients reported that their
pain was worse after surgery and therefore, are considered failures.
There was spatial variability within the biopsies obtained. None
were truly normal. Collagen typing revealed a variable concentra-
tion of Type I and Type II collagen by qualitative gel electrophoresis
and by immunohistochemical labeling. An independent blinded
reviewer (DS) found that within each biopsy there were spatial
histologic variations. Forty-two of 66 biopsies (63.6%) showed
strong and consistent evidence of replacement of their articular sur-
face by histological criteria. Eighteen of 66 (27.3%) biopsies were
judged to have areas of cartilage in the biopsy indistinguishablefrom normal. The ﬁgure below reveals a biopsy consistent with
repair hyaline cartilage.
Conclusions: The paste mixture of articular cartilage and cancel-
lous bone appears to provide a long lasting, supportive matrix for
cartilage formation. Pain relief, reduced stiffness, as well as
improved functioning is attained if careful surgical technique and
a deﬁned rehabilitation program are followed.
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A MECHANISTIC STUDY INTO THE CARTILAGE PROTECTIVE
AND ANTI-INFLAMMATORY EFFECTS OF THE HERBAL
PREPARATION SKI 306X
A. Hartog, S. Hougee, J. C. Zuurman, A. Sanders, J. Faber, M. A.
Hoijer, H. F. Smit, J. Garssen
Biomedical Research, Numico Research, Wageningen, Nether-
lands
Aim: SKI 306X is a puriﬁed preparation of three herbal extracts,
Clematis mandshurica, Trichosanthes kirilowii, and Prunella vulga-
ris. Clinical studies indicate that SKI 306X improves joint pain and
functionality in osteoarthritis patients. In the current in vitro study it
was evaluated by which possible mechanisms SKI 306X and its
individual components exert their effects.
Methods: Bovine cartilage explants from the metacarpophalangeal
joint were used as a model to study the effects of the herbal
extracts on interleukin-1b (IL-1b) induced proteoglycan (PG)
degradation. Explants were cultured with human recombinant IL-
1b (10 ng/ml) and herbal preparations (0–300 mg/ml) for 7 days.
The release of PG into the supernatant was measured using the
1,9-dimethylmethylene blue (DMB) assay. Prostaglandin E2
(PGE2), nitric oxide (NO) production and cytotoxicity were detected
by ELISA, Griess, and lactate dehydrogenase (LDH) assay,
respectively.
Human peripheral blood monocytes (PBMCs) were treated with
LPS (10 ng/ml) with or without herbal preparations for 20 h.
Production of IL-1b, tumor necrosis factor-a (TNF-a) and PGE2 in
the culture supernatant was measured by ELISA.
Results: Bovine cartilage explants: The three individual herbal
extracts and SKI 306X inhibited the IL-1b-induced PG release and
NO production in a dose dependent manner. SKI 306X and Prunella
completely inhibited IL-1b-induced NO release at 100 mg/ml
(P ! 0.0001). Prunella was able to counteract the IL-1b-induced
PGE2 production completely at a concentration of 30 mg/ml
(P ! 0.001).
PBMCs: Clematis, Prunella, and SKI 306X showed a dose de-
pendent inhibition of the LPS-stimulated PGE2, TNF-a and IL-1b
production. PGE2 and IL-1b production were completely counter-
acted by Prunella at a concentration of 125 mg/ml (P ! 0.006).
Conclusions: SKI 306X as well as its individual herbal extracts
inhibit IL-1b-induced PG degradation and NO production in
cartilage explant cultures, indicating cartilage protective activity.
Anti-inﬂammatory effects are observed by the inhibition of pro-
duction of inﬂammatory mediators such as PGE2, TNF-a and IL-1b.
S140P338
OSTENIL HYALURONAN FOR INOPERABLE ARTHRITIS OF
THE SHOULDER
L. Funk
Orthopaedic Department, Hope Hospital, Manchester, Lancashire,
United Kingdom
Aim: The aim of this study was to assess the efﬁcacy of Ostenil in
the treatment of shoulder arthritis in patients not suitable for
shoulder replacement surgery.
Methods: Seven patients presenting to a busy shoulder service
over a 2 year period were found to have disabling arthritis of the
shoulder, but were too medically unﬁt or refused shoulder
replacement surgery. All patients received a course of three Ostenil
injections into the glenohumeral joint at weekly intervals. Patients
were assessed pre-injection and at 3 months post-injection using
the Constant Score and additional quality of life questions.
Results: The mean patient age was 83 years (range 72 to 93),
including six females and one male. Five patients had osteoarthri-
tis, one rheumatoid arthritis and one cuff arthropathy.
The mean pre-injection Constant Score was 15.5 (10–25). The
mean Constant Score at 3 months was 49.5 (25–84). Pain was
improved signiﬁcantly by the injections from 11.6 (10–14) to 4.7 (0–
9). All patients had their sleep disturbed by pain prior to the
injections. Only three had some disturbance of sleep at 3 months
post-injection, with none having their sleep disturbed at all times
after the injections. Subjective shoulder elevation improved from
chest level to hand above head, whilst objectively it improved from
61.8( (30–90) to 92.1( (60–130). Patient satisfaction (on a scale of
0 to 10) improved from 1.3 (0–2) pre-injection to 8.4 (4–10)
following the injections (Table I).
Conclusions: Ostenil Hyaluronan appears to reduce pain and
improve patient satisfaction in patients with advanced arthritis of the
shoulder.
P339
PD-0200347, AN ALPHA 2 DELTA LIGAND, CAN REDUCE THE
PROGRESSION OF EXPERIMENTAL OSTEOARTHRITIS BY
INHIBITING A MAJOR CATABOLIC SIGNALING PATHWAY
C. Boileauy, J. Martel-Pelletiery, J. Brunety, G. Tardify, D. Schrierz,
C. Floryz, M. Boilyy, J. P. Pelletiery
y Osteoarthritis Research Unit, University of Montreal Hospital
Centre, Notre-Dame Hospital, Montreal, QC, Canada
z Pfizer Global Research and Development, Ann Arbour, MI, USA
The aim of this study was to examine the effect of PD-0200347, an
a2d ligand of voltage-activated Ca2C channels and a member of
the gabapentin family, in the ACL dog experimental model of
osteoarthritis (OA) and investigate its mechanism of action on the
major signaling pathways implicated in OA.
OA was surgically induced in dogs by sectioning the anterior
cruciate ligament. OA dogs were divided into three groups and
treated orally with (1) placebo, (2) 15 mg/kg/day of PD-0200347, or
(3) 90 mg/kg/day of PD-0200347. Dogs were sacriﬁced 12 weeks
after surgery. The severity of lesions was scored macroscopically
and histologically. Cartilage specimens from femoral condyles and
tibial plateaus were processed for quantitative PCR and immuno-
histochemistry. Speciﬁc probes and antibodies were used to study
iNOS, MMP-1, MMP-3 and MMP-13 mRNA and protein levels,
Pre-injection 3 months
post-injection
Constant score 15.5 (10–25) 49.5 (25–84)
Pain (VAS:0–15) 11.6 (10–14) 4.7 (0–9)
Subjective range of motion Chest level Above head
Shoulder elevation 61.8( (30–90) 92.1( (60–130)
Patient satisfaction (%) 13 (0–20) 84 (40–100)respectively. Speciﬁc phospho-antibodies were also used to study
the level of activity of PKCa, Ras and Raf, the MAP kinases, JNK,
P38 and ERK1/2 and the transcription factors CREB and Elk-1.
No clinical signs of drug toxicity were noted in the treated animals.
PD-0200347 treatment at both dosages tested (15 or 90 mg/kg/
day) reduced the development of cartilage lesions. Quantitative
PCR and immunohistochemical analyses showed that PD-0200347
treatment also reduced key OA mediators, iNOS, MMP-1, MMP-3
and MMP-13 gene expression and synthesis. PD-0200347 de-
creased dose-dependently the activity of PKCa, Raf, ERK1/2 and
Elk-1.
This study demonstrated the efﬁcacy of PD-0200347 at reducing
the progression of cartilage structural changes in experimental OA.
It also showed that this effect is linked to the inhibition, at the
transcriptional level, of the major pathophysiological mediators. The
mechanism of action could be related to a signiﬁcant reduction of
Ca2C current amplitude via voltage gated calcium channels, which
in turn down-regulates the downstream PKC, Raf and ERK1/2
signaling pathway.
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Aim: To assess the efﬁcacy of lumiracoxib 100 mg qd vs placebo
and celecoxib 200 mg qd over 13 weeks in patients with primary
knee osteoarthritis (OA) using OMERACT-OARSI criteria, a single
measure of OA treatment response incorporating three variables:
pain intensity, functional status and patient’s global assessment of
disease activity.
Methods: Patients (1551) with primary knee OA and pain intensity
in the target knee R 40 mm on a 100 mm visual analog scale after
a 3–7-day washout for NSAIDs were randomized to lumiracoxib
100 mg qd (nZ 391), lumiracoxib 200 mg qd for 2 weeks followed
by 100 mg qd (200/100 mg qd; nZ 385), celecoxib 200 mg qd (nZ
393) or placebo (n Z 382) at centers in the US and Canada.
Efﬁcacy was assessed according to OMERACT-OARSI criteria at
Weeks 2 and 13 in which patients were considered responders if
they had a reduction of: R 50% from baseline and an absolute
reduction of R 20 in either OA pain intensity or the WOMAC
Difﬁculty in Performing Daily Activities (DPDA) subscale (rescaled
to 0–100); or R20% from baseline and an absolute reduction of
R10 in R 2 of the following: OA pain intensity, WOMAC DPDA
subscale (rescaled to 0–100) or patient’s global assessment of
disease activity.
Results: Lumiracoxib (100 mg qd and 200/100 mg qd) was an
effective treatment for OA in terms of the proportion of patients
meeting the OMERACT-OARSI criteria at Week 13 (64.7% and
66.8%, respectively, vs 49.3 for placebo; both P ! 0.001). There
was no signiﬁcant difference between lumiracoxib groups, or
between either lumiracoxib group or the celecoxib group (respond-
ers: 61.6%). Lumiracoxib was effective from the ﬁrst assessment
(Week 2), where the proportion of responders in the lumiracoxib
100 mg qd and lumiracoxib 200/100 mg qd groups was 60.6% and
64.2%, respectively, vs 39.4% for placebo (both P ! 0.001).
Neither lumiracoxib group was signiﬁcantly different from the
S141celecoxib group (responders: 62.8%). In addition, no signiﬁcant
differences were detected between lumiracoxib treatment groups.
Conclusions: Lumiracoxib 100 mg qd was superior to placebo and
similar to celecoxib 200 mg qd in the treatment of knee OA
assessed using OMERACT-OARSI criteria, indicating signiﬁcant
improvements in pain, functional status and patient’s global
assessment of disease activity.
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THE EFFECTS OF NON-STEROIDAL ANTI-INFLAMMATORY
DRUGS ON THE EXPRESSION OF M-CALPAIN IN CULTURED
HUMAN CHONDROCYTES
K. Fushimiy, S. Nakashimaz, Y. Bannoz, A. Akaikex, M. Takigawajj,
K. Shimizuy
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Aim of study: The effects of non-steroidal anti-inﬂammatory drugs
(NSAIDs) on the release of m-calpain, which is detected in synovial
ﬂuid of arthritic joints and possesses the proteoglycanase activity,
were investigated in the cultured chondrocytes.
Methods: Human chondrocytic HCS-2/8 cells were stimulated by
tumor necrosis factor-a (TNF-a) in the presence or absence of an
NSAID (aspirin, loxoprofen-SRS, diclofenac sodium, indomethacin
and NS398). m-Calpain in the cells and culture medium was
quantiﬁed by Western blot analysis using an anti-m-calpain
antibody. m-Calpain in the culture medium was partially puriﬁed
by DEAE-cellulose chromatography. Western blots were subjected
to densitometric analysis and band intensities were determined.
Amount of prostaglandin E2 (PGE2) in culture medium was
measured using a commercial EIA kit.
Results: At 50 ng/ml TNF-a the increase of m-calpain in the culture
medium was accompanied with LDH release and cleavage of poly
(ADP-ribose) polymerase (PARP), a maker of apoptotic cell death.
Therefore, a part of released m-calpain was derived passively from
apoptotic cells. However, its signiﬁcant increase was observed in
the culture medium at 48 h after stimulation with TNF-a at
a concentration as low as 1 ng/ml, which did not stimulate the
release of LDH. At 10 ng/ml TNF-a the level of m-calpain in the
culture medium at 48 h reached about 20-fold over that of
unstimulated control cells; the increase of which far exceeded that
of LDH release (nearly two-fold increase at 48 h after stimulation).
The m-calpain release by 10 ng/ml TNF-a was accompanied by its
transient increase in the cells. Therefore, the induction of m-calpain
was associated with the release from the cells. The NSAIDs
examined did not affect the leakage of small amount of LDH from
TNF-a-treated HCS-2/8 cells. On the other hand, TNF-a-induced
release of m-calpain into the culture medium was potently inhibited
by the NSAIDs at concentrations, which effectively inhibited the
activities of COXs. Among the NSAIDs examined, NS398,
a selective COX-2 inhibitor, blocked m-calpain release in the
lowest concentration (0.1 mM). Transient increase of intracellular
m-calpain seen at 24 h after stimulation with 10 ng/ml TNF-a was
also signiﬁcantly downregulated by the NSAIDs. The NSAIDs
tested almost abolished TNF-a-mediated production of PGE2 PGE2
alone upto 1 mM had no effect on m-calpain release. However,
PGE2 enhanced release into the culture medium and transient
increase in the cells of m-calpain stimulated by a lower concen-
tration of TNF-a (1 ng/ml). Moreover, inhibition of m-calpain release
by an NSAID, loxoprofen-SRS, was signiﬁcantly reversed by 100
nM PGE2.
Conclusions: These results suggest that TNF-a stimulates the
release of m-calpain and that PGE2 is deeply involved in this
process. Increase of m-calpain in the culture medium implies that
this Ca2C-dependent protease may play a role in the degradation ofcartilage extracellular matrix during arthritis. The therapeutic effects
of NSAIDs may be due to, at least in part, the blockage of m-calpain
release.
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EFFECT OF INTRA-ARTICULAR INJECTION OF SODIUM
HYALURONATE ON RECOVERY AFTER ARTHROSCOPIC
KNEE SURGERY
S. Anandy, S. Mitchelly, C. Bamforthz, T. Asumuy, K. A. Buchy
y Department of Orthopaedic Surgery, Royal Oldham Hospital,
Oldham, Lancashire, United Kingdom
z Department of Physiotherapy, Royal Oldham Hospital, Oldham,
Lancashire, United Kingdom
Aim: To determine effect of single post-operative injection of
Sodium Hyaluronate (Viscoseal) on the pain and joint function,
following arthroscopic knee surgery.
Method: Study design: A randomized, prospective, controlled,
double blinded trial after ethical approval. Study procedure:
Consenting patients (age group 18–60 years) undergoing arthro-
scopic knee surgery were randomized to either study group or
control group, after the completion of their operation. Control group
had 10 ml of 0.5% Bupivacaine injected in the joint after the
procedure, while study group had 10 ml of Viscoseal (Sodium
Hyaluronate preparation devoid of animal protein) injected in the
joint. Patients were given questionnaires to assess their pain and
function at various times (Preoperatively; 2 h following surgery; Day
1, Day 7, 3 weeks and 6 weeks following surgery). Primary efﬁcacy
parameters used were Pain visual analogue scores at rest, on
movement and on weight bearing. Secondary efﬁcacy parameters
used included WOMAC questionnaire, SF-12 general health
questionnaire and use of rescue medication. Patients were
evaluated clinically at 6 weeks by a blinded physiotherapist.
Results: Forty-eight patients (Average aged41 years, 20 females,
28 males) undergoing knee arthroscopy were randomized (24
patients each). The hyaluronate group exhibited markedly lesser
degrees of immediate post-operative pain and swelling; reduced
need for analgesics, and a signiﬁcantly larger drop in WOMAC
scores than the bupivacaine group (P ! 0.05). SF-12 scores and
delayed pain VAS score improved by a comparable amount. In
particular, those undergoing partial meniscectomy exhibited greater
beneﬁts with hyaluronate. No complications were recorded in either
of the groups.
Conclusion: Sodium hyaluronate (Viscoseal) injections could be
safely used following arthroscopic knee surgery, to facilitate
patient’s recovery.
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EXPEDITED FINITE ELEMENT ANALYSIS OF PRESERVATION
OF ANKLE JOINT DISTRACTION
J. K. Nielseny, C. L. Saltzmanyz, T. D. Brownyz
y Biomedical Engineering, University of Iowa, Iowa City, IA, USA
z Orthopaedics and Rehabilitation, University of Iowa, Iowa City, IA,
USA
Introduction: Joint distraction by external ﬁxation is an intriguing
new treatment for end-stage osteoarthritis. In ongoing clinical study
of this intervention for ankle OA, it is desirable to ensure that the
initial 5 mm intraoperative distraction is maintained during weight
bearing, since mechanical contact between the articular surfaces
can lead to an unintended abrupt increase in the pressure on the
cartilage. Unfortunately, the wide variation in ﬁxator construct
geometry makes determination of ﬁxation stiffness for each case
problematic. Therefore, a construct-speciﬁc ﬁnite element model
was developed to determine the magnitude of individual patients’
axial tibial displacement under loading during distraction treatment.
Methods: Distraction for all cases was carried out using an Ilizarov
ankle ﬁxator consisting of two tibial rings, two half-pins, and one or
S142two transﬁxion wires for tibial ﬁxation. The placement and
orientation of transﬁxion hardware and the ring geometry varied
between constructs.
Conﬁguration-speciﬁc data were entered using a graphical user
interface that allowed complete speciﬁcation of ﬁxator geometry.
ABAQUS ﬁnite element software completed the analysis of each
ﬁxator construct in less than 15 s. The interface program outputs
the tibial displacement relative to the talus. The model was run both
for speciﬁc clinical OA distraction cases, and for a parametric series
investigating the effects of 15 individual construct parameters,
including wire and pin placement, and ring spacing and diameter.
Results: The parametric series showed that the length of the two
tibial half-pins was the strongest determinant of ﬁxation stiffness.
This length was affected by the position of the tibia within the rings,
as well as by the circumferential mounting location of the half-pins.
Results from analysis of hardware applied to individual OA patients
showed that the stiffness of ﬁxators varied dramatically. The model
reported vertical tibial displacements between 1.76 mm and 6.16
mm, for a 900 N load. This result suggests that the nominal 5 mm
intraoperative tibio-talar distraction is potentially compromised
during ambulation in certain patients, whereas others may safely
load their limb without incurring the high mechanical stresses
associated with cartilage-on-cartilage contact.
Discussion: Most OA patients in the clinical series showed
a positive response to ankle joint distraction, although the
mechanisms responsible for treatment efﬁcacy remain to be fully
determined. The development of a very fast-running ﬁnite element
model has provided a tool for helping to ensure adequate distractor
ﬁxation stiffness, on a patient-speciﬁc basis. The speed and
interactive nature of this model invite its application intraoperatively
for evaluation of ﬁxator conﬁguration alternatives, not only in the
context of distraction for OA treatment, but also for fracture ﬁxation
and limb lengthening procedures.
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SIGNIFICANT JOINT SPACE NARROWING (JSN) IN MEDIAL
KNEE OSTEOARTHRITIS (OA) IS ASSOCIATED WITH IN-
CREASED JOINT SYMPTOMS: RESULTS OF A 2-YEAR
RANDOMIZED PLACEBO-CONTROLLED STUDY OF RISEDR-
ONATE
C. Bingham, J. Beary, S. Adami, D. Clauw, S. Cohen,
M. Dougados, G. Cline, J. Meyer
Rheumatology, NYU-Hospital for Joint Diseases, New York, NY,
USA
Arthritis Research, Procter and Gamble Pharmaceuticals, Mason,
OH, USA
Rheumatology, University of Verona, Verona, Italy
Rheumatology, University of Michigan, Ann Arbor, MI, USA
Rheumatology, St. Paul Medical Center, Dallas, TX, USA
Rheumatology, Hopital Cochin, Paris, France
Purpose: Previous reports do not demonstrate an association
between JSN and OA symptoms. We investigated the relationship
between joint symptoms and changes in joint space width in large
multicenter studies of mild-moderate knee OA in North America
(NA) and Europe (EU).
Methods: These 2-year, prospective, double-blind, placebo-con-
trolled trials studied risedronate 5 mg qd, 15 mg qd, and 35 mg qwk
(EU) or 50 mg qwk (NA). A total of 1232 subjects were randomized
in NA and 1251 in EU. Study patients had symptomatic and
radiographic knee OA with at least one osteophyte and medial
compartment JSW between 2 and 4 mm using the radiographic
method of Buckland-Wright. WOMAC pain, function, and stiffness
and patients’ global assessment (PGA) were measured at baseline,
6 months, 12 months, 18 months, and 24 months. Assessments
were preceded by a 5-day medication stepdown/washout for
analgesics.
Results: Mean age was 60.5(63.6) years in NA (EU) studies. Sixty-
one percent (79%) were females; mean BMI was 30.3 kg/m2
(29.4). Baseline total WOMAC was 40 mm (NA), and 46 mm (EU).
Baseline JSW was 2.94 mm G 0.04 (NA) and 3.00 G 0.04 (EU).Baseline values were consistent in all study arms. No overall drug
effect on OA symptoms or JSW was demonstrated. Radiographic
progression (loss of R 0.6 mm) was observed in 13.5% of 2154
patients. Patients with a 50–60% decrease in JSW showed
clinically relevant 10 mm increases in pain, function, and total
WOMAC scores. NA results are shown. EU results were similar.
Conclusions: While the number of progressors in this study was
small, in patients with higher degrees of JSN, a signiﬁcant increase
in joint symptoms and concurrent decrease in function were
observed. These results suggest that future studies to evaluate
SMOADS and symptomatic improvement in OA may need to be
limited to patients at risk for rapid and signiﬁcant progression.
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TREATMENT OF PATIENTS WITH KNEE OSTEOARTHRITIS
WAITING BY REPLACEMENT SURGERY WITH INTRA-ARTIC-
ULAR HYALURONIC ACID (ADANT)
F. J. Blanco Garciay, J. L. Fernandez Sueiroy, J. A. Pintoy,
J. C. Fernandez Lopezy, M. Ramosz, M. Gimenoz, P. Coronelz,
F. Galdoy
y Laboratory of Investigation, Rheumatology Division, C.H.U. Juan
Canalejo, A Corun˜a, Spain
z Tedec-Meiji Farma S.A. Alcala´ de Henares, Madrid, Spain
Aim: The main objective of the study is to comparatively assess
with placebo if 500 kDa Hyaluronic Acid (HA) delays and/or
reduces the indication of knee replacement surgery (KRS), as seen
in the improvement of the patient’s condition. To analyse the
economic repercussions by the effectiveness produced by ex-
penses related to treatment of osteoarthritis (OA) in those patients
included.
Material and methods: A pilot, prospective, unicentre, simple blind,
randomized, controlled clinical trial with three treatment groups
(Group I: Placebo treatment, Group II: 500 kDa HA-ADANT
treatment, Group III, without intra-articular (IA) treatment under
surgery) was carried out. The duration of IA treatment (HA and
Placebo) has been two cycles of ﬁve injections with an interval of 6
months between each one. The control group for the pharmaeco-
nomic study has been made up of those patients from Group III.
The group without IA treatment has been operated on KRS
following the established order on the waiting list. The efﬁcacy
variable has been measured by change of pain, articular mobility,
functional capacity and total index score measured by WOMAC.
For pharmaeconomic assessment, costs have been measured
from a hospital perspective (not taking into account indirect costs
such as loss of production). A covariance analysis (ANCOVA) has
been used in order to compare the main efﬁcacy variable for each
treatment arm. All the efﬁcacy variables have been analysed for
intent-to-treat population.
Results: A total of 77 patients (14M/63F) were enrolled in the study
(Group I: 26; Group II: 26 and Group III: 25). The study of the
change in WOMAC pain subscale and pain VAS scale scores at 3
and 6 months after ﬁrst injection did not show statistical differences
S143between group I and II, but it was observed that group II showed at
6 months a higher pain relief than group I (108.6 vs 55.8).
Change in WOMAC articular mobility subscale at 6 months when
compared to baseline score was 4.3 in Group I and 44.8 in
Group II (P Z 0.081). Both change in WOMAC functional capacity
subscale (Group I Z 74.9 vs Group II Z 420.1) and change in
total WOMAC index score (Group I Z 134.9 vs Group II Z
573.5) at 6 months when compared to baseline score were
statistical signiﬁcant. From all patients of Group I and II, three and
nine patients did not receive KRS, respectively. The determination
of the NNT was 5. Total cost of all the patients included in the
Group I, II and III after 6 months to start the study was
132,969.20V, 106,375.36V and 239,951.12V, respectively.
Conclusion: Patients treat with intra-articular HA seems to show
a better efﬁcacy proﬁle than those from placebo. Intra-articular HA
could delay the moment of KRS. In patients waiting by KRS, the
treatment of knee OA with HA reduces the cost.
This clinical trail was supported by TEDEC-MEIJI Farma-SPAIN.
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BOTULINIC TOXIN FOR THE REHABILITATION OF OSTEOAR-
THRITIS FIXED-FLEXION KNEE DEFORMITY
M. L. Pucinelliy, L. H. Mercuriz, F. A. Fernandesy, H. Holanday
y Rheumatology, UNIFESP-EPM, Sao Paulo, Sao Paulo, Brazil
z Fisiatria, UNIFESP-EPM, Sao Paulo, Sao Paulo, Brazil
Introduction: Patients with knee osteoarthritis eventually develop
ﬂexion attitude of the knee that can progress to ﬁxed-ﬂexion
deformity. Fixed-ﬂexion deformity impairs walking and can contrib-
ute to cartilage degradation. Fixed-ﬂexion deformity is caused, at
least partially, by hamstring muscles contracture, which is usually
difﬁcult to revert with physiotherapy.
Aim: In this preliminary study we evaluate the effectiveness of
botulinic toxin injections to improve ﬁxed-ﬂexion deformity in
patients with knee osteoarthritis.
Patients and methods: Six patients with knee osteoarthritis and
ﬁxed-ﬂexion deformity were included in this study. All patients
answered Lequesne functional questionnaire and had range of
motion measured by goniometry before and 4 weeks after
treatment. Four patients had Kellgren/Lawrence (KL) scale grade
III for knee osteoarthritis and the other 2 had grade IV. Botulinic
toxin in a single dose of 300 IU was injected in the hamstring
muscles guided by electro stimulation. Patients were asked to
perform stretching exercises at home.
Results: Botulinic toxin was beneﬁcial for most patients, increasing
range of motion and decreasing Lequesne scores. Before
treatment average ﬂexion deformity angle and Lequesne score
were 11.3( and 10.5, respectively. After treatment these parame-
ters were 8.6( and 8.5, respectively. Separate analysis showed
that patients with KL grade IV had no beneﬁts from the injections,
while KL grade III patients had accentuated reduction in Lequesne
scores in spite of small increase in range of motion.
Conclusion: Further prospective controlled studies will be needed
to evaluate whether hamstring blockage with botulinic toxin has
therapeutic potential in the management of knee osteoarthritis with
ﬁxed-ﬂexion deformity.
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OSTENIL MINI IN THE TREATMENT OF HALLUX LIMITUS. A
SINGLE BLIND, RANDOMISED STUDY
F. Alvarezy, M. Ponsy, J. Solanay, E. Rodriguezy, R. Viladoty,
L. Varelaz
y Orthopaedic Surgery, Hospital San Rafael, Barcelona, Spain
z Scientific Department, Masterfarm S.L., Barcelona, Spain
Aim: To assess the efﬁcacy and safety of Ostenil mini (TRB
CHEMEDICA AG, Germany), a synovial ﬂuid substitute containing1.0% hyaluronan, in the treatment of osteoarthritis (OA) of the ﬁrst
metatarsophalangeal (FMTP) joint, compared to standard steroid
injection.
Methods: Patients (40–80 years old) with painful OA of the FMTP
joint were recruited after giving written informed consent and
randomised after conﬁrmation of inclusion/exclusion criteria. Those
in the Ostenil group (OG) received one intraarticular (i.a.) injection
of Ostenil mini (1.0 ml), while the steroid group (SG) received one
i.a. injection of 1 ml of 1% triamcinolone acetonide. Only
paracetamol 500 mg tablets were allowed as escape medication.
Patients were assessed on days 0, 14, 28, 56 and 84 (end of
study). Efﬁcacy was evaluated with the following parameters: pain
at the MTP joint (VAS) on palpation, on passive motion and on
walking 20 m with standard shoes; the Hallux Metatarsophalan-
geal-Interphalangeal Scale of the American Orthopaedic Foot and
Ankle Society (AOFAS); general evaluation of treatment by patients
and physician (5 level scale); and the use of analgesics. Tolerability
to treatment was assessed by patients and physician (5 level scale)
and all adverse events were recorded. Variables were analysed
using the Chi-square test, non-parametric Mann–Whitney U test,
Wilcoxon test and Friedman test.
Results: Thirty-seven patients (mean age: 62.0 years; females:
85%) (40 joints) were recruited and completed the study (OG: n Z
20 joints; SG: n Z 20 joints). Pain on palpation and on passive
motion decreased signiﬁcantly (P ! 0.01) in both groups
throughout the study compared to baseline, but there were no
differences between groups (P > 0.05). Pain on walking 20 m
decreased more in the OG being signiﬁcant (P! 0.05) at Days 28
and 56. AOFAS scale evaluation showed no differences in function
and alignment, but a signiﬁcant reduction (P ! 0.05) in pain and
total score was observed for OG at all visits. General evaluation of
treatment by the patient showed increased patient satisfaction in
both groups, but it was signiﬁcant (P ! 0.05) only in OG. Adverse
events appeared in two joints in OG and in one in SG (P > 0.01) and
consisted of pain and/or swelling at the injection site.
Conclusion: Ostenil mini is effective and safe in decreasing pain
due to OA of the FMTP joint. Pain and AOFAS total score showed
signiﬁcant improvement with Ostenil mini compared to a steroid
injection. No severe adverse reactions were observed.
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PRELIMINARY STUDY TO EVALUATE THE EFFICACY AND
TOLERANCE OF JOINT LAVAGE IN SHOULDER PAIN VS
INTRA-ARTICULAR INJECTION OF HYALURONIC ACID
A. R. De la Serna, M. A. Moreno, A. A. Pereira
Rheumatology, Hospital Sant Pau, Barcelona, Spain
Objectives: To evaluate the efﬁcacy and tolerance of joint lavage in
shoulder pain vs intra-articular injections of hyaluronic acid.
Methods: In this prospective comparative and randomized study,
were treated 30 patients (24 females), 15 in each group. Both
groups were evaluated at baseline, 1 week, 1 month and at 3 and 6
months after the treatment procedure.
The main inclusion criterion was a minimum pain score of 50 mm
on a visual analogue scale (VAS) from 0 to 100 mm.
The primary endpoints were the efﬁcacy on the pain level; mobility
(active and passive) and patient’s and physician’s opinion and
ability (LDA). The secondary endpoint was the treatment tolerance.
A comparison response rates between two groups were made for
ANCOVA model: one variant analysis of two factors: time factor
(two levels, before and after) of repeated measurements and group
factor (two levels, hyaluronic acid and joint lavage) the independent
measures, evaluating both factors and interactions between them.
The signiﬁcant level was 0.05.
Results: Both treatment groups were comparable at baseline.
There was a signiﬁcant improvement in the VAS score, mobility and
patient’s and physician’s opinion and ability at 1 week, 1 month,
and 3 and 6 months (P ! 0.0001) compared at baseline.
Tolerance results showed no adverse events in either group. No
patient dropped-out.
S144Conclusion: Treatment with AL of the shoulder joint is safe and
comparable with hyaluronic acid injections in the treatment of
shoulder pain.
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CLINICAL EFFICACY OF EXTRACORPOREAL SHOCK-WAVE
THERAPY IN KNEE OSTEOARTHRITIS
Y. Wada, T. Saisu, K. Takahashi, N. Takahashi, S. Ohtori,
T. Sasho, K. Nakagawa, M. Tahara, Y. Kawaguchi, A. Watanabe,
R. Murata, N. Ochiai, H. Moriya
Department of Orthopedic Surgery, Chiba University, Graduate
School of Medicine, Chiba City, Chiba pref., Japan
Introduction: A new variety of non-operative treatments for
osteoarthritis have been receiving considerable attention. The
purpose of this study is to investigate the efﬁcacy of extracorporeal
shock-wave therapy (ESWT) in knee osteoarthritis.
Methods: ESWT were applied using Epos (Dornier Co., Germany)
in 15 knees of 12 patients who had had an inadequate response to
prior conventional conservative treatments for more than 6 months.
The mean follow-up period was 22.2 (G20.6 SD) weeks. We
investigated the clinical efﬁcacy of ESWT according to pain,
function, X-ray and MRI ﬁndings. We used Japan Orthopaedics
Association osteoarthritis score (JOAscore) and the Visual Analog
Scale score (VASscore) for the clinical evaluation of knee
osteoarthritis. JOA score becomes 0–100 according to OA
symptoms and knee function. The lower score means the severer
symptoms and dysfunctions of affected knee joint.
Results: Subjective symptoms improved in 11 of 15 knees (77.3%),
and total score of JOA increased from 66.7 points to 84.7 during
follow up. Particularly, pain score signiﬁcantly reduced. Theanalgesic effect of ESWT was observed from immediately after
treatment and ‘night pain’, ‘pain on walking’ and ‘tenderness’
reduced but tenderness was likely to remain ﬁnally. There was no
deterioration of symptom and we did not detect any complication by
radiographic analysis
Discussion: The efﬁcacy of ESWT in enthesopathy such as tennis
elbow or plantar fasciitis already has been reported, while there
was no report on the efﬁcacy of ESWT in knee osteoarthritis.
Although the reason of the efﬁcacy is unknown, pain related from
the tendon and ligament insertion of the knee seemed to be
relieved with shock waves. This is the ﬁrst report, which shows the
clinical efﬁcacy of ESWT in knee osteoarthritis.
Conclusion: ESWT could be an alternative therapy in the treatment
of knee osteoarthritis refractory to the other therapy.
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AN IN VITRO EVALUATION OF THE EFFECT OF MIXING
HYLAN G-F 20 AND CORTICOSTEROID
L. P. Yuy, M. G. Changy, E. Voschiny, E. M. Skrabuty, J. W. Burnsy,
D. B. Magilavyz
y Biomaterials Science & Engineering, Genzyme Corporation,
Cambridge, MA, USA
z Clinical Research, Genzyme Corporation, Cambridge, MA, USA
Aim: This study was designed to determine if the rheological
properties of hylan G-F 20, a viscosupplement for treating pain due
to osteoarthritis of the knee, are adversely affected by dilution with
a corticosteroid suspension, and to determine if there is a chemical
interaction between corticosteroid and hylan G-F 20.
Methods: Triamcinolone acetonide (TAA) (40 mg/ml), and methyl-
prednisolone acetate (MPA) (80 mg/ml), were aseptically mixedFig. 1. Effect of storage time at 37(C on G# of hylan G-F 20 when mixed with buffer, TAA or MPA.
Fig. 2. Effect of storage time at 37(C on corticosteroid recovery following mixing with hylan G-F 20.
S145Table I
Comparison of hylan G-F 20 G# and G$ following mixing with buffer or corticosteroid
Hylan-Buffer 3:1 Hylan-Buffer 4:1 Hylan-MPA 3:1 Hylan-MPA 4:1 Hylan-TAA 3:1 Hylan-TAA 4:1
G# (Pa) Mean 74.3 85.3 77.0 85.3 73.0 85.0
St. Dev 1.5 1.5 0.0 1.2 3.5 1.0
G$ (Pa) Mean 13.3 13.7 14.7 15.7 14.7 16.0
St. Dev 0.6 0.6 0.6 0.6 0.6 0.0with hylan G-F 20 (9 mg/ml) at volume ratios of 4:1 and 3:1 (hylan
G-F 20:corticosteroid). The lowest dilution of hylan G-F 20
represented a dose of 20 mg and 40 mg per injection for TAA
and MPA, respectively. Following mixing, the samples were stored
at 37(C for 24, 48 and 72 h. The rheology of diluted hylan G-F 20
samples, as represented by the storage (G#) and loss moduli (G$),
were assessed at the indicated time points and compared to the
speciﬁcations of hylan G-F 20 (G# R 60 Pa and G$% 35 Pa) and
for any changes relative to mixing with buffer alone. Corticosteroid
recovery, representing drug structure and availability, was analyzed
by HPLC. Each sample was tested in triplicate.
Results: Dilution with either TAA or MPA at 4:1 and 3:1 did not
affect hylan G-F 20 G# and G$ when compared to the buffer control.
Additionally, the hylan G-F 20/steroid mixtures remained within
speciﬁcations for these rheological parameters (Table I) over 3
days at 37(C (Fig. 1). HPLC analysis of the corticosteroid/hylan G-
F 20 mixtures showed full recovery of TAA and MPA after mixing
and incubation (Fig. 2).
Conclusions: We conclude that triamcinolone acetonide and
methylprednisolone acetate had minimal effect on the rheological
properties of hylan G-F 20. Additionally, we did not observe any
chemical interactions with hylan G-F 20 that would affect
corticosteroid structure and availability.
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A LARGE STUDY PHASE IV OF INTRAARTICULAR ARTHRUM
H IN KNEE OA PATIENTS
T. Bardiny, P. Kiefferz, K. Hassayniaz, P. Vincentz, F. Vincent
Aubryz
y Service de Rhumatologie, Hopital Lariboisiere, Paris, France
z LCA Pharmaceutical, Chartres, France
Arthrum H is a 2400 kDa non-crosslinked hyaluronate, obtained
from bacterial biofermentation, which is presently available in
France and Spain. We report the results of an open phase IV study
of intrarticular Arthrum H in knee OA, performed by 153
rheumatologists in these two countries, in which tolerance and
efﬁcacy parameters as well as analgesics and NSAIDs consump-
tion were prospectively monitored. Patients (3349) fulﬁlling the ACR
clinical criteria were included, of whom 41 were excluded for major
protocal deviation. At inclusion, patients had a mean age of 69.2
years, an average BMI of 27.4 (range 14.5–56.0), a disease
duration of 7.0 C 6.2 years, and a mean Lequesne index of 11.2.
The percentage of patients that received analgesic or NSAID
therapy was 63.1%. Patients received 3 weekly 2 ml (40 mg)
intraarticular injections of Arthrum in one knee and were followed
during 90 days (5 visits at days 0, 15, 30, 60, 90). One thousand
eight hundred twenty-ﬁve patients were followed up to the J90 visit.
Complete analysis showed that the mean Lequesne index value
signiﬁcantly (P! 0.01) improved from 11.2 at D0, to 8.9 at D15, 7.6
at D 30, 6.7 at D60, 6.2 at D90. No preinjection parameter was
found to be predictive of the Lequesne index change. Similarly,
patient assessment of efﬁcacy on a 5 point scale was positive for
59.2%, 68.2%, 65.9%, 65.9% of patients at D 15, 30, 60 and 90,
respectively. Percentage of patients taking analgesic and/or
NSAIDs decreased from 63.1% at D0 to 29.9% at D90. The daily
deﬁned dose per patient taking these drugs did not change.
Tolerance was overall fair: 7.1% of patients complained of transient
postinjection pain episodes, and 7.2% of self-remitting joint
swelling. Poor tolerance was the cause of drug discontinuation in
2.2% of patients. No serious adverse event was recorded.In conclusion, in this large phase IV study intraarticular Arthrum H
appeared to have a rapid and sustained efﬁcacy, allowing reduction
of analgesics and NSAIDs, and was well tolerated.
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REPORT OF 44 PATIENTS SUFFERING FROM SYMPTOMATIC
HIP OSTEOARTHRITIS TREATED WITH INTRA-ARTICULAR
ADMINISTRATION OF HYLAN G-F 20 (SYNVISC)
A. Migliorey, S. Tormentaz, U. Massafray, M. Granatax, L. Grilloy,
A. Alimontiy
y Internal Medicine, ‘‘S.Pietro-FBF’’ Hosp. Centro Ricerche S.Pietro
AFaR, Rome, Italy
z Radiology, ‘‘S.Pietro-FBF’’ Hosp. Centro Ricerche S.Pietro AFaR,
Rome, Italy
x Rheumatology, ‘‘San Filippo Neri’’ Hosp, Rome, Italy
Aim of the study: Report of the duration of clinical beneﬁt after
ultrasound-guided IA injection of hylan G-F 20 (Synvisc) in
patients with symptomatic hip OA.
Materials and methods: Adults, ambulatory patients suffering from
hip OA grade I to III according to Kellgren and Lawrence were
considered eligible for the Study. Patients were injected with one
syringe (2 ml) of hylan G-F 20, possibly repeated if clinically
necessary every 3 months, under ultrasound guidance. A 7 MHz
linear or 3.5 MHz convex transducer was used with a sterilised
biopsy guide attached. The hip joint was scanned by means of an
anterior parasagittal approach. The efﬁcacy of the injection was
assessed by using the WOMAC index, global patient evaluation,
global physician evaluation and a hip OA VAS pain score at
baseline, and then at 3, 6 and 12 months after the ﬁrst injection of
hylan G-F 20. Safety was assessed by recording any adverse event
during the follow up period.
Results: Forty-four patients were enrolled in our Day-Hospital for
treatment, 16 had bilateral hip OA. Seven patients dropped out for hip
replacement. Twenty-one patients had 12 months follow up, seven
patients had 9 months, nine patients had 6 months follow up. In the
44 patients, 28 patients received 1 injection, 14 patients received 2
injections, one patient received 3 injections and one patient 4
injections for a total of 77 injections. A reduction of theWOMAC index
and pain VAS, global patient evaluation and global physician
evaluation respectively was observed either at 3- 6-9-12 months
follow up group vs baseline. All these differences are statistically
signiﬁcant. No septic or systemic complications were reported.
Conclusions: Hylan G-F 20 intra-articular treatment is safe and
may have a beneﬁcial impact on pain and function for 12 months
in hip OA patients. Further studies with control group are
warranted in order to establish the optimal dosing regimen of
hylan G-F 20 and to evaluate the precise duration of its beneﬁt in
hip OA.
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A POWDER PREPARED FROM SEEDS AND SHELLS OF
A SUBTYPE OF ROSE-HIP ROSA CANINA REDUCES PAIN IN
PATIENTS WITH OSTEOARTHRITIS OF THE HAND – A DOU-
BLE-BLIND, PLACE-CONTROLLED, RANDOMIZED STUDY
K. Winther, A. Kharazmi
Biochemistry, Copenhagen County Hospital, Copenhagen, Denmark
Clinical Microbiology, University Hospital Rigshospitalet, Copenha-
gen, Denmark
S146Aim of study: To study the impact of a standardized dried powder,
made from the seeds and shells of a sub-species of rose hip, Rosa
canina, on pain and stiffness in patients with osteoarthritis of the
hands.
Methods: The design was double-blind, placebo-controlled, cross-
over. Thirty-two patients with osteoarthritis of one or both hands
were randomly allocated to treatment with either rose-hip powder or
placebo.
Treatment: Five capsules of 0.5 gram standardized rose-hip
powder, or an identical placebo, was given twice daily, for a 3
months period, after which the patients switched immediately to the
corresponding medication. Before and after each of the two
treatment periods, the patients evaluated their pain and stiffness
while performing one of 15 different daily activities of the hand,
using a separate 10-step categorical scale for each. They also
assessed their overall feeling of discomfort from the disease on
a similar scale. A blood sample for determination of C-reactive
protein was also taken.
Results: Taking the average of their 15 individual activity pain
scores as the index of effect for each person showed a signiﬁcant
reduction of pain while on active treatment (P ! 0.0428). In the
group initially given active treatment for 3 months, 88% reported
reduction in pain when evaluated on the response/no response
basis, as compared with 36% in the placebo group (P ! 0.009).
Evaluation of stiffness showed a similar pattern and the overall
feeling of discomfort from the disease was reduced while on active
treatment (P! 0.0324). Active treatment caused a signiﬁcant fall of
the C-reactive protein level (P ! 0.047) below the pre-treatment
level.
Conclusion: The data suggest that powder from the present sub-
species of rose-hip can reduce pain and the feeling of discomfort in
patients with osteoarthritis of the hand.
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DOES AQUATIC EXERCISE HAVE ANY EFFECT ON FUNC-
TION AND PAIN IN KNEE OSTEOARTHRITIS – A SYSTEMATIC
REVIEW
E. M. Bartelsy, H. Lundz, R. Christensenz, B. Danneskiold-
Samsøez
y The Danish National Library of Science and Medicine, Copenha-
gen, Denmark
z The Parker Institute, Frederiksberg Hospital, Frederiksberg,
Denmark
Aquatic exercise is a frequently used method in the treatment of
knee osteoarthritis (OA) patients. The effects of this treatment are
not completely clear. The aim of this study was to carry out a meta-
analysis of studies applying aquatic exercise to knee OA.
A thorough literature search was performed, and 26 studies were
chosen according to our inclusion criteria. A closer reading of these
studies left us with four studies, which fulﬁlled the following criteria:
randomised controlled studies where knee OA patients could be
identiﬁed and where the intervention included active physical
exercise in the water. However, a meta-analysis could not be
carried out due to different designs, interventions and outcome
measures. When aquatic exercise was compared to a control
group, aquatic exercise showed a signiﬁcant better effect on pain
(effect size: from 0.28 to 0.34) and disability (effect size: from 0.28
to 0.30). When comparing aquatic exercise with land-based
exercise, the same positive effect was found in both groups.
Recreational activities in water do not improve range of motion or
function when compared to exercise in water. It can be concluded
that aquatic exercise for knee OA patients may have a beneﬁcial
effect, even though land-based exercise is just as good. However,
too few clearly deﬁned studies with a statistically acceptable
number of participants exist to be able to draw a ﬁnal conclusion
about effects of different types of exercise in OA treatment. Further
studies are needed where aquatic exercise for OA patients is
compared to both land-based exercise and a control group
receiving no exercise therapy.P355
RETROSPECTIVE COMPARATIVE ANALYSIS OF THE SAFETY
AND EFFICACY OF INTRA-ARTICULAR HYALURONAN THER-
APIES IN CLINICAL PRACTICE
M. I. Hamburger, M. K. Hamburger, L. Brandt, A. T. Kaell,
R. S. Bennett, S. Johnson, P. Rumore, P. Schulman
Medicine, State University of New York at Stony Brook, Stony
Brook, NY, USA
The objectives of the study were to compare safety and efﬁcacy of
hyaluronan (HA) therapies for treating pain associated with
osteoarthritis (OA) of the knee in use in a clinical rheumatology
practice. The analysis was based upon a retrospective review of
171 patients that received at least two treatment cycles of intra-
articular hyaluronans between 09/01/1997 and 09/15/2002 (72.5%
had 2 courses, 21% 3 courses, 6.5% more than 3 courses),
representing approximately 1400 intra-articular injections. Forty-
four percent of these patients had bilateral OA involvement. A total
of 247 knees were treated. One hundred thirty-six (203 knees) of
the patients (79.5%) were treated with HyalganO` (sodium
hyaluronate), HYL, and 35 (44 knees) of the patients (20.5 %)
were treated with SynviscO` (hylan G-F 20), SYN. Patients’ ages
ranged from 40 to 95 years (mean 69.9G 11.3); the mean age was
69.8G 10.9 in the HYL group and 70.0G 13.3 for the SYN group.
No signiﬁcant differences were noted in other demographics
between populations (height 65.9 G 4.2 inches; weight 186.1 lb
G 37.3, BMI 30.1 G 6.3. HYL is presently approved for a 3 or 5
weekly injection regimen, but all patients received ﬁve injections. All
SYN patients received 3 weekly injections. Selection of treatment
was based upon patient and physician’s preference and was not
randomized. The primary efﬁcacy measure was the time to return
for repeat treatment, as a measure of duration of clinical efﬁcacy.
The duration of the ﬁrst course ranged from 119 to 1282 days, with
the mean duration in HYL 446.6 G 199.6 days and for SYN 370.3
G 162.2 days (P Z 0.018 in favour of HYL). All charts were also
examined for the relative safety proﬁle for each product. No serious
unexpected adverse event requiring hospitalization was reported
for either product. However, 16.3% of the SYN treated patients
reported a Severe Acute Inﬂammatory Reaction (SAIR) resembling
a septic joint, and requiring additional clinical intervention. No such
reactions were reported with HYL, which was statistically different
from the SYN (P! 0.0001). All SAIRs occurred after the second or
third injection of the ﬁrst course of SYN. One hypersensitivity
reaction to HYL (0.5% of patients) was reported and none to SYN
(P > 0.1). HA therapy was found to be safe and effective in a clinical
rheumatology practice with an average duration of effect exceeding
1 year. HA therapy would seem to be a cost effective management
tool compared to other common therapies for managing OA pain.
The results of this study also suggest that the relevant risks and
beneﬁts should be considered when discussing treatment options
with patients, especially for re-treatment.
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PHARMACOECONOMIC ANALYSIS OF OSTEOARTHRITIS
TREATMENT WITH CHONDROITIN SULFATE VS NSAIDS
J. Vergesy, E. Tomasy, I. Mollerz, C. Rubiox
y Pharmacoeconomy Unit, Scientific Medical Department, Bioiber-
ica Farma, Barcelona, Spain
z Instituto Poal de Reumatologia, Barcelona, Spain
x HERO Consulting, Health Economics and Research of Out-
comes, Madrid, Spain
Aims: To compare the efﬁciency of the following drug treatments:
chondroitin sulfate (CS) (Condrosan, Bioiberica Farma, Barce-
lona, Spain), sodium diclofenac (DS), ibuprofen (IB), celecoxib (CC)
or rofecoxib (RC) in Spanish patients with osteoarthritis.
Methods: Cost-minimization model that compared treatments
administered at the recommended doses and regimens during
a 6-month period. Resources utilization and unit costs were
S147estimated from Spanish sources. The effectiveness and incidence
of adverse events were estimated from meta-analyses based on
randomized clinical trials. Simple univariate sensitivity analyses
were conducted from the basic case.
Results: The 6-month estimated cost per patient treated with CS,
DS, IB, CC or RC was 85.88 Euro (V), 96.42 V, 88.27 V, 270.68 V
and 285.93 V, respectively. If an hypothetical cohort of 10,000
patients with osteoarthritis was treated with CS, the expected 6
months savings to the National Health System would range from
23,900 V to 2,000,500 V, in comparison to the alternative treat-
ments. In addition, many cases of gastrointestinal adverse events
considering both the total number of adverse events (1782 to 2730)
and the number of serious adverse events (17 to 90), as well as
possible myocardial infarction episodes (5 to 29), would be
avoided. Sensitivity analyses conﬁrmed the strength of the basic
case in most of the scenarios.
Conclusions: Chondroitin sulfate is an effective osteoarthritis treat-
ment with less costs and better gastrointestinal tolerance compared to
sodium diclofenac, ibuprofen, celecoxib or rofecoxib treatment.
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EVALUATION OF THE INDICATORS OF THE ARTHROSCOPIC
POSTERO-MEDIAL RELEASE OF VARUS KNEE OSTEOAR-
THRITIS BY USING X-RAY GRADING AND JAPAN KNEE
OSTEOARTHRITIS MEASURE
M. Tahara, T. Sasho, Y. Wada, M. Suzuki, H. Moriya
Orthopaedic Surgery, Chiba University Graduate School of
Medicine, Chiba, Japan
Aim of study: The purpose of this study is to investigate the
indicators of the arthroscopic postero-medial release of varus knee
osteoarthritis by using X-ray grading and Japan Knee Osteoarthritis
Measure, in Japanese population retrospectively.
Methods: Radiographic evaluation by Kellgren and Lawrence
grading and Ahlba¨ch grading was performed in 149 patients with
varus knee OA (187 knees) who had been operated by
arthroscopic postero-medial release (PMR) (n Z 27) or high tibial
osteotomy (HTO) (n Z 24) or total knee arthroplasty (TKA) (n Z
136) from Dec 1, 2000 to Dec 31, 2002. The Japan Orthopaedic
Association (JOA) score, visual analog scale (VAS) and Japan
Knee Osteoarthritis Measure (JKOM) were also incorporated into
the clinical evaluation. JKOM is new self-entry method for
evaluating functional disability caused by knee osteoarthritis in
Japanese. That is ﬁve-grade assessment and has 25 question-
naires that included knee pain, knee stiffness, ability of daily life,
daily activities and physical conditions.
Results: The percentage of female patients were 87.9% and 12.1%
were males. Mean age at operation was 71.0 years. A mean follow-
up interval is 19 months. In Ahlba¨ch grading 1–2 that is not
revealed any attrition of tibia plateau, there was no statistical
difference between PMR and the other methods about improving
and ﬁnal follow-up score of the JOA score and VAS. Factor analysis
including Akaike’s Information Criteria for JKOM showed ‘‘Pre-
operative difﬁculty of stepping’’ ‘‘Pre-operative standing pain’’ and
‘‘Pre-operative pain at squatting and standing up’’ were most
important questionnaires to select the operation, PMR or TKA.
Conclusion: In this study, we suggested that the pre-operative
existence of attrition of tibia plateau on X-ray and pre-operative
evaluation by JKOM were useful indicators for arthroscopic
postero-medial release operation.
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PATIENT-PERCEIVED EFFICACY OF NON-ANIMAL STABI-
LIZED HYALURONIC ACID IN THE TREATMENT OF OSTEO-
ARTHRITIS OF THE KNEE
C. A˚kermarky, T. Adalberthz, J. Ericsa¨terz, J. Isacssony
y Department of Orthopedics, Ortopediska Huset, Stockholm,
Sweden
z Department of Orthopedics, La¨karhuset Ellenbogen, Malmo¨,
SwedenAim of study: To assess the subjective efﬁcacy of treatment with
a single intra-articular injection of non-animal stabilized hyaluronic
acid (NASHA) in patients with knee osteoarthritis.
Methods: Open, prospective, 12-week study of patients with X-ray
diagnosed knee osteoarthritis, treated with a single intra-articular
injection of NASHA. A total of 149 patients (mean age 65.5, mean
Kellgren-Lawrence score 2.6) completed the study. Subjective
efﬁcacy was measured by self-assessed knee pain associated
with: activities of daily living; using the stairs; standing up after
sitting; and at night. For each parameter, the extent of pain was
recorded as: none (0), mild (1), moderate (2), severe (3) or very
severe (4). An overall pain score was derived from the sum of all
four values (scale from 0 to 16). Patient satisfaction and willingness
to undergo further treatment was also assessed.
Results: There were notable improvements in knee pain associated
with all four assessed parameters following treatment. The largest
response was observed with knee pain associated with standing up
after sitting, with 80 patients (53%) at week 8 and 81 patients (54%)
at week 12 reporting improvement. The mean overall pain score
decreased from 8.2 at baseline to 6.0 at week 8 (PZ 0.0001), and
the reduction was maintained to week 12 (mean score 6.1, P Z
0.0001 vs baseline). Satisfaction with treatment (fair/good/very
good) was reported by 70% of patients, and 64% conﬁrmed
willingness to undergo further treatment with NASHA.
Conclusions: A single intra-articular injection of NASHA provides
clear patient-perceived improvements in pain associated with
osteoarthritis for up to 12 weeks post-treatment.
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IMMEDIATE PAIN REDUCTION AND PLASMA MYOGLOBINE
INCREASE FOLLOWING MASSAGE TO KNEE OSTEOARTHRI-
TIS PATIENTS. NO EFFECT ON KNEE JOINT POSITION SENSE
H. Lund, M. Henriksen, H. Bliddal, B. Danneskiold-Samsøe
The Parker Institute, Frederiksberg Hospital, Frederiksberg, Den-
mark
The purpose of this study was to investigate the effect of
a stimulating massage applied to the quadriceps, sartorial, gracile
and hamstring muscles on acute muscle pain, plasma level of
myoglobin and the knee joint position sense (JPS) in patients
suffering from OA. In a cross-over design, 20 patients with knee
osteoarthritis (18 females) were randomly allocated to receive
massage and a week later act as control or vice versa. Participants
were having their JPS measured and blood test (plasma
myoglobine and CK) taken immediately before the 10 min massage
session. Immediately after, the JPS were measured again, and 1 h
later another blood test was drawn. A visual analogue scale
measuring both pain and inconvenience with the pain were
completed before and after the massage session. The subjects
received 10 min of vigorous stimulating massage of the quadriceps,
sartorial, gracile, semimembranous, semitendinous and femoral
biceps muscles. A physiotherapist specially trained to this study
applied the massage. JPS was measured as the participants’ ability
to reproduce the same position in one joint, and was repeated 3
times (target vs estimated angle). Results were expressed as the
mean difference between target and estimated angle (Absolute
Error, AE), and the standard deviation of the differences (Variable
Error, VE), where AE and VE was the mean respective standard
deviation of the two closest differences between target and
estimated angle.
A signiﬁcant reduction in pain (29.5 mm to 14.3 mm, PZ 0.41) and
inconvenience (30.4 mm to 7.6 mm, P Z 0.0003) was observed
following the massage session and a signiﬁcant increase in
myoglobine (mean difference: 7.8 IU, P Z 0.12). No signiﬁcant
alteration in CK or JPS was observed.
It can be concluded that massage has a beneﬁcial effect on muscle
pain in patients with knee OA, and that the effect of massage for
some part can be explained by a removal of Mb from the interstice.
Massage has no effect on knee joint position sense, but we cannot
preclude the possibility that massage may have an effect on other
aspects of proprioception such as threshold to detection of passive
movement. Further studies are needed in order to test that.
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INTRA-ARTICULAR SYNJECT IN THE MANAGEMENT OF
KNEE OA IN NIGERIA – AN INITIAL REPORT
T. O. Alonge, A. Akinpelu, S. O. Ogunlade, O. M. Akinosun
Surgery, College of Medicine, University of Ibadan, Ibadan, Oyo,
Nigeria
Physiotherapy, College of Medicine, University of Ibadan, Ibadan,
Oyo, Nigeria
Chemical Pathology, College of Medicine, University of Ibadan,
Ibadan, Oyo, Nigeria
Aim of study: This study was aimed at evaluating the efﬁcacy of
intra-articular ’Synject’, a brand of 1.0% hyaluronic acid in the
management of patients with osteoarthritis of the knee in Nigeria.
Almost all patients with knee OA in Nigeria present to the Western
trained Orthopaedic surgeon after the failure of other forms of
treatment, most of which are based on self medication, pain relief
was the measure of the efﬁcacy of this drug therapy.
Patients and method: Twenty consecutive patients with clinical and
radiological features of OA of the knee seen at the Orthopaedic
outpatient clinic at the University College Hospital, Ibadan, South
Western Nigeria were recruited into the study. The plain radio-
graphs of the knees were graded using the Spector and Cooper
atlas. The knee pain was scored using the visual analogue scale
(VAS) and under aspetic conditions, 2 ml of ’Synject’, 1.0%hyaluronic acid was injected into the affected knee joint (after
removal of excess synovial ﬂuid if indicated). The patients were
seen after 1 and 2 weeks for a repeat injection again after the knee
pain score had been recorded.
Result: There were 18 female and 2 male patients in this study. The
mean VAS prior to the injection was 7.5 and this reduced to 3 after
1 week and 4 after 2 weeks. Many of the patients declined further
injections after the second because they felt much better and saw
no reason for the injections. The severity of the knee OA as
assessed using the radiological atlas of Cooper and Spector had
over 90% of the patients in the severe OA group. Of the 10 patients
being followed up for 12 weeks the knee pain continued to decline
until it reached a plateau.
Conclusion: In Nigeria, control of drug purchase is almost non-
existent as patients could obtain most analgesics and non-steroidal
anti-inﬂammatory drugs from the counter without prescription. In
the wake of fake drugs which is very common in the country
coupled with the fact that in most cases, the patients take sub-
optimal doses, there is a need to seek to align with the current
concepts in the management of this chronic but dynamic disease.
This initial result with intra-articular injection of 1.0% hyaluronic acid
(’Synject’) (for knee OA) marketed in Nigeria by Fidson health care
is encouraging and may help alleviate the pains of patients with
knee OA who have to battle with poverty, fake drugs and disabling
pain from osteoarthritis of the knee. The patients in this pilot study
will be followed-up for much longer to ascertain the long-term
efﬁcacy of this viscosupplement.
